ID	Gene Name	Species	BBID	BIOCARTA	GOTERM_BP_DIRECT	GOTERM_CC_DIRECT	GOTERM_MF_DIRECT	INTERPRO	KEGG_PATHWAY	OMIM_DISEASE	PIR_SUPERFAMILY	SMART	UP_KW_BIOLOGICAL_PROCESS	UP_KW_CELLULAR_COMPONENT	UP_KW_DEVELOPMENTAL_STAGE	UP_KW_DISEASE	UP_KW_DOMAIN	UP_KW_LIGAND	UP_KW_MOLECULAR_FUNCTION	UP_KW_PTM	UP_SEQ_FEATURE
Q64591	2,4-dienoyl-CoA reductase 1(Decr1)	Rattus norvegicus			GO:0006635~fatty acid beta-oxidation,	GO:0005654~nucleoplasm,GO:0005739~mitochondrion,GO:0005829~cytosol,GO:1902494~catalytic complex,	GO:0008670~2,4-dienoyl-CoA reductase (NADPH) activity,GO:0016491~oxidoreductase activity,GO:0042802~identical protein binding,GO:0070402~NADPH binding,	IPR002347:SDR_fam,IPR036291:NAD(P)-bd_dom_sf,					KW-0276~Fatty acid metabolism,KW-0443~Lipid metabolism,	KW-0496~Mitochondrion,			KW-0809~Transit peptide,	KW-0521~NADP,	KW-0560~Oxidoreductase,	KW-0007~Acetylation,KW-0597~Phosphoprotein,	ACT_SITE:Proton acceptor,TRANSIT:Mitochondrion,
P51639	3-hydroxy-3-methylglutaryl-CoA reductase(Hmgcr)	Rattus norvegicus			GO:0006695~cholesterol biosynthetic process,GO:0006743~ubiquinone metabolic process,GO:0007584~response to nutrient,GO:0008284~positive regulation of cell proliferation,GO:0008299~isoprenoid biosynthetic process,GO:0008542~visual learning,GO:0010664~negative regulation of striated muscle cell apoptotic process,GO:0010666~positive regulation of cardiac muscle cell apoptotic process,GO:0015936~coenzyme A metabolic process,GO:0016126~sterol biosynthetic process,GO:0031667~response to nutrient levels,GO:0032874~positive regulation of stress-activated MAPK cascade,GO:0038183~bile acid signaling pathway,GO:0042177~negative regulation of protein catabolic process,GO:0042632~cholesterol homeostasis,GO:0043066~negative regulation of apoptotic process,GO:0045445~myoblast differentiation,GO:0045471~response to ethanol,GO:0045907~positive regulation of vasoconstriction,GO:0048643~positive regulation of skeletal muscle tissue development,GO:0048661~positive regulation of smooth muscle cell proliferation,GO:0050709~negative regulation of protein secretion,GO:0060291~long-term synaptic potentiation,GO:0061179~negative regulation of insulin secretion involved in cellular response to glucose stimulus,GO:0070328~triglyceride homeostasis,GO:0070372~regulation of ERK1 and ERK2 cascade,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0070723~response to cholesterol,GO:1900222~negative regulation of beta-amyloid clearance,	GO:0005778~peroxisomal membrane,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,	GO:0004420~hydroxymethylglutaryl-CoA reductase (NADPH) activity,GO:0030695~GTPase regulator activity,GO:0042802~identical protein binding,GO:0050661~NADP binding,GO:0051721~protein phosphatase 2A binding,GO:0070402~NADPH binding,	IPR000731:SSD,IPR002202:HMG_CoA_Rdtase,IPR004554:HMG_CoA_Rdtase_eu_arc,IPR004816:HMG_CoA_Rdtase_metazoan,IPR009023:HMG_CoA_Rdtase_NAD(P)-bd_sf,IPR009029:HMG_CoA_Rdtase_sub-bd_dom_sf,IPR023074:HMG_CoA_Rdtase_cat_sf,IPR023076:HMG_CoA_Rdtase_CS,IPR023282:HMG_CoA_Rdtase_N,	rno00900:Terpenoid backbone biosynthesis,rno01100:Metabolic pathways,rno04152:AMPK signaling pathway,rno04976:Bile secretion,				KW-0152~Cholesterol biosynthesis,KW-0153~Cholesterol metabolism,KW-0443~Lipid metabolism,KW-0444~Lipid biosynthesis,KW-0752~Steroid biosynthesis,KW-0753~Steroid metabolism,KW-0756~Sterol biosynthesis,KW-1207~Sterol metabolism,	KW-0256~Endoplasmic reticulum,KW-0472~Membrane,KW-0576~Peroxisome,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0521~NADP,	KW-0560~Oxidoreductase,	KW-0325~Glycoprotein,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	ACT_SITE:Charge relay system,ACT_SITE:Proton donor,CARBOHYD:N-linked (GlcNAc...) asparagine,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),DOMAIN:SSD,MOTIF:INSIG-binding motif,TOPO_DOM:Cytoplasmic,TOPO_DOM:Lumenal,TRANSMEM:Helical,
Q29551	3-oxoacid CoA-transferase 1(OXCT1)	Sus scrofa			GO:0042182~ketone catabolic process,GO:0046950~cellular ketone body metabolic process,GO:0046952~ketone body catabolic process,	GO:0005739~mitochondrion,GO:0016020~membrane,	GO:0008260~3-oxoacid CoA-transferase activity,GO:0008410~CoA-transferase activity,GO:0042803~protein homodimerization activity,	IPR004163:CoA_transf_BS,IPR004164:CoA_transf_AS,IPR004165:CoA_trans_fam_I,IPR012791:3-oxoacid_CoA-transf_B,IPR012792:3-oxoacid_CoA-transf_A,IPR014388:3-oxoacid_CoA-transferase,IPR037171:NagB/RpiA_transferase-like,	ssc00280:Valine, leucine and isoleucine degradation,ssc00650:Butanoate metabolism,ssc01100:Metabolic pathways,		PIRSF000858:SCOT-t,	SM00882:CoA_trans,	KW-0443~Lipid metabolism,	KW-0472~Membrane,KW-0496~Mitochondrion,			KW-0732~Signal,KW-0809~Transit peptide,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0808~Transferase,	KW-0597~Phosphoprotein,	ACT_SITE:5-glutamyl coenzyme A thioester intermediate,MUTAGEN:C->A: Decreases KM for acetoacetyl-CoA 3-fold. No effect on KM for acetoacetate, succinyl-CoA and succinate.,MUTAGEN:C->S: Decreases KM for acetoacetate and acetoacetyl-CoA 2-fold. Increases KM for succinate 2-fold. Decreases KM for succinyl-CoA nearly 4-fold. Strongly reduces catalytic activity.,MUTAGEN:C->S: Similar specific activity to wild-type.,TRANSIT:Mitochondrion,TRANSMEM:Helical,
Q969T7	5'-nucleotidase, cytosolic IIIB(NT5C3B)	Homo sapiens			GO:0009117~nucleotide metabolic process,GO:0043928~exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay,	GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0000166~nucleotide binding,GO:0000287~magnesium ion binding,GO:0005515~protein binding,GO:0008253~5'-nucleotidase activity,	IPR006434:Pyrimidine_nucleotidase_eu,IPR023214:HAD_sf,IPR036412:HAD-like_sf,	hsa00240:Pyrimidine metabolism,hsa01100:Metabolic pathways,hsa01232:Nucleotide metabolism,				KW-0546~Nucleotide metabolism,	KW-0963~Cytoplasm,				KW-0460~Magnesium,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,	KW-0378~Hydrolase,	KW-0007~Acetylation,	ACT_SITE:Nucleophile,ACT_SITE:Proton donor,REGION:Disordered,
Q9D110	5, 10-methenyltetrahydrofolate synthetase(Mthfs)	Mus musculus			GO:0006353~DNA-templated transcription, termination,GO:0006393~termination of mitochondrial transcription,GO:0006536~glutamate metabolic process,GO:0009396~folic acid-containing compound biosynthetic process,GO:0032392~DNA geometric change,GO:0035999~tetrahydrofolate interconversion,GO:0046653~tetrahydrofolate metabolic process,GO:0046657~folic acid catabolic process,	GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,GO:0005829~cytosol,GO:0016020~membrane,GO:0042645~mitochondrial nucleoid,	GO:0000166~nucleotide binding,GO:0003690~double-stranded DNA binding,GO:0005524~ATP binding,GO:0005542~folic acid binding,GO:0016874~ligase activity,GO:0030272~5-formyltetrahydrofolate cyclo-ligase activity,GO:0046872~metal ion binding,	IPR002698:FTHF_cligase,IPR024185:FTHF_cligase-like_sf,IPR037171:NagB/RpiA_transferase-like,	mmu00670:One carbon pool by folate,mmu01100:Metabolic pathways,		PIRSF006806:FTHF_cligase,			KW-0472~Membrane,KW-0963~Cytoplasm,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0067~ATP-binding,KW-0290~Folate-binding,KW-0460~Magnesium,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,	KW-0436~Ligase,	KW-0007~Acetylation,	TRANSMEM:Helical,
Q9D110	5, 10-methenyltetrahydrofolate synthetase-like(Mthfsl)	Mus musculus			GO:0006353~DNA-templated transcription, termination,GO:0006393~termination of mitochondrial transcription,GO:0006536~glutamate metabolic process,GO:0009396~folic acid-containing compound biosynthetic process,GO:0032392~DNA geometric change,GO:0035999~tetrahydrofolate interconversion,GO:0046653~tetrahydrofolate metabolic process,GO:0046657~folic acid catabolic process,	GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,GO:0005829~cytosol,GO:0016020~membrane,GO:0042645~mitochondrial nucleoid,	GO:0003690~double-stranded DNA binding,GO:0005524~ATP binding,GO:0005542~folic acid binding,GO:0030272~5-formyltetrahydrofolate cyclo-ligase activity,GO:0046872~metal ion binding,	IPR002698:FTHF_cligase,IPR024185:FTHF_cligase-like_sf,IPR037171:NagB/RpiA_transferase-like,	mmu00670:One carbon pool by folate,mmu01100:Metabolic pathways,		PIRSF006806:FTHF_cligase,			KW-0472~Membrane,KW-0963~Cytoplasm,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0067~ATP-binding,KW-0290~Folate-binding,KW-0460~Magnesium,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,	KW-0436~Ligase,	KW-0007~Acetylation,	TRANSMEM:Helical,
Q6IND6	5-hydroxymethylcytosine binding, ES cell specific L homeolog(hmces.L)	Xenopus laevis			GO:0006508~proteolysis,GO:0006974~cellular response to DNA damage stimulus,GO:0018142~protein-DNA covalent cross-linking,GO:0036297~interstrand cross-link repair,GO:0045830~positive regulation of isotype switching,	GO:0005657~replication fork,GO:0005694~chromosome,	GO:0003677~DNA binding,GO:0003697~single-stranded DNA binding,GO:0008233~peptidase activity,GO:0016787~hydrolase activity,	IPR003738:SRAP,IPR036590:SRAP-like,					KW-0227~DNA damage,	KW-0158~Chromosome,					KW-0238~DNA-binding,KW-0378~Hydrolase,KW-0645~Protease,	KW-0068~Autocatalytic cleavage,KW-0190~Covalent protein-DNA linkage,	ACT_SITE:Nucleophile,COMPBIAS:Basic and acidic residues,REGION:Disordered,SITE:Required for sensing abasic sites,SITE:Required to stabilize abasic sites,
O70212	5-hydroxytryptamine receptor 3A(Htr3a)	Cavia porcellus			GO:0006812~cation transport,GO:0007165~signal transduction,GO:0007268~chemical synaptic transmission,GO:0034220~ion transmembrane transport,GO:0042391~regulation of membrane potential,GO:0050877~neurological system process,GO:0098662~inorganic cation transmembrane transport,	GO:0005886~plasma membrane,GO:0030672~synaptic vesicle membrane,GO:0032154~cleavage furrow,GO:0043005~neuron projection,GO:0045202~synapse,GO:0045211~postsynaptic membrane,GO:1904602~serotonin-activated cation-selective channel complex,	GO:0004890~GABA-A receptor activity,GO:0005230~extracellular ligand-gated ion channel activity,GO:0022848~acetylcholine-gated cation-selective channel activity,GO:0022850~serotonin-gated cation-selective channel activity,GO:0042802~identical protein binding,GO:0051378~serotonin binding,GO:0099507~ligand-gated ion channel activity involved in regulation of presynaptic membrane potential,	IPR006029:Neurotrans-gated_channel_TM,IPR006201:Neur_channel,IPR006202:Neur_chan_lig-bd,IPR008132:5HT3_rcpt,IPR008133:5HT3_rcpt_A,IPR018000:Neurotransmitter_ion_chnl_CS,IPR036719:Neuro-gated_channel_TM_sf,IPR036734:Neur_chan_lig-bd_sf,IPR038050:Neuro_actylchol_rec,	cpoc04726:Serotonergic synapse,cpoc04742:Taste transduction,				KW-0406~Ion transport,KW-0813~Transport,	KW-0472~Membrane,KW-0628~Postsynaptic cell membrane,KW-0770~Synapse,KW-1003~Cell membrane,			KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0407~Ion channel,KW-0675~Receptor,KW-1071~Ligand-gated ion channel,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Neurotransmitter-gated ion-channel ligand-binding,DOMAIN:Neurotransmitter-gated ion-channel transmembrane,REGION:Disordered,REGION:HA-stretch; determines single-channel conductance in 5-HT3 receptors,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,TRANSMEM:Helical; Name=1,TRANSMEM:Helical; Name=2,TRANSMEM:Helical; Name=3,TRANSMEM:Helical; Name=4,
P25114	6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4(Pfkfb4)	Rattus norvegicus			GO:0006000~fructose metabolic process,GO:0006003~fructose 2,6-bisphosphate metabolic process,GO:0046835~carbohydrate phosphorylation,	GO:0005829~cytosol,	GO:0003873~6-phosphofructo-2-kinase activity,GO:0004331~fructose-2,6-bisphosphate 2-phosphatase activity,GO:0005524~ATP binding,GO:0016787~hydrolase activity,	IPR001345:PG/BPGM_mutase_AS,IPR003094:6Pfruct_kin,IPR013078:His_Pase_superF_clade-1,IPR013079:6Phosfructo_kin,IPR027417:P-loop_NTPase,IPR029033:His_PPase_superfam,	rno00051:Fructose and mannose metabolism,rno01100:Metabolic pathways,rno04152:AMPK signaling pathway,		PIRSF000709:6PFK_2-Ptase,	SM00855:PGAM,						KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0378~Hydrolase,KW-0418~Kinase,KW-0511~Multifunctional enzyme,KW-0808~Transferase,	KW-0597~Phosphoprotein,	ACT_SITE:Proton donor/acceptor,ACT_SITE:Tele-phosphohistidine intermediate,DOMAIN:6-phosphofructo-2-kinase,REGION:6-phosphofructo-2-kinase,REGION:Fructose-2,6-bisphosphatase,SITE:Transition state stabilizer,
Q9R001	ADAM metallopeptidase with thrombospondin type 1 motif 5(Adamts5)	Mus musculus			GO:0003180~aortic valve morphogenesis,GO:0003184~pulmonary valve morphogenesis,GO:0003203~endocardial cushion morphogenesis,GO:0006508~proteolysis,GO:0007520~myoblast fusion,GO:0022617~extracellular matrix disassembly,GO:0030198~extracellular matrix organization,GO:0042742~defense response to bacterium,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0031012~extracellular matrix,	GO:0004175~endopeptidase activity,GO:0004222~metalloendopeptidase activity,GO:0008201~heparin binding,GO:0008233~peptidase activity,GO:0008237~metallopeptidase activity,GO:0008270~zinc ion binding,GO:0016787~hydrolase activity,GO:0042802~identical protein binding,GO:0046872~metal ion binding,GO:0050840~extracellular matrix binding,	IPR000884:TSP1_rpt,IPR001590:Peptidase_M12B,IPR006586:ADAM_Cys-rich,IPR010294:ADAMTS_spacer1,IPR013273:ADAMTS/ADAMTS-like,IPR013276:Pept_M12B_ADAM-TS5,IPR024079:MetalloPept_cat_dom_sf,IPR036383:TSP1_rpt_sf,IPR041645:ADAMTS_CR_2,IPR045371:ADAMTS_CR_3,				SM00209:TSP1,SM00608:ACR,		KW-0272~Extracellular matrix,KW-0964~Secreted,			KW-0677~Repeat,KW-0732~Signal,	KW-0106~Calcium,KW-0479~Metal-binding,KW-0862~Zinc,	KW-0378~Hydrolase,KW-0482~Metalloprotease,KW-0645~Protease,	KW-0165~Cleavage on pair of basic residues,KW-0325~Glycoprotein,KW-0865~Zymogen,KW-1015~Disulfide bond,	BINDING:in inhibited form,CARBOHYD:C-linked (Man) tryptophan,CARBOHYD:N-linked (GlcNAc...) asparagine,CARBOHYD:O-linked (Fuc...) serine,DOMAIN:Disintegrin,DOMAIN:Peptidase M12B,DOMAIN:TSP type-1 1,DOMAIN:TSP type-1 2,MOTIF:Cysteine switch,REGION:Disordered,REGION:Spacer,
Q8BLI0	ADAMTS-like 1(Adamtsl1)	Mus musculus			GO:0030198~extracellular matrix organization,	GO:0005576~extracellular region,GO:0031012~extracellular matrix,		IPR000884:TSP1_rpt,IPR003598:Ig_sub2,IPR003599:Ig_sub,IPR007110:Ig-like_dom,IPR010294:ADAMTS_spacer1,IPR010909:PLAC,IPR013098:Ig_I-set,IPR013273:ADAMTS/ADAMTS-like,IPR013783:Ig-like_fold,IPR036179:Ig-like_dom_sf,IPR036383:TSP1_rpt_sf,IPR045371:ADAMTS_CR_3,				SM00209:TSP1,SM00408:IGc2,SM00409:IG,		KW-0272~Extracellular matrix,KW-0964~Secreted,			KW-0393~Immunoglobulin domain,KW-0677~Repeat,KW-0732~Signal,			KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,CARBOHYD:O-linked (Fuc...) serine,CARBOHYD:O-linked (Fuc...) threonine,DOMAIN:ADAMTS/ADAMTS-like Spacer 1,DOMAIN:ADAMTS/ADAMTS-like cysteine-rich,DOMAIN:Ig-like,DOMAIN:Ig-like C2-type 1,DOMAIN:Ig-like C2-type 2,DOMAIN:Ig-like C2-type 3,DOMAIN:Ig-like C2-type 4,DOMAIN:PLAC,DOMAIN:TSP type-1 1,DOMAIN:TSP type-1 2,DOMAIN:TSP type-1 3,DOMAIN:TSP type-1 4,DOMAIN:TSP type-1 5,DOMAIN:TSP type-1 6,DOMAIN:TSP type-1 7,DOMAIN:TSP type-1 8,DOMAIN:TSP type-1 9,REGION:Disordered,
Q3MHM8	ADP ribosylation factor like GTPase 6 interacting protein 6(ARL6IP6)	Bos taurus				GO:0005637~nuclear inner membrane,		IPR029383:ARL6IP6,						KW-0472~Membrane,KW-0539~Nucleus,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0597~Phosphoprotein,	REGION:Disordered,TRANSMEM:Helical,
Q7SYL1	ADP-ribosylation factor-like 2 binding protein(arl2bp)	Danio rerio			GO:0042531~positive regulation of tyrosine phosphorylation of STAT protein,GO:0051457~maintenance of protein location in nucleus,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005758~mitochondrial intermembrane space,GO:0005813~centrosome,GO:0005819~spindle,GO:0005856~cytoskeleton,GO:0005929~cilium,GO:0042995~cell projection,		IPR023379:BART_dom,IPR038849:ARL2BP,IPR042541:BART_sf,						KW-0206~Cytoskeleton,KW-0496~Mitochondrion,KW-0539~Nucleus,KW-0963~Cytoplasm,KW-0966~Cell projection,KW-0969~Cilium,							DOMAIN:BART,
Q920A7	AFG3-like AAA ATPase 1(Afg3l1)	Mus musculus			GO:0006508~proteolysis,GO:0007005~mitochondrion organization,GO:0008053~mitochondrial fusion,GO:0016485~protein processing,GO:0034982~mitochondrial protein processing,GO:0042407~cristae formation,	GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0005745~m-AAA complex,GO:0016020~membrane,	GO:0000166~nucleotide binding,GO:0004176~ATP-dependent peptidase activity,GO:0004222~metalloendopeptidase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008233~peptidase activity,GO:0008237~metallopeptidase activity,GO:0008270~zinc ion binding,GO:0016787~hydrolase activity,GO:0016887~ATPase activity,GO:0046872~metal ion binding,	IPR000642:Peptidase_M41,IPR003593:AAA+_ATPase,IPR003959:ATPase_AAA_core,IPR003960:ATPase_AAA_CS,IPR005936:FtsH,IPR011546:Pept_M41_FtsH_extracell,IPR027417:P-loop_NTPase,IPR037219:Peptidase_M41-like,IPR041569:AAA_lid_3,	mmu05017:Spinocerebellar ataxia,			SM00382:AAA,		KW-0472~Membrane,KW-0496~Mitochondrion,KW-0999~Mitochondrion inner membrane,			KW-0809~Transit peptide,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0067~ATP-binding,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,KW-0862~Zinc,	KW-0378~Hydrolase,KW-0482~Metalloprotease,KW-0645~Protease,		COMPBIAS:Basic and acidic residues,MUTAGEN:E->Q: Absence of proteolytic activity. Loss of its processing into the mature form.,REGION:Disordered,TRANSIT:Mitochondrion,TRANSMEM:Helical,
Q9H553	ALG2 alpha-1,3/1,6-mannosyltransferase(ALG2)	Homo sapiens			GO:0006486~protein glycosylation,GO:0006488~dolichol-linked oligosaccharide biosynthetic process,GO:0006490~oligosaccharide-lipid intermediate biosynthetic process,GO:0051592~response to calcium ion,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005789~endoplasmic reticulum membrane,GO:0016020~membrane,GO:0048471~perinuclear region of cytoplasm,	GO:0000033~alpha-1,3-mannosyltransferase activity,GO:0004378~GDP-Man:Man1GlcNAc2-PP-Dol alpha-1,3-mannosyltransferase activity,GO:0005515~protein binding,GO:0046982~protein heterodimerization activity,GO:0048306~calcium-dependent protein binding,GO:0102704~GDP-Man:Man2GlcNAc2-PP-dolichol alpha-1,6-mannosyltransferase activity,	IPR001296:Glyco_trans_1,IPR027054:ALG2,IPR028098:Glyco_trans_4-like_N,	hsa00510:N-Glycan biosynthesis,hsa00513:Various types of N-glycan biosynthesis,hsa01100:Metabolic pathways,	607906~Congenital disorder of glycosylation, type Ii,616228~Myasthenic syndrome, congenital, 14, with tubular aggregates,				KW-0472~Membrane,		KW-0225~Disease variant,KW-0900~Congenital disorder of glycosylation,KW-1004~Congenital myasthenic syndrome,	KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0328~Glycosyltransferase,KW-0808~Transferase,		TRANSMEM:Helical,
Q5F364	ATP binding cassette subfamily C member 1(ABCC1)	Gallus gallus			GO:0006869~lipid transport,GO:0034775~glutathione transmembrane transport,GO:0042908~xenobiotic transport,GO:0070729~cyclic nucleotide transport,	GO:0005886~plasma membrane,GO:0016323~basolateral plasma membrane,	GO:0005524~ATP binding,GO:0008559~xenobiotic-transporting ATPase activity,GO:0016887~ATPase activity,GO:0034634~glutathione transmembrane transporter activity,	IPR003439:ABC_transporter-like_ATP-bd,IPR003593:AAA+_ATPase,IPR005292:MRP,IPR011527:ABC1_TM_dom,IPR017871:ABC_transporter-like_CS,IPR027417:P-loop_NTPase,IPR036640:ABC1_TM_sf,	gga02010:ABC transporters,			SM00382:AAA,	KW-0445~Lipid transport,KW-0813~Transport,	KW-0472~Membrane,KW-1003~Cell membrane,			KW-0677~Repeat,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0378~Hydrolase,KW-1278~Translocase,		DOMAIN:ABC transmembrane type-1,DOMAIN:ABC transmembrane type-1 1,DOMAIN:ABC transmembrane type-1 2,DOMAIN:ABC transporter,DOMAIN:ABC transporter 1,DOMAIN:ABC transporter 2,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,TRANSMEM:Helical; Name=1,TRANSMEM:Helical; Name=10,TRANSMEM:Helical; Name=11,TRANSMEM:Helical; Name=12,TRANSMEM:Helical; Name=13,TRANSMEM:Helical; Name=14,TRANSMEM:Helical; Name=15,TRANSMEM:Helical; Name=16,TRANSMEM:Helical; Name=17,TRANSMEM:Helical; Name=2,TRANSMEM:Helical; Name=3,TRANSMEM:Helical; Name=4,TRANSMEM:Helical; Name=5,TRANSMEM:Helical; Name=6,TRANSMEM:Helical; Name=7,TRANSMEM:Helical; Name=8,TRANSMEM:Helical; Name=9,
Q8N5M1	ATP synthase mitochondrial F1 complex assembly factor 2(ATPAF2)	Homo sapiens			GO:0033615~mitochondrial proton-transporting ATP synthase complex assembly,GO:0043461~proton-transporting ATP synthase complex assembly,	GO:0005739~mitochondrion,GO:0005829~cytosol,GO:0016607~nuclear speck,	GO:0005515~protein binding,	IPR011419:ATP12_ATP_synth-F1-assembly,IPR023335:ATP12_ortho_dom_sf,IPR042272:ATP12_ATP_synth-F1-assembly_N,		604273~Mitochondrial complex V (ATP synthase) deficiency, nuclear type 1,				KW-0496~Mitochondrion,		KW-0225~Disease variant,KW-1274~Primary mitochondrial disease,	KW-0809~Transit peptide,		KW-0143~Chaperone,		REGION:Disordered,TRANSIT:Mitochondrion,
Q4R761	ATPase H+ transporting V1 subunit E1(ATP6V1E1)	Macaca fascicularis			GO:0097401~synaptic vesicle lumen acidification,GO:1902600~hydrogen ion transmembrane transport,	GO:0000221~vacuolar proton-transporting V-type ATPase, V1 domain,GO:0005768~endosome,GO:0005829~cytosol,GO:0005902~microvillus,GO:0016324~apical plasma membrane,GO:0030665~clathrin-coated vesicle membrane,GO:0030672~synaptic vesicle membrane,GO:0033178~proton-transporting two-sector ATPase complex, catalytic domain,GO:0098793~presynapse,	GO:0046961~proton-transporting ATPase activity, rotational mechanism,	IPR002842:ATPase_V1_Esu,IPR038495:ATPase_E_C,	mcf00190:Oxidative phosphorylation,mcf01100:Metabolic pathways,mcf04145:Phagosome,mcf04150:mTOR signaling pathway,mcf04721:Synaptic vesicle cycle,mcf04966:Collecting duct acid secretion,mcf05165:Human papillomavirus infection,mcf05323:Rheumatoid arthritis,				KW-0375~Hydrogen ion transport,KW-0406~Ion transport,KW-0813~Transport,	KW-0472~Membrane,KW-0770~Synapse,KW-0968~Cytoplasmic vesicle,KW-1003~Cell membrane,						KW-0007~Acetylation,KW-0597~Phosphoprotein,
Q96QE3	ATPase family AAA domain containing 5(ATAD5)	Homo sapiens			GO:0008283~cell proliferation,GO:0030890~positive regulation of B cell proliferation,GO:0033260~nuclear DNA replication,GO:0042770~signal transduction in response to DNA damage,GO:0042771~intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,GO:0045190~isotype switching,GO:0045740~positive regulation of DNA replication,GO:0048304~positive regulation of isotype switching to IgG isotypes,GO:0090305~nucleic acid phosphodiester bond hydrolysis,GO:0090618~DNA clamp unloading,GO:1901990~regulation of mitotic cell cycle phase transition,GO:1902166~negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,GO:1902751~positive regulation of cell cycle G2/M phase transition,	GO:0005634~nucleus,GO:0031391~Elg1 RFC-like complex,	GO:0003677~DNA binding,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016887~ATPase activity,	IPR003593:AAA+_ATPase,IPR003959:ATPase_AAA_core,IPR027417:P-loop_NTPase,				SM00382:AAA,	KW-0227~DNA damage,	KW-0539~Nucleus,				KW-0067~ATP-binding,KW-0547~Nucleotide-binding,		KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,COMPBIAS:Pro residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),DOMAIN:ATPase AAA-type core,MOTIF:LXCXE motif,MUTAGEN:C->G: Abolishes RB1 binding. Abolishes RB1 binding; when associated with K-1432. Weakly detected after methyl methane-sulfonate (MMS) treatment. Expression detected after MMS treatment; when associated with K-1432. Weakly affects the RAD9A interaction after MMS exposure. No effect on the RAD9A interaction after MMS exposure; when associated with K-1432. Resists to DNA damage after MMS exposure; when associated with K-1432.,MUTAGEN:E->K: Abolishes RB1 binding; when associated with G-1430. Expression detected after methyl methane-sulfonate (MMS) treatment; when associated with G-1430. No effect on the RAD9A interaction after MMS exposure; when associated with G-1430. Resists to DNA damage after MMS exposure; when associated with G-1430.,MUTAGEN:K->E: Results in defective PCNA removal from chromatin and recruitment of RAD51 at site of stalled replication forks under replication stress. Loss of processing of stalled replication forks. Retains interaction with PCNA and RFC4.,MUTAGEN:Missing: Abolishes interaction with WDR48 and recruitment of RAD51 at site of stalled replication forks under replication stress. Reduces down-regulation of PCNA monoubiquitination but retains the ability to unload PCNA from chromatin.,MUTAGEN:Missing: Loss of interaction with RAD51 and loading of RAD51 to stalled replication forks during replication stress. Loss of processing of stalled replication forks. Retains PCNA-unloading ability.,MUTAGEN:S->A: No effect on the RAD9A interaction after MMS exposure. Resists to DNA damage after MMS exposure.,MUTAGEN:S->A: Weakly affects the RAD9A interaction after MMS exposure.,REGION:Disordered,REGION:Interaction with RAD51 and RFC5,REGION:Interaction with WDR48,
Q03669	ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2(ATP2A2)	Gallus gallus			GO:0000045~autophagosome assembly,GO:0002026~regulation of the force of heart contraction,GO:0006816~calcium ion transport,GO:0006874~cellular calcium ion homeostasis,GO:0006984~ER-nucleus signaling pathway,GO:0009410~response to xenobiotic stimulus,GO:0010666~positive regulation of cardiac muscle cell apoptotic process,GO:0014883~transition between fast and slow fiber,GO:0014898~cardiac muscle hypertrophy in response to stress,GO:0016240~autophagosome docking,GO:0032470~positive regulation of endoplasmic reticulum calcium ion concentration,GO:0033292~T-tubule organization,GO:0034599~cellular response to oxidative stress,GO:0045822~negative regulation of heart contraction,GO:0070050~neuron cellular homeostasis,GO:0070588~calcium ion transmembrane transport,GO:1903233~regulation of calcium ion-dependent exocytosis of neurotransmitter,GO:1903515~calcium ion transport from cytosol to endoplasmic reticulum,GO:1990036~calcium ion import into sarcoplasmic reticulum,GO:1990456~mitochondrion-ER tethering,	GO:0016020~membrane,GO:0033017~sarcoplasmic reticulum membrane,GO:0097470~ribbon synapse,	GO:0005388~calcium-transporting ATPase activity,GO:0005509~calcium ion binding,GO:0005524~ATP binding,GO:0016887~ATPase activity,GO:0019899~enzyme binding,GO:0044325~ion channel binding,GO:0044548~S100 protein binding,GO:0046872~metal ion binding,GO:0086039~calcium-transporting ATPase activity involved in regulation of cardiac muscle cell membrane potential,	IPR001757:P_typ_ATPase,IPR004014:ATPase_P-typ_cation-transptr_N,IPR005782:P-type_ATPase_IIA,IPR006068:ATPase_P-typ_cation-transptr_C,IPR008250:ATPase_P-typ_transduc_dom_A_sf,IPR018303:ATPase_P-typ_P_site,IPR023214:HAD_sf,IPR023298:ATPase_P-typ_TM_dom_sf,IPR023299:ATPase_P-typ_cyto_dom_N,IPR036412:HAD-like_sf,IPR044492:P_typ_ATPase_HD_dom,	gga04020:Calcium signaling pathway,gga04148:Efferocytosis,gga04260:Cardiac muscle contraction,gga04261:Adrenergic signaling in cardiomyocytes,			SM00831:Cation_ATPase_N,	KW-0109~Calcium transport,KW-0406~Ion transport,KW-0813~Transport,	KW-0256~Endoplasmic reticulum,KW-0472~Membrane,KW-0703~Sarcoplasmic reticulum,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0067~ATP-binding,KW-0106~Calcium,KW-0460~Magnesium,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,	KW-1278~Translocase,	KW-0597~Phosphoprotein,KW-1015~Disulfide bond,	ACT_SITE:4-aspartylphosphate intermediate,DOMAIN:Cation-transporting P-type ATPase N-terminal,REGION:Interaction with PLN,TOPO_DOM:Cytoplasmic,TOPO_DOM:Lumenal,TRANSMEM:Helical,TRANSMEM:Helical; Name=1,TRANSMEM:Helical; Name=10,TRANSMEM:Helical; Name=2,TRANSMEM:Helical; Name=3,TRANSMEM:Helical; Name=4,TRANSMEM:Helical; Name=5,TRANSMEM:Helical; Name=6,TRANSMEM:Helical; Name=7,TRANSMEM:Helical; Name=8,TRANSMEM:Helical; Name=9,
Q9Z0H7	B cell leukemia/lymphoma 10(Bcl10)	Mus musculus			GO:0001783~B cell apoptotic process,GO:0001819~positive regulation of cytokine production,GO:0001843~neural tube closure,GO:0002224~toll-like receptor signaling pathway,GO:0002250~adaptive immune response,GO:0002376~immune system process,GO:0002906~negative regulation of mature B cell apoptotic process,GO:0006915~apoptotic process,GO:0006919~activation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0006968~cellular defense response,GO:0007249~I-kappaB kinase/NF-kappaB signaling,GO:0009620~response to fungus,GO:0012501~programmed cell death,GO:0016064~immunoglobulin mediated immune response,GO:0031398~positive regulation of protein ubiquitination,GO:0031663~lipopolysaccharide-mediated signaling pathway,GO:0032094~response to food,GO:0032757~positive regulation of interleukin-8 production,GO:0038061~NIK/NF-kappaB signaling,GO:0042327~positive regulation of phosphorylation,GO:0042981~regulation of apoptotic process,GO:0043065~positive regulation of apoptotic process,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling,GO:0043280~positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0045087~innate immune response,GO:0045576~mast cell activation,GO:0045893~positive regulation of transcription, DNA-templated,GO:0050852~T cell receptor signaling pathway,GO:0050856~regulation of T cell receptor signaling pathway,GO:0050862~positive regulation of T cell receptor signaling pathway,GO:0050870~positive regulation of T cell activation,GO:0051092~positive regulation of NF-kappaB transcription factor activity,GO:0051260~protein homooligomerization,GO:0061760~antifungal innate immune response,GO:0070231~T cell apoptotic process,GO:0071222~cellular response to lipopolysaccharide,GO:0071260~cellular response to mechanical stimulus,GO:1900119~positive regulation of execution phase of apoptosis,GO:2001238~positive regulation of extrinsic apoptotic signaling pathway,	GO:0001772~immunological synapse,GO:0002096~polkadots,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005764~lysosome,GO:0005829~cytosol,GO:0005881~cytoplasmic microtubule,GO:0016020~membrane,GO:0032449~CBM complex,GO:0032991~macromolecular complex,GO:0045121~membrane raft,GO:0048471~perinuclear region of cytoplasm,	GO:0002020~protease binding,GO:0003713~transcription coactivator activity,GO:0005515~protein binding,GO:0008656~cysteine-type endopeptidase activator activity involved in apoptotic process,GO:0019209~kinase activator activity,GO:0031625~ubiquitin protein ligase binding,GO:0035591~signaling adaptor activity,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,GO:0043422~protein kinase B binding,GO:0043621~protein self-association,GO:0044877~macromolecular complex binding,GO:0046982~protein heterodimerization activity,GO:0050700~CARD domain binding,GO:0051059~NF-kappaB binding,	IPR001315:CARD,IPR011029:DEATH-like_dom_sf,IPR033238:BCL10/E10,IPR042143:CARD_BCL10,	mmu04064:NF-kappa B signaling pathway,mmu04625:C-type lectin receptor signaling pathway,mmu04660:T cell receptor signaling pathway,mmu04662:B cell receptor signaling pathway,mmu05152:Tuberculosis,				KW-0053~Apoptosis,KW-0391~Immunity,KW-0399~Innate immunity,KW-1064~Adaptive immunity,	KW-0472~Membrane,KW-0963~Cytoplasm,		KW-0043~Tumor suppressor,				KW-0007~Acetylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),DOMAIN:CARD,MUTAGEN:E->A: Decreased interaction with CARD11.,REGION:Disordered,SITE:Cleavage; by MALT1,
Q503B7	B9 protein domain 1(b9d1)	Danio rerio			GO:0007224~smoothened signaling pathway,GO:0030030~cell projection organization,GO:0060271~cilium assembly,	GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005856~cytoskeleton,GO:0035869~ciliary transition zone,GO:0036038~MKS complex,GO:0036064~ciliary basal body,GO:0042995~cell projection,	GO:0008158~hedgehog receptor activity,	IPR010796:C2_B9-type_dom,					KW-0970~Cilium biogenesis/degradation,	KW-0206~Cytoskeleton,KW-0963~Cytoplasm,KW-0966~Cell projection,							DOMAIN:C2 B9-type,
Q6P026	BAF nuclear assembly factor 1(banf1)	Danio rerio			GO:0006325~chromatin organization,GO:0006979~response to oxidative stress,GO:0007084~mitotic nuclear envelope reassembly,GO:0010836~negative regulation of protein ADP-ribosylation,GO:0032480~negative regulation of type I interferon production,GO:0051276~chromosome organization,	GO:0000785~chromatin,GO:0000793~condensed chromosome,GO:0005634~nucleus,GO:0005635~nuclear envelope,GO:0005694~chromosome,GO:0005737~cytoplasm,	GO:0003677~DNA binding,	IPR004122:BAF_prot,IPR036617:BAF_sf,				SM01023:BAF,		KW-0158~Chromosome,KW-0539~Nucleus,KW-0963~Cytoplasm,					KW-0238~DNA-binding,	KW-0597~Phosphoprotein,
Q3KR97	BAR/IMD domain containing adaptor protein 2 like 1(Baiap2l1)	Rattus norvegicus			GO:0007009~plasma membrane organization,GO:0030838~positive regulation of actin filament polymerization,GO:0032956~regulation of actin cytoskeleton organization,GO:0051017~actin filament bundle assembly,GO:0051764~actin crosslink formation,	GO:0005654~nucleoplasm,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0015629~actin cytoskeleton,	GO:0003779~actin binding,GO:0070064~proline-rich region binding,	IPR001452:SH3_domain,IPR013606:I-BAR_dom,IPR027267:AH/BAR_dom_sf,IPR027681:IRSp53/IRTKS/Pinkbar,IPR030060:Baiap2l1_I-BAR_dom,IPR035592:IRTKS_SH3,IPR036028:SH3-like_dom_sf,				SM00326:SH3,		KW-0206~Cytoskeleton,KW-0963~Cytoplasm,			KW-0175~Coiled coil,KW-0728~SH3 domain,		KW-0009~Actin-binding,	KW-0597~Phosphoprotein,	COMPBIAS:Polar residues,DOMAIN:IMD,DOMAIN:SH3,REGION:Binds F-actin,REGION:Disordered,
Q5EAD0	BAR/IMD domain containing adaptor protein 2(BAIAP2)	Bos taurus			GO:0007009~plasma membrane organization,GO:0008360~regulation of cell shape,GO:0016358~dendrite development,GO:0030838~positive regulation of actin filament polymerization,GO:0032956~regulation of actin cytoskeleton organization,GO:0048167~regulation of synaptic plasticity,GO:0051017~actin filament bundle assembly,GO:0051764~actin crosslink formation,	GO:0001726~ruffle,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0015629~actin cytoskeleton,GO:0016020~membrane,GO:0030175~filopodium,GO:0043005~neuron projection,GO:0098685~Schaffer collateral - CA1 synapse,	GO:0005515~protein binding,GO:0008093~cytoskeletal adaptor activity,GO:0042802~identical protein binding,GO:0070064~proline-rich region binding,	IPR001452:SH3_domain,IPR013606:I-BAR_dom,IPR027267:AH/BAR_dom_sf,IPR027681:IRSp53/IRTKS/Pinkbar,IPR030128:IRSp53_I-BAR_dom,IPR035594:Irsp53_SH3,IPR036028:SH3-like_dom_sf,	bta04520:Adherens junction,bta04810:Regulation of actin cytoskeleton,bta05135:Yersinia infection,			SM00326:SH3,		KW-0206~Cytoskeleton,KW-0472~Membrane,KW-0963~Cytoplasm,KW-0966~Cell projection,			KW-0175~Coiled coil,KW-0728~SH3 domain,			KW-0597~Phosphoprotein,	COMPBIAS:Polar residues,DOMAIN:IMD,DOMAIN:SH3,REGION:Disordered,
A3KPW9	BCL2 associated athanogene 6, like(bag6l)	Danio rerio			GO:0001822~kidney development,GO:0006325~chromatin organization,GO:0006511~ubiquitin-dependent protein catabolic process,GO:0006915~apoptotic process,GO:0007130~synaptonemal complex assembly,GO:0007283~spermatogenesis,GO:0007420~brain development,GO:0010498~proteasomal protein catabolic process,GO:0018393~internal peptidyl-lysine acetylation,GO:0030324~lung development,GO:0030433~ubiquitin-dependent ERAD pathway,GO:0032435~negative regulation of proteasomal ubiquitin-dependent protein catabolic process,GO:0042771~intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,GO:0042981~regulation of apoptotic process,GO:0045861~negative regulation of proteolysis,GO:0045995~regulation of embryonic development,GO:0050821~protein stabilization,GO:0070059~intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,GO:0071712~ER-associated misfolded protein catabolic process,GO:0071816~tail-anchored membrane protein insertion into ER membrane,	GO:0005576~extracellular region,GO:0005634~nucleus,GO:0005829~cytosol,GO:0071818~BAT3 complex,	GO:0031593~polyubiquitin binding,GO:0043022~ribosome binding,GO:0051787~misfolded protein binding,GO:0070628~proteasome binding,	IPR000626:Ubiquitin-like_dom,IPR021925:BAG6,IPR029071:Ubiquitin-like_domsf,IPR048926:Bag6_BAGS,	dre03060:Protein export,			SM00213:UBQ,	KW-0053~Apoptosis,KW-0813~Transport,	KW-0539~Nucleus,KW-0963~Cytoplasm,KW-0964~Secreted,					KW-0143~Chaperone,KW-0156~Chromatin regulator,		COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,COMPBIAS:Pro residues,DOMAIN:Ubiquitin-like,REGION:Disordered,
Q9Z2F7	BCL2/adenovirus E1B interacting protein 3-like(Bnip3l)	Mus musculus			GO:0006915~apoptotic process,GO:0010917~negative regulation of mitochondrial membrane potential,GO:0016239~positive regulation of macroautophagy,GO:0019222~regulation of metabolic process,GO:0035694~mitochondrial protein catabolic process,GO:0035794~positive regulation of mitochondrial membrane permeability,GO:0043065~positive regulation of apoptotic process,GO:0043066~negative regulation of apoptotic process,GO:0043067~regulation of programmed cell death,GO:0043069~negative regulation of programmed cell death,GO:0051607~defense response to virus,GO:0071456~cellular response to hypoxia,GO:0097345~mitochondrial outer membrane permeabilization,GO:1901524~regulation of macromitophagy,GO:1903146~regulation of mitophagy,GO:1903214~regulation of protein targeting to mitochondrion,	GO:0005634~nucleus,GO:0005635~nuclear envelope,GO:0005739~mitochondrion,GO:0005740~mitochondrial envelope,GO:0005741~mitochondrial outer membrane,GO:0005783~endoplasmic reticulum,GO:0016020~membrane,GO:0016607~nuclear speck,	GO:0005515~protein binding,GO:0005521~lamin binding,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,	IPR010548:BNIP3,	mmu04137:Mitophagy - animal,				KW-0053~Apoptosis,	KW-0256~Endoplasmic reticulum,KW-0472~Membrane,KW-0496~Mitochondrion,KW-0539~Nucleus,KW-1000~Mitochondrion outer membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0597~Phosphoprotein,	COMPBIAS:Polar residues,MOTIF:BH3,REGION:Disordered,TRANSMEM:Helical,
P50615	BTG anti-proliferation factor 3(Btg3)	Mus musculus			GO:0008285~negative regulation of cell proliferation,GO:0045930~negative regulation of mitotic cell cycle,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0005515~protein binding,	IPR002087:Anti_prolifrtn,IPR033332:BTG,IPR036054:BTG-like_sf,	mmu03018:RNA degradation,			SM00099:btg1,									DOMAIN:Anti-proliferative protein,REGION:Disordered,
O43683	BUB1 mitotic checkpoint serine/threonine kinase(BUB1)	Homo sapiens			GO:0006338~chromatin remodeling,GO:0006915~apoptotic process,GO:0007059~chromosome segregation,GO:0007063~regulation of sister chromatid cohesion,GO:0007094~mitotic spindle assembly checkpoint,GO:0016310~phosphorylation,GO:0051301~cell division,GO:0051754~meiotic sister chromatid cohesion, centromeric,GO:0051983~regulation of chromosome segregation,GO:2000720~positive regulation of maintenance of mitotic sister chromatid cohesion, centromeric,	GO:0000776~kinetochore,GO:0000940~condensed chromosome outer kinetochore,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005829~cytosol,GO:0016020~membrane,GO:0043229~intracellular organelle,GO:0043231~intracellular membrane-bounded organelle,	GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016301~kinase activity,	IPR000719:Prot_kinase_dom,IPR008271:Ser/Thr_kinase_AS,IPR011009:Kinase-like_dom_sf,IPR013212:Mad3/Bub1_I,IPR015661:Bub1/Mad3,IPR017441:Protein_kinase_ATP_BS,	hsa04110:Cell cycle,hsa04114:Oocyte meiosis,hsa04914:Progesterone-mediated oocyte maturation,	114500~Colorectal cancer with chromosomal instability, somatic,620183~Microcephaly 30, primary, autosomal recessive,		SM00220:S_TKc,SM00777:Mad3_BUB1_I,	KW-0053~Apoptosis,KW-0131~Cell cycle,KW-0132~Cell division,KW-0159~Chromosome partition,KW-0498~Mitosis,KW-0945~Host-virus interaction,	KW-0137~Centromere,KW-0158~Chromosome,KW-0539~Nucleus,KW-0995~Kinetochore,		KW-0905~Primary microcephaly,KW-0991~Intellectual disability,		KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0418~Kinase,KW-0723~Serine/threonine-protein kinase,KW-0808~Transferase,	KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,	ACT_SITE:Proton acceptor,DOMAIN:BUB1 N-terminal,DOMAIN:Protein kinase,MOTIF:KEN box 1,MOTIF:KEN box 2,MOTIF:Nuclear localization signal,MUTAGEN:A->D,W: Loss of interaction with KNL1.,MUTAGEN:A->S: Partial rescue of the spindle-assembly checkpoint activity. Increased rate of chromosome congression errors. Impaired localization to kinetochores and loss of kinetochore binding of CENPF, SGO1 and BUBR1 but not of MCAK, MAD1L1 or MAD2L1.,MUTAGEN:E->A: Loss of ubiquitination and CDH1-dependent degradation; when associated with A-535 and A-537.,MUTAGEN:E->A: Loss of ubiquitination and CDH1-dependent degradation; when associated with A-625 and A-627.,MUTAGEN:K->A: Loss of activity.,MUTAGEN:K->A: Loss of ubiquitination and CDH1-dependent degradation; when associated with A-536 and A-537.,MUTAGEN:K->A: Loss of ubiquitination and CDH1-dependent degradation; when associated with A-626 and A-627.,MUTAGEN:L->G: Loss of interaction with KNL1.,MUTAGEN:N->A: Loss of ubiquitination and CDH1-dependent degradation; when associated with A-535 and A-536.,MUTAGEN:N->A: Loss of ubiquitination and CDH1-dependent degradation; when associated with A-625 and A-626.,MUTAGEN:T->A: Diminished interaction with PLK1.,REGION:Disordered,REGION:Essential for loading of BUBR1, MAD1L1 and MAD2L1 to kinetochores,REGION:Necessary for interaction with BUB3,REGION:Necessary for interaction with KNL1,REGION:Necessary for kinetochore localization,
Q5U4T7	BicC family RNA binding protein 1 L homeolog(bicc1.L)	Xenopus laevis					GO:0003676~nucleic acid binding,GO:0003723~RNA binding,	IPR001660:SAM,IPR004087:KH_dom,IPR004088:KH_dom_type_1,IPR013761:SAM/pointed_sf,IPR036612:KH_dom_type_1_sf,IPR037974:BICC1_SAM_dom,IPR047549:BICC1_KH-I_rpt1,IPR047553:BICC1_KH-I_rpt3,IPR047554:BICC1_KH-I_rpt2,				SM00322:KH,SM00454:SAM,					KW-0677~Repeat,		KW-0217~Developmental protein,KW-0694~RNA-binding,KW-9996~Developmental protein,		COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:KH 1,DOMAIN:KH 2,DOMAIN:SAM,REGION:Disordered,
Q6UNA4	C5a receptor(c5ar)	Oncorhynchus mykiss			GO:0002430~complement receptor mediated signaling pathway,GO:0002690~positive regulation of leukocyte chemotaxis,GO:0006935~chemotaxis,GO:0006954~inflammatory response,GO:0007200~phospholipase C-activating G-protein coupled receptor signaling pathway,GO:0007204~positive regulation of cytosolic calcium ion concentration,GO:0042789~mRNA transcription from RNA polymerase II promoter,GO:0050679~positive regulation of epithelial cell proliferation,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0071624~positive regulation of granulocyte chemotaxis,	GO:0005886~plasma membrane,GO:0016020~membrane,GO:0016323~basolateral plasma membrane,GO:0045177~apical part of cell,	GO:0001856~complement component C5a binding,GO:0004875~complement receptor activity,GO:0004878~complement component C5a receptor activity,GO:0004930~G-protein coupled receptor activity,	IPR000276:GPCR_Rhodpsn,IPR000826:Formyl_rcpt-rel,IPR017452:GPCR_Rhodpsn_7TM,	omy04080:Neuroactive ligand-receptor interaction,			SM01381:7TM_GPCR_Srsx,	KW-0145~Chemotaxis,	KW-0472~Membrane,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0297~G-protein coupled receptor,KW-0675~Receptor,KW-0807~Transducer,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:G-protein coupled receptors family 1 profile,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,TRANSMEM:Helical; Name=1,TRANSMEM:Helical; Name=2,TRANSMEM:Helical; Name=3,TRANSMEM:Helical; Name=4,TRANSMEM:Helical; Name=5,TRANSMEM:Helical; Name=6,TRANSMEM:Helical; Name=7,
P49716	CCAAT enhancer binding protein delta(CEBPD)	Homo sapiens			GO:0002244~hematopoietic progenitor cell differentiation,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0045444~fat cell differentiation,GO:0045595~regulation of cell differentiation,GO:0045669~positive regulation of osteoblast differentiation,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048839~inner ear development,	GO:0000785~chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0090575~RNA polymerase II transcription factor complex,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0005515~protein binding,GO:0042802~identical protein binding,GO:1990837~sequence-specific double-stranded DNA binding,	IPR004827:bZIP,IPR016468:C/EBP_chordates,IPR031106:C/EBP,IPR046347:bZIP_sf,			PIRSF005879:CCAAT/enhancer-binding,	SM00338:BRLZ,	KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,					KW-0010~Activator,KW-0238~DNA-binding,	KW-0007~Acetylation,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Basic and acidic residues,COMPBIAS:Pro residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO),DOMAIN:bZIP,MUTAGEN:K->A: Loss of sumoylation.,REGION:Basic motif,REGION:Disordered,REGION:Leucine-zipper,
P62634	CCHC-type zinc finger, nucleic acid binding protein(Cnbp)	Rattus norvegicus			GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0008284~positive regulation of cell proliferation,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0071919~G-quadruplex DNA formation,GO:2000767~positive regulation of cytoplasmic translation,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005783~endoplasmic reticulum,GO:0005829~cytosol,	GO:0003676~nucleic acid binding,GO:0003697~single-stranded DNA binding,GO:0003727~single-stranded RNA binding,GO:0003729~mRNA binding,GO:0008270~zinc ion binding,GO:0045182~translation regulator activity,GO:0051880~G-quadruplex DNA binding,	IPR001878:Znf_CCHC,IPR036875:Znf_CCHC_sf,				SM00343:ZnF_C2HC,	KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0256~Endoplasmic reticulum,KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0677~Repeat,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0238~DNA-binding,KW-0678~Repressor,	KW-0007~Acetylation,KW-0488~Methylation,KW-0597~Phosphoprotein,	DOMAIN:CCHC-type,REGION:RNA-binding Arg/Gly-rich region (RGG-box),ZN_FING:CCHC-type 1,ZN_FING:CCHC-type 2,ZN_FING:CCHC-type 3,ZN_FING:CCHC-type 4,ZN_FING:CCHC-type 5,ZN_FING:CCHC-type 6,ZN_FING:CCHC-type 7,
Q93033	CD101 molecule(CD101)	Homo sapiens			GO:0002763~positive regulation of myeloid leukocyte differentiation,GO:0007166~cell surface receptor signaling pathway,	GO:0005886~plasma membrane,GO:0016020~membrane,GO:0070062~extracellular exosome,	GO:0016812~hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides,	IPR002195:Dihydroorotase_CS,IPR003599:Ig_sub,IPR007110:Ig-like_dom,IPR013106:Ig_V-set,IPR013783:Ig-like_fold,IPR036179:Ig-like_dom_sf,				SM00406:IGv,SM00409:IG,		KW-0472~Membrane,			KW-0393~Immunoglobulin domain,KW-0677~Repeat,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Ig-like,DOMAIN:Ig-like C2-type 1,DOMAIN:Ig-like C2-type 2,DOMAIN:Ig-like C2-type 3,DOMAIN:Ig-like C2-type 4,DOMAIN:Ig-like C2-type 5,DOMAIN:Ig-like C2-type 6,DOMAIN:Ig-like C2-type 7,DOMAIN:Immunoglobulin subtype,MOTIF:EWI motif,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q9HCU0	CD248 molecule(CD248)	Homo sapiens	84.Ubiquitination_Pathways_Cell_Cycle,		GO:0010761~fibroblast migration,GO:0016477~cell migration,GO:0048144~fibroblast proliferation,GO:0048146~positive regulation of fibroblast proliferation,GO:0048535~lymph node development,GO:0060033~anatomical structure regression,GO:0072577~endothelial cell apoptotic process,GO:2000353~positive regulation of endothelial cell apoptotic process,	GO:0005737~cytoplasm,GO:0009897~external side of plasma membrane,GO:0031012~extracellular matrix,GO:0070062~extracellular exosome,	GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0030246~carbohydrate binding,GO:0050840~extracellular matrix binding,GO:1990430~extracellular matrix protein binding,	IPR000742:EGF-like_dom,IPR001304:C-type_lectin-like,IPR001881:EGF-like_Ca-bd_dom,IPR009030:Growth_fac_rcpt_cys_sf,IPR016186:C-type_lectin-like/link_sf,IPR016187:CTDL_fold,IPR018097:EGF_Ca-bd_CS,				SM00034:CLECT,SM00179:EGF_CA,SM00181:EGF,		KW-0472~Membrane,			KW-0245~EGF-like domain,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0106~Calcium,KW-0430~Lectin,		KW-0325~Glycoprotein,KW-0597~Phosphoprotein,KW-1015~Disulfide bond,	CARBOHYD:O-linked (GalNAc...) serine,CARBOHYD:O-linked (GalNAc...) threonine,COMPBIAS:Polar residues,DOMAIN:C-type lectin,DOMAIN:EGF-like; calcium-binding,DOMAIN:Sushi,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
A8WH74	CD302 molecule(CD302)	Bos taurus				GO:0005902~microvillus,GO:0005938~cell cortex,GO:0009897~external side of plasma membrane,GO:0016020~membrane,GO:0030175~filopodium,	GO:0030246~carbohydrate binding,GO:0038023~signaling receptor activity,	IPR001304:C-type_lectin-like,IPR016186:C-type_lectin-like/link_sf,IPR016187:CTDL_fold,				SM00034:CLECT,		KW-0472~Membrane,KW-0963~Cytoplasm,KW-0966~Cell projection,			KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0430~Lectin,	KW-0675~Receptor,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:C-type lectin,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
P61025	CDC28 protein kinase 1b(Cks1b)	Mus musculus		m_p27Pathway:Regulation of p27 Phosphorylation during Cell Cycle Progression,	GO:0006355~regulation of transcription, DNA-templated,GO:0007049~cell cycle,GO:0007346~regulation of mitotic cell cycle,GO:0009790~embryo development,GO:0044772~mitotic cell cycle phase transition,GO:0048144~fibroblast proliferation,GO:0051301~cell division,	GO:0000307~cyclin-dependent protein kinase holoenzyme complex,GO:0019005~SCF ubiquitin ligase complex,	GO:0016538~cyclin-dependent protein serine/threonine kinase regulator activity,GO:0019901~protein kinase binding,GO:0042393~histone binding,GO:0043130~ubiquitin binding,GO:0061575~cyclin-dependent protein serine/threonine kinase activator activity,	IPR000789:Cyclin-dep_kinase_reg-sub,IPR036858:Cyclin-dep_kinase_reg-sub_sf,	mmu05200:Pathways in cancer,mmu05222:Small cell lung cancer,			SM01084:CKS,	KW-0131~Cell cycle,KW-0132~Cell division,							KW-0007~Acetylation,	COMPBIAS:Polar residues,REGION:Disordered,
Q80TV8	CLIP associating protein 1(Clasp1)	Mus musculus			GO:0000226~microtubule cytoskeleton organization,GO:0001578~microtubule bundle formation,GO:0006903~vesicle targeting,GO:0007020~microtubule nucleation,GO:0007026~negative regulation of microtubule depolymerization,GO:0007030~Golgi organization,GO:0007049~cell cycle,GO:0007052~mitotic spindle organization,GO:0010458~exit from mitosis,GO:0010470~regulation of gastrulation,GO:0010634~positive regulation of epithelial cell migration,GO:0010717~regulation of epithelial to mesenchymal transition,GO:0016477~cell migration,GO:0030010~establishment of cell polarity,GO:0030953~astral microtubule organization,GO:0031023~microtubule organizing center organization,GO:0031111~negative regulation of microtubule polymerization or depolymerization,GO:0034453~microtubule anchoring,GO:0040001~establishment of mitotic spindle localization,GO:0045921~positive regulation of exocytosis,GO:0051128~regulation of cellular component organization,GO:0051294~establishment of spindle orientation,GO:0051301~cell division,GO:0051497~negative regulation of stress fiber assembly,GO:0051893~regulation of focal adhesion assembly,GO:0070507~regulation of microtubule cytoskeleton organization,GO:0090091~positive regulation of extracellular matrix disassembly,GO:0090307~mitotic spindle assembly,GO:1903690~negative regulation of wound healing, spreading of epidermal cells,GO:1904261~positive regulation of basement membrane assembly involved in embryonic body morphogenesis,	GO:0000775~chromosome, centromeric region,GO:0000776~kinetochore,GO:0005694~chromosome,GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0005813~centrosome,GO:0005815~microtubule organizing center,GO:0005856~cytoskeleton,GO:0005874~microtubule,GO:0005876~spindle microtubule,GO:0005881~cytoplasmic microtubule,GO:0005925~focal adhesion,GO:0005938~cell cortex,GO:0015630~microtubule cytoskeleton,GO:0030981~cortical microtubule cytoskeleton,GO:0031592~centrosomal corona,GO:0045180~basal cortex,GO:0072686~mitotic spindle,	GO:0002162~dystroglycan binding,GO:0005515~protein binding,GO:0008017~microtubule binding,GO:0043515~kinetochore binding,GO:0051010~microtubule plus-end binding,	IPR011989:ARM-like,IPR016024:ARM-type_fold,IPR021133:HEAT_type_2,IPR024395:CLASP_N_dom,IPR034085:TOG,IPR048491:XMAP215_CLASP_TOG,				SM01349:TOG,	KW-0131~Cell cycle,KW-0132~Cell division,KW-0498~Mitosis,	KW-0137~Centromere,KW-0158~Chromosome,KW-0206~Cytoskeleton,KW-0333~Golgi apparatus,KW-0493~Microtubule,KW-0963~Cytoplasm,KW-0995~Kinetochore,			KW-0175~Coiled coil,KW-0677~Repeat,			KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:TOG,REGION:Disordered,REGION:Interaction with CLIP2 and RSN,REGION:Interaction with PHLDB2,REGION:Interaction with microtubules, MAPRE1 and MAPRE3,REGION:Localization to kinetochores,REPEAT:HEAT,REPEAT:HEAT 1,REPEAT:HEAT 2,REPEAT:HEAT 3,REPEAT:HEAT 4,REPEAT:HEAT 5,REPEAT:HEAT 6,REPEAT:HEAT 7,
Q9CZ04	COP9 signalosome subunit 7A(Cops7a)	Mus musculus			GO:0000338~protein deneddylation,GO:0010387~COP9 signalosome assembly,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0008180~COP9 signalosome,		IPR000717:PCI_dom,IPR041481:CSN7_helixI,IPR045237:COPS7/eIF3m,				SM00088:PINT,		KW-0539~Nucleus,KW-0736~Signalosome,KW-0963~Cytoplasm,			KW-0175~Coiled coil,			KW-0007~Acetylation,KW-0597~Phosphoprotein,	COMPBIAS:Polar residues,DOMAIN:PCI,REGION:Disordered,
Q5R664	COPI coat complex subunit beta 2(COPB2)	Pongo abelii			GO:0006886~intracellular protein transport,GO:0006888~ER to Golgi vesicle-mediated transport,GO:0006890~retrograde vesicle-mediated transport, Golgi to ER,GO:0006891~intra-Golgi vesicle-mediated transport,GO:0016192~vesicle-mediated transport,	GO:0000139~Golgi membrane,GO:0005829~cytosol,GO:0030117~membrane coat,GO:0030126~COPI vesicle coat,GO:0030663~COPI-coated vesicle membrane,	GO:0005198~structural molecule activity,GO:0005515~protein binding,	IPR001680:WD40_rpt,IPR006692:Coatomer_WD-assoc_reg,IPR011044:Quino_amine_DH_bsu,IPR015943:WD40/YVTN_repeat-like_dom_sf,IPR016453:COPB2,IPR020472:G-protein_beta_WD-40_rep,IPR036322:WD40_repeat_dom_sf,			PIRSF005567:Coatomer_beta'_subunit,	SM00320:WD40,	KW-0653~Protein transport,KW-0813~Transport,KW-0931~ER-Golgi transport,	KW-0333~Golgi apparatus,KW-0472~Membrane,KW-0963~Cytoplasm,KW-0968~Cytoplasmic vesicle,			KW-0175~Coiled coil,KW-0677~Repeat,KW-0853~WD repeat,			KW-0007~Acetylation,KW-0597~Phosphoprotein,	COMPBIAS:Polar residues,DOMAIN:Coatomer WD associated region,REGION:Disordered,REPEAT:WD,REPEAT:WD 1,REPEAT:WD 2,REPEAT:WD 3,REPEAT:WD 4,REPEAT:WD 5,REPEAT:WD 6,REPEAT:WD 7,REPEAT:WD 8,REPEAT:WD 9,
Q8IUR6	CREB3 regulatory factor(CREBRF)	Homo sapiens			GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006986~response to unfolded protein,GO:0034976~response to endoplasmic reticulum stress,GO:0045732~positive regulation of protein catabolic process,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:1900102~negative regulation of endoplasmic reticulum unfolded protein response,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0016604~nuclear body,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,	IPR004827:bZIP,IPR039165:CREBRF,IPR046347:bZIP_sf,					KW-0346~Stress response,KW-0804~Transcription,KW-0805~Transcription regulation,KW-0813~Transport,KW-0834~Unfolded protein response,	KW-0539~Nucleus,					KW-0678~Repressor,		COMPBIAS:Acidic residues,COMPBIAS:Polar residues,DOMAIN:BZIP,DOMAIN:bZIP,REGION:Basic motif,REGION:Disordered,REGION:Leucine-zipper,
B5X4H8	CT054 protein(ct054)	Salmo salar			GO:0032218~riboflavin transport,	GO:0005886~plasma membrane,	GO:0032217~riboflavin transporter activity,	IPR009357:Riboflavin_transptr,					KW-0813~Transport,	KW-0472~Membrane,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Basic and acidic residues,REGION:Disordered,TRANSMEM:Helical,
Q5RGJ5	CWF19 like cell cycle control factor 1(cwf19l1)	Danio rerio			GO:0000398~mRNA splicing, via spliceosome,	GO:0071014~post-mRNA release spliceosomal complex,	GO:0061632~RNA lariat debranching enzyme activator activity,	IPR006767:Cwf19-like_C_dom-2,IPR006768:Cwf19-like_C_dom-1,IPR029052:Metallo-depent_PP-like,IPR036265:HIT-like_sf,IPR040194:Cwf19-like,													COMPBIAS:Basic and acidic residues,DOMAIN:Cwf19-like C-terminal,DOMAIN:Cwf19-like protein C-terminal,REGION:Disordered,
Q4KMJ1	ChaC, cation transport regulator homolog 2 (E. coli)(chac2)	Danio rerio			GO:0006751~glutathione catabolic process,	GO:0005737~cytoplasm,	GO:0003839~gamma-glutamylcyclotransferase activity,GO:0016829~lyase activity,	IPR006840:ChaC,IPR013024:GGCT-like,IPR036568:GGCT-like_sf,	dre00480:Glutathione metabolism,dre01100:Metabolic pathways,										KW-0456~Lyase,		ACT_SITE:Proton acceptor,
Q8VDW0	DEAD box helicase 39a(Ddx39a)	Mus musculus			GO:0000398~mRNA splicing, via spliceosome,GO:0006397~mRNA processing,GO:0006406~mRNA export from nucleus,GO:0008380~RNA splicing,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0016607~nuclear speck,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0003724~RNA helicase activity,GO:0003729~mRNA binding,GO:0004386~helicase activity,GO:0005524~ATP binding,GO:0016787~hydrolase activity,GO:0016887~ATPase activity,GO:0042802~identical protein binding,	IPR001650:Helicase_C,IPR011545:DEAD/DEAH_box_helicase_dom,IPR014001:Helicase_ATP-bd,IPR014014:RNA_helicase_DEAD_Q_motif,IPR027417:P-loop_NTPase,				SM00487:DEXDc,SM00490:HELICc,	KW-0507~mRNA processing,KW-0508~mRNA splicing,	KW-0539~Nucleus,KW-0963~Cytoplasm,				KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0347~Helicase,KW-0378~Hydrolase,	KW-0007~Acetylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Acidic residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate,DOMAIN:DEAD-box RNA helicase Q,DOMAIN:Helicase ATP-binding,DOMAIN:Helicase C-terminal,MOTIF:DECD box,MOTIF:Q motif,REGION:Disordered,
Q7L7V1	DEAH-box helicase 32 (putative)(DHX32)	Homo sapiens				GO:0005622~intracellular,GO:0005681~spliceosomal complex,GO:0005739~mitochondrion,	GO:0003723~RNA binding,GO:0003724~RNA helicase activity,GO:0004386~helicase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016887~ATPase activity,	IPR007502:Helicase-assoc_dom,IPR011709:DEAD-box_helicase_OB_fold,IPR014001:Helicase_ATP-bd,IPR027417:P-loop_NTPase,IPR048333:HA2_WH,				SM00847:HA2,		KW-0496~Mitochondrion,KW-0539~Nucleus,				KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0347~Helicase,KW-0378~Hydrolase,	KW-0007~Acetylation,	DOMAIN:Helicase ATP-binding,DOMAIN:Helicase-associated,MOTIF:DEAH box,REGION:Disordered,
Q9H5Z1	DEAH-box helicase 35(DHX35)	Homo sapiens			GO:0000398~mRNA splicing, via spliceosome,GO:0001701~in utero embryonic development,	GO:0005622~intracellular,GO:0005654~nucleoplasm,GO:0071013~catalytic step 2 spliceosome,	GO:0003723~RNA binding,GO:0003724~RNA helicase activity,GO:0004386~helicase activity,GO:0005524~ATP binding,GO:0016787~hydrolase activity,GO:0016887~ATPase activity,	IPR001650:Helicase_C,IPR002464:DNA/RNA_helicase_DEAH_CS,IPR007502:Helicase-assoc_dom,IPR011709:DEAD-box_helicase_OB_fold,IPR014001:Helicase_ATP-bd,IPR027417:P-loop_NTPase,IPR048333:HA2_WH,				SM00487:DEXDc,SM00490:HELICc,SM00847:HA2,	KW-0507~mRNA processing,KW-0508~mRNA splicing,	KW-0747~Spliceosome,				KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0347~Helicase,KW-0378~Hydrolase,		DOMAIN:DEAD-box helicase OB fold,DOMAIN:Helicase ATP-binding,DOMAIN:Helicase C-terminal,MOTIF:DEAH box,
Q96C10	DExH-box helicase 58(DHX58)	Homo sapiens			GO:0002753~cytoplasmic pattern recognition receptor signaling pathway,GO:0009615~response to virus,GO:0009617~response to bacterium,GO:0032480~negative regulation of type I interferon production,GO:0032481~positive regulation of type I interferon production,GO:0039534~negative regulation of MDA-5 signaling pathway,GO:0039536~negative regulation of RIG-I signaling pathway,GO:0045087~innate immune response,GO:0045088~regulation of innate immune response,GO:0045824~negative regulation of innate immune response,GO:0051607~defense response to virus,GO:1900245~positive regulation of MDA-5 signaling pathway,GO:1900246~positive regulation of RIG-I signaling pathway,	GO:0005737~cytoplasm,	GO:0003677~DNA binding,GO:0003723~RNA binding,GO:0003724~RNA helicase activity,GO:0003725~double-stranded RNA binding,GO:0003727~single-stranded RNA binding,GO:0004386~helicase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008270~zinc ion binding,GO:0016787~hydrolase activity,GO:0016887~ATPase activity,GO:0046872~metal ion binding,	IPR001650:Helicase_C,IPR006935:Helicase/UvrB_N,IPR014001:Helicase_ATP-bd,IPR021673:RLR_CTR,IPR027417:P-loop_NTPase,IPR038557:RLR_C_sf,IPR041204:RIG-I-like_C,	hsa04622:RIG-I-like receptor signaling pathway,			SM00487:DEXDc,SM00490:HELICc,	KW-0051~Antiviral defense,KW-0391~Immunity,KW-0399~Innate immunity,KW-0945~Host-virus interaction,	KW-0963~Cytoplasm,			KW-0175~Coiled coil,	KW-0067~ATP-binding,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,KW-0862~Zinc,	KW-0347~Helicase,KW-0378~Hydrolase,KW-0694~RNA-binding,		DOMAIN:Helicase ATP-binding,DOMAIN:Helicase C-terminal,DOMAIN:RLR CTR,MOTIF:DECH box,MUTAGEN:DECH->AACA: Loss of dsRNA-induced ATPase activity.,MUTAGEN:FTRT->ATRA: Loss of dsRNA-induced ATPase activity. No effect on cytoplasmic pattern recognition receptor signaling pathway in response to virus.,MUTAGEN:K->A: Loss of dsRNA-induced ATPase activity. No effect on ds-RNA binding. No effect on cytoplasmic pattern recognition receptor signaling pathway in response to virus.,MUTAGEN:K->E: Abolishes RNA binding.,MUTAGEN:QARGR->AARGA: Loss of dsRNA-induced ATPase activity. No effect on cytoplasmic pattern recognition receptor signaling pathway in response to virus.,MUTAGEN:TAS->AAA: Loss of dsRNA-induced ATPase activity. Loss of ds-RNA binding. No effect on cytoplasmic pattern recognition receptor signaling pathway in response to virus.,MUTAGEN:TSVAE->ASVAA: Loss of dsRNA-induced ATPase activity. No effect on cytoplasmic pattern recognition receptor signaling pathway in response to virus.,REGION:RNA-binding,
Q8K4R9	DLG associated protein 5(Dlgap5)	Mus musculus			GO:0007049~cell cycle,GO:0007052~mitotic spindle organization,GO:0007059~chromosome segregation,GO:0007346~regulation of mitotic cell cycle,GO:0023052~signaling,GO:0051382~kinetochore assembly,GO:0051642~centrosome localization,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0031616~spindle pole centrosome,GO:0072686~mitotic spindle,	GO:0008017~microtubule binding,	IPR005026:SAPAP,					KW-0131~Cell cycle,	KW-0206~Cytoskeleton,KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0175~Coiled coil,			KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,REGION:Disordered,
A7YWS7	DNA polymerase epsilon 2, accessory subunit(POLE2)	Bos taurus			GO:0006261~DNA-dependent DNA replication,GO:0042276~error-prone translesion synthesis,	GO:0008622~epsilon DNA polymerase complex,	GO:0003677~DNA binding,	IPR007185:DNA_pol_a/d/e_bsu,IPR016266:POLE2,IPR024639:DNA_pol_e_bsu_N,	bta03030:DNA replication,bta03410:Base excision repair,bta03420:Nucleotide excision repair,		PIRSF000799:DNA_pol_eps_2,		KW-0235~DNA replication,	KW-0539~Nucleus,					KW-0238~DNA-binding,		DOMAIN:DNA polymerase alpha/delta/epsilon subunit B,DOMAIN:DNA polymerase epsilon subunit B N-terminal,
O75417	DNA polymerase theta(POLQ)	Homo sapiens			GO:0006261~DNA-dependent DNA replication,GO:0006278~RNA-dependent DNA biosynthetic process,GO:0006281~DNA repair,GO:0006284~base-excision repair,GO:0006302~double-strand break repair,GO:0006974~cellular response to DNA damage stimulus,GO:0016446~somatic hypermutation of immunoglobulin genes,GO:0031297~replication fork processing,GO:0032508~DNA duplex unwinding,GO:0042276~error-prone translesion synthesis,GO:0051260~protein homooligomerization,GO:0097681~double-strand break repair via alternative nonhomologous end joining,GO:2000042~negative regulation of double-strand break repair via homologous recombination,	GO:0005654~nucleoplasm,GO:0005794~Golgi apparatus,GO:0005829~cytosol,GO:0035861~site of double-strand break,GO:0090734~site of DNA damage,	GO:0000014~single-stranded DNA endodeoxyribonuclease activity,GO:0000287~magnesium ion binding,GO:0003677~DNA binding,GO:0003678~DNA helicase activity,GO:0003682~chromatin binding,GO:0003684~damaged DNA binding,GO:0003887~DNA-directed DNA polymerase activity,GO:0003964~RNA-directed DNA polymerase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016887~ATPase activity,GO:0017116~single-stranded DNA-dependent ATP-dependent DNA helicase activity,GO:0042802~identical protein binding,GO:0051575~5'-deoxyribose-5-phosphate lyase activity,	IPR001098:DNA-dir_DNA_pol_A_palm_dom,IPR001650:Helicase_C,IPR002298:DNA_polymerase_A,IPR011545:DEAD/DEAH_box_helicase_dom,IPR012337:RNaseH-like_sf,IPR014001:Helicase_ATP-bd,IPR019760:DNA-dir_DNA_pol_A_CS,IPR027417:P-loop_NTPase,IPR036397:RNaseH_sf,IPR043502:DNA/RNA_pol_sf,IPR046931:HTH_61,IPR048960:POLQ-like_helical,				SM00482:POLAc,SM00487:DEXDc,SM00490:HELICc,	KW-0227~DNA damage,KW-0234~DNA repair,	KW-0158~Chromosome,KW-0539~Nucleus,			KW-0175~Coiled coil,	KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0239~DNA-directed DNA polymerase,KW-0255~Endonuclease,KW-0347~Helicase,KW-0378~Hydrolase,KW-0511~Multifunctional enzyme,KW-0540~Nuclease,KW-0548~Nucleotidyltransferase,KW-0808~Transferase,	KW-0007~Acetylation,KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:DNA polymerase theta-like helix-turn-helix,DOMAIN:Helicase ATP-binding,DOMAIN:Helicase C-terminal,MOTIF:DEAH box,MUTAGEN:D->A: Abolished DNA polymerase and endonuclease activities.,MUTAGEN:DE->AA: Abolishes DNA polymerase activity.,MUTAGEN:K->A: Abolished DNA polymerase and endonuclease activities.,MUTAGEN:K->A: Impaired ability to bypasse abasic sites.,MUTAGEN:K->M: Abolished ATPase activity.,MUTAGEN:R->A,V: Impaired ability to bypasse abasic sites.,MUTAGEN:R->A: Impaired ability to bypasse abasic sites. In Pol-theta(RR) mutant; abolished polymerase activity; when associated with V-2254.,MUTAGEN:R->V: In Pol-theta(RR) mutant; abolished polymerase activity; when associated with A-2202.,MUTAGEN:S->P: Decreased protein stability.,MUTAGEN:SLNMSDSLLFDS->ALNMADALLFDA: In 4S-P mutant; decreased phosphorylation by PLK1, leading to impaired interaction with TOPBP1 and recruitment to DNA damage sites.,MUTAGEN:Y->F: Slower kinetics for DNA polymerase and endonuclease activities.,REGION:DNA polymerase activity,REGION:Disordered,REGION:Helicase activity,REGION:Interaction with RAD51,REGION:Loop 1,REGION:Loop 2,REGION:Loop 3,
O89044	DNA primase subunit 2(Prim2)	Rattus norvegicus			GO:0006260~DNA replication,GO:0006269~DNA replication, synthesis of RNA primer,GO:0006270~DNA replication initiation,GO:1903934~positive regulation of DNA primase activity,	GO:0005658~alpha DNA polymerase:primase complex,	GO:0003677~DNA binding,GO:0046872~metal ion binding,GO:0051539~4 iron, 4 sulfur cluster binding,GO:0071667~DNA/RNA hybrid binding,	IPR007238:DNA_primase_lsu_euk/arc,IPR016558:DNA_primase_lsu_euk,	rno03030:DNA replication,		PIRSF009449:DNA_primase_large_subunit,		KW-0235~DNA replication,	KW-0639~Primosome,				KW-0004~4Fe-4S,KW-0408~Iron,KW-0411~Iron-sulfur,KW-0479~Metal-binding,	KW-0238~DNA-binding,	KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,REGION:Disordered,REGION:Interacts with PRIM1,REGION:Interdomain linker,REGION:RNA:DNA duplex binding,
Q66I84	DNA replication and sister chromatid cohesion 1(dscc1)	Danio rerio			GO:0006260~DNA replication,GO:0006275~regulation of DNA replication,GO:0007049~cell cycle,GO:0007064~mitotic sister chromatid cohesion,GO:0034088~maintenance of mitotic sister chromatid cohesion,	GO:0000775~chromosome, centromeric region,GO:0000785~chromatin,GO:0005634~nucleus,GO:0031390~Ctf18 RFC-like complex,	GO:0003677~DNA binding,	IPR019128:Dcc1,					KW-0131~Cell cycle,KW-0235~DNA replication,	KW-0539~Nucleus,					KW-0238~DNA-binding,
Q7T346	DNA-damage-inducible transcript 4(ddit4)	Danio rerio			GO:0001666~response to hypoxia,GO:0006915~apoptotic process,GO:0009953~dorsal/ventral pattern formation,GO:0009968~negative regulation of signal transduction,GO:0032007~negative regulation of TOR signaling,	GO:0005737~cytoplasm,GO:0005739~mitochondrion,	GO:0071889~14-3-3 protein binding,	IPR012918:RTP801-like,IPR038281:RTP801-like_C_sf,	dre04140:Autophagy - animal,dre04150:mTOR signaling pathway,				KW-0053~Apoptosis,	KW-0496~Mitochondrion,KW-0963~Cytoplasm,							COMPBIAS:Polar residues,REGION:Disordered,
Q9Y3R5	DOP1 leucine zipper like protein B(DOP1B)	Homo sapiens			GO:0006895~Golgi to endosome transport,GO:0007029~endoplasmic reticulum organization,GO:0009880~embryonic pattern specification,GO:0015031~protein transport,GO:0050890~cognition,	GO:0000139~Golgi membrane,GO:0005768~endosome,GO:0005802~trans-Golgi network,GO:0005829~cytosol,GO:0031901~early endosome membrane,GO:0070062~extracellular exosome,	GO:0005515~protein binding,	IPR007249:Dopey_N,IPR040314:DOP1,					KW-0653~Protein transport,KW-0813~Transport,	KW-0333~Golgi apparatus,KW-0472~Membrane,KW-0967~Endosome,						KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:Dopey N-terminal,REGION:Disordered,
Q5RAJ6	DnaJ heat shock protein family (Hsp40) member B11(DNAJB11)	Pongo abelii			GO:0006457~protein folding,GO:0016556~mRNA modification,GO:0050768~negative regulation of neurogenesis,GO:0051604~protein maturation,	GO:0005615~extracellular space,GO:0005634~nucleus,GO:0005783~endoplasmic reticulum,GO:0005788~endoplasmic reticulum lumen,GO:0101031~chaperone complex,	GO:0005102~receptor binding,GO:0051082~unfolded protein binding,GO:0051787~misfolded protein binding,	IPR001623:DnaJ_domain,IPR002939:DnaJ_C,IPR008971:HSP40/DnaJ_pept-bd,IPR018253:DnaJ_domain_CS,IPR036869:J_dom_sf,	pon04141:Protein processing in endoplasmic reticulum,			SM00271:DnaJ,		KW-0256~Endoplasmic reticulum,			KW-0732~Signal,		KW-0143~Chaperone,	KW-0325~Glycoprotein,KW-0597~Phosphoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Chaperone DnaJ C-terminal,DOMAIN:J,
G3H0N9	DnaJ heat shock protein family (Hsp40) member B9(Dnajb9)	Cricetulus griseus			GO:0002639~positive regulation of immunoglobulin production,GO:0006986~response to unfolded protein,GO:0030183~B cell differentiation,GO:0030433~ubiquitin-dependent ERAD pathway,GO:0034976~response to endoplasmic reticulum stress,GO:1903895~negative regulation of IRE1-mediated unfolded protein response,	GO:0005783~endoplasmic reticulum,GO:0005788~endoplasmic reticulum lumen,	GO:0030544~Hsp70 protein binding,GO:0051087~chaperone binding,GO:0051787~misfolded protein binding,	IPR001623:DnaJ_domain,IPR018253:DnaJ_domain_CS,IPR036869:J_dom_sf,				SM00271:DnaJ,	KW-0834~Unfolded protein response,	KW-0256~Endoplasmic reticulum,			KW-0732~Signal,		KW-0143~Chaperone,	KW-0597~Phosphoprotein,	DOMAIN:J,MUTAGEN:H->Q: Abolishes ability to stimulate ATPase activity of HSPA5/BiP.,REGION:Divergent targeting domain,
Q90977	E2F transcription factor 1(E2F1)	Gallus gallus			GO:0000082~G1/S transition of mitotic cell cycle,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,	GO:0005634~nucleus,GO:0005667~transcription factor complex,GO:0035189~Rb-E2F complex,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0001216~bacterial-type RNA polymerase transcriptional activator activity, sequence-specific DNA binding,GO:0046983~protein dimerization activity,	IPR003316:E2F_WHTH_DNA-bd_dom,IPR015633:E2F,IPR032198:E2F_CC-MB,IPR036388:WH-like_DNA-bd_sf,IPR036390:WH_DNA-bd_sf,IPR037241:E2F-DP_heterodim,	gga04110:Cell cycle,gga04137:Mitophagy - animal,gga04218:Cellular senescence,			SM01372:E2F_TDP,	KW-0131~Cell cycle,KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,			KW-0175~Coiled coil,		KW-0010~Activator,KW-0238~DNA-binding,		DOMAIN:E2F/DP family winged-helix DNA-binding,MOTIF:DEF box,REGION:Cyclin A/CDK2 binding,REGION:Dimerization,REGION:Disordered,REGION:Leucine-zipper,REGION:Retinoblastoma protein RB1 binding,REGION:Transactivation,
P54756	EPH receptor A5(EPHA5)	Homo sapiens			GO:0006468~protein phosphorylation,GO:0007411~axon guidance,GO:0016310~phosphorylation,GO:0019933~cAMP-mediated signaling,GO:0021766~hippocampus development,GO:0032793~positive regulation of CREB transcription factor activity,GO:0032956~regulation of actin cytoskeleton organization,GO:0043087~regulation of GTPase activity,GO:0048013~ephrin receptor signaling pathway,GO:0048666~neuron development,GO:0061178~regulation of insulin secretion involved in cellular response to glucose stimulus,	GO:0005791~rough endoplasmic reticulum,GO:0005886~plasma membrane,GO:0009897~external side of plasma membrane,GO:0016020~membrane,GO:0030424~axon,GO:0030425~dendrite,GO:0043025~neuronal cell body,GO:0048471~perinuclear region of cytoplasm,	GO:0005003~ephrin receptor activity,GO:0005004~GPI-linked ephrin receptor activity,GO:0005005~transmembrane-ephrin receptor activity,GO:0005515~protein binding,GO:0005524~ATP binding,	IPR000719:Prot_kinase_dom,IPR001090:Ephrin_rcpt_lig-bd_dom,IPR001245:Ser-Thr/Tyr_kinase_cat_dom,IPR001426:Tyr_kinase_rcpt_V_CS,IPR001660:SAM,IPR003961:FN3_dom,IPR008266:Tyr_kinase_AS,IPR008979:Galactose-bd-like_sf,IPR009030:Growth_fac_rcpt_cys_sf,IPR011009:Kinase-like_dom_sf,IPR013761:SAM/pointed_sf,IPR013783:Ig-like_fold,IPR016257:Tyr_kinase_ephrin_rcpt,IPR017441:Protein_kinase_ATP_BS,IPR020635:Tyr_kinase_cat_dom,IPR027936:Eph_TM,IPR034277:EphA5_rcpt_lig-bd,IPR036116:FN3_sf,	hsa04360:Axon guidance,		PIRSF000666:TyrPK_ephrin_receptor,	SM00060:FN3,SM00219:TyrKc,SM00454:SAM,SM00615:EPH_lbd,SM01411:Ephrin_rec_like,	KW-0524~Neurogenesis,	KW-0472~Membrane,KW-0966~Cell projection,KW-1003~Cell membrane,			KW-0677~Repeat,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0418~Kinase,KW-0675~Receptor,KW-0808~Transferase,KW-0829~Tyrosine-protein kinase,	KW-0325~Glycoprotein,KW-0597~Phosphoprotein,KW-1015~Disulfide bond,	ACT_SITE:Proton acceptor,CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Eph LBD,DOMAIN:Fibronectin type-III,DOMAIN:Fibronectin type-III 1,DOMAIN:Fibronectin type-III 2,DOMAIN:Protein kinase,DOMAIN:SAM,MOTIF:PDZ-binding,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q91WL0	EPS8-like 3(Eps8l3)	Mus musculus			GO:0007266~Rho protein signal transduction,GO:0035023~regulation of Rho protein signal transduction,GO:0042634~regulation of hair cycle,GO:1900029~positive regulation of ruffle assembly,	GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0032587~ruffle membrane,	GO:0003779~actin binding,	IPR001452:SH3_domain,IPR011993:PH-like_dom_sf,IPR013625:PTB,IPR013761:SAM/pointed_sf,IPR033928:EPS8_PTB,IPR035462:Eps8_SH3,IPR036028:SH3-like_dom_sf,IPR039801:EPS8-like,IPR041418:SAM_3,				SM00326:SH3,		KW-0963~Cytoplasm,			KW-0728~SH3 domain,			KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:PTB,DOMAIN:SH3,REGION:Disordered,
Q92611	ER degradation enhancing alpha-mannosidase like protein 1(EDEM1)	Homo sapiens		h_eradPathway:ERï¿½associated degradation (ERAD) Pathway,	GO:0005975~carbohydrate metabolic process,GO:0006058~mannoprotein catabolic process,GO:0006511~ubiquitin-dependent protein catabolic process,GO:0006986~response to unfolded protein,GO:0030433~ubiquitin-dependent ERAD pathway,GO:0036503~ERAD pathway,GO:0045047~protein targeting to ER,GO:0097466~ubiquitin-dependent glycoprotein ERAD pathway,GO:1904154~positive regulation of retrograde protein transport, ER to cytosol,GO:1904380~endoplasmic reticulum mannose trimming,GO:1904382~mannose trimming involved in glycoprotein ERAD pathway,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0016020~membrane,GO:0016235~aggresome,GO:0044322~endoplasmic reticulum quality control compartment,	GO:0004571~mannosyl-oligosaccharide 1,2-alpha-mannosidase activity,GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0051787~misfolded protein binding,	IPR001382:Glyco_hydro_47,IPR012341:6hp_glycosidase-like_sf,IPR036026:Seven-hairpin_glycosidases,IPR044674:EDEM1/2/3,	hsa04141:Protein processing in endoplasmic reticulum,				KW-0834~Unfolded protein response,	KW-0256~Endoplasmic reticulum,KW-0472~Membrane,			KW-0735~Signal-anchor,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0326~Glycosidase,KW-0378~Hydrolase,	KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,MUTAGEN:D->N: Normal affinity for misfolded glycoproteins, but impaired SEL1L binding.,MUTAGEN:E->Q: Normal affinity for misfolded glycoproteins, but impaired SEL1L binding.,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Lumenal,TRANSMEM:Helical; Signal-anchor for type II membrane protein,
P70459	Ets2 repressor factor(Erf)	Mus musculus			GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001701~in utero embryonic development,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0010668~ectodermal cell differentiation,GO:0030154~cell differentiation,GO:0060707~trophoblast giant cell differentiation,GO:0060710~chorio-allantoic fusion,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005829~cytosol,	GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0001227~transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0043565~sequence-specific DNA binding,	IPR000418:Ets_dom,IPR036388:WH-like_DNA-bd_sf,IPR036390:WH_DNA-bd_sf,IPR046328:ETS_fam,				SM00413:ETS,	KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,					KW-0238~DNA-binding,KW-0678~Repressor,	KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Acidic residues,COMPBIAS:Polar residues,COMPBIAS:Pro residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),DNA_BIND:ETS,DOMAIN:ETS,REGION:Disordered,
Q17QK6	F-box protein 2(FBXO2)	Bos taurus			GO:0006516~glycoprotein catabolic process,GO:0016567~protein ubiquitination,GO:0030433~ubiquitin-dependent ERAD pathway,GO:0031146~SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,	GO:0005737~cytoplasm,GO:0005783~endoplasmic reticulum,GO:0005829~cytosol,GO:0016020~membrane,GO:0019005~SCF ubiquitin ligase complex,	GO:0005515~protein binding,GO:0030246~carbohydrate binding,GO:0061630~ubiquitin protein ligase activity,	IPR001810:F-box_dom,IPR007397:F-box-assoc_dom,IPR008979:Galactose-bd-like_sf,IPR036047:F-box-like_dom_sf,IPR039752:F-box_only,	bta04120:Ubiquitin mediated proteolysis,bta04141:Protein processing in endoplasmic reticulum,			SM01198:FBA,	KW-0833~Ubl conjugation pathway,	KW-0256~Endoplasmic reticulum,KW-0472~Membrane,KW-0492~Microsome,KW-0963~Cytoplasm,				KW-0430~Lectin,			COMPBIAS:Acidic residues,DOMAIN:F-box,DOMAIN:FBA,REGION:Disordered,SITE:Important for carbohydrate binding,
Q9NW38	FA complementation group L(FANCL)	Homo sapiens			GO:0006281~DNA repair,GO:0006513~protein monoubiquitination,GO:0006974~cellular response to DNA damage stimulus,GO:0007276~gamete generation,GO:0036297~interstrand cross-link repair,GO:0042127~regulation of cell proliferation,	GO:0000785~chromatin,GO:0005634~nucleus,GO:0005635~nuclear envelope,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0016020~membrane,GO:0016604~nuclear body,GO:0043231~intracellular membrane-bounded organelle,GO:0043240~Fanconi anaemia nuclear complex,	GO:0004842~ubiquitin-protein transferase activity,GO:0005515~protein binding,GO:0016874~ligase activity,GO:0031625~ubiquitin protein ligase binding,GO:0046872~metal ion binding,GO:0061630~ubiquitin protein ligase activity,	IPR013083:Znf_RING/FYVE/PHD,IPR016135:UBQ-conjugating_enzyme/RWD,IPR019162:FancL_WD-rpt_cont_dom,IPR026848:Fancl,IPR026850:FANCL_C,IPR043003:FANCL_d3_sf,IPR043898:FANCL_d2,IPR044037:FANCL_d3,	hsa03460:Fanconi anemia pathway,hsa04120:Ubiquitin mediated proteolysis,	614083~Fanconi anemia, complementation group L,		SM01197:FANCL_C,	KW-0227~DNA damage,KW-0234~DNA repair,KW-0833~Ubl conjugation pathway,	KW-0472~Membrane,KW-0539~Nucleus,KW-0963~Cytoplasm,		KW-0923~Fanconi anemia,	KW-0812~Transmembrane,KW-0863~Zinc-finger,KW-1133~Transmembrane helix,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0436~Ligase,KW-0808~Transferase,	KW-0007~Acetylation,KW-0832~Ubl conjugation,	DOMAIN:FANCL C-terminal,DOMAIN:FANCL UBC-like,DOMAIN:Fanconi anemia complex subunit FancL WD-repeat containing,MUTAGEN:C->A: Abolishes ubiquitin ligase activity.,MUTAGEN:F->A: Does not affect interaction with FANCI and FANCD2; when associated with A-149.,MUTAGEN:F->A: Impairs interaction with FANCI and FANCD2; when associated with A-248, A-254 and A-265.,MUTAGEN:I->A: Impairs interaction with FANCI and FANCD2; when associated with A-248, A-252 and A-254.,MUTAGEN:I->A: Loss of interaction with UBE2T.,MUTAGEN:L->A: Impairs interaction with FANCI and FANCD2; when associated with A-248, A-252 and A-265.,MUTAGEN:L->A: Impairs interaction with FANCI and FANCD2; when associated with A-252, A-254 and A-265.,MUTAGEN:L->A: No effect on interaction with FANCI and FANCD2; when associated with A-166.,MUTAGEN:VY->AA: No effect on interaction with FANCI and FANCD2.,MUTAGEN:W->A: Loss of interaction with UBE2T.,MUTAGEN:W->G: Abolishes interaction with UBE2T and ubiquitin ligase activity.,MUTAGEN:WVL->AVA: Impairs interaction with FANCI and FANCD2.,MUTAGEN:Y->A: Loss of interaction with UBE2T.,MUTAGEN:YP->AA: Abolishes UBE2T charging.,REGION:UBC-RWD region (URD),TRANSMEM:Helical,ZN_FING:RING-type; degenerate,
Q8BIE6	FERM domain containing 4A(Frmd4a)	Mus musculus			GO:0050709~negative regulation of protein secretion,GO:0050714~positive regulation of protein secretion,GO:0090162~establishment of epithelial cell polarity,	GO:0005737~cytoplasm,GO:0005856~cytoskeleton,GO:0005912~adherens junction,GO:0005923~bicellular tight junction,GO:0070161~anchoring junction,	GO:0030674~protein binding, bridging,	IPR000299:FERM_domain,IPR011993:PH-like_dom_sf,IPR014352:FERM/acyl-CoA-bd_prot_sf,IPR018979:FERM_N,IPR018980:FERM_PH-like_C,IPR019747:FERM_CS,IPR019748:FERM_central,IPR019749:Band_41_domain,IPR021774:CUPID,IPR029071:Ubiquitin-like_domsf,IPR035963:FERM_2,IPR041785:FRMD4A/B_FERM_C,IPR047176:FRMD4A/B,				SM00295:B41,SM01196:FERM_C,		KW-0206~Cytoskeleton,KW-0796~Tight junction,KW-0963~Cytoplasm,KW-0965~Cell junction,			KW-0175~Coiled coil,			KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,COMPBIAS:Pro residues,DOMAIN:Cytohesin Ubiquitin Protein Inducing,DOMAIN:FERM,REGION:Disordered,REGION:Necessary for interaction with CYTH1,REGION:Necessary for tight junction and adherens junction localization; Requires for interaction with PARD3,
F1LYQ8	FERM, ARH/RhoGEF and pleckstrin domain protein 1(Farp1)	Rattus norvegicus			GO:0007167~enzyme linked receptor protein signaling pathway,GO:0007416~synapse assembly,GO:0016601~Rac protein signal transduction,GO:0048813~dendrite morphogenesis,GO:0098942~retrograde trans-synaptic signaling by trans-synaptic protein complex,GO:0098974~postsynaptic actin cytoskeleton organization,GO:1904395~positive regulation of skeletal muscle acetylcholine-gated channel clustering,GO:1905606~regulation of presynapse assembly,	GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0009898~cytoplasmic side of plasma membrane,GO:0030175~filopodium,GO:0030425~dendrite,GO:0043197~dendritic spine,GO:0098890~extrinsic component of postsynaptic membrane,GO:0098978~glutamatergic synapse,	GO:0005085~guanyl-nucleotide exchange factor activity,GO:0008092~cytoskeletal protein binding,GO:0031267~small GTPase binding,	IPR000219:DH-domain,IPR000299:FERM_domain,IPR000798:Ez/rad/moesin-like,IPR001849:PH_domain,IPR011993:PH-like_dom_sf,IPR014352:FERM/acyl-CoA-bd_prot_sf,IPR014847:FA,IPR018979:FERM_N,IPR018980:FERM_PH-like_C,IPR019747:FERM_CS,IPR019748:FERM_central,IPR019749:Band_41_domain,IPR029071:Ubiquitin-like_domsf,IPR035899:DBL_dom_sf,IPR035963:FERM_2,IPR041788:FARP1/FARP2/FRMD7_FERM_C,				SM00233:PH,SM00295:B41,SM00325:RhoGEF,SM01195:FA,SM01196:FERM_C,		KW-0472~Membrane,KW-0770~Synapse,KW-0771~Synaptosome,KW-0963~Cytoplasm,KW-0966~Cell projection,KW-1003~Cell membrane,			KW-0677~Repeat,		KW-0217~Developmental protein,KW-0344~Guanine-nucleotide releasing factor,KW-9996~Developmental protein,	KW-0597~Phosphoprotein,	COMPBIAS:Polar residues,DOMAIN:DH,DOMAIN:FERM,DOMAIN:PH,DOMAIN:PH 1,DOMAIN:PH 2,REGION:Disordered,
Q62446	FK506 binding protein 3(Fkbp3)	Mus musculus				GO:0005634~nucleus,	GO:0003755~peptidyl-prolyl cis-trans isomerase activity,GO:0005515~protein binding,GO:0016853~isomerase activity,	IPR001179:PPIase_FKBP_dom,IPR041200:FKBP3_BTHB,IPR043368:FKBP3,IPR046357:PPIase_dom_sf,						KW-0539~Nucleus,					KW-0413~Isomerase,KW-0697~Rotamase,	KW-0007~Acetylation,KW-0597~Phosphoprotein,	DOMAIN:FKBP3 basic tilted helix bundle,DOMAIN:PPIase FKBP-type,REGION:Disordered,
Q9TRY0	FKBP prolyl isomerase 4(FKBP4)	Bos taurus			GO:0010977~negative regulation of neuron projection development,GO:0031111~negative regulation of microtubule polymerization or depolymerization,GO:0061077~chaperone-mediated protein folding,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005829~cytosol,GO:0005874~microtubule,GO:0044295~axonal growth cone,	GO:0003755~peptidyl-prolyl cis-trans isomerase activity,GO:0005515~protein binding,GO:0031072~heat shock protein binding,	IPR001179:PPIase_FKBP_dom,IPR001440:TPR_1,IPR011990:TPR-like_helical_dom_sf,IPR013105:TPR_2,IPR019734:TPR_repeat,IPR046357:PPIase_dom_sf,	bta04915:Estrogen signaling pathway,			SM00028:TPR,		KW-0206~Cytoskeleton,KW-0493~Microtubule,KW-0496~Mitochondrion,KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0677~Repeat,KW-0802~TPR repeat,		KW-0143~Chaperone,KW-0413~Isomerase,KW-0697~Rotamase,	KW-0007~Acetylation,KW-0488~Methylation,KW-0597~Phosphoprotein,	DOMAIN:PPIase FKBP-type,DOMAIN:PPIase FKBP-type 1,DOMAIN:PPIase FKBP-type 2,REGION:Disordered,REGION:Interaction with tubulin,REPEAT:TPR,REPEAT:TPR 1,REPEAT:TPR 2,REPEAT:TPR 3,
Q13451	FKBP prolyl isomerase 5(FKBP5)	Homo sapiens			GO:0000413~protein peptidyl-prolyl isomerization,GO:0006457~protein folding,GO:0009617~response to bacterium,GO:0061077~chaperone-mediated protein folding,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0016020~membrane,GO:0070062~extracellular exosome,	GO:0003755~peptidyl-prolyl cis-trans isomerase activity,GO:0005515~protein binding,GO:0005528~FK506 binding,GO:0031072~heat shock protein binding,	IPR001179:PPIase_FKBP_dom,IPR001440:TPR_1,IPR011990:TPR-like_helical_dom_sf,IPR019734:TPR_repeat,IPR046357:PPIase_dom_sf,	hsa04915:Estrogen signaling pathway,	608516~Major depressive disorder and accelerated response to antidepressant drug treatment,		SM00028:TPR,		KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0677~Repeat,KW-0802~TPR repeat,		KW-0143~Chaperone,KW-0413~Isomerase,KW-0697~Rotamase,	KW-0007~Acetylation,KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:PPIase FKBP-type,DOMAIN:PPIase FKBP-type 1,DOMAIN:PPIase FKBP-type 2,MUTAGEN:K->Q: Mimics acetylation; impaired interaction with AKT1 and PHLPP1; when associated with Q-155.,MUTAGEN:K->Q: Mimics acetylation; impaired interaction with AKT1 and PHLPP1; when associated with Q-28.,MUTAGEN:K->R: Decreased acetylation; promotes interaction with AKT1 and PHLPP1; when associated with R-155.,MUTAGEN:K->R: Decreased acetylation; promotes interaction with AKT1 and PHLPP1; when associated with R-28.,REGION:Disordered,REPEAT:TPR,REPEAT:TPR 1,REPEAT:TPR 2,REPEAT:TPR 3,
P18625	FOS like 2, AP-1 transcription factor subunit(FOSL2)	Gallus gallus			GO:0000902~cell morphogenesis,GO:0001649~osteoblast differentiation,GO:0001666~response to hypoxia,GO:0001865~NK T cell differentiation,GO:0002062~chondrocyte differentiation,GO:0002437~inflammatory response to antigenic stimulus,GO:0003334~keratinocyte development,GO:0003417~growth plate cartilage development,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0009410~response to xenobiotic stimulus,GO:0010467~gene expression,GO:0030183~B cell differentiation,GO:0030223~neutrophil differentiation,GO:0030225~macrophage differentiation,GO:0030282~bone mineralization,GO:0030316~osteoclast differentiation,GO:0032496~response to lipopolysaccharide,GO:0032964~collagen biosynthetic process,GO:0035264~multicellular organism growth,GO:0035962~response to interleukin-13,GO:0035988~chondrocyte proliferation,GO:0036446~myofibroblast differentiation,GO:0040014~regulation of multicellular organism growth,GO:0042100~B cell proliferation,GO:0042593~glucose homeostasis,GO:0045087~innate immune response,GO:0045444~fat cell differentiation,GO:0048146~positive regulation of fibroblast proliferation,GO:0048745~smooth muscle tissue development,GO:0048771~tissue remodeling,GO:0048873~homeostasis of number of cells within a tissue,GO:0050852~T cell receptor signaling pathway,GO:0051384~response to glucocorticoid,GO:0060427~lung connective tissue development,GO:0060613~fat pad development,GO:0061144~alveolar secondary septum development,GO:0070254~mucus secretion,GO:0098760~response to interleukin-7,GO:1901142~insulin metabolic process,GO:1904606~fat cell apoptotic process,GO:1904760~regulation of myofibroblast differentiation,GO:1904975~response to bleomycin,GO:1990823~response to leukemia inhibitory factor,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0090575~RNA polymerase II transcription factor complex,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,	IPR000837:AP-1,IPR004827:bZIP,IPR046347:bZIP_sf,				SM00338:BRLZ,		KW-0539~Nucleus,		KW-0656~Proto-oncogene,	KW-0175~Coiled coil,		KW-0238~DNA-binding,		COMPBIAS:Polar residues,DOMAIN:BZIP,DOMAIN:bZIP,REGION:Basic motif,REGION:Disordered,REGION:Leucine-zipper,
Q5H8C1	FRAS1 related extracellular matrix 1(FREM1)	Homo sapiens			GO:0007154~cell communication,GO:0007160~cell-matrix adhesion,GO:0009653~anatomical structure morphogenesis,GO:0097094~craniofacial suture morphogenesis,	GO:0005576~extracellular region,GO:0005604~basement membrane,GO:0016020~membrane,	GO:0005515~protein binding,GO:0030246~carbohydrate binding,GO:0046872~metal ion binding,	IPR001304:C-type_lectin-like,IPR003644:Calx_beta,IPR016186:C-type_lectin-like/link_sf,IPR016187:CTDL_fold,IPR038081:CalX-like_sf,IPR039005:CSPG_rpt,IPR045658:FRAS1-rel_N,	hsa04512:ECM-receptor interaction,	248450~Manitoba oculotrichoanal syndrome,608980~Bifid nose with or without anorectal and renal anomalies,614485~Trigonocephaly 2,		SM00034:CLECT,	KW-0130~Cell adhesion,	KW-0084~Basement membrane,KW-0272~Extracellular matrix,KW-0964~Secreted,		KW-0225~Disease variant,KW-0989~Craniosynostosis,	KW-0677~Repeat,KW-0732~Signal,	KW-0106~Calcium,KW-0430~Lectin,KW-0479~Metal-binding,	KW-0217~Developmental protein,KW-9996~Developmental protein,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:C-type lectin,DOMAIN:Calx-beta,DOMAIN:FRAS1-related extracellular matrix protein N-terminal,MOTIF:Cell attachment site,REPEAT:CSPG,REPEAT:CSPG 1,REPEAT:CSPG 10,REPEAT:CSPG 11,REPEAT:CSPG 12,REPEAT:CSPG 2,REPEAT:CSPG 3,REPEAT:CSPG 4,REPEAT:CSPG 5,REPEAT:CSPG 6,REPEAT:CSPG 7,REPEAT:CSPG 8,REPEAT:CSPG 9,
P25445	Fas cell surface death receptor(FAS)	Homo sapiens	38.Cell_cycle_arrest_and_apoptosis_ceramide,39.Deg_of_Chromosomal_DNA,46.P13K_PTEN,58.(CD40L)_immnosurveillance,72.IAP_interaction_with_cell_death_pathways,97.Immune_injury_MS-lesions_MS_antigen,	h_asbcellPathway:Antigen Dependent B Cell Activation,h_bbcellPathway:Bystander B Cell Activation,h_ctlPathway:CTL mediated immune response against target cells ,h_fasPathway:FAS signaling pathway ( CD95 ),h_hivnefPathway:HIV-I Nef: negative effector of Fas and TNF,h_hsp27Pathway:Stress Induction of HSP Regulation,h_il2rbPathway:IL-2 Receptor Beta Chain in T cell Activation,h_keratinocytePathway:Keratinocyte Differentiation,h_pmlPathway:Regulation of transcriptional activity by PML,h_tcapoptosisPathway:HIV Induced T Cell Apoptosis,	GO:0001934~positive regulation of protein phosphorylation,GO:0006915~apoptotic process,GO:0006924~activation-induced cell death of T cells,GO:0006955~immune response,GO:0007165~signal transduction,GO:0032872~regulation of stress-activated MAPK cascade,GO:0033209~tumor necrosis factor-mediated signaling pathway,GO:0034198~cellular response to amino acid starvation,GO:0036337~Fas signaling pathway,GO:0042981~regulation of apoptotic process,GO:0043065~positive regulation of apoptotic process,GO:0043066~negative regulation of apoptotic process,GO:0065003~macromolecular complex assembly,GO:0071260~cellular response to mechanical stimulus,GO:0071455~cellular response to hyperoxia,GO:0097049~motor neuron apoptotic process,GO:0097191~extrinsic apoptotic signaling pathway,GO:0097192~extrinsic apoptotic signaling pathway in absence of ligand,GO:0097527~necroptotic signaling pathway,GO:2001235~positive regulation of apoptotic signaling pathway,GO:2001269~positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,	GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0009897~external side of plasma membrane,GO:0009986~cell surface,GO:0016020~membrane,GO:0016604~nuclear body,GO:0031264~death-inducing signaling complex,GO:0031265~CD95 death-inducing signaling complex,GO:0045121~membrane raft,GO:0070062~extracellular exosome,	GO:0004888~transmembrane signaling receptor activity,GO:0005031~tumor necrosis factor-activated receptor activity,GO:0005515~protein binding,GO:0005516~calmodulin binding,GO:0019900~kinase binding,GO:0038023~signaling receptor activity,GO:0042802~identical protein binding,	IPR000488:Death_domain,IPR001368:TNFR/NGFR_Cys_rich_reg,IPR008063:Fas_rcpt,IPR011029:DEATH-like_dom_sf,IPR033998:TNFRSF6_death,IPR033999:TNFRSF6_N,	hsa01524:Platinum drug resistance,hsa04010:MAPK signaling pathway,hsa04060:Cytokine-cytokine receptor interaction,hsa04115:p53 signaling pathway,hsa04210:Apoptosis,hsa04217:Necroptosis,hsa04650:Natural killer cell mediated cytotoxicity,hsa04668:TNF signaling pathway,hsa04932:Non-alcoholic fatty liver disease,hsa04936:Alcoholic liver disease,hsa04940:Type I diabetes mellitus,hsa05010:Alzheimer disease,hsa05022:Pathways of neurodegeneration - multiple diseases,hsa05130:Pathogenic Escherichia coli infection,hsa05142:Chagas disease,hsa05143:African trypanosomiasis,hsa05160:Hepatitis C,hsa05161:Hepatitis B,hsa05162:Measles,hsa05163:Human cytomegalovirus infection,hsa05164:Influenza A,hsa05165:Human papillomavirus infection,hsa05167:Kaposi sarcoma-associated herpesvirus infection,hsa05168:Herpes simplex virus 1 infection,hsa05169:Epstein-Barr virus infection,hsa05170:Human immunodeficiency virus 1 infection,hsa05200:Pathways in cancer,hsa05205:Proteoglycans in cancer,hsa05320:Autoimmune thyroid disease,hsa05330:Allograft rejection,hsa05332:Graft-versus-host disease,hsa05417:Lipid and atherosclerosis,	601859~Autoimmune lymphoproliferative syndrome,601859~Autoimmune lymphoproliferative syndrome, type IA,Squamous cell carcinoma, burn scar-related, somatic~Squamous cell carcinoma, burn scar-related, somatic,		SM00005:DEATH,SM00208:TNFR,	KW-0053~Apoptosis,	KW-0472~Membrane,KW-0964~Secreted,KW-1003~Cell membrane,		KW-0225~Disease variant,	KW-0677~Repeat,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0112~Calmodulin-binding,KW-0675~Receptor,	KW-0325~Glycoprotein,KW-0449~Lipoprotein,KW-0564~Palmitate,KW-0597~Phosphoprotein,KW-1015~Disulfide bond,	CARBOHYD:(Microbial infection) N-beta-linked (GlcNAc) arginine,CARBOHYD:N-linked (GlcNAc...) asparagine,CARBOHYD:O-linked (GalNAc...) threonine,DOMAIN:Death,DOMAIN:TNFR-Cys,LIPID:S-palmitoyl cysteine,MUTAGEN:C->V: Loss of palmitoylation.,MUTAGEN:E->K: Loss of interaction with FADD.,MUTAGEN:I->D: Constitutive activation. Promotes apoptosis, both in the presence and in the absence of stimulation by a ligand.,MUTAGEN:K->D: Strongly decreased interaction with FADD.,MUTAGEN:Q->K: Loss of interaction with FADD.,MUTAGEN:R->A: Abolished GlcNAcylation by E.coli NleB1.,MUTAGEN:R->E: Strongly decreased interaction with FADD.,MUTAGEN:Y->D: Decreased interaction with FADD.,REGION:Interaction with CALM,REGION:Interaction with HIPK3,REPEAT:TNFR-Cys,REPEAT:TNFR-Cys 1,REPEAT:TNFR-Cys 2,REPEAT:TNFR-Cys 3,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q5ZKM1	FtsJ homolog 3(FTSJ3)	Gallus gallus			GO:0000463~maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),GO:0000466~maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),GO:0001510~RNA methylation,GO:0031167~rRNA methylation,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0030687~preribosome, large subunit precursor,GO:0030688~preribosome, small subunit precursor,	GO:0008171~O-methyltransferase activity,GO:0008649~rRNA methyltransferase activity,GO:0008650~rRNA (uridine-2'-O-)-methyltransferase activity,GO:0016435~rRNA (guanine) methyltransferase activity,	IPR002877:RNA_MeTrfase_FtsJ_dom,IPR012920:rRNA_MeTfrase_SPB1-like_C,IPR015507:rRNA-MeTfrase_E,IPR024576:rRNA_MeTfrase_Spb1_DUF3381,IPR028589:SPB1-like,IPR029063:SAM-dependent_MTases_sf,					KW-0690~Ribosome biogenesis,KW-0698~rRNA processing,	KW-0539~Nucleus,			KW-0175~Coiled coil,	KW-0949~S-adenosyl-L-methionine,	KW-0489~Methyltransferase,KW-0808~Transferase,		ACT_SITE:Proton acceptor,COMPBIAS:Basic and acidic residues,DOMAIN:DUF3381,DOMAIN:Ribosomal RNA methyltransferase FtsJ,DOMAIN:Ribosomal RNA methyltransferase SPB1-like C-terminal,REGION:Disordered,
P50151	G protein subunit gamma 10(GNG10)	Homo sapiens			GO:0007165~signal transduction,GO:0007186~G-protein coupled receptor signaling pathway,	GO:0005834~heterotrimeric G-protein complex,GO:0005886~plasma membrane,	GO:0003924~GTPase activity,GO:0005515~protein binding,GO:0031681~G-protein beta-subunit binding,	IPR001770:Gprotein-gamma,IPR015898:G-protein_gamma-like_dom,IPR036284:GGL_sf,	hsa04014:Ras signaling pathway,hsa04062:Chemokine signaling pathway,hsa04151:PI3K-Akt signaling pathway,hsa04371:Apelin signaling pathway,hsa04713:Circadian entrainment,hsa04723:Retrograde endocannabinoid signaling,hsa04724:Glutamatergic synapse,hsa04725:Cholinergic synapse,hsa04726:Serotonergic synapse,hsa04727:GABAergic synapse,hsa04728:Dopaminergic synapse,hsa04926:Relaxin signaling pathway,hsa05032:Morphine addiction,hsa05034:Alcoholism,hsa05163:Human cytomegalovirus infection,hsa05167:Kaposi sarcoma-associated herpesvirus infection,hsa05170:Human immunodeficiency virus 1 infection,hsa05200:Pathways in cancer,			SM00224:GGL,SM01224:G_gamma,		KW-0472~Membrane,KW-1003~Cell membrane,					KW-0807~Transducer,	KW-0007~Acetylation,KW-0449~Lipoprotein,KW-0488~Methylation,KW-0636~Prenylation,	LIPID:S-geranylgeranyl cysteine,PROPEP:Removed in mature form,
Q9I918	G protein-coupled receptor 173(gpr173)	Danio rerio			GO:0007165~signal transduction,GO:0007186~G-protein coupled receptor signaling pathway,	GO:0005886~plasma membrane,GO:0016020~membrane,	GO:0004930~G-protein coupled receptor activity,	IPR000276:GPCR_Rhodpsn,IPR017452:GPCR_Rhodpsn_7TM,						KW-0472~Membrane,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0297~G-protein coupled receptor,KW-0675~Receptor,KW-0807~Transducer,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:G-protein coupled receptors family 1 profile,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,TRANSMEM:Helical; Name=1,TRANSMEM:Helical; Name=2,TRANSMEM:Helical; Name=3,TRANSMEM:Helical; Name=4,TRANSMEM:Helical; Name=5,TRANSMEM:Helical; Name=6,TRANSMEM:Helical; Name=7,
O60883	G protein-coupled receptor 37 like 1(GPR37L1)	Homo sapiens			GO:0003085~negative regulation of systemic arterial blood pressure,GO:0007193~adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway,GO:0007224~smoothened signaling pathway,GO:0021940~positive regulation of cerebellar granule cell precursor proliferation,GO:0034614~cellular response to reactive oxygen species,GO:0043410~positive regulation of MAPK cascade,GO:0045665~negative regulation of neuron differentiation,GO:0045879~negative regulation of smoothened signaling pathway,GO:0048712~negative regulation of astrocyte differentiation,GO:0060020~Bergmann glial cell differentiation,	GO:0005886~plasma membrane,GO:0016020~membrane,GO:0043235~receptor complex,GO:0060170~ciliary membrane,	GO:0004930~G-protein coupled receptor activity,GO:0005515~protein binding,GO:0008528~G-protein coupled peptide receptor activity,GO:0036505~prosaposin receptor activity,GO:0042277~peptide binding,	IPR000276:GPCR_Rhodpsn,IPR003909:GPR37_orph,IPR017452:GPCR_Rhodpsn_7TM,						KW-0472~Membrane,KW-0966~Cell projection,KW-1003~Cell membrane,			KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0297~G-protein coupled receptor,KW-0675~Receptor,KW-0807~Transducer,	KW-0325~Glycoprotein,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,CARBOHYD:O-linked (GalNAc...) serine,CARBOHYD:O-linked (GalNAc...) threonine,COMPBIAS:Basic and acidic residues,DOMAIN:G-protein coupled receptors family 1 profile,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,TRANSMEM:Helical; Name=1,TRANSMEM:Helical; Name=2,TRANSMEM:Helical; Name=3,TRANSMEM:Helical; Name=4,TRANSMEM:Helical; Name=5,TRANSMEM:Helical; Name=6,TRANSMEM:Helical; Name=7,
Q8C010	G protein-coupled receptor 61(Gpr61)	Mus musculus			GO:0007165~signal transduction,GO:0007186~G-protein coupled receptor signaling pathway,GO:0038035~G-protein coupled receptor signaling in absence of ligand,GO:0043950~positive regulation of cAMP-mediated signaling,	GO:0005768~endosome,GO:0005886~plasma membrane,GO:0010008~endosome membrane,GO:0016020~membrane,GO:0043235~receptor complex,	GO:0004930~G-protein coupled receptor activity,GO:1990763~arrestin family protein binding,	IPR000276:GPCR_Rhodpsn,IPR017452:GPCR_Rhodpsn_7TM,						KW-0472~Membrane,KW-0967~Endosome,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0297~G-protein coupled receptor,KW-0675~Receptor,KW-0807~Transducer,	KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Polar residues,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical; Name=1,TRANSMEM:Helical; Name=2,TRANSMEM:Helical; Name=3,TRANSMEM:Helical; Name=4,TRANSMEM:Helical; Name=5,TRANSMEM:Helical; Name=6,TRANSMEM:Helical; Name=7,
Q5F4A1	G2/M-phase specific E3 ubiquitin protein ligase(G2E3)	Gallus gallus			GO:0006915~apoptotic process,GO:0016567~protein ubiquitination,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005737~cytoplasm,	GO:0004842~ubiquitin-protein transferase activity,GO:0046872~metal ion binding,	IPR000569:HECT_dom,IPR001965:Znf_PHD,IPR011011:Znf_FYVE_PHD,IPR013083:Znf_RING/FYVE/PHD,IPR034732:EPHD,IPR035983:Hect_E3_ubiquitin_ligase,IPR042012:PHF7/G2E3_PHD,IPR042013:PHF7/G2E3_ePHD,				SM00119:HECTc,SM00249:PHD,	KW-0053~Apoptosis,KW-0833~Ubl conjugation pathway,	KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0175~Coiled coil,KW-0677~Repeat,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0217~Developmental protein,KW-0808~Transferase,KW-9996~Developmental protein,		DOMAIN:HECT,DOMAIN:PHD-type,ZN_FING:C2HC pre-PHD-type,ZN_FING:PHD-type 1,ZN_FING:PHD-type 2; degenerate,ZN_FING:PHD-type 3,
O00451	GDNF family receptor alpha 2(GFRA2)	Homo sapiens			GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0007399~nervous system development,GO:0035860~glial cell-derived neurotrophic factor receptor signaling pathway,	GO:0005886~plasma membrane,GO:0009897~external side of plasma membrane,GO:0019898~extrinsic component of membrane,GO:0043235~receptor complex,	GO:0016167~glial cell-derived neurotrophic factor receptor activity,GO:0038023~signaling receptor activity,	IPR003438:GDNF_rcpt,IPR003504:GDNF_rcpt_a2,IPR016017:GDNF/GAS1,IPR017372:Glial_neurotroph_fac_rcpt_a1/2,IPR037193:GDNF_alpha,			PIRSF038071:GDNF_family_receptor_alpha,	SM00907:GDNF,		KW-0472~Membrane,KW-1003~Cell membrane,			KW-0732~Signal,		KW-0675~Receptor,	KW-0325~Glycoprotein,KW-0336~GPI-anchor,KW-0449~Lipoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Polar residues,DOMAIN:GDNF/GAS1,LIPID:GPI-anchor amidated serine,PROPEP:Removed in mature form,REGION:Disordered,
Q8K3X2	GDP-L-fucose synthase(Gfus)	Cricetulus griseus			GO:0009226~nucleotide-sugar biosynthetic process,GO:0010595~positive regulation of endothelial cell migration,GO:0042351~'de novo' GDP-L-fucose biosynthetic process,GO:1904906~positive regulation of endothelial cell-matrix adhesion via fibronectin,		GO:0016491~oxidoreductase activity,GO:0016853~isomerase activity,GO:0050577~GDP-L-fucose synthase activity,	IPR001509:Epimerase_deHydtase,IPR028614:GDP_fucose/colitose_synth,IPR036291:NAD(P)-bd_dom_sf,	cge00051:Fructose and mannose metabolism,cge00520:Amino sugar and nucleotide sugar metabolism,cge01100:Metabolic pathways,cge01250:Biosynthesis of nucleotide sugars,									KW-0521~NADP,	KW-0413~Isomerase,KW-0511~Multifunctional enzyme,KW-0560~Oxidoreductase,		ACT_SITE:Proton donor/acceptor,DOMAIN:NAD-dependent epimerase/dehydratase,SITE:Important for catalytic activity,SITE:Lowers pKa of active site Tyr,
Q6GMK8	GDP-mannose pyrophosphorylase Aa(gmppaa)	Danio rerio			GO:0009058~biosynthetic process,GO:0009298~GDP-mannose biosynthetic process,	GO:0005737~cytoplasm,	GO:0000166~nucleotide binding,GO:0004475~mannose-1-phosphate guanylyltransferase activity,GO:0005525~GTP binding,GO:0016740~transferase activity,GO:0016779~nucleotidyltransferase activity,	IPR001451:Hexapep,IPR005835:NTP_transferase_dom,IPR018357:Hexapep_transf_CS,IPR029044:Nucleotide-diphossugar_trans,	dre00051:Fructose and mannose metabolism,dre00520:Amino sugar and nucleotide sugar metabolism,dre01100:Metabolic pathways,dre01240:Biosynthesis of cofactors,dre01250:Biosynthesis of nucleotide sugars,									KW-0342~GTP-binding,KW-0547~Nucleotide-binding,	KW-0548~Nucleotidyltransferase,KW-0808~Transferase,		DOMAIN:Nucleotidyl transferase,
Q7ZT47	GINS complex subunit 1 (Psf1 homolog) S homeolog(gins1.S)	Xenopus laevis			GO:0006260~DNA replication,	GO:0000811~GINS complex,GO:0005634~nucleus,GO:0005694~chromosome,GO:0071162~CMG complex,	GO:0003682~chromatin binding,	IPR005339:GINS_Psf1,IPR021151:GINS_A,IPR036224:GINS_bundle-like_dom_sf,					KW-0235~DNA replication,	KW-0158~Chromosome,KW-0539~Nucleus,
Q7ZT48	GINS complex subunit 4 (Sld5 homolog) L homeolog(gins4.L)	Xenopus laevis			GO:0006260~DNA replication,GO:0006261~DNA-dependent DNA replication,	GO:0000811~GINS complex,GO:0005634~nucleus,GO:0005694~chromosome,GO:0005737~cytoplasm,GO:0071162~CMG complex,	GO:0003682~chromatin binding,	IPR008591:GINS_Sld5,IPR021151:GINS_A,IPR031633:SLD5_C,IPR036224:GINS_bundle-like_dom_sf,IPR038749:Sld5_GINS_A,			PIRSF007764:Sld5,		KW-0235~DNA replication,	KW-0158~Chromosome,KW-0539~Nucleus,KW-0963~Cytoplasm,							DOMAIN:DNA replication complex GINS protein SLD5 C-terminal,DOMAIN:GINS subunit,
Q68FF6	GIT ArfGAP 1(Git1)	Mus musculus			GO:0001771~immunological synapse formation,GO:0001957~intramembranous ossification,GO:0007420~brain development,GO:0007626~locomotory behavior,GO:0008277~regulation of G-protein coupled receptor protein signaling pathway,GO:0032012~regulation of ARF protein signal transduction,GO:0032013~negative regulation of ARF protein signal transduction,GO:0032465~regulation of cytokinesis,GO:0032691~negative regulation of interleukin-1 beta production,GO:0036465~synaptic vesicle recycling,GO:0045454~cell redox homeostasis,GO:0045820~negative regulation of glycolytic process,GO:0048013~ephrin receptor signaling pathway,GO:0048666~neuron development,GO:0060996~dendritic spine development,GO:0061743~motor learning,GO:0071222~cellular response to lipopolysaccharide,GO:0071364~cellular response to epidermal growth factor stimulus,GO:0090063~positive regulation of microtubule nucleation,GO:0099645~neurotransmitter receptor localization to postsynaptic specialization membrane,GO:2000300~regulation of synaptic vesicle exocytosis,GO:2000646~positive regulation of receptor catabolic process,	GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005768~endosome,GO:0005813~centrosome,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005925~focal adhesion,GO:0014069~postsynaptic density,GO:0030027~lamellipodium,GO:0030425~dendrite,GO:0030426~growth cone,GO:0042995~cell projection,GO:0043005~neuron projection,GO:0044305~calyx of Held,GO:0045202~synapse,GO:0060076~excitatory synapse,GO:0060077~inhibitory synapse,GO:0070161~anchoring junction,GO:0097431~mitotic spindle pole,GO:0098794~postsynapse,GO:0098978~glutamatergic synapse,GO:0098982~GABA-ergic synapse,	GO:0005096~GTPase activator activity,GO:0005515~protein binding,GO:0019903~protein phosphatase binding,GO:0031267~small GTPase binding,GO:0042802~identical protein binding,GO:0043015~gamma-tubulin binding,GO:0044877~macromolecular complex binding,GO:0046872~metal ion binding,GO:0097110~scaffold protein binding,GO:0098879~structural constituent of postsynaptic specialization,GO:1990782~protein tyrosine kinase binding,	IPR001164:ArfGAP_dom,IPR002110:Ankyrin_rpt,IPR013724:GIT_SHD,IPR022018:GIT1_C,IPR032352:GIT1/2_CC,IPR036770:Ankyrin_rpt-contain_sf,IPR037278:ARFGAP/RecO,IPR038508:ArfGAP_dom_sf,IPR047161:GIT-like,	mmu04144:Endocytosis,mmu04810:Regulation of actin cytoskeleton,			SM00105:ArfGap,SM00248:ANK,SM00555:GIT,		KW-0206~Cytoskeleton,KW-0770~Synapse,KW-0963~Cytoplasm,KW-0965~Cell junction,KW-0966~Cell projection,			KW-0040~ANK repeat,KW-0175~Coiled coil,KW-0677~Repeat,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0343~GTPase activation,	KW-0597~Phosphoprotein,	COMPBIAS:Polar residues,DOMAIN:ARF GTPase-activating protein GIT1 C-terminal,DOMAIN:Arf-GAP,MUTAGEN:Missing: Loss of interaction with MAPK1.,REGION:Disordered,REGION:Interaction with ARHGEF7,REGION:Interaction with IKBKG,REGION:Interaction with MAPK1,REGION:Interaction with NCK2 and GRIN3A,REGION:Interaction with PCLO,REGION:Interaction with PTK2/FAK1,REGION:Interaction with PXN and TGFB1I1,REGION:Interaction with gamma-tubulin and localization to the centrosome,REGION:Required for localization at synapses,REPEAT:ANK,REPEAT:ANK 1,REPEAT:ANK 2,REPEAT:ANK 3,ZN_FING:C4-type,
Q8NHV1	GTPase, IMAP family member 7(GIMAP7)	Homo sapiens			GO:0046039~GTP metabolic process,	GO:0005783~endoplasmic reticulum,GO:0005794~Golgi apparatus,GO:0005811~lipid particle,	GO:0003924~GTPase activity,GO:0005515~protein binding,GO:0005525~GTP binding,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,	IPR006703:G_AIG1,IPR027417:P-loop_NTPase,IPR045058:GIMA/IAN/Toc,						KW-0256~Endoplasmic reticulum,KW-0333~Golgi apparatus,KW-0551~Lipid droplet,KW-0963~Cytoplasm,			KW-0175~Coiled coil,	KW-0342~GTP-binding,KW-0547~Nucleotide-binding,			DOMAIN:AIG1-type G,MUTAGEN:E->W: Impairs dimerization and abolishes GTPase activity. No effect on GTP binding.,MUTAGEN:R->D: Abolishes GTPase activity. No effect on GTP binding and on dimerization.,REGION:G1,REGION:G2,REGION:G3,REGION:G4,REGION:G5,SITE:Important for catalytic activity,
Q6GM86	H2A.X variant histone S homeolog(h2ax.S)	Xenopus laevis			GO:0006281~DNA repair,GO:0006310~DNA recombination,GO:0006974~cellular response to DNA damage stimulus,GO:0007049~cell cycle,GO:0051321~meiotic cell cycle,	GO:0000786~nucleosome,GO:0005634~nucleus,GO:0005694~chromosome,GO:0005813~centrosome,	GO:0003677~DNA binding,GO:0030527~structural constituent of chromatin,GO:0046982~protein heterodimerization activity,	IPR002119:Histone_H2A,IPR007125:Histone_H2A/H2B/H3,IPR009072:Histone-fold,IPR032454:Histone_H2A_C,IPR032458:Histone_H2A_CS,	xla03082:ATP-dependent chromatin remodeling,xla04217:Necroptosis,			SM00414:H2A,	KW-0131~Cell cycle,KW-0227~DNA damage,KW-0233~DNA recombination,KW-0234~DNA repair,KW-0469~Meiosis,	KW-0158~Chromosome,KW-0539~Nucleus,KW-0544~Nucleosome core,					KW-0238~DNA-binding,	KW-0007~Acetylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Polar residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),DOMAIN:Histone H2A C-terminal,DOMAIN:Histone H2A/H2B/H3,MOTIF:[ST]-Q motif,REGION:Disordered,
Q9NVX0	HAUS augmin like complex subunit 2(HAUS2)	Homo sapiens			GO:0007020~microtubule nucleation,GO:0007098~centrosome cycle,GO:0010968~regulation of microtubule nucleation,GO:0031023~microtubule organizing center organization,GO:0051225~spindle assembly,GO:0051301~cell division,	GO:0005813~centrosome,GO:0005829~cytosol,GO:0070652~HAUS complex,GO:1990498~mitotic spindle microtubule,	GO:0005515~protein binding,	IPR026242:HAUS2_metazoa,IPR028346:HAUS2,					KW-0131~Cell cycle,KW-0132~Cell division,KW-0498~Mitosis,	KW-0206~Cytoskeleton,KW-0493~Microtubule,KW-0963~Cytoplasm,			KW-0175~Coiled coil,
Q9BT25	HAUS augmin like complex subunit 8(HAUS8)	Homo sapiens			GO:0007098~centrosome cycle,GO:0010968~regulation of microtubule nucleation,GO:0051225~spindle assembly,GO:0051301~cell division,	GO:0000922~spindle pole,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005829~cytosol,GO:0005880~nuclear microtubule,GO:0070652~HAUS complex,GO:1990498~mitotic spindle microtubule,	GO:0005515~protein binding,GO:0008017~microtubule binding,						KW-0131~Cell cycle,KW-0132~Cell division,KW-0498~Mitosis,	KW-0206~Cytoskeleton,KW-0493~Microtubule,KW-0963~Cytoplasm,			KW-0175~Coiled coil,			KW-0007~Acetylation,KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,REGION:Disordered,
Q8BHX1	HAUS augmin-like complex, subunit 1(Haus1)	Mus musculus			GO:0007049~cell cycle,GO:0007098~centrosome cycle,GO:0051225~spindle assembly,GO:0051301~cell division,	GO:0000922~spindle pole,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005874~microtubule,GO:0070652~HAUS complex,GO:1990498~mitotic spindle microtubule,		IPR026243:HAUS1,					KW-0131~Cell cycle,KW-0132~Cell division,KW-0498~Mitosis,	KW-0206~Cytoskeleton,KW-0493~Microtubule,KW-0963~Cytoplasm,			KW-0175~Coiled coil,
Q8BKT8	HAUS augmin-like complex, subunit 7(Haus7)	Mus musculus			GO:0007049~cell cycle,GO:0007098~centrosome cycle,GO:0051225~spindle assembly,GO:0051301~cell division,	GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005856~cytoskeleton,GO:0005874~microtubule,GO:0005886~plasma membrane,GO:0070652~HAUS complex,GO:1990498~mitotic spindle microtubule,	GO:0031996~thioesterase binding,GO:0051011~microtubule minus-end binding,	IPR029711:Haus7-like,					KW-0131~Cell cycle,KW-0132~Cell division,KW-0498~Mitosis,	KW-0206~Cytoskeleton,KW-0493~Microtubule,KW-0963~Cytoplasm,							COMPBIAS:Polar residues,REGION:Disordered,
Q15034	HECT and RLD domain containing E3 ubiquitin protein ligase 3(HERC3)	Homo sapiens			GO:0006511~ubiquitin-dependent protein catabolic process,GO:0016567~protein ubiquitination,	GO:0005737~cytoplasm,GO:0031410~cytoplasmic vesicle,	GO:0004842~ubiquitin-protein transferase activity,GO:0061630~ubiquitin protein ligase activity,	IPR000408:Reg_chr_condens,IPR000569:HECT_dom,IPR009091:RCC1/BLIP-II,IPR028641:RCC2,IPR035983:Hect_E3_ubiquitin_ligase,	hsa04120:Ubiquitin mediated proteolysis,			SM00119:HECTc,	KW-0833~Ubl conjugation pathway,	KW-0963~Cytoplasm,KW-0968~Cytoplasmic vesicle,			KW-0677~Repeat,		KW-0808~Transferase,	KW-0832~Ubl conjugation,	ACT_SITE:Glycyl thioester intermediate,DOMAIN:HECT,REPEAT:RCC1,REPEAT:RCC1 1,REPEAT:RCC1 2,REPEAT:RCC1 3,REPEAT:RCC1 4,REPEAT:RCC1 5,REPEAT:RCC1 6,REPEAT:RCC1 7,
Q5PQN1	HECT and RLD domain containing E3 ubiquitin protein ligase 4(Herc4)	Rattus norvegicus			GO:0006511~ubiquitin-dependent protein catabolic process,GO:0007283~spermatogenesis,GO:0016567~protein ubiquitination,GO:0030154~cell differentiation,GO:0045879~negative regulation of smoothened signaling pathway,	GO:0001650~fibrillar center,GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0004842~ubiquitin-protein transferase activity,GO:0061630~ubiquitin protein ligase activity,	IPR000408:Reg_chr_condens,IPR000569:HECT_dom,IPR009091:RCC1/BLIP-II,IPR035983:Hect_E3_ubiquitin_ligase,	rno04120:Ubiquitin mediated proteolysis,			SM00119:HECTc,	KW-0221~Differentiation,KW-0744~Spermatogenesis,KW-0833~Ubl conjugation pathway,	KW-0963~Cytoplasm,			KW-0677~Repeat,		KW-0808~Transferase,		ACT_SITE:Glycyl thioester intermediate,DOMAIN:HECT,REPEAT:RCC1,REPEAT:RCC1 1,REPEAT:RCC1 2,REPEAT:RCC1 3,REPEAT:RCC1 4,REPEAT:RCC1 5,REPEAT:RCC1 6,REPEAT:RCC1 7,
Q8IVU3	HECT and RLD domain containing E3 ubiquitin protein ligase family member 6(HERC6)	Homo sapiens			GO:0000209~protein polyubiquitination,GO:0002244~hematopoietic progenitor cell differentiation,GO:0006511~ubiquitin-dependent protein catabolic process,GO:0009617~response to bacterium,GO:0016567~protein ubiquitination,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0061630~ubiquitin protein ligase activity,	IPR000408:Reg_chr_condens,IPR000569:HECT_dom,IPR009091:RCC1/BLIP-II,IPR035983:Hect_E3_ubiquitin_ligase,IPR044611:E3A/B/C-like,				SM00119:HECTc,	KW-0833~Ubl conjugation pathway,	KW-0963~Cytoplasm,			KW-0677~Repeat,		KW-0808~Transferase,		ACT_SITE:Glycyl thioester intermediate,DOMAIN:HECT,REGION:Disordered,REPEAT:RCC1,REPEAT:RCC1 1,REPEAT:RCC1 2,REPEAT:RCC1 3,REPEAT:RCC1 4,REPEAT:RCC1 5,
F4JTS8	Histidine kinase-, DNA gyrase B-, and HSP90-like ATPase family protein(NOV)	Arabidopsis thaliana			GO:0001708~cell fate specification,GO:0009793~embryo development ending in seed dormancy,GO:0009926~auxin polar transport,GO:0010305~leaf vascular tissue pattern formation,GO:0019827~stem cell population maintenance,GO:0048364~root development,	GO:0005634~nucleus,		IPR024975:NOV_C,IPR036890:HATPase_C_sf,						KW-0539~Nucleus,							COMPBIAS:Basic and acidic residues,DOMAIN:Protein NO VEIN C-terminal,MOTIF:Nuclear localization signal 1,MOTIF:Nuclear localization signal 2,MUTAGEN:P->S: In nov-1; many auxin-dependent development defects including narrow rosette leaves with few veins. Abnormal presence of starch granules in roots columella stem cells associated with an altered maintenance of cortex/endodermis stem cells. Enhanced effect of 1-naphthylphthalamic acid (NPA), an inhibitor of polar auxin transport. Disturbed subcellular localizations of PIN1, PIN2, PIN3, PIN4 and PIN7 in leaf primordia and root tips.,REGION:Disordered,
Q08881	IL2 inducible T cell kinase(ITK)	Homo sapiens		h_ctla4Pathway:The Co-Stimulatory Signal During T-cell Activation,	GO:0001819~positive regulation of cytokine production,GO:0001865~NK T cell differentiation,GO:0002250~adaptive immune response,GO:0006468~protein phosphorylation,GO:0006968~cellular defense response,GO:0007165~signal transduction,GO:0007202~activation of phospholipase C activity,GO:0016310~phosphorylation,GO:0035556~intracellular signal transduction,GO:0042110~T cell activation,GO:0046629~gamma-delta T cell activation,GO:0050852~T cell receptor signaling pathway,GO:0050853~B cell receptor signaling pathway,	GO:0005634~nucleus,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005911~cell-cell junction,	GO:0004715~non-membrane spanning protein tyrosine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0046872~metal ion binding,	IPR000719:Prot_kinase_dom,IPR000980:SH2,IPR001245:Ser-Thr/Tyr_kinase_cat_dom,IPR001452:SH3_domain,IPR001562:Znf_Btk_motif,IPR001849:PH_domain,IPR008266:Tyr_kinase_AS,IPR011009:Kinase-like_dom_sf,IPR011993:PH-like_dom_sf,IPR017441:Protein_kinase_ATP_BS,IPR020635:Tyr_kinase_cat_dom,IPR035583:ITK_SH3,IPR036028:SH3-like_dom_sf,IPR036860:SH2_dom_sf,IPR042785:ITK_PTKc,IPR043539:Grb2-like,	hsa04062:Chemokine signaling pathway,hsa04660:T cell receptor signaling pathway,hsa04670:Leukocyte transendothelial migration,	613011~Lymphoproliferative syndrome 1,		SM00107:BTK,SM00219:TyrKc,SM00233:PH,SM00252:SH2,SM00326:SH3,	KW-0391~Immunity,KW-1064~Adaptive immunity,	KW-0539~Nucleus,KW-0963~Cytoplasm,		KW-0225~Disease variant,	KW-0727~SH2 domain,KW-0728~SH3 domain,KW-0863~Zinc-finger,	KW-0067~ATP-binding,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,KW-0862~Zinc,	KW-0418~Kinase,KW-0808~Transferase,KW-0829~Tyrosine-protein kinase,	KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,	ACT_SITE:Proton acceptor,DOMAIN:PH,DOMAIN:Protein kinase,DOMAIN:SH2,DOMAIN:SH3,MUTAGEN:P->G: Complete loss of interaction with PPIA/CYPA.,REGION:Disordered,ZN_FING:Btk-type,
Q76M68	IQ motif and Sec7 domain ArfGEF 3(Iqsec3)	Rattus norvegicus			GO:0030036~actin cytoskeleton organization,GO:0032012~regulation of ARF protein signal transduction,GO:0051056~regulation of small GTPase mediated signal transduction,GO:0090630~activation of GTPase activity,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0014069~postsynaptic density,GO:0045211~postsynaptic membrane,GO:0060077~inhibitory synapse,GO:0098982~GABA-ergic synapse,GO:0099629~postsynaptic specialization of symmetric synapse,	GO:0005085~guanyl-nucleotide exchange factor activity,	IPR000048:IQ_motif_EF-hand-BS,IPR000904:Sec7_dom,IPR011993:PH-like_dom_sf,IPR023394:Sec7_C_sf,IPR033742:IQSEC_PH,IPR035999:Sec7_dom_sf,	rno04144:Endocytosis,			SM00222:Sec7,		KW-0770~Synapse,KW-0963~Cytoplasm,			KW-0175~Coiled coil,			KW-0597~Phosphoprotein,	COMPBIAS:Polar residues,COMPBIAS:Pro residues,DOMAIN:IQ,DOMAIN:PH,DOMAIN:SEC7,REGION:Disordered,
Q6IPM2	IQ motif containing E(IQCE)	Homo sapiens			GO:0035108~limb morphogenesis,	GO:0005929~cilium,GO:0060170~ciliary membrane,	GO:0005515~protein binding,	IPR000048:IQ_motif_EF-hand-BS,IPR027417:P-loop_NTPase,	hsa04340:Hedgehog signaling pathway,	617642~Polydactyly, postaxial, type A7,		SM00015:IQ,		KW-0472~Membrane,KW-0966~Cell projection,KW-1003~Cell membrane,			KW-0175~Coiled coil,KW-0677~Repeat,			KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:IQ 1,DOMAIN:IQ 2,REGION:Disordered,
P0DOX7	Immunoglobulin kappa light chain (IGK_HUMAN)	Homo sapiens			GO:0002250~adaptive immune response,	GO:0005576~extracellular region,GO:0005886~plasma membrane,GO:0019814~immunoglobulin complex,		IPR003006:Ig/MHC_CS,IPR003597:Ig_C1-set,IPR003599:Ig_sub,IPR007110:Ig-like_dom,IPR013106:Ig_V-set,IPR013783:Ig-like_fold,IPR036179:Ig-like_dom_sf,				SM00406:IGv,SM00407:IGc1,SM00409:IG,	KW-0391~Immunity,KW-1064~Adaptive immunity,	KW-0472~Membrane,KW-0964~Secreted,KW-1003~Cell membrane,KW-1280~Immunoglobulin,			KW-0393~Immunoglobulin domain,KW-0677~Repeat,			KW-1015~Disulfide bond,	DISULFID:Interchain (with a heavy chain),DOMAIN:Ig-like 1,DOMAIN:Ig-like 2,REGION:Constant (C) domain,REGION:Variable (V) domain, involved in antigen recognition,
P97812	Indian hedgehog(Ihh)	Mus musculus			GO:0001501~skeletal system development,GO:0001503~ossification,GO:0001569~branching involved in blood vessel morphogenesis,GO:0001649~osteoblast differentiation,GO:0001701~in utero embryonic development,GO:0001708~cell fate specification,GO:0001763~morphogenesis of a branching structure,GO:0001944~vasculature development,GO:0001947~heart looping,GO:0002053~positive regulation of mesenchymal cell proliferation,GO:0002062~chondrocyte differentiation,GO:0003382~epithelial cell morphogenesis,GO:0003406~retinal pigment epithelium development,GO:0003413~chondrocyte differentiation involved in endochondral bone morphogenesis,GO:0006029~proteoglycan metabolic process,GO:0006508~proteolysis,GO:0007224~smoothened signaling pathway,GO:0007267~cell-cell signaling,GO:0007275~multicellular organism development,GO:0007389~pattern specification process,GO:0008283~cell proliferation,GO:0008284~positive regulation of cell proliferation,GO:0009612~response to mechanical stimulus,GO:0009790~embryo development,GO:0009880~embryonic pattern specification,GO:0010468~regulation of gene expression,GO:0016539~intein-mediated protein splicing,GO:0016540~protein autoprocessing,GO:0030704~vitelline membrane formation,GO:0031016~pancreas development,GO:0032331~negative regulation of chondrocyte differentiation,GO:0032355~response to estradiol,GO:0032967~positive regulation of collagen biosynthetic process,GO:0033085~negative regulation of T cell differentiation in thymus,GO:0033088~negative regulation of immature T cell proliferation in thymus,GO:0033089~positive regulation of T cell differentiation in thymus,GO:0035264~multicellular organism growth,GO:0035988~chondrocyte proliferation,GO:0040008~regulation of growth,GO:0042733~embryonic digit morphogenesis,GO:0043010~camera-type eye development,GO:0043066~negative regulation of apoptotic process,GO:0045453~bone resorption,GO:0045880~positive regulation of smoothened signaling pathway,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046638~positive regulation of alpha-beta T cell differentiation,GO:0046639~negative regulation of alpha-beta T cell differentiation,GO:0048074~negative regulation of eye pigmentation,GO:0048469~cell maturation,GO:0048513~animal organ development,GO:0048557~embryonic digestive tract morphogenesis,GO:0048596~embryonic camera-type eye morphogenesis,GO:0048666~neuron development,GO:0048731~system development,GO:0048745~smooth muscle tissue development,GO:0050679~positive regulation of epithelial cell proliferation,GO:0051216~cartilage development,GO:0060135~maternal process involved in female pregnancy,GO:0060220~camera-type eye photoreceptor cell fate commitment,GO:0060323~head morphogenesis,GO:0060350~endochondral bone morphogenesis,GO:0061053~somite development,GO:0072498~embryonic skeletal joint development,GO:0090136~epithelial cell-cell adhesion,GO:0097264~self proteolysis,GO:0097421~liver regeneration,	GO:0000139~Golgi membrane,GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0031012~extracellular matrix,	GO:0005113~patched binding,GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0008233~peptidase activity,GO:0016740~transferase activity,GO:0016787~hydrolase activity,GO:0034189~very-low-density lipoprotein particle binding,GO:0046872~metal ion binding,	IPR000320:Hedgehog_signalling_dom,IPR001657:Hedgehog,IPR001767:Hedgehog_Hint,IPR003586:Hint_dom_C,IPR003587:Hint_dom_N,IPR006141:Intein_N,IPR009045:Hedgehog_sig/DD-Pept_Zn-bd_sf,IPR036844:Hint_dom_sf,	mmu04340:Hedgehog signaling pathway,mmu05205:Proteoglycans in cancer,		PIRSF009400:Peptidase_C46,	SM00305:HintC,SM00306:HintN,		KW-0256~Endoplasmic reticulum,KW-0333~Golgi apparatus,KW-0472~Membrane,KW-0964~Secreted,KW-1003~Cell membrane,			KW-0732~Signal,	KW-0106~Calcium,KW-0479~Metal-binding,KW-0862~Zinc,	KW-0217~Developmental protein,KW-0378~Hydrolase,KW-0645~Protease,KW-0808~Transferase,KW-9996~Developmental protein,	KW-0068~Autocatalytic cleavage,KW-0325~Glycoprotein,KW-0449~Lipoprotein,KW-0564~Palmitate,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Polar residues,DOMAIN:Hint,LIPID:Cholesterol glycine ester,LIPID:N-palmitoyl cysteine,REGION:Disordered,SITE:Cleavage; by autolysis,SITE:Essential for auto-cleavage,SITE:Involved in auto-cleavage,SITE:Involved in cholesterol transfer,
Q07666	KH RNA binding domain containing, signal transduction associated 1(KHDRBS1)	Homo sapiens		h_sam68Pathway:Regulation of Splicing through Sam68,	GO:0000082~G1/S transition of mitotic cell cycle,GO:0000086~G2/M transition of mitotic cell cycle,GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0000381~regulation of alternative mRNA splicing, via spliceosome,GO:0006397~mRNA processing,GO:0007283~spermatogenesis,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045948~positive regulation of translational initiation,GO:0046831~regulation of RNA export from nucleus,GO:0046833~positive regulation of RNA export from nucleus,GO:0050852~T cell receptor signaling pathway,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0016020~membrane,GO:0032991~macromolecular complex,GO:0070618~Grb2-Sos complex,	GO:0003677~DNA binding,GO:0003723~RNA binding,GO:0003729~mRNA binding,GO:0005515~protein binding,GO:0008143~poly(A) binding,GO:0008266~poly(U) RNA binding,GO:0017124~SH3 domain binding,GO:0019904~protein domain specific binding,GO:0035591~signaling adaptor activity,GO:0042169~SH2 domain binding,GO:0042802~identical protein binding,GO:0044877~macromolecular complex binding,GO:1990782~protein tyrosine kinase binding,	IPR004087:KH_dom,IPR004088:KH_dom_type_1,IPR032335:Sam68-YY,IPR032571:Qua1_dom,IPR036612:KH_dom_type_1_sf,IPR045071:BBP-like,				SM00322:KH,	KW-0131~Cell cycle,KW-0507~mRNA processing,KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0472~Membrane,KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0729~SH3-binding,		KW-0694~RNA-binding,	KW-0007~Acetylation,KW-0488~Methylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Polar residues,COMPBIAS:Pro residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate,DOMAIN:K Homology,DOMAIN:KH,MUTAGEN:E->A: Impairs homodimerization.,MUTAGEN:E->K: Disrupts interaction with APC.,MUTAGEN:F->S: Disrupts homodimerization, impairs influence on alternative splicing.,MUTAGEN:V->F: Disrupts binding to poly(A). Decreased binding to the BCL2L1 mRNA. Loss of function in BCL2L1 splicing. Changed nuclear localization.,MUTAGEN:Y->E: Fails to influence alternative splicing of CD44, NRXN2 and NRXN3.,MUTAGEN:Y->F: Completely blocks nuclear localization.,MUTAGEN:Y->F: No effect on the nuclear localization.,MUTAGEN:Y->K: Impairs interaction with APC.,MUTAGEN:Y->S: Impairs homodimerization.,REGION:Disordered,REGION:Interaction with HNRNPA1,REGION:Interaction with ZBTB7A,REGION:Involved in homodimerization,
Q91V33	KH RNA binding domain containing, signal transduction associated 1(Khdrbs1)	Rattus norvegicus			GO:0000086~G2/M transition of mitotic cell cycle,GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0000381~regulation of alternative mRNA splicing, via spliceosome,GO:0006397~mRNA processing,GO:0007166~cell surface receptor signaling pathway,GO:0007283~spermatogenesis,GO:0009966~regulation of signal transduction,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045948~positive regulation of translational initiation,GO:0046831~regulation of RNA export from nucleus,GO:0046833~positive regulation of RNA export from nucleus,GO:0048024~regulation of mRNA splicing, via spliceosome,GO:0050852~T cell receptor signaling pathway,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0016020~membrane,GO:0032991~macromolecular complex,GO:0070618~Grb2-Sos complex,	GO:0003723~RNA binding,GO:0003729~mRNA binding,GO:0005515~protein binding,GO:0008143~poly(A) binding,GO:0008266~poly(U) RNA binding,GO:0017124~SH3 domain binding,GO:0019904~protein domain specific binding,GO:0035591~signaling adaptor activity,GO:0042169~SH2 domain binding,GO:0042802~identical protein binding,GO:0044877~macromolecular complex binding,GO:1990782~protein tyrosine kinase binding,	IPR004087:KH_dom,IPR004088:KH_dom_type_1,IPR032335:Sam68-YY,IPR032571:Qua1_dom,IPR036612:KH_dom_type_1_sf,IPR045071:BBP-like,				SM00322:KH,	KW-0131~Cell cycle,KW-0507~mRNA processing,KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0472~Membrane,KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0729~SH3-binding,		KW-0694~RNA-binding,	KW-0007~Acetylation,KW-0488~Methylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate,DOMAIN:K Homology,DOMAIN:KH,REGION:Disordered,REGION:Interaction with HNRNPA1,REGION:Interaction with ZBTB7A,REGION:Involved in homodimerization,
Q9Y5W3	KLF transcription factor 2(KLF2)	Homo sapiens			GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0000902~cell morphogenesis,GO:0001701~in utero embryonic development,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0032715~negative regulation of interleukin-6 production,GO:0035264~multicellular organism growth,GO:0036003~positive regulation of transcription from RNA polymerase II promoter in response to stress,GO:0040029~regulation of gene expression, epigenetic,GO:0042311~vasodilation,GO:0043249~erythrocyte maturation,GO:0045429~positive regulation of nitric oxide biosynthetic process,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048386~positive regulation of retinoic acid receptor signaling pathway,GO:0051247~positive regulation of protein metabolic process,GO:0060509~Type I pneumocyte differentiation,GO:0070301~cellular response to hydrogen peroxide,GO:0071347~cellular response to interleukin-1,GO:0071356~cellular response to tumor necrosis factor,GO:0071409~cellular response to cycloheximide,GO:0071498~cellular response to fluid shear stress,GO:0071499~cellular response to laminar fluid shear stress,GO:0097533~cellular stress response to acid chemical,GO:1901653~cellular response to peptide,GO:1903671~negative regulation of sprouting angiogenesis,	GO:0000785~chromatin,GO:0005634~nucleus,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0046872~metal ion binding,GO:1990837~sequence-specific double-stranded DNA binding,	IPR013087:Znf_C2H2_type,IPR036236:Znf_C2H2_sf,	hsa04068:FoxO signaling pathway,hsa04371:Apelin signaling pathway,hsa05418:Fluid shear stress and atherosclerosis,			SM00355:ZnF_C2H2,	KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,			KW-0677~Repeat,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0010~Activator,KW-0238~DNA-binding,	KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,COMPBIAS:Pro residues,MOTIF:9aaTAD,REGION:Disordered,REGION:Interaction with WWP1,ZN_FING:C2H2-type 1,ZN_FING:C2H2-type 2,ZN_FING:C2H2-type 3,
P30533	LDL receptor related protein associated protein 1(LRPAP1)	Homo sapiens			GO:0002091~negative regulation of receptor internalization,GO:0007165~signal transduction,GO:0010916~negative regulation of very-low-density lipoprotein particle clearance,GO:0032091~negative regulation of protein binding,GO:0048259~regulation of receptor-mediated endocytosis,GO:1900116~extracellular negative regulation of signal transduction,GO:1900222~negative regulation of beta-amyloid clearance,GO:1900223~positive regulation of beta-amyloid clearance,	GO:0005576~extracellular region,GO:0005768~endosome,GO:0005783~endoplasmic reticulum,GO:0005793~endoplasmic reticulum-Golgi intermediate compartment,GO:0005794~Golgi apparatus,GO:0005796~Golgi lumen,GO:0005801~cis-Golgi network,GO:0005886~plasma membrane,GO:0009986~cell surface,GO:0012505~endomembrane system,GO:0031904~endosome lumen,GO:0048237~rough endoplasmic reticulum lumen,	GO:0001540~beta-amyloid binding,GO:0005102~receptor binding,GO:0005515~protein binding,GO:0008201~heparin binding,GO:0035473~lipase binding,GO:0048018~receptor agonist activity,GO:0048019~receptor antagonist activity,GO:0050750~low-density lipoprotein particle receptor binding,GO:0070326~very-low-density lipoprotein particle receptor binding,	IPR009066:MG_RAP_rcpt_1,IPR010483:Alpha_2_MRAP_C,IPR036744:RAP_sf,IPR037999:RAP_D3,IPR038001:RAP_D2,IPR038003:A2-macroglobuin_RAP,	hsa04979:Cholesterol metabolism,	615431~Myopia 23, autosomal recessive,				KW-0256~Endoplasmic reticulum,KW-0333~Golgi apparatus,KW-0967~Endosome,			KW-0175~Coiled coil,KW-0732~Signal,		KW-0358~Heparin-binding,KW-0675~Receptor,	KW-0325~Glycoprotein,KW-0449~Lipoprotein,KW-0597~Phosphoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Basic and acidic residues,DOMAIN:Alpha-2-macroglobulin RAP C-terminal,DOMAIN:Alpha-2-macroglobulin receptor-associated protein,MOTIF:Prevents secretion from ER,MUTAGEN:H->A: Strongly reduced interaction with LRP1; when associated with A-283; A-291; A-293; A-302 and A-307.,MUTAGEN:H->A: Strongly reduced interaction with LRP1; when associated with A-283; A-291; A-293; A-302 and A-341.,MUTAGEN:H->A: Strongly reduced interaction with LRP1; when associated with A-283; A-291; A-293; A-307 and A-341.,MUTAGEN:H->A: Strongly reduced interaction with LRP1; when associated with A-283; A-291; A-302; A-307 and A-341.,MUTAGEN:H->A: Strongly reduced interaction with LRP1; when associated with A-283; A-293; A-302; A-307 and A-341.,MUTAGEN:H->A: Strongly reduced interaction with LRP1; when associated with A-291; A-293; A-302; A-307 and A-341.,MUTAGEN:K->A: Reduces competition with MAPT for binding to LRP1; when associated with A-290.,MUTAGEN:K->A: Reduces competition with MAPT for binding to LRP1; when associated with A-304.,REGION:Disordered,REGION:LDL receptor binding,
G5E5X0	LIM domain containing 1(LIMD1)	Bos taurus			GO:0001666~response to hypoxia,GO:0002076~osteoblast development,GO:0006355~regulation of transcription, DNA-templated,GO:0007010~cytoskeleton organization,GO:0008360~regulation of cell shape,GO:0016310~phosphorylation,GO:0016477~cell migration,GO:0033962~cytoplasmic mRNA processing body assembly,GO:0035278~miRNA mediated inhibition of translation,GO:0035331~negative regulation of hippo signaling,GO:0045668~negative regulation of osteoblast differentiation,GO:0045892~negative regulation of transcription, DNA-templated,GO:0090090~negative regulation of canonical Wnt signaling pathway,GO:2000637~positive regulation of gene silencing by miRNA,	GO:0000932~P-body,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0005912~adherens junction,GO:0005925~focal adhesion,GO:0016442~RISC complex,	GO:0003714~transcription corepressor activity,GO:0046872~metal ion binding,	IPR001781:Znf_LIM,IPR047172:Ajuba-like,IPR047245:Ajuba-like_LIM1,IPR047247:Ajuba-like_LIM2,IPR047248:Ajuba-like_LIM3,	bta04390:Hippo signaling pathway,bta04392:Hippo signaling pathway - multiple species,			SM00132:LIM,	KW-0804~Transcription,KW-0805~Transcription regulation,KW-0943~RNA-mediated gene silencing,	KW-0539~Nucleus,KW-0963~Cytoplasm,KW-0965~Cell junction,		KW-0043~Tumor suppressor,	KW-0440~LIM domain,KW-0677~Repeat,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0678~Repressor,	KW-0597~Phosphoprotein,	COMPBIAS:Polar residues,DOMAIN:LIM zinc-binding 1,DOMAIN:LIM zinc-binding 2,DOMAIN:LIM zinc-binding 3,REGION:Disordered,REGION:Interaction with EGLN1/PHD2,REGION:Interaction with RB1,REGION:Mediates nuclear export,REGION:Necessary for nuclear localization,
Q80W90	LIM homeobox 9(Lhx9)	Rattus norvegicus			GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0008283~cell proliferation,GO:0008584~male gonad development,GO:0008585~female gonad development,GO:0030182~neuron differentiation,GO:0035262~gonad morphogenesis,GO:0045892~negative regulation of transcription, DNA-templated,GO:0048731~system development,GO:0097380~dorsal spinal cord interneuron anterior axon guidance,	GO:0005634~nucleus,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0003677~DNA binding,GO:0046872~metal ion binding,GO:1990837~sequence-specific double-stranded DNA binding,	IPR001356:Homeobox_dom,IPR001781:Znf_LIM,IPR009057:Homeobox-like_sf,IPR017970:Homeobox_CS,				SM00132:LIM,SM00389:HOX,		KW-0539~Nucleus,			KW-0371~Homeobox,KW-0440~LIM domain,KW-0677~Repeat,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0238~DNA-binding,		DNA_BIND:Homeobox,DOMAIN:Homeobox,DOMAIN:LIM zinc-binding,DOMAIN:LIM zinc-binding 1,DOMAIN:LIM zinc-binding 2,REGION:Disordered,
P48059	LIM zinc finger domain containing 1(LIMS1)	Homo sapiens			GO:0010628~positive regulation of gene expression,GO:0010811~positive regulation of cell-substrate adhesion,GO:0033209~tumor necrosis factor-mediated signaling pathway,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling,GO:0043547~positive regulation of GTPase activity,GO:0045184~establishment of protein localization,GO:0045216~cell-cell junction organization,GO:0045892~negative regulation of transcription, DNA-templated,GO:0051894~positive regulation of focal adhesion assembly,GO:0071560~cellular response to transforming growth factor beta stimulus,GO:0098609~cell-cell adhesion,GO:1900026~positive regulation of substrate adhesion-dependent cell spreading,GO:2001046~positive regulation of integrin-mediated signaling pathway,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005911~cell-cell junction,GO:0005925~focal adhesion,GO:0048471~perinuclear region of cytoplasm,	GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0019901~protein kinase binding,GO:0046872~metal ion binding,	IPR001781:Znf_LIM,IPR017351:PINCH-1-4-like,IPR047944:LIMS1/2-like_LIM1,IPR047946:PINCH-1/2-like,			PIRSF038003:PINCH,	SM00132:LIM,		KW-0472~Membrane,KW-0965~Cell junction,KW-1003~Cell membrane,			KW-0440~LIM domain,KW-0677~Repeat,	KW-0479~Metal-binding,KW-0862~Zinc,		KW-0007~Acetylation,	DOMAIN:LIM zinc-binding,DOMAIN:LIM zinc-binding 1,DOMAIN:LIM zinc-binding 2,DOMAIN:LIM zinc-binding 3,DOMAIN:LIM zinc-binding 4,DOMAIN:LIM zinc-binding 5,MUTAGEN:D->A: Alters interaction with ILK.,MUTAGEN:F->A: Loss of interaction with ILK and loss of localization to focal adhesion.,MUTAGEN:H->D: Alters interaction with ILK.,MUTAGEN:L->D: Alters interaction with ILK.,MUTAGEN:R->A: Alters interaction with ILK.,REGION:Disordered,
D3YY23	LON peptidase N-terminal domain and ring finger 1(Lonrf1)	Mus musculus				GO:0005737~cytoplasm,	GO:0046872~metal ion binding,GO:0061630~ubiquitin protein ligase activity,	IPR001841:Znf_RING,IPR003111:Lon_prtase_N,IPR011990:TPR-like_helical_dom_sf,IPR013083:Znf_RING/FYVE/PHD,IPR015947:PUA-like_sf,IPR017907:Znf_RING_CS,IPR019734:TPR_repeat,IPR046336:Lon_prtase_N_sf,				SM00028:TPR,SM00184:RING,SM00464:LON,					KW-0677~Repeat,KW-0802~TPR repeat,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,		KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,DOMAIN:Lon N-terminal,DOMAIN:RING-type,REGION:Disordered,REPEAT:TPR 1,REPEAT:TPR 2,REPEAT:TPR 3,REPEAT:TPR 4,ZN_FING:RING-type 1,ZN_FING:RING-type 2,
B3DFV0	LYR motif containing 9(lyrm9)	Danio rerio						IPR008011:Complex1_LYR_dom,IPR045291:Complex1_LYR_LYRM9,
A6NHS7	MANSC domain containing 4(MANSC4)	Homo sapiens			GO:0008544~epidermis development,GO:0030198~extracellular matrix organization,GO:0060429~epithelium development,	GO:0005886~plasma membrane,	GO:0004867~serine-type endopeptidase inhibitor activity,	IPR011106:MANSC_N,IPR013980:MANSC_dom,				SM00765:MANEC,		KW-0472~Membrane,			KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:MANSC,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q8CIP4	MAP/microtubule affinity regulating kinase 4(Mark4)	Mus musculus			GO:0000226~microtubule cytoskeleton organization,GO:0001578~microtubule bundle formation,GO:0006468~protein phosphorylation,GO:0007049~cell cycle,GO:0007399~nervous system development,GO:0016310~phosphorylation,GO:0030030~cell projection organization,GO:0035556~intracellular signal transduction,GO:0044782~cilium organization,GO:0045724~positive regulation of cilium assembly,GO:0045787~positive regulation of cell cycle,GO:0046605~regulation of centrosome cycle,GO:0051301~cell division,GO:1900227~positive regulation of NLRP3 inflammasome complex assembly,GO:1904781~positive regulation of protein localization to centrosome,	GO:0000930~gamma-tubulin complex,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005815~microtubule organizing center,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0015630~microtubule cytoskeleton,GO:0030425~dendrite,GO:0030496~midbody,GO:0036064~ciliary basal body,GO:0042995~cell projection,GO:0043005~neuron projection,	GO:0000166~nucleotide binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005524~ATP binding,GO:0008017~microtubule binding,GO:0008093~cytoskeletal adaptor activity,GO:0016301~kinase activity,GO:0016740~transferase activity,GO:0043015~gamma-tubulin binding,GO:0050321~tau-protein kinase activity,	IPR000719:Prot_kinase_dom,IPR001772:KA1_dom,IPR008271:Ser/Thr_kinase_AS,IPR011009:Kinase-like_dom_sf,IPR015940:UBA,IPR017441:Protein_kinase_ATP_BS,IPR028375:KA1/Ssp2_C,				SM00165:UBA,SM00220:S_TKc,	KW-0131~Cell cycle,KW-0132~Cell division,KW-0498~Mitosis,KW-0970~Cilium biogenesis/degradation,	KW-0206~Cytoskeleton,KW-0963~Cytoplasm,KW-0966~Cell projection,				KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0418~Kinase,KW-0723~Serine/threonine-protein kinase,KW-0808~Transferase,	KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,	ACT_SITE:Proton acceptor,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,COMPBIAS:Pro residues,DOMAIN:KA1,DOMAIN:Protein kinase,DOMAIN:UBA,REGION:Disordered,
P57097	MER proto-oncogene, tyrosine kinase(Mertk)	Rattus norvegicus			GO:0001779~natural killer cell differentiation,GO:0001818~negative regulation of cytokine production,GO:0006909~phagocytosis,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0007275~multicellular organism development,GO:0007283~spermatogenesis,GO:0007399~nervous system development,GO:0016310~phosphorylation,GO:0016477~cell migration,GO:0030168~platelet activation,GO:0032940~secretion by cell,GO:0033674~positive regulation of kinase activity,GO:0034446~substrate adhesion-dependent cell spreading,GO:0043277~apoptotic cell clearance,GO:0043491~protein kinase B signaling,GO:0046649~lymphocyte activation,GO:0050766~positive regulation of phagocytosis,GO:0051250~negative regulation of lymphocyte activation,GO:0051649~establishment of localization in cell,GO:0051897~positive regulation of protein kinase B signaling,GO:0060041~retina development in camera-type eye,GO:0060068~vagina development,GO:0097350~neutrophil clearance,GO:2000107~negative regulation of leukocyte apoptotic process,	GO:0001750~photoreceptor outer segment,GO:0005615~extracellular space,GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0043235~receptor complex,	GO:0004713~protein tyrosine kinase activity,GO:0004714~transmembrane receptor protein tyrosine kinase activity,GO:0005524~ATP binding,	IPR000719:Prot_kinase_dom,IPR001245:Ser-Thr/Tyr_kinase_cat_dom,IPR003599:Ig_sub,IPR003961:FN3_dom,IPR007110:Ig-like_dom,IPR008266:Tyr_kinase_AS,IPR011009:Kinase-like_dom_sf,IPR013151:Immunoglobulin,IPR013783:Ig-like_fold,IPR017441:Protein_kinase_ATP_BS,IPR020635:Tyr_kinase_cat_dom,IPR036116:FN3_sf,IPR036179:Ig-like_dom_sf,	rno04148:Efferocytosis,			SM00060:FN3,SM00219:TyrKc,SM00409:IG,		KW-0472~Membrane,KW-1003~Cell membrane,		KW-0656~Proto-oncogene,	KW-0393~Immunoglobulin domain,KW-0677~Repeat,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0418~Kinase,KW-0675~Receptor,KW-0808~Transferase,KW-0829~Tyrosine-protein kinase,	KW-0325~Glycoprotein,KW-0597~Phosphoprotein,KW-1015~Disulfide bond,	ACT_SITE:Proton acceptor,CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Polar residues,DOMAIN:Fibronectin type-III,DOMAIN:Fibronectin type-III 1,DOMAIN:Fibronectin type-III 2,DOMAIN:Ig-like,DOMAIN:Ig-like C2-type 1,DOMAIN:Ig-like C2-type 2,DOMAIN:Protein kinase,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q9NYP9	MIS18 kinetochore protein A(MIS18A)	Homo sapiens			GO:0007059~chromosome segregation,GO:0034080~CENP-A containing nucleosome assembly,GO:0044030~regulation of DNA methylation,GO:0051301~cell division,	GO:0000775~chromosome, centromeric region,GO:0000785~chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005829~cytosol,	GO:0005515~protein binding,GO:0042802~identical protein binding,GO:0046872~metal ion binding,	IPR004910:Yippee/Mis18/Cereblon,IPR034752:Mis18,					KW-0131~Cell cycle,KW-0132~Cell division,KW-0498~Mitosis,	KW-0137~Centromere,KW-0158~Chromosome,KW-0539~Nucleus,				KW-0479~Metal-binding,KW-0862~Zinc,		KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),DOMAIN:Mis18,MUTAGEN:C->A: Abolishes location at the centromere.,MUTAGEN:C->A: No effect.,MUTAGEN:V->E: Abolishes interaction with OIP5; when associated with D-176.,MUTAGEN:Y->D: Abolishes interaction with OIP5; when associated with E-82.,
Q70IA6	MOB kinase activator 2(MOB2)	Homo sapiens			GO:0001934~positive regulation of protein phosphorylation,GO:0007165~signal transduction,GO:0016310~phosphorylation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0048471~perinuclear region of cytoplasm,	GO:0005515~protein binding,GO:0016301~kinase activity,GO:0030295~protein kinase activator activity,GO:0046872~metal ion binding,	IPR005301:MOB_kinase_act_fam,IPR036703:MOB_kinase_act_sf,				SM01388:Mob1_phocein,		KW-0539~Nucleus,KW-0963~Cytoplasm,				KW-0479~Metal-binding,KW-0862~Zinc,	KW-0418~Kinase,KW-0808~Transferase,	KW-0597~Phosphoprotein,	REGION:Disordered,
Q7Z3U7	MON2 homolog, regulator of endosome-to-Golgi trafficking(MON2)	Homo sapiens			GO:0006895~Golgi to endosome transport,GO:0015031~protein transport,GO:0015986~ATP synthesis coupled proton transport,	GO:0000276~mitochondrial proton-transporting ATP synthase complex, coupling factor F(o),GO:0005829~cytosol,GO:0031901~early endosome membrane,GO:0070062~extracellular exosome,	GO:0005515~protein binding,GO:0015078~hydrogen ion transmembrane transporter activity,	IPR001421:ATP8_metazoa,IPR011989:ARM-like,IPR015403:Mon2/Sec7/BIG1-like_HDS,IPR016024:ARM-type_fold,IPR032629:DCB_dom,IPR032691:Mon2/Sec7/BIG1-like_HUS,IPR032817:Mon2_C,					KW-0066~ATP synthesis,KW-0375~Hydrogen ion transport,KW-0406~Ion transport,KW-0653~Protein transport,KW-0813~Transport,	KW-0138~CF(0),KW-0472~Membrane,KW-0967~Endosome,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0007~Acetylation,KW-0597~Phosphoprotein,	DOMAIN:Mon2 C-terminal,DOMAIN:Mon2/Sec7/BIG1-like HDS,DOMAIN:Mon2/Sec7/BIG1-like HUS,DOMAIN:Mon2/Sec7/BIG1-like dimerisation and cyclophilin-binding,REGION:Disordered,TRANSMEM:Helical,
Q2TBP7	MYC binding protein(MYCBP)	Bos taurus			GO:0006355~regulation of transcription, DNA-templated,GO:0007283~spermatogenesis,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005739~mitochondrion,	GO:0003713~transcription coactivator activity,	IPR026060:AMY1,					KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0175~Coiled coil,
Q1LXK5	Mov10 RNA helicase b, tandem duplicate 2(mov10b.2)	Danio rerio			GO:0031047~gene silencing by RNA,GO:0035194~posttranscriptional gene silencing by RNA,GO:0035279~mRNA cleavage involved in gene silencing by miRNA,	GO:0000932~P-body,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0043186~P granule,	GO:0000166~nucleotide binding,GO:0003723~RNA binding,GO:0003724~RNA helicase activity,GO:0004386~helicase activity,GO:0005524~ATP binding,GO:0016787~hydrolase activity,GO:0016887~ATPase activity,GO:0032574~5'-3' RNA helicase activity,	IPR026122:MOV-10/SDE3_DEXXQ/H-box,IPR027417:P-loop_NTPase,IPR041677:DNA2/NAM7_AAA_11,IPR041679:DNA2/NAM7-like_C,IPR047187:SF1_C_Upf1,IPR049075:MOV-10_N,IPR049077:MOV-10_Ig-like,IPR049079:Mov-10_helical,IPR049080:MOV-10-like_beta-barrel,					KW-0943~RNA-mediated gene silencing,	KW-0963~Cytoplasm,				KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0347~Helicase,KW-0378~Hydrolase,KW-0694~RNA-binding,		COMPBIAS:Polar residues,MOTIF:DEAG box,REGION:Disordered,
P11246	N-acetyltransferase 1(NAT1)	Oryctolagus cuniculus				GO:0005737~cytoplasm,	GO:0004060~arylamine N-acetyltransferase activity,GO:0016407~acetyltransferase activity,	IPR001447:Arylamine_N-AcTrfase,IPR038765:Papain-like_cys_pep_sf,	ocu00232:Caffeine metabolism,ocu00983:Drug metabolism - other enzymes,ocu01100:Metabolic pathways,ocu05204:Chemical carcinogenesis - DNA adducts,					KW-0963~Cytoplasm,					KW-0012~Acyltransferase,KW-0808~Transferase,		ACT_SITE:Acyl-thioester intermediate,
Q6IQ20	N-acyl phosphatidylethanolamine phospholipase D(NAPEPLD)	Homo sapiens			GO:0001523~retinoid metabolic process,GO:0001659~temperature homeostasis,GO:0009395~phospholipid catabolic process,GO:0048874~homeostasis of number of cells in a free-living population,GO:0050729~positive regulation of inflammatory response,GO:0070291~N-acylethanolamine metabolic process,GO:0070292~N-acylphosphatidylethanolamine metabolic process,GO:0090336~positive regulation of brown fat cell differentiation,	GO:0000139~Golgi membrane,GO:0005635~nuclear envelope,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005769~early endosome,GO:0005794~Golgi apparatus,GO:0031901~early endosome membrane,GO:0042622~photoreceptor outer segment membrane,GO:0043227~membrane-bounded organelle,GO:0070062~extracellular exosome,	GO:0008270~zinc ion binding,GO:0032052~bile acid binding,GO:0042802~identical protein binding,GO:0070290~N-acylphosphatidylethanolamine-specific phospholipase D activity,	IPR001279:Metallo-B-lactamas,IPR024884:NAPE-PLD,IPR036866:RibonucZ/Hydroxyglut_hydro,	hsa04723:Retrograde endocannabinoid signaling,		PIRSF038896:NAPE-PLD,		KW-0442~Lipid degradation,KW-0443~Lipid metabolism,KW-0595~Phospholipid degradation,KW-1208~Phospholipid metabolism,	KW-0333~Golgi apparatus,KW-0472~Membrane,KW-0539~Nucleus,KW-0967~Endosome,				KW-0479~Metal-binding,KW-0862~Zinc,	KW-0378~Hydrolase,	KW-0007~Acetylation,	COMPBIAS:Polar residues,DOMAIN:Metallo-beta-lactamase,MUTAGEN:H->R: Loss of activity.,MUTAGEN:L->F: Loss of activity.,MUTAGEN:Q->S: Impairs homodimerization resulting in loss of activity; when associated with S-159.,MUTAGEN:R->A: Impairs binding to bile acids resulting in loss of activity.,MUTAGEN:Y->S: Impairs homodimerization resulting in loss of activity; when associated with S-158.,REGION:Disordered,
Q13287	N-myc and STAT interactor(NMI)	Homo sapiens		h_il2rbPathway:IL-2 Receptor Beta Chain in T cell Activation,h_il7Pathway:IL-7 Signal Transduction,	GO:0002281~macrophage activation involved in immune response,GO:0007259~JAK-STAT cascade,GO:0008285~negative regulation of cell proliferation,GO:0009615~response to virus,GO:0032687~negative regulation of interferon-alpha production,GO:0032688~negative regulation of interferon-beta production,GO:0034142~toll-like receptor 4 signaling pathway,GO:0045087~innate immune response,GO:0045089~positive regulation of innate immune response,GO:0045824~negative regulation of innate immune response,GO:0050729~positive regulation of inflammatory response,GO:0070936~protein K48-linked ubiquitination,GO:1901223~negative regulation of NIK/NF-kappaB signaling,GO:1901224~positive regulation of NIK/NF-kappaB signaling,GO:1902524~positive regulation of protein K48-linked ubiquitination,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0016020~membrane,	GO:0005515~protein binding,GO:0042802~identical protein binding,	IPR009909:Nmi/IFP35_dom,IPR009938:Nmi/IFP35_N,IPR012677:Nucleotide-bd_a/b_plait_sf,					KW-0391~Immunity,KW-0399~Innate immunity,KW-0945~Host-virus interaction,	KW-0539~Nucleus,KW-0963~Cytoplasm,KW-0964~Secreted,			KW-0175~Coiled coil,			KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),DOMAIN:NID,DOMAIN:NID 1,DOMAIN:NID 2,DOMAIN:Nmi/IFP 35,MUTAGEN:K->R: Loss of TRIM21-mediated ubiquitination and loss of Sendai virus-triggered type I IFN-beta production. Loss of TRIM21-mediated ubiquitination and decreased Sendai virus-triggered type I IFN-beta production; when associated with R-27.,MUTAGEN:K->R: No change in TRIM21-mediated ubiquitination and no change in Sendai virus-triggered type I IFN-beta production. Loss of TRIM21-mediated ubiquitination and decreased Sendai virus-triggered type I IFN-beta production; when associated with R-22.,MUTAGEN:K->R: No change in TRIM21-mediated ubiquitination; when associated with R-176.,MUTAGEN:K->R: No change in TRIM21-mediated ubiquitination; when associated with R-183.,MUTAGEN:K->R: No change in TRIM21-mediated ubiquitination; when associated with R-56.,MUTAGEN:K->R: No change in TRIM21-mediated ubiquitination; when associated with R-61.,REGION:Disordered,
P51955	NIMA related kinase 2(NEK2)	Homo sapiens			GO:0000278~mitotic cell cycle,GO:0001824~blastocyst development,GO:0006468~protein phosphorylation,GO:0007059~chromosome segregation,GO:0007088~regulation of mitotic nuclear division,GO:0016310~phosphorylation,GO:0032212~positive regulation of telomere maintenance via telomerase,GO:0046602~regulation of mitotic centrosome separation,GO:0046777~protein autophosphorylation,GO:0051225~spindle assembly,GO:0051299~centrosome separation,GO:0051301~cell division,GO:0051321~meiotic cell cycle,GO:0051973~positive regulation of telomerase activity,GO:0051988~regulation of attachment of spindle microtubules to kinetochore,GO:0090307~mitotic spindle assembly,GO:1903126~negative regulation of centriole-centriole cohesion,GO:1904355~positive regulation of telomere capping,	GO:0000776~kinetochore,GO:0000794~condensed nuclear chromosome,GO:0000922~spindle pole,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005829~cytosol,GO:0005874~microtubule,GO:0030496~midbody,GO:0032991~macromolecular complex,	GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0019903~protein phosphatase binding,GO:0046872~metal ion binding,	IPR000719:Prot_kinase_dom,IPR008271:Ser/Thr_kinase_AS,IPR011009:Kinase-like_dom_sf,		615565~Retinitis pigmentosa 67,		SM00220:S_TKc,	KW-0131~Cell cycle,KW-0132~Cell division,KW-0159~Chromosome partition,KW-0469~Meiosis,KW-0498~Mitosis,	KW-0137~Centromere,KW-0158~Chromosome,KW-0206~Cytoskeleton,KW-0493~Microtubule,KW-0539~Nucleus,KW-0963~Cytoplasm,KW-0995~Kinetochore,		KW-0682~Retinitis pigmentosa,	KW-0175~Coiled coil,	KW-0067~ATP-binding,KW-0460~Magnesium,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,	KW-0418~Kinase,KW-0723~Serine/threonine-protein kinase,KW-0808~Transferase,	KW-0597~Phosphoprotein,	ACT_SITE:Proton acceptor,DOMAIN:Protein kinase,MUTAGEN:D->A: Loss of autophosphorylation.,MUTAGEN:K->R: Loss of kinase activity and of ability to activate NEK11. Loss of phosphorylation of CCDC102B.,MUTAGEN:S->A: Loss of kinase activity.,MUTAGEN:S->A: No effect on kinase activity.,MUTAGEN:S->D: Kinase activity increased by two fold.,MUTAGEN:S->D: Loss of kinase activity.,MUTAGEN:T->A: Kinase activity decreased by two fold.,MUTAGEN:T->A: Loss of kinase activity.,MUTAGEN:T->A: No effect on kinase activity.,MUTAGEN:T->E: Kinase activity increased by two fold.,MUTAGEN:T->E: Loss of kinase activity.,REGION:Interaction with CEP85,REGION:Interaction with PCNT,REGION:Interaction with SAV1 and STK3/MST2,REGION:Leucine-zipper,REGION:Necessary for interaction with MAD1L1,REGION:Required for microtubule binding and for localization to the centrosomes,
Q3T042	NIN1 (RPN12) binding protein 1 homolog(NOB1)	Bos taurus			GO:0007601~visual perception,GO:0030490~maturation of SSU-rRNA,GO:0042274~ribosomal small subunit biogenesis,	GO:0005634~nucleus,GO:0030688~preribosome, small subunit precursor,	GO:0004521~endoribonuclease activity,GO:0046872~metal ion binding,	IPR002716:PIN_dom,IPR014881:NOB1_Zn-bd,IPR017117:Nob1_euk,IPR033411:Ribonuclease_PIN,IPR033461:WRNPLPNID,IPR036283:NOB1_Zf-like_sf,IPR039907:NOB1,	bta03008:Ribosome biogenesis in eukaryotes,		PIRSF037125:D-site_20S_pre-rRNA_nuclease,	SM00670:PINc,		KW-0539~Nucleus,			KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0255~Endonuclease,KW-0378~Hydrolase,KW-0540~Nuclease,	KW-0597~Phosphoprotein,	COMPBIAS:Acidic residues,COMPBIAS:Basic and acidic residues,DOMAIN:PIN,DOMAIN:PINc,REGION:Disordered,ZN_FING:NOB1,
Q7RTR2	NLR family CARD domain containing 3(NLRC3)	Homo sapiens			GO:0007249~I-kappaB kinase/NF-kappaB signaling,GO:0032088~negative regulation of NF-kappaB transcription factor activity,GO:0032687~negative regulation of interferon-alpha production,GO:0032688~negative regulation of interferon-beta production,GO:0032715~negative regulation of interleukin-6 production,GO:0032720~negative regulation of tumor necrosis factor production,GO:0035556~intracellular signal transduction,GO:0042110~T cell activation,GO:0043124~negative regulation of I-kappaB kinase/NF-kappaB signaling,GO:0045824~negative regulation of innate immune response,GO:0048147~negative regulation of fibroblast proliferation,GO:0050680~negative regulation of epithelial cell proliferation,GO:0050728~negative regulation of inflammatory response,GO:0051898~negative regulation of protein kinase B signaling,GO:1900016~negative regulation of cytokine production involved in inflammatory response,GO:1900226~negative regulation of NLRP3 inflammasome complex assembly,GO:1901223~negative regulation of NIK/NF-kappaB signaling,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0034451~centriolar satellite,GO:0043231~intracellular membrane-bounded organelle,GO:0048471~perinuclear region of cytoplasm,	GO:0005515~protein binding,GO:0005524~ATP binding,GO:0036312~phosphatidylinositol 3-kinase regulatory subunit binding,	IPR001611:Leu-rich_rpt,IPR007111:NACHT_NTPase,IPR027417:P-loop_NTPase,IPR032675:LRR_dom_sf,IPR041075:NOD2_WH,IPR041267:NLRP_HD2,				SM00368:LRR_RI,		KW-0963~Cytoplasm,			KW-0433~Leucine-rich repeat,KW-0677~Repeat,	KW-0067~ATP-binding,KW-0547~Nucleotide-binding,			DOMAIN:NACHT,MOTIF:TRAF6-binding,MUTAGEN:SLQE->AAAA: Strong decrease of TRAF6-binding.,MUTAGEN:SVEE->AAAA: Almost no effect on TRAF6-binding.,REGION:Disordered,REPEAT:LRR 1,REPEAT:LRR 10,REPEAT:LRR 11,REPEAT:LRR 12,REPEAT:LRR 13,REPEAT:LRR 14,REPEAT:LRR 15,REPEAT:LRR 16,REPEAT:LRR 2,REPEAT:LRR 3,REPEAT:LRR 4,REPEAT:LRR 5,REPEAT:LRR 6,REPEAT:LRR 7,REPEAT:LRR 8,REPEAT:LRR 9,
Q9UHC9	NPC1 like intracellular cholesterol transporter 1(NPC1L1)	Homo sapiens			GO:0006695~cholesterol biosynthetic process,GO:0009410~response to xenobiotic stimulus,GO:0014850~response to muscle activity,GO:0030299~intestinal cholesterol absorption,GO:0030301~cholesterol transport,GO:0042157~lipoprotein metabolic process,GO:0042360~vitamin E metabolic process,GO:0042632~cholesterol homeostasis,GO:0051180~vitamin transport,GO:0070508~cholesterol import,GO:0071501~cellular response to sterol depletion,	GO:0005886~plasma membrane,GO:0016020~membrane,GO:0016324~apical plasma membrane,GO:0030659~cytoplasmic vesicle membrane,GO:0031526~brush border membrane,	GO:0005319~lipid transporter activity,GO:0005515~protein binding,GO:0008431~vitamin E binding,GO:0015485~cholesterol binding,GO:0031267~small GTPase binding,GO:0031489~myosin V binding,GO:0042803~protein homodimerization activity,GO:1901363~heterocyclic compound binding,	IPR000731:SSD,IPR003392:Ptc/Disp,IPR004765:NPC1-like,IPR032190:NPC1_N,	hsa04975:Fat digestion and absorption,	617966~Ezetimibe, nonresponse to,617966~Low density lipoprotein cholesterol level QTL 7,			KW-0153~Cholesterol metabolism,KW-0443~Lipid metabolism,KW-0753~Steroid metabolism,KW-0813~Transport,KW-1207~Sterol metabolism,	KW-0472~Membrane,KW-0968~Cytoplasmic vesicle,KW-1003~Cell membrane,			KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:SSD,MUTAGEN:EE->AA: Does not affect interaction with LIMA1.,MUTAGEN:LALE->AAAA: Does not affect interaction with LIMA1.,MUTAGEN:QKR->AAA: Abolishes interaction with LIMA1.,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,TRANSMEM:Helical; Name=1,TRANSMEM:Helical; Name=10,TRANSMEM:Helical; Name=11,TRANSMEM:Helical; Name=12,TRANSMEM:Helical; Name=13,TRANSMEM:Helical; Name=2,TRANSMEM:Helical; Name=3,TRANSMEM:Helical; Name=4,TRANSMEM:Helical; Name=5,TRANSMEM:Helical; Name=6,TRANSMEM:Helical; Name=7,TRANSMEM:Helical; Name=8,TRANSMEM:Helical; Name=9,
Q641K5	NUAK family, SNF1-like kinase, 1(Nuak1)	Mus musculus			GO:0006468~protein phosphorylation,GO:0006974~cellular response to DNA damage stimulus,GO:0007155~cell adhesion,GO:0016310~phosphorylation,GO:0030155~regulation of cell adhesion,GO:0032007~negative regulation of TOR signaling,GO:0035507~regulation of myosin-light-chain-phosphatase activity,GO:0035556~intracellular signal transduction,GO:0042149~cellular response to glucose starvation,GO:2000772~regulation of cellular senescence,	GO:0001650~fibrillar center,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0015630~microtubule cytoskeleton,GO:0031588~nucleotide-activated protein kinase complex,	GO:0000166~nucleotide binding,GO:0002039~p53 binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005524~ATP binding,GO:0016301~kinase activity,GO:0016740~transferase activity,	IPR000719:Prot_kinase_dom,IPR008271:Ser/Thr_kinase_AS,IPR011009:Kinase-like_dom_sf,IPR017441:Protein_kinase_ATP_BS,				SM00220:S_TKc,	KW-0130~Cell adhesion,KW-0227~DNA damage,	KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0732~Signal,	KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0418~Kinase,KW-0723~Serine/threonine-protein kinase,KW-0808~Transferase,	KW-0007~Acetylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,	ACT_SITE:Proton acceptor,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:Protein kinase,MOTIF:GILK motif,REGION:Disordered,
Q6DHR8	NUS1 dehydrodolichyl diphosphate synthase subunit(nus1)	Danio rerio			GO:0002040~sprouting angiogenesis,GO:0006486~protein glycosylation,GO:0019408~dolichol biosynthetic process,GO:0032367~intracellular cholesterol transport,GO:0036269~swimming behavior,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0016020~membrane,GO:1904423~dehydrodolichyl diphosphate synthase complex,	GO:0016740~transferase activity,GO:0016765~transferase activity, transferring alkyl or aryl (other than methyl) groups,GO:0045547~dehydrodolichyl diphosphate synthase activity,	IPR001441:UPP_synth-like,IPR036424:UPP_synth-like_sf,IPR038887:Nus1/NgBR,	dre00900:Terpenoid backbone biosynthesis,					KW-0256~Endoplasmic reticulum,KW-0472~Membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0460~Magnesium,	KW-0675~Receptor,KW-0808~Transferase,	KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,TRANSMEM:Helical; Name=1,TRANSMEM:Helical; Name=2,TRANSMEM:Helical; Name=3,
Q6NYD7	OCIA domain containing 1(ociad1)	Danio rerio				GO:0005768~endosome,		IPR009764:OCIA_dom,IPR040187:OCAD1/2,						KW-0967~Endosome,							COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:OCIA,REGION:Disordered,
Q6DHU8	PDZ binding kinase(pbk)	Danio rerio			GO:0016310~phosphorylation,GO:0018105~peptidyl-serine phosphorylation,		GO:0000166~nucleotide binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0004708~MAP kinase kinase activity,GO:0004713~protein tyrosine kinase activity,GO:0005524~ATP binding,GO:0016301~kinase activity,GO:0016740~transferase activity,	IPR000719:Prot_kinase_dom,IPR008271:Ser/Thr_kinase_AS,IPR011009:Kinase-like_dom_sf,IPR041989:PKc_TOPK,			PIRSF000654:Integrin-linked_kinase,	SM00220:S_TKc,						KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0418~Kinase,KW-0723~Serine/threonine-protein kinase,KW-0808~Transferase,	KW-0597~Phosphoprotein,	ACT_SITE:Proton acceptor,DOMAIN:Protein kinase,
Q502L2	PGAM family member 5, serine/threonine protein phosphatase, mitochondrial(pgam5)	Danio rerio			GO:0012501~programmed cell death,GO:0035970~peptidyl-threonine dephosphorylation,GO:0090141~positive regulation of mitochondrial fission,	GO:0005739~mitochondrion,GO:0005741~mitochondrial outer membrane,GO:0016020~membrane,	GO:0004722~protein serine/threonine phosphatase activity,GO:0016787~hydrolase activity,GO:0017018~myosin phosphatase activity,	IPR013078:His_Pase_superF_clade-1,IPR029033:His_PPase_superfam,	dre04137:Mitophagy - animal,dre04217:Necroptosis,			SM00855:PGAM,	KW-1210~Necrosis,	KW-0472~Membrane,KW-0496~Mitochondrion,KW-1000~Mitochondrion outer membrane,			KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0378~Hydrolase,		COMPBIAS:Polar residues,REGION:Disordered,TRANSMEM:Helical,
Q6NWE1	PHD finger protein 10(phf10)	Danio rerio			GO:0007399~nervous system development,	GO:0005634~nucleus,GO:0071564~npBAF complex,	GO:0046872~metal ion binding,	IPR001965:Znf_PHD,IPR011011:Znf_FYVE_PHD,IPR013083:Znf_RING/FYVE/PHD,IPR019787:Znf_PHD-finger,IPR038045:PHF10_PHD_finger_1,	dre03082:ATP-dependent chromatin remodeling,			SM00249:PHD,	KW-0524~Neurogenesis,KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,			KW-0677~Repeat,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,			COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:PHD-type,REGION:Disordered,REGION:SAY,ZN_FING:PHD-type 1; degenerate,ZN_FING:PHD-type 2; degenerate,
Q7ZV90	PIF1 5'-to-3' DNA helicase homolog (S. cerevisiae)(pif1)	Danio rerio			GO:0000002~mitochondrial genome maintenance,GO:0000723~telomere maintenance,GO:0006260~DNA replication,GO:0006281~DNA repair,GO:0006310~DNA recombination,GO:0006974~cellular response to DNA damage stimulus,GO:0032508~DNA duplex unwinding,	GO:0005634~nucleus,GO:0005657~replication fork,GO:0005739~mitochondrion,	GO:0000166~nucleotide binding,GO:0003677~DNA binding,GO:0003678~DNA helicase activity,GO:0004386~helicase activity,GO:0005524~ATP binding,GO:0016787~hydrolase activity,GO:0016887~ATPase activity,GO:0043139~5'-3' DNA helicase activity,	IPR003593:AAA+_ATPase,IPR010285:DNA_helicase_pif1-like,IPR027417:P-loop_NTPase,IPR048293:PIF1_RRM3_pfh1,IPR049163:Pif1-like_2B_dom,				SM00382:AAA,	KW-0227~DNA damage,KW-0233~DNA recombination,KW-0234~DNA repair,	KW-0496~Mitochondrion,KW-0539~Nucleus,				KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0238~DNA-binding,KW-0347~Helicase,KW-0378~Hydrolase,
Q99575	POP1 homolog, ribonuclease P/MRP subunit(POP1)	Homo sapiens			GO:0001682~tRNA 5'-leader removal,GO:0008033~tRNA processing,GO:0016078~tRNA catabolic process,	GO:0000172~ribonuclease MRP complex,GO:0005615~extracellular space,GO:0005654~nucleoplasm,GO:0005655~nucleolar ribonuclease P complex,GO:0005730~nucleolus,GO:0030681~multimeric ribonuclease P complex,	GO:0003723~RNA binding,GO:0004526~ribonuclease P activity,GO:0005515~protein binding,GO:0033204~ribonuclease P RNA binding,	IPR009723:Pop1_N,IPR012590:POPLD_dom,IPR039182:Pop1,	hsa03008:Ribosome biogenesis in eukaryotes,	617396~Anauxetic dysplasia 2,			KW-0819~tRNA processing,	KW-0539~Nucleus,		KW-0225~Disease variant,KW-0242~Dwarfism,			KW-0694~RNA-binding,	KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:POPLD,DOMAIN:Pop1 N-terminal,REGION:Disordered,
Q15032	R3H domain containing 1(R3HDM1)	Homo sapiens					GO:0003676~nucleic acid binding,GO:0003723~RNA binding,	IPR001374:R3H_dom,IPR024771:SUZ,IPR036867:R3H_dom_sf,				SM00393:R3H,								KW-0488~Methylation,KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,COMPBIAS:Pro residues,DOMAIN:R3H,DOMAIN:SUZ,REGION:Disordered,
Q17QU4	RAB39B, member RAS oncogene family(RAB39B)	Bos taurus			GO:0006914~autophagy,GO:0010506~regulation of autophagy,GO:0015031~protein transport,GO:0016192~vesicle-mediated transport,GO:0032482~Rab protein signal transduction,GO:0050808~synapse organization,	GO:0000139~Golgi membrane,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0030659~cytoplasmic vesicle membrane,GO:0043005~neuron projection,	GO:0003924~GTPase activity,GO:0005525~GTP binding,GO:0031489~myosin V binding,	IPR001806:Small_GTPase,IPR005225:Small_GTP-bd_dom,IPR027417:P-loop_NTPase,IPR041818:Rab39,	bta04140:Autophagy - animal,bta05014:Amyotrophic lateral sclerosis,bta05022:Pathways of neurodegeneration - multiple diseases,			SM00173:RAS,SM00174:RHO,SM00175:RAB,SM00176:RAN,	KW-0072~Autophagy,KW-0653~Protein transport,KW-0813~Transport,	KW-0333~Golgi apparatus,KW-0472~Membrane,KW-0968~Cytoplasmic vesicle,KW-1003~Cell membrane,				KW-0342~GTP-binding,KW-0547~Nucleotide-binding,		KW-0449~Lipoprotein,KW-0488~Methylation,KW-0597~Phosphoprotein,KW-0636~Prenylation,	LIPID:S-geranylgeranyl cysteine,MOTIF:Effector region,
P35280	RAB8A, member RAS oncogene family(Rab8a)	Rattus norvegicus			GO:0006904~vesicle docking involved in exocytosis,GO:0006914~autophagy,GO:0007030~Golgi organization,GO:0007409~axonogenesis,GO:0009306~protein secretion,GO:0010506~regulation of autophagy,GO:0017157~regulation of exocytosis,GO:0032456~endocytic recycling,GO:0032869~cellular response to insulin stimulus,GO:0032880~regulation of protein localization,GO:0042593~glucose homeostasis,GO:0046326~positive regulation of glucose import,GO:0048169~regulation of long-term neuronal synaptic plasticity,GO:0048210~Golgi vesicle fusion to target membrane,GO:0051179~localization,GO:0051223~regulation of protein transport,GO:0060271~cilium assembly,GO:0061512~protein localization to cilium,GO:0072659~protein localization to plasma membrane,GO:0098887~neurotransmitter receptor transport, endosome to postsynaptic membrane,GO:0098969~neurotransmitter receptor transport to postsynaptic membrane,GO:0099003~vesicle-mediated transport in synapse,	GO:0005768~endosome,GO:0005794~Golgi apparatus,GO:0005813~centrosome,GO:0005814~centriole,GO:0005886~plasma membrane,GO:0005929~cilium,GO:0008021~synaptic vesicle,GO:0010008~endosome membrane,GO:0014069~postsynaptic density,GO:0016020~membrane,GO:0030140~trans-Golgi network transport vesicle,GO:0030425~dendrite,GO:0030496~midbody,GO:0030659~cytoplasmic vesicle membrane,GO:0030670~phagocytic vesicle membrane,GO:0031410~cytoplasmic vesicle,GO:0036064~ciliary basal body,GO:0043005~neuron projection,GO:0043025~neuronal cell body,GO:0043197~dendritic spine,GO:0045202~synapse,GO:0045335~phagocytic vesicle,GO:0055037~recycling endosome,GO:0055038~recycling endosome membrane,GO:0060170~ciliary membrane,GO:0070382~exocytic vesicle,GO:0097546~ciliary base,GO:0097730~non-motile cilium,GO:0098978~glutamatergic synapse,	GO:0003924~GTPase activity,GO:0005525~GTP binding,GO:0019003~GDP binding,GO:0019901~protein kinase binding,GO:0031489~myosin V binding,GO:1990782~protein tyrosine kinase binding,	IPR001806:Small_GTPase,IPR005225:Small_GTP-bd_dom,IPR027417:P-loop_NTPase,	rno04140:Autophagy - animal,rno04144:Endocytosis,rno04152:AMPK signaling pathway,rno04530:Tight junction,rno04972:Pancreatic secretion,rno05014:Amyotrophic lateral sclerosis,rno05022:Pathways of neurodegeneration - multiple diseases,			SM00173:RAS,SM00174:RHO,SM00175:RAB,SM00176:RAN,SM00177:ARF,	KW-0072~Autophagy,KW-0653~Protein transport,KW-0813~Transport,KW-0970~Cilium biogenesis/degradation,	KW-0206~Cytoskeleton,KW-0333~Golgi apparatus,KW-0472~Membrane,KW-0963~Cytoplasm,KW-0966~Cell projection,KW-0967~Endosome,KW-0968~Cytoplasmic vesicle,KW-0969~Cilium,KW-1003~Cell membrane,				KW-0342~GTP-binding,KW-0547~Nucleotide-binding,	KW-0378~Hydrolase,	KW-0449~Lipoprotein,KW-0488~Methylation,KW-0597~Phosphoprotein,KW-0636~Prenylation,	LIPID:S-geranylgeranyl cysteine,MOTIF:Effector region,PROPEP:Removed in mature form,REGION:Disordered,
Q924H5	RAD51 paralog C(Rad51c)	Mus musculus			GO:0000707~meiotic DNA recombinase assembly,GO:0000722~telomere maintenance via recombination,GO:0000724~double-strand break repair via homologous recombination,GO:0006281~DNA repair,GO:0006310~DNA recombination,GO:0006974~cellular response to DNA damage stimulus,GO:0007066~female meiosis sister chromatid cohesion,GO:0007131~reciprocal meiotic recombination,GO:0007141~male meiosis I,GO:0007283~spermatogenesis,GO:0010971~positive regulation of G2/M transition of mitotic cell cycle,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005657~replication fork,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005829~cytosol,GO:0030054~cell junction,GO:0033063~Rad51B-Rad51C-Rad51D-XRCC2 complex,GO:0033065~Rad51C-XRCC3 complex,GO:0043231~intracellular membrane-bounded organelle,GO:0048471~perinuclear region of cytoplasm,GO:0048476~Holliday junction resolvase complex,	GO:0000166~nucleotide binding,GO:0000400~four-way junction DNA binding,GO:0003677~DNA binding,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008821~crossover junction endodeoxyribonuclease activity,	IPR010995:DNA_repair_Rad51/TF_NusA_a-hlx,IPR013632:DNA_recomb/repair_Rad51_C,IPR016467:DNA_recomb/repair_RecA-like,IPR020588:RecA_ATP-bd,IPR027417:P-loop_NTPase,	mmu03440:Homologous recombination,mmu03460:Fanconi anemia pathway,		PIRSF005856:Rad51,		KW-0227~DNA damage,KW-0233~DNA recombination,KW-0234~DNA repair,	KW-0496~Mitochondrion,KW-0539~Nucleus,KW-0963~Cytoplasm,				KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0238~DNA-binding,	KW-0597~Phosphoprotein,	DOMAIN:RecA family profile 1,MOTIF:Nuclear localization signal,REGION:Disordered,REGION:Interaction with RAD51B, RAD51D and XRCC3,REGION:Required for Holliday junction resolution activity,
Q06609	RAD51 recombinase(RAD51)	Homo sapiens		h_atmPathway:ATM Signaling Pathway,h_atrbrcaPathway:Role of BRCA1,  BRCA2 and ATR in Cancer Susceptibility,	GO:0000722~telomere maintenance via recombination,GO:0000724~double-strand break repair via homologous recombination,GO:0000730~DNA recombinase assembly,GO:0001932~regulation of protein phosphorylation,GO:0006268~DNA unwinding involved in DNA replication,GO:0006281~DNA repair,GO:0006310~DNA recombination,GO:0006312~mitotic recombination,GO:0006974~cellular response to DNA damage stimulus,GO:0007131~reciprocal meiotic recombination,GO:0010569~regulation of double-strand break repair via homologous recombination,GO:0010833~telomere maintenance via telomere lengthening,GO:0031297~replication fork processing,GO:0036297~interstrand cross-link repair,GO:0042148~strand invasion,GO:0051106~positive regulation of DNA ligation,GO:0051321~meiotic cell cycle,GO:0051865~protein autoubiquitination,GO:0070192~chromosome organization involved in meiotic cell cycle,GO:0071479~cellular response to ionizing radiation,GO:0072711~cellular response to hydroxyurea,GO:0072757~cellular response to camptothecin,GO:1990414~replication-born double-strand break repair via sister chromatid exchange,GO:1990426~mitotic recombination-dependent replication fork processing,GO:1990918~double-strand break repair involved in meiotic recombination,GO:2000001~regulation of DNA damage checkpoint,	GO:0000152~nuclear ubiquitin ligase complex,GO:0000228~nuclear chromosome,GO:0000781~chromosome, telomeric region,GO:0000785~chromatin,GO:0000793~condensed chromosome,GO:0000794~condensed nuclear chromosome,GO:0000800~lateral element,GO:0001673~male germ cell nucleus,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,GO:0005813~centrosome,GO:0005829~cytosol,GO:0016605~PML body,GO:0032991~macromolecular complex,GO:0035861~site of double-strand break,GO:0048471~perinuclear region of cytoplasm,	GO:0000150~recombinase activity,GO:0000166~nucleotide binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003690~double-stranded DNA binding,GO:0003697~single-stranded DNA binding,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008094~DNA-dependent ATPase activity,GO:0016887~ATPase activity,GO:0017116~single-stranded DNA-dependent ATP-dependent DNA helicase activity,GO:0019899~enzyme binding,GO:0042802~identical protein binding,GO:0070182~DNA polymerase binding,	IPR003593:AAA+_ATPase,IPR010995:DNA_repair_Rad51/TF_NusA_a-hlx,IPR011941:DNA_recomb/repair_Rad51,IPR013632:DNA_recomb/repair_Rad51_C,IPR016467:DNA_recomb/repair_RecA-like,IPR020587:RecA_monomer-monomer_interface,IPR020588:RecA_ATP-bd,IPR027417:P-loop_NTPase,	hsa03440:Homologous recombination,hsa03460:Fanconi anemia pathway,hsa05200:Pathways in cancer,hsa05212:Pancreatic cancer,	114480~Breast cancer, susceptibility to,614508~Mirror movements 2,617244~Fanconi anemia, complementation group R,	PIRSF005856:Rad51,	SM00382:AAA,	KW-0227~DNA damage,KW-0233~DNA recombination,KW-0234~DNA repair,	KW-0158~Chromosome,KW-0206~Cytoskeleton,KW-0496~Mitochondrion,KW-0539~Nucleus,KW-0963~Cytoplasm,		KW-0225~Disease variant,KW-0923~Fanconi anemia,		KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0238~DNA-binding,	KW-0007~Acetylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),DOMAIN:HhH,DOMAIN:RecA family profile 1,DOMAIN:RecA family profile 2,MOTIF:Nuclear export signal; masked by the interaction with BRCA2,MUTAGEN:A->E: Loss of homooligomerization.,MUTAGEN:F->A: Loss of homooligomerization.,MUTAGEN:K->R: Impaired ubiquitination; when associated with R-58.,MUTAGEN:K->R: Impaired ubiquitination; when associated with R-64.,MUTAGEN:S->A: Abolished phosphorylation by PLK1 and subsequent phosphorylation by CK2.,MUTAGEN:SA->LE: Disrupts interaction with BRCA2, no effect on homooligomerization, promotes interaction with XPO1 and cytoplasmic localization.,MUTAGEN:T->A: Abolished phosphorylation by CK2.,MUTAGEN:T->A: Confers hypersensitivity to hydroxyurea.,REGION:Disordered,REGION:Interaction with PALB2,
F1Q8K0	RAD54 like(rad54l)	Danio rerio			GO:0007131~reciprocal meiotic recombination,GO:0045003~double-strand break repair via synthesis-dependent strand annealing,	GO:0005634~nucleus,	GO:0000166~nucleotide binding,GO:0003677~DNA binding,GO:0004386~helicase activity,GO:0005524~ATP binding,GO:0008094~DNA-dependent ATPase activity,GO:0015616~DNA translocase activity,GO:0016787~hydrolase activity,	IPR000330:SNF2_N,IPR001650:Helicase_C,IPR014001:Helicase_ATP-bd,IPR027417:P-loop_NTPase,IPR038718:SNF2-like_sf,	dre03440:Homologous recombination,			SM00487:DEXDc,SM00490:HELICc,						KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0347~Helicase,KW-0378~Hydrolase,	KW-0597~Phosphoprotein,	DOMAIN:Helicase ATP-binding,DOMAIN:Helicase C-terminal,MOTIF:DEAH box,REGION:Disordered,
P34022	RAN binding protein 1(Ranbp1)	Mus musculus		m_ranMSPathway:Role of Ran in mitotic spindle regulation,m_ranPathway:Cycling of Ran in nucleocytoplasmic transport,	GO:0006913~nucleocytoplasmic transport,GO:0007051~spindle organization,GO:0010976~positive regulation of neuron projection development,GO:0046604~positive regulation of mitotic centrosome separation,GO:0046907~intracellular transport,GO:0072750~cellular response to leptomycin B,	GO:0005643~nuclear pore,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005829~cytosol,GO:0032838~cell projection cytoplasm,GO:1904115~axon cytoplasm,	GO:0005092~GDP-dissociation inhibitor activity,GO:0005096~GTPase activator activity,	IPR000156:Ran_bind_dom,IPR011993:PH-like_dom_sf,IPR045255:RanBP1-like,IPR045256:RanBP1_RanBD,	mmu05166:Human T-cell leukemia virus 1 infection,mmu05203:Viral carcinogenesis,			SM00160:RanBD,							KW-0343~GTPase activation,	KW-0007~Acetylation,KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,DOMAIN:RanBD1,REGION:Disordered,
F1QLY4	RAR-related orphan receptor A, paralog a(roraa)	Danio rerio			GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0010468~regulation of gene expression,GO:0010628~positive regulation of gene expression,GO:0021587~cerebellum morphogenesis,GO:0048511~rhythmic process,	GO:0005634~nucleus,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0004879~RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding,GO:0008270~zinc ion binding,GO:0043565~sequence-specific DNA binding,GO:0046872~metal ion binding,	IPR000536:Nucl_hrmn_rcpt_lig-bd,IPR001628:Znf_hrmn_rcpt,IPR001723:Nuclear_hrmn_rcpt,IPR003079:ROR_rcpt,IPR013088:Znf_NHR/GATA,IPR035500:NHR-like_dom_sf,IPR044101:NR_DBD_ROR,				SM00399:ZnF_C4,SM00430:HOLI,	KW-0090~Biological rhythms,KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,			KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0010~Activator,KW-0217~Developmental protein,KW-0238~DNA-binding,KW-0675~Receptor,KW-9996~Developmental protein,		COMPBIAS:Polar residues,DNA_BIND:Nuclear receptor,DOMAIN:NR LBD,DOMAIN:Nuclear receptor,REGION:AF-2,REGION:Disordered,ZN_FING:NR C4-type,
Q4R698	RIB43A domain with coiled-coils 1(RIBC1)	Macaca fascicularis						IPR008805:RIB43A,									KW-0175~Coiled coil,				COMPBIAS:Basic and acidic residues,REGION:Disordered,
Q8R3Y5	RIKEN cDNA 2310022A10 gene(2310022A10Rik)	Mus musculus				GO:0005634~nucleus,GO:0005654~nucleoplasm,		IPR013761:SAM/pointed_sf,IPR039161:C19orf47-like,IPR040772:C19orf47_SAM,IPR041477:DUF5577,												KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Polar residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),DOMAIN:DUF5577,REGION:Disordered,
Q8R092	RIKEN cDNA 4933434E20 gene(4933434E20Rik)	Mus musculus			GO:0001701~in utero embryonic development,GO:0006909~phagocytosis,	GO:0005739~mitochondrion,GO:0005794~Golgi apparatus,GO:0005829~cytosol,GO:0016020~membrane,		IPR010876:C1orf43,						KW-0333~Golgi apparatus,KW-0472~Membrane,KW-0496~Mitochondrion,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,				COMPBIAS:Polar residues,REGION:Disordered,TRANSMEM:Helical,
Q9CWB7	RIKEN cDNA C330018D20 gene(C330018D20Rik)	Mus musculus				GO:0005739~mitochondrion,		IPR008554:Glutaredoxin-like,IPR036249:Thioredoxin-like_sf,					KW-0249~Electron transport,KW-0813~Transport,							KW-1015~Disulfide bond,	DISULFID:Redox-active,
Q5ZJX4	RNA binding motif protein 38(RBM38)	Gallus gallus			GO:0006397~mRNA processing,GO:0008380~RNA splicing,GO:0030154~cell differentiation,GO:0043484~regulation of RNA splicing,	GO:0005634~nucleus,GO:0005829~cytosol,	GO:0003723~RNA binding,GO:0003730~mRNA 3'-UTR binding,	IPR000504:RRM_dom,IPR012677:Nucleotide-bd_a/b_plait_sf,IPR035979:RBD_domain_sf,				SM00360:RRM,	KW-0221~Differentiation,KW-0507~mRNA processing,KW-0508~mRNA splicing,	KW-0539~Nucleus,KW-0963~Cytoplasm,					KW-0694~RNA-binding,		DOMAIN:RRM,
Q8C7Q4	RNA binding motif protein 4(Rbm4)	Mus musculus			GO:0000381~regulation of alternative mRNA splicing, via spliceosome,GO:0000398~mRNA splicing, via spliceosome,GO:0002190~cap-independent translational initiation,GO:0002192~IRES-dependent translational initiation,GO:0006397~mRNA processing,GO:0006417~regulation of translation,GO:0007623~circadian rhythm,GO:0008380~RNA splicing,GO:0010468~regulation of gene expression,GO:0010628~positive regulation of gene expression,GO:0017148~negative regulation of translation,GO:0030154~cell differentiation,GO:0031016~pancreas development,GO:0031047~gene silencing by RNA,GO:0032055~negative regulation of translation in response to stress,GO:0032922~circadian regulation of gene expression,GO:0035278~miRNA mediated inhibition of translation,GO:0035773~insulin secretion involved in cellular response to glucose stimulus,GO:0035883~enteroendocrine cell differentiation,GO:0042593~glucose homeostasis,GO:0043153~entrainment of circadian clock by photoperiod,GO:0045727~positive regulation of translation,GO:0045947~negative regulation of translational initiation,GO:0046626~regulation of insulin receptor signaling pathway,GO:0046685~response to arsenic-containing substance,GO:0046822~regulation of nucleocytoplasmic transport,GO:0051149~positive regulation of muscle cell differentiation,GO:0097167~circadian regulation of translation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0010494~cytoplasmic stress granule,GO:0016607~nuclear speck,GO:0032991~macromolecular complex,GO:0048471~perinuclear region of cytoplasm,	GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0003729~mRNA binding,GO:0003730~mRNA 3'-UTR binding,GO:0008270~zinc ion binding,GO:0030332~cyclin binding,GO:0035198~miRNA binding,GO:0036002~pre-mRNA binding,GO:0046872~metal ion binding,GO:0097157~pre-mRNA intronic binding,GO:0097158~pre-mRNA intronic pyrimidine-rich binding,	IPR000504:RRM_dom,IPR001878:Znf_CCHC,IPR012677:Nucleotide-bd_a/b_plait_sf,IPR034897:RBM4_RRM1,IPR034898:RBM4_RRM2,IPR035979:RBD_domain_sf,				SM00343:ZnF_C2HC,SM00360:RRM,	KW-0221~Differentiation,KW-0507~mRNA processing,KW-0508~mRNA splicing,KW-0943~RNA-mediated gene silencing,	KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0677~Repeat,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0010~Activator,KW-0694~RNA-binding,	KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),DOMAIN:CCHC-type,DOMAIN:RRM,DOMAIN:RRM 1,DOMAIN:RRM 2,REGION:Disordered,REGION:Interaction with TNPO3,ZN_FING:CCHC-type,
Q7ZW41	RNA polymerase II subunit G(polr2g)	Danio rerio			GO:0000291~nuclear-transcribed mRNA catabolic process, exonucleolytic,GO:0006351~transcription, DNA-templated,GO:0006352~DNA-templated transcription, initiation,GO:0006366~transcription from RNA polymerase II promoter,GO:0006367~transcription initiation from RNA polymerase II promoter,GO:0045948~positive regulation of translational initiation,GO:0060213~positive regulation of nuclear-transcribed mRNA poly(A) tail shortening,	GO:0000428~DNA-directed RNA polymerase complex,GO:0000932~P-body,GO:0005634~nucleus,GO:0005665~DNA-directed RNA polymerase II, core complex,	GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003697~single-stranded DNA binding,GO:0003727~single-stranded RNA binding,GO:0031369~translation initiation factor binding,	IPR003029:S1_domain,IPR005576:Rpb7-like_N,IPR012340:NA-bd_OB-fold,IPR036898:RNA_pol_Rpb7-like_N_sf,IPR045113:Rpb7-like,	dre03020:RNA polymerase,dre03420:Nucleotide excision repair,			SM00316:S1,	KW-0804~Transcription,	KW-0240~DNA-directed RNA polymerase,KW-0539~Nucleus,KW-9994~DNA-directed RNA polymerase,							DOMAIN:S1 motif,
P21328	RNA-directed DNA polymerase from mobile element jockey(pol)	Drosophila melanogaster			GO:0006313~transposition, DNA-mediated,GO:0006508~proteolysis,GO:0015074~DNA integration,	GO:0005634~nucleus,GO:0042575~DNA polymerase complex,	GO:0003676~nucleic acid binding,GO:0003887~DNA-directed DNA polymerase activity,GO:0003964~RNA-directed DNA polymerase activity,GO:0004190~aspartic-type endopeptidase activity,GO:0004519~endonuclease activity,GO:0008233~peptidase activity,GO:0046872~metal ion binding,	IPR000477:RT_dom,IPR001584:Integrase_cat-core,IPR001969:Aspartic_peptidase_AS,IPR005135:Endo/exonuclease/phosphatase,IPR012337:RNaseH-like_sf,IPR013087:Znf_C2H2_type,IPR021109:Peptidase_aspartic_dom_sf,IPR036397:RNaseH_sf,IPR036691:Endo/exonu/phosph_ase_sf,IPR041373:RT_RNaseH,IPR041588:Integrase_H2C2,IPR043128:Rev_trsase/Diguanyl_cyclase,IPR043502:DNA/RNA_pol_sf,				SM00355:ZnF_C2H2,					KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0064~Aspartyl protease,KW-0255~Endonuclease,KW-0378~Hydrolase,KW-0540~Nuclease,KW-0548~Nucleotidyltransferase,KW-0645~Protease,KW-0695~RNA-directed DNA polymerase,KW-0808~Transferase,		ACT_SITE:For protease activity,DOMAIN:Integrase catalytic,DOMAIN:Reverse transcriptase,REGION:Disordered,ZN_FING:C2H2-type,
Q96C34	RUN domain containing 1(RUNDC1)	Homo sapiens			GO:0001701~in utero embryonic development,			IPR004012:Run_dom,IPR037213:Run_dom_sf,				SM00593:RUN,					KW-0175~Coiled coil,			KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:RUN,REGION:Disordered,
Q8TEU7	Rap guanine nucleotide exchange factor 6(RAPGEF6)	Homo sapiens			GO:0007264~small GTPase mediated signal transduction,GO:0007265~Ras protein signal transduction,GO:0030033~microvillus assembly,GO:0043087~regulation of GTPase activity,GO:0043547~positive regulation of GTPase activity,GO:0072659~protein localization to plasma membrane,	GO:0005813~centrosome,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0016324~apical plasma membrane,GO:0030139~endocytic vesicle,	GO:0005085~guanyl-nucleotide exchange factor activity,GO:0005515~protein binding,GO:0030742~GTP-dependent protein binding,GO:0031267~small GTPase binding,GO:0070300~phosphatidic acid binding,	IPR000159:RA_dom,IPR000595:cNMP-bd_dom,IPR000651:Ras-like_Gua-exchang_fac_N,IPR001478:PDZ,IPR001895:RASGEF_cat_dom,IPR008937:Ras-like_GEF,IPR014710:RmlC-like_jellyroll,IPR018490:cNMP-bd_dom_sf,IPR023578:Ras_GEF_dom_sf,IPR036034:PDZ_sf,IPR036964:RASGEF_cat_dom_sf,	hsa04015:Rap1 signaling pathway,hsa04530:Tight junction,			SM00100:cNMP,SM00147:RasGEF,SM00228:PDZ,SM00229:RasGEFN,SM00314:RA,		KW-0472~Membrane,KW-0963~Cytoplasm,KW-1003~Cell membrane,					KW-0344~Guanine-nucleotide releasing factor,	KW-0007~Acetylation,KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:Cyclic nucleotide-binding,DOMAIN:N-terminal Ras-GEF,DOMAIN:PDZ,DOMAIN:Ras-GEF,DOMAIN:Ras-associating,REGION:Disordered,
A7UA95	Ras association and DIL domains(radil)	Danio rerio			GO:0001755~neural crest cell migration,GO:0007155~cell adhesion,GO:0007165~signal transduction,GO:0034446~substrate adhesion-dependent cell spreading,	GO:0005874~microtubule,	GO:0051020~GTPase binding,	IPR000159:RA_dom,IPR000253:FHA_dom,IPR001478:PDZ,IPR002710:Dilute_dom,IPR008984:SMAD_FHA_dom_sf,IPR029071:Ubiquitin-like_domsf,IPR036034:PDZ_sf,IPR037983:CBD_Rasip1/Radil,	dre04520:Adherens junction,			SM00228:PDZ,SM00314:RA,SM01132:DIL,	KW-0130~Cell adhesion,						KW-0217~Developmental protein,KW-9996~Developmental protein,		COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:Dilute,DOMAIN:FHA,DOMAIN:PDZ,DOMAIN:Ras-associating,REGION:Disordered,
Q02094	Rh associated glycoprotein(RHAG)	Homo sapiens			GO:0006873~cellular ion homeostasis,GO:0015670~carbon dioxide transport,GO:0015701~bicarbonate transport,GO:0035378~carbon dioxide transmembrane transport,GO:0048821~erythrocyte development,GO:0060586~multicellular organismal iron ion homeostasis,GO:0072488~ammonium transmembrane transport,GO:0072489~methylammonium transmembrane transport,GO:0097272~ammonia homeostasis,GO:0098662~inorganic cation transmembrane transport,	GO:0005886~plasma membrane,GO:0016020~membrane,	GO:0005515~protein binding,GO:0008519~ammonium transmembrane transporter activity,GO:0015200~methylammonium transmembrane transporter activity,GO:0022840~leak channel activity,GO:0030506~ankyrin binding,GO:0035379~carbon dioxide transmembrane transporter activity,	IPR002229:RhesusRHD,IPR024041:NH4_transpt_AmtB-like_dom,IPR029020:Ammonium/urea_transptr,		185000~Overhydrated hereditary stomatocytosis,268150~Anemia, hemolytic, Rh-null, regulator type,			KW-0813~Transport,KW-0924~Ammonia transport,	KW-0472~Membrane,		KW-0225~Disease variant,KW-0360~Hereditary hemolytic anemia,	KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Ammonium transporter AmtB-like,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q6INE5	Rho GTPase activating protein 19 L homeolog(arhgap19.L)	Xenopus laevis			GO:0007165~signal transduction,		GO:0005096~GTPase activator activity,	IPR000198:RhoGAP_dom,IPR008936:Rho_GTPase_activation_prot,IPR047941:ARHGAP19_RhoGAP,				SM00324:RhoGAP,							KW-0343~GTPase activation,		COMPBIAS:Polar residues,DOMAIN:Rho-GAP,REGION:Disordered,
Q5TG30	Rho GTPase activating protein 40(ARHGAP40)	Homo sapiens			GO:0007165~signal transduction,GO:0030833~regulation of actin filament polymerization,GO:0051056~regulation of small GTPase mediated signal transduction,	GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0005096~GTPase activator activity,	IPR000198:RhoGAP_dom,IPR008936:Rho_GTPase_activation_prot,				SM00324:RhoGAP,							KW-0343~GTPase activation,		COMPBIAS:Polar residues,DOMAIN:Rho-GAP,REGION:Disordered,
Q6SA80	Rho family GTPase 3(Rnd3)	Rattus norvegicus			GO:0007015~actin filament organization,GO:0007165~signal transduction,GO:0007264~small GTPase mediated signal transduction,GO:0016477~cell migration,GO:0032956~regulation of actin cytoskeleton organization,	GO:0005829~cytosol,GO:0005886~plasma membrane,	GO:0003924~GTPase activity,GO:0005525~GTP binding,GO:0019901~protein kinase binding,	IPR001806:Small_GTPase,IPR003578:Small_GTPase_Rho,IPR005225:Small_GTP-bd_dom,IPR027417:P-loop_NTPase,IPR041843:RhoE,				SM00173:RAS,SM00174:RHO,SM00175:RAB,		KW-0472~Membrane,KW-1003~Cell membrane,				KW-0342~GTP-binding,KW-0547~Nucleotide-binding,		KW-0449~Lipoprotein,KW-0488~Methylation,KW-0636~Prenylation,	LIPID:S-farnesyl cysteine,MOTIF:Effector region,PROPEP:Removed in mature form,
Q14155	Rho guanine nucleotide exchange factor 7(ARHGEF7)	Homo sapiens			GO:0002244~hematopoietic progenitor cell differentiation,GO:0007030~Golgi organization,GO:0007165~signal transduction,GO:0007266~Rho protein signal transduction,GO:0007399~nervous system development,GO:0010763~positive regulation of fibroblast migration,GO:0030032~lamellipodium assembly,GO:0035556~intracellular signal transduction,GO:0043065~positive regulation of apoptotic process,GO:0043547~positive regulation of GTPase activity,GO:0048013~ephrin receptor signaling pathway,GO:0048041~focal adhesion assembly,GO:0060124~positive regulation of growth hormone secretion,GO:1900026~positive regulation of substrate adhesion-dependent cell spreading,GO:1905833~negative regulation of microtubule nucleation,GO:2000394~positive regulation of lamellipodium morphogenesis,	GO:0000322~storage vacuole,GO:0001726~ruffle,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005925~focal adhesion,GO:0005938~cell cortex,GO:0030027~lamellipodium,GO:0032991~macromolecular complex,GO:0043005~neuron projection,GO:0043025~neuronal cell body,GO:0097431~mitotic spindle pole,GO:0098794~postsynapse,	GO:0005085~guanyl-nucleotide exchange factor activity,GO:0005515~protein binding,GO:0019901~protein kinase binding,GO:0043015~gamma-tubulin binding,	IPR000219:DH-domain,IPR001331:GDS_CDC24_CS,IPR001452:SH3_domain,IPR001715:CH_dom,IPR001849:PH_domain,IPR011993:PH-like_dom_sf,IPR032409:GEF6/7_CC,IPR035789:BetaPIX_SH3,IPR035899:DBL_dom_sf,IPR036028:SH3-like_dom_sf,IPR036872:CH_dom_sf,IPR046376:PH_Cool_Pix,	hsa04810:Regulation of actin cytoskeleton,hsa05135:Yersinia infection,			SM00033:CH,SM00233:PH,SM00325:RhoGEF,SM00326:SH3,	KW-0524~Neurogenesis,	KW-0963~Cytoplasm,KW-0965~Cell junction,KW-0966~Cell projection,			KW-0175~Coiled coil,KW-0728~SH3 domain,		KW-0344~Guanine-nucleotide releasing factor,	KW-0007~Acetylation,KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:Calponin-homology (CH),DOMAIN:DH,DOMAIN:PH,DOMAIN:Rho guanine nucleotide exchange factor 6/7 coiled-coil,DOMAIN:SH3,REGION:Disordered,
O94885	SAM and SH3 domain containing 1(SASH1)	Homo sapiens			GO:0000209~protein polyubiquitination,GO:0010595~positive regulation of endothelial cell migration,GO:0010632~regulation of epithelial cell migration,GO:0031666~positive regulation of lipopolysaccharide-mediated signaling pathway,GO:0043507~positive regulation of JUN kinase activity,GO:0045766~positive regulation of angiogenesis,GO:1900044~regulation of protein K63-linked ubiquitination,GO:1900745~positive regulation of p38MAPK cascade,GO:1901224~positive regulation of NIK/NF-kappaB signaling,GO:1902498~regulation of protein autoubiquitination,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0016020~membrane,GO:0032991~macromolecular complex,	GO:0001965~G-protein alpha-subunit binding,GO:0005515~protein binding,GO:0019901~protein kinase binding,GO:0031435~mitogen-activated protein kinase kinase kinase binding,GO:0060090~binding, bridging,	IPR001452:SH3_domain,IPR001660:SAM,IPR013761:SAM/pointed_sf,IPR021090:SPIDER,IPR035720:SASH1_SH3,IPR036028:SH3-like_dom_sf,IPR037627:SASH1_SAM_repeat1,IPR037630:SASH1_SAM_repeat2,		127500~Dyschromatosis universalis hereditaria 1,618373~Cancer, alopecia, pigment dyscrasia, onychodystrophy, and keratoderma,		SM00326:SH3,SM00454:SAM,		KW-0472~Membrane,KW-0963~Cytoplasm,		KW-0043~Tumor suppressor,KW-0225~Disease variant,KW-1007~Palmoplantar keratoderma,KW-1063~Hypotrichosis,	KW-0677~Repeat,KW-0728~SH3 domain,KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,COMPBIAS:Pro residues,DOMAIN:SAM,DOMAIN:SAM 1,DOMAIN:SAM 2,DOMAIN:SH3,MUTAGEN:Missing: Abolishes interaction with TRAF6.,REGION:Disordered,REGION:Required for interaction with TRAF6,TRANSMEM:Helical,
P21158	SDR family oxidoreductase(MXAN_RS06255)	Myxococcus xanthus DK 1622			GO:0030435~sporulation resulting in formation of a cellular spore,	GO:0005576~extracellular region,GO:0009279~cell outer membrane,		IPR002347:SDR_fam,IPR036291:NAD(P)-bd_dom_sf,					KW-0346~Stress response,KW-0749~Sporulation,	KW-0472~Membrane,KW-0964~Secreted,KW-0998~Cell outer membrane,	KW-0293~Fruiting body,
Q92503	SEC14 like lipid binding 1(SEC14L1)	Homo sapiens			GO:0015871~choline transport,GO:0039536~negative regulation of RIG-I signaling pathway,GO:0045087~innate immune response,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005758~mitochondrial intermembrane space,GO:0005794~Golgi apparatus,GO:0005829~cytosol,	GO:0005515~protein binding,GO:0039552~RIG-I binding,	IPR001251:CRAL-TRIO_dom,IPR006797:PRELI/MSF1_dom,IPR009038:GOLD_dom,IPR011074:CRAL/TRIO_N_dom,IPR036273:CRAL/TRIO_N_dom_sf,IPR036598:GOLD_dom_sf,IPR036865:CRAL-TRIO_dom_sf,IPR037365:Slowmo/Ups,				SM00516:SEC14,SM01100:CRAL_TRIO_N,	KW-0391~Immunity,KW-0399~Innate immunity,	KW-0333~Golgi apparatus,KW-0963~Cytoplasm,					KW-0734~Signal transduction inhibitor,	KW-0597~Phosphoprotein,	COMPBIAS:Polar residues,DOMAIN:CRAL-TRIO,DOMAIN:GOLD,DOMAIN:PRELI/MSF1,REGION:Disordered,REGION:Required for interaction and inhibitory function toward RIGI,
Q7SZU9	SEC61 translocon subunit gamma(sec61g)	Gadus morhua			GO:0006605~protein targeting,GO:0031204~posttranslational protein targeting to membrane, translocation,GO:0045047~protein targeting to ER,	GO:0005789~endoplasmic reticulum membrane,GO:0016020~membrane,GO:0071261~Ssh1 translocon complex,	GO:0008320~protein transmembrane transporter activity,GO:0043022~ribosome binding,	IPR001901:Translocase_SecE/Sec61-g,IPR008158:Translocase_Sec61-g,IPR023391:Prot_translocase_SecE_dom_sf,					KW-0653~Protein transport,KW-0811~Translocation,KW-0813~Transport,	KW-0256~Endoplasmic reticulum,KW-0472~Membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,				TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q80UJ9	SET domain without mariner transposase fusion(Setmar)	Mus musculus			GO:0000729~DNA double-strand break processing,GO:0006303~double-strand break repair via nonhomologous end joining,GO:0006308~DNA catabolic process,GO:0006325~chromatin organization,GO:0008283~cell proliferation,GO:0015074~DNA integration,GO:0031297~replication fork processing,GO:0032259~methylation,GO:0044774~mitotic DNA integrity checkpoint,GO:0045892~negative regulation of transcription, DNA-templated,GO:0090304~nucleic acid metabolic process,GO:0090305~nucleic acid phosphodiester bond hydrolysis,GO:2000373~positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity,GO:2001034~positive regulation of double-strand break repair via nonhomologous end joining,GO:2001251~negative regulation of chromosome organization,	GO:0000793~condensed chromosome,GO:0005634~nucleus,GO:0005694~chromosome,GO:0005730~nucleolus,GO:0035861~site of double-strand break,	GO:0000014~single-stranded DNA endodeoxyribonuclease activity,GO:0003677~DNA binding,GO:0003690~double-stranded DNA binding,GO:0003697~single-stranded DNA binding,GO:0004519~endonuclease activity,GO:0008168~methyltransferase activity,GO:0008270~zinc ion binding,GO:0016740~transferase activity,GO:0042054~histone methyltransferase activity,GO:0042800~histone methyltransferase activity (H3-K4 specific),GO:0042803~protein homodimerization activity,GO:0044547~DNA topoisomerase binding,GO:0046872~metal ion binding,GO:0046975~histone methyltransferase activity (H3-K36 specific),	IPR001214:SET_dom,IPR003616:Post-SET_dom,IPR007728:Pre-SET_dom,IPR046341:SET_dom_sf,	mmu00310:Lysine degradation,mmu01100:Metabolic pathways,			SM00317:SET,SM00468:PreSET,		KW-0158~Chromosome,KW-0539~Nucleus,				KW-0479~Metal-binding,KW-0862~Zinc,KW-0949~S-adenosyl-L-methionine,	KW-0156~Chromatin regulator,KW-0489~Methyltransferase,KW-0808~Transferase,		DOMAIN:Post-SET,DOMAIN:Pre-SET,DOMAIN:SET,
Q01105	SET nuclear proto-oncogene(SET)	Homo sapiens		h_setPathway:Granzyme A mediated Apoptosis Pathway,	GO:0006260~DNA replication,GO:0006334~nucleosome assembly,GO:0006337~nucleosome disassembly,GO:0035067~negative regulation of histone acetylation,GO:0043524~negative regulation of neuron apoptotic process,GO:0045892~negative regulation of transcription, DNA-templated,	GO:0000785~chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005783~endoplasmic reticulum,GO:0005811~lipid particle,GO:0005829~cytosol,GO:0032991~macromolecular complex,GO:0048471~perinuclear region of cytoplasm,	GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0004864~protein phosphatase inhibitor activity,GO:0005515~protein binding,GO:0019888~protein phosphatase regulator activity,GO:0042393~histone binding,	IPR002164:NAP_family,IPR037231:NAP-like_sf,		618106~Intellectual developmental disorder, autosomal dominant 58,			KW-0945~Host-virus interaction,	KW-0256~Endoplasmic reticulum,KW-0539~Nucleus,KW-0963~Cytoplasm,		KW-0225~Disease variant,KW-0656~Proto-oncogene,KW-0991~Intellectual disability,	KW-0175~Coiled coil,		KW-0143~Chaperone,KW-0238~DNA-binding,	KW-0007~Acetylation,KW-0488~Methylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Acidic residues,COMPBIAS:Basic and acidic residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),REGION:Dimerization,REGION:Disordered,REGION:Earmuff domain,SITE:Breakpoint for translocation to form SET-CAN oncogene,
Q925Q9	SH3 domain-containing kinase-binding protein 1(Sh3kbp1)	Rattus norvegicus			GO:0006897~endocytosis,GO:0006915~apoptotic process,GO:0007010~cytoskeleton organization,GO:0007015~actin filament organization,GO:0008360~regulation of cell shape,GO:0016310~phosphorylation,GO:0016477~cell migration,GO:0042981~regulation of apoptotic process,GO:0050871~positive regulation of B cell activation,	GO:0005737~cytoplasm,GO:0005856~cytoskeleton,GO:0005911~cell-cell junction,GO:0005925~focal adhesion,GO:0030139~endocytic vesicle,GO:0030659~cytoplasmic vesicle membrane,GO:0043005~neuron projection,GO:0045202~synapse,	GO:0005515~protein binding,GO:0016301~kinase activity,GO:0017124~SH3 domain binding,GO:0031625~ubiquitin protein ligase binding,	IPR001452:SH3_domain,IPR035770:CIN85_SH3_1,IPR035771:CIN85_SH3_2,IPR035772:CIN85_SH3_3,IPR036028:SH3-like_dom_sf,	rno04144:Endocytosis,			SM00326:SH3,	KW-0053~Apoptosis,KW-0254~Endocytosis,	KW-0206~Cytoskeleton,KW-0472~Membrane,KW-0770~Synapse,KW-0771~Synaptosome,KW-0963~Cytoplasm,KW-0965~Cell junction,KW-0968~Cytoplasmic vesicle,			KW-0175~Coiled coil,KW-0677~Repeat,KW-0728~SH3 domain,KW-0729~SH3-binding,		KW-0418~Kinase,KW-0808~Transferase,	KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:SH3,DOMAIN:SH3 1,DOMAIN:SH3 2,DOMAIN:SH3 3,REGION:Disordered,
Q92529	SHC adaptor protein 3(SHC3)	Homo sapiens			GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0007173~epidermal growth factor receptor signaling pathway,GO:0007417~central nervous system development,GO:0035556~intracellular signal transduction,	GO:0005829~cytosol,GO:0005886~plasma membrane,	GO:0001784~phosphotyrosine binding,GO:0005515~protein binding,GO:0030971~receptor tyrosine kinase binding,	IPR000980:SH2,IPR006019:PID_Shc-like,IPR006020:PTB/PI_dom,IPR011993:PH-like_dom_sf,IPR035676:SHC_SH2,IPR036860:SH2_dom_sf,	hsa01521:EGFR tyrosine kinase inhibitor resistance,hsa01522:Endocrine resistance,hsa04012:ErbB signaling pathway,hsa04014:Ras signaling pathway,hsa04062:Chemokine signaling pathway,hsa04072:Phospholipase D signaling pathway,hsa04510:Focal adhesion,hsa04650:Natural killer cell mediated cytotoxicity,hsa04722:Neurotrophin signaling pathway,hsa04910:Insulin signaling pathway,hsa04915:Estrogen signaling pathway,hsa04917:Prolactin signaling pathway,hsa04926:Relaxin signaling pathway,hsa04935:Growth hormone synthesis, secretion and action,hsa05034:Alcoholism,hsa05100:Bacterial invasion of epithelial cells,hsa05214:Glioma,hsa05220:Chronic myeloid leukemia,hsa05224:Breast cancer,hsa05225:Hepatocellular carcinoma,hsa05226:Gastric cancer,			SM00252:SH2,SM00462:PTB,					KW-0727~SH2 domain,			KW-0597~Phosphoprotein,	DOMAIN:PID,DOMAIN:SH2,REGION:CH1,REGION:Disordered,
P59692	SIVA1, apoptosis-inducing factor(Siva1)	Rattus norvegicus			GO:0006915~apoptotic process,GO:0006924~activation-induced cell death of T cells,GO:0046718~viral entry into host cell,GO:0097191~extrinsic apoptotic signaling pathway,GO:0097193~intrinsic apoptotic signaling pathway,GO:1901030~positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005739~mitochondrion,	GO:0001618~virus receptor activity,GO:0005164~tumor necrosis factor receptor binding,GO:0005175~CD27 receptor binding,GO:0008270~zinc ion binding,GO:0046872~metal ion binding,	IPR022773:Siva,	rno04115:p53 signaling pathway,		PIRSF038096:Siva_cd27_bd,		KW-0053~Apoptosis,	KW-0539~Nucleus,KW-0963~Cytoplasm,				KW-0479~Metal-binding,KW-0862~Zinc,		KW-0597~Phosphoprotein,	REGION:Interaction with BCL2L1 isoform Bcl-x(L) and inhibition of BCL2L1 anti-apoptotic activity,
Q9W7E7	SMAD family member 5(smad5)	Danio rerio			GO:0001945~lymph vessel development,GO:0001947~heart looping,GO:0003143~embryonic heart tube morphogenesis,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0007179~transforming growth factor beta receptor signaling pathway,GO:0007368~determination of left/right symmetry,GO:0009653~anatomical structure morphogenesis,GO:0009880~embryonic pattern specification,GO:0009953~dorsal/ventral pattern formation,GO:0030154~cell differentiation,GO:0030509~BMP signaling pathway,GO:0030510~regulation of BMP signaling pathway,GO:0031099~regeneration,GO:0036342~post-anal tail morphogenesis,GO:0043049~otic placode formation,GO:0045893~positive regulation of transcription, DNA-templated,GO:0048262~determination of dorsal/ventral asymmetry,GO:0048264~determination of ventral identity,GO:0048514~blood vessel morphogenesis,GO:0048919~posterior lateral line neuromast development,GO:0048922~posterior lateral line neuromast deposition,GO:0060021~palate development,GO:0060030~dorsal convergence,GO:0060037~pharyngeal system development,GO:0060395~SMAD protein signal transduction,	GO:0005634~nucleus,GO:0005667~transcription factor complex,GO:0005737~cytoplasm,GO:0071144~SMAD2-SMAD3 protein complex,	GO:0000976~transcription regulatory region sequence-specific DNA binding,GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0046872~metal ion binding,GO:0070411~I-SMAD binding,	IPR001132:SMAD_dom_Dwarfin-type,IPR003619:MAD_homology1_Dwarfin-type,IPR008984:SMAD_FHA_dom_sf,IPR013019:MAD_homology_MH1,IPR013790:Dwarfin,IPR017855:SMAD-like_dom_sf,IPR036578:SMAD_MH1_sf,	dre04350:TGF-beta signaling pathway,			SM00523:DWA,SM00524:DWB,	KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,KW-0963~Cytoplasm,				KW-0479~Metal-binding,KW-0862~Zinc,	KW-0217~Developmental protein,KW-0238~DNA-binding,KW-9996~Developmental protein,		COMPBIAS:Polar residues,DOMAIN:MH1,DOMAIN:MH2,REGION:Disordered,
O15105	SMAD family member 7(SMAD7)	Homo sapiens		h_tgfbPathway:TGF beta signaling pathway,	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001657~ureteric bud development,GO:0002725~negative regulation of T cell cytokine production,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0007179~transforming growth factor beta receptor signaling pathway,GO:0009653~anatomical structure morphogenesis,GO:0010717~regulation of epithelial to mesenchymal transition,GO:0010719~negative regulation of epithelial to mesenchymal transition,GO:0010801~negative regulation of peptidyl-threonine phosphorylation,GO:0010944~negative regulation of transcription by competitive promoter binding,GO:0017015~regulation of transforming growth factor beta receptor signaling pathway,GO:0022409~positive regulation of cell-cell adhesion,GO:0030154~cell differentiation,GO:0030279~negative regulation of ossification,GO:0030336~negative regulation of cell migration,GO:0030512~negative regulation of transforming growth factor beta receptor signaling pathway,GO:0030514~negative regulation of BMP signaling pathway,GO:0031397~negative regulation of protein ubiquitination,GO:0031503~protein complex localization,GO:0032436~positive regulation of proteasomal ubiquitin-dependent protein catabolic process,GO:0032926~negative regulation of activin receptor signaling pathway,GO:0033137~negative regulation of peptidyl-serine phosphorylation,GO:0034333~adherens junction assembly,GO:0034616~response to laminar fluid shear stress,GO:0048844~artery morphogenesis,GO:0050821~protein stabilization,GO:0051444~negative regulation of ubiquitin-protein transferase activity,GO:0055010~ventricular cardiac muscle tissue morphogenesis,GO:0055117~regulation of cardiac muscle contraction,GO:0060373~regulation of ventricular cardiac muscle cell membrane depolarization,GO:0060392~negative regulation of SMAD protein import into nucleus,GO:0060395~SMAD protein signal transduction,GO:0060412~ventricular septum morphogenesis,GO:0071560~cellular response to transforming growth factor beta stimulus,GO:1902731~negative regulation of chondrocyte proliferation,GO:1903043~positive regulation of chondrocyte hypertrophy,GO:1990830~cellular response to leukemia inhibitory factor,GO:2000317~negative regulation of T-helper 17 type immune response,GO:2000320~negative regulation of T-helper 17 cell differentiation,	GO:0000785~chromatin,GO:0001650~fibrillar center,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005912~adherens junction,GO:0032991~macromolecular complex,GO:0071144~SMAD2-SMAD3 protein complex,	GO:0003714~transcription corepressor activity,GO:0005515~protein binding,GO:0005518~collagen binding,GO:0008013~beta-catenin binding,GO:0031625~ubiquitin protein ligase binding,GO:0034713~type I transforming growth factor beta receptor binding,GO:0046872~metal ion binding,GO:0070411~I-SMAD binding,GO:0070697~activin receptor binding,GO:1990756~protein binding, bridging involved in substrate recognition for ubiquitination,	IPR001132:SMAD_dom_Dwarfin-type,IPR003619:MAD_homology1_Dwarfin-type,IPR008984:SMAD_FHA_dom_sf,IPR013019:MAD_homology_MH1,IPR013790:Dwarfin,IPR017855:SMAD-like_dom_sf,IPR036578:SMAD_MH1_sf,	hsa04350:TGF-beta signaling pathway,hsa04390:Hippo signaling pathway,	612229~Colorectal cancer, susceptibility to, 3,		SM00523:DWA,SM00524:DWB,	KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,KW-0963~Cytoplasm,				KW-0479~Metal-binding,KW-0862~Zinc,		KW-0007~Acetylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate,DOMAIN:MH1,DOMAIN:MH2,MOTIF:PY-motif,MUTAGEN:K->A: Loss of acetylation, and of SMURF1-dependent degradation; when associated with A-64.,MUTAGEN:K->A: Loss of acetylation, and of SMURF1-dependent degradation; when associated with A-70.,MUTAGEN:Missing: 90% reduction in TGF-beta receptor binding.,MUTAGEN:Missing: Diminishes interaction with SMURF2.,MUTAGEN:Y->A: Diminishes interaction with SMURF2 and reduces inhibition of TGF-beta signaling.,REGION:Disordered,REGION:Important for interaction with SMURF2,
Q503N2	SPC24 component of NDC80 kinetochore complex(spc24)	Danio rerio			GO:0007049~cell cycle,GO:0007059~chromosome segregation,GO:0051301~cell division,	GO:0000775~chromosome, centromeric region,GO:0000776~kinetochore,GO:0005634~nucleus,GO:0005694~chromosome,GO:0031262~Ndc80 complex,	GO:0008017~microtubule binding,	IPR013252:Ndc80_Spc24,					KW-0131~Cell cycle,KW-0132~Cell division,KW-0498~Mitosis,	KW-0137~Centromere,KW-0158~Chromosome,KW-0539~Nucleus,KW-0995~Kinetochore,			KW-0175~Coiled coil,
Q8UVK2	SPT6 homolog, histone chaperone and transcription elongation factor(supt6h)	Danio rerio			GO:0001756~somitogenesis,GO:0006139~nucleobase-containing compound metabolic process,GO:0006366~transcription from RNA polymerase II promoter,GO:0006368~transcription elongation from RNA polymerase II promoter,GO:0006412~translation,GO:0006414~translational elongation,GO:0007507~heart development,GO:0032968~positive regulation of transcription elongation from RNA polymerase II promoter,GO:0034728~nucleosome organization,GO:0035050~embryonic heart tube development,GO:0071599~otic vesicle development,	GO:0005634~nucleus,GO:0008023~transcription elongation factor complex,	GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003746~translation elongation factor activity,GO:0031491~nucleosome binding,GO:0042393~histone binding,	IPR000980:SH2,IPR003029:S1_domain,IPR006641:YqgF/RNaseH-like_dom,IPR010994:RuvA_2-like,IPR012337:RNaseH-like_sf,IPR012340:NA-bd_OB-fold,IPR017072:TF_Spt6,IPR023319:Tex-like_HTH_dom_sf,IPR023323:Tex-like_dom_sf,IPR028083:Spt6_acidic_N_dom,IPR028088:Spt6_HTH_DNA-bd_dom,IPR028231:Spt6_YqgF,IPR032706:Spt6_HHH,IPR035018:Spt6_SH2_C,IPR035019:Spt6_SH2_N,IPR035420:Spt6_SH2,IPR036860:SH2_dom_sf,IPR037027:YqgF/RNaseH-like_dom_sf,IPR041692:HHH_9,IPR042066:Spt6_death-like,			PIRSF036947:Spt6,	SM00252:SH2,SM00732:YqgFc,	KW-0648~Protein biosynthesis,KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,			KW-0175~Coiled coil,KW-0727~SH2 domain,		KW-0143~Chaperone,KW-0251~Elongation factor,	KW-0597~Phosphoprotein,	COMPBIAS:Acidic residues,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:S1 motif,DOMAIN:SH2,REGION:Disordered,
E2RG47	STT3 oligosaccharyltransferase complex catalytic subunit B(STT3B)	Canis lupus familiaris			GO:0006486~protein glycosylation,GO:0006516~glycoprotein catabolic process,GO:0006986~response to unfolded protein,GO:0018279~protein N-linked glycosylation via asparagine,GO:0030433~ubiquitin-dependent ERAD pathway,GO:0043686~co-translational protein modification,GO:0043687~post-translational protein modification,	GO:0016020~membrane,GO:0034998~oligosaccharyltransferase I complex,GO:0034999~oligosaccharyltransferase II complex,	GO:0004576~oligosaccharyl transferase activity,GO:0004579~dolichyl-diphosphooligosaccharide-protein glycotransferase activity,GO:0046872~metal ion binding,	IPR003674:Oligo_trans_STT3,IPR048307:STT3_N,IPR048999:STT3-PglB_core,	cfa00510:N-Glycan biosynthesis,cfa00513:Various types of N-glycan biosynthesis,cfa01100:Metabolic pathways,cfa04141:Protein processing in endoplasmic reticulum,					KW-0256~Endoplasmic reticulum,KW-0472~Membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0460~Magnesium,KW-0464~Manganese,KW-0479~Metal-binding,	KW-0328~Glycosyltransferase,KW-0808~Transferase,	KW-0007~Acetylation,KW-0325~Glycoprotein,KW-0597~Phosphoprotein,	CARBOHYD:N-linked (GlcNAc...) (high mannose) asparagine,CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Polar residues,DOMAIN:Oligosaccharyl transferase STT3 N-terminal,DOMAIN:STT3/PglB/AglB core,MOTIF:DK motif,MOTIF:DXD motif 1,MOTIF:DXD motif 2,MOTIF:SVSE motif,MOTIF:WWDYG motif,REGION:Disordered,REGION:Interacts with target acceptor peptide in protein substrate,SITE:Important for catalytic activity,SITE:Interacts with target acceptor peptide in protein substrate,TOPO_DOM:Cytoplasmic,TOPO_DOM:Lumenal,TRANSMEM:Helical,
Q5ZK03	Sec23 homolog A, coat complex II component(SEC23A)	Gallus gallus			GO:0006886~intracellular protein transport,GO:0006888~ER to Golgi vesicle-mediated transport,GO:0072659~protein localization to plasma membrane,GO:0090110~cargo loading into COPII-coated vesicle,GO:0090114~COPII-coated vesicle budding,	GO:0000139~Golgi membrane,GO:0005789~endoplasmic reticulum membrane,GO:0005829~cytosol,GO:0030127~COPII vesicle coat,GO:0048471~perinuclear region of cytoplasm,GO:0070971~endoplasmic reticulum exit site,	GO:0005096~GTPase activator activity,GO:0008270~zinc ion binding,	IPR006895:Znf_Sec23_Sec24,IPR006896:Sec23/24_trunk_dom,IPR006900:Sec23/24_helical_dom,IPR007123:Gelsolin-like_dom,IPR012990:Sec23_24_beta_S,IPR029006:ADF-H/Gelsolin-like_dom_sf,IPR036174:Znf_Sec23_Sec24_sf,IPR036175:Sec23/24_helical_dom_sf,IPR036180:Gelsolin-like_dom_sf,IPR036465:vWFA_dom_sf,IPR037364:Sec23,IPR037550:Sec23_C,	gga04141:Protein processing in endoplasmic reticulum,				KW-0653~Protein transport,KW-0813~Transport,KW-0931~ER-Golgi transport,	KW-0256~Endoplasmic reticulum,KW-0472~Membrane,KW-0963~Cytoplasm,KW-0968~Cytoplasmic vesicle,				KW-0479~Metal-binding,KW-0862~Zinc,			DOMAIN:Gelsolin-like,DOMAIN:Sec23/Sec24 beta-sandwich,DOMAIN:Sec23/Sec24 helical,DOMAIN:Sec23/Sec24 trunk,DOMAIN:Zinc finger Sec23/Sec24-type,REPEAT:Gelsolin-like,
Q5ZK03	Sec23 homolog B, coat complex II component(SEC23B)	Gallus gallus			GO:0006886~intracellular protein transport,GO:0006888~ER to Golgi vesicle-mediated transport,GO:0072659~protein localization to plasma membrane,GO:0090110~cargo loading into COPII-coated vesicle,GO:0090114~COPII-coated vesicle budding,	GO:0000139~Golgi membrane,GO:0005789~endoplasmic reticulum membrane,GO:0005829~cytosol,GO:0030127~COPII vesicle coat,GO:0048471~perinuclear region of cytoplasm,GO:0070971~endoplasmic reticulum exit site,	GO:0005096~GTPase activator activity,GO:0008270~zinc ion binding,	IPR006895:Znf_Sec23_Sec24,IPR006896:Sec23/24_trunk_dom,IPR006900:Sec23/24_helical_dom,IPR007123:Gelsolin-like_dom,IPR012990:Sec23_24_beta_S,IPR029006:ADF-H/Gelsolin-like_dom_sf,IPR036174:Znf_Sec23_Sec24_sf,IPR036175:Sec23/24_helical_dom_sf,IPR036180:Gelsolin-like_dom_sf,IPR036465:vWFA_dom_sf,IPR037364:Sec23,IPR037550:Sec23_C,	gga04141:Protein processing in endoplasmic reticulum,				KW-0653~Protein transport,KW-0813~Transport,KW-0931~ER-Golgi transport,	KW-0256~Endoplasmic reticulum,KW-0472~Membrane,KW-0963~Cytoplasm,KW-0968~Cytoplasmic vesicle,				KW-0479~Metal-binding,KW-0862~Zinc,			DOMAIN:Gelsolin-like,DOMAIN:Sec23/Sec24 beta-sandwich,DOMAIN:Sec23/Sec24 helical,DOMAIN:Sec23/Sec24 trunk,DOMAIN:Zinc finger Sec23/Sec24-type,REPEAT:Gelsolin-like,
Q7ZTU9	T-box transcription factor 2b(tbx2b)	Danio rerio			GO:0001708~cell fate specification,GO:0001947~heart looping,GO:0003205~cardiac chamber development,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0007155~cell adhesion,GO:0007420~brain development,GO:0008016~regulation of heart contraction,GO:0021538~epithalamus development,GO:0021982~pineal gland development,GO:0030509~BMP signaling pathway,GO:0030903~notochord development,GO:0035050~embryonic heart tube development,GO:0035777~pronephric distal tubule development,GO:0036302~atrioventricular canal development,GO:0042074~cell migration involved in gastrulation,GO:0042461~photoreceptor cell development,GO:0042671~retinal cone cell fate determination,GO:0043704~photoreceptor cell fate specification,GO:0045893~positive regulation of transcription, DNA-templated,GO:0046548~retinal rod cell development,GO:0046549~retinal cone cell development,GO:0046551~retinal cone cell fate commitment,GO:0048318~axial mesoderm development,GO:0048484~enteric nervous system development,GO:0048663~neuron fate commitment,GO:0048793~pronephros development,GO:0060219~camera-type eye photoreceptor cell differentiation,GO:0070365~hepatocyte differentiation,GO:0072019~proximal convoluted tubule development,GO:0072068~late distal convoluted tubule development,	GO:0000785~chromatin,GO:0005634~nucleus,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,	IPR001699:TF_T-box,IPR002070:TF_Brachyury,IPR008967:p53-like_TF_DNA-bd_sf,IPR018186:TF_T-box_CS,IPR022582:TBX2/3_TAD,IPR036960:T-box_sf,IPR046360:T-box_DNA-bd,IPR048387:TBX2_3_RD,				SM00425:TBOX,	KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,			KW-0175~Coiled coil,		KW-0217~Developmental protein,KW-0238~DNA-binding,KW-9996~Developmental protein,		COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DNA_BIND:T-box,DOMAIN:T-box transcription factor 2/3 repressor,DOMAIN:T-box transcription factor 2/3 transcription activation,REGION:Disordered,
Q6P0T2	TAF8 RNA polymerase II, TATA box binding protein (TBP)-associated factor(taf8)	Danio rerio			GO:0006367~transcription initiation from RNA polymerase II promoter,GO:0030154~cell differentiation,	GO:0005634~nucleus,GO:0005669~transcription factor TFIID complex,GO:0005737~cytoplasm,	GO:0046982~protein heterodimerization activity,	IPR006565:BTP,IPR009072:Histone-fold,IPR019473:TFIID_su8_C,IPR037818:TAF8,	dre03022:Basal transcription factors,			SM00576:BTP,	KW-0221~Differentiation,KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,KW-0963~Cytoplasm,					KW-0217~Developmental protein,KW-9996~Developmental protein,	KW-0597~Phosphoprotein,	COMPBIAS:Polar residues,DOMAIN:Histone-fold,MOTIF:Nuclear localization signal,REGION:Disordered,
Q28F51	TAR DNA binding protein(tardbp)	Xenopus tropicalis			GO:0006397~mRNA processing,GO:0008380~RNA splicing,GO:0010468~regulation of gene expression,GO:0031647~regulation of protein stability,GO:0042752~regulation of circadian rhythm,GO:0048511~rhythmic process,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0010494~cytoplasmic stress granule,	GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003723~RNA binding,	IPR000504:RRM_dom,IPR012677:Nucleotide-bd_a/b_plait_sf,IPR035979:RBD_domain_sf,IPR041105:TDP43_N,IPR049124:TDP-43_C,	xtr03015:mRNA surveillance pathway,			SM00360:RRM,	KW-0090~Biological rhythms,KW-0507~mRNA processing,KW-0508~mRNA splicing,KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0496~Mitochondrion,KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0677~Repeat,		KW-0238~DNA-binding,KW-0678~Repressor,KW-0694~RNA-binding,		COMPBIAS:Polar residues,DOMAIN:RRM,DOMAIN:RRM 1,DOMAIN:RRM 2,REGION:Disordered,
Q92804	TATA-box binding protein associated factor 15(TAF15)	Homo sapiens			GO:0006355~regulation of transcription, DNA-templated,GO:0008380~RNA splicing,GO:0045893~positive regulation of transcription, DNA-templated,GO:0048255~mRNA stabilization,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,	GO:0003677~DNA binding,GO:0003712~transcription cofactor activity,GO:0003723~RNA binding,GO:0003730~mRNA 3'-UTR binding,GO:0005515~protein binding,GO:0046872~metal ion binding,	IPR000504:RRM_dom,IPR001876:Znf_RanBP2,IPR012677:Nucleotide-bd_a/b_plait_sf,IPR034870:TET_fam,IPR035979:RBD_domain_sf,IPR036443:Znf_RanBP2_sf,	hsa03022:Basal transcription factors,hsa05202:Transcriptional misregulation in cancer,	612237~Chondrosarcoma, extraskeletal myxoid,		SM00360:RRM,SM00547:ZnF_RBZ,		KW-0539~Nucleus,KW-0963~Cytoplasm,		KW-0656~Proto-oncogene,	KW-0677~Repeat,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0238~DNA-binding,KW-0694~RNA-binding,	KW-0007~Acetylation,KW-0013~ADP-ribosylation,KW-0488~Methylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate,DOMAIN:RRM,DOMAIN:RanBP2-type,REGION:21 X approximate tandem repeats of D-R-[S,G](0,3)-G-G-Y-G-G,REGION:Disordered,REPEAT:1,REPEAT:10,REPEAT:11,REPEAT:12,REPEAT:13,REPEAT:14,REPEAT:15,REPEAT:16,REPEAT:17,REPEAT:18,REPEAT:19,REPEAT:2,REPEAT:20,REPEAT:21,REPEAT:3,REPEAT:4,REPEAT:5,REPEAT:6,REPEAT:7,REPEAT:8,REPEAT:9,ZN_FING:RanBP2-type,
H2LP95	TBC1 domain family, member 31(tbc1d31)	Oryzias latipes			GO:0030030~cell projection organization,GO:0060271~cilium assembly,	GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0034451~centriolar satellite,GO:0036064~ciliary basal body,GO:0042995~cell projection,	GO:0005515~protein binding,GO:0060090~binding, bridging,	IPR000195:Rab-GAP-TBC_dom,IPR001680:WD40_rpt,IPR015943:WD40/YVTN_repeat-like_dom_sf,IPR035969:Rab-GAP_TBC_sf,IPR036322:WD40_repeat_dom_sf,				SM00320:WD40,	KW-0970~Cilium biogenesis/degradation,	KW-0206~Cytoskeleton,KW-0963~Cytoplasm,KW-0966~Cell projection,			KW-0175~Coiled coil,KW-0677~Repeat,KW-0853~WD repeat,				COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:Rab-GAP TBC,REGION:Disordered,REPEAT:WD,REPEAT:WD 1,REPEAT:WD 2,REPEAT:WD 3,REPEAT:WD 4,
Q5RFW2	TGF-beta activated kinase 1 (MAP3K7) binding protein 2(tab2)	Danio rerio			GO:0007507~heart development,GO:0016310~phosphorylation,GO:0043009~chordate embryonic development,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling,GO:0045860~positive regulation of protein kinase activity,GO:0060027~convergent extension involved in gastrulation,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0016020~membrane,	GO:0008270~zinc ion binding,GO:0016301~kinase activity,GO:0016740~transferase activity,GO:0043130~ubiquitin binding,GO:0046872~metal ion binding,GO:0070530~K63-linked polyubiquitin binding,	IPR001876:Znf_RanBP2,IPR003892:CUE,IPR036443:Znf_RanBP2_sf,IPR041911:TAB2/3_CUE,	dre04010:MAPK signaling pathway,dre04620:Toll-like receptor signaling pathway,dre04621:NOD-like receptor signaling pathway,dre05132:Salmonella infection,dre05168:Herpes simplex virus 1 infection,			SM00546:CUE,SM00547:ZnF_RBZ,		KW-0472~Membrane,KW-0963~Cytoplasm,			KW-0175~Coiled coil,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0418~Kinase,KW-0808~Transferase,		COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:CUE,DOMAIN:RanBP2-type,REGION:Disordered,ZN_FING:RanBP2-type,
Q9GZN2	TGFB induced factor homeobox 2(TGIF2)	Homo sapiens			GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006355~regulation of transcription, DNA-templated,GO:0010470~regulation of gastrulation,GO:0035881~amacrine cell differentiation,GO:0038092~nodal signaling pathway,GO:1902871~positive regulation of amacrine cell differentiation,	GO:0000785~chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005813~centrosome,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0001227~transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:1990837~sequence-specific double-stranded DNA binding,	IPR001356:Homeobox_dom,IPR008422:Homeobox_KN_domain,IPR009057:Homeobox-like_sf,	hsa04350:TGF-beta signaling pathway,			SM00389:HOX,	KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,			KW-0371~Homeobox,		KW-0238~DNA-binding,	KW-0597~Phosphoprotein,	DNA_BIND:Homeobox,DNA_BIND:Homeobox; TALE-type,DOMAIN:Homeobox,DOMAIN:Homeobox KN,MUTAGEN:T->V: Decrease of phosphorylation. Strong decrease of phosphorylation; when associated with V-182.,MUTAGEN:T->V: Decrease of phosphorylation. Strong decrease of phosphorylation; when associated with V-186.,REGION:Disordered,REGION:Repressive function,
Q6DDV8	TPX2, microtubule-associated S homeolog(tpx2.S)	Xenopus laevis			GO:0007049~cell cycle,GO:0051301~cell division,GO:0060236~regulation of mitotic spindle organization,	GO:0000922~spindle pole,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005819~spindle,GO:0005856~cytoskeleton,GO:0005874~microtubule,		IPR009675:TPX2_fam,IPR015128:Aurora-A-bd,IPR027329:TPX2_C,IPR027330:TPX2_central_dom,					KW-0131~Cell cycle,KW-0132~Cell division,KW-0498~Mitosis,	KW-0206~Cytoskeleton,KW-0493~Microtubule,KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0175~Coiled coil,			KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Basic residues,COMPBIAS:Polar residues,DOMAIN:Aurora-A binding,DOMAIN:TPX2 C-terminal,DOMAIN:TPX2 central,REGION:Disordered,
Q6NRV0	TRAF interacting protein L homeolog(traip.L)	Xenopus laevis			GO:0006281~DNA repair,GO:0006974~cellular response to DNA damage stimulus,GO:0016567~protein ubiquitination,GO:0036297~interstrand cross-link repair,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0090734~site of DNA damage,	GO:0004842~ubiquitin-protein transferase activity,GO:0016740~transferase activity,GO:0046872~metal ion binding,GO:1904931~MCM complex binding,	IPR001841:Znf_RING,IPR013083:Znf_RING/FYVE/PHD,				SM00184:RING,	KW-0227~DNA damage,KW-0234~DNA repair,KW-0833~Ubl conjugation pathway,	KW-0158~Chromosome,KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0175~Coiled coil,KW-0677~Repeat,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0808~Transferase,		MOTIF:PIP-box,MUTAGEN:C->A: Abolished ability to mediate ubiquitination of mcm7.,MUTAGEN:Missing: Does not affect ability to mediate ubiquitination of mcm7.,MUTAGEN:R->C: Impaired ability to mediate ubiquitination of mcm7. Abolished ability to promote ubiquitination of covalent DNA-protein cross-links (DPCs).,REGION:Disordered,ZN_FING:RING-type; atypical,
Q5RED5	TSC22 domain family member 3(TSC22D3)	Pongo abelii			GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006970~response to osmotic stress,GO:0070236~negative regulation of activation-induced cell death of T cells,	GO:0005634~nucleus,GO:0005737~cytoplasm,		IPR000580:TSC22/Bun,IPR047862:TSC22/BUN_CS,						KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0175~Coiled coil,			KW-0597~Phosphoprotein,	COMPBIAS:Polar residues,REGION:AP1-binding,REGION:Disordered,REGION:Leucine-zipper,
Q3KRG3	TSR2 ribosome maturation factor(tsr2)	Danio rerio			GO:0000462~maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),GO:0006364~rRNA processing,	GO:0005634~nucleus,		IPR019398:Pre-rRNA_process_TSR2,					KW-0698~rRNA processing,								COMPBIAS:Acidic residues,COMPBIAS:Basic and acidic residues,REGION:Disordered,
Q6DRL4	TopBP1-interacting, checkpoint, and replication regulator(ticrr)	Danio rerio			GO:0006260~DNA replication,GO:0006281~DNA repair,GO:0006974~cellular response to DNA damage stimulus,GO:0007049~cell cycle,GO:0007093~mitotic cell cycle checkpoint,GO:0007095~mitotic G2 DNA damage checkpoint,GO:0010212~response to ionizing radiation,GO:0030174~regulation of DNA-dependent DNA replication initiation,GO:0033314~mitotic DNA replication checkpoint,	GO:0005634~nucleus,	GO:0003682~chromatin binding,	IPR026153:Treslin,IPR032746:Treslin_N,	dre04110:Cell cycle,				KW-0131~Cell cycle,KW-0227~DNA damage,KW-0234~DNA repair,	KW-0539~Nucleus,							COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,REGION:Disordered,
A1A4K8	U2 small nuclear RNA auxiliary factor 1(U2AF1)	Bos taurus			GO:0000398~mRNA splicing, via spliceosome,	GO:0005681~spliceosomal complex,GO:0016607~nuclear speck,GO:0089701~U2AF,	GO:0003723~RNA binding,GO:0030628~pre-mRNA 3'-splice site binding,GO:0046872~metal ion binding,	IPR000504:RRM_dom,IPR000571:Znf_CCCH,IPR003954:RRM_dom_euk,IPR009145:U2AF_small,IPR012677:Nucleotide-bd_a/b_plait_sf,IPR035979:RBD_domain_sf,	bta03040:Spliceosome,			SM00356:ZnF_C3H1,SM00360:RRM,SM00361:RRM_1,	KW-0507~mRNA processing,KW-0508~mRNA splicing,	KW-0539~Nucleus,KW-0747~Spliceosome,			KW-0677~Repeat,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0694~RNA-binding,	KW-0007~Acetylation,KW-0488~Methylation,KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Basic residues,DOMAIN:C3H1-type,DOMAIN:RRM,REGION:Disordered,ZN_FING:C3H1-type,ZN_FING:C3H1-type 1,ZN_FING:C3H1-type 2,
Q80X89	UDP glucuronosyltransferase 2 family, polypeptide A1(Ugt2a1)	Mus musculus			GO:0006629~lipid metabolic process,GO:0007606~sensory perception of chemical stimulus,GO:0007608~sensory perception of smell,GO:0008206~bile acid metabolic process,GO:0050896~response to stimulus,GO:0052695~cellular glucuronidation,	GO:0016020~membrane,	GO:0008194~UDP-glycosyltransferase activity,GO:0015020~glucuronosyltransferase activity,GO:0016740~transferase activity,GO:0016757~transferase activity, transferring glycosyl groups,	IPR002213:UDP_glucos_trans,IPR035595:UDP_glycos_trans_CS,	mmu00040:Pentose and glucuronate interconversions,mmu00053:Ascorbate and aldarate metabolism,mmu00140:Steroid hormone biosynthesis,mmu00830:Retinol metabolism,mmu00860:Porphyrin metabolism,mmu00980:Metabolism of xenobiotics by cytochrome P450,mmu00982:Drug metabolism - cytochrome P450,mmu00983:Drug metabolism - other enzymes,mmu01100:Metabolic pathways,mmu01240:Biosynthesis of cofactors,mmu04976:Bile secretion,mmu05204:Chemical carcinogenesis - DNA adducts,mmu05207:Chemical carcinogenesis - receptor activation,				KW-0443~Lipid metabolism,KW-0552~Olfaction,KW-0716~Sensory transduction,	KW-0472~Membrane,			KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0328~Glycosyltransferase,KW-0808~Transferase,	KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q7ZW63	UF2 component of NDC80 kinetochore complex(nuf2)	Danio rerio			GO:0007049~cell cycle,GO:0007052~mitotic spindle organization,GO:0007507~heart development,GO:0045132~meiotic chromosome segregation,GO:0051301~cell division,GO:0051315~attachment of mitotic spindle microtubules to kinetochore,GO:0051383~kinetochore organization,	GO:0000775~chromosome, centromeric region,GO:0000776~kinetochore,GO:0005634~nucleus,GO:0005694~chromosome,GO:0031262~Ndc80 complex,	GO:0008017~microtubule binding,GO:0044877~macromolecular complex binding,	IPR005549:Kinetochore_Nuf2_N,IPR038275:Nuf2_N_sf,					KW-0131~Cell cycle,KW-0132~Cell division,KW-0498~Mitosis,	KW-0137~Centromere,KW-0158~Chromosome,KW-0539~Nucleus,KW-0995~Kinetochore,			KW-0175~Coiled coil,
Q4R761	V-type proton ATPase subunit E 1(LOC102137390)	Macaca fascicularis			GO:0097401~synaptic vesicle lumen acidification,GO:1902600~hydrogen ion transmembrane transport,	GO:0000221~vacuolar proton-transporting V-type ATPase, V1 domain,GO:0005768~endosome,GO:0005829~cytosol,GO:0005902~microvillus,GO:0016324~apical plasma membrane,GO:0030665~clathrin-coated vesicle membrane,GO:0030672~synaptic vesicle membrane,GO:0033178~proton-transporting two-sector ATPase complex, catalytic domain,GO:0098793~presynapse,	GO:0046961~proton-transporting ATPase activity, rotational mechanism,	IPR002842:ATPase_V1_Esu,IPR038495:ATPase_E_C,	mcf00190:Oxidative phosphorylation,mcf01100:Metabolic pathways,mcf04145:Phagosome,mcf04150:mTOR signaling pathway,mcf04721:Synaptic vesicle cycle,mcf04966:Collecting duct acid secretion,mcf05165:Human papillomavirus infection,mcf05323:Rheumatoid arthritis,				KW-0375~Hydrogen ion transport,KW-0406~Ion transport,KW-0813~Transport,	KW-0472~Membrane,KW-0770~Synapse,KW-0968~Cytoplasmic vesicle,KW-1003~Cell membrane,						KW-0007~Acetylation,KW-0597~Phosphoprotein,
Q5TYV4	VPS33B interacting protein, apical-basolateral polarity regulator, spe-39 homolog(vipas39)	Danio rerio			GO:0006886~intracellular protein transport,GO:0007034~vacuolar transport,GO:0007283~spermatogenesis,GO:0015031~protein transport,GO:0030154~cell differentiation,GO:0061008~hepaticobiliary system development,	GO:0005737~cytoplasm,GO:0005768~endosome,GO:0005769~early endosome,GO:0005770~late endosome,GO:0031410~cytoplasmic vesicle,GO:0055037~recycling endosome,		IPR006925:Vps16_C,IPR040057:Spe-39,					KW-0221~Differentiation,KW-0653~Protein transport,KW-0744~Spermatogenesis,KW-0804~Transcription,KW-0805~Transcription regulation,KW-0813~Transport,	KW-0963~Cytoplasm,KW-0967~Endosome,KW-0968~Cytoplasmic vesicle,
Q5RBZ2	WD repeat domain 77(WDR77)	Pongo abelii			GO:0000209~protein polyubiquitination,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006511~ubiquitin-dependent protein catabolic process,GO:0007309~oocyte axis specification,GO:0008284~positive regulation of cell proliferation,GO:0060528~secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development,GO:0060767~epithelial cell proliferation involved in prostate gland development,GO:0060770~negative regulation of epithelial cell proliferation involved in prostate gland development,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0005829~cytosol,GO:0031465~Cul4B-RING E3 ubiquitin ligase complex,GO:0034709~methylosome,	GO:0005515~protein binding,GO:0008327~methyl-CpG binding,GO:0030374~ligand-dependent nuclear receptor transcription coactivator activity,GO:1990756~protein binding, bridging involved in substrate recognition for ubiquitination,	IPR001680:WD40_rpt,IPR015943:WD40/YVTN_repeat-like_dom_sf,IPR019775:WD40_repeat_CS,IPR036322:WD40_repeat_dom_sf,				SM00320:WD40,		KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0677~Repeat,KW-0853~WD repeat,			KW-0597~Phosphoprotein,	REPEAT:WD,REPEAT:WD 1,REPEAT:WD 2,REPEAT:WD 3,REPEAT:WD 4,REPEAT:WD 5,REPEAT:WD 6,REPEAT:WD 7,
P46094	X-C motif chemokine receptor 1(XCR1)	Homo sapiens			GO:0006935~chemotaxis,GO:0006954~inflammatory response,GO:0006955~immune response,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007187~G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger,GO:0007204~positive regulation of cytosolic calcium ion concentration,GO:0019722~calcium-mediated signaling,GO:0051209~release of sequestered calcium ion into cytosol,GO:0060326~cell chemotaxis,GO:0070098~chemokine-mediated signaling pathway,	GO:0005886~plasma membrane,GO:0009897~external side of plasma membrane,GO:0016020~membrane,	GO:0004950~chemokine receptor activity,GO:0005515~protein binding,GO:0016493~C-C chemokine receptor activity,GO:0019957~C-C chemokine binding,	IPR000276:GPCR_Rhodpsn,IPR005393:Chemokine_XCR1,IPR017452:GPCR_Rhodpsn_7TM,	hsa04060:Cytokine-cytokine receptor interaction,hsa04061:Viral protein interaction with cytokine and cytokine receptor,hsa04062:Chemokine signaling pathway,					KW-0472~Membrane,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0297~G-protein coupled receptor,KW-0675~Receptor,KW-0807~Transducer,	KW-1015~Disulfide bond,	DOMAIN:G-protein coupled receptors family 1 profile,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,TRANSMEM:Helical; Name=1,TRANSMEM:Helical; Name=2,TRANSMEM:Helical; Name=3,TRANSMEM:Helical; Name=4,TRANSMEM:Helical; Name=5,TRANSMEM:Helical; Name=6,TRANSMEM:Helical; Name=7,
Q3TUF7	YEATS domain containing 2(Yeats2)	Mus musculus			GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006338~chromatin remodeling,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0045995~regulation of embryonic development,GO:0051302~regulation of cell division,GO:0051726~regulation of cell cycle,GO:0090043~regulation of tubulin deacetylation,	GO:0005634~nucleus,GO:0035267~NuA4 histone acetyltransferase complex,GO:0072686~mitotic spindle,	GO:0003714~transcription corepressor activity,GO:0017025~TBP-class protein binding,GO:0042393~histone binding,	IPR005033:YEATS,IPR038704:YEAST_sf,						KW-0539~Nucleus,			KW-0175~Coiled coil,			KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate,DOMAIN:YEATS,REGION:Disordered,REGION:Histone H3K27cr binding,
Q07352	ZFP36 ring finger protein like 1(ZFP36L1)	Homo sapiens			GO:0000165~MAPK cascade,GO:0000288~nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,GO:0001570~vasculogenesis,GO:0003342~proepicardium development,GO:0006397~mRNA processing,GO:0006417~regulation of translation,GO:0006915~apoptotic process,GO:0007507~heart development,GO:0008283~cell proliferation,GO:0009611~response to wounding,GO:0010468~regulation of gene expression,GO:0010837~regulation of keratinocyte proliferation,GO:0021915~neural tube development,GO:0031086~nuclear-transcribed mRNA catabolic process, deadenylation-independent decay,GO:0031440~regulation of mRNA 3'-end processing,GO:0032869~cellular response to insulin stimulus,GO:0033077~T cell differentiation in thymus,GO:0035264~multicellular organism growth,GO:0038066~p38MAPK cascade,GO:0043488~regulation of mRNA stability,GO:0043491~protein kinase B signaling,GO:0044344~cellular response to fibroblast growth factor stimulus,GO:0045577~regulation of B cell differentiation,GO:0045600~positive regulation of fat cell differentiation,GO:0045616~regulation of keratinocyte differentiation,GO:0045647~negative regulation of erythrocyte differentiation,GO:0045657~positive regulation of monocyte differentiation,GO:0045661~regulation of myoblast differentiation,GO:0048382~mesendoderm development,GO:0051028~mRNA transport,GO:0060710~chorio-allantoic fusion,GO:0060712~spongiotrophoblast layer development,GO:0061158~3'-UTR-mediated mRNA destabilization,GO:0070371~ERK1 and ERK2 cascade,GO:0071320~cellular response to cAMP,GO:0071356~cellular response to tumor necrosis factor,GO:0071364~cellular response to epidermal growth factor stimulus,GO:0071375~cellular response to peptide hormone stimulus,GO:0071385~cellular response to glucocorticoid stimulus,GO:0071456~cellular response to hypoxia,GO:0071472~cellular response to salt stress,GO:0071560~cellular response to transforming growth factor beta stimulus,GO:0072091~regulation of stem cell proliferation,GO:0097403~cellular response to raffinose,GO:1900153~positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,GO:1901991~negative regulation of mitotic cell cycle phase transition,GO:1902172~regulation of keratinocyte apoptotic process,GO:1904582~positive regulation of intracellular mRNA localization,	GO:0000932~P-body,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:1990904~ribonucleoprotein complex,	GO:0003677~DNA binding,GO:0003723~RNA binding,GO:0003729~mRNA binding,GO:0005515~protein binding,GO:0035925~mRNA 3'-UTR AU-rich region binding,GO:0046872~metal ion binding,GO:0071889~14-3-3 protein binding,	IPR000571:Znf_CCCH,IPR007635:Tis11B_N,IPR036855:Znf_CCCH_sf,IPR045877:ZFP36-like,	hsa04218:Cellular senescence,			SM00356:ZnF_C3H1,	KW-0507~mRNA processing,KW-0509~mRNA transport,KW-0813~Transport,	KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0677~Repeat,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0217~Developmental protein,KW-0238~DNA-binding,KW-0687~Ribonucleoprotein,KW-0694~RNA-binding,KW-9996~Developmental protein,	KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:C3H1-type,DOMAIN:Tis11B-like protein N-terminal,MUTAGEN:C->R: Reduces binding to ARE-containing mRNAs and ARE-mediated mRNA decay. Inhibits binding to ARE-containing mRNAs and ARE-mediated mRNA decay; when associated with R-120.,MUTAGEN:C->R: Reduces binding to ARE-containing mRNAs and ARE-mediated mRNA decay. Inhibits binding to ARE-containing mRNAs and ARE-mediated mRNA decay; when associated with R-158.,MUTAGEN:S->A: Inhibits MAPKAPK2-mediated ARE-containing mRNA stabilization; when associated with A-54 and A-203. Inhibits interaction with 14-3-3 proteins and AKT1-mediated ARE-containing mRNA stabilization; when associated with A-203. Inhibits interaction with 14-3-3 proteins and AKT1-mediated ARE-containing mRNA stabilization, but does not affect ARE binding; when associated with A-90.,MUTAGEN:S->A: Inhibits MAPKAPK2-mediated ARE-containing mRNA stabilization; when associated with A-92 and A-203.,MUTAGEN:S->A: Inhibits interaction with 14-3-3 proteins and AKT1-mediated ARE-containing mRNA stabilization, but does not affect ARE binding; when associated with A-92.,MUTAGEN:S->A: Inhibits interaction with 14-3-3 proteins and AKT1-mediated ARE-containing mRNA stabilization; when associated with A-92. Inhibits MAPKAPK2-mediated ARE-containing mRNA stabilization; when associated with A-54 and A-92.,MUTAGEN:S->A: Inhibits p38 MAPK-mediated LDLR mRNA stabilization, but does not inhibit interaction with CNOT1 and CNOT7; when associated with A-334.,MUTAGEN:S->A: Inhibits p38 MAPK-mediated LDLR mRNA stabilization, but does not inhibit interaction with CNOT1 and CNOT7; when associated with A-336.,REGION:Disordered,REGION:Necessary and sufficient for the association with mRNA decay enzymes and mRNA decay activation,REGION:Necessary for mRNA decay activation,ZN_FING:C3H1-type,ZN_FING:C3H1-type 1,ZN_FING:C3H1-type 2,
Q9R1V4	a disintegrin and metallopeptidase domain 11(Adam11)	Mus musculus			GO:0006508~proteolysis,GO:0033555~multicellular organismal response to stress,GO:0045184~establishment of protein localization,GO:0061367~behavioral response to acetic acid induced pain,GO:0061368~behavioral response to formalin induced pain,	GO:0005886~plasma membrane,GO:0016020~membrane,GO:0030424~axon,GO:0042734~presynaptic membrane,GO:0042995~cell projection,GO:0043204~perikaryon,GO:0045202~synapse,	GO:0004222~metalloendopeptidase activity,GO:0005515~protein binding,GO:0008237~metallopeptidase activity,	IPR000742:EGF-like_dom,IPR001590:Peptidase_M12B,IPR001762:Disintegrin_dom,IPR002870:Peptidase_M12B_N,IPR006586:ADAM_Cys-rich,IPR013111:EGF_extracell,IPR018358:Disintegrin_CS,IPR024079:MetalloPept_cat_dom_sf,IPR034027:Reprolysin_adamalysin,IPR036436:Disintegrin_dom_sf,				SM00050:DISIN,SM00608:ACR,		KW-0472~Membrane,KW-0770~Synapse,KW-0966~Cell projection,KW-1003~Cell membrane,			KW-0245~EGF-like domain,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0165~Cleavage on pair of basic residues,KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Disintegrin,DOMAIN:EGF-like,DOMAIN:Peptidase M12B,REGION:Disordered,REGION:Required for localization to cerebellar cortex basket cell terminals. Also required for localization of KCNA1, KCNA2, DLG4 and ADAM22 to cerebellar cortex basket cell terminal perisomatic axons and pinceaux,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q08C93	abhydrolase domain containing 12, lysophospholipase(abhd12)	Danio rerio			GO:0006629~lipid metabolic process,GO:0006660~phosphatidylserine catabolic process,GO:0009395~phospholipid catabolic process,GO:0010842~retina layer formation,GO:0036269~swimming behavior,GO:0042552~myelination,GO:0043010~camera-type eye development,GO:0046464~acylglycerol catabolic process,GO:0048899~anterior lateral line development,GO:0048919~posterior lateral line neuromast development,GO:0052651~monoacylglycerol catabolic process,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0016020~membrane,	GO:0004620~phospholipase activity,GO:0004622~lysophospholipase activity,GO:0016787~hydrolase activity,GO:0016788~hydrolase activity, acting on ester bonds,GO:0047372~acylglycerol lipase activity,	IPR000073:AB_hydrolase_1,IPR029058:AB_hydrolase,					KW-0443~Lipid metabolism,	KW-0256~Endoplasmic reticulum,KW-0472~Membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0378~Hydrolase,	KW-0325~Glycoprotein,	ACT_SITE:Charge relay system,ACT_SITE:Nucleophile,CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q8IZP0	abl interactor 1(ABI1)	Homo sapiens			GO:0001756~somitogenesis,GO:0001764~neuron migration,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0008154~actin polymerization or depolymerization,GO:0008285~negative regulation of cell proliferation,GO:0035855~megakaryocyte development,GO:0048813~dendrite morphogenesis,GO:0061098~positive regulation of protein tyrosine kinase activity,GO:0072673~lamellipodium morphogenesis,	GO:0005634~nucleus,GO:0005783~endoplasmic reticulum,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0014069~postsynaptic density,GO:0030027~lamellipodium,GO:0030175~filopodium,GO:0030426~growth cone,GO:0031209~SCAR complex,GO:0032433~filopodium tip,GO:0070062~extracellular exosome,GO:0098858~actin-based cell projection,	GO:0005515~protein binding,GO:0008092~cytoskeletal protein binding,GO:0017124~SH3 domain binding,GO:0030296~protein tyrosine kinase activator activity,GO:0035591~signaling adaptor activity,GO:0045296~cadherin binding,	IPR000727:T_SNARE_dom,IPR001452:SH3_domain,IPR012849:Abl-interactor_HHR_dom,IPR028457:ABI,IPR035725:Abi1_SH3,IPR036028:SH3-like_dom_sf,	hsa05130:Pathogenic Escherichia coli infection,hsa05132:Salmonella infection,			SM00326:SH3,	KW-0945~Host-virus interaction,	KW-0206~Cytoskeleton,KW-0539~Nucleus,KW-0770~Synapse,KW-0963~Cytoplasm,KW-0966~Cell projection,			KW-0175~Coiled coil,KW-0728~SH3 domain,			KW-0007~Acetylation,KW-0597~Phosphoprotein,	COMPBIAS:Polar residues,COMPBIAS:Pro residues,DOMAIN:SH3,DOMAIN:T-SNARE coiled-coil homology,DOMAIN:t-SNARE coiled-coil homology,REGION:Disordered,REGION:Required for binding to WASF1,SITE:Breakpoint for translocation to form KMT2A/MLL1-ABI1,
Q9BWD1	acetyl-CoA acetyltransferase 2(ACAT2)	Homo sapiens			GO:0006629~lipid metabolic process,GO:0006635~fatty acid beta-oxidation,	GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005829~cytosol,GO:0070062~extracellular exosome,	GO:0003985~acetyl-CoA C-acetyltransferase activity,GO:0005515~protein binding,GO:0016747~transferase activity, transferring acyl groups other than amino-acyl groups,	IPR002155:Thiolase,IPR016039:Thiolase-like,IPR020610:Thiolase_AS,IPR020613:Thiolase_CS,IPR020616:Thiolase_N,IPR020617:Thiolase_C,	hsa00071:Fatty acid degradation,hsa00280:Valine, leucine and isoleucine degradation,hsa00310:Lysine degradation,hsa00380:Tryptophan metabolism,hsa00620:Pyruvate metabolism,hsa00630:Glyoxylate and dicarboxylate metabolism,hsa00650:Butanoate metabolism,hsa00900:Terpenoid backbone biosynthesis,hsa01100:Metabolic pathways,hsa01200:Carbon metabolism,hsa01212:Fatty acid metabolism,hsa04975:Fat digestion and absorption,	614055~ACAT2 deficiency,	PIRSF000429:Ac-CoA_Ac_transf,			KW-0963~Cytoplasm,					KW-0012~Acyltransferase,KW-0808~Transferase,	KW-0007~Acetylation,	ACT_SITE:Acyl-thioester intermediate,ACT_SITE:Proton acceptor,ACT_SITE:Proton donor/acceptor,DOMAIN:Thiolase C-terminal,DOMAIN:Thiolase N-terminal,SITE:Increases nucleophilicity of active site Cys,
Q5SWU9	acetyl-Coenzyme A carboxylase alpha(Acaca)	Mus musculus			GO:0001894~tissue homeostasis,GO:0006084~acetyl-CoA metabolic process,GO:0006629~lipid metabolic process,GO:0006631~fatty acid metabolic process,GO:0006633~fatty acid biosynthetic process,GO:0008152~metabolic process,GO:0008610~lipid biosynthetic process,GO:0014070~response to organic cyclic compound,GO:0019538~protein metabolic process,GO:0051289~protein homotetramerization,GO:0055088~lipid homeostasis,GO:0071380~cellular response to prostaglandin E stimulus,GO:2001295~malonyl-CoA biosynthetic process,	GO:0001650~fibrillar center,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005829~cytosol,GO:0015629~actin cytoskeleton,	GO:0000166~nucleotide binding,GO:0003824~catalytic activity,GO:0003989~acetyl-CoA carboxylase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0009374~biotin binding,GO:0016874~ligase activity,GO:0019900~kinase binding,GO:0042802~identical protein binding,GO:0046872~metal ion binding,	IPR000089:Biotin_lipoyl,IPR001882:Biotin_BS,IPR005479:CbamoylP_synth_lsu-like_ATP-bd,IPR005481:BC-like_N,IPR005482:Biotin_COase_C,IPR011053:Single_hybrid_motif,IPR011054:Rudment_hybrid_motif,IPR011761:ATP-grasp,IPR011762:COA_CT_N,IPR011763:COA_CT_C,IPR011764:Biotin_carboxylation_dom,IPR013537:AcCoA_COase_cen,IPR013815:ATP_grasp_subdomain_1,IPR016185:PreATP-grasp_dom_sf,IPR029045:ClpP/crotonase-like_dom_sf,IPR034733:AcCoA_carboxyl_beta,IPR049074:ACCA_BT,IPR049076:ACCA,	mmu00061:Fatty acid biosynthesis,mmu00620:Pyruvate metabolism,mmu00640:Propanoate metabolism,mmu01100:Metabolic pathways,mmu01212:Fatty acid metabolism,mmu04152:AMPK signaling pathway,mmu04910:Insulin signaling pathway,mmu04922:Glucagon signaling pathway,mmu04936:Alcoholic liver disease,			SM00878:Biotin_carb_C,	KW-0275~Fatty acid biosynthesis,KW-0276~Fatty acid metabolism,KW-0443~Lipid metabolism,KW-0444~Lipid biosynthesis,	KW-0963~Cytoplasm,			KW-0732~Signal,	KW-0067~ATP-binding,KW-0092~Biotin,KW-0460~Magnesium,KW-0464~Manganese,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,	KW-0021~Allosteric enzyme,KW-0436~Ligase,KW-0511~Multifunctional enzyme,	KW-0007~Acetylation,KW-0597~Phosphoprotein,	DOMAIN:ATP-grasp,DOMAIN:Acetyl-CoA carboxylase central,DOMAIN:Biotin carboxylation,DOMAIN:Biotinyl-binding,DOMAIN:CoA carboxyltransferase C-terminal,DOMAIN:CoA carboxyltransferase N-terminal,REGION:Carboxyltransferase,
Q92038	acyl-CoA desaturase-like(LOC109092553)	Cyprinus carpio			GO:0006633~fatty acid biosynthetic process,GO:0006636~unsaturated fatty acid biosynthetic process,GO:0070542~response to fatty acid,	GO:0005789~endoplasmic reticulum membrane,GO:0016020~membrane,	GO:0004768~stearoyl-CoA 9-desaturase activity,GO:0005506~iron ion binding,GO:0016215~acyl-CoA desaturase activity,GO:0016491~oxidoreductase activity,GO:0032896~palmitoyl-CoA 9-desaturase activity,GO:0046872~metal ion binding,	IPR001522:FADS-1_CS,IPR005804:FA_desaturase_dom,IPR015876:Acyl-CoA_DS,	ccar01040:Biosynthesis of unsaturated fatty acids,ccar01100:Metabolic pathways,ccar01212:Fatty acid metabolism,ccar03320:PPAR signaling pathway,				KW-0275~Fatty acid biosynthesis,KW-0276~Fatty acid metabolism,KW-0346~Stress response,KW-0443~Lipid metabolism,KW-0444~Lipid biosynthesis,	KW-0256~Endoplasmic reticulum,KW-0472~Membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0408~Iron,KW-0479~Metal-binding,	KW-0560~Oxidoreductase,		DOMAIN:Fatty acid desaturase,MOTIF:Histidine box-1,MOTIF:Histidine box-2,MOTIF:Histidine box-3,TOPO_DOM:Cytoplasmic,TOPO_DOM:Lumenal,TRANSMEM:Helical,
Q5REB8	acyl-CoA synthetase short chain family member 3(ACSS3)	Pongo abelii			GO:0006629~lipid metabolic process,	GO:0005759~mitochondrial matrix,	GO:0003987~acetate-CoA ligase activity,GO:0005524~ATP binding,GO:0047760~butyrate-CoA ligase activity,GO:0050218~propionate-CoA ligase activity,	IPR000873:AMP-dep_Synth/Lig_com,IPR020845:AMP-binding_CS,IPR025110:AMP-bd_C,IPR032387:ACAS_N,IPR042099:ANL_N_sf,IPR045851:AMP-bd_C_sf,	pon00640:Propanoate metabolism,pon01100:Metabolic pathways,				KW-0443~Lipid metabolism,	KW-0496~Mitochondrion,			KW-0809~Transit peptide,	KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0436~Ligase,	KW-0007~Acetylation,	DOMAIN:AMP-binding enzyme C-terminal,DOMAIN:AMP-dependent synthetase/ligase,DOMAIN:Acetyl-coenzyme A synthetase N-terminal,TRANSIT:Mitochondrion,
Q9QYR7	acyl-CoA thioesterase 3(Acot3)	Mus musculus			GO:0000038~very long-chain fatty acid metabolic process,GO:0001676~long-chain fatty acid metabolic process,GO:0006629~lipid metabolic process,GO:0006631~fatty acid metabolic process,GO:0006637~acyl-CoA metabolic process,GO:0032788~saturated monocarboxylic acid metabolic process,GO:0032789~unsaturated monocarboxylic acid metabolic process,	GO:0005777~peroxisome,GO:0005829~cytosol,	GO:0016290~palmitoyl-CoA hydrolase activity,GO:0016787~hydrolase activity,GO:0016790~thiolester hydrolase activity,GO:0047617~acyl-CoA hydrolase activity,GO:0052689~carboxylic ester hydrolase activity,GO:0102991~myristoyl-CoA hydrolase activity,	IPR006862:Thio_Ohase/aa_AcTrfase,IPR014940:BAAT_C,IPR016662:Acyl-CoA_thioEstase_long-chain,IPR029058:AB_hydrolase,IPR042490:Thio_Ohase/BAAT_N,	mmu00062:Fatty acid elongation,mmu01040:Biosynthesis of unsaturated fatty acids,mmu01100:Metabolic pathways,mmu04913:Ovarian steroidogenesis,		PIRSF016521:Acyl-CoA_hydro,		KW-0276~Fatty acid metabolism,KW-0443~Lipid metabolism,	KW-0576~Peroxisome,					KW-0378~Hydrolase,KW-0719~Serine esterase,		ACT_SITE:Charge relay system,DOMAIN:Acyl-CoA thioester hydrolase/bile acid-CoA amino acid N-acetyltransferase,DOMAIN:BAAT/Acyl-CoA thioester hydrolase C-terminal,MOTIF:Microbody targeting signal,REGION:Disordered,
P61967	adaptor protein complex AP-1, sigma 1(Ap1s1)	Mus musculus			GO:0006886~intracellular protein transport,GO:0009615~response to virus,GO:0015031~protein transport,GO:0016192~vesicle-mediated transport,GO:0042147~retrograde transport, endosome to Golgi,GO:0060155~platelet dense granule organization,GO:1903232~melanosome assembly,	GO:0005765~lysosomal membrane,GO:0005769~early endosome,GO:0005794~Golgi apparatus,GO:0005802~trans-Golgi network,GO:0005829~cytosol,GO:0005905~clathrin-coated pit,GO:0016020~membrane,GO:0030117~membrane coat,GO:0030121~AP-1 adaptor complex,GO:0031410~cytoplasmic vesicle,GO:0032588~trans-Golgi network membrane,GO:0043195~terminal bouton,GO:0043231~intracellular membrane-bounded organelle,	GO:0005515~protein binding,GO:0035615~clathrin adaptor activity,	IPR000804:Clathrin_sm-chain_CS,IPR011012:Longin-like_dom_sf,IPR016635:AP_complex_ssu,IPR022775:AP_mu_sigma_su,IPR044733:AP1_sigma,	mmu04142:Lysosome,mmu05170:Human immunodeficiency virus 1 infection,		PIRSF015588:AP_complex_sigma,		KW-0653~Protein transport,KW-0813~Transport,	KW-0168~Coated pit,KW-0333~Golgi apparatus,KW-0472~Membrane,KW-0968~Cytoplasmic vesicle,						KW-0597~Phosphoprotein,	DOMAIN:AP complex mu/sigma subunit,
Q0VC81	adenosine A3 receptor(ADORA3)	Bos taurus			GO:0001973~adenosine receptor signaling pathway,GO:0008285~negative regulation of cell proliferation,GO:0030336~negative regulation of cell migration,	GO:0005886~plasma membrane,GO:0016020~membrane,GO:0030425~dendrite,GO:0045202~synapse,	GO:0001609~G-protein coupled adenosine receptor activity,	IPR000276:GPCR_Rhodpsn,IPR000466:Adeno_A3_rcpt,IPR001634:Adenosn_rcpt,IPR017452:GPCR_Rhodpsn_7TM,	bta04022:cGMP-PKG signaling pathway,bta04071:Sphingolipid signaling pathway,bta04080:Neuroactive ligand-receptor interaction,			SM01381:7TM_GPCR_Srsx,		KW-0472~Membrane,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0297~G-protein coupled receptor,KW-0675~Receptor,KW-0807~Transducer,	KW-0325~Glycoprotein,KW-0449~Lipoprotein,KW-0564~Palmitate,KW-0597~Phosphoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,LIPID:S-palmitoyl cysteine,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical; Name=1,TRANSMEM:Helical; Name=2,TRANSMEM:Helical; Name=3,TRANSMEM:Helical; Name=4,TRANSMEM:Helical; Name=5,TRANSMEM:Helical; Name=6,TRANSMEM:Helical; Name=7,
Q91ZS8	adenosine deaminase, RNA-specific, B1(Adarb1)	Mus musculus			GO:0006382~adenosine to inosine editing,GO:0006396~RNA processing,GO:0006397~mRNA processing,GO:0007274~neuromuscular synaptic transmission,GO:0008285~negative regulation of cell proliferation,GO:0016553~base conversion or substitution editing,GO:0016556~mRNA modification,GO:0021610~facial nerve morphogenesis,GO:0021618~hypoglossal nerve morphogenesis,GO:0021965~spinal cord ventral commissure morphogenesis,GO:0030336~negative regulation of cell migration,GO:0035264~multicellular organism growth,GO:0044387~negative regulation of protein kinase activity by regulation of protein phosphorylation,GO:0045070~positive regulation of viral genome replication,GO:0050685~positive regulation of mRNA processing,GO:0050884~neuromuscular process controlling posture,GO:0051726~regulation of cell cycle,GO:0060384~innervation,GO:0060415~muscle tissue morphogenesis,GO:0061744~motor behavior,GO:0097049~motor neuron apoptotic process,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0016020~membrane,GO:0045202~synapse,	GO:0003723~RNA binding,GO:0003725~double-stranded RNA binding,GO:0003726~double-stranded RNA adenosine deaminase activity,GO:0004000~adenosine deaminase activity,GO:0008251~tRNA-specific adenosine deaminase activity,GO:0016787~hydrolase activity,GO:0042802~identical protein binding,GO:0046872~metal ion binding,	IPR002466:A_deamin,IPR014720:dsRBD_dom,IPR044458:ADAR2_DSRM_1,IPR044459:ADAR2_DSRM_2,				SM00358:DSRM,SM00552:ADEAMc,	KW-0507~mRNA processing,	KW-0472~Membrane,KW-0539~Nucleus,			KW-0677~Repeat,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0378~Hydrolase,KW-0694~RNA-binding,	KW-0597~Phosphoprotein,	ACT_SITE:Proton donor,COMPBIAS:Polar residues,DOMAIN:A to I editase,DOMAIN:DRBM,DOMAIN:DRBM 1,DOMAIN:DRBM 2,REGION:Disordered,REGION:Interaction with substrate RNA,TRANSMEM:Helical,
Q5ZI16	adenosine deaminase, tRNA specific 1(ADAT1)	Gallus gallus			GO:0006396~RNA processing,GO:0008033~tRNA processing,		GO:0003723~RNA binding,GO:0004000~adenosine deaminase activity,GO:0008251~tRNA-specific adenosine deaminase activity,GO:0043829~tRNA-specific adenosine-37 deaminase activity,GO:0046872~metal ion binding,	IPR002466:A_deamin,				SM00552:ADEAMc,	KW-0819~tRNA processing,					KW-0479~Metal-binding,KW-0862~Zinc,	KW-0378~Hydrolase,		ACT_SITE:Proton donor,DOMAIN:A to I editase,
P51830	adenylate cyclase 9(Adcy9)	Mus musculus			GO:0001701~in utero embryonic development,GO:0006171~cAMP biosynthetic process,GO:0007189~adenylate cyclase-activating G-protein coupled receptor signaling pathway,GO:0009190~cyclic nucleotide biosynthetic process,GO:0035556~intracellular signal transduction,GO:0071880~adenylate cyclase-activating adrenergic receptor signaling pathway,	GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0030424~axon,GO:0030425~dendrite,	GO:0000166~nucleotide binding,GO:0004016~adenylate cyclase activity,GO:0005524~ATP binding,GO:0016829~lyase activity,GO:0016849~phosphorus-oxygen lyase activity,GO:0046872~metal ion binding,	IPR001054:A/G_cyclase,IPR018297:A/G_cyclase_CS,IPR029787:Nucleotide_cyclase,	mmu00230:Purine metabolism,mmu01100:Metabolic pathways,mmu01522:Endocrine resistance,mmu04015:Rap1 signaling pathway,mmu04020:Calcium signaling pathway,mmu04022:cGMP-PKG signaling pathway,mmu04024:cAMP signaling pathway,mmu04062:Chemokine signaling pathway,mmu04072:Phospholipase D signaling pathway,mmu04114:Oocyte meiosis,mmu04211:Longevity regulating pathway,mmu04213:Longevity regulating pathway - multiple species,mmu04261:Adrenergic signaling in cardiomyocytes,mmu04270:Vascular smooth muscle contraction,mmu04371:Apelin signaling pathway,mmu04540:Gap junction,mmu04611:Platelet activation,mmu04713:Circadian entrainment,mmu04714:Thermogenesis,mmu04723:Retrograde endocannabinoid signaling,mmu04724:Glutamatergic synapse,mmu04725:Cholinergic synapse,mmu04727:GABAergic synapse,mmu04750:Inflammatory mediator regulation of TRP channels,mmu04911:Insulin secretion,mmu04912:GnRH signaling pathway,mmu04913:Ovarian steroidogenesis,mmu04914:Progesterone-mediated oocyte maturation,mmu04915:Estrogen signaling pathway,mmu04916:Melanogenesis,mmu04918:Thyroid hormone synthesis,mmu04921:Oxytocin signaling pathway,mmu04923:Regulation of lipolysis in adipocytes,mmu04925:Aldosterone synthesis and secretion,mmu04926:Relaxin signaling pathway,mmu04927:Cortisol synthesis and secretion,mmu04928:Parathyroid hormone synthesis, secretion and action,mmu04934:Cushing syndrome,mmu04935:Growth hormone synthesis, secretion and action,mmu04961:Endocrine and other factor-regulated calcium reabsorption,mmu04962:Vasopressin-regulated water reabsorption,mmu04970:Salivary secretion,mmu04971:Gastric acid secretion,mmu04972:Pancreatic secretion,mmu04976:Bile secretion,mmu05032:Morphine addiction,mmu05163:Human cytomegalovirus infection,mmu05166:Human T-cell leukemia virus 1 infection,mmu05200:Pathways in cancer,mmu05207:Chemical carcinogenesis - receptor activation,mmu05414:Dilated cardiomyopathy,			SM00044:CYCc,	KW-0115~cAMP biosynthesis,	KW-0472~Membrane,KW-1003~Cell membrane,			KW-0677~Repeat,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0067~ATP-binding,KW-0460~Magnesium,KW-0464~Manganese,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,	KW-0456~Lyase,	KW-0325~Glycoprotein,KW-0597~Phosphoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Polar residues,DOMAIN:Guanylate cyclase,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q61549	adhesion G protein-coupled receptor E1(Adgre1)	Mus musculus			GO:0002250~adaptive immune response,GO:0002376~immune system process,GO:0007165~signal transduction,GO:0007166~cell surface receptor signaling pathway,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007189~adenylate cyclase-activating G-protein coupled receptor signaling pathway,	GO:0005886~plasma membrane,GO:0009897~external side of plasma membrane,GO:0016020~membrane,GO:0071944~cell periphery,	GO:0004888~transmembrane signaling receptor activity,GO:0004930~G-protein coupled receptor activity,GO:0005509~calcium ion binding,	IPR000152:EGF-type_Asp/Asn_hydroxyl_site,IPR000203:GPS,IPR000742:EGF-like_dom,IPR000832:GPCR_2_secretin-like,IPR001740:GPCR_2_EMR1-like_rcpt,IPR001881:EGF-like_Ca-bd_dom,IPR009030:Growth_fac_rcpt_cys_sf,IPR017981:GPCR_2-like_7TM,IPR017983:GPCR_2_secretin-like_CS,IPR018097:EGF_Ca-bd_CS,IPR046338:GAIN_dom_sf,				SM00179:EGF_CA,SM00181:EGF,SM00303:GPS,	KW-0391~Immunity,KW-1064~Adaptive immunity,	KW-0472~Membrane,KW-1003~Cell membrane,			KW-0245~EGF-like domain,KW-0677~Repeat,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0106~Calcium,	KW-0297~G-protein coupled receptor,KW-0675~Receptor,KW-0807~Transducer,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:EGF-like,DOMAIN:EGF-like 1,DOMAIN:EGF-like 2,DOMAIN:EGF-like 3; calcium-binding,DOMAIN:EGF-like 4; calcium-binding,DOMAIN:EGF-like 5; calcium-binding,DOMAIN:EGF-like 6; calcium-binding,DOMAIN:EGF-like 7; calcium-binding,DOMAIN:G-protein coupled receptors family 2 profile 2,DOMAIN:GPS,MOTIF:Cell attachment site,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,TRANSMEM:Helical; Name=1,TRANSMEM:Helical; Name=2,TRANSMEM:Helical; Name=3,TRANSMEM:Helical; Name=4,TRANSMEM:Helical; Name=5,TRANSMEM:Helical; Name=6,TRANSMEM:Helical; Name=7,
Q9BYV1	alanine--glyoxylate aminotransferase 2(AGXT2)	Homo sapiens			GO:0009436~glyoxylate catabolic process,GO:0019265~glycine biosynthetic process, by transamination of glyoxylate,GO:0019481~L-alanine catabolic process, by transamination,GO:0045429~positive regulation of nitric oxide biosynthetic process,GO:2001299~N(omega),N(omega)-dimethyl-L-arginine catabolic process,	GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,	GO:0008453~alanine-glyoxylate transaminase activity,GO:0008483~transaminase activity,GO:0016223~beta-alanine-pyruvate transaminase activity,GO:0030170~pyridoxal phosphate binding,GO:0047305~(R)-3-amino-2-methylpropionate-pyruvate transaminase activity,	IPR005814:Aminotrans_3,IPR015421:PyrdxlP-dep_Trfase_major,IPR015422:PyrdxlP-dep_Trfase_small,IPR015424:PyrdxlP-dep_Trfase,	hsa00250:Alanine, aspartate and glutamate metabolism,hsa00260:Glycine, serine and threonine metabolism,hsa00270:Cysteine and methionine metabolism,hsa00280:Valine, leucine and isoleucine degradation,hsa01100:Metabolic pathways,hsa01210:2-Oxocarboxylic acid metabolism,	210100~Beta-aminoisobutyric acid, urinary excretion of,	PIRSF000521:Transaminase_4ab_Lys_Orn,			KW-0496~Mitochondrion,		KW-0225~Disease variant,	KW-0809~Transit peptide,	KW-0663~Pyridoxal phosphate,	KW-0032~Aminotransferase,KW-0808~Transferase,	KW-0007~Acetylation,	TRANSIT:Mitochondrion,
P26325	alcohol dehydrogenase 1(LOC115543782)	Gadus morhua			GO:0046294~formaldehyde catabolic process,	GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0004022~alcohol dehydrogenase (NAD) activity,GO:0004024~alcohol dehydrogenase activity, zinc-dependent,GO:0008270~zinc ion binding,GO:0016491~oxidoreductase activity,GO:0051903~S-(hydroxymethyl)glutathione dehydrogenase activity,	IPR002328:ADH_Zn_CS,IPR011032:GroES-like_sf,IPR013149:ADH-like_C,IPR013154:ADH-like_N,IPR020843:PKS_ER,IPR036291:NAD(P)-bd_dom_sf,				SM00829:PKS_ER,		KW-0963~Cytoplasm,				KW-0479~Metal-binding,KW-0520~NAD,KW-0862~Zinc,	KW-0560~Oxidoreductase,	KW-0007~Acetylation,	DOMAIN:Alcohol dehydrogenase-like C-terminal,DOMAIN:Alcohol dehydrogenase-like N-terminal,DOMAIN:Enoyl reductase (ER),
Q8K009	aldehyde dehydrogenase 1 family, member L2(Aldh1l2)	Mus musculus			GO:0006635~fatty acid beta-oxidation,GO:0006730~one-carbon metabolic process,GO:0006740~NADPH regeneration,GO:0009058~biosynthetic process,GO:0009258~10-formyltetrahydrofolate catabolic process,GO:0046655~folic acid metabolic process,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005739~mitochondrion,	GO:0003824~catalytic activity,GO:0004029~aldehyde dehydrogenase (NAD) activity,GO:0016155~formyltetrahydrofolate dehydrogenase activity,GO:0016491~oxidoreductase activity,GO:0016620~oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor,	IPR001555:GART_AS,IPR002376:Formyl_transf_N,IPR005793:Formyl_trans_C,IPR006162:Ppantetheine_attach_site,IPR009081:PP-bd_ACP,IPR011034:Formyl_transferase-like_C_sf,IPR011407:10_FTHF_DH,IPR015590:Aldehyde_DH_dom,IPR016160:Ald_DH_CS_CYS,IPR016161:Ald_DH/histidinol_DH,IPR016162:Ald_DH_N,IPR016163:Ald_DH_C,IPR029510:Ald_DH_CS_GLU,IPR036477:Formyl_transf_N_sf,IPR036736:ACP-like_sf,IPR037022:Formyl_trans_C_sf,	mmu00670:One carbon pool by folate,mmu01100:Metabolic pathways,		PIRSF036489:10-FTHFDH,		KW-0554~One-carbon metabolism,	KW-0496~Mitochondrion,			KW-0809~Transit peptide,	KW-0521~NADP,	KW-0560~Oxidoreductase,	KW-0007~Acetylation,KW-0596~Phosphopantetheine,KW-0597~Phosphoprotein,	ACT_SITE:Proton acceptor,ACT_SITE:Proton donor,DOMAIN:Carrier,REGION:Aldehyde dehydrogenase domain,REGION:Hydrolase domain,SITE:Essential for catalytic activity,TRANSIT:Mitochondrion; not cleaved,
P51857	aldo-keto reductase family 1 member D1(AKR1D1)	Homo sapiens			GO:0006699~bile acid biosynthetic process,GO:0006707~cholesterol catabolic process,GO:0007586~digestion,GO:0008207~C21-steroid hormone metabolic process,GO:0008209~androgen metabolic process,GO:0030573~bile acid catabolic process,	GO:0005829~cytosol,	GO:0004032~alditol:NADP+ 1-oxidoreductase activity,GO:0004033~aldo-keto reductase (NADP) activity,GO:0005496~steroid binding,GO:0016229~steroid dehydrogenase activity,GO:0047086~ketosteroid monooxygenase activity,GO:0047568~3-oxo-5-beta-steroid 4-dehydrogenase activity,GO:0047787~delta4-3-oxosteroid 5beta-reductase activity,	IPR018170:Aldo/ket_reductase_CS,IPR020471:AKR,IPR023210:NADP_OxRdtase_dom,IPR036812:NADP_OxRdtase_dom_sf,IPR044483:AKR1D1,	hsa00120:Primary bile acid biosynthesis,hsa00140:Steroid hormone biosynthesis,hsa01100:Metabolic pathways,	235555~Bile acid synthesis defect, congenital, 2,	PIRSF000097:AKR,		KW-0088~Bile acid catabolism,KW-0442~Lipid degradation,KW-0443~Lipid metabolism,KW-0753~Steroid metabolism,	KW-0963~Cytoplasm,		KW-0225~Disease variant,KW-0988~Intrahepatic cholestasis,		KW-0521~NADP,	KW-0560~Oxidoreductase,		ACT_SITE:Proton donor,DOMAIN:NADP-dependent oxidoreductase,MUTAGEN:E->A: Loss of activity.,MUTAGEN:Y->A: Loss of activity.,
Q9UJX5	anaphase promoting complex subunit 4(ANAPC4)	Homo sapiens			GO:0007049~cell cycle,GO:0007346~regulation of mitotic cell cycle,GO:0030071~regulation of mitotic metaphase/anaphase transition,GO:0031145~anaphase-promoting complex-dependent catabolic process,GO:0051301~cell division,GO:0051445~regulation of meiotic cell cycle,GO:0070979~protein K11-linked ubiquitination,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005680~anaphase-promoting complex,GO:0005829~cytosol,GO:0034399~nuclear periphery,	GO:0004842~ubiquitin-protein transferase activity,GO:0005515~protein binding,GO:0019903~protein phosphatase binding,	IPR015943:WD40/YVTN_repeat-like_dom_sf,IPR017169:APC4_metazoa,IPR024789:APC4,IPR024790:APC4_long_dom,IPR024977:Apc4-like_WD40_dom,IPR036322:WD40_repeat_dom_sf,	hsa04110:Cell cycle,hsa04114:Oocyte meiosis,hsa04120:Ubiquitin mediated proteolysis,hsa04914:Progesterone-mediated oocyte maturation,hsa05166:Human T-cell leukemia virus 1 infection,		PIRSF037303:APC4,		KW-0131~Cell cycle,KW-0132~Cell division,KW-0498~Mitosis,KW-0833~Ubl conjugation pathway,	KW-0539~Nucleus,						KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),DOMAIN:Anaphase-promoting complex subunit 4 long,DOMAIN:Anaphase-promoting complex subunit 4-like WD40,MUTAGEN:D->K: Impairs UBE2S-mediated polyubiquitination, decreasing substrate affinity. Does not affect UBE2C-mediated multiubiquitination.,
Q5RE52	anaphase promoting complex subunit 5(ANAPC5)	Pongo abelii			GO:0007049~cell cycle,GO:0016567~protein ubiquitination,GO:0031145~anaphase-promoting complex-dependent catabolic process,GO:0045842~positive regulation of mitotic metaphase/anaphase transition,GO:0051301~cell division,GO:0070979~protein K11-linked ubiquitination,	GO:0005634~nucleus,GO:0005680~anaphase-promoting complex,GO:0005737~cytoplasm,GO:0005819~spindle,	GO:0005515~protein binding,GO:0019903~protein phosphatase binding,	IPR011990:TPR-like_helical_dom_sf,IPR019734:TPR_repeat,IPR026000:Apc5_dom,IPR037679:Apc5,IPR048968:Apc5_N,	pon04110:Cell cycle,pon04114:Oocyte meiosis,pon04120:Ubiquitin mediated proteolysis,pon04657:IL-17 signaling pathway,pon04914:Progesterone-mediated oocyte maturation,pon05166:Human T-cell leukemia virus 1 infection,			SM00028:TPR,	KW-0131~Cell cycle,KW-0132~Cell division,KW-0498~Mitosis,KW-0833~Ubl conjugation pathway,	KW-0206~Cytoskeleton,KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0677~Repeat,KW-0802~TPR repeat,			KW-0597~Phosphoprotein,	DOMAIN:Anaphase-promoting complex subunit 5,DOMAIN:Anaphase-promoting complex subunit 5 N-terminal,REPEAT:TPR 1,REPEAT:TPR 10,REPEAT:TPR 11,REPEAT:TPR 12,REPEAT:TPR 13,REPEAT:TPR 2,REPEAT:TPR 3,REPEAT:TPR 4,REPEAT:TPR 5,REPEAT:TPR 6,REPEAT:TPR 7,REPEAT:TPR 8,REPEAT:TPR 9,
P15207	androgen receptor(Ar)	Rattus norvegicus			GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0000165~MAPK cascade,GO:0001701~in utero embryonic development,GO:0003073~regulation of systemic arterial blood pressure,GO:0003382~epithelial cell morphogenesis,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0007283~spermatogenesis,GO:0007338~single fertilization,GO:0007620~copulation,GO:0008049~male courtship behavior,GO:0008284~positive regulation of cell proliferation,GO:0008285~negative regulation of cell proliferation,GO:0008584~male gonad development,GO:0009566~fertilization,GO:0010468~regulation of gene expression,GO:0010628~positive regulation of gene expression,GO:0014734~skeletal muscle hypertrophy,GO:0019098~reproductive behavior,GO:0019102~male somatic sex determination,GO:0030518~intracellular steroid hormone receptor signaling pathway,GO:0030520~intracellular estrogen receptor signaling pathway,GO:0030521~androgen receptor signaling pathway,GO:0030522~intracellular receptor signaling pathway,GO:0032355~response to estradiol,GO:0032868~response to insulin,GO:0033148~positive regulation of intracellular estrogen receptor signaling pathway,GO:0033327~Leydig cell differentiation,GO:0033574~response to testosterone,GO:0035264~multicellular organism growth,GO:0042327~positive regulation of phosphorylation,GO:0043410~positive regulation of MAPK cascade,GO:0043568~positive regulation of insulin-like growth factor receptor signaling pathway,GO:0045597~positive regulation of cell differentiation,GO:0045720~negative regulation of integrin biosynthetic process,GO:0045726~positive regulation of integrin biosynthetic process,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0045945~positive regulation of transcription from RNA polymerase III promoter,GO:0046661~male sex differentiation,GO:0048009~insulin-like growth factor receptor signaling pathway,GO:0048608~reproductive structure development,GO:0048638~regulation of developmental growth,GO:0048645~animal organ formation,GO:0048808~male genitalia morphogenesis,GO:0050673~epithelial cell proliferation,GO:0050680~negative regulation of epithelial cell proliferation,GO:0051092~positive regulation of NF-kappaB transcription factor activity,GO:0060406~positive regulation of penile erection,GO:0060520~activation of prostate induction by androgen receptor signaling pathway,GO:0060571~morphogenesis of an epithelial fold,GO:0060599~lateral sprouting involved in mammary gland duct morphogenesis,GO:0060685~regulation of prostatic bud formation,GO:0060736~prostate gland growth,GO:0060740~prostate gland epithelium morphogenesis,GO:0060742~epithelial cell differentiation involved in prostate gland development,GO:0060748~tertiary branching involved in mammary gland duct morphogenesis,GO:0060749~mammary gland alveolus development,GO:0060769~positive regulation of epithelial cell proliferation involved in prostate gland development,GO:0061458~reproductive system development,GO:0071372~cellular response to follicle-stimulating hormone stimulus,GO:0071383~cellular response to steroid hormone stimulus,GO:0071391~cellular response to estrogen stimulus,GO:0071394~cellular response to testosterone stimulus,GO:0072520~seminiferous tubule development,GO:1902895~positive regulation of pri-miRNA transcription from RNA polymerase II promoter,GO:1903076~regulation of protein localization to plasma membrane,GO:2001237~negative regulation of extrinsic apoptotic signaling pathway,	GO:0000785~chromatin,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0016607~nuclear speck,GO:0030424~axon,GO:0030425~dendrite,GO:0032991~macromolecular complex,	GO:0000976~transcription regulatory region sequence-specific DNA binding,GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001091~RNA polymerase II basal transcription factor binding,GO:0001223~transcription coactivator binding,GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0004879~RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding,GO:0005102~receptor binding,GO:0005496~steroid binding,GO:0005497~androgen binding,GO:0005515~protein binding,GO:0008013~beta-catenin binding,GO:0008270~zinc ion binding,GO:0019899~enzyme binding,GO:0019904~protein domain specific binding,GO:0032553~ribonucleotide binding,GO:0034056~estrogen response element binding,GO:0043565~sequence-specific DNA binding,GO:0050681~androgen receptor binding,GO:0051117~ATPase binding,GO:0060090~binding, bridging,GO:0061629~RNA polymerase II sequence-specific DNA binding transcription factor binding,GO:0070974~POU domain binding,	IPR000536:Nucl_hrmn_rcpt_lig-bd,IPR001103:Andrgn_rcpt,IPR001628:Znf_hrmn_rcpt,IPR013088:Znf_NHR/GATA,IPR035500:NHR-like_dom_sf,	rno04114:Oocyte meiosis,rno05200:Pathways in cancer,rno05207:Chemical carcinogenesis - receptor activation,rno05215:Prostate cancer,			SM00399:ZnF_C4,SM00430:HOLI,	KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,KW-0963~Cytoplasm,		KW-0225~Disease variant,	KW-0863~Zinc-finger,	KW-0446~Lipid-binding,KW-0479~Metal-binding,KW-0754~Steroid-binding,KW-0862~Zinc,	KW-0238~DNA-binding,KW-0675~Receptor,	KW-0449~Lipoprotein,KW-0564~Palmitate,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO),CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),DNA_BIND:Nuclear receptor,DOMAIN:NR LBD,DOMAIN:Nuclear receptor,REGION:Disordered,REGION:Interaction with CCAR1,REGION:Interaction with HIPK3,REGION:Interaction with KAT7,REGION:Interaction with LPXN,REGION:Interaction with ZNF318,REGION:Modulating,SITE:Interaction with coactivator FXXLF and FXXFY motifs,SITE:Interaction with coactivator LXXL and FXXFY motifs,ZN_FING:NR C4-type,
Q9Y264	angiopoietin 4(ANGPT4)	Homo sapiens			GO:0001525~angiogenesis,GO:0007165~signal transduction,GO:0007219~Notch signaling pathway,GO:0010595~positive regulation of endothelial cell migration,GO:0016525~negative regulation of angiogenesis,GO:0043066~negative regulation of apoptotic process,GO:0043536~positive regulation of blood vessel endothelial cell migration,GO:0043537~negative regulation of blood vessel endothelial cell migration,GO:0045766~positive regulation of angiogenesis,GO:0050731~positive regulation of peptidyl-tyrosine phosphorylation,GO:0071456~cellular response to hypoxia,	GO:0005576~extracellular region,GO:0005615~extracellular space,	GO:0030297~transmembrane receptor protein tyrosine kinase activator activity,GO:0030971~receptor tyrosine kinase binding,	IPR002181:Fibrinogen_a/b/g_C_dom,IPR014716:Fibrinogen_a/b/g_C_1,IPR020837:Fibrinogen_CS,IPR036056:Fibrinogen-like_C,	hsa04010:MAPK signaling pathway,hsa04014:Ras signaling pathway,hsa04015:Rap1 signaling pathway,hsa04066:HIF-1 signaling pathway,hsa04151:PI3K-Akt signaling pathway,			SM00186:FBG,	KW-0037~Angiogenesis,	KW-0964~Secreted,			KW-0175~Coiled coil,KW-0732~Signal,			KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Fibrinogen C-terminal,
Q9NQW6	anillin, actin binding protein(ANLN)	Homo sapiens			GO:0000281~mitotic cytokinesis,GO:0000915~actomyosin contractile ring assembly,GO:0000921~septin ring assembly,GO:0002244~hematopoietic progenitor cell differentiation,GO:0007096~regulation of exit from mitosis,GO:0031106~septin ring organization,GO:0090521~glomerular visceral epithelial cell migration,GO:1904172~positive regulation of bleb assembly,	GO:0005654~nucleoplasm,GO:0005826~actomyosin contractile ring,GO:0005829~cytosol,GO:0005938~cell cortex,GO:0015629~actin cytoskeleton,GO:0030496~midbody,GO:0032059~bleb,	GO:0003779~actin binding,GO:0045296~cadherin binding,	IPR001849:PH_domain,IPR011993:PH-like_dom_sf,IPR012966:AHD,IPR031970:Anillin_N,IPR037840:PH_Anillin,		616032~Focal segmental glomerulosclerosis 8,		SM00233:PH,	KW-0131~Cell cycle,KW-0132~Cell division,KW-0498~Mitosis,	KW-0206~Cytoskeleton,KW-0539~Nucleus,KW-0963~Cytoplasm,KW-0966~Cell projection,		KW-0225~Disease variant,	KW-0175~Coiled coil,		KW-0009~Actin-binding,	KW-0007~Acetylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1),DOMAIN:Anillin N-terminal,DOMAIN:Anillin homology,DOMAIN:PH,MUTAGEN:L->A: Abrogates ubiquitin-mediated proteolysis; when associated with A-41.,MUTAGEN:R->A: Abrogates interaction with CD2AP.,MUTAGEN:R->A: Abrogates ubiquitin-mediated proteolysis; when associated with A-44.,REGION:Disordered,REGION:Interaction with CD2AP,REGION:Interaction with F-actin,REGION:Localization to the cleavage furrow,REGION:Nuclear localization,REGION:Required for ubiquitination,
Q91ZT8	ankyrin repeat and SOCS box-containing 9(Asb9)	Mus musculus			GO:0016567~protein ubiquitination,GO:0035556~intracellular signal transduction,GO:0045732~positive regulation of protein catabolic process,	GO:0005739~mitochondrion,	GO:0005515~protein binding,	IPR001496:SOCS_box,IPR002110:Ankyrin_rpt,IPR036036:SOCS_box-like_dom_sf,IPR036770:Ankyrin_rpt-contain_sf,				SM00248:ANK,SM00969:SOCS_box,	KW-0833~Ubl conjugation pathway,	KW-0496~Mitochondrion,			KW-0040~ANK repeat,KW-0677~Repeat,			KW-0007~Acetylation,	DOMAIN:SOCS box,REGION:Disordered,REPEAT:ANK 1,REPEAT:ANK 2,REPEAT:ANK 3,REPEAT:ANK 4,REPEAT:ANK 5,REPEAT:ANK 6,SITE:Essential for binding to CKB,
Q5VYY1	ankyrin repeat domain 22(ANKRD22)	Homo sapiens						IPR002110:Ankyrin_rpt,IPR036770:Ankyrin_rpt-contain_sf,IPR042802:ANR22,				SM00248:ANK,					KW-0040~ANK repeat,KW-0677~Repeat,				REPEAT:ANK 1,REPEAT:ANK 2,REPEAT:ANK 3,REPEAT:ANK 4,
Q8BLD6	ankyrin repeat domain 55(Ankrd55)	Mus musculus						IPR002110:Ankyrin_rpt,IPR036770:Ankyrin_rpt-contain_sf,				SM00248:ANK,					KW-0040~ANK repeat,KW-0677~Repeat,			KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,REGION:Disordered,REPEAT:ANK,REPEAT:ANK 1,REPEAT:ANK 2,REPEAT:ANK 3,REPEAT:ANK 4,REPEAT:ANK 5,REPEAT:ANK 6,REPEAT:ANK 7,REPEAT:ANK 8,REPEAT:ANK 9,
P07356	annexin A2(Anxa2)	Mus musculus			GO:0001525~angiogenesis,GO:0001765~membrane raft assembly,GO:0001921~positive regulation of receptor recycling,GO:0001934~positive regulation of protein phosphorylation,GO:0002091~negative regulation of receptor internalization,GO:0006900~membrane budding,GO:0007155~cell adhesion,GO:0007160~cell-matrix adhesion,GO:0007589~body fluid secretion,GO:0010756~positive regulation of plasminogen activation,GO:0014823~response to activity,GO:0030199~collagen fibril organization,GO:0030324~lung development,GO:0031340~positive regulation of vesicle fusion,GO:0032804~negative regulation of low-density lipoprotein particle receptor catabolic process,GO:0036035~osteoclast development,GO:0042730~fibrinolysis,GO:0042789~mRNA transcription from RNA polymerase II promoter,GO:0044090~positive regulation of vacuole organization,GO:0045921~positive regulation of exocytosis,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048146~positive regulation of fibroblast proliferation,GO:0050767~regulation of neurogenesis,GO:0051099~positive regulation of binding,GO:0071229~cellular response to acid chemical,GO:0072659~protein localization to plasma membrane,GO:1904019~epithelial cell apoptotic process,GO:1905581~positive regulation of low-density lipoprotein particle clearance,GO:1905597~positive regulation of low-density lipoprotein particle receptor binding,GO:1905599~positive regulation of low-density lipoprotein receptor activity,GO:1905602~positive regulation of receptor-mediated endocytosis involved in cholesterol transport,GO:1905686~positive regulation of plasma membrane repair,	GO:0001533~cornified envelope,GO:0001725~stress fiber,GO:0001726~ruffle,GO:0005576~extracellular region,GO:0005604~basement membrane,GO:0005615~extracellular space,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005765~lysosomal membrane,GO:0005768~endosome,GO:0005769~early endosome,GO:0005811~lipid particle,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005938~cell cortex,GO:0009986~cell surface,GO:0016020~membrane,GO:0016323~basolateral plasma membrane,GO:0016363~nuclear matrix,GO:0030054~cell junction,GO:0030496~midbody,GO:0031902~late endosome membrane,GO:0031982~vesicle,GO:0032991~macromolecular complex,GO:0035749~myelin sheath adaxonal region,GO:0042383~sarcolemma,GO:0042470~melanosome,GO:0043220~Schmidt-Lanterman incisure,GO:0044354~macropinosome,GO:0045121~membrane raft,GO:0048471~perinuclear region of cytoplasm,GO:0070062~extracellular exosome,GO:0090575~RNA polymerase II transcription factor complex,GO:0098797~plasma membrane protein complex,GO:1990665~AnxA2-p11 complex,GO:1990667~PCSK9-AnxA2 complex,	GO:0001786~phosphatidylserine binding,GO:0002020~protease binding,GO:0004859~phospholipase inhibitor activity,GO:0004867~serine-type endopeptidase inhibitor activity,GO:0005262~calcium channel activity,GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0005544~calcium-dependent phospholipid binding,GO:0005546~phosphatidylinositol-4,5-bisphosphate binding,GO:0008092~cytoskeletal protein binding,GO:0019834~phospholipase A2 inhibitor activity,GO:0031267~small GTPase binding,GO:0042802~identical protein binding,GO:0044548~S100 protein binding,GO:0044730~bone sialoprotein binding,GO:0046790~virion binding,GO:0048306~calcium-dependent protein binding,	IPR001464:Annexin,IPR002389:ANX2,IPR018252:Annexin_repeat_CS,IPR018502:Annexin_repeat,IPR037104:Annexin_sf,	mmu05132:Salmonella infection,			SM00335:ANX,		KW-0084~Basement membrane,KW-0272~Extracellular matrix,KW-0964~Secreted,			KW-0041~Annexin,KW-0677~Repeat,	KW-0106~Calcium,KW-0111~Calcium/phospholipid-binding,		KW-0007~Acetylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate,REGION:S100A10-binding site,REPEAT:Annexin 1,REPEAT:Annexin 2,REPEAT:Annexin 3,REPEAT:Annexin 4,
P33703	apolipoprotein H(APOH)	Canis lupus familiaris			GO:0001937~negative regulation of endothelial cell proliferation,GO:0006641~triglyceride metabolic process,GO:0007597~blood coagulation, intrinsic pathway,GO:0010596~negative regulation of endothelial cell migration,GO:0016525~negative regulation of angiogenesis,GO:0030195~negative regulation of blood coagulation,GO:0031639~plasminogen activation,GO:0033033~negative regulation of myeloid cell apoptotic process,GO:0034392~negative regulation of smooth muscle cell apoptotic process,GO:0051918~negative regulation of fibrinolysis,	GO:0005576~extracellular region,GO:0009986~cell surface,GO:0034361~very-low-density lipoprotein particle,GO:0034364~high-density lipoprotein particle,GO:0042627~chylomicron,	GO:0005543~phospholipid binding,GO:0008201~heparin binding,GO:0042802~identical protein binding,GO:0060230~lipoprotein lipase activator activity,	IPR000436:Sushi_SCR_CCP_dom,IPR015104:Sushi_2,IPR035976:Sushi/SCR/CCP_sf,	cfa04979:Cholesterol metabolism,			SM00032:CCP,		KW-0964~Secreted,			KW-0677~Repeat,KW-0732~Signal,KW-0768~Sushi,		KW-0358~Heparin-binding,	KW-0325~Glycoprotein,KW-0449~Lipoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,CARBOHYD:O-linked (GalNAc...) threonine,DOMAIN:Sushi,DOMAIN:Sushi 1,DOMAIN:Sushi 2,DOMAIN:Sushi 3,DOMAIN:Sushi 4,REGION:Sushi-like,
Q9BUR5	apolipoprotein O(APOO)	Homo sapiens			GO:0006869~lipid transport,GO:0007007~inner mitochondrial membrane organization,GO:0042407~cristae formation,	GO:0000139~Golgi membrane,GO:0001401~mitochondrial sorting and assembly machinery complex,GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0005789~endoplasmic reticulum membrane,GO:0005829~cytosol,GO:0034361~very-low-density lipoprotein particle,GO:0034362~low-density lipoprotein particle,GO:0034364~high-density lipoprotein particle,GO:0044284~mitochondrial crista junction,GO:0061617~MICOS complex,	GO:0005515~protein binding,	IPR019166:MIC26/MIC27,IPR033182:MIC26/MIC27_animal,					KW-0445~Lipid transport,KW-0813~Transport,	KW-0256~Endoplasmic reticulum,KW-0333~Golgi apparatus,KW-0345~HDL,KW-0427~LDL,KW-0472~Membrane,KW-0496~Mitochondrion,KW-0850~VLDL,KW-0964~Secreted,KW-0999~Mitochondrion inner membrane,			KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0325~Glycoprotein,KW-0654~Proteoglycan,	CARBOHYD:O-linked (Xyl...) (chondroitin sulfate) serine,TRANSMEM:Helical,
O43315	aquaporin 9(AQP9)	Homo sapiens			GO:0006833~water transport,GO:0006863~purine nucleobase transport,GO:0015722~canalicular bile acid transport,GO:0015793~glycerol transport,GO:0015837~amine transport,GO:0015855~pyrimidine nucleobase transport,GO:0048265~response to pain,GO:0071320~cellular response to cAMP,GO:0071918~urea transmembrane transport,GO:0072531~pyrimidine-containing compound transmembrane transport,GO:1904823~purine nucleobase transmembrane transport,	GO:0005886~plasma membrane,GO:0016020~membrane,GO:0016323~basolateral plasma membrane,GO:0043231~intracellular membrane-bounded organelle,	GO:0005345~purine nucleobase transmembrane transporter activity,GO:0005350~pyrimidine nucleobase transmembrane transporter activity,GO:0005515~protein binding,GO:0015204~urea transmembrane transporter activity,GO:0015250~water channel activity,GO:0015254~glycerol channel activity,GO:0015265~urea channel activity,	IPR000425:MIP,IPR015685:Aquaporin_9,IPR022357:MIP_CS,IPR023271:Aquaporin-like,	hsa04613:Neutrophil extracellular trap formation,hsa04976:Bile secretion,				KW-0813~Transport,	KW-0472~Membrane,KW-1003~Cell membrane,			KW-0677~Repeat,KW-0812~Transmembrane,KW-1133~Transmembrane helix,				INTRAMEM:Discontinuously helical,MOTIF:NPA 1,MOTIF:NPA 2,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
D3ZKX9	arachidonate lipoxygenase 3(Aloxe3)	Rattus norvegicus			GO:0006665~sphingolipid metabolic process,GO:0019233~sensory perception of pain,GO:0019369~arachidonic acid metabolic process,GO:0019372~lipoxygenase pathway,GO:0034440~lipid oxidation,GO:0035357~peroxisome proliferator activated receptor signaling pathway,GO:0043651~linoleic acid metabolic process,GO:0045444~fat cell differentiation,GO:0046513~ceramide biosynthetic process,GO:0051122~hepoxilin biosynthetic process,GO:0061436~establishment of skin barrier,	GO:0005737~cytoplasm,	GO:0005506~iron ion binding,GO:0016702~oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen,GO:0050486~intramolecular transferase activity, transferring hydroxy groups,GO:0051120~hepoxilin A3 synthase activity,	IPR000907:LipOase,IPR001024:PLAT/LH2_dom,IPR001885:LipOase_mml,IPR013819:LipOase_C,IPR020833:LipOase_Fe_BS,IPR020834:LipOase_CS,IPR036226:LipOase_C_sf,IPR036392:PLAT/LH2_dom_sf,IPR042062:PLAT_LOX_verte,	rno00590:Arachidonic acid metabolism,rno01100:Metabolic pathways,			SM00308:LH2,	KW-0276~Fatty acid metabolism,KW-0443~Lipid metabolism,	KW-0963~Cytoplasm,				KW-0408~Iron,KW-0479~Metal-binding,	KW-0223~Dioxygenase,KW-0413~Isomerase,KW-0456~Lyase,KW-0560~Oxidoreductase,		DOMAIN:Lipoxygenase,DOMAIN:PLAT,
O77808	arginine vasopressin receptor 2(AVPR2)	Canis lupus familiaris			GO:0001992~regulation of systemic arterial blood pressure by vasopressin,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007249~I-kappaB kinase/NF-kappaB signaling,GO:0008285~negative regulation of cell proliferation,GO:0010628~positive regulation of gene expression,GO:0032870~cellular response to hormone stimulus,GO:0034097~response to cytokine,GO:0045907~positive regulation of vasoconstriction,	GO:0005768~endosome,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0030139~endocytic vesicle,GO:0048471~perinuclear region of cytoplasm,	GO:0005000~vasopressin receptor activity,GO:0042277~peptide binding,	IPR000161:Vprsn_rcpt_V2,IPR000276:GPCR_Rhodpsn,IPR001817:Vasoprsn_rcpt,IPR017452:GPCR_Rhodpsn_7TM,	cfa04072:Phospholipase D signaling pathway,cfa04080:Neuroactive ligand-receptor interaction,cfa04962:Vasopressin-regulated water reabsorption,					KW-0472~Membrane,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0297~G-protein coupled receptor,KW-0675~Receptor,KW-0807~Transducer,	KW-0325~Glycoprotein,KW-0449~Lipoprotein,KW-0564~Palmitate,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Polar residues,DOMAIN:G-protein coupled receptors family 1 profile,LIPID:S-palmitoyl cysteine,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,TRANSMEM:Helical; Name=1,TRANSMEM:Helical; Name=2,TRANSMEM:Helical; Name=3,TRANSMEM:Helical; Name=4,TRANSMEM:Helical; Name=5,TRANSMEM:Helical; Name=6,TRANSMEM:Helical; Name=7,
Q3ZBE1	armadillo repeat containing 1(ARMC1)	Bos taurus			GO:0048312~intracellular distribution of mitochondria,	GO:0005741~mitochondrial outer membrane,GO:0005829~cytosol,	GO:0005515~protein binding,GO:0046872~metal ion binding,	IPR000225:Armadillo,IPR011989:ARM-like,IPR016024:ARM-type_fold,IPR016617:ARMC1,IPR036163:HMA_dom_sf,			PIRSF013899:UCP013899,			KW-0472~Membrane,KW-0496~Mitochondrion,KW-0963~Cytoplasm,KW-1000~Mitochondrion outer membrane,						KW-0007~Acetylation,KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,REGION:Disordered,REPEAT:ARM,
Q3UJZ3	armadillo repeat containing 7(Armc7)	Mus musculus			GO:0006397~mRNA processing,GO:0008380~RNA splicing,	GO:0005681~spliceosomal complex,		IPR000225:Armadillo,IPR011989:ARM-like,IPR016024:ARM-type_fold,IPR042462:ARMC7,				SM00185:ARM,	KW-0507~mRNA processing,KW-0508~mRNA splicing,	KW-0747~Spliceosome,			KW-0677~Repeat,			KW-0597~Phosphoprotein,	REPEAT:ARM 1,REPEAT:ARM 2,
Q8TBH0	arrestin domain containing 2(ARRDC2)	Homo sapiens			GO:0015031~protein transport,	GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0031410~cytoplasmic vesicle,	GO:0005515~protein binding,	IPR011021:Arrestin-like_N,IPR011022:Arrestin_C-like,IPR014752:Arrestin-like_C,IPR014756:Ig_E-set,				SM01017:Arrestin_C,									DOMAIN:Arrestin C-terminal-like,
P51689	arylsulfatase D(ARSD)	Homo sapiens				GO:0005764~lysosome,GO:0005788~endoplasmic reticulum lumen,GO:0016020~membrane,	GO:0004065~arylsulfatase activity,GO:0008484~sulfuric ester hydrolase activity,GO:0046872~metal ion binding,	IPR000917:Sulfatase_N,IPR017850:Alkaline_phosphatase_core_sf,IPR024607:Sulfatase_CS,						KW-0458~Lysosome,KW-0472~Membrane,			KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0106~Calcium,KW-0479~Metal-binding,	KW-0378~Hydrolase,	KW-0325~Glycoprotein,	ACT_SITE:Nucleophile,BINDING:via 3-oxoalanine,CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Sulfatase N-terminal,TRANSMEM:Helical,
Q1LYL8	asteroid homolog 1a(aste1a)	Danio rerio						IPR026832:Asteroid,IPR029060:PIN-like_dom_sf,
Q9WU60	attractin(Atrn)	Mus musculus			GO:0006954~inflammatory response,GO:0006979~response to oxidative stress,GO:0021549~cerebellum development,GO:0040014~regulation of multicellular organism growth,GO:0042552~myelination,GO:0043473~pigmentation,	GO:0005615~extracellular space,GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0016020~membrane,	GO:0003682~chromatin binding,GO:0005515~protein binding,GO:0030246~carbohydrate binding,GO:0038023~signaling receptor activity,	IPR000742:EGF-like_dom,IPR000859:CUB_dom,IPR001304:C-type_lectin-like,IPR002049:LE_dom,IPR002165:Plexin_repeat,IPR006652:Kelch_1,IPR011043:Gal_Oxase/kelch_b-propeller,IPR015915:Kelch-typ_b-propeller,IPR016186:C-type_lectin-like/link_sf,IPR016187:CTDL_fold,IPR016201:PSI,IPR035914:Sperma_CUB_dom_sf,				SM00034:CLECT,SM00042:CUB,SM00180:EGF_Lam,SM00181:EGF,SM00423:PSI,	KW-0395~Inflammatory response,	KW-0472~Membrane,KW-1003~Cell membrane,			KW-0245~EGF-like domain,KW-0424~Laminin EGF-like domain,KW-0677~Repeat,KW-0732~Signal,KW-0812~Transmembrane,KW-0880~Kelch repeat,KW-1133~Transmembrane helix,	KW-0430~Lectin,	KW-0675~Receptor,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:C-type lectin,DOMAIN:CUB,DOMAIN:EGF-like,DOMAIN:Laminin EGF-like,DOMAIN:Laminin EGF-like 1,DOMAIN:Laminin EGF-like 2,DOMAIN:PSI 1,DOMAIN:PSI 2,DOMAIN:PSI 3,DOMAIN:PSI 4,REGION:Disordered,REPEAT:Kelch 1,REPEAT:Kelch 2,REPEAT:Kelch 3,REPEAT:Kelch 4,REPEAT:Kelch 5,REPEAT:Kelch 6,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q6NW76	aurora kinase B(aurkb)	Danio rerio			GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0000226~microtubule cytoskeleton organization,GO:0000281~mitotic cytokinesis,GO:0002903~negative regulation of B cell apoptotic process,GO:0006468~protein phosphorylation,GO:0007052~mitotic spindle organization,GO:0007059~chromosome segregation,GO:0009838~abscission,GO:0016310~phosphorylation,GO:0032465~regulation of cytokinesis,GO:0032466~negative regulation of cytokinesis,GO:0032467~positive regulation of cytokinesis,GO:0034501~protein localization to kinetochore,GO:0034644~cellular response to UV,GO:0036089~cleavage furrow formation,GO:0043687~post-translational protein modification,GO:0044878~mitotic cytokinesis checkpoint,GO:0051256~mitotic spindle midzone assembly,	GO:0000775~chromosome, centromeric region,GO:0000776~kinetochore,GO:0005634~nucleus,GO:0005694~chromosome,GO:0005737~cytoplasm,GO:0005856~cytoskeleton,GO:0005876~spindle microtubule,GO:0030496~midbody,GO:0031616~spindle pole centrosome,GO:0032133~chromosome passenger complex,GO:0051233~spindle midzone,	GO:0000166~nucleotide binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005524~ATP binding,GO:0016301~kinase activity,GO:0016740~transferase activity,	IPR000719:Prot_kinase_dom,IPR008271:Ser/Thr_kinase_AS,IPR011009:Kinase-like_dom_sf,IPR017441:Protein_kinase_ATP_BS,IPR030616:Aur-like,	dre03083:Polycomb repressive complex,dre04110:Cell cycle,			SM00220:S_TKc,	KW-0159~Chromosome partition,	KW-0137~Centromere,KW-0158~Chromosome,KW-0206~Cytoskeleton,KW-0539~Nucleus,KW-0963~Cytoplasm,				KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0217~Developmental protein,KW-0418~Kinase,KW-0723~Serine/threonine-protein kinase,KW-0808~Transferase,KW-9996~Developmental protein,		ACT_SITE:Proton acceptor,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),DOMAIN:Protein kinase,REGION:Disordered,
F1QW76	basic leucine zipper transcription factor, ATF-like(batf)	Danio rerio			GO:0001819~positive regulation of cytokine production,GO:0002320~lymphoid progenitor cell differentiation,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006974~cellular response to DNA damage stimulus,GO:0030154~cell differentiation,GO:0030330~DNA damage response, signal transduction by p53 class mediator,GO:0042832~defense response to protozoan,GO:0043011~myeloid dendritic cell differentiation,GO:0045064~T-helper 2 cell differentiation,GO:0045190~isotype switching,GO:0060218~hematopoietic stem cell differentiation,GO:0072539~T-helper 17 cell differentiation,GO:0072540~T-helper 17 cell lineage commitment,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0043565~sequence-specific DNA binding,	IPR000837:AP-1,IPR004827:bZIP,IPR046347:bZIP_sf,				SM00338:BRLZ,	KW-0221~Differentiation,KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,KW-0963~Cytoplasm,					KW-0010~Activator,KW-0238~DNA-binding,KW-0678~Repressor,		COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:BZIP,DOMAIN:bZIP,REGION:Basic motif,REGION:Disordered,REGION:Leucine-zipper,
Q67FY3	bcl9 like(bcl9l)	Danio rerio			GO:0030512~negative regulation of transforming growth factor beta receptor signaling pathway,GO:0036342~post-anal tail morphogenesis,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048368~lateral mesoderm development,GO:0060070~canonical Wnt signaling pathway,	GO:0005634~nucleus,GO:1990907~beta-catenin-TCF complex,	GO:0003713~transcription coactivator activity,GO:0008013~beta-catenin binding,	IPR013083:Znf_RING/FYVE/PHD,IPR015668:Bcl-9/Bcl-9l,IPR024670:BCL9_beta-catenin-bd_dom,					KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,					KW-0010~Activator,KW-0217~Developmental protein,KW-9996~Developmental protein,		COMPBIAS:Polar residues,DOMAIN:B-cell lymphoma 9 beta-catenin binding,REGION:Disordered,
Q6Y288	beta 3-glucosyltransferase(B3GLCT)	Homo sapiens			GO:0006004~fucose metabolic process,GO:0036066~protein O-linked fucosylation,	GO:0005789~endoplasmic reticulum membrane,	GO:0008375~acetylglucosaminyltransferase activity,GO:0016757~transferase activity, transferring glycosyl groups,	IPR003378:Fringe-like,IPR029044:Nucleotide-diphossugar_trans,	hsa00514:Other types of O-glycan biosynthesis,	261540~Peters-plus syndrome,			KW-0119~Carbohydrate metabolism,KW-0294~Fucose metabolism,	KW-0256~Endoplasmic reticulum,KW-0472~Membrane,		KW-0242~Dwarfism,KW-0900~Congenital disorder of glycosylation,	KW-0735~Signal-anchor,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0328~Glycosyltransferase,KW-0808~Transferase,	KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,MOTIF:Prevents secretion from ER,MUTAGEN:Missing: Abolishes endoplasmic reticulum localization.,TOPO_DOM:Cytoplasmic,TOPO_DOM:Lumenal,TRANSMEM:Helical; Signal-anchor for type II membrane protein,
O43825	beta-1,3-galactosyltransferase 2(B3GALT2)	Homo sapiens		h_aMANpathway:Steps in the Glycosylation of Mammalian N-linked Oligosaccarides,	GO:0006486~protein glycosylation,GO:0006493~protein O-linked glycosylation,GO:0006682~galactosylceramide biosynthetic process,GO:0009312~oligosaccharide biosynthetic process,	GO:0000139~Golgi membrane,GO:0016020~membrane,	GO:0008499~UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity,GO:0047275~glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity,	IPR002659:Glyco_trans_31,IPR045821:B3GT2_N,	hsa00601:Glycosphingolipid biosynthesis - lacto and neolacto series,hsa01100:Metabolic pathways,				KW-0443~Lipid metabolism,	KW-0333~Golgi apparatus,KW-0472~Membrane,			KW-0735~Signal-anchor,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0464~Manganese,	KW-0328~Glycosyltransferase,KW-0808~Transferase,	KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Lumenal,TRANSMEM:Helical; Signal-anchor for type II membrane protein,
Q32LQ4	betaine-homocysteine methyltransferase(bhmt)	Danio rerio			GO:0003323~type B pancreatic cell development,GO:0006579~amino-acid betaine catabolic process,GO:0009086~methionine biosynthetic process,GO:0032259~methylation,GO:0055123~digestive system development,GO:0071267~L-methionine salvage,	GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0008168~methyltransferase activity,GO:0008270~zinc ion binding,GO:0016740~transferase activity,GO:0046872~metal ion binding,GO:0047150~betaine-homocysteine S-methyltransferase activity,	IPR003726:HCY_dom,IPR017226:Betaine-hCys_S-MeTrfase_BHMT,IPR036589:HCY_dom_sf,	dre00260:Glycine, serine and threonine metabolism,dre00270:Cysteine and methionine metabolism,dre01100:Metabolic pathways,		PIRSF037505:Betaine_HMT,			KW-0963~Cytoplasm,				KW-0479~Metal-binding,KW-0862~Zinc,	KW-0489~Methyltransferase,KW-0808~Transferase,		DOMAIN:Hcy-binding,
Q3SZZ0	biogenesis of ribosomes BRX1(BRIX1)	Bos taurus			GO:0000027~ribosomal large subunit assembly,GO:0006364~rRNA processing,	GO:0005694~chromosome,GO:0005730~nucleolus,	GO:0003723~RNA binding,GO:0019843~rRNA binding,	IPR007109:Brix,IPR026532:BRX1,				SM00879:Brix,	KW-0690~Ribosome biogenesis,	KW-0539~Nucleus,						KW-0007~Acetylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Basic and acidic residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),DOMAIN:Brix,REGION:Disordered,
Q02930	cAMP responsive element binding protein 5(CREB5)	Homo sapiens			GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0045893~positive regulation of transcription, DNA-templated,	GO:0000785~chromatin,GO:0005634~nucleus,GO:0070062~extracellular exosome,	GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0035497~cAMP response element binding,GO:0042802~identical protein binding,GO:0046872~metal ion binding,GO:1990837~sequence-specific double-stranded DNA binding,	IPR004827:bZIP,IPR013087:Znf_C2H2_type,IPR016378:TF_CRE-BP1-typ,IPR036236:Znf_C2H2_sf,IPR046347:bZIP_sf,	hsa04022:cGMP-PKG signaling pathway,hsa04024:cAMP signaling pathway,hsa04151:PI3K-Akt signaling pathway,hsa04152:AMPK signaling pathway,hsa04211:Longevity regulating pathway,hsa04261:Adrenergic signaling in cardiomyocytes,hsa04668:TNF signaling pathway,hsa04714:Thermogenesis,hsa04725:Cholinergic synapse,hsa04728:Dopaminergic synapse,hsa04911:Insulin secretion,hsa04915:Estrogen signaling pathway,hsa04918:Thyroid hormone synthesis,hsa04922:Glucagon signaling pathway,hsa04925:Aldosterone synthesis and secretion,hsa04926:Relaxin signaling pathway,hsa04927:Cortisol synthesis and secretion,hsa04928:Parathyroid hormone synthesis, secretion and action,hsa04931:Insulin resistance,hsa04934:Cushing syndrome,hsa04935:Growth hormone synthesis, secretion and action,hsa04962:Vasopressin-regulated water reabsorption,hsa05016:Huntington disease,hsa05020:Prion disease,hsa05030:Cocaine addiction,hsa05031:Amphetamine addiction,hsa05034:Alcoholism,hsa05161:Hepatitis B,hsa05163:Human cytomegalovirus infection,hsa05165:Human papillomavirus infection,hsa05166:Human T-cell leukemia virus 1 infection,hsa05203:Viral carcinogenesis,hsa05207:Chemical carcinogenesis - receptor activation,hsa05215:Prostate cancer,		PIRSF003153:ATF2_CRE-BP1,	SM00338:BRLZ,	KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,			KW-0175~Coiled coil,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0010~Activator,KW-0238~DNA-binding,	KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Basic and acidic residues,COMPBIAS:Basic residues,COMPBIAS:Polar residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),DOMAIN:BZIP,DOMAIN:C2H2-type,DOMAIN:bZIP,REGION:Basic motif,REGION:Disordered,REGION:Leucine-zipper,ZN_FING:C2H2-type,
P33146	cadherin 15(Cdh15)	Mus musculus			GO:0000902~cell morphogenesis,GO:0007043~cell-cell junction assembly,GO:0007155~cell adhesion,GO:0007156~homophilic cell adhesion via plasma membrane adhesion molecules,GO:0007275~multicellular organism development,GO:0016339~calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules,GO:0034332~adherens junction organization,GO:0044331~cell-cell adhesion mediated by cadherin,GO:0098609~cell-cell adhesion,	GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0005901~caveola,GO:0005912~adherens junction,GO:0016020~membrane,GO:0016342~catenin complex,GO:0031594~neuromuscular junction,	GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0045296~cadherin binding,GO:0046872~metal ion binding,	IPR000233:Cadherin_Y-type_LIR,IPR002126:Cadherin-like_dom,IPR015919:Cadherin-like_sf,IPR020894:Cadherin_CS,IPR027397:Catenin-bd_sf,IPR039808:Cadherin,	mmu04514:Cell adhesion molecules,			SM00112:CA,	KW-0130~Cell adhesion,	KW-0472~Membrane,KW-1003~Cell membrane,			KW-0677~Repeat,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0106~Calcium,KW-0479~Metal-binding,		KW-0165~Cleavage on pair of basic residues,KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Cadherin 1,DOMAIN:Cadherin 2,DOMAIN:Cadherin 3,DOMAIN:Cadherin 4,DOMAIN:Cadherin 5,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
O88338	cadherin 16(Cdh16)	Mus musculus			GO:0007155~cell adhesion,GO:0007156~homophilic cell adhesion via plasma membrane adhesion molecules,GO:0016339~calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules,GO:0098609~cell-cell adhesion,	GO:0005886~plasma membrane,GO:0016020~membrane,GO:0016323~basolateral plasma membrane,	GO:0005509~calcium ion binding,GO:0046872~metal ion binding,	IPR002126:Cadherin-like_dom,IPR015919:Cadherin-like_sf,IPR039808:Cadherin,				SM00112:CA,	KW-0130~Cell adhesion,	KW-0472~Membrane,KW-1003~Cell membrane,			KW-0677~Repeat,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0106~Calcium,KW-0479~Metal-binding,		KW-0325~Glycoprotein,KW-0597~Phosphoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Polar residues,DOMAIN:Cadherin,DOMAIN:Cadherin 1,DOMAIN:Cadherin 2,DOMAIN:Cadherin 3,DOMAIN:Cadherin 4,DOMAIN:Cadherin 5,DOMAIN:Cadherin 6,REGION:Disordered,REGION:Ectodomain G,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
A4D0V7	cadherin like and PC-esterase domain containing 1(CPED1)	Homo sapiens				GO:0005783~endoplasmic reticulum,		IPR025883:Cadherin-like_b_sandwich,									KW-0732~Signal,			KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Cadherin-like beta sandwich,REGION:Disordered,
O18737	calcium binding and coiled-coil domain 2(CALCOCO2)	Bos taurus			GO:0034341~response to interferon-gamma,GO:0098792~xenophagy,GO:1901098~positive regulation of autophagosome maturation,	GO:0000421~autophagosome membrane,GO:0005776~autophagosome,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0016605~PML body,GO:0031410~cytoplasmic vesicle,GO:0048471~perinuclear region of cytoplasm,	GO:0042803~protein homodimerization activity,GO:0046872~metal ion binding,	IPR041611:SKICH,IPR041641:CALCOCO1/2_Zn_UBZ1,	bta04137:Mitophagy - animal,bta04140:Autophagy - animal,bta05164:Influenza A,				KW-0072~Autophagy,	KW-0206~Cytoskeleton,KW-0472~Membrane,KW-0963~Cytoplasm,KW-0968~Cytoplasmic vesicle,			KW-0175~Coiled coil,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,			DOMAIN:UBZ1-type,MOTIF:CLIR,MOTIF:LIR-like,REGION:Interaction with LGALS8,REGION:Interaction with MYO6,ZN_FING:UBZ1-type,
Q9NP86	calcium binding protein 5(CABP5)	Homo sapiens			GO:0007165~signal transduction,	GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0005246~calcium channel regulator activity,GO:0005509~calcium ion binding,GO:0005515~protein binding,	IPR002048:EF_hand_dom,IPR011992:EF-hand-dom_pair,IPR018247:EF_Hand_1_Ca_BS,IPR043582:CaBP1/2/4/5,				SM00054:EFh,		KW-0963~Cytoplasm,			KW-0677~Repeat,	KW-0106~Calcium,KW-0479~Metal-binding,			DOMAIN:EF-hand 1,DOMAIN:EF-hand 2,DOMAIN:EF-hand 3,DOMAIN:EF-hand 4,
Q5RJF7	calcium channel, voltage-dependent, alpha 2/delta subunit 4(Cacna2d4)	Mus musculus			GO:0006811~ion transport,GO:0006816~calcium ion transport,GO:0034220~ion transmembrane transport,GO:0050908~detection of light stimulus involved in visual perception,GO:0070588~calcium ion transmembrane transport,	GO:0005891~voltage-gated calcium channel complex,GO:0016020~membrane,GO:0034702~ion channel complex,	GO:0005245~voltage-gated calcium channel activity,GO:0005262~calcium channel activity,GO:0046872~metal ion binding,	IPR002035:VWF_A,IPR013608:VWA_N,IPR013680:VDCC_a2/dsu,IPR036465:vWFA_dom_sf,	mmu04010:MAPK signaling pathway,mmu04260:Cardiac muscle contraction,mmu04261:Adrenergic signaling in cardiomyocytes,mmu04921:Oxytocin signaling pathway,mmu05410:Hypertrophic cardiomyopathy,mmu05412:Arrhythmogenic right ventricular cardiomyopathy,mmu05414:Dilated cardiomyopathy,			SM00327:VWA,	KW-0109~Calcium transport,KW-0406~Ion transport,KW-0813~Transport,	KW-0472~Membrane,		KW-0182~Cone-rod dystrophy,	KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0106~Calcium,KW-0479~Metal-binding,	KW-0107~Calcium channel,KW-0407~Ion channel,KW-0851~Voltage-gated channel,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DISULFID:Interchain (between alpha-2-4 and delta-4 chains),DOMAIN:Cache,DOMAIN:VWFA,DOMAIN:Voltage-dependent calcium channel alpha-2/delta subunit conserved region,MOTIF:MIDAS-like motif,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q561R8	calcium homeostasis modulator family member 6(Calhm6)	Rattus norvegicus			GO:0098655~cation transmembrane transport,	GO:0016020~membrane,	GO:0005261~cation channel activity,	IPR029569:CALHM,					KW-0406~Ion transport,KW-0813~Transport,	KW-0472~Membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0407~Ion channel,		TRANSMEM:Helical,
B0K012	calmodulin-lysine N-methyltransferase(Camkmt)	Rattus norvegicus			GO:0007005~mitochondrion organization,GO:0032259~methylation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0032991~macromolecular complex,	GO:0018025~calmodulin-lysine N-methyltransferase activity,GO:0031072~heat shock protein binding,	IPR019410:Methyltransf_16,IPR025800:CaM-Lys-N-MeTrfase,IPR029063:SAM-dependent_MTases_sf,	rno00310:Lysine degradation,rno01100:Metabolic pathways,					KW-0539~Nucleus,KW-0963~Cytoplasm,				KW-0949~S-adenosyl-L-methionine,	KW-0489~Methyltransferase,KW-0808~Transferase,		REGION:Disordered,
Q15417	calponin 3(CNN3)	Homo sapiens			GO:0007015~actin filament organization,GO:0030855~epithelial cell differentiation,GO:0031032~actomyosin structure organization,GO:0098609~cell-cell adhesion,	GO:0005829~cytosol,GO:0005912~adherens junction,GO:0005925~focal adhesion,GO:0015629~actin cytoskeleton,	GO:0003779~actin binding,GO:0005516~calmodulin binding,GO:0051015~actin filament binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR000557:Calponin_repeat,IPR001715:CH_dom,IPR001997:Calponin/LIMCH1,IPR003096:SM22_calponin,IPR036872:CH_dom_sf,				SM00033:CH,					KW-0677~Repeat,		KW-0009~Actin-binding,KW-0112~Calmodulin-binding,	KW-0007~Acetylation,KW-0488~Methylation,KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:Calponin-homology (CH),REGION:Disordered,REPEAT:Calponin-like 1,REPEAT:Calponin-like 2,REPEAT:Calponin-like 3,
B5X186	calumenin-A-like(LOC106576025)	Salmo salar				GO:0005576~extracellular region,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005794~Golgi apparatus,GO:0033018~sarcoplasmic reticulum lumen,GO:0042470~melanosome,	GO:0005509~calcium ion binding,	IPR002048:EF_hand_dom,IPR011992:EF-hand-dom_pair,IPR018247:EF_Hand_1_Ca_BS,				SM00054:EFh,		KW-0256~Endoplasmic reticulum,KW-0333~Golgi apparatus,KW-0472~Membrane,KW-0703~Sarcoplasmic reticulum,KW-0964~Secreted,			KW-0677~Repeat,KW-0732~Signal,	KW-0106~Calcium,KW-0479~Metal-binding,		KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:EF-hand,DOMAIN:EF-hand 1,DOMAIN:EF-hand 2,DOMAIN:EF-hand 3,DOMAIN:EF-hand 4,DOMAIN:EF-hand 5,DOMAIN:EF-hand 6,MOTIF:Prevents secretion from ER,
Q2L6L1	canopy FGF signaling regulator 1(cnpy1)	Danio rerio			GO:0007368~determination of left/right symmetry,GO:0008543~fibroblast growth factor receptor signaling pathway,GO:0030917~midbrain-hindbrain boundary development,GO:0040036~regulation of fibroblast growth factor receptor signaling pathway,GO:0070121~Kupffer's vesicle development,	GO:0005783~endoplasmic reticulum,		IPR021852:DUF3456,IPR042415:CNPY,						KW-0256~Endoplasmic reticulum,			KW-0732~Signal,		KW-0217~Developmental protein,KW-9996~Developmental protein,	KW-1015~Disulfide bond,	DOMAIN:DUF3456,DOMAIN:Saposin B-type,MOTIF:Prevents secretion from ER,MUTAGEN:HSEL->KDEL: Does not abolish endoplasmic reticulum localization.,MUTAGEN:Missing: Abolishes endoplasmic reticulum localization.,
Q8BK48	carboxylesterase 2E(Ces2e)	Mus musculus			GO:0006693~prostaglandin metabolic process,	GO:0005783~endoplasmic reticulum,GO:0043231~intracellular membrane-bounded organelle,	GO:0016787~hydrolase activity,GO:0047376~all-trans-retinyl-palmitate hydrolase, all-trans-retinol forming activity,GO:0050253~retinyl-palmitate esterase activity,GO:0052689~carboxylic ester hydrolase activity,GO:0102209~trans-permethrin hydrolase activity,	IPR002018:CarbesteraseB,IPR019819:Carboxylesterase_B_CS,IPR019826:Carboxylesterase_B_AS,IPR029058:AB_hydrolase,	mmu00983:Drug metabolism - other enzymes,					KW-0256~Endoplasmic reticulum,KW-0492~Microsome,			KW-0732~Signal,		KW-0378~Hydrolase,KW-0719~Serine esterase,	KW-0325~Glycoprotein,KW-0597~Phosphoprotein,KW-0873~Pyrrolidone carboxylic acid,KW-1015~Disulfide bond,	ACT_SITE:Acyl-ester intermediate,ACT_SITE:Charge relay system,CARBOHYD:N-linked (GlcNAc...) asparagine,
Q5U2V5	cardiolipin synthase 1(Crls1)	Rattus norvegicus			GO:0008654~phospholipid biosynthetic process,GO:0032049~cardiolipin biosynthetic process,GO:0097068~response to thyroxine,GO:1905711~response to phosphatidylethanolamine,	GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0016020~membrane,GO:0031966~mitochondrial membrane,	GO:0016780~phosphotransferase activity, for other substituted phosphate groups,GO:0043337~CDP-diacylglycerol-phosphatidylglycerol phosphatidyltransferase activity,	IPR000462:CDP-OH_P_trans,IPR043130:CDP-OH_PTrfase_TM_dom,	rno00564:Glycerophospholipid metabolism,rno01100:Metabolic pathways,				KW-0443~Lipid metabolism,KW-0444~Lipid biosynthesis,KW-0594~Phospholipid biosynthesis,KW-1208~Phospholipid metabolism,	KW-0472~Membrane,KW-0496~Mitochondrion,KW-0999~Mitochondrion inner membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0808~Transferase,		REGION:Disordered,TRANSMEM:Helical,
Q9PT92	catalase(cat)	Danio rerio			GO:0006979~response to oxidative stress,GO:0042542~response to hydrogen peroxide,GO:0042744~hydrogen peroxide catabolic process,GO:0046688~response to copper ion,	GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005777~peroxisome,	GO:0004096~catalase activity,GO:0004601~peroxidase activity,GO:0016491~oxidoreductase activity,GO:0020037~heme binding,GO:0046872~metal ion binding,	IPR002226:Catalase_haem_BS,IPR010582:Catalase_immune_responsive,IPR011614:Catalase_core,IPR018028:Catalase,IPR020835:Catalase_sf,IPR024708:Catalase_AS,IPR024711:Catalase_clade1/3,IPR040333:Catalase_3,	dre00380:Tryptophan metabolism,dre00630:Glyoxylate and dicarboxylate metabolism,dre01100:Metabolic pathways,dre01200:Carbon metabolism,dre04068:FoxO signaling pathway,dre04146:Peroxisome,		PIRSF038928:Catalase_clade1-3,	SM01060:Catalase,	KW-0376~Hydrogen peroxide,	KW-0576~Peroxisome,				KW-0349~Heme,KW-0408~Iron,KW-0479~Metal-binding,KW-0521~NADP,	KW-0560~Oxidoreductase,KW-0575~Peroxidase,		BINDING:axial binding residue,COMPBIAS:Basic and acidic residues,DOMAIN:Catalase core,REGION:Disordered,
O46427	cathepsin H(CTSH)	Sus scrofa			GO:0001656~metanephros development,GO:0001913~T cell mediated cytotoxicity,GO:0002764~immune response-regulating signaling pathway,GO:0006508~proteolysis,GO:0006955~immune response,GO:0008284~positive regulation of cell proliferation,GO:0010628~positive regulation of gene expression,GO:0010634~positive regulation of epithelial cell migration,GO:0010813~neuropeptide catabolic process,GO:0010815~bradykinin catabolic process,GO:0010952~positive regulation of peptidase activity,GO:0030335~positive regulation of cell migration,GO:0031638~zymogen activation,GO:0031648~protein destabilization,GO:0032526~response to retinoic acid,GO:0033619~membrane protein proteolysis,GO:0043066~negative regulation of apoptotic process,GO:0043129~surfactant homeostasis,GO:0045766~positive regulation of angiogenesis,GO:0051603~proteolysis involved in cellular protein catabolic process,GO:0060448~dichotomous subdivision of terminal units involved in lung branching,GO:0070371~ERK1 and ERK2 cascade,GO:0097067~cellular response to thyroid hormone stimulus,GO:2001235~positive regulation of apoptotic signaling pathway,	GO:0005615~extracellular space,GO:0005764~lysosome,GO:0005829~cytosol,GO:0036464~cytoplasmic ribonucleoprotein granule,GO:0097208~alveolar lamellar body,	GO:0004175~endopeptidase activity,GO:0004177~aminopeptidase activity,GO:0004197~cysteine-type endopeptidase activity,GO:0004252~serine-type endopeptidase activity,GO:0008234~cysteine-type peptidase activity,GO:0008656~cysteine-type endopeptidase activator activity involved in apoptotic process,GO:0030108~HLA-A specific activating MHC class I receptor activity,GO:0070324~thyroid hormone binding,	IPR000169:Pept_cys_AS,IPR000668:Peptidase_C1A_C,IPR013128:Peptidase_C1A,IPR013201:Prot_inhib_I29,IPR025660:Pept_his_AS,IPR025661:Pept_asp_AS,IPR038765:Papain-like_cys_pep_sf,IPR039417:Peptidase_C1A_papain-like,	ssc04142:Lysosome,ssc04210:Apoptosis,			SM00645:Pept_C1,SM00848:Inhibitor_I29,		KW-0458~Lysosome,			KW-0732~Signal,		KW-0378~Hydrolase,KW-0645~Protease,KW-0788~Thiol protease,	KW-0325~Glycoprotein,KW-0865~Zymogen,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Cathepsin propeptide inhibitor,DOMAIN:Peptidase C1A papain C-terminal,PEPTIDE:Cathepsin H mini chain,REGION:Disordered,
P70232	cell adhesion molecule L1-like(Chl1)	Mus musculus			GO:0001764~neuron migration,GO:0007155~cell adhesion,GO:0007275~multicellular organism development,GO:0007399~nervous system development,GO:0007411~axon guidance,GO:0008344~adult locomotory behavior,GO:0030154~cell differentiation,GO:0031103~axon regeneration,GO:0031175~neuron projection development,GO:0035640~exploration behavior,GO:0043524~negative regulation of neuron apoptotic process,GO:0050890~cognition,	GO:0005576~extracellular region,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0030425~dendrite,GO:0045177~apical part of cell,	GO:0002020~protease binding,GO:0005515~protein binding,	IPR003598:Ig_sub2,IPR003599:Ig_sub,IPR003961:FN3_dom,IPR007110:Ig-like_dom,IPR013098:Ig_I-set,IPR013783:Ig-like_fold,IPR026966:Neurofascin/L1/NrCAM_C,IPR036116:FN3_sf,IPR036179:Ig-like_dom_sf,IPR043204:Basigin-like,				SM00060:FN3,SM00408:IGc2,SM00409:IG,	KW-0130~Cell adhesion,KW-0221~Differentiation,KW-0524~Neurogenesis,	KW-0272~Extracellular matrix,KW-0472~Membrane,KW-0964~Secreted,KW-1003~Cell membrane,			KW-0393~Immunoglobulin domain,KW-0677~Repeat,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0217~Developmental protein,KW-9996~Developmental protein,	KW-0325~Glycoprotein,KW-0597~Phosphoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Basic and acidic residues,DOMAIN:Fibronectin type-III,DOMAIN:Fibronectin type-III 1,DOMAIN:Fibronectin type-III 2,DOMAIN:Fibronectin type-III 3,DOMAIN:Fibronectin type-III 4,DOMAIN:Ig-like,DOMAIN:Ig-like C2-type 1,DOMAIN:Ig-like C2-type 2,DOMAIN:Ig-like C2-type 3,DOMAIN:Ig-like C2-type 4,DOMAIN:Ig-like C2-type 5,DOMAIN:Ig-like C2-type 6,MOTIF:DGEA,MOTIF:FIG[AQ]Y,MUTAGEN:DGEA->AGEV: Inhibition of migration potentiation.,MUTAGEN:Y->A: Inhibition of migration potentiation.,REGION:Disordered,SITE:Cleavage; by ADAM8,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
A0A0R4IVA4	cell division cycle 14Ab(cdc14ab)	Danio rerio			GO:0000226~microtubule cytoskeleton organization,GO:0007049~cell cycle,GO:0007096~regulation of exit from mitosis,GO:0016311~dephosphorylation,GO:0032467~positive regulation of cytokinesis,GO:0051301~cell division,GO:0060271~cilium assembly,	GO:0000922~spindle pole,GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005856~cytoskeleton,GO:0042995~cell projection,GO:0043227~membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0060091~kinocilium,GO:0072686~mitotic spindle,	GO:0004721~phosphoprotein phosphatase activity,GO:0004722~protein serine/threonine phosphatase activity,GO:0004725~protein tyrosine phosphatase activity,GO:0008138~protein tyrosine/serine/threonine phosphatase activity,GO:0016787~hydrolase activity,GO:0016791~phosphatase activity,GO:0017018~myosin phosphatase activity,	IPR000340:Dual-sp_phosphatase_cat-dom,IPR000387:Tyr_Pase_dom,IPR016130:Tyr_Pase_AS,IPR020422:TYR_PHOSPHATASE_DUAL_dom,IPR029021:Prot-tyrosine_phosphatase-like,IPR029260:DSPn,IPR044506:CDC14_C,	dre04110:Cell cycle,			SM00195:DSPc,	KW-0131~Cell cycle,KW-0132~Cell division,	KW-0206~Cytoskeleton,KW-0539~Nucleus,KW-0963~Cytoplasm,KW-0966~Cell projection,					KW-0378~Hydrolase,KW-0904~Protein phosphatase,	KW-0597~Phosphoprotein,	ACT_SITE:Phosphocysteine intermediate,COMPBIAS:Polar residues,DOMAIN:Tyrosine specific protein phosphatases,DOMAIN:Tyrosine-protein phosphatase,REGION:A,REGION:B,REGION:Disordered,REGION:Linker,
Q9YHZ6	cell division cycle 45 L homeolog(cdc45.L)	Xenopus laevis			GO:0006260~DNA replication,GO:0006270~DNA replication initiation,GO:0007049~cell cycle,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0071162~CMG complex,	GO:0003682~chromatin binding,GO:0005515~protein binding,	IPR003874:CDC45,	xla04110:Cell cycle,				KW-0131~Cell cycle,KW-0235~DNA replication,	KW-0158~Chromosome,KW-0539~Nucleus,							COMPBIAS:Acidic residues,REGION:Disordered,
Q9D0M2	cell division cycle associated 7(Cdca7)	Mus musculus			GO:0006355~regulation of transcription, DNA-templated,GO:0006915~apoptotic process,GO:0042127~regulation of cell proliferation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,		IPR018866:Znf-4CXXC_R1,IPR040221:CDCA7/CDA7L,					KW-0053~Apoptosis,KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,KW-0963~Cytoplasm,						KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Acidic residues,COMPBIAS:Basic and acidic residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),MOTIF:Nuclear localization signal,REGION:Disordered,REGION:Interaction with MYC,REGION:Mediates transcriptional activity,
Q5XLR4	cell division cycle associated 8(cdca8)	Danio rerio			GO:0000070~mitotic sister chromatid segregation,GO:0007049~cell cycle,GO:0007507~heart development,GO:0051301~cell division,	GO:0000775~chromosome, centromeric region,GO:0005634~nucleus,GO:0005694~chromosome,GO:0005737~cytoplasm,GO:0005856~cytoskeleton,GO:0032133~chromosome passenger complex,GO:0051233~spindle midzone,		IPR018851:Borealin_N,IPR018867:Cell_div_borealin,IPR046466:Borealin_C,					KW-0131~Cell cycle,KW-0132~Cell division,KW-0498~Mitosis,	KW-0137~Centromere,KW-0158~Chromosome,KW-0206~Cytoskeleton,KW-0539~Nucleus,KW-0963~Cytoplasm,							COMPBIAS:Polar residues,DOMAIN:Borealin C-terminal,DOMAIN:Borealin N-terminal,REGION:Disordered,
P86347	cell division cycle associated 9(cdca9)	Danio rerio			GO:0000070~mitotic sister chromatid segregation,GO:0007049~cell cycle,GO:0051301~cell division,	GO:0000775~chromosome, centromeric region,GO:0005634~nucleus,GO:0032133~chromosome passenger complex,GO:0051233~spindle midzone,		IPR018851:Borealin_N,IPR018867:Cell_div_borealin,					KW-0131~Cell cycle,KW-0132~Cell division,KW-0498~Mitosis,	KW-0137~Centromere,KW-0158~Chromosome,KW-0539~Nucleus,							COMPBIAS:Polar residues,DOMAIN:Borealin N-terminal,REGION:Disordered,
Q8BGC9	cellular repressor of E1A-stimulated genes 2(Creg2)	Mus musculus				GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005783~endoplasmic reticulum,GO:0005794~Golgi apparatus,		IPR012349:Split_barrel_FMN-bd,IPR014631:CREG,			PIRSF036911:CREG,			KW-0964~Secreted,			KW-0732~Signal,			KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,MUTAGEN:N->Q: Abolishes N-glycosylation.,MUTAGEN:N->Q: N-glycosylated.,MUTAGEN:NSTGIPFFYMTAKDPAVADLVKN->QSTGIPFFYMTAKDPAVADLVKQ: Abolishes N-glycosylation.,REGION:Disordered,
Q02224	centromere protein E(CENPE)	Homo sapiens			GO:0000278~mitotic cell cycle,GO:0007018~microtubule-based movement,GO:0007052~mitotic spindle organization,GO:0007059~chromosome segregation,GO:0007079~mitotic chromosome movement towards spindle pole,GO:0007080~mitotic metaphase plate congression,GO:0030071~regulation of mitotic metaphase/anaphase transition,GO:0045860~positive regulation of protein kinase activity,GO:0051301~cell division,GO:0051310~metaphase plate congression,GO:0051315~attachment of mitotic spindle microtubules to kinetochore,GO:0051382~kinetochore assembly,GO:0099606~microtubule plus-end directed mitotic chromosome migration,GO:0099607~lateral attachment of mitotic spindle microtubules to kinetochore,	GO:0000775~chromosome, centromeric region,GO:0000776~kinetochore,GO:0000779~condensed chromosome, centromeric region,GO:0005634~nucleus,GO:0005694~chromosome,GO:0005828~kinetochore microtubule,GO:0005829~cytosol,GO:0005874~microtubule,GO:0015630~microtubule cytoskeleton,GO:0016020~membrane,GO:0030496~midbody,GO:0043231~intracellular membrane-bounded organelle,GO:0045171~intercellular bridge,GO:0051233~spindle midzone,GO:0072686~mitotic spindle,GO:1990023~mitotic spindle midzone,	GO:0003777~microtubule motor activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008017~microtubule binding,GO:0043515~kinetochore binding,	IPR001752:Kinesin_motor_dom,IPR019821:Kinesin_motor_CS,IPR027417:P-loop_NTPase,IPR027640:Kinesin-like_fam,IPR036961:Kinesin_motor_dom_sf,	hsa04814:Motor proteins,	616051~Microcephaly 13, primary, autosomal recessive,		SM00129:KISc,	KW-0131~Cell cycle,KW-0132~Cell division,KW-0498~Mitosis,	KW-0137~Centromere,KW-0158~Chromosome,KW-0206~Cytoskeleton,KW-0493~Microtubule,KW-0963~Cytoplasm,KW-0995~Kinetochore,		KW-0225~Disease variant,KW-0905~Primary microcephaly,	KW-0175~Coiled coil,	KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0217~Developmental protein,KW-0505~Motor protein,KW-9996~Developmental protein,	KW-0449~Lipoprotein,KW-0488~Methylation,KW-0597~Phosphoprotein,KW-0636~Prenylation,KW-0832~Ubl conjugation,	COMPBIAS:Polar residues,DOMAIN:Kinesin motor,LIPID:S-farnesyl cysteine,PROPEP:Removed in mature form,REGION:Disordered,REGION:Globular autoinhibitory domain,REGION:Kinetochore-binding domain,
Q8AYS7	centromere protein I(CENPI)	Gallus gallus			GO:0000070~mitotic sister chromatid segregation,GO:0034080~CENP-A containing nucleosome assembly,GO:0034508~centromere complex assembly,	GO:0000776~kinetochore,GO:0000939~condensed chromosome inner kinetochore,GO:0005634~nucleus,		IPR012485:CENP-I,						KW-0137~Centromere,KW-0158~Chromosome,KW-0539~Nucleus,							COMPBIAS:Basic residues,COMPBIAS:Polar residues,REGION:Disordered,
Q6DRD4	centromere protein L(cenpl)	Danio rerio				GO:0000775~chromosome, centromeric region,GO:0005634~nucleus,GO:0005694~chromosome,		IPR025204:CENP-L,						KW-0137~Centromere,KW-0158~Chromosome,KW-0539~Nucleus,							REGION:Disordered,
Q8N8E3	centrosomal protein 112(CEP112)	Homo sapiens			GO:0097120~receptor localization to synapse,	GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005886~plasma membrane,GO:0060077~inhibitory synapse,	GO:0005515~protein binding,	IPR027831:DUF4485,		619044~Spermatogenic failure 44,				KW-0206~Cytoskeleton,KW-0963~Cytoplasm,		KW-0225~Disease variant,	KW-0175~Coiled coil,				DOMAIN:DUF4485,
O94986	centrosomal protein 152(CEP152)	Homo sapiens			GO:0007099~centriole replication,GO:0030030~cell projection organization,GO:0051298~centrosome duplication,GO:0098535~de novo centriole assembly involved in multi-ciliated epithelial cell differentiation,	GO:0000242~pericentriolar material,GO:0005654~nucleoplasm,GO:0005813~centrosome,GO:0005814~centriole,GO:0005829~cytosol,GO:0098536~deuterosome,	GO:0005515~protein binding,GO:0019901~protein kinase binding,			613823~Seckel syndrome 5,614852~Microcephaly 9, primary, autosomal recessive,			KW-0970~Cilium biogenesis/degradation,	KW-0206~Cytoskeleton,KW-0963~Cytoplasm,		KW-0225~Disease variant,KW-0242~Dwarfism,KW-0905~Primary microcephaly,KW-0991~Intellectual disability,	KW-0175~Coiled coil,			KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,MUTAGEN:E->K: Impairs interaction with PLK4; impaired procentriole assembly and chromosome segregation.,REGION:Disordered,REGION:Interaction with PLK4,
Q9Z265	checkpoint kinase 2(Chek2)	Mus musculus		m_atmPathway:ATM Signaling Pathway,m_atrbrcaPathway:Role of BRCA1,  BRCA2 and ATR in Cancer Susceptibility,	GO:0000077~DNA damage checkpoint,GO:0000085~mitotic G2 phase,GO:0000086~G2/M transition of mitotic cell cycle,GO:0001934~positive regulation of protein phosphorylation,GO:0006281~DNA repair,GO:0006302~double-strand break repair,GO:0006355~regulation of transcription, DNA-templated,GO:0006468~protein phosphorylation,GO:0006915~apoptotic process,GO:0006974~cellular response to DNA damage stimulus,GO:0006978~DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,GO:0007049~cell cycle,GO:0008630~intrinsic apoptotic signaling pathway in response to DNA damage,GO:0010332~response to gamma radiation,GO:0016310~phosphorylation,GO:0018105~peptidyl-serine phosphorylation,GO:0030163~protein catabolic process,GO:0031573~intra-S DNA damage checkpoint,GO:0042176~regulation of protein catabolic process,GO:0042770~signal transduction in response to DNA damage,GO:0042771~intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,GO:0044773~mitotic DNA damage checkpoint,GO:0045893~positive regulation of transcription, DNA-templated,GO:0046777~protein autophosphorylation,GO:0050821~protein stabilization,GO:0051301~cell division,GO:0070242~thymocyte apoptotic process,GO:0071480~cellular response to gamma radiation,GO:0090307~mitotic spindle assembly,GO:2000002~negative regulation of DNA damage checkpoint,GO:2000210~positive regulation of anoikis,	GO:0000781~chromosome, telomeric region,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0016605~PML body,	GO:0000166~nucleotide binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005524~ATP binding,GO:0016301~kinase activity,GO:0016740~transferase activity,GO:0019901~protein kinase binding,GO:0031625~ubiquitin protein ligase binding,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,GO:0046872~metal ion binding,	IPR000253:FHA_dom,IPR000719:Prot_kinase_dom,IPR008271:Ser/Thr_kinase_AS,IPR008984:SMAD_FHA_dom_sf,IPR011009:Kinase-like_dom_sf,	mmu04110:Cell cycle,mmu04115:p53 signaling pathway,mmu04218:Cellular senescence,mmu05166:Human T-cell leukemia virus 1 infection,			SM00220:S_TKc,SM00240:FHA,	KW-0053~Apoptosis,KW-0131~Cell cycle,KW-0132~Cell division,KW-0227~DNA damage,KW-0234~DNA repair,KW-0498~Mitosis,KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,				KW-0067~ATP-binding,KW-0460~Magnesium,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,	KW-0418~Kinase,KW-0723~Serine/threonine-protein kinase,KW-0808~Transferase,	KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,	ACT_SITE:Proton acceptor,COMPBIAS:Polar residues,DOMAIN:FHA,DOMAIN:Protein kinase,MUTAGEN:Y->C: Does not inhibit cell survival upon DNA damage. Not phosphorylates p53/TP53.,REGION:Disordered,REGION:T-loop/activation segment,
Q95LH1	chemerin chemokine-like receptor 2(CMKLR2)	Macaca fascicularis			GO:0002430~complement receptor mediated signaling pathway,GO:0006954~inflammatory response,GO:0007200~phospholipase C-activating G-protein coupled receptor signaling pathway,GO:0007204~positive regulation of cytosolic calcium ion concentration,GO:0042593~glucose homeostasis,	GO:0005654~nucleoplasm,GO:0005886~plasma membrane,	GO:0004875~complement receptor activity,GO:0004930~G-protein coupled receptor activity,GO:0097003~adipokinetic hormone receptor activity,GO:0097004~adipokinetic hormone binding,	IPR000276:GPCR_Rhodpsn,IPR000826:Formyl_rcpt-rel,IPR002275:CML2,IPR017452:GPCR_Rhodpsn_7TM,						KW-0472~Membrane,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0297~G-protein coupled receptor,KW-0675~Receptor,KW-0807~Transducer,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:G-protein coupled receptors family 1 profile,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,TRANSMEM:Helical; Name=1,TRANSMEM:Helical; Name=2,TRANSMEM:Helical; Name=3,TRANSMEM:Helical; Name=4,TRANSMEM:Helical; Name=5,TRANSMEM:Helical; Name=6,TRANSMEM:Helical; Name=7,
Q6RY07	chitinase, acidic(Chia)	Rattus norvegicus			GO:0000272~polysaccharide catabolic process,GO:0002376~immune system process,GO:0002532~production of molecular mediator involved in inflammatory response,GO:0005975~carbohydrate metabolic process,GO:0006032~chitin catabolic process,GO:0006915~apoptotic process,GO:0006955~immune response,GO:0032722~positive regulation of chemokine production,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005737~cytoplasm,GO:0016020~membrane,	GO:0004568~chitinase activity,GO:0005129~granulocyte macrophage colony-stimulating factor receptor binding,GO:0008061~chitin binding,GO:0008083~growth factor activity,GO:0019900~kinase binding,	IPR000773:GM_colony-stim-fac,IPR001223:Glyco_hydro18_cat,IPR001579:Glyco_hydro_18_chit_AS,IPR002557:Chitin-bd_dom,IPR009079:4_helix_cytokine-like_core,IPR011583:Chitinase_II,IPR017853:Glycoside_hydrolase_SF,IPR029070:Chitinase_insertion_sf,IPR036508:Chitin-bd_dom_sf,	rno00520:Amino sugar and nucleotide sugar metabolism,rno01100:Metabolic pathways,			SM00040:CSF2,SM00494:ChtBD2,SM00636:Glyco_18,	KW-0053~Apoptosis,KW-0119~Carbohydrate metabolism,KW-0146~Chitin degradation,KW-0391~Immunity,KW-0395~Inflammatory response,KW-0624~Polysaccharide degradation,	KW-0472~Membrane,KW-0963~Cytoplasm,KW-0964~Secreted,			KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0147~Chitin-binding,	KW-0326~Glycosidase,KW-0378~Hydrolase,	KW-1015~Disulfide bond,	ACT_SITE:Proton donor,COMPBIAS:Polar residues,DOMAIN:Chitin-binding type-2,DOMAIN:GH18,REGION:Disordered,TRANSMEM:Helical,
Q63931	cholecystokinin A receptor(Cckar)	Cavia porcellus			GO:0001764~neuron migration,GO:0007218~neuropeptide signaling pathway,GO:0007409~axonogenesis,GO:0030900~forebrain development,	GO:0005654~nucleoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,	GO:0004951~cholecystokinin receptor activity,GO:0008188~neuropeptide receptor activity,GO:0017046~peptide hormone binding,	IPR000276:GPCR_Rhodpsn,IPR000596:Cholcy_rcpt_A,IPR009126:Cholcskin_rcpt,IPR015276:CholecystokininA_recpt_N,IPR017452:GPCR_Rhodpsn_7TM,IPR036472:CholecystokininA_recpt_N_sf,	cpoc04020:Calcium signaling pathway,cpoc04080:Neuroactive ligand-receptor interaction,cpoc04911:Insulin secretion,cpoc04972:Pancreatic secretion,			SM01381:7TM_GPCR_Srsx,		KW-0472~Membrane,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0297~G-protein coupled receptor,KW-0675~Receptor,KW-0807~Transducer,	KW-0325~Glycoprotein,KW-0449~Lipoprotein,KW-0564~Palmitate,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,LIPID:S-palmitoyl cysteine,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical; Name=1,TRANSMEM:Helical; Name=2,TRANSMEM:Helical; Name=3,TRANSMEM:Helical; Name=4,TRANSMEM:Helical; Name=5,TRANSMEM:Helical; Name=6,TRANSMEM:Helical; Name=7,
P41984	cholinergic receptor muscarinic 3(CHRM3)	Bos taurus			GO:0003056~regulation of vascular smooth muscle contraction,GO:0007187~G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger,GO:0007197~adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway,GO:0007268~chemical synaptic transmission,GO:0045987~positive regulation of smooth muscle contraction,GO:0046541~saliva secretion,GO:0071880~adenylate cyclase-activating adrenergic receptor signaling pathway,	GO:0005789~endoplasmic reticulum membrane,GO:0005886~plasma membrane,GO:0016323~basolateral plasma membrane,GO:0016328~lateral plasma membrane,GO:0030425~dendrite,GO:0045202~synapse,GO:0045211~postsynaptic membrane,	GO:0004930~G-protein coupled receptor activity,GO:0004993~G-protein coupled serotonin receptor activity,GO:0016907~G-protein coupled acetylcholine receptor activity,	IPR000276:GPCR_Rhodpsn,IPR000995:Musac_Ach_rcpt,IPR001183:Musac_Ach_M3_rcpt,IPR017452:GPCR_Rhodpsn_7TM,	bta04020:Calcium signaling pathway,bta04080:Neuroactive ligand-receptor interaction,bta04725:Cholinergic synapse,bta04742:Taste transduction,bta04810:Regulation of actin cytoskeleton,bta04911:Insulin secretion,bta04970:Salivary secretion,bta04971:Gastric acid secretion,bta04972:Pancreatic secretion,bta05010:Alzheimer disease,bta05022:Pathways of neurodegeneration - multiple diseases,			SM01381:7TM_GPCR_Srsx,		KW-0256~Endoplasmic reticulum,KW-0472~Membrane,KW-0628~Postsynaptic cell membrane,KW-0770~Synapse,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0297~G-protein coupled receptor,KW-0675~Receptor,KW-0807~Transducer,	KW-0325~Glycoprotein,KW-0597~Phosphoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Polar residues,DOMAIN:G-protein coupled receptors family 1 profile,MOTIF:Basolateral sorting signal,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,TRANSMEM:Helical; Name=1,TRANSMEM:Helical; Name=2,TRANSMEM:Helical; Name=3,TRANSMEM:Helical; Name=4,TRANSMEM:Helical; Name=5,TRANSMEM:Helical; Name=6,TRANSMEM:Helical; Name=7,
Q9D0N7	chromatin assembly factor 1, subunit B(Chaf1b)	Mus musculus			GO:0006260~DNA replication,GO:0006281~DNA repair,GO:0006334~nucleosome assembly,GO:0006335~DNA replication-dependent nucleosome assembly,GO:0006974~cellular response to DNA damage stimulus,GO:0007049~cell cycle,	GO:0000785~chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0032991~macromolecular complex,GO:0033186~CAF-1 complex,	GO:0005515~protein binding,	IPR001632:Gprotein_B,IPR001680:WD40_rpt,IPR015943:WD40/YVTN_repeat-like_dom_sf,IPR019775:WD40_repeat_CS,IPR029129:CAF1_p60_C,IPR036322:WD40_repeat_dom_sf,IPR045145:PTHR15271,				SM00320:WD40,	KW-0131~Cell cycle,KW-0227~DNA damage,KW-0234~DNA repair,KW-0235~DNA replication,KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0677~Repeat,KW-0853~WD repeat,			KW-0007~Acetylation,KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,REGION:Disordered,REPEAT:WD,REPEAT:WD 1,REPEAT:WD 2,REPEAT:WD 3,REPEAT:WD 4,REPEAT:WD 5,REPEAT:WD 6,REPEAT:WD 7,
Q5R6X7	chromobox 3(CBX3)	Pongo abelii			GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006325~chromatin organization,GO:0006974~cellular response to DNA damage stimulus,GO:0045892~negative regulation of transcription, DNA-templated,GO:0048511~rhythmic process,	GO:0000779~condensed chromosome, centromeric region,GO:0000785~chromatin,GO:0000791~euchromatin,GO:0000792~heterochromatin,GO:0005634~nucleus,GO:0005635~nuclear envelope,GO:0005721~pericentric heterochromatin,GO:0005819~spindle,GO:0090734~site of DNA damage,	GO:0003682~chromatin binding,GO:0019904~protein domain specific binding,GO:0035064~methylated histone binding,	IPR000953:Chromo/chromo_shadow_dom,IPR008251:Chromo_shadow_dom,IPR016197:Chromo-like_dom_sf,IPR017984:Chromo_dom_subgr,IPR023779:Chromodomain_CS,IPR023780:Chromo_domain,IPR038033:CBX3_chromo_domain,	pon03083:Polycomb repressive complex,			SM00298:CHROMO,SM00300:ChSh,	KW-0090~Biological rhythms,KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,			KW-0677~Repeat,		KW-0156~Chromatin regulator,KW-0678~Repressor,	KW-0007~Acetylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Basic and acidic residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate,DOMAIN:Chromo,DOMAIN:Chromo 1,DOMAIN:Chromo 2; shadow subtype,REGION:Disordered,
Q9QXV1	chromobox 8(Cbx8)	Mus musculus			GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006325~chromatin organization,GO:0008284~positive regulation of cell proliferation,GO:0031507~heterochromatin assembly,GO:0032967~positive regulation of collagen biosynthetic process,GO:0045739~positive regulation of DNA repair,GO:0070301~cellular response to hydrogen peroxide,	GO:0000785~chromatin,GO:0000792~heterochromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0031519~PcG protein complex,GO:0035102~PRC1 complex,	GO:0003682~chromatin binding,GO:0003727~single-stranded RNA binding,GO:0005515~protein binding,GO:0035064~methylated histone binding,GO:0097027~ubiquitin-protein transferase activator activity,	IPR000953:Chromo/chromo_shadow_dom,IPR016197:Chromo-like_dom_sf,IPR023779:Chromodomain_CS,IPR023780:Chromo_domain,IPR033773:CBX7_C,	mmu03083:Polycomb repressive complex,			SM00298:CHROMO,	KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0158~Chromosome,KW-0539~Nucleus,					KW-0156~Chromatin regulator,KW-0678~Repressor,	KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:Chromo,REGION:Disordered,
Q3L8U1	chromodomain helicase DNA binding protein 9(CHD9)	Homo sapiens			GO:0006338~chromatin remodeling,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005829~cytosol,	GO:0003677~DNA binding,GO:0004386~helicase activity,GO:0005524~ATP binding,GO:0016787~hydrolase activity,GO:0016887~ATPase activity,	IPR000330:SNF2_N,IPR000953:Chromo/chromo_shadow_dom,IPR001650:Helicase_C,IPR006576:BRK_domain,IPR014001:Helicase_ATP-bd,IPR016197:Chromo-like_dom_sf,IPR023780:Chromo_domain,IPR027417:P-loop_NTPase,IPR037259:BRK_sf,IPR038718:SNF2-like_sf,				SM00298:CHROMO,SM00487:DEXDc,SM00490:HELICc,SM00592:BRK,	KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0677~Repeat,	KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0156~Chromatin regulator,KW-0238~DNA-binding,KW-0347~Helicase,KW-0378~Hydrolase,	KW-0007~Acetylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),DOMAIN:BRK,DOMAIN:Chromo,DOMAIN:Chromo 1,DOMAIN:Chromo 2,DOMAIN:Helicase ATP-binding,DOMAIN:Helicase C-terminal,MOTIF:DEAH box,MOTIF:LXXLL motif 1,MOTIF:LXXLL motif 2,MOTIF:LXXLL motif 3,MOTIF:LXXLL motif 4,MOTIF:LXXLL motif 5,REGION:A.T hook-like,REGION:Binds A/T-rich DNA,REGION:Disordered,
Q0VCL9	chromosome 1 C3orf38 homolog(C1H3orf38)	Bos taurus			GO:0006915~apoptotic process,GO:0043065~positive regulation of apoptotic process,	GO:0005634~nucleus,		IPR026698:UPF_C3orf38,IPR032710:NTF2-like_dom_sf,					KW-0053~Apoptosis,								COMPBIAS:Polar residues,REGION:Disordered,
Q8IXR9	chromosome 12 open reading frame 56(C12orf56)	Homo sapiens						IPR027878:DUF4551,													COMPBIAS:Polar residues,REGION:Disordered,
A4FUB0	chromosome 20 C5orf34 homolog(C20H5orf34)	Bos taurus						IPR027830:DUF4524,IPR027865:DUF4520,													DOMAIN:DUF4520,DOMAIN:DUF4524,
Q0II29	chromosome 7 C5orf24 homolog(C7H5orf24)	Bos taurus						IPR040419:DUF5568,												KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Polar residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),REGION:Disordered,
Q9BRJ6	chromosome 7 open reading frame 50(C7orf50)	Homo sapiens					GO:0003723~RNA binding,GO:0005515~protein binding,	IPR019327:WKF,												KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,DOMAIN:WKF,REGION:Disordered,
P0CG11	chromosome transmission fidelity factor 8(CHTF8)	Bos taurus			GO:0006260~DNA replication,GO:0007064~mitotic sister chromatid cohesion,GO:0032508~DNA duplex unwinding,GO:1900264~positive regulation of DNA-directed DNA polymerase activity,	GO:0031390~Ctf18 RFC-like complex,	GO:0003677~DNA binding,	IPR018607:Ctf8,					KW-0131~Cell cycle,KW-0235~DNA replication,	KW-0539~Nucleus,					KW-0238~DNA-binding,
Q7M3E1	chymotrypsin C(CTRC)	Bos taurus			GO:0006508~proteolysis,GO:0006874~cellular calcium ion homeostasis,	GO:0005615~extracellular space,GO:0016020~membrane,	GO:0004252~serine-type endopeptidase activity,	IPR001254:Trypsin_dom,IPR001314:Peptidase_S1A,IPR009003:Peptidase_S1_PA,IPR018114:TRYPSIN_HIS,IPR033116:TRYPSIN_SER,IPR043504:Peptidase_S1_PA_chymotrypsin,				SM00020:Tryp_SPc,		KW-0472~Membrane,KW-0964~Secreted,			KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0378~Hydrolase,KW-0645~Protease,KW-0720~Serine protease,	KW-0325~Glycoprotein,KW-0865~Zymogen,KW-1015~Disulfide bond,	ACT_SITE:Charge relay system,CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Peptidase S1,PROPEP:Activation peptide,REGION:Disordered,TRANSMEM:Helical,
Q6DRC3	cilia and flagella associated protein 298(cfap298)	Danio rerio			GO:0003352~regulation of cilium movement,GO:0007368~determination of left/right symmetry,GO:0044458~motile cilium assembly,GO:0048793~pronephros development,GO:0060271~cilium assembly,GO:0061524~central canal development,GO:0072114~pronephros morphogenesis,GO:0090660~cerebrospinal fluid circulation,	GO:0005576~extracellular region,GO:0005737~cytoplasm,GO:0005856~cytoskeleton,GO:0005929~cilium,GO:0042995~cell projection,		IPR021298:CFAP298,						KW-0206~Cytoskeleton,KW-0963~Cytoplasm,KW-0966~Cell projection,KW-0969~Cilium,							MUTAGEN:I->N: In tm304; temperature sensitive allele with strongest phenotypes at 32 degrees Celsius and milder phenotypes at 25 degrees Celsius. Body curvature defects and kidney cysts are seen in larval stages. Left-right asymmetry is abnormal with reversed or random positioning of heart, liver and pancreas. Males are infertile. Cilium length and number are unaffected. Initiation of cilium motility is impaired, and cilium outer dynein arms are absent. Cilium polarity is disorganized.,
Q96MR6	cilia and flagella associated protein 57(CFAP57)	Homo sapiens						IPR001680:WD40_rpt,IPR011047:Quinoprotein_ADH-like_supfam,IPR015943:WD40/YVTN_repeat-like_dom_sf,IPR036322:WD40_repeat_dom_sf,				SM00320:WD40,					KW-0175~Coiled coil,KW-0677~Repeat,KW-0853~WD repeat,				REPEAT:WD,REPEAT:WD 1,REPEAT:WD 10,REPEAT:WD 2,REPEAT:WD 3,REPEAT:WD 4,REPEAT:WD 5,REPEAT:WD 6,REPEAT:WD 7,REPEAT:WD 8,REPEAT:WD 9,
B1H283	ciliary microtubule associated protein 2(Cimap2)	Rattus norvegicus			GO:0008284~positive regulation of cell proliferation,GO:1903862~positive regulation of oxidative phosphorylation,	GO:0005739~mitochondrion,	GO:0097177~mitochondrial ribosome binding,	IPR010736:SHIPPO-rpt,IPR033557:CIMAP2,
Q66JN8	ciliogenesis and planar polarity effector 2(cplane2)	Danio rerio			GO:0006887~exocytosis,GO:0008104~protein localization,GO:0015031~protein transport,GO:0017157~regulation of exocytosis,GO:0030030~cell projection organization,GO:0031338~regulation of vesicle fusion,GO:0060271~cilium assembly,	GO:0005737~cytoplasm,GO:0005856~cytoskeleton,GO:0005929~cilium,GO:0036064~ciliary basal body,GO:0042995~cell projection,	GO:0000166~nucleotide binding,GO:0003924~GTPase activity,GO:0005525~GTP binding,	IPR001806:Small_GTPase,IPR027417:P-loop_NTPase,IPR039677:RSG1,				SM00175:RAB,	KW-0268~Exocytosis,KW-0653~Protein transport,KW-0813~Transport,KW-0970~Cilium biogenesis/degradation,	KW-0206~Cytoskeleton,KW-0963~Cytoplasm,KW-0966~Cell projection,KW-0969~Cilium,				KW-0342~GTP-binding,KW-0547~Nucleotide-binding,			REGION:Small GTPase-like,
Q2KIY2	claudin 15(CLDN15)	Bos taurus			GO:0006811~ion transport,GO:0007155~cell adhesion,GO:0070830~bicellular tight junction assembly,	GO:0005886~plasma membrane,GO:0005923~bicellular tight junction,	GO:0005198~structural molecule activity,	IPR004031:PMP22/EMP/MP20/Claudin,IPR006187:Claudin,IPR008094:Claudin15,IPR017974:Claudin_CS,	bta04514:Cell adhesion molecules,bta04530:Tight junction,bta04670:Leukocyte transendothelial migration,bta05160:Hepatitis C,				KW-0406~Ion transport,KW-0813~Transport,	KW-0472~Membrane,KW-0796~Tight junction,KW-0965~Cell junction,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0449~Lipoprotein,KW-0564~Palmitate,KW-0597~Phosphoprotein,KW-1015~Disulfide bond,	REGION:Important for the formation of tight-junction strand-like structures,SITE:Important for Na(+)-selective paracellular ion transport,SITE:Important for the formation of tight-junction strand-like structures,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q2HJ22	claudin 5(CLDN5)	Bos taurus			GO:0007155~cell adhesion,GO:0070830~bicellular tight junction assembly,	GO:0005886~plasma membrane,GO:0005923~bicellular tight junction,	GO:0005198~structural molecule activity,	IPR003551:Claudin5,IPR004031:PMP22/EMP/MP20/Claudin,IPR006187:Claudin,IPR017974:Claudin_CS,	bta04514:Cell adhesion molecules,bta04530:Tight junction,bta04670:Leukocyte transendothelial migration,bta05160:Hepatitis C,					KW-0472~Membrane,KW-0796~Tight junction,KW-0965~Cell junction,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,				REGION:Interactions with TJP1, TJP2 and TJP3,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
P25155	coagulation factor X(F10)	Gallus gallus			GO:0006508~proteolysis,GO:0007596~blood coagulation,GO:0032008~positive regulation of TOR signaling,	GO:0005576~extracellular region,GO:0005615~extracellular space,	GO:0004252~serine-type endopeptidase activity,GO:0005509~calcium ion binding,GO:0005543~phospholipid binding,	IPR000152:EGF-type_Asp/Asn_hydroxyl_site,IPR000294:GLA_domain,IPR000742:EGF-like_dom,IPR001254:Trypsin_dom,IPR001314:Peptidase_S1A,IPR001881:EGF-like_Ca-bd_dom,IPR009003:Peptidase_S1_PA,IPR009030:Growth_fac_rcpt_cys_sf,IPR012224:Pept_S1A_FX,IPR017857:Coagulation_fac-like_Gla_dom,IPR018097:EGF_Ca-bd_CS,IPR018114:TRYPSIN_HIS,IPR033116:TRYPSIN_SER,IPR035972:GLA-like_dom_SF,IPR043504:Peptidase_S1_PA_chymotrypsin,			PIRSF001143:Factor_X,	SM00020:Tryp_SPc,SM00069:GLA,SM00179:EGF_CA,SM00181:EGF,	KW-0094~Blood coagulation,KW-0356~Hemostasis,	KW-0964~Secreted,			KW-0245~EGF-like domain,KW-0677~Repeat,KW-0732~Signal,	KW-0106~Calcium,	KW-0378~Hydrolase,KW-0645~Protease,KW-0720~Serine protease,	KW-0165~Cleavage on pair of basic residues,KW-0301~Gamma-carboxyglutamic acid,KW-0325~Glycoprotein,KW-0379~Hydroxylation,KW-0865~Zymogen,KW-1015~Disulfide bond,	ACT_SITE:Charge relay system,CARBOHYD:N-linked (GlcNAc...) asparagine,DISULFID:Interchain (between light and heavy chains),DOMAIN:EGF-like,DOMAIN:EGF-like 1; calcium-binding,DOMAIN:EGF-like 2,DOMAIN:Gla,DOMAIN:Peptidase S1,PROPEP:Activation peptide,REGION:Disordered,
Q9BQI4	coiled-coil domain containing 3(CCDC3)	Homo sapiens			GO:0008610~lipid biosynthetic process,GO:0010629~negative regulation of gene expression,GO:0010804~negative regulation of tumor necrosis factor-mediated signaling pathway,GO:0045600~positive regulation of fat cell differentiation,GO:0045833~negative regulation of lipid metabolic process,GO:0046889~positive regulation of lipid biosynthetic process,GO:0051055~negative regulation of lipid biosynthetic process,	GO:0005576~extracellular region,GO:0005783~endoplasmic reticulum,		IPR040311:CCDC3,						KW-0964~Secreted,			KW-0175~Coiled coil,KW-0732~Signal,			KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,
Q6DFC2	coiled-coil domain containing 77 L homeolog(ccdc77.L)	Xenopus laevis						IPR037696:CCDC77,									KW-0175~Coiled coil,				COMPBIAS:Polar residues,REGION:Disordered,
A2CEM9	coiled-coil domain containing 85B(ccdc85b)	Danio rerio			GO:0001843~neural tube closure,GO:0045892~negative regulation of transcription, DNA-templated,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005856~cytoskeleton,GO:0005912~adherens junction,GO:0070161~anchoring junction,		IPR019359:CCDC85,						KW-0206~Cytoskeleton,KW-0539~Nucleus,KW-0963~Cytoplasm,KW-0965~Cell junction,			KW-0175~Coiled coil,				REGION:Disordered,
Q8SPI2	coiled-coil-helix-coiled-coil-helix domain containing 7(CHCHD7)	Macaca fascicularis				GO:0005758~mitochondrial intermembrane space,		IPR009069:Cys_alpha_HP_mot_SF,IPR048280:COX6B-like,						KW-0496~Mitochondrion,						KW-1015~Disulfide bond,	DOMAIN:CHCH,MOTIF:Cx9C motif 1,MOTIF:Cx9C motif 2,
Q9DED4	cold inducible RNA binding protein S homeolog(cirbp.S)	Xenopus laevis			GO:0007369~gastrulation,GO:0009409~response to cold,GO:0009792~embryo development ending in birth or egg hatching,GO:0016477~cell migration,GO:0022008~neurogenesis,GO:0045727~positive regulation of translation,GO:0048255~mRNA stabilization,GO:0048793~pronephros development,GO:0060212~negative regulation of nuclear-transcribed mRNA poly(A) tail shortening,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,	GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0003729~mRNA binding,GO:0003730~mRNA 3'-UTR binding,GO:0005515~protein binding,GO:0019899~enzyme binding,GO:0043022~ribosome binding,	IPR000504:RRM_dom,IPR003954:RRM_dom_euk,IPR012677:Nucleotide-bd_a/b_plait_sf,IPR034278:RBM3/CIRBP_RRM,IPR035979:RBD_domain_sf,				SM00360:RRM,SM00361:RRM_1,	KW-0346~Stress response,	KW-0539~Nucleus,KW-0963~Cytoplasm,					KW-0217~Developmental protein,KW-0694~RNA-binding,KW-9996~Developmental protein,	KW-0488~Methylation,	COMPBIAS:Polar residues,DOMAIN:RRM,REGION:Disordered,
Q5RF83	cold inducible RNA binding protein(CIRBP)	Pongo abelii			GO:0009411~response to UV,GO:0030308~negative regulation of cell growth,GO:0034063~stress granule assembly,GO:0045727~positive regulation of translation,GO:0048026~positive regulation of mRNA splicing, via spliceosome,GO:0048255~mRNA stabilization,GO:0070417~cellular response to cold,GO:1902806~regulation of cell cycle G1/S phase transition,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005681~spliceosomal complex,GO:0005737~cytoplasm,GO:0010494~cytoplasmic stress granule,	GO:0003723~RNA binding,GO:0003730~mRNA 3'-UTR binding,GO:0008266~poly(U) RNA binding,GO:0030371~translation repressor activity,GO:0070181~small ribosomal subunit rRNA binding,	IPR000504:RRM_dom,IPR003954:RRM_dom_euk,IPR012677:Nucleotide-bd_a/b_plait_sf,IPR034278:RBM3/CIRBP_RRM,IPR035979:RBD_domain_sf,				SM00360:RRM,SM00361:RRM_1,	KW-0346~Stress response,	KW-0539~Nucleus,KW-0963~Cytoplasm,					KW-0694~RNA-binding,	KW-0597~Phosphoprotein,	COMPBIAS:Polar residues,DOMAIN:RRM,REGION:Disordered,
Q00780	collagen, type VIII, alpha 1(Col8a1)	Mus musculus			GO:0001525~angiogenesis,GO:0001935~endothelial cell proliferation,GO:0007155~cell adhesion,GO:0010811~positive regulation of cell-substrate adhesion,GO:0030198~extracellular matrix organization,GO:0035987~endodermal cell differentiation,GO:0048593~camera-type eye morphogenesis,	GO:0005576~extracellular region,GO:0005581~collagen trimer,GO:0005604~basement membrane,GO:0005615~extracellular space,	GO:0030020~extracellular matrix structural constituent conferring tensile strength,	IPR001073:C1q_dom,IPR008160:Collagen,IPR008983:Tumour_necrosis_fac-like_dom,	mmu04974:Protein digestion and absorption,			SM00110:C1Q,	KW-0037~Angiogenesis,KW-0130~Cell adhesion,	KW-0084~Basement membrane,KW-0272~Extracellular matrix,KW-0964~Secreted,			KW-0176~Collagen,KW-0677~Repeat,KW-0732~Signal,			KW-0379~Hydroxylation,	COMPBIAS:Pro residues,DOMAIN:C1q,REGION:Disordered,REGION:Nonhelical region (NC1),REGION:Nonhelical region (NC2),REGION:Triple-helical region (COL1),
Q641F3	collagen, type XXI, alpha 1 L homeolog(col21a1.L)	Xenopus laevis				GO:0005576~extracellular region,GO:0005581~collagen trimer,GO:0005737~cytoplasm,		IPR002035:VWF_A,IPR008160:Collagen,IPR013320:ConA-like_dom_sf,IPR036465:vWFA_dom_sf,IPR048287:TSPN-like_N,				SM00210:TSPN,SM00327:VWA,		KW-0272~Extracellular matrix,KW-0963~Cytoplasm,KW-0964~Secreted,			KW-0176~Collagen,KW-0677~Repeat,KW-0732~Signal,				COMPBIAS:Basic and acidic residues,DOMAIN:Collagen-like 1,DOMAIN:Collagen-like 2,DOMAIN:Collagen-like 3,DOMAIN:Collagen-like 4,DOMAIN:Collagen-like 5,DOMAIN:Collagen-like 6,DOMAIN:Collagen-like 7,DOMAIN:Collagen-like 8,DOMAIN:Laminin G-like,DOMAIN:VWFA,REGION:Disordered,
Q4G3H4	component of inhibitor of nuclear factor kappa B kinase complex(chuk)	Danio rerio			GO:0001757~somite specification,GO:0007417~central nervous system development,GO:0016310~phosphorylation,GO:0018105~peptidyl-serine phosphorylation,GO:0033209~tumor necrosis factor-mediated signaling pathway,GO:0043066~negative regulation of apoptotic process,GO:0043124~negative regulation of I-kappaB kinase/NF-kappaB signaling,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0051092~positive regulation of NF-kappaB transcription factor activity,GO:0055113~epiboly involved in gastrulation with mouth forming second,GO:0071356~cellular response to tumor necrosis factor,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0008385~IkappaB kinase complex,	GO:0000166~nucleotide binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008384~IkappaB kinase activity,GO:0016301~kinase activity,GO:0016740~transferase activity,GO:0042803~protein homodimerization activity,GO:0046982~protein heterodimerization activity,	IPR000719:Prot_kinase_dom,IPR008271:Ser/Thr_kinase_AS,IPR011009:Kinase-like_dom_sf,IPR017441:Protein_kinase_ATP_BS,IPR022007:IKKbetaNEMObind,IPR041185:IKBKB_SDD,IPR046375:IKBKB_SDD_sf,	dre04010:MAPK signaling pathway,dre04068:FoxO signaling pathway,dre04150:mTOR signaling pathway,dre04210:Apoptosis,dre04620:Toll-like receptor signaling pathway,dre04621:NOD-like receptor signaling pathway,dre04622:RIG-I-like receptor signaling pathway,dre04623:Cytosolic DNA-sensing pathway,dre04625:C-type lectin receptor signaling pathway,dre04920:Adipocytokine signaling pathway,dre05132:Salmonella infection,dre05168:Herpes simplex virus 1 infection,			SM00220:S_TKc,SM01239:IKKbetaNEMObind,		KW-0539~Nucleus,KW-0963~Cytoplasm,				KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0418~Kinase,KW-0723~Serine/threonine-protein kinase,KW-0808~Transferase,	KW-0597~Phosphoprotein,	ACT_SITE:Proton acceptor,DOMAIN:Protein kinase,REGION:Leucine-zipper,REGION:NEMO-binding,
P36551	coproporphyrinogen oxidase(CPOX)	Homo sapiens		h_ahspPathway:Hemoglobin's Chaperone,	GO:0006782~protoporphyrinogen IX biosynthetic process,GO:0006783~heme biosynthetic process,GO:0006784~heme a biosynthetic process,GO:0006785~heme b biosynthetic process,GO:0048034~heme O biosynthetic process,	GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005758~mitochondrial intermembrane space,GO:0005829~cytosol,GO:0016020~membrane,	GO:0004109~coproporphyrinogen oxidase activity,GO:0005212~structural constituent of eye lens,GO:0042803~protein homodimerization activity,	IPR001260:Coprogen_oxidase_aer,IPR018375:Coprogen_oxidase_CS,IPR036406:Coprogen_oxidase_aer_sf,	hsa00860:Porphyrin metabolism,hsa01100:Metabolic pathways,hsa01240:Biosynthesis of cofactors,	121300~Coproporphyria,618892~Harderoporphyria,			KW-0350~Heme biosynthesis,KW-0627~Porphyrin biosynthesis,	KW-0472~Membrane,KW-0496~Mitochondrion,		KW-0225~Disease variant,KW-0360~Hereditary hemolytic anemia,	KW-0809~Transit peptide,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0560~Oxidoreductase,	KW-0007~Acetylation,KW-0597~Phosphoprotein,	ACT_SITE:Proton donor,MUTAGEN:Missing: Loss for dimerization.,REGION:Disordered,REGION:Important for dimerization,SITE:Important for dimerization,TRANSIT:Mitochondrion,TRANSMEM:Helical,
P20248	cyclin A2(CCNA2)	Homo sapiens			GO:0000079~regulation of cyclin-dependent protein serine/threonine kinase activity,GO:0000082~G1/S transition of mitotic cell cycle,GO:0000086~G2/M transition of mitotic cell cycle,GO:0006275~regulation of DNA replication,GO:0006351~transcription, DNA-templated,GO:0007265~Ras protein signal transduction,GO:0031100~animal organ regeneration,GO:0033762~response to glucagon,GO:0036120~cellular response to platelet-derived growth factor stimulus,GO:0043687~post-translational protein modification,GO:0044320~cellular response to leptin stimulus,GO:0044772~mitotic cell cycle phase transition,GO:0044843~cell cycle G1/S phase transition,GO:0045893~positive regulation of transcription, DNA-templated,GO:0048146~positive regulation of fibroblast proliferation,GO:0051301~cell division,GO:0071314~cellular response to cocaine,GO:0071373~cellular response to luteinizing hormone stimulus,GO:0071392~cellular response to estradiol stimulus,GO:0071456~cellular response to hypoxia,GO:0071732~cellular response to nitric oxide,GO:0090102~cochlea development,GO:1990314~cellular response to insulin-like growth factor stimulus,GO:2000573~positive regulation of DNA biosynthetic process,	GO:0000307~cyclin-dependent protein kinase holoenzyme complex,GO:0001939~female pronucleus,GO:0001940~male pronucleus,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005829~cytosol,GO:0097122~cyclin A2-CDK1 complex,GO:0097124~cyclin A2-CDK2 complex,	GO:0005515~protein binding,GO:0016538~cyclin-dependent protein serine/threonine kinase regulator activity,GO:0019901~protein kinase binding,GO:0019904~protein domain specific binding,	IPR004367:Cyclin_C-dom,IPR006671:Cyclin_N,IPR013763:Cyclin-like_dom,IPR032447:Cyclin-A_N,IPR036915:Cyclin-like_sf,IPR039361:Cyclin,IPR046965:Cyclin_A/B-like,IPR048258:Cyclins_cyclin-box,	hsa04110:Cell cycle,hsa04152:AMPK signaling pathway,hsa04218:Cellular senescence,hsa04914:Progesterone-mediated oocyte maturation,hsa05161:Hepatitis B,hsa05165:Human papillomavirus infection,hsa05166:Human T-cell leukemia virus 1 infection,hsa05169:Epstein-Barr virus infection,hsa05200:Pathways in cancer,hsa05202:Transcriptional misregulation in cancer,hsa05203:Viral carcinogenesis,hsa05221:Acute myeloid leukemia,		PIRSF001771:Cyclin_A_B_D_E,	SM00385:CYCLIN,SM01332:Cyclin_C,	KW-0131~Cell cycle,KW-0132~Cell division,KW-0498~Mitosis,KW-0945~Host-virus interaction,	KW-0539~Nucleus,KW-0963~Cytoplasm,					KW-0195~Cyclin,	KW-0007~Acetylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,	REGION:Disordered,
Q92162	cyclin B1(ccnb1)	Carassius auratus			GO:0000079~regulation of cyclin-dependent protein serine/threonine kinase activity,GO:0007080~mitotic metaphase plate congression,GO:0044772~mitotic cell cycle phase transition,GO:0051301~cell division,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005759~mitochondrial matrix,GO:0097125~cyclin B1-CDK1 complex,	GO:0016538~cyclin-dependent protein serine/threonine kinase regulator activity,	IPR004367:Cyclin_C-dom,IPR006671:Cyclin_N,IPR013763:Cyclin-like_dom,IPR036915:Cyclin-like_sf,IPR039361:Cyclin,IPR046965:Cyclin_A/B-like,IPR048026:CCNB1_first_cyclin-box,IPR048258:Cyclins_cyclin-box,	caua04068:FoxO signaling pathway,caua04110:Cell cycle,caua04114:Oocyte meiosis,caua04115:p53 signaling pathway,caua04218:Cellular senescence,caua04914:Progesterone-mediated oocyte maturation,		PIRSF001771:Cyclin_A_B_D_E,	SM00385:CYCLIN,SM01332:Cyclin_C,	KW-0131~Cell cycle,KW-0132~Cell division,KW-0498~Mitosis,						KW-0195~Cyclin,		DOMAIN:Cyclin C-terminal,DOMAIN:Cyclin-like,REGION:Disordered,
P39963	cyclin B3(CCNB3)	Gallus gallus			GO:0000079~regulation of cyclin-dependent protein serine/threonine kinase activity,GO:0044772~mitotic cell cycle phase transition,GO:0051301~cell division,	GO:0000307~cyclin-dependent protein kinase holoenzyme complex,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005813~centrosome,	GO:0016538~cyclin-dependent protein serine/threonine kinase regulator activity,	IPR004367:Cyclin_C-dom,IPR006671:Cyclin_N,IPR013763:Cyclin-like_dom,IPR036915:Cyclin-like_sf,IPR039361:Cyclin,IPR046965:Cyclin_A/B-like,IPR048258:Cyclins_cyclin-box,	gga04068:FoxO signaling pathway,gga04110:Cell cycle,gga04218:Cellular senescence,gga04914:Progesterone-mediated oocyte maturation,		PIRSF001771:Cyclin_A_B_D_E,	SM00385:CYCLIN,SM01332:Cyclin_C,	KW-0131~Cell cycle,KW-0132~Cell division,	KW-0539~Nucleus,					KW-0195~Cyclin,	KW-0832~Ubl conjugation,	COMPBIAS:Polar residues,DOMAIN:Cyclin C-terminal,DOMAIN:Cyclin-like,MOTIF:D-box,REGION:Disordered,
P30280	cyclin D2(Ccnd2)	Mus musculus		m_cellcyclePathway:Cyclins and Cell Cycle Regulation,	GO:0000079~regulation of cyclin-dependent protein serine/threonine kinase activity,GO:0000082~G1/S transition of mitotic cell cycle,GO:0001934~positive regulation of protein phosphorylation,GO:0007049~cell cycle,GO:0007616~long-term memory,GO:0008284~positive regulation of cell proliferation,GO:0008344~adult locomotory behavior,GO:0043066~negative regulation of apoptotic process,GO:0044772~mitotic cell cycle phase transition,GO:0045737~positive regulation of cyclin-dependent protein serine/threonine kinase activity,GO:0050679~positive regulation of epithelial cell proliferation,GO:0051301~cell division,GO:0051726~regulation of cell cycle,GO:0060045~positive regulation of cardiac muscle cell proliferation,GO:0071481~cellular response to X-ray,GO:1900087~positive regulation of G1/S transition of mitotic cell cycle,GO:2000726~negative regulation of cardiac muscle cell differentiation,	GO:0000307~cyclin-dependent protein kinase holoenzyme complex,GO:0000785~chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005829~cytosol,GO:0016020~membrane,GO:0031965~nuclear membrane,GO:0097129~cyclin D2-CDK4 complex,	GO:0005515~protein binding,GO:0016538~cyclin-dependent protein serine/threonine kinase regulator activity,GO:0019901~protein kinase binding,GO:0061575~cyclin-dependent protein serine/threonine kinase activator activity,	IPR004367:Cyclin_C-dom,IPR006671:Cyclin_N,IPR013763:Cyclin-like_dom,IPR036915:Cyclin-like_sf,IPR039361:Cyclin,IPR048258:Cyclins_cyclin-box,	mmu04068:FoxO signaling pathway,mmu04110:Cell cycle,mmu04115:p53 signaling pathway,mmu04151:PI3K-Akt signaling pathway,mmu04218:Cellular senescence,mmu04310:Wnt signaling pathway,mmu04340:Hedgehog signaling pathway,mmu04390:Hippo signaling pathway,mmu04510:Focal adhesion,mmu04630:JAK-STAT signaling pathway,mmu04917:Prolactin signaling pathway,mmu05162:Measles,mmu05165:Human papillomavirus infection,mmu05166:Human T-cell leukemia virus 1 infection,mmu05169:Epstein-Barr virus infection,mmu05200:Pathways in cancer,mmu05202:Transcriptional misregulation in cancer,mmu05203:Viral carcinogenesis,mmu05206:MicroRNAs in cancer,			SM00385:CYCLIN,SM01332:Cyclin_C,	KW-0131~Cell cycle,KW-0132~Cell division,	KW-0472~Membrane,KW-0539~Nucleus,KW-0963~Cytoplasm,					KW-0195~Cyclin,	KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,	COMPBIAS:Polar residues,DOMAIN:Cyclin C-terminal,DOMAIN:Cyclin N-terminal,DOMAIN:Cyclin-like,REGION:Disordered,
Q5E9K7	cyclin E2(CCNE2)	Bos taurus			GO:0000079~regulation of cyclin-dependent protein serine/threonine kinase activity,GO:0000082~G1/S transition of mitotic cell cycle,GO:0051301~cell division,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0097134~cyclin E1-CDK2 complex,GO:0097135~cyclin E2-CDK2 complex,	GO:0016538~cyclin-dependent protein serine/threonine kinase regulator activity,	IPR004367:Cyclin_C-dom,IPR006671:Cyclin_N,IPR013763:Cyclin-like_dom,IPR036915:Cyclin-like_sf,IPR039361:Cyclin,IPR046965:Cyclin_A/B-like,IPR048258:Cyclins_cyclin-box,	bta04110:Cell cycle,bta04114:Oocyte meiosis,bta04115:p53 signaling pathway,bta04151:PI3K-Akt signaling pathway,bta04218:Cellular senescence,bta04934:Cushing syndrome,bta05161:Hepatitis B,bta05162:Measles,bta05165:Human papillomavirus infection,bta05166:Human T-cell leukemia virus 1 infection,bta05169:Epstein-Barr virus infection,bta05200:Pathways in cancer,bta05203:Viral carcinogenesis,bta05206:MicroRNAs in cancer,bta05215:Prostate cancer,bta05222:Small cell lung cancer,bta05226:Gastric cancer,		PIRSF001771:Cyclin_A_B_D_E,	SM00385:CYCLIN,SM01332:Cyclin_C,	KW-0131~Cell cycle,KW-0132~Cell division,	KW-0539~Nucleus,					KW-0195~Cyclin,	KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,REGION:Disordered,
Q6NYX6	cyclin F(ccnf)	Danio rerio			GO:0000079~regulation of cyclin-dependent protein serine/threonine kinase activity,GO:0007049~cell cycle,GO:0010826~negative regulation of centrosome duplication,GO:0016567~protein ubiquitination,GO:0031146~SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,GO:0044772~mitotic cell cycle phase transition,GO:0051301~cell division,	GO:0000307~cyclin-dependent protein kinase holoenzyme complex,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005814~centriole,GO:0005856~cytoskeleton,GO:0019005~SCF ubiquitin ligase complex,GO:0048471~perinuclear region of cytoplasm,	GO:0016538~cyclin-dependent protein serine/threonine kinase regulator activity,	IPR001810:F-box_dom,IPR004367:Cyclin_C-dom,IPR006671:Cyclin_N,IPR013763:Cyclin-like_dom,IPR036047:F-box-like_dom_sf,IPR036915:Cyclin-like_sf,IPR039361:Cyclin,IPR048258:Cyclins_cyclin-box,				SM00256:FBOX,SM00385:CYCLIN,SM01332:Cyclin_C,	KW-0131~Cell cycle,KW-0132~Cell division,KW-0498~Mitosis,KW-0833~Ubl conjugation pathway,	KW-0206~Cytoskeleton,KW-0539~Nucleus,KW-0963~Cytoplasm,					KW-0195~Cyclin,		COMPBIAS:Polar residues,DOMAIN:Cyclin N-terminal,DOMAIN:F-box,MOTIF:D box 1,MOTIF:Nuclear localization signal 1,MOTIF:Nuclear localization signal 2,REGION:Disordered,REGION:PEST,
Q6GN15	cyclin L1 S homeolog(ccnl1.S)	Xenopus laevis			GO:0006357~regulation of transcription from RNA polymerase II promoter,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0016607~nuclear speck,	GO:0016538~cyclin-dependent protein serine/threonine kinase regulator activity,	IPR004367:Cyclin_C-dom,IPR006671:Cyclin_N,IPR013763:Cyclin-like_dom,IPR036915:Cyclin-like_sf,IPR043198:Cyclin/Ssn8,			PIRSF036580:Cyclin_L,	SM00385:CYCLIN,SM01332:Cyclin_C,	KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,			KW-0677~Repeat,		KW-0195~Cyclin,		COMPBIAS:Basic and acidic residues,COMPBIAS:Basic residues,DOMAIN:Cyclin C-terminal,DOMAIN:Cyclin-like,REGION:Cyclin-like 1,REGION:Cyclin-like 2,REGION:Disordered,REGION:RS,
P51958	cyclin-dependent kinase 1(cdk1)	Carassius auratus			GO:0000086~G2/M transition of mitotic cell cycle,GO:0006468~protein phosphorylation,GO:0007049~cell cycle,GO:0007095~mitotic G2 DNA damage checkpoint,GO:0016310~phosphorylation,GO:0051301~cell division,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005813~centrosome,	GO:0004674~protein serine/threonine kinase activity,GO:0004693~cyclin-dependent protein serine/threonine kinase activity,GO:0005524~ATP binding,GO:0008353~RNA polymerase II carboxy-terminal domain kinase activity,	IPR000719:Prot_kinase_dom,IPR008271:Ser/Thr_kinase_AS,IPR011009:Kinase-like_dom_sf,IPR017441:Protein_kinase_ATP_BS,	caua04110:Cell cycle,caua04114:Oocyte meiosis,caua04115:p53 signaling pathway,caua04218:Cellular senescence,caua04540:Gap junction,caua04914:Progesterone-mediated oocyte maturation,			SM00220:S_TKc,	KW-0131~Cell cycle,KW-0132~Cell division,KW-0498~Mitosis,	KW-0206~Cytoskeleton,KW-0539~Nucleus,KW-0963~Cytoplasm,				KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0418~Kinase,KW-0723~Serine/threonine-protein kinase,KW-0808~Transferase,	KW-0597~Phosphoprotein,	ACT_SITE:Proton acceptor,DOMAIN:Protein kinase,
Q29473	cytochrome P450 2D(CYP2D15)	Canis lupus familiaris			GO:0006805~xenobiotic metabolic process,GO:0008210~estrogen metabolic process,GO:0009804~coumarin metabolic process,GO:0009822~alkaloid catabolic process,GO:0016098~monoterpenoid metabolic process,GO:0019369~arachidonic acid metabolic process,GO:0033076~isoquinoline alkaloid metabolic process,GO:0042178~xenobiotic catabolic process,GO:0042572~retinol metabolic process,GO:0070989~oxidative demethylation,GO:0090350~negative regulation of cellular organofluorine metabolic process,	GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0016020~membrane,GO:0043231~intracellular membrane-bounded organelle,	GO:0004497~monooxygenase activity,GO:0005506~iron ion binding,GO:0016705~oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen,GO:0016712~oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen,GO:0020037~heme binding,GO:0070330~aromatase activity,	IPR001128:Cyt_P450,IPR002401:Cyt_P450_E_grp-I,IPR008069:Cyt_P450_E_grp-I_CYP2D-like,IPR017972:Cyt_P450_CS,IPR036396:Cyt_P450_sf,	cfa00140:Steroid hormone biosynthesis,cfa04726:Serotonergic synapse,					KW-0256~Endoplasmic reticulum,KW-0472~Membrane,KW-0492~Microsome,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0349~Heme,KW-0408~Iron,KW-0479~Metal-binding,	KW-0503~Monooxygenase,KW-0560~Oxidoreductase,		BINDING:axial binding residue,REGION:Disordered,TRANSMEM:Helical,
Q92090	cytochrome P450 2K1(LOC110511678)	Oncorhynchus mykiss			GO:0002933~lipid hydroxylation,GO:0006082~organic acid metabolic process,GO:0006805~xenobiotic metabolic process,GO:0046222~aflatoxin metabolic process,GO:0048252~lauric acid metabolic process,	GO:0005737~cytoplasm,GO:0005789~endoplasmic reticulum membrane,GO:0043231~intracellular membrane-bounded organelle,	GO:0004497~monooxygenase activity,GO:0005506~iron ion binding,GO:0016705~oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen,GO:0016712~oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen,GO:0020037~heme binding,GO:0070330~aromatase activity,	IPR001128:Cyt_P450,IPR002401:Cyt_P450_E_grp-I,IPR017972:Cyt_P450_CS,IPR036396:Cyt_P450_sf,						KW-0256~Endoplasmic reticulum,KW-0472~Membrane,KW-0492~Microsome,				KW-0349~Heme,KW-0408~Iron,KW-0479~Metal-binding,	KW-0503~Monooxygenase,KW-0560~Oxidoreductase,		BINDING:axial binding residue,
Q98T91	cytochrome P450 3A40(cyp3a40)	Oryzias latipes				GO:0005789~endoplasmic reticulum membrane,	GO:0005506~iron ion binding,GO:0008395~steroid hydroxylase activity,GO:0016712~oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen,GO:0020037~heme binding,GO:0070330~aromatase activity,	IPR001128:Cyt_P450,IPR002402:Cyt_P450_E_grp-II,IPR008072:Cyt_P450_E_CYP3A,IPR017972:Cyt_P450_CS,IPR036396:Cyt_P450_sf,	ola00140:Steroid hormone biosynthesis,ola00591:Linoleic acid metabolism,ola00830:Retinol metabolism,ola01100:Metabolic pathways,					KW-0256~Endoplasmic reticulum,KW-0472~Membrane,KW-0492~Microsome,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0349~Heme,KW-0408~Iron,KW-0479~Metal-binding,	KW-0503~Monooxygenase,KW-0560~Oxidoreductase,		BINDING:axial binding residue,TRANSMEM:Helical,
Q16696	cytochrome P450 family 2 subfamily A member 13(CYP2A13)	Homo sapiens			GO:0006805~xenobiotic metabolic process,GO:0009804~coumarin metabolic process,GO:0019373~epoxygenase P450 pathway,GO:0046222~aflatoxin metabolic process,	GO:0005737~cytoplasm,GO:0005789~endoplasmic reticulum membrane,GO:0043231~intracellular membrane-bounded organelle,	GO:0004497~monooxygenase activity,GO:0005506~iron ion binding,GO:0008389~coumarin 7-hydroxylase activity,GO:0008392~arachidonic acid epoxygenase activity,GO:0016712~oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen,GO:0020037~heme binding,GO:0070330~aromatase activity,	IPR001128:Cyt_P450,IPR002401:Cyt_P450_E_grp-I,IPR008067:Cyt_P450_E_grp-I_CYP2A-like,IPR017972:Cyt_P450_CS,IPR036396:Cyt_P450_sf,	hsa00980:Metabolism of xenobiotics by cytochrome P450,hsa05204:Chemical carcinogenesis - DNA adducts,					KW-0256~Endoplasmic reticulum,KW-0472~Membrane,KW-0492~Microsome,			KW-0732~Signal,	KW-0349~Heme,KW-0408~Iron,KW-0479~Metal-binding,	KW-0503~Monooxygenase,KW-0560~Oxidoreductase,		BINDING:axial binding residue,MUTAGEN:A->G: Decreases phenacetin O-deethylation activity 20 fold.,MUTAGEN:A->S: Decreases phenacetin O-deethylation activity 2 fold.,MUTAGEN:A->V: Increases phenacetin O-deethylation activity 5 fold.,MUTAGEN:F->I: Decreases phenacetin O-deethylation activity 40 fold.,MUTAGEN:G->S: Decreases phenacetin O-deethylation activity 9 fold.,MUTAGEN:H->R: Decreases phenacetin O-deethylation activity 3 fold.,MUTAGEN:L->I: Increases phenacetin O-deethylation activity 3 fold.,MUTAGEN:L->V: Decreases phenacetin O-deethylation activity 8 fold.,MUTAGEN:M->V: Decreases phenacetin O-deethylation activity 7 fold.,MUTAGEN:S->I: Decreases phenacetin O-deethylation activity 10 fold.,
Q08477	cytochrome P450 family 4 subfamily F member 3(CYP4F3)	Homo sapiens			GO:0000038~very long-chain fatty acid metabolic process,GO:0001676~long-chain fatty acid metabolic process,GO:0003091~renal water homeostasis,GO:0003095~pressure natriuresis,GO:0006690~icosanoid metabolic process,GO:0006691~leukotriene metabolic process,GO:0006805~xenobiotic metabolic process,GO:0007596~blood coagulation,GO:0008217~regulation of blood pressure,GO:0010430~fatty acid omega-oxidation,GO:0019369~arachidonic acid metabolic process,GO:0019373~epoxygenase P450 pathway,GO:0032304~negative regulation of icosanoid secretion,GO:0032305~positive regulation of icosanoid secretion,GO:0036101~leukotriene B4 catabolic process,GO:0042360~vitamin E metabolic process,GO:0042361~menaquinone catabolic process,GO:0042376~phylloquinone catabolic process,GO:0042377~vitamin K catabolic process,GO:0055078~sodium ion homeostasis,GO:0097267~omega-hydroxylase P450 pathway,GO:2001302~lipoxin A4 metabolic process,GO:2001304~lipoxin B4 metabolic process,	GO:0005737~cytoplasm,GO:0005789~endoplasmic reticulum membrane,GO:0016020~membrane,GO:0016324~apical plasma membrane,GO:0043231~intracellular membrane-bounded organelle,	GO:0004497~monooxygenase activity,GO:0005506~iron ion binding,GO:0008392~arachidonic acid epoxygenase activity,GO:0016705~oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen,GO:0016709~oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen,GO:0018685~alkane 1-monooxygenase activity,GO:0020037~heme binding,GO:0050051~leukotriene-B4 20-monooxygenase activity,GO:0052869~arachidonic acid omega-hydroxylase activity,GO:0052871~alpha-tocopherol omega-hydroxylase activity,GO:0052872~tocotrienol omega-hydroxylase activity,GO:0070330~aromatase activity,GO:0097258~20-hydroxy-leukotriene B4 omega oxidase activity,GO:0097259~20-aldehyde-leukotriene B4 20-monooxygenase activity,GO:0102033~cytochrome P450 fatty acid omega-hydroxylase activity,	IPR001128:Cyt_P450,IPR002401:Cyt_P450_E_grp-I,IPR017972:Cyt_P450_CS,IPR036396:Cyt_P450_sf,	hsa00590:Arachidonic acid metabolism,hsa01100:Metabolic pathways,				KW-0276~Fatty acid metabolism,KW-0443~Lipid metabolism,	KW-0256~Endoplasmic reticulum,KW-0472~Membrane,KW-0492~Microsome,			KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0349~Heme,KW-0408~Iron,KW-0479~Metal-binding,	KW-0503~Monooxygenase,KW-0560~Oxidoreductase,		BINDING:axial binding residue,BINDING:covalent,TRANSMEM:Helical,
O35293	cytochrome P450, family 2, subfamily f, polypeptide 4(Cyp2f4)	Rattus norvegicus			GO:0006805~xenobiotic metabolic process,GO:0009636~response to toxic substance,GO:0018979~trichloroethylene metabolic process,GO:0019373~epoxygenase P450 pathway,GO:1901170~naphthalene catabolic process,	GO:0005737~cytoplasm,GO:0005789~endoplasmic reticulum membrane,GO:0016020~membrane,GO:0043231~intracellular membrane-bounded organelle,	GO:0004497~monooxygenase activity,GO:0005506~iron ion binding,GO:0008392~arachidonic acid epoxygenase activity,GO:0016705~oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen,GO:0016712~oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen,GO:0019825~oxygen binding,GO:0020037~heme binding,	IPR001128:Cyt_P450,IPR002401:Cyt_P450_E_grp-I,IPR017972:Cyt_P450_CS,IPR020469:Cyt_P450_CYP2_fam,IPR036396:Cyt_P450_sf,	rno00980:Metabolism of xenobiotics by cytochrome P450,rno05208:Chemical carcinogenesis - reactive oxygen species,					KW-0256~Endoplasmic reticulum,KW-0472~Membrane,KW-0492~Microsome,			KW-0732~Signal,	KW-0349~Heme,KW-0408~Iron,KW-0479~Metal-binding,	KW-0503~Monooxygenase,KW-0560~Oxidoreductase,		BINDING:axial binding residue,
Q0P487	cytochrome b5 reductase 2(cyb5r2)	Danio rerio			GO:0001878~response to yeast,GO:0006629~lipid metabolic process,GO:0006694~steroid biosynthetic process,GO:0008202~steroid metabolic process,GO:0016126~sterol biosynthetic process,	GO:0005739~mitochondrion,GO:0016020~membrane,	GO:0004128~cytochrome-b5 reductase activity, acting on NAD(P)H,GO:0016491~oxidoreductase activity,GO:0071949~FAD binding,	IPR001433:OxRdtase_FAD/NAD-bd,IPR001709:Flavoprot_Pyr_Nucl_cyt_Rdtase,IPR001834:CBR-like,IPR008333:Cbr1-like_FAD-bd_dom,IPR017927:FAD-bd_FR_type,IPR017938:Riboflavin_synthase-like_b-brl,IPR039261:FNR_nucleotide-bd,	dre00520:Amino sugar and nucleotide sugar metabolism,				KW-0443~Lipid metabolism,KW-0444~Lipid biosynthesis,KW-0752~Steroid biosynthesis,KW-0753~Steroid metabolism,KW-0756~Sterol biosynthesis,KW-1207~Sterol metabolism,	KW-0472~Membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0274~FAD,KW-0285~Flavoprotein,KW-0520~NAD,	KW-0560~Oxidoreductase,		DOMAIN:FAD-binding FR-type,TRANSMEM:Helical,
O13085	cytochrome c oxidase subunit VIa(LOC100335037)	Oncorhynchus mykiss			GO:0006119~oxidative phosphorylation,GO:0006123~mitochondrial electron transport, cytochrome c to oxygen,	GO:0005743~mitochondrial inner membrane,GO:0005751~mitochondrial respiratory chain complex IV,	GO:0016491~oxidoreductase activity,GO:0030234~enzyme regulator activity,	IPR001349:Cyt_c_oxidase_su6a,IPR018507:Cyt_c_oxidase_su6a_CS,IPR036418:Cyt_c_oxidase_su6a_sf,	omy00190:Oxidative phosphorylation,omy01100:Metabolic pathways,omy04260:Cardiac muscle contraction,		PIRSF000277:COX6A1,			KW-0472~Membrane,KW-0496~Mitochondrion,KW-0999~Mitochondrion inner membrane,			KW-0809~Transit peptide,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0560~Oxidoreductase,		REGION:Disordered,TOPO_DOM:Mitochondrial intermembrane,TOPO_DOM:Mitochondrial matrix,TRANSIT:Mitochondrion,TRANSMEM:Helical,
A5PK21	cytoskeleton associated protein 2 like(CKAP2L)	Bos taurus				GO:0000922~spindle pole,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005829~cytosol,GO:0072686~mitotic spindle,		IPR029197:CKAP2_C,						KW-0206~Cytoskeleton,KW-0963~Cytoplasm,						KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Polar residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate,DOMAIN:Cytoskeleton-associated protein 2 C-terminal,REGION:Disordered,
Q9H773	dCTP pyrophosphatase 1(DCTPP1)	Homo sapiens			GO:0006253~dCTP catabolic process,GO:0009143~nucleoside triphosphate catabolic process,GO:0042262~DNA protection,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005739~mitochondrion,GO:0005829~cytosol,	GO:0000287~magnesium ion binding,GO:0005515~protein binding,GO:0032556~pyrimidine deoxyribonucleotide binding,GO:0042802~identical protein binding,GO:0047429~nucleoside-triphosphate diphosphatase activity,GO:0047840~dCTP diphosphatase activity,	IPR025984:DCTPP,	hsa00240:Pyrimidine metabolism,hsa01100:Metabolic pathways,hsa01232:Nucleotide metabolism,					KW-0496~Mitochondrion,KW-0539~Nucleus,KW-0963~Cytoplasm,				KW-0460~Magnesium,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,	KW-0378~Hydrolase,	KW-0007~Acetylation,KW-0597~Phosphoprotein,	MUTAGEN:E->Q: Loss of dCTP diphosphatase activity.,REGION:Disordered,
Q8VDF3	death-associated protein kinase 2(Dapk2)	Mus musculus			GO:0006468~protein phosphorylation,GO:0006915~apoptotic process,GO:0016310~phosphorylation,GO:0035556~intracellular signal transduction,GO:0043065~positive regulation of apoptotic process,GO:0043276~anoikis,GO:0090023~positive regulation of neutrophil chemotaxis,GO:1990266~neutrophil migration,GO:2000424~positive regulation of eosinophil chemotaxis,GO:2001242~regulation of intrinsic apoptotic signaling pathway,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0031410~cytoplasmic vesicle,GO:0034423~autophagosome lumen,GO:0043231~intracellular membrane-bounded organelle,	GO:0000166~nucleotide binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005516~calmodulin binding,GO:0005524~ATP binding,GO:0016301~kinase activity,GO:0016740~transferase activity,GO:0042802~identical protein binding,	IPR000719:Prot_kinase_dom,IPR008271:Ser/Thr_kinase_AS,IPR011009:Kinase-like_dom_sf,IPR017441:Protein_kinase_ATP_BS,	mmu04140:Autophagy - animal,mmu05200:Pathways in cancer,mmu05219:Bladder cancer,			SM00220:S_TKc,	KW-0053~Apoptosis,	KW-0963~Cytoplasm,KW-0968~Cytoplasmic vesicle,			KW-0175~Coiled coil,	KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0112~Calmodulin-binding,KW-0418~Kinase,KW-0723~Serine/threonine-protein kinase,KW-0808~Transferase,	KW-0597~Phosphoprotein,	ACT_SITE:Proton acceptor,DOMAIN:Protein kinase,REGION:Autoinhibitory domain,REGION:Calmodulin-binding,
Q96HP0	dedicator of cytokinesis 6(DOCK6)	Homo sapiens			GO:0007264~small GTPase mediated signal transduction,GO:0043547~positive regulation of GTPase activity,	GO:0005829~cytosol,GO:0048471~perinuclear region of cytoplasm,	GO:0005085~guanyl-nucleotide exchange factor activity,GO:0005515~protein binding,	IPR021816:DOCK_C/D_N,IPR026791:DOCK,IPR027007:C2_DOCK-type_domain,IPR027357:DOCKER_dom,IPR035892:C2_domain_sf,IPR037808:C2_Dock-C,IPR043161:DOCK_C_lobe_A,IPR043162:DOCK_C_lobe_C,IPR046769:DOCKER_Lobe_A,IPR046770:DOCKER_Lobe_B,IPR046773:DOCKER_Lobe_C,		614219~Adams-Oliver syndrome 2,				KW-0963~Cytoplasm,					KW-0344~Guanine-nucleotide releasing factor,	KW-0488~Methylation,KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:C2 DOCK-type,DOMAIN:DOCKER,REGION:Disordered,
Q5PRA2	dehydrogenase E1 and transketolase domain containing 1(dhtkd1)	Danio rerio			GO:0006096~glycolytic process,GO:0006099~tricarboxylic acid cycle,	GO:0005739~mitochondrion,	GO:0004591~oxoglutarate dehydrogenase (succinyl-transferring) activity,GO:0016491~oxidoreductase activity,GO:0016624~oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor,GO:0030976~thiamine pyrophosphate binding,	IPR001017:DH_E1,IPR005475:Transketolase-like_Pyr-bd,IPR011603:2oxoglutarate_DH_E1,IPR029061:THDP-binding,IPR031717:KGD_C,IPR042179:KGD_C_sf,	dre00310:Lysine degradation,dre00380:Tryptophan metabolism,dre00785:Lipoic acid metabolism,dre01100:Metabolic pathways,dre01210:2-Oxocarboxylic acid metabolism,		PIRSF000157:Oxoglu_dh_E1,	SM00861:Transket_pyr,	KW-0324~Glycolysis,	KW-0496~Mitochondrion,			KW-0809~Transit peptide,	KW-0786~Thiamine pyrophosphate,	KW-0560~Oxidoreductase,		COMPBIAS:Basic and acidic residues,REGION:Disordered,TRANSIT:Mitochondrion,
Q9UGM3	deleted in malignant brain tumors 1(DMBT1)	Homo sapiens			GO:0006897~endocytosis,GO:0006952~defense response,GO:0015031~protein transport,GO:0030154~cell differentiation,GO:0030855~epithelial cell differentiation,GO:0043152~induction of bacterial agglutination,GO:0045087~innate immune response,GO:0050829~defense response to Gram-negative bacterium,GO:0050830~defense response to Gram-positive bacterium,GO:0051607~defense response to virus,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005737~cytoplasm,GO:0016020~membrane,GO:0030670~phagocytic vesicle membrane,GO:0031012~extracellular matrix,GO:0042589~zymogen granule membrane,GO:0070062~extracellular exosome,	GO:0005044~scavenger receptor activity,GO:0005515~protein binding,GO:0035375~zymogen binding,GO:0038187~pattern recognition receptor activity,GO:0048306~calcium-dependent protein binding,	IPR000859:CUB_dom,IPR001190:SRCR,IPR001507:ZP_dom,IPR017448:SRCR-like_dom,IPR017977:ZP_dom_CS,IPR035914:Sperma_CUB_dom_sf,IPR036772:SRCR-like_dom_sf,IPR042235:ZP-C,	hsa04970:Salivary secretion,			SM00042:CUB,SM00202:SR,SM00241:ZP,	KW-0051~Antiviral defense,KW-0221~Differentiation,KW-0653~Protein transport,KW-0813~Transport,KW-0945~Host-virus interaction,	KW-0964~Secreted,		KW-0043~Tumor suppressor,	KW-0677~Repeat,KW-0732~Signal,		KW-0217~Developmental protein,KW-9996~Developmental protein,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Polar residues,DOMAIN:CUB,DOMAIN:CUB 1,DOMAIN:CUB 2,DOMAIN:SRCR,DOMAIN:SRCR 1,DOMAIN:SRCR 10,DOMAIN:SRCR 11,DOMAIN:SRCR 12,DOMAIN:SRCR 13,DOMAIN:SRCR 14,DOMAIN:SRCR 2,DOMAIN:SRCR 3,DOMAIN:SRCR 4,DOMAIN:SRCR 5,DOMAIN:SRCR 6,DOMAIN:SRCR 7,DOMAIN:SRCR 8,DOMAIN:SRCR 9,DOMAIN:ZP,REGION:Disordered,
Q8TDB6	deltex E3 ubiquitin ligase 3L(DTX3L)	Homo sapiens			GO:0000077~DNA damage checkpoint,GO:0002230~positive regulation of defense response to virus by host,GO:0006302~double-strand break repair,GO:0006511~ubiquitin-dependent protein catabolic process,GO:0007219~Notch signaling pathway,GO:0008333~endosome to lysosome transport,GO:0015031~protein transport,GO:0032092~positive regulation of protein binding,GO:0035563~positive regulation of chromatin binding,GO:0045087~innate immune response,GO:0045893~positive regulation of transcription, DNA-templated,GO:0051444~negative regulation of ubiquitin-protein transferase activity,GO:0051607~defense response to virus,GO:0051865~protein autoubiquitination,GO:0070936~protein K48-linked ubiquitination,GO:1900182~positive regulation of protein localization to nucleus,GO:1902966~positive regulation of protein localization to early endosome,GO:2000646~positive regulation of receptor catabolic process,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005764~lysosome,GO:0005765~lysosomal membrane,GO:0005769~early endosome,GO:0005829~cytosol,GO:0031901~early endosome membrane,GO:0032991~macromolecular complex,	GO:0004842~ubiquitin-protein transferase activity,GO:0004857~enzyme inhibitor activity,GO:0005515~protein binding,GO:0019899~enzyme binding,GO:0042393~histone binding,GO:0044389~ubiquitin-like protein ligase binding,GO:0046872~metal ion binding,GO:0097677~STAT family protein binding,	IPR001841:Znf_RING,IPR012677:Nucleotide-bd_a/b_plait_sf,IPR013083:Znf_RING/FYVE/PHD,IPR017907:Znf_RING_CS,IPR039396:Deltex_C,IPR039398:Deltex_fam,IPR039399:Deltex_C_sf,IPR042843:TX3L_RING-HC,IPR048409:DTX3L_KH-like,IPR048418:DTX3L_a/b_dom,	hsa04330:Notch signaling pathway,			SM00184:RING,	KW-0051~Antiviral defense,KW-0227~DNA damage,KW-0234~DNA repair,KW-0391~Immunity,KW-0399~Innate immunity,KW-0653~Protein transport,KW-0813~Transport,KW-0833~Ubl conjugation pathway,KW-0945~Host-virus interaction,	KW-0458~Lysosome,KW-0472~Membrane,KW-0539~Nucleus,KW-0963~Cytoplasm,KW-0967~Endosome,			KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0156~Chromatin regulator,KW-0808~Transferase,	KW-0007~Acetylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,	COMPBIAS:Polar residues,MUTAGEN:C->A: Loss of catalytic activity but does not affect its capacity to inhibit ITCH catalytic activity; when associated with A-561 and A-596.,MUTAGEN:C->A: Loss of catalytic activity but does not affect its capacity to inhibit ITCH catalytic activity; when associated with A-561 and A-599.,MUTAGEN:C->A: Loss of catalytic activity but does not affect its capacity to inhibit ITCH catalytic activity; when associated with A-596 and A-599.,MUTAGEN:CVIC->SVIS: Loss of catalytic activity. Loss of histone H2B ubiquitination. No effect on STAT1 phosphorylation and on the interaction with PARP9 and STAT1.,REGION:Disordered,ZN_FING:RING-type,
P43346	deoxycytidine kinase(Dck)	Mus musculus			GO:0006139~nucleobase-containing compound metabolic process,GO:0006220~pyrimidine nucleotide metabolic process,GO:0009157~deoxyribonucleoside monophosphate biosynthetic process,GO:0009165~nucleotide biosynthetic process,GO:0016310~phosphorylation,GO:0046092~deoxycytidine metabolic process,GO:1901135~carbohydrate derivative metabolic process,GO:1901293~nucleoside phosphate biosynthetic process,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005829~cytosol,	GO:0000166~nucleotide binding,GO:0000287~magnesium ion binding,GO:0004136~deoxyadenosine kinase activity,GO:0004137~deoxycytidine kinase activity,GO:0004138~deoxyguanosine kinase activity,GO:0005524~ATP binding,GO:0016301~kinase activity,GO:0016740~transferase activity,GO:0019136~deoxynucleoside kinase activity,GO:0032546~deoxyribonucleoside binding,GO:0032548~pyrimidine deoxyribonucleoside binding,GO:0042803~protein homodimerization activity,GO:0043771~cytidine kinase activity,	IPR002624:DCK/DGK,IPR027417:P-loop_NTPase,IPR031314:DNK_dom,	mmu00230:Purine metabolism,mmu00240:Pyrimidine metabolism,mmu01100:Metabolic pathways,mmu01232:Nucleotide metabolism,		PIRSF000705:DNK,			KW-0539~Nucleus,				KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0418~Kinase,KW-0808~Transferase,	KW-0597~Phosphoprotein,	ACT_SITE:Proton acceptor,DOMAIN:Deoxynucleoside kinase,
P00375	dihydrofolate reductase(Dhfr)	Mus musculus		m_g1Pathway:Cell Cycle: G1/S Check Point ,	GO:0006545~glycine biosynthetic process,GO:0006729~tetrahydrobiopterin biosynthetic process,GO:0006730~one-carbon metabolic process,GO:0031103~axon regeneration,GO:0031427~response to methotrexate,GO:0035094~response to nicotine,GO:0035999~tetrahydrofolate interconversion,GO:0046452~dihydrofolate metabolic process,GO:0046653~tetrahydrofolate metabolic process,GO:0046654~tetrahydrofolate biosynthetic process,GO:0046655~folic acid metabolic process,GO:0051000~positive regulation of nitric-oxide synthase activity,GO:2000121~regulation of removal of superoxide radicals,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0005759~mitochondrial matrix,GO:0005829~cytosol,	GO:0000900~translation repressor activity, nucleic acid binding,GO:0003723~RNA binding,GO:0003729~mRNA binding,GO:0004146~dihydrofolate reductase activity,GO:0005542~folic acid binding,GO:0016491~oxidoreductase activity,GO:0050661~NADP binding,GO:0051871~dihydrofolic acid binding,GO:0070402~NADPH binding,GO:1990825~sequence-specific mRNA binding,	IPR001796:DHFR_dom,IPR012259:DHFR,IPR017925:DHFR_CS,IPR024072:DHFR-like_dom_sf,	mmu00670:One carbon pool by folate,mmu00790:Folate biosynthesis,mmu01100:Metabolic pathways,mmu01240:Biosynthesis of cofactors,mmu01523:Antifolate resistance,				KW-0487~Methotrexate resistance,KW-0554~One-carbon metabolism,	KW-0496~Mitochondrion,KW-0963~Cytoplasm,				KW-0521~NADP,	KW-0560~Oxidoreductase,KW-0694~RNA-binding,	KW-0007~Acetylation,	DOMAIN:DHFR,
P22411	dipeptidyl peptidase 4(DPP4)	Sus scrofa			GO:0001662~behavioral fear response,GO:0001666~response to hypoxia,GO:0006508~proteolysis,GO:0007155~cell adhesion,GO:0008284~positive regulation of cell proliferation,GO:0010716~negative regulation of extracellular matrix disassembly,GO:0031295~T cell costimulation,GO:0033632~regulation of cell-cell adhesion mediated by integrin,GO:0035641~locomotory exploration behavior,GO:0036343~psychomotor behavior,GO:0042110~T cell activation,GO:0043542~endothelial cell migration,GO:0090024~negative regulation of neutrophil chemotaxis,	GO:0005576~extracellular region,GO:0005886~plasma membrane,GO:0009986~cell surface,GO:0016020~membrane,GO:0016324~apical plasma membrane,GO:0030027~lamellipodium,GO:0030139~endocytic vesicle,GO:0031258~lamellipodium membrane,GO:0042995~cell projection,GO:0045121~membrane raft,GO:0046581~intercellular canaliculus,GO:0070161~anchoring junction,	GO:0001618~virus receptor activity,GO:0002020~protease binding,GO:0004177~aminopeptidase activity,GO:0004252~serine-type endopeptidase activity,GO:0005102~receptor binding,GO:0008236~serine-type peptidase activity,GO:0008239~dipeptidyl-peptidase activity,GO:0016787~hydrolase activity,GO:0042803~protein homodimerization activity,GO:0045499~chemorepellent activity,	IPR001375:Peptidase_S9,IPR002469:Peptidase_S9B_N,IPR002471:Pept_S9_AS,IPR029058:AB_hydrolase,IPR040522:DPPIV_rep,	ssc04974:Protein digestion and absorption,				KW-0130~Cell adhesion,	KW-0472~Membrane,KW-0964~Secreted,KW-0965~Cell junction,KW-0966~Cell projection,KW-1003~Cell membrane,			KW-0735~Signal-anchor,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0031~Aminopeptidase,KW-0378~Hydrolase,KW-0645~Protease,KW-0720~Serine protease,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	ACT_SITE:Charge relay system,CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Dipeptidyl peptidase 4 low complexity region,DOMAIN:Dipeptidylpeptidase IV N-terminal,DOMAIN:Peptidase S9 prolyl oligopeptidase catalytic,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,TRANSMEM:Helical; Signal-anchor for type II membrane protein,
Q9EPB1	dipeptidylpeptidase 7(Dpp7)	Rattus norvegicus			GO:0006508~proteolysis,GO:0030163~protein catabolic process,GO:1905146~lysosomal protein catabolic process,	GO:0005576~extracellular region,GO:0005764~lysosome,GO:0005794~Golgi apparatus,GO:0031410~cytoplasmic vesicle,GO:0031982~vesicle,GO:0043231~intracellular membrane-bounded organelle,	GO:0004177~aminopeptidase activity,GO:0008239~dipeptidyl-peptidase activity,GO:0070008~serine-type exopeptidase activity,	IPR008758:Peptidase_S28,IPR029058:AB_hydrolase,IPR042269:Ser_carbopepase_S28_SKS,						KW-0458~Lysosome,KW-0964~Secreted,KW-0968~Cytoplasmic vesicle,			KW-0732~Signal,		KW-0031~Aminopeptidase,KW-0378~Hydrolase,KW-0645~Protease,KW-0720~Serine protease,	KW-0325~Glycoprotein,KW-0865~Zymogen,	ACT_SITE:Charge relay system,CARBOHYD:N-linked (GlcNAc...) asparagine,
Q1RLQ5	divergent protein kinase domain 1Aa(dipk1aa)	Danio rerio				GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0016020~membrane,		IPR022049:FAM69_kinase_dom,IPR029244:FAM69_N,				SM01299:PIP49_N,		KW-0256~Endoplasmic reticulum,KW-0472~Membrane,			KW-0735~Signal-anchor,KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-1015~Disulfide bond,	TOPO_DOM:Cytoplasmic,TOPO_DOM:Lumenal,TRANSMEM:Helical,
Q5DU00	doublecortin domain containing 2a(Dcdc2a)	Mus musculus			GO:0001764~neuron migration,GO:0007399~nervous system development,GO:0007605~sensory perception of sound,GO:0008542~visual learning,GO:0019228~neuronal action potential,GO:0030030~cell projection organization,GO:0030111~regulation of Wnt signaling pathway,GO:0035249~synaptic transmission, glutamatergic,GO:0035556~intracellular signal transduction,GO:0045880~positive regulation of smoothened signaling pathway,GO:0048813~dendrite morphogenesis,GO:0060271~cilium assembly,GO:1902017~regulation of cilium assembly,	GO:0005737~cytoplasm,GO:0005815~microtubule organizing center,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005874~microtubule,GO:0005929~cilium,GO:0005930~axoneme,GO:0015630~microtubule cytoskeleton,GO:0034451~centriolar satellite,GO:0042995~cell projection,GO:0045202~synapse,GO:0060091~kinocilium,GO:0072686~mitotic spindle,	GO:0019894~kinesin binding,	IPR003533:Doublecortin_dom,IPR033036:DCDC2_DCX_dom2,IPR036572:Doublecortin_dom_sf,				SM00537:DCX,	KW-0524~Neurogenesis,KW-0970~Cilium biogenesis/degradation,	KW-0206~Cytoskeleton,KW-0963~Cytoplasm,KW-0966~Cell projection,			KW-0677~Repeat,			KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:Doublecortin,DOMAIN:Doublecortin 1,DOMAIN:Doublecortin 2,REGION:Disordered,
Q16643	drebrin 1(DBN1)	Homo sapiens			GO:0001701~in utero embryonic development,GO:0007015~actin filament organization,GO:0010643~cell communication by chemical coupling,GO:0010644~cell communication by electrical coupling,GO:0031915~positive regulation of synaptic plasticity,GO:0032507~maintenance of protein location in cell,GO:0048168~regulation of neuronal synaptic plasticity,GO:0048699~generation of neurons,GO:0050773~regulation of dendrite development,GO:0051220~cytoplasmic sequestering of protein,GO:0061003~positive regulation of dendritic spine morphogenesis,GO:0061351~neural precursor cell proliferation,GO:1902685~positive regulation of receptor localization to synapse,	GO:0005737~cytoplasm,GO:0005856~cytoskeleton,GO:0005921~gap junction,GO:0014069~postsynaptic density,GO:0015629~actin cytoskeleton,GO:0030425~dendrite,GO:0030426~growth cone,GO:0030863~cortical cytoskeleton,GO:0042641~actomyosin,GO:0045211~postsynaptic membrane,GO:0098978~glutamatergic synapse,GO:0099524~postsynaptic cytosol,	GO:0003779~actin binding,GO:0005515~protein binding,GO:0005522~profilin binding,GO:0045296~cadherin binding,	IPR002108:ADF-H,IPR029006:ADF-H/Gelsolin-like_dom_sf,				SM00102:ADF,	KW-0221~Differentiation,KW-0524~Neurogenesis,	KW-0963~Cytoplasm,KW-0965~Cell junction,KW-0966~Cell projection,		KW-0026~Alzheimer disease,KW-0523~Neurodegeneration,KW-1008~Amyloidosis,			KW-0009~Actin-binding,KW-0217~Developmental protein,KW-9996~Developmental protein,	KW-0007~Acetylation,KW-0597~Phosphoprotein,	COMPBIAS:Acidic residues,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,COMPBIAS:Pro residues,DOMAIN:ADF-H,MUTAGEN:C->Q: Decreased binding to ZMYND8.,MUTAGEN:R->D,G: Loss of binding to ZMYND8. Loss of ZMYND8 cytoplasmic localization.,REGION:Disordered,
Q8HZK2	dual oxidase 2(DUOX2)	Sus scrofa			GO:0006590~thyroid hormone generation,GO:0006952~defense response,GO:0006979~response to oxidative stress,GO:0009566~fertilization,GO:0019221~cytokine-mediated signaling pathway,GO:0030282~bone mineralization,GO:0030878~thyroid gland development,GO:0035264~multicellular organism growth,GO:0042335~cuticle development,GO:0042446~hormone biosynthetic process,GO:0042554~superoxide anion generation,GO:0042744~hydrogen peroxide catabolic process,GO:0048839~inner ear development,GO:0048855~adenohypophysis morphogenesis,GO:0051591~response to cAMP,	GO:0005783~endoplasmic reticulum,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0016324~apical plasma membrane,GO:0043020~NADPH oxidase complex,GO:0045177~apical part of cell,GO:0070161~anchoring junction,	GO:0004601~peroxidase activity,GO:0005509~calcium ion binding,GO:0016174~NAD(P)H oxidase activity,GO:0016175~superoxide-generating NADPH oxidase activity,GO:0020037~heme binding,	IPR002048:EF_hand_dom,IPR010255:Haem_peroxidase_sf,IPR011992:EF-hand-dom_pair,IPR013112:FAD-bd_8,IPR013121:Fe_red_NAD-bd_6,IPR013130:Fe3_Rdtase_TM_dom,IPR017927:FAD-bd_FR_type,IPR017938:Riboflavin_synthase-like_b-brl,IPR018247:EF_Hand_1_Ca_BS,IPR019791:Haem_peroxidase_animal,IPR034821:DUOX_peroxidase,IPR037120:Haem_peroxidase_sf_animal,IPR039261:FNR_nucleotide-bd,	ssc04918:Thyroid hormone synthesis,			SM00054:EFh,	KW-0376~Hydrogen peroxide,KW-0893~Thyroid hormones biosynthesis,	KW-0472~Membrane,KW-0965~Cell junction,KW-1003~Cell membrane,			KW-0677~Repeat,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0106~Calcium,KW-0274~FAD,KW-0285~Flavoprotein,KW-0479~Metal-binding,KW-0521~NADP,	KW-0560~Oxidoreductase,KW-0575~Peroxidase,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DISULFID:Interchain (with C-167 in DUOXA2),DISULFID:Interchain (with C-233 in DUOXA2),DOMAIN:EF-hand,DOMAIN:EF-hand 1,DOMAIN:EF-hand 2,DOMAIN:EF-hand 3,DOMAIN:FAD-binding FR-type,DOMAIN:Ferric oxidoreductase,REGION:Interaction with TXNDC11,REGION:Peroxidase-like; mediates peroxidase activity,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
P28562	dual specificity phosphatase 1(DUSP1)	Homo sapiens		h_cd40Pathway:CD40L Signaling Pathway,h_dspPathway:Regulation of MAP Kinase Pathways Through Dual Specificity Phosphatases,h_nthiPathway:NFkB activation by Nontypeable Hemophilus influenzae,h_PparaPathway:Mechanism of Gene Regulation by Peroxisome Proliferators via PPARa(alpha),h_tnfr2Pathway:TNFR2 Signaling Pathway,	GO:0001706~endoderm formation,GO:0007049~cell cycle,GO:0007162~negative regulation of cell adhesion,GO:0008285~negative regulation of cell proliferation,GO:0016311~dephosphorylation,GO:0035335~peptidyl-tyrosine dephosphorylation,GO:0035970~peptidyl-threonine dephosphorylation,GO:0043407~negative regulation of MAP kinase activity,GO:0043409~negative regulation of MAPK cascade,GO:0051447~negative regulation of meiotic cell cycle,GO:0070262~peptidyl-serine dephosphorylation,GO:0090027~negative regulation of monocyte chemotaxis,GO:0090266~regulation of mitotic cell cycle spindle assembly checkpoint,GO:1903753~negative regulation of p38MAPK cascade,GO:1990869~cellular response to chemokine,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0004722~protein serine/threonine phosphatase activity,GO:0004725~protein tyrosine phosphatase activity,GO:0005515~protein binding,GO:0008138~protein tyrosine/serine/threonine phosphatase activity,GO:0008330~protein tyrosine/threonine phosphatase activity,GO:0017017~MAP kinase tyrosine/serine/threonine phosphatase activity,GO:0017018~myosin phosphatase activity,GO:0033550~MAP kinase tyrosine phosphatase activity,GO:0051019~mitogen-activated protein kinase binding,	IPR000340:Dual-sp_phosphatase_cat-dom,IPR000387:Tyr_Pase_dom,IPR001763:Rhodanese-like_dom,IPR003595:Tyr_Pase_cat,IPR008343:MKP,IPR016130:Tyr_Pase_AS,IPR020422:TYR_PHOSPHATASE_DUAL_dom,IPR029021:Prot-tyrosine_phosphatase-like,IPR036873:Rhodanese-like_dom_sf,	hsa04010:MAPK signaling pathway,hsa04726:Serotonergic synapse,hsa05012:Parkinson disease,hsa05418:Fluid shear stress and atherosclerosis,		PIRSF000939:MAPK_Ptase,	SM00195:DSPc,SM00404:PTPc_motif,SM00450:RHOD,	KW-0131~Cell cycle,KW-0346~Stress response,	KW-0539~Nucleus,					KW-0378~Hydrolase,KW-0904~Protein phosphatase,	KW-0597~Phosphoprotein,	ACT_SITE:Phosphocysteine intermediate,DOMAIN:Rhodanese,DOMAIN:Tyrosine specific protein phosphatases,DOMAIN:Tyrosine-protein phosphatase,MUTAGEN:C->S: Loss of phosphatase activity.,
Q0IID7	dual specificity phosphatase 10(DUSP10)	Bos taurus			GO:0002819~regulation of adaptive immune response,GO:0006470~protein dephosphorylation,GO:0010633~negative regulation of epithelial cell migration,GO:0016311~dephosphorylation,GO:0032496~response to lipopolysaccharide,GO:0043508~negative regulation of JUN kinase activity,GO:0045591~positive regulation of regulatory T cell differentiation,GO:0046329~negative regulation of JNK cascade,GO:0048709~oligodendrocyte differentiation,GO:0050680~negative regulation of epithelial cell proliferation,GO:0051403~stress-activated MAPK cascade,GO:0060266~negative regulation of respiratory burst involved in inflammatory response,GO:0070373~negative regulation of ERK1 and ERK2 cascade,GO:0090335~regulation of brown fat cell differentiation,GO:1903753~negative regulation of p38MAPK cascade,GO:1905042~negative regulation of epithelium regeneration,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0008330~protein tyrosine/threonine phosphatase activity,GO:0008432~JUN kinase binding,GO:0017017~MAP kinase tyrosine/serine/threonine phosphatase activity,GO:0017018~myosin phosphatase activity,GO:0033549~MAP kinase phosphatase activity,GO:0033550~MAP kinase tyrosine phosphatase activity,GO:0048273~mitogen-activated protein kinase p38 binding,	IPR000340:Dual-sp_phosphatase_cat-dom,IPR000387:Tyr_Pase_dom,IPR001763:Rhodanese-like_dom,IPR008343:MKP,IPR016130:Tyr_Pase_AS,IPR020422:TYR_PHOSPHATASE_DUAL_dom,IPR029021:Prot-tyrosine_phosphatase-like,IPR036873:Rhodanese-like_dom_sf,	bta04010:MAPK signaling pathway,			SM00195:DSPc,SM00450:RHOD,		KW-0539~Nucleus,KW-0963~Cytoplasm,					KW-0378~Hydrolase,KW-0904~Protein phosphatase,		ACT_SITE:Phosphocysteine intermediate,DOMAIN:Rhodanese,DOMAIN:Tyrosine-protein phosphatase,REGION:Interaction with MAP kinases,
Q1LWL2	dual specificity phosphatase 22a(dusp22a)	Danio rerio			GO:0007165~signal transduction,GO:0016311~dephosphorylation,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0004721~phosphoprotein phosphatase activity,GO:0004725~protein tyrosine phosphatase activity,GO:0008138~protein tyrosine/serine/threonine phosphatase activity,GO:0016787~hydrolase activity,GO:0016791~phosphatase activity,GO:0017018~myosin phosphatase activity,	IPR000340:Dual-sp_phosphatase_cat-dom,IPR000387:Tyr_Pase_dom,IPR016130:Tyr_Pase_AS,IPR020422:TYR_PHOSPHATASE_DUAL_dom,IPR029021:Prot-tyrosine_phosphatase-like,				SM00195:DSPc,		KW-0539~Nucleus,KW-0963~Cytoplasm,					KW-0378~Hydrolase,KW-0904~Protein phosphatase,		ACT_SITE:Phosphocysteine intermediate,DOMAIN:Tyrosine-protein phosphatase,
Q566R7	dual specificity phosphatase 22b(dusp22b)	Danio rerio			GO:0007165~signal transduction,GO:0016311~dephosphorylation,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0004721~phosphoprotein phosphatase activity,GO:0004725~protein tyrosine phosphatase activity,GO:0008138~protein tyrosine/serine/threonine phosphatase activity,GO:0016787~hydrolase activity,GO:0016791~phosphatase activity,GO:0017018~myosin phosphatase activity,	IPR000340:Dual-sp_phosphatase_cat-dom,IPR000387:Tyr_Pase_dom,IPR020422:TYR_PHOSPHATASE_DUAL_dom,IPR029021:Prot-tyrosine_phosphatase-like,				SM00195:DSPc,		KW-0539~Nucleus,KW-0963~Cytoplasm,					KW-0378~Hydrolase,KW-0904~Protein phosphatase,		ACT_SITE:Phosphocysteine intermediate,DOMAIN:Tyrosine-protein phosphatase,
Q9NQM4	dynein axonemal assembly factor 6(DNAAF6)	Homo sapiens			GO:0003341~cilium movement,GO:0030317~flagellated sperm motility,GO:0036158~outer dynein arm assembly,GO:0036159~inner dynein arm assembly,GO:0070286~axonemal dynein complex assembly,	GO:0005737~cytoplasm,GO:0005802~trans-Golgi network,	GO:0005515~protein binding,GO:0045505~dynein intermediate chain binding,GO:0051087~chaperone binding,	IPR026697:DNAAF6,IPR041442:PIH1D1/2/3_CS-like,		300991~Ciliary dyskinesia, primary, 36, X-linked,				KW-0333~Golgi apparatus,KW-0963~Cytoplasm,		KW-0225~Disease variant,KW-0990~Primary ciliary dyskinesia,KW-1012~Kartagener syndrome,KW-1186~Ciliopathy,					REGION:Disordered,
F1QMY1	dynein light chain Tctex-type 2B(dynlt2b)	Danio rerio			GO:0007018~microtubule-based movement,GO:0035721~intraciliary retrograde transport,	GO:0005737~cytoplasm,GO:0005868~cytoplasmic dynein complex,GO:0005929~cilium,	GO:0045505~dynein intermediate chain binding,	IPR005334:Tctex-1-like,IPR038586:Tctex-1-like_sf,						KW-0963~Cytoplasm,
Q6NTY6	early growth response 1 S homeolog(egr1.S)	Xenopus laevis			GO:0006355~regulation of transcription, DNA-templated,GO:0032922~circadian regulation of gene expression,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048511~rhythmic process,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0008270~zinc ion binding,GO:0010385~double-stranded methylated DNA binding,GO:0043565~sequence-specific DNA binding,GO:0044729~hemi-methylated DNA-binding,GO:0046872~metal ion binding,GO:1990841~promoter-specific chromatin binding,	IPR013087:Znf_C2H2_type,IPR021839:EGR1_C,IPR021849:EGR_N,IPR036236:Znf_C2H2_sf,	xla04371:Apelin signaling pathway,xla04912:GnRH signaling pathway,			SM00355:ZnF_C2H2,	KW-0090~Biological rhythms,KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0677~Repeat,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0010~Activator,KW-0238~DNA-binding,		DOMAIN:C2H2-type,REGION:Disordered,SITE:Interaction with DNA,ZN_FING:C2H2-type 1,ZN_FING:C2H2-type 2,ZN_FING:C2H2-type 3,
P49961	ectonucleoside triphosphate diphosphohydrolase 1(ENTPD1)	Homo sapiens			GO:0007155~cell adhesion,GO:0007596~blood coagulation,GO:0009134~nucleoside diphosphate catabolic process,GO:0070527~platelet aggregation,	GO:0005886~plasma membrane,GO:0005901~caveola,GO:0016020~membrane,GO:0070062~extracellular exosome,	GO:0003924~GTPase activity,GO:0004382~guanosine-diphosphatase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016787~hydrolase activity,GO:0016887~ATPase activity,GO:0017110~nucleoside-diphosphatase activity,GO:0017111~nucleoside-triphosphatase activity,GO:0036384~cytidine diphosphatase activity,GO:0043262~adenosine-diphosphatase activity,GO:0043273~CTPase activity,GO:0045134~uridine-diphosphatase activity,GO:0103023~ITPase activity,GO:1990003~IDP phosphatase activity,	IPR000407:GDA1_CD39_NTPase,	hsa00230:Purine metabolism,hsa00240:Pyrimidine metabolism,hsa01100:Metabolic pathways,hsa01232:Nucleotide metabolism,hsa05169:Epstein-Barr virus infection,	615683~Spastic paraplegia 64, autosomal recessive,				KW-0472~Membrane,		KW-0225~Disease variant,KW-0523~Neurodegeneration,KW-0890~Hereditary spastic paraplegia,	KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0067~ATP-binding,KW-0106~Calcium,KW-0460~Magnesium,KW-0547~Nucleotide-binding,	KW-0378~Hydrolase,	KW-0325~Glycoprotein,KW-0449~Lipoprotein,KW-0564~Palmitate,KW-1015~Disulfide bond,	ACT_SITE:Proton acceptor,CARBOHYD:N-linked (GlcNAc...) asparagine,LIPID:S-palmitoyl cysteine,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
E1C1L6	ectonucleoside triphosphate diphosphohydrolase 5(ENTPD5)	Gallus gallus			GO:0006011~UDP-glucose metabolic process,GO:0006256~UDP catabolic process,GO:0006487~protein N-linked glycosylation,GO:0009134~nucleoside diphosphate catabolic process,GO:0051084~'de novo' posttranslational protein folding,	GO:0005576~extracellular region,GO:0005783~endoplasmic reticulum,GO:0016020~membrane,	GO:0004382~guanosine-diphosphatase activity,GO:0005524~ATP binding,GO:0016787~hydrolase activity,GO:0036384~cytidine diphosphatase activity,GO:0043262~adenosine-diphosphatase activity,GO:0045134~uridine-diphosphatase activity,GO:1990003~IDP phosphatase activity,	IPR000407:GDA1_CD39_NTPase,	gga00230:Purine metabolism,gga00240:Pyrimidine metabolism,gga01100:Metabolic pathways,gga01232:Nucleotide metabolism,					KW-0256~Endoplasmic reticulum,KW-0964~Secreted,			KW-0732~Signal,	KW-0067~ATP-binding,KW-0106~Calcium,KW-0460~Magnesium,KW-0547~Nucleotide-binding,	KW-0378~Hydrolase,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	ACT_SITE:Proton acceptor,CARBOHYD:N-linked (GlcNAc...) asparagine,
Q8R2E9	endoplasmic reticulum oxidoreductase 1 beta(Ero1b)	Mus musculus			GO:0006888~ER to Golgi vesicle-mediated transport,GO:0018401~peptidyl-proline hydroxylation to 4-hydroxy-L-proline,GO:0022417~protein maturation by protein folding,GO:0030070~insulin processing,GO:0030198~extracellular matrix organization,GO:0034975~protein folding in endoplasmic reticulum,GO:0042593~glucose homeostasis,GO:0045454~cell redox homeostasis,	GO:0005783~endoplasmic reticulum,GO:0005788~endoplasmic reticulum lumen,GO:0005789~endoplasmic reticulum membrane,GO:0016020~membrane,	GO:0015035~protein disulfide oxidoreductase activity,GO:0015036~disulfide oxidoreductase activity,GO:0016491~oxidoreductase activity,GO:0016972~thiol oxidase activity,GO:0071949~FAD binding,	IPR007266:Ero1,IPR037192:ERO1-like_sf,	mmu04141:Protein processing in endoplasmic reticulum,		PIRSF017205:ERO1,		KW-0249~Electron transport,KW-0813~Transport,	KW-0256~Endoplasmic reticulum,KW-0472~Membrane,			KW-0676~Redox-active center,KW-0732~Signal,	KW-0274~FAD,KW-0285~Flavoprotein,	KW-0560~Oxidoreductase,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	ACT_SITE:Nucleophile,CARBOHYD:N-linked (GlcNAc...) asparagine,DISULFID:Alternate,DISULFID:Redox-active,DISULFID:Redox-active; alternate,MUTAGEN:C->A: Complete loss of disulfide oxidase activity in vitro.,
Q6UXG2	endosome-lysosome associated apoptosis and autophagy regulator 1(ELAPOR1)	Homo sapiens			GO:0000045~autophagosome assembly,GO:0009267~cellular response to starvation,GO:0044090~positive regulation of vacuole organization,GO:2000786~positive regulation of autophagosome assembly,	GO:0005764~lysosome,GO:0005765~lysosomal membrane,GO:0005770~late endosome,GO:0005789~endoplasmic reticulum membrane,GO:0005794~Golgi apparatus,GO:0005802~trans-Golgi network,GO:0005886~plasma membrane,GO:0031902~late endosome membrane,GO:0070062~extracellular exosome,	GO:0003723~RNA binding,	IPR009011:Man6P_isomerase_rcpt-bd_dom_sf,IPR009030:Growth_fac_rcpt_cys_sf,IPR039181:EIG121-like,IPR044865:MRH_dom,				SM01411:Ephrin_rec_like,	KW-0072~Autophagy,	KW-0256~Endoplasmic reticulum,KW-0333~Golgi apparatus,KW-0458~Lysosome,KW-0472~Membrane,KW-0967~Endosome,KW-1003~Cell membrane,			KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:MRH,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
A6QLI0	ependymin related 1(EPDR1)	Bos taurus			GO:0007160~cell-matrix adhesion,GO:1990764~myofibroblast contraction,	GO:0005576~extracellular region,GO:0005764~lysosome,GO:0043202~lysosomal lumen,	GO:0005509~calcium ion binding,GO:0005543~phospholipid binding,GO:0042802~identical protein binding,GO:1905573~ganglioside GM1 binding,	IPR001299:Ependymin,				SM00026:EPEND,		KW-0458~Lysosome,KW-0964~Secreted,			KW-0732~Signal,	KW-0446~Lipid-binding,		KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,
P07099	epoxide hydrolase 1(EPHX1)	Homo sapiens		h_eicosanoidPathway:Eicosanoid Metabolism,	GO:0006805~xenobiotic metabolic process,GO:0009636~response to toxic substance,GO:0014070~response to organic cyclic compound,GO:0019369~arachidonic acid metabolic process,GO:0019439~aromatic compound catabolic process,GO:0097176~epoxide metabolic process,	GO:0005789~endoplasmic reticulum membrane,	GO:0004301~epoxide hydrolase activity,GO:0005515~protein binding,GO:0008142~oxysterol binding,GO:0016787~hydrolase activity,GO:0033961~cis-stilbene-oxide hydrolase activity,	IPR000073:AB_hydrolase_1,IPR000639:Epox_hydrolase-like,IPR010497:Epoxide_hydro_N,IPR016292:Epoxide_hydrolase,IPR029058:AB_hydrolase,	hsa00980:Metabolism of xenobiotics by cytochrome P450,hsa04976:Bile secretion,hsa05204:Chemical carcinogenesis - DNA adducts,hsa05207:Chemical carcinogenesis - receptor activation,hsa05208:Chemical carcinogenesis - reactive oxygen species,		PIRSF001112:Epoxide_hydrolase,		KW-0058~Aromatic hydrocarbons catabolism,KW-0216~Detoxification,KW-0443~Lipid metabolism,	KW-0256~Endoplasmic reticulum,KW-0472~Membrane,KW-0492~Microsome,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0378~Hydrolase,	KW-0488~Methylation,	ACT_SITE:Nucleophile,ACT_SITE:Proton acceptor,ACT_SITE:Proton donor,DOMAIN:AB hydrolase-1,DOMAIN:Epoxide hydrolase N-terminal,TOPO_DOM:Cytoplasmic,TRANSMEM:Helical; Signal-anchor for type III membrane protein,
Q96PL5	erythroblast membrane associated protein (Scianna blood group)(ERMAP)	Homo sapiens			GO:0001817~regulation of cytokine production,GO:0050852~T cell receptor signaling pathway,	GO:0005794~Golgi apparatus,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0009897~external side of plasma membrane,GO:0016020~membrane,	GO:0005102~receptor binding,GO:0005515~protein binding,	IPR001870:B30.2/SPRY,IPR003599:Ig_sub,IPR003877:SPRY_dom,IPR003879:Butyrophylin_SPRY,IPR006574:PRY,IPR007110:Ig-like_dom,IPR013106:Ig_V-set,IPR013320:ConA-like_dom_sf,IPR013783:Ig-like_fold,IPR036179:Ig-like_dom_sf,IPR043136:B30.2/SPRY_sf,		111620~Blood group, Radin,111750~Blood group, Scianna system,		SM00406:IGv,SM00409:IG,SM00449:SPRY,SM00589:PRY,		KW-0472~Membrane,KW-0963~Cytoplasm,KW-1003~Cell membrane,			KW-0393~Immunoglobulin domain,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0095~Blood group antigen,	KW-0325~Glycoprotein,KW-0597~Phosphoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:B30.2/SPRY,DOMAIN:Ig-like,DOMAIN:Ig-like V-type,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q9HCM4	erythrocyte membrane protein band 4.1 like 5(EPB41L5)	Homo sapiens			GO:0001701~in utero embryonic development,GO:0001837~epithelial to mesenchymal transition,GO:0001839~neural plate morphogenesis,GO:0003383~apical constriction,GO:0006931~substrate-dependent cell migration, cell attachment to substrate,GO:0007398~ectoderm development,GO:0007492~endoderm development,GO:0007509~mesoderm migration involved in gastrulation,GO:0009826~unidimensional cell growth,GO:0010608~posttranscriptional regulation of gene expression,GO:0010634~positive regulation of epithelial cell migration,GO:0022408~negative regulation of cell-cell adhesion,GO:0031032~actomyosin structure organization,GO:0032525~somite rostral/caudal axis specification,GO:0048319~axial mesoderm morphogenesis,GO:0048339~paraxial mesoderm development,GO:0048617~embryonic foregut morphogenesis,GO:0051894~positive regulation of focal adhesion assembly,GO:0070201~regulation of establishment of protein localization,GO:0070986~left/right axis specification,GO:0071560~cellular response to transforming growth factor beta stimulus,	GO:0001917~photoreceptor inner segment,GO:0005654~nucleoplasm,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0005912~adherens junction,GO:0005925~focal adhesion,GO:0032587~ruffle membrane,	GO:0005515~protein binding,GO:0008092~cytoskeletal protein binding,GO:0019904~protein domain specific binding,	IPR000299:FERM_domain,IPR000798:Ez/rad/moesin-like,IPR011993:PH-like_dom_sf,IPR014352:FERM/acyl-CoA-bd_prot_sf,IPR014847:FA,IPR018979:FERM_N,IPR018980:FERM_PH-like_C,IPR019747:FERM_CS,IPR019748:FERM_central,IPR019749:Band_41_domain,IPR029071:Ubiquitin-like_domsf,IPR035963:FERM_2,				SM00295:B41,SM01195:FA,SM01196:FERM_C,		KW-0472~Membrane,KW-0963~Cytoplasm,KW-0965~Cell junction,KW-1003~Cell membrane,						KW-0597~Phosphoprotein,	DOMAIN:FERM,REGION:Required for interaction with CRB1,
Q9PVZ9	estrogen receptor 1(esr1)	Sparus aurata			GO:0006355~regulation of transcription, DNA-templated,GO:0043401~steroid hormone mediated signaling pathway,	GO:0005634~nucleus,	GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005496~steroid binding,GO:0008270~zinc ion binding,GO:0030284~estrogen receptor activity,GO:0042562~hormone binding,GO:0043565~sequence-specific DNA binding,	IPR000536:Nucl_hrmn_rcpt_lig-bd,IPR001292:Estr_rcpt,IPR001628:Znf_hrmn_rcpt,IPR001723:Nuclear_hrmn_rcpt,IPR013088:Znf_NHR/GATA,IPR024178:Est_rcpt/est-rel_rcp,IPR035500:NHR-like_dom_sf,IPR046944:Estr_rcpt_N,			PIRSF002527:ER-like_NR,PIRSF500101:ER-a,	SM00399:ZnF_C4,SM00430:HOLI,	KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,			KW-0863~Zinc-finger,	KW-0446~Lipid-binding,KW-0479~Metal-binding,KW-0754~Steroid-binding,KW-0862~Zinc,	KW-0238~DNA-binding,KW-0675~Receptor,		COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DNA_BIND:Nuclear receptor,DOMAIN:NR LBD,DOMAIN:Nuclear receptor,REGION:Disordered,REGION:Hinge,REGION:Modulating,ZN_FING:NR C4-type,
Q78T81	estrogen-induced osteoclastogenesis regulator 1(Eeig1)	Mus musculus			GO:0045672~positive regulation of osteoclast differentiation,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0016020~membrane,GO:0045121~membrane raft,	GO:0005515~protein binding,	IPR019448:NT-C2,IPR039931:EEIG1/2-like,						KW-0472~Membrane,KW-0539~Nucleus,KW-0963~Cytoplasm,							COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:C2 NT-type,REGION:Disordered,REGION:Required for interaction with TNFRSF11A/RANK,
Q5RA42	eukaryotic translation initiation factor 1A X-linked(EIF1AX)	Pongo abelii			GO:0006413~translational initiation,	GO:0005737~cytoplasm,	GO:0000049~tRNA binding,GO:0003723~RNA binding,GO:0003743~translation initiation factor activity,	IPR001253:TIF_eIF-1A,IPR006196:RNA-binding_domain_S1_IF1,IPR012340:NA-bd_OB-fold,IPR018104:TIF_eIF-1A_CS,				SM00652:eIF1a,	KW-0648~Protein biosynthesis,	KW-0963~Cytoplasm,					KW-0396~Initiation factor,KW-0694~RNA-binding,KW-0820~tRNA-binding,		COMPBIAS:Acidic residues,COMPBIAS:Basic and acidic residues,DOMAIN:S1-like,REGION:Disordered,
Q5RA42	eukaryotic translation initiation factor 1A Y-linked(EIF1AY)	Pongo abelii			GO:0006413~translational initiation,	GO:0005737~cytoplasm,	GO:0000049~tRNA binding,GO:0003723~RNA binding,GO:0003743~translation initiation factor activity,	IPR001253:TIF_eIF-1A,IPR006196:RNA-binding_domain_S1_IF1,IPR012340:NA-bd_OB-fold,IPR018104:TIF_eIF-1A_CS,				SM00652:eIF1a,	KW-0648~Protein biosynthesis,	KW-0963~Cytoplasm,					KW-0396~Initiation factor,KW-0694~RNA-binding,KW-0820~tRNA-binding,		COMPBIAS:Acidic residues,COMPBIAS:Basic and acidic residues,DOMAIN:S1-like,REGION:Disordered,
Q63184	eukaryotic translation initiation factor 2-alpha kinase 2(Eif2ak2)	Rattus norvegicus			GO:0001819~positive regulation of cytokine production,GO:0006412~translation,GO:0006468~protein phosphorylation,GO:0009612~response to mechanical stimulus,GO:0009615~response to virus,GO:0009636~response to toxic substance,GO:0010033~response to organic substance,GO:0016310~phosphorylation,GO:0017148~negative regulation of translation,GO:0030968~endoplasmic reticulum unfolded protein response,GO:0032496~response to lipopolysaccharide,GO:0032722~positive regulation of chemokine production,GO:0032874~positive regulation of stress-activated MAPK cascade,GO:0033197~response to vitamin E,GO:0033689~negative regulation of osteoblast proliferation,GO:0034198~cellular response to amino acid starvation,GO:0035455~response to interferon-alpha,GO:0036492~eiF2alpha phosphorylation in response to endoplasmic reticulum stress,GO:0043065~positive regulation of apoptotic process,GO:0043066~negative regulation of apoptotic process,GO:0043330~response to exogenous dsRNA,GO:0043410~positive regulation of MAPK cascade,GO:0045071~negative regulation of viral genome replication,GO:0046777~protein autophosphorylation,GO:0051092~positive regulation of NF-kappaB transcription factor activity,GO:1900225~regulation of NLRP3 inflammasome complex assembly,GO:1901224~positive regulation of NIK/NF-kappaB signaling,GO:1901532~regulation of hematopoietic progenitor cell differentiation,GO:1902033~regulation of hematopoietic stem cell proliferation,GO:1902036~regulation of hematopoietic stem cell differentiation,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0048471~perinuclear region of cytoplasm,	GO:0003725~double-stranded RNA binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0004694~eukaryotic translation initiation factor 2alpha kinase activity,GO:0004715~non-membrane spanning protein tyrosine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016301~kinase activity,GO:0042802~identical protein binding,	IPR000719:Prot_kinase_dom,IPR008271:Ser/Thr_kinase_AS,IPR011009:Kinase-like_dom_sf,IPR014720:dsRBD_dom,IPR017441:Protein_kinase_ATP_BS,IPR044452:EIF2AK2_DSRM_1,IPR044453:EIF2AK2_DSRM_2,	rno04217:Necroptosis,rno05010:Alzheimer disease,rno05160:Hepatitis C,rno05162:Measles,rno05164:Influenza A,rno05165:Human papillomavirus infection,rno05167:Kaposi sarcoma-associated herpesvirus infection,rno05168:Herpes simplex virus 1 infection,rno05169:Epstein-Barr virus infection,rno05171:Coronavirus disease - COVID-19,rno05203:Viral carcinogenesis,			SM00220:S_TKc,SM00358:DSRM,	KW-0051~Antiviral defense,KW-0391~Immunity,KW-0399~Innate immunity,KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0677~Repeat,	KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0418~Kinase,KW-0694~RNA-binding,KW-0723~Serine/threonine-protein kinase,KW-0808~Transferase,KW-0829~Tyrosine-protein kinase,	KW-0007~Acetylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	ACT_SITE:Proton acceptor,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ISG15),DOMAIN:DRBM,DOMAIN:DRBM 1,DOMAIN:DRBM 2,DOMAIN:Protein kinase,REGION:Interaction with TRAF5,
P23588	eukaryotic translation initiation factor 4B(EIF4B)	Homo sapiens		h_mtorPathway:mTOR Signaling Pathway,	GO:0006413~translational initiation,GO:0006446~regulation of translational initiation,	GO:0005829~cytosol,GO:0016281~eukaryotic translation initiation factor 4F complex,	GO:0003723~RNA binding,GO:0003743~translation initiation factor activity,GO:0005515~protein binding,	IPR000504:RRM_dom,IPR012677:Nucleotide-bd_a/b_plait_sf,IPR033107:EIF-4B_RRM,IPR035979:RBD_domain_sf,	hsa04150:mTOR signaling pathway,hsa04151:PI3K-Akt signaling pathway,hsa05205:Proteoglycans in cancer,			SM00360:RRM,	KW-0648~Protein biosynthesis,						KW-0396~Initiation factor,KW-0694~RNA-binding,	KW-0007~Acetylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,COMPBIAS:Pro residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),DOMAIN:RRM,MUTAGEN:S->A: Non-phosphorylatable mutant whose expression results in reduced SLC4A7 protein levels in TSC2-deficient cells accompanied by decrease in the bicarbonate-dependent flux into nucleotide synthesis.,REGION:Disordered,
P48597	eukaryotic translation initiation factor 4E family member 1B S homeolog(eif4e1b.S)	Xenopus laevis			GO:0006406~mRNA export from nucleus,GO:0006412~translation,GO:0006413~translational initiation,GO:0006417~regulation of translation,GO:0051028~mRNA transport,	GO:0000932~P-body,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005845~mRNA cap binding complex,GO:0016281~eukaryotic translation initiation factor 4F complex,GO:0016607~nuclear speck,GO:0032991~macromolecular complex,	GO:0003723~RNA binding,GO:0003743~translation initiation factor activity,GO:0005515~protein binding,	IPR001040:TIF_eIF_4E,IPR019770:TIF_eIF_4E_CS,IPR023398:TIF_eIF4e-like,	xla04150:mTOR signaling pathway,xla04910:Insulin signaling pathway,				KW-0509~mRNA transport,KW-0648~Protein biosynthesis,KW-0810~Translation regulation,KW-0813~Transport,	KW-0539~Nucleus,KW-0963~Cytoplasm,					KW-0396~Initiation factor,KW-0694~RNA-binding,		COMPBIAS:Basic and acidic residues,MUTAGEN:S->A,D: Does not affect ability to restore translation to an EIF4E-dependent in vitro translation system. Does not affect efficient EIF4E-mediated promotion of EIF4G cleavage by L-protease.,REGION:Disordered,
Q8BMB3	eukaryotic translation initiation factor 4E member 2(Eif4e2)	Mus musculus			GO:0001701~in utero embryonic development,GO:0006412~translation,GO:0006413~translational initiation,GO:0006417~regulation of translation,GO:0017148~negative regulation of translation,GO:0031047~gene silencing by RNA,GO:0035278~miRNA mediated inhibition of translation,GO:0045947~negative regulation of translational initiation,GO:0060339~negative regulation of type I interferon-mediated signaling pathway,GO:0072344~rescue of stalled ribosome,	GO:0000932~P-body,GO:0005737~cytoplasm,GO:0005845~mRNA cap binding complex,GO:0016281~eukaryotic translation initiation factor 4F complex,	GO:0000340~RNA 7-methylguanosine cap binding,GO:0003723~RNA binding,GO:0003743~translation initiation factor activity,GO:0031625~ubiquitin protein ligase binding,	IPR001040:TIF_eIF_4E,IPR019770:TIF_eIF_4E_CS,IPR023398:TIF_eIF4e-like,	mmu01521:EGFR tyrosine kinase inhibitor resistance,mmu04066:HIF-1 signaling pathway,mmu04150:mTOR signaling pathway,mmu04151:PI3K-Akt signaling pathway,mmu04211:Longevity regulating pathway,mmu04910:Insulin signaling pathway,				KW-0648~Protein biosynthesis,KW-0810~Translation regulation,KW-0943~RNA-mediated gene silencing,	KW-0963~Cytoplasm,					KW-0396~Initiation factor,KW-0694~RNA-binding,	KW-0007~Acetylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Basic and acidic residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ISG15),CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ISG15); alternate,REGION:Disordered,REGION:EIF4EBP1/2/3 binding,
Q6ZM19	eukaryotic translation initiation factor 6(eif6)	Danio rerio			GO:0000054~ribosomal subunit export from nucleus,GO:0000460~maturation of 5.8S rRNA,GO:0000470~maturation of LSU-rRNA,GO:0006412~translation,GO:0006413~translational initiation,GO:0042254~ribosome biogenesis,GO:0042256~mature ribosome assembly,GO:1902626~assembly of large subunit precursor of preribosome,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0030687~preribosome, large subunit precursor,	GO:0003743~translation initiation factor activity,GO:0043022~ribosome binding,GO:0043023~ribosomal large subunit binding,	IPR002769:eIF6,	dre03008:Ribosome biogenesis in eukaryotes,		PIRSF006413:IF-6,	SM00654:eIF6,	KW-0648~Protein biosynthesis,KW-0690~Ribosome biogenesis,	KW-0539~Nucleus,KW-0963~Cytoplasm,					KW-0396~Initiation factor,
A2BGR3	excision repair cross-complementation group 6-like(ercc6l)	Danio rerio			GO:0007049~cell cycle,GO:0016539~intein-mediated protein splicing,GO:0051301~cell division,	GO:0000775~chromosome, centromeric region,GO:0000776~kinetochore,GO:0005694~chromosome,	GO:0000166~nucleotide binding,GO:0003677~DNA binding,GO:0004386~helicase activity,GO:0005524~ATP binding,GO:0015616~DNA translocase activity,GO:0016787~hydrolase activity,GO:0016887~ATPase activity,	IPR000330:SNF2_N,IPR001650:Helicase_C,IPR006141:Intein_N,IPR014001:Helicase_ATP-bd,IPR019734:TPR_repeat,IPR027417:P-loop_NTPase,IPR038718:SNF2-like_sf,				SM00487:DEXDc,SM00490:HELICc,	KW-0131~Cell cycle,KW-0132~Cell division,KW-0498~Mitosis,	KW-0137~Centromere,KW-0158~Chromosome,KW-0995~Kinetochore,			KW-0175~Coiled coil,KW-0677~Repeat,KW-0802~TPR repeat,	KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0238~DNA-binding,KW-0347~Helicase,KW-0378~Hydrolase,	KW-0597~Phosphoprotein,	COMPBIAS:Acidic residues,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:Helicase ATP-binding,DOMAIN:Helicase C-terminal,MOTIF:DEAH box,REGION:Disordered,REPEAT:TPR,REPEAT:TPR 1,REPEAT:TPR 2,
Q9Y3B2	exosome component 1(EXOSC1)	Homo sapiens			GO:0006364~rRNA processing,GO:0006396~RNA processing,GO:0006401~RNA catabolic process,	GO:0000176~nuclear exosome (RNase complex),GO:0000177~cytoplasmic exosome (RNase complex),GO:0000178~exosome (RNase complex),GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0101019~nucleolar exosome (RNase complex),	GO:0003723~RNA binding,GO:0005515~protein binding,	IPR003029:S1_domain,IPR012340:NA-bd_OB-fold,IPR019495:EXOSC1_C,IPR025721:Exosome_cplx_N_dom,IPR039771:Csl4,	hsa03018:RNA degradation,	619304~Pontocerebellar hypoplasia, type 1F,		SM00316:S1,	KW-0698~rRNA processing,	KW-0271~Exosome,KW-0539~Nucleus,KW-0963~Cytoplasm,		KW-0225~Disease variant,KW-0523~Neurodegeneration,			KW-0694~RNA-binding,	KW-0597~Phosphoprotein,	DOMAIN:Exosome complex component CSL4 C-terminal,DOMAIN:Exosome complex component N-terminal,DOMAIN:S1 motif,
P60330	extra spindle pole bodies 1, separase(Espl1)	Mus musculus			GO:0000070~mitotic sister chromatid segregation,GO:0000212~meiotic spindle organization,GO:0000278~mitotic cell cycle,GO:0000280~nuclear division,GO:0006508~proteolysis,GO:0007059~chromosome segregation,GO:0007127~meiosis I,GO:0045143~homologous chromosome segregation,GO:0051307~meiotic chromosome separation,GO:0098813~nuclear chromosome segregation,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0072686~mitotic spindle,	GO:0004197~cysteine-type endopeptidase activity,GO:0008233~peptidase activity,GO:0008234~cysteine-type peptidase activity,GO:0016787~hydrolase activity,	IPR005314:Peptidase_C50,IPR030397:SEPARIN_core_dom,	mmu04110:Cell cycle,mmu04114:Oocyte meiosis,mmu05166:Human T-cell leukemia virus 1 infection,				KW-0159~Chromosome partition,	KW-0539~Nucleus,KW-0963~Cytoplasm,					KW-0378~Hydrolase,KW-0645~Protease,KW-0788~Thiol protease,	KW-0068~Autocatalytic cleavage,KW-0597~Phosphoprotein,	DOMAIN:Peptidase C50,REGION:Disordered,SITE:Cleavage; by autolysis,
A4QP72	family with sequence similarity 83 member D(fam83d)	Danio rerio			GO:0007049~cell cycle,GO:0007165~signal transduction,GO:0008283~cell proliferation,GO:0032006~regulation of TOR signaling,GO:0051301~cell division,GO:0051310~metaphase plate congression,GO:0070372~regulation of ERK1 and ERK2 cascade,GO:1902480~protein localization to mitotic spindle,GO:1902808~positive regulation of cell cycle G1/S phase transition,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0097431~mitotic spindle pole,	GO:0019901~protein kinase binding,	IPR012461:FAM83_N,					KW-0131~Cell cycle,KW-0132~Cell division,KW-0498~Mitosis,	KW-0206~Cytoskeleton,KW-0963~Cytoplasm,							COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,REGION:Disordered,
Q96AE4	far upstream element binding protein 1(FUBP1)	Homo sapiens			GO:0006355~regulation of transcription, DNA-templated,GO:0010468~regulation of gene expression,GO:0010628~positive regulation of gene expression,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,	GO:0003676~nucleic acid binding,GO:0003697~single-stranded DNA binding,GO:0003723~RNA binding,GO:0003729~mRNA binding,GO:0005515~protein binding,	IPR004087:KH_dom,IPR004088:KH_dom_type_1,IPR015096:FUBP_C,IPR036612:KH_dom_type_1_sf,IPR048249:KH-I_FUBP1_dom1,IPR048250:KH-I_FUBP1_dom2,IPR048251:KH-I_FUBP1_dom3,IPR048252:KH-I_FUBP1_dom4,				SM00322:KH,	KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,			KW-0677~Repeat,		KW-0238~DNA-binding,KW-0694~RNA-binding,	KW-0007~Acetylation,KW-0488~Methylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,	COMPBIAS:Polar residues,COMPBIAS:Pro residues,DOMAIN:Far upstream element-binding protein C-terminal,DOMAIN:K Homology,DOMAIN:KH 1,DOMAIN:KH 2,DOMAIN:KH 3,DOMAIN:KH 4,REGION:Disordered,
Q61239	farnesyltransferase, CAAX box, alpha(Fnta)	Mus musculus			GO:0007167~enzyme linked receptor protein signaling pathway,GO:0007528~neuromuscular junction development,GO:0008284~positive regulation of cell proliferation,GO:0010035~response to inorganic substance,GO:0014070~response to organic cyclic compound,GO:0018342~protein prenylation,GO:0018343~protein farnesylation,GO:0018344~protein geranylgeranylation,GO:0034097~response to cytokine,GO:0035022~positive regulation of Rac protein signal transduction,GO:0043066~negative regulation of apoptotic process,GO:0045787~positive regulation of cell cycle,GO:0051770~positive regulation of nitric-oxide synthase biosynthetic process,GO:0051771~negative regulation of nitric-oxide synthase biosynthetic process,GO:0071340~skeletal muscle acetylcholine-gated channel clustering,GO:0090044~positive regulation of tubulin deacetylation,GO:0090045~positive regulation of deacetylase activity,GO:1904395~positive regulation of skeletal muscle acetylcholine-gated channel clustering,	GO:0005737~cytoplasm,GO:0005875~microtubule associated complex,GO:0005886~plasma membrane,GO:0005953~CAAX-protein geranylgeranyltransferase complex,GO:0005965~protein farnesyltransferase complex,	GO:0004659~prenyltransferase activity,GO:0004660~protein farnesyltransferase activity,GO:0004661~protein geranylgeranyltransferase activity,GO:0004662~CAAX-protein geranylgeranyltransferase activity,GO:0004663~Rab geranylgeranyltransferase activity,GO:0008017~microtubule binding,GO:0008270~zinc ion binding,GO:0008318~protein prenyltransferase activity,GO:0016740~transferase activity,GO:0030971~receptor tyrosine kinase binding,GO:0036094~small molecule binding,GO:0042277~peptide binding,GO:0043014~alpha-tubulin binding,GO:0060090~binding, bridging,GO:1901363~heterocyclic compound binding,	IPR002088:Prenyl_trans_a,	mmu00900:Terpenoid backbone biosynthesis,								KW-0175~Coiled coil,KW-0677~Repeat,	KW-0460~Magnesium,	KW-0637~Prenyltransferase,KW-0808~Transferase,	KW-0007~Acetylation,KW-0597~Phosphoprotein,	COMPBIAS:Pro residues,MUTAGEN:K->A: Inhibits prenylation activity. In myoblasts, impaired insulin-induced RAC1 activation, possibly due to impaired insulin-induced geranyl-geranyltransferase activation. No effect on MUSK-binding.,MUTAGEN:Y->F: Inhibits prenylation activity. In myoblasts, impaired insulin-induced RAC1 activation, possibly due to impaired insulin-induced geranyl-geranyltransferase activation. 68% decrease in MUSK-binding.,REGION:Disordered,REPEAT:PFTA 1,REPEAT:PFTA 2,REPEAT:PFTA 3,REPEAT:PFTA 4,REPEAT:PFTA 5,
Q9GKT2	fatty acid hydroxylase domain containing 2(FAXDC2)	Macaca fascicularis			GO:0001934~positive regulation of protein phosphorylation,GO:0008610~lipid biosynthetic process,GO:0016126~sterol biosynthetic process,GO:0045654~positive regulation of megakaryocyte differentiation,	GO:0005737~cytoplasm,GO:0016020~membrane,	GO:0000254~C-4 methylsterol oxidase activity,GO:0005506~iron ion binding,GO:0016491~oxidoreductase activity,	IPR006694:Fatty_acid_hydroxylase,						KW-0472~Membrane,KW-0963~Cytoplasm,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,				DOMAIN:Fatty acid hydroxylase,TRANSMEM:Helical,
P12276	fatty acid synthase(FASN)	Gallus gallus			GO:0006089~lactate metabolic process,GO:0006633~fatty acid biosynthetic process,GO:0032100~positive regulation of appetite,	GO:0005737~cytoplasm,	GO:0003697~single-stranded DNA binding,GO:0004312~fatty acid synthase activity,GO:0004313~[acyl-carrier-protein] S-acetyltransferase activity,GO:0004314~[acyl-carrier-protein] S-malonyltransferase activity,GO:0004315~3-oxoacyl-[acyl-carrier-protein] synthase activity,GO:0004316~3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity,GO:0004317~3-hydroxypalmitoyl-[acyl-carrier-protein] dehydratase activity,GO:0008659~(3R)-hydroxymyristoyl-[acyl-carrier-protein] dehydratase activity,GO:0008693~3-hydroxydecanoyl-[acyl-carrier-protein] dehydratase activity,GO:0008757~S-adenosylmethionine-dependent methyltransferase activity,GO:0016295~myristoyl-[acyl-carrier-protein] hydrolase activity,GO:0016296~palmitoyl-[acyl-carrier-protein] hydrolase activity,GO:0016491~oxidoreductase activity,GO:0016787~hydrolase activity,GO:0016829~lyase activity,GO:0031177~phosphopantetheine binding,GO:0047117~enoyl-[acyl-carrier-protein] reductase (NADPH, A-specific) activity,GO:0047450~crotonoyl-[acyl-carrier-protein] hydratase activity,GO:0047451~3-hydroxyoctanoyl-[acyl-carrier-protein] dehydratase activity,	IPR001031:Thioesterase,IPR001227:Ac_transferase_dom_sf,IPR006162:Ppantetheine_attach_site,IPR009081:PP-bd_ACP,IPR011032:GroES-like_sf,IPR013149:ADH-like_C,IPR013968:PKS_KR,IPR014030:Ketoacyl_synth_N,IPR014031:Ketoacyl_synth_C,IPR014043:Acyl_transferase,IPR016035:Acyl_Trfase/lysoPLipase,IPR016036:Malonyl_transacylase_ACP-bd,IPR016039:Thiolase-like,IPR018201:Ketoacyl_synth_AS,IPR020806:PKS_PP-bd,IPR020807:PKS_DH,IPR020841:PKS_Beta-ketoAc_synthase_dom,IPR020843:PKS_ER,IPR029058:AB_hydrolase,IPR029063:SAM-dependent_MTases_sf,IPR032821:PKS_assoc,IPR036291:NAD(P)-bd_dom_sf,IPR036736:ACP-like_sf,IPR042104:PKS_dehydratase_sf,IPR049391:FAS_pseudo-KR,	gga00061:Fatty acid biosynthesis,gga01100:Metabolic pathways,gga01212:Fatty acid metabolism,gga04910:Insulin signaling pathway,			SM00822:PKS_KR,SM00823:PKS_PP,SM00825:PKS_KS,SM00826:PKS_DH,SM00827:PKS_AT,SM00829:PKS_ER,	KW-0275~Fatty acid biosynthesis,KW-0276~Fatty acid metabolism,KW-0443~Lipid metabolism,KW-0444~Lipid biosynthesis,					KW-0520~NAD,KW-0521~NADP,KW-0663~Pyridoxal phosphate,	KW-0378~Hydrolase,KW-0456~Lyase,KW-0511~Multifunctional enzyme,KW-0560~Oxidoreductase,KW-0808~Transferase,	KW-0007~Acetylation,KW-0596~Phosphopantetheine,KW-0597~Phosphoprotein,KW-0702~S-nitrosylation,	ACT_SITE:For acyl/malonyl transferase activity,ACT_SITE:For beta-ketoacyl synthase activity,ACT_SITE:For thioesterase activity,ACT_SITE:Proton acceptor; for dehydratase activity,ACT_SITE:Proton donor; for dehydratase activity,COMPBIAS:Polar residues,DOMAIN:Carrier,DOMAIN:Ketosynthase family 3 (KS3),DOMAIN:PKS/mFAS DH,REGION:Acyl and malonyl transferases,REGION:Beta-ketoacyl reductase,REGION:C-terminal hotdog fold,REGION:Disordered,REGION:Enoyl reductase,REGION:N-terminal hotdog fold,REGION:Thioesterase,
P61150	fibroblast growth factor 12(Fgf12)	Rattus norvegicus			GO:0003254~regulation of membrane depolarization,GO:0007165~signal transduction,GO:0007254~JNK cascade,GO:0007268~chemical synaptic transmission,GO:0008344~adult locomotory behavior,GO:0010765~positive regulation of sodium ion transport,GO:0050905~neuromuscular process,GO:0098908~regulation of neuronal action potential,GO:1902305~regulation of sodium ion transmembrane transport,GO:1905150~regulation of voltage-gated sodium channel activity,GO:2000649~regulation of sodium ion transmembrane transporter activity,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0045202~synapse,	GO:0005515~protein binding,GO:0008083~growth factor activity,GO:0008201~heparin binding,GO:0017080~sodium channel regulator activity,GO:0044325~ion channel binding,	IPR002209:Fibroblast_GF_fam,IPR008996:IL1/FGF,				SM00442:FGF,		KW-0539~Nucleus,					KW-0339~Growth factor,		COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,MOTIF:Bipartite nuclear localization signal,REGION:Disordered,
Q8K4T4	filamin A interacting protein 1(Filip1)	Rattus norvegicus			GO:0099010~modification of postsynaptic structure,	GO:0001725~stress fiber,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0015629~actin cytoskeleton,GO:0098794~postsynapse,GO:0098871~postsynaptic actin cytoskeleton,GO:0098978~glutamatergic synapse,		IPR019131:Cortactin-binding_p2_N,						KW-0206~Cytoskeleton,KW-0963~Cytoplasm,			KW-0175~Coiled coil,			KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:Cortactin-binding protein-2 N-terminal,REGION:Disordered,
Q5I4H3	flap structure-specific endonuclease 1(fen1)	Xiphophorus maculatus			GO:0006284~base-excision repair,GO:0043137~DNA replication, removal of RNA primer,GO:0060041~retina development in camera-type eye,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005739~mitochondrion,	GO:0000287~magnesium ion binding,GO:0003677~DNA binding,GO:0004523~RNA-DNA hybrid ribonuclease activity,GO:0008409~5'-3' exonuclease activity,GO:0017108~5'-flap endonuclease activity,GO:0030145~manganese ion binding,	IPR002421:5-3_exonuclease,IPR006084:XPG/Rad2,IPR006085:XPG_DNA_repair_N,IPR006086:XPG-I_dom,IPR008918:HhH2,IPR019974:XPG_CS,IPR023426:Flap_endonuc,IPR029060:PIN-like_dom_sf,IPR036279:5-3_exonuclease_C_sf,	xma03030:DNA replication,xma03410:Base excision repair,xma03450:Non-homologous end-joining,			SM00279:HhH2,SM00475:53EXOc,SM00484:XPGI,SM00485:XPGN,	KW-0227~DNA damage,KW-0234~DNA repair,KW-0235~DNA replication,	KW-0496~Mitochondrion,KW-0539~Nucleus,				KW-0460~Magnesium,KW-0479~Metal-binding,	KW-0255~Endonuclease,KW-0269~Exonuclease,KW-0378~Hydrolase,KW-0540~Nuclease,	KW-0597~Phosphoprotein,	COMPBIAS:Polar residues,REGION:Disordered,REGION:I-domain,REGION:Interaction with PCNA,REGION:N-domain,
P97872	flavin containing monooxygenase 5(Fmo5)	Mus musculus			GO:0006629~lipid metabolic process,GO:0006805~xenobiotic metabolic process,GO:0070995~NADPH oxidation,GO:0090181~regulation of cholesterol metabolic process,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005829~cytosol,GO:0016020~membrane,GO:0043231~intracellular membrane-bounded organelle,	GO:0004031~aldehyde oxidase activity,GO:0004497~monooxygenase activity,GO:0004499~N,N-dimethylaniline monooxygenase activity,GO:0016174~NAD(P)H oxidase activity,GO:0016491~oxidoreductase activity,GO:0047822~hypotaurine dehydrogenase activity,GO:0050660~flavin adenine dinucleotide binding,GO:0050661~NADP binding,	IPR000960:Flavin_mOase,IPR002257:Flavin_mOase_5,IPR020946:Flavin_mOase-like,IPR036188:FAD/NAD-bd_sf,	mmu00430:Taurine and hypotaurine metabolism,mmu00982:Drug metabolism - cytochrome P450,mmu01100:Metabolic pathways,		PIRSF000332:FMO,		KW-0443~Lipid metabolism,	KW-0256~Endoplasmic reticulum,KW-0472~Membrane,KW-0492~Microsome,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0274~FAD,KW-0285~Flavoprotein,KW-0521~NADP,	KW-0503~Monooxygenase,KW-0560~Oxidoreductase,	KW-0488~Methylation,KW-0597~Phosphoprotein,	TRANSMEM:Helical,
Q4VYR7	forkhead box P4 S homeolog(foxp4.S)	Xenopus laevis			GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006355~regulation of transcription, DNA-templated,GO:0045892~negative regulation of transcription, DNA-templated,	GO:0005634~nucleus,	GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0043565~sequence-specific DNA binding,GO:0046872~metal ion binding,	IPR001766:Fork_head_dom,IPR030456:TF_fork_head_CS_2,IPR032354:FOXP-CC,IPR036388:WH-like_DNA-bd_sf,IPR036390:WH_DNA-bd_sf,IPR047414:FH_FOXP4,				SM00339:FH,	KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,			KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0238~DNA-binding,KW-0678~Repressor,		COMPBIAS:Polar residues,DNA_BIND:Fork-head,DOMAIN:Fork-head,REGION:Disordered,REGION:Leucine-zipper,REGION:ctbp1-binding,ZN_FING:C2H2-type,
Q6ZQ03	formin binding protein 4(Fnbp4)	Mus musculus				GO:0005654~nucleoplasm,	GO:0005515~protein binding,	IPR001202:WW_dom,IPR036020:WW_dom_sf,				SM00456:WW,					KW-0677~Repeat,			KW-0007~Acetylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Acidic residues,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,COMPBIAS:Pro residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1),CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate,DOMAIN:WW,DOMAIN:WW 1,DOMAIN:WW 2,REGION:Disordered,
Q9JL26	formin-like 1(Fmnl1)	Mus musculus			GO:0006929~substrate-dependent cell migration,GO:0007010~cytoskeleton organization,GO:0008360~regulation of cell shape,GO:0016043~cellular component organization,GO:0016477~cell migration,GO:0022604~regulation of cell morphogenesis,GO:0030036~actin cytoskeleton organization,GO:0030866~cortical actin cytoskeleton organization,GO:0051014~actin filament severing,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0031410~cytoplasmic vesicle,GO:0045335~phagocytic vesicle,	GO:0003779~actin binding,GO:0005515~protein binding,GO:0005522~profilin binding,GO:0031267~small GTPase binding,GO:0032794~GTPase activating protein binding,GO:0051015~actin filament binding,	IPR010472:FH3_dom,IPR010473:GTPase-bd,IPR011989:ARM-like,IPR014767:DAD_dom,IPR014768:GBD/FH3_dom,IPR015425:FH2_Formin,IPR016024:ARM-type_fold,IPR042201:FH2_Formin_sf,IPR043592:FMNL_animal,				SM00498:FH2,SM01139:Drf_FH3,SM01140:Drf_GBD,		KW-0472~Membrane,KW-0963~Cytoplasm,KW-0968~Cytoplasmic vesicle,KW-1003~Cell membrane,			KW-0175~Coiled coil,			KW-0449~Lipoprotein,KW-0519~Myristate,KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,COMPBIAS:Pro residues,DOMAIN:DAD,DOMAIN:FH2,DOMAIN:GBD/FH3,LIPID:N-myristoyl glycine,REGION:Disordered,
Q6NXC0	formin-like 3(fmnl3)	Danio rerio			GO:0001525~angiogenesis,GO:0002040~sprouting angiogenesis,GO:0007010~cytoskeleton organization,GO:0008360~regulation of cell shape,GO:0016043~cellular component organization,GO:0016477~cell migration,GO:0022604~regulation of cell morphogenesis,GO:0030036~actin cytoskeleton organization,GO:0030041~actin filament polymerization,GO:0030866~cortical actin cytoskeleton organization,GO:0046847~filopodium assembly,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0016020~membrane,	GO:0003779~actin binding,GO:0005515~protein binding,GO:0031267~small GTPase binding,GO:0051015~actin filament binding,	IPR010472:FH3_dom,IPR010473:GTPase-bd,IPR011989:ARM-like,IPR014767:DAD_dom,IPR014768:GBD/FH3_dom,IPR015425:FH2_Formin,IPR016024:ARM-type_fold,IPR042201:FH2_Formin_sf,IPR043592:FMNL_animal,				SM00498:FH2,SM01139:Drf_FH3,SM01140:Drf_GBD,	KW-0037~Angiogenesis,	KW-0472~Membrane,KW-0963~Cytoplasm,KW-1003~Cell membrane,			KW-0175~Coiled coil,		KW-0009~Actin-binding,KW-0217~Developmental protein,KW-9996~Developmental protein,	KW-0449~Lipoprotein,KW-0519~Myristate,	COMPBIAS:Pro residues,DOMAIN:DAD,DOMAIN:FH2,DOMAIN:GBD/FH3,LIPID:N-myristoyl glycine,REGION:Disordered,
Q8N0W3	fucose kinase(FCSK)	Homo sapiens			GO:0016310~phosphorylation,GO:0042352~GDP-L-fucose salvage,GO:0044238~primary metabolic process,GO:0046835~carbohydrate phosphorylation,GO:0071704~organic substance metabolic process,GO:1903350~response to dopamine,	GO:0005829~cytosol,	GO:0000166~nucleotide binding,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016301~kinase activity,GO:0016772~transferase activity, transferring phosphorus-containing groups,GO:0016773~phosphotransferase activity, alcohol group as acceptor,GO:0050201~fucokinase activity,	IPR006204:GHMP_kinase_N_dom,IPR012887:Fucokinase,IPR013750:GHMP_kinase_C_dom,IPR014721:Ribsml_uS5_D2-typ_fold_subgr,IPR020568:Ribosomal_Su5_D2-typ_SF,IPR036554:GHMP_kinase_C_sf,	hsa00051:Fructose and mannose metabolism,hsa00520:Amino sugar and nucleotide sugar metabolism,hsa01100:Metabolic pathways,hsa01250:Biosynthesis of nucleotide sugars,	618324~Congenital disorder of glycosylation with defective fucosylation 2,						KW-0225~Disease variant,KW-0900~Congenital disorder of glycosylation,		KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0418~Kinase,KW-0808~Transferase,		DOMAIN:GHMP kinase C-terminal,DOMAIN:GHMP kinase N-terminal,DOMAIN:L-fucokinase,
Q70AG8	fucosyltransferase 11 (alpha (1,3) fucosyltransferase)(fut11)	Takifugu rubripes			GO:0006486~protein glycosylation,GO:0036065~fucosylation,	GO:0000139~Golgi membrane,GO:0032580~Golgi cisterna membrane,	GO:0046920~alpha-(1->3)-fucosyltransferase activity,	IPR001503:Glyco_trans_10,IPR017176:Alpha-1_3-FUT_met,IPR031481:Glyco_tran_10_N,IPR038577:GT10-like_C_sf,			PIRSF037332:Alpha1_3FUT_met,			KW-0333~Golgi apparatus,KW-0472~Membrane,			KW-0735~Signal-anchor,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0328~Glycosyltransferase,KW-0808~Transferase,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Fucosyltransferase N-terminal,TOPO_DOM:Cytoplasmic,TOPO_DOM:Lumenal,TRANSMEM:Helical,TRANSMEM:Helical; Signal-anchor for type II membrane protein,
P35505	fumarylacetoacetate hydrolase(Fah)	Mus musculus			GO:0006527~arginine catabolic process,GO:0006559~L-phenylalanine catabolic process,GO:0006572~tyrosine catabolic process,GO:0006629~lipid metabolic process,GO:0009072~aromatic amino acid family metabolic process,GO:1902000~homogentisate catabolic process,		GO:0003824~catalytic activity,GO:0004334~fumarylacetoacetase activity,GO:0016787~hydrolase activity,GO:0046872~metal ion binding,	IPR005959:Fumarylacetoacetase,IPR011234:Fumarylacetoacetase-like_C,IPR015377:Fumarylacetoacetase_N,IPR036462:Fumarylacetoacetase_N_sf,IPR036663:Fumarylacetoacetase_C_sf,	mmu00350:Tyrosine metabolism,mmu01100:Metabolic pathways,				KW-0443~Lipid metabolism,KW-0585~Phenylalanine catabolism,KW-0828~Tyrosine catabolism,					KW-0106~Calcium,KW-0460~Magnesium,KW-0479~Metal-binding,	KW-0378~Hydrolase,	KW-0007~Acetylation,KW-0597~Phosphoprotein,	ACT_SITE:Proton acceptor,DOMAIN:Fumarylacetoacetase N-terminal,MUTAGEN:E->G: Decrease in activity.,
Q9TRY9	galactosidase beta 1(GLB1)	Canis lupus dingo			GO:0005975~carbohydrate metabolic process,	GO:0005615~extracellular space,GO:0005764~lysosome,GO:0005773~vacuole,GO:0005794~Golgi apparatus,	GO:0004565~beta-galactosidase activity,GO:0042803~protein homodimerization activity,	IPR001944:Glycoside_Hdrlase_35,IPR008979:Galactose-bd-like_sf,IPR017853:Glycoside_hydrolase_SF,IPR019801:Glyco_hydro_35_CS,IPR026283:B-gal_1-like,IPR031330:Gly_Hdrlase_35_cat,IPR048912:BetaGal1-like_ABD1,IPR048913:BetaGal_gal-bd,	clud00052:Galactose metabolism,clud00511:Other glycan degradation,clud00531:Glycosaminoglycan degradation,clud00600:Sphingolipid metabolism,clud00604:Glycosphingolipid biosynthesis - ganglio series,clud01100:Metabolic pathways,clud04142:Lysosome,		PIRSF006336:B-gal,			KW-0458~Lysosome,			KW-0732~Signal,		KW-0326~Glycosidase,KW-0378~Hydrolase,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	ACT_SITE:Nucleophile,ACT_SITE:Proton donor,CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Beta-galactosidase 1-like first all-beta,DOMAIN:Beta-galactosidase galactose-binding,DOMAIN:Glycoside hydrolase 35 catalytic,
Q9TRY9	galactosidase beta 1(GLB1)	Canis lupus familiaris			GO:0005975~carbohydrate metabolic process,	GO:0005615~extracellular space,GO:0005764~lysosome,GO:0005773~vacuole,GO:0005794~Golgi apparatus,GO:0016020~membrane,	GO:0004553~hydrolase activity, hydrolyzing O-glycosyl compounds,GO:0004565~beta-galactosidase activity,GO:0042803~protein homodimerization activity,	IPR001944:Glycoside_Hdrlase_35,IPR004843:Calcineurin-like_PHP_ApaH,IPR008979:Galactose-bd-like_sf,IPR017853:Glycoside_hydrolase_SF,IPR019801:Glyco_hydro_35_CS,IPR026283:B-gal_1-like,IPR029052:Metallo-depent_PP-like,IPR031330:Gly_Hdrlase_35_cat,IPR048912:BetaGal1-like_ABD1,IPR048913:BetaGal_gal-bd,	cfa00052:Galactose metabolism,cfa00511:Other glycan degradation,cfa00531:Glycosaminoglycan degradation,cfa00600:Sphingolipid metabolism,cfa00604:Glycosphingolipid biosynthesis - ganglio series,cfa01100:Metabolic pathways,cfa04142:Lysosome,		PIRSF006336:B-gal,			KW-0458~Lysosome,KW-0472~Membrane,			KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0326~Glycosidase,KW-0378~Hydrolase,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	ACT_SITE:Nucleophile,ACT_SITE:Proton donor,CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Beta-galactosidase 1-like first all-beta,DOMAIN:Beta-galactosidase galactose-binding,DOMAIN:Calcineurin-like phosphoesterase,DOMAIN:Glycoside hydrolase 35 catalytic,REGION:Disordered,TRANSMEM:Helical,
Q99928	gamma-aminobutyric acid type A receptor subunit gamma3(GABRG3)	Homo sapiens			GO:0007214~gamma-aminobutyric acid signaling pathway,GO:0009410~response to xenobiotic stimulus,GO:0050877~neurological system process,GO:0051932~synaptic transmission, GABAergic,GO:0060078~regulation of postsynaptic membrane potential,GO:1902476~chloride transmembrane transport,GO:1904862~inhibitory synapse assembly,	GO:0005730~nucleolus,GO:0005886~plasma membrane,GO:0015630~microtubule cytoskeleton,GO:0016020~membrane,GO:0032590~dendrite membrane,GO:0034707~chloride channel complex,GO:0043005~neuron projection,GO:0045202~synapse,GO:0045211~postsynaptic membrane,GO:0098794~postsynapse,GO:0098982~GABA-ergic synapse,GO:1902495~transmembrane transporter complex,GO:1902711~GABA-A receptor complex,	GO:0004888~transmembrane signaling receptor activity,GO:0004890~GABA-A receptor activity,GO:0005230~extracellular ligand-gated ion channel activity,GO:0005237~inhibitory extracellular ligand-gated ion channel activity,GO:0005254~chloride channel activity,GO:0008503~benzodiazepine receptor activity,GO:0022851~GABA-gated chloride ion channel activity,GO:1904315~transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential,	IPR005437:GABRG-1/4,IPR005440:GABBAg3_rcpt,IPR006028:GABAA/Glycine_rcpt,IPR006029:Neurotrans-gated_channel_TM,IPR006201:Neur_channel,IPR006202:Neur_chan_lig-bd,IPR018000:Neurotransmitter_ion_chnl_CS,IPR036719:Neuro-gated_channel_TM_sf,IPR036734:Neur_chan_lig-bd_sf,IPR038050:Neuro_actylchol_rec,	hsa04080:Neuroactive ligand-receptor interaction,hsa04723:Retrograde endocannabinoid signaling,hsa04727:GABAergic synapse,hsa05032:Morphine addiction,hsa05033:Nicotine addiction,				KW-0406~Ion transport,KW-0813~Transport,	KW-0472~Membrane,KW-0628~Postsynaptic cell membrane,KW-0770~Synapse,KW-1003~Cell membrane,			KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0868~Chloride,	KW-0407~Ion channel,KW-0869~Chloride channel,	KW-0325~Glycoprotein,KW-0449~Lipoprotein,KW-0564~Palmitate,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Neurotransmitter-gated ion-channel ligand-binding,DOMAIN:Neurotransmitter-gated ion-channel transmembrane,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q0II76	gamma-aminobutyric acid type A receptor subunit rho2(GABRR2)	Bos taurus			GO:0007165~signal transduction,GO:0007214~gamma-aminobutyric acid signaling pathway,GO:0007268~chemical synaptic transmission,GO:0007601~visual perception,GO:0034220~ion transmembrane transport,GO:0042391~regulation of membrane potential,GO:0050877~neurological system process,GO:1902476~chloride transmembrane transport,	GO:0016020~membrane,GO:0034707~chloride channel complex,GO:0043005~neuron projection,GO:0045202~synapse,GO:0045211~postsynaptic membrane,GO:1902711~GABA-A receptor complex,	GO:0004890~GABA-A receptor activity,GO:0005230~extracellular ligand-gated ion channel activity,GO:0005254~chloride channel activity,GO:0030594~neurotransmitter receptor activity,	IPR006028:GABAA/Glycine_rcpt,IPR006029:Neurotrans-gated_channel_TM,IPR006201:Neur_channel,IPR006202:Neur_chan_lig-bd,IPR008057:GABAAa_rho_rcpt,IPR008059:GABAAa_rho2_rcpt,IPR018000:Neurotransmitter_ion_chnl_CS,IPR036719:Neuro-gated_channel_TM_sf,IPR036734:Neur_chan_lig-bd_sf,IPR038050:Neuro_actylchol_rec,	bta04080:Neuroactive ligand-receptor interaction,bta04723:Retrograde endocannabinoid signaling,bta04727:GABAergic synapse,bta05032:Morphine addiction,bta05033:Nicotine addiction,				KW-0406~Ion transport,KW-0813~Transport,	KW-0472~Membrane,KW-0628~Postsynaptic cell membrane,KW-0770~Synapse,KW-1003~Cell membrane,			KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0868~Chloride,	KW-0407~Ion channel,KW-0869~Chloride channel,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q9QZU7	gamma-butyrobetaine hydroxylase 1(Bbox1)	Rattus norvegicus			GO:0045329~carnitine biosynthetic process,	GO:0005739~mitochondrion,GO:0005829~cytosol,	GO:0005506~iron ion binding,GO:0008270~zinc ion binding,GO:0008336~gamma-butyrobetaine dioxygenase activity,GO:0042802~identical protein binding,GO:0051213~dioxygenase activity,	IPR003819:TauD/TfdA-like,IPR010376:GBBH-like_N,IPR012775:GBBH-like,IPR038492:GBBH-like_N_sf,IPR042098:TauD-like_sf,	rno00310:Lysine degradation,rno01100:Metabolic pathways,				KW-0124~Carnitine biosynthesis,	KW-0963~Cytoplasm,				KW-0408~Iron,KW-0479~Metal-binding,KW-0862~Zinc,	KW-0223~Dioxygenase,KW-0560~Oxidoreductase,	KW-0597~Phosphoprotein,	DOMAIN:Gamma-butyrobetaine hydroxylase-like N-terminal,DOMAIN:TauD/TfdA-like,
Q60928	gamma-glutamyltransferase 1(Ggt1)	Mus musculus			GO:0002682~regulation of immune system process,GO:0006508~proteolysis,GO:0006536~glutamate metabolic process,GO:0006749~glutathione metabolic process,GO:0006750~glutathione biosynthetic process,GO:0006751~glutathione catabolic process,GO:0007283~spermatogenesis,GO:0019344~cysteine biosynthetic process,GO:0031179~peptide modification,GO:0031638~zymogen activation,GO:0032355~response to estradiol,GO:0032496~response to lipopolysaccharide,GO:0034599~cellular response to oxidative stress,GO:0034612~response to tumor necrosis factor,GO:0050727~regulation of inflammatory response,GO:0061017~hepatoblast differentiation,GO:0070365~hepatocyte differentiation,GO:0097305~response to alcohol,GO:0097421~liver regeneration,	GO:0005615~extracellular space,GO:0005783~endoplasmic reticulum,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0031982~vesicle,GO:0048471~perinuclear region of cytoplasm,	GO:0000048~peptidyltransferase activity,GO:0002951~leukotriene-C(4) hydrolase,GO:0008233~peptidase activity,GO:0016740~transferase activity,GO:0016746~transferase activity, transferring acyl groups,GO:0016755~transferase activity, transferring amino-acyl groups,GO:0016787~hydrolase activity,GO:0036374~glutathione hydrolase activity,	IPR000101:GGT_peptidase,IPR029055:Ntn_hydrolases_N,IPR043137:GGT_ssub,IPR043138:GGT_lsub_C,	mmu00430:Taurine and hypotaurine metabolism,mmu00480:Glutathione metabolism,mmu00590:Arachidonic acid metabolism,mmu01100:Metabolic pathways,				KW-0317~Glutathione biosynthesis,	KW-0472~Membrane,KW-1003~Cell membrane,			KW-0735~Signal-anchor,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0012~Acyltransferase,KW-0378~Hydrolase,KW-0645~Protease,KW-0808~Transferase,	KW-0325~Glycoprotein,KW-0865~Zymogen,KW-1015~Disulfide bond,	ACT_SITE:Nucleophile,CARBOHYD:N-linked (GlcNAc...) asparagine,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,TRANSMEM:Helical; Signal-anchor for type II membrane protein,
Q0V990	gap junction protein alpha 4(gja4)	Xenopus tropicalis			GO:0007154~cell communication,GO:0007267~cell-cell signaling,	GO:0005886~plasma membrane,GO:0005921~gap junction,GO:0005922~connexin complex,GO:0016020~membrane,GO:0070161~anchoring junction,	GO:0005243~gap junction channel activity,	IPR000500:Connexin,IPR013092:Connexin_N,IPR017990:Connexin_CS,IPR019570:Connexin_CCC,IPR034634:Connexin_C,IPR038359:Connexin_N_sf,				SM00037:CNX,SM01089:Connexin_CCC,		KW-0303~Gap junction,KW-0472~Membrane,KW-0965~Cell junction,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,				COMPBIAS:Polar residues,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
U3JA75	gap junction protein epsilon 1a(gje1a)	Danio rerio			GO:0007154~cell communication,GO:0007267~cell-cell signaling,GO:0055085~transmembrane transport,	GO:0005886~plasma membrane,GO:0005922~connexin complex,GO:0016020~membrane,	GO:0005243~gap junction channel activity,	IPR000500:Connexin,IPR013092:Connexin_N,IPR019570:Connexin_CCC,IPR038359:Connexin_N_sf,				SM01089:Connexin_CCC,	KW-0813~Transport,	KW-0472~Membrane,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-1015~Disulfide bond,	DOMAIN:Gap junction protein cysteine-rich,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q9IA78	general transcription factor IIA, 2(gtf2a2)	Paralichthys olivaceus			GO:0006367~transcription initiation from RNA polymerase II promoter,GO:0051123~RNA polymerase II transcriptional preinitiation complex assembly,	GO:0005672~transcription factor TFIIA complex,	GO:0017025~TBP-class protein binding,	IPR003194:TFIIA_gsu,IPR009083:TFIIA_a-hlx,IPR009088:TFIIA_b-brl,IPR015871:TFIIA_gsu_C,IPR015872:TFIIA_gsu_N,	pov03022:Basal transcription factors,		PIRSF009415:Hum_TFIIA_gamma,		KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,
O88958	glucosamine-6-phosphate deaminase 1(Gnpda1)	Mus musculus			GO:0005975~carbohydrate metabolic process,GO:0006002~fructose 6-phosphate metabolic process,GO:0006041~glucosamine metabolic process,GO:0006043~glucosamine catabolic process,GO:0006044~N-acetylglucosamine metabolic process,GO:0006046~N-acetylglucosamine catabolic process,GO:0006048~UDP-N-acetylglucosamine biosynthetic process,GO:0006091~generation of precursor metabolites and energy,GO:0007340~acrosome reaction,GO:0019262~N-acetylneuraminate catabolic process,GO:0046370~fructose biosynthetic process,	GO:0005737~cytoplasm,	GO:0004342~glucosamine-6-phosphate deaminase activity,GO:0016787~hydrolase activity,GO:0016853~isomerase activity,GO:0042802~identical protein binding,	IPR004547:Glucosamine6P_isomerase,IPR006148:Glc/Gal-6P_isomerase,IPR018321:Glucosamine6P_isomerase_CS,IPR037171:NagB/RpiA_transferase-like,	mmu00520:Amino sugar and nucleotide sugar metabolism,mmu01100:Metabolic pathways,				KW-0119~Carbohydrate metabolism,	KW-0963~Cytoplasm,					KW-0378~Hydrolase,KW-0413~Isomerase,	KW-0597~Phosphoprotein,	ACT_SITE:For ring-opening step,ACT_SITE:Proton acceptor; for enolization step,ACT_SITE:Proton acceptor; for ring-opening step,DOMAIN:Glucosamine/galactosamine-6-phosphate isomerase,
P48506	glutamate-cysteine ligase catalytic subunit(GCLC)	Homo sapiens			GO:0006534~cysteine metabolic process,GO:0006536~glutamate metabolic process,GO:0006750~glutathione biosynthetic process,GO:0006979~response to oxidative stress,GO:0007584~response to nutrient,GO:0009408~response to heat,GO:0009410~response to xenobiotic stimulus,GO:0009725~response to hormone,GO:0014823~response to activity,GO:0019852~L-ascorbic acid metabolic process,GO:0031397~negative regulation of protein ubiquitination,GO:0032436~positive regulation of proteasomal ubiquitin-dependent protein catabolic process,GO:0032869~cellular response to insulin stimulus,GO:0035729~cellular response to hepatocyte growth factor stimulus,GO:0043066~negative regulation of apoptotic process,GO:0043524~negative regulation of neuron apoptotic process,GO:0044344~cellular response to fibroblast growth factor stimulus,GO:0044752~response to human chorionic gonadotropin,GO:0045454~cell redox homeostasis,GO:0045892~negative regulation of transcription, DNA-templated,GO:0046685~response to arsenic-containing substance,GO:0046686~response to cadmium ion,GO:0051409~response to nitrosative stress,GO:0051900~regulation of mitochondrial depolarization,GO:0070555~response to interleukin-1,GO:0071260~cellular response to mechanical stimulus,GO:0071333~cellular response to glucose stimulus,GO:0071372~cellular response to follicle-stimulating hormone stimulus,GO:0097069~cellular response to thyroxine stimulus,GO:0097746~regulation of blood vessel diameter,GO:1901029~negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,GO:2000490~negative regulation of hepatic stellate cell activation,GO:2001237~negative regulation of extrinsic apoptotic signaling pathway,	GO:0005739~mitochondrion,GO:0005829~cytosol,GO:0017109~glutamate-cysteine ligase complex,	GO:0000287~magnesium ion binding,GO:0004357~glutamate-cysteine ligase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016595~glutamate binding,GO:0043531~ADP binding,GO:0044877~macromolecular complex binding,	IPR004308:GCS,IPR014746:Gln_synth/guanido_kin_cat_dom,	hsa00270:Cysteine and methionine metabolism,hsa00480:Glutathione metabolism,hsa01100:Metabolic pathways,hsa01240:Biosynthesis of cofactors,hsa04216:Ferroptosis,	230450~Hemolytic anemia due to gamma-glutamylcysteine synthetase deficiency,608446~Myocardial infarction, susceptibility to,			KW-0317~Glutathione biosynthesis,			KW-0225~Disease variant,KW-0360~Hereditary hemolytic anemia,		KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0436~Ligase,	KW-0007~Acetylation,KW-0597~Phosphoprotein,
Q6NYL5	glutamic--pyruvic transaminase(gpt)	Danio rerio			GO:0006103~2-oxoglutarate metabolic process,GO:0009058~biosynthetic process,GO:0042851~L-alanine metabolic process,GO:0042853~L-alanine catabolic process,		GO:0003824~catalytic activity,GO:0004021~L-alanine:2-oxoglutarate aminotransferase activity,GO:0008483~transaminase activity,GO:0016740~transferase activity,GO:0030170~pyridoxal phosphate binding,	IPR004839:Aminotransferase_I/II,IPR015421:PyrdxlP-dep_Trfase_major,IPR015422:PyrdxlP-dep_Trfase_small,IPR015424:PyrdxlP-dep_Trfase,IPR045088:ALAT1/2-like,	dre00220:Arginine biosynthesis,dre00250:Alanine, aspartate and glutamate metabolism,dre01100:Metabolic pathways,dre01200:Carbon metabolism,dre01210:2-Oxocarboxylic acid metabolism,dre01230:Biosynthesis of amino acids,									KW-0663~Pyridoxal phosphate,	KW-0032~Aminotransferase,KW-0808~Transferase,		DOMAIN:Aminotransferase class I/classII,
P13264	glutaminase(Gls)	Rattus norvegicus			GO:0001967~suckling behavior,GO:0002087~regulation of respiratory gaseous exchange by neurological system process,GO:0006537~glutamate biosynthetic process,GO:0006541~glutamine metabolic process,GO:0006543~glutamine catabolic process,GO:0007268~chemical synaptic transmission,GO:0051289~protein homotetramerization,GO:0090461~glutamate homeostasis,	GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,GO:0005829~cytosol,GO:0045202~synapse,	GO:0004359~glutaminase activity,GO:0005515~protein binding,GO:0042802~identical protein binding,	IPR002110:Ankyrin_rpt,IPR012338:Beta-lactam/transpept-like,IPR015868:Glutaminase,IPR036770:Ankyrin_rpt-contain_sf,IPR041541:Glutaminase_EF-hand,	rno00220:Arginine biosynthesis,rno00250:Alanine, aspartate and glutamate metabolism,rno00470:D-Amino acid metabolism,rno01100:Metabolic pathways,rno04724:Glutamatergic synapse,rno04727:GABAergic synapse,rno04964:Proximal tubule bicarbonate reclamation,rno05206:MicroRNAs in cancer,rno05230:Central carbon metabolism in cancer,			SM00248:ANK,		KW-0496~Mitochondrion,KW-0963~Cytoplasm,			KW-0040~ANK repeat,KW-0677~Repeat,KW-0809~Transit peptide,		KW-0378~Hydrolase,	KW-0007~Acetylation,KW-0597~Phosphoprotein,	COMPBIAS:Polar residues,DOMAIN:Glutaminase EF-hand,REGION:Disordered,REGION:Highly mobile activation loop,REPEAT:ANK,REPEAT:ANK 1,REPEAT:ANK 2,SITE:Cleavage; MPP,TRANSIT:Mitochondrion,
Q0P5J0	glutamine rich 1(QRICH1)	Bos taurus			GO:0030968~endoplasmic reticulum unfolded protein response,GO:0034976~response to endoplasmic reticulum stress,GO:0036499~PERK-mediated unfolded protein response,GO:0043065~positive regulation of apoptotic process,GO:0045893~positive regulation of transcription, DNA-templated,GO:0070059~intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005886~plasma membrane,	GO:0003677~DNA binding,	IPR021893:DUF3504,					KW-0804~Transcription,KW-0805~Transcription regulation,KW-0834~Unfolded protein response,	KW-0472~Membrane,KW-0539~Nucleus,KW-0963~Cytoplasm,KW-1003~Cell membrane,						KW-0007~Acetylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),DOMAIN:CARD,REGION:Disordered,
P47897	glutaminyl-tRNA synthetase 1(QARS1)	Homo sapiens			GO:0006412~translation,GO:0006418~tRNA aminoacylation for protein translation,GO:0006425~glutaminyl-tRNA aminoacylation,GO:0006469~negative regulation of protein kinase activity,GO:0007420~brain development,GO:0032873~negative regulation of stress-activated MAPK cascade,GO:0043039~tRNA aminoacylation,GO:0045892~negative regulation of transcription, DNA-templated,GO:2001234~negative regulation of apoptotic signaling pathway,	GO:0005737~cytoplasm,GO:0005759~mitochondrial matrix,GO:0005829~cytosol,GO:0016020~membrane,GO:0017101~aminoacyl-tRNA synthetase multienzyme complex,GO:0032991~macromolecular complex,	GO:0004812~aminoacyl-tRNA ligase activity,GO:0004819~glutamine-tRNA ligase activity,GO:0004860~protein kinase inhibitor activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0019901~protein kinase binding,	IPR000924:Glu/Gln-tRNA-synth,IPR001412:aa-tRNA-synth_I_CS,IPR004514:Gln-tRNA-synth,IPR007638:Gln-tRNA-synth_Ib_RNA-bd_2,IPR007639:Gln-tRNA-synth_Ib_RNA-bd_N,IPR011035:Ribosomal_bL25/Gln-tRNA_synth,IPR014729:Rossmann-like_a/b/a_fold,IPR020056:Rbsml_bL25/Gln-tRNA_synth_N,IPR020058:Glu/Gln-tRNA-synth_Ib_cat-dom,IPR020059:Glu/Gln-tRNA-synth_Ib_codon-bd,IPR020061:Glu_tRNA_lig_a-bdl,IPR042558:Gln-tRNA-synth_Ib_RNA-bd_N_1,IPR042559:Gln-tRNA-synth_Ib_RNA-bd_N_2,IPR049437:tRNA-synt_1c_C2,	hsa00970:Aminoacyl-tRNA biosynthesis,hsa01100:Metabolic pathways,	615760~Microcephaly, progressive, seizures, and cerebral and cerebellar atrophy,			KW-0648~Protein biosynthesis,	KW-0472~Membrane,KW-0963~Cytoplasm,		KW-0225~Disease variant,KW-0887~Epilepsy,KW-0905~Primary microcephaly,	KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0030~Aminoacyl-tRNA synthetase,KW-0436~Ligase,	KW-0007~Acetylation,KW-0597~Phosphoprotein,	DOMAIN:Glutaminyl-tRNA synthetase class Ib non-specific RNA-binding,DOMAIN:Glutamyl/glutaminyl-tRNA synthetase class Ib anti-codon binding,DOMAIN:Glutamyl/glutaminyl-tRNA synthetase class Ib catalytic,DOMAIN:tRNA synthetases class I (E and Q) anti-codon binding,MOTIF:'HIGH' region,MOTIF:'KMSKS' region,MUTAGEN:H->A: Decreases catalytic efficiency about 60-fold.,TRANSMEM:Helical,
Q6DDT5	glutathione S-transferase, C-terminal domain containing L homeolog(gstcd.L)	Xenopus laevis				GO:0005737~cytoplasm,	GO:0008757~S-adenosylmethionine-dependent methyltransferase activity,	IPR025714:Methyltranfer_dom,IPR029063:SAM-dependent_MTases_sf,IPR036282:Glutathione-S-Trfase_C_sf,						KW-0963~Cytoplasm,							DOMAIN:GST C-terminal,DOMAIN:Methyltransferase,
Q9WVL0	glutathione transferase zeta 1 (maleylacetoacetate isomerase)(Gstz1)	Mus musculus			GO:0006559~L-phenylalanine catabolic process,GO:0006572~tyrosine catabolic process,GO:0006749~glutathione metabolic process,GO:0008152~metabolic process,GO:0009072~aromatic amino acid family metabolic process,	GO:0005737~cytoplasm,GO:0005739~mitochondrion,	GO:0003824~catalytic activity,GO:0004364~glutathione transferase activity,GO:0016034~maleylacetoacetate isomerase activity,GO:0016740~transferase activity,GO:0016853~isomerase activity,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,	IPR004045:Glutathione_S-Trfase_N,IPR004046:GST_C,IPR005955:GST_Zeta,IPR010987:Glutathione-S-Trfase_C-like,IPR034330:GST_Zeta_C,IPR034333:GST_Zeta_N,IPR036249:Thioredoxin-like_sf,IPR036282:Glutathione-S-Trfase_C_sf,IPR040079:Glutathione_S-Trfase,	mmu00350:Tyrosine metabolism,mmu01100:Metabolic pathways,				KW-0585~Phenylalanine catabolism,KW-0828~Tyrosine catabolism,	KW-0963~Cytoplasm,					KW-0413~Isomerase,KW-0511~Multifunctional enzyme,KW-0808~Transferase,	KW-0007~Acetylation,KW-0597~Phosphoprotein,	DOMAIN:GST C-terminal,DOMAIN:GST N-terminal,
Q6DG38	glycerol-3-phosphate acyltransferase 3(gpat3)	Danio rerio			GO:0006629~lipid metabolic process,GO:0008654~phospholipid biosynthetic process,GO:0016024~CDP-diacylglycerol biosynthetic process,GO:0019432~triglyceride biosynthetic process,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0016020~membrane,	GO:0003841~1-acylglycerol-3-phosphate O-acyltransferase activity,GO:0004366~glycerol-3-phosphate O-acyltransferase activity,GO:0008374~O-acyltransferase activity,GO:0016740~transferase activity,GO:0016746~transferase activity, transferring acyl groups,	IPR002123:Plipid/glycerol_acylTrfase,IPR045252:LPCAT1-like,	dre00561:Glycerolipid metabolism,dre00564:Glycerophospholipid metabolism,dre01100:Metabolic pathways,			SM00563:PlsC,	KW-0443~Lipid metabolism,KW-0444~Lipid biosynthesis,KW-0594~Phospholipid biosynthesis,KW-1208~Phospholipid metabolism,	KW-0256~Endoplasmic reticulum,KW-0472~Membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0012~Acyltransferase,KW-0808~Transferase,		DOMAIN:Phospholipid/glycerol acyltransferase,MOTIF:HXXXXD motif,TRANSMEM:Helical,
Q9JL56	glycerophosphodiester phosphodiesterase 1(Gde1)	Mus musculus			GO:0006580~ethanolamine metabolic process,GO:0006629~lipid metabolic process,GO:0006644~phospholipid metabolic process,GO:0007186~G-protein coupled receptor signaling pathway,GO:0070291~N-acylethanolamine metabolic process,	GO:0005886~plasma membrane,GO:0016020~membrane,GO:0030659~cytoplasmic vesicle membrane,GO:0031410~cytoplasmic vesicle,	GO:0004622~lysophospholipase activity,GO:0008081~phosphoric diester hydrolase activity,GO:0008889~glycerophosphodiester phosphodiesterase activity,GO:0016787~hydrolase activity,GO:0046872~metal ion binding,GO:0047395~glycerophosphoinositol glycerophosphodiesterase activity,	IPR017946:PLC-like_Pdiesterase_TIM-brl,IPR030395:GP_PDE_dom,					KW-0443~Lipid metabolism,	KW-0472~Membrane,KW-0968~Cytoplasmic vesicle,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0460~Magnesium,KW-0479~Metal-binding,	KW-0378~Hydrolase,	KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:GP-PDE,TOPO_DOM:Cytoplasmic,TOPO_DOM:Lumenal,TRANSMEM:Helical,
P11183	glycine cleavage system protein H(GCSH)	Gallus gallus			GO:0009249~protein lipoylation,GO:0019464~glycine decarboxylation via glycine cleavage system,	GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005960~glycine cleavage complex,		IPR000089:Biotin_lipoyl,IPR002930:GCV_H,IPR003016:2-oxoA_DH_lipoyl-BS,IPR011053:Single_hybrid_motif,IPR017453:GCV_H_sub,IPR033753:GCV_H/Fam206,	gga00260:Glycine, serine and threonine metabolism,gga00630:Glyoxylate and dicarboxylate metabolism,gga00785:Lipoic acid metabolism,gga01100:Metabolic pathways,gga01200:Carbon metabolism,					KW-0496~Mitochondrion,			KW-0450~Lipoyl,KW-0809~Transit peptide,				DOMAIN:Lipoyl-binding,TRANSIT:Mitochondrion,
Q5U3H3	glycosyltransferase 8 domain containing 1(glt8d1)	Danio rerio				GO:0005794~Golgi apparatus,GO:0016020~membrane,	GO:0008194~UDP-glycosyltransferase activity,GO:0016740~transferase activity,GO:0016757~transferase activity, transferring glycosyl groups,GO:0016758~transferase activity, transferring hexosyl groups,	IPR002495:Glyco_trans_8,IPR029044:Nucleotide-diphossugar_trans,						KW-0472~Membrane,			KW-0735~Signal-anchor,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0328~Glycosyltransferase,KW-0808~Transferase,	KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,TOPO_DOM:Cytoplasmic,TOPO_DOM:Lumenal,TRANSMEM:Helical; Signal-anchor for type II membrane protein,
O73755	gremlin 1, DAN family BMP antagonist(GREM1)	Gallus gallus			GO:0000902~cell morphogenesis,GO:0002042~cell migration involved in sprouting angiogenesis,GO:0002092~positive regulation of receptor internalization,GO:0003337~mesenchymal to epithelial transition involved in metanephros morphogenesis,GO:0007267~cell-cell signaling,GO:0008284~positive regulation of cell proliferation,GO:0009887~animal organ morphogenesis,GO:0009954~proximal/distal pattern formation,GO:0010717~regulation of epithelial to mesenchymal transition,GO:0030199~collagen fibril organization,GO:0030326~embryonic limb morphogenesis,GO:0032331~negative regulation of chondrocyte differentiation,GO:0033689~negative regulation of osteoblast proliferation,GO:0038098~sequestering of BMP from receptor via BMP binding,GO:0043066~negative regulation of apoptotic process,GO:0045668~negative regulation of osteoblast differentiation,GO:0045766~positive regulation of angiogenesis,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046851~negative regulation of bone remodeling,GO:0048263~determination of dorsal identity,GO:0051893~regulation of focal adhesion assembly,GO:0055007~cardiac muscle cell differentiation,GO:0060173~limb development,GO:0060379~cardiac muscle cell myoblast differentiation,GO:0060392~negative regulation of SMAD protein import into nucleus,GO:0060676~ureteric bud formation,GO:0090090~negative regulation of canonical Wnt signaling pathway,GO:0090190~positive regulation of branching involved in ureteric bud morphogenesis,GO:0090291~negative regulation of osteoclast proliferation,GO:1900086~positive regulation of peptidyl-tyrosine autophosphorylation,GO:1900155~negative regulation of bone trabecula formation,GO:1900158~negative regulation of bone mineralization involved in bone maturation,GO:1901224~positive regulation of NIK/NF-kappaB signaling,	GO:0005615~extracellular space,GO:0009986~cell surface,	GO:0005125~cytokine activity,GO:0030297~transmembrane receptor protein tyrosine kinase activator activity,GO:0036122~BMP binding,GO:0042803~protein homodimerization activity,GO:0043184~vascular endothelial growth factor receptor 2 binding,GO:0048018~receptor agonist activity,	IPR004133:DAN,IPR006207:Cys_knot_C,IPR017159:Gremlin-1/2,IPR029034:Cystine-knot_cytokine,	gga04350:TGF-beta signaling pathway,		PIRSF037254:Gremlin_precursor,	SM00041:CT,		KW-0964~Secreted,			KW-0732~Signal,		KW-0202~Cytokine,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:CTCK,REGION:Disordered,
A5A4K9	growth hormone secretagogue receptor(GHSR)	Oryctolagus cuniculus			GO:0007186~G-protein coupled receptor signaling pathway,GO:0008154~actin polymerization or depolymerization,GO:0008343~adult feeding behavior,GO:0009755~hormone-mediated signaling pathway,GO:0030252~growth hormone secretion,GO:0032094~response to food,GO:0032100~positive regulation of appetite,GO:0032691~negative regulation of interleukin-1 beta production,GO:0032715~negative regulation of interleukin-6 production,GO:0032720~negative regulation of tumor necrosis factor production,GO:0032869~cellular response to insulin stimulus,GO:0040018~positive regulation of multicellular organism growth,GO:0043568~positive regulation of insulin-like growth factor receptor signaling pathway,GO:0046697~decidualization,GO:0048009~insulin-like growth factor receptor signaling pathway,GO:0050728~negative regulation of inflammatory response,GO:0051963~regulation of synapse assembly,	GO:0005886~plasma membrane,GO:0009986~cell surface,GO:0043005~neuron projection,GO:0045121~membrane raft,	GO:0001616~growth hormone secretagogue receptor activity,GO:0016520~growth hormone-releasing hormone receptor activity,	IPR000276:GPCR_Rhodpsn,IPR003905:GHS-R/MTLR,IPR017452:GPCR_Rhodpsn_7TM,	ocu04024:cAMP signaling pathway,ocu04080:Neuroactive ligand-receptor interaction,ocu04935:Growth hormone synthesis, secretion and action,					KW-0472~Membrane,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0297~G-protein coupled receptor,KW-0675~Receptor,KW-0807~Transducer,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:G-protein coupled receptors family 1 profile,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,TRANSMEM:Helical; Name=1,TRANSMEM:Helical; Name=2,TRANSMEM:Helical; Name=3,TRANSMEM:Helical; Name=4,TRANSMEM:Helical; Name=5,TRANSMEM:Helical; Name=6,TRANSMEM:Helical; Name=7,
Q71N41	guanidinoacetate N-methyltransferase(gamt)	Danio rerio			GO:0006601~creatine biosynthetic process,GO:0032259~methylation,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0008168~methyltransferase activity,GO:0016740~transferase activity,GO:0030731~guanidinoacetate N-methyltransferase activity,	IPR016550:GuanidinoAc_N-MeTrfase,IPR026480:RMT2_dom,IPR029063:SAM-dependent_MTases_sf,	dre00260:Glycine, serine and threonine metabolism,dre00330:Arginine and proline metabolism,dre01100:Metabolic pathways,		PIRSF009285:GAMT,							KW-0949~S-adenosyl-L-methionine,	KW-0489~Methyltransferase,KW-0808~Transferase,		DOMAIN:RMT2,REGION:S-adenosyl-L-methionine,
Q6PBY0	guanine nucleotide binding protein (G protein), beta 5b(gnb5b)	Danio rerio			GO:0007165~signal transduction,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007212~dopamine receptor signaling pathway,	GO:0005737~cytoplasm,GO:0005834~heterotrimeric G-protein complex,GO:0016020~membrane,	GO:0030159~receptor signaling complex scaffold activity,	IPR001632:Gprotein_B,IPR001680:WD40_rpt,IPR015943:WD40/YVTN_repeat-like_dom_sf,IPR016346:Guanine_nucleotide-bd_bsu,IPR019775:WD40_repeat_CS,IPR020472:G-protein_beta_WD-40_rep,IPR036322:WD40_repeat_dom_sf,	dre04371:Apelin signaling pathway,		PIRSF002394:GN-bd_beta,	SM00320:WD40,		KW-0472~Membrane,			KW-0677~Repeat,KW-0853~WD repeat,		KW-0807~Transducer,		REPEAT:WD 1,REPEAT:WD 2,REPEAT:WD 3,REPEAT:WD 4,REPEAT:WD 5,REPEAT:WD 6,REPEAT:WD 7,
Q91WM2	haloacid dehalogenase like hydrolase domain containing 5(Hdhd5)	Mus musculus			GO:0046474~glycerophospholipid biosynthetic process,	GO:0005739~mitochondrion,		IPR006353:HAD-SF_hydro_IIA_CECR5,IPR006357:HAD-SF_hydro_IIA,IPR023214:HAD_sf,IPR036412:HAD-like_sf,									KW-0732~Signal,
Q96MB7	harbinger transposase derived 1(HARBI1)	Homo sapiens				GO:0005634~nucleus,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0034451~centriolar satellite,	GO:0004518~nuclease activity,GO:0046872~metal ion binding,	IPR026103:HARBI1_animal,IPR027806:HARBI1_dom,						KW-0539~Nucleus,KW-0963~Cytoplasm,				KW-0479~Metal-binding,	KW-0378~Hydrolase,KW-0540~Nuclease,		DOMAIN:DDE Tnp4,
P08108	heat shock protein 8(hspa8)	Oncorhynchus mykiss			GO:0009408~response to heat,GO:0016192~vesicle-mediated transport,GO:0034620~cellular response to unfolded protein,GO:0042026~protein refolding,GO:0046686~response to cadmium ion,GO:0046688~response to copper ion,GO:0051085~chaperone mediated protein folding requiring cofactor,GO:1903842~response to arsenite ion,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0016020~membrane,	GO:0005524~ATP binding,GO:0016887~ATPase activity,GO:0031072~heat shock protein binding,GO:0051082~unfolded protein binding,GO:0051787~misfolded protein binding,	IPR013126:Hsp_70_fam,IPR018181:Heat_shock_70_CS,IPR029047:HSP70_peptide-bd_sf,IPR029048:HSP70_C_sf,IPR043129:ATPase_NBD,	omy03040:Spliceosome,omy04010:MAPK signaling pathway,omy04141:Protein processing in endoplasmic reticulum,omy04144:Endocytosis,				KW-0346~Stress response,					KW-0067~ATP-binding,KW-0547~Nucleotide-binding,			REGION:Disordered,
P34932	heat shock protein family A (Hsp70) member 4(HSPA4)	Homo sapiens			GO:0006457~protein folding,GO:0006986~response to unfolded protein,GO:0045040~protein import into mitochondrial outer membrane,GO:0051131~chaperone-mediated protein complex assembly,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005829~cytosol,GO:0070062~extracellular exosome,	GO:0000774~adenyl-nucleotide exchange factor activity,GO:0005515~protein binding,GO:0005524~ATP binding,	IPR013126:Hsp_70_fam,IPR018181:Heat_shock_70_CS,IPR029047:HSP70_peptide-bd_sf,IPR029048:HSP70_C_sf,IPR042052:HSPA4_NBD,IPR043129:ATPase_NBD,	hsa04530:Tight junction,hsa04612:Antigen processing and presentation,hsa05417:Lipid and atherosclerosis,				KW-0346~Stress response,	KW-0963~Cytoplasm,				KW-0067~ATP-binding,KW-0547~Nucleotide-binding,		KW-0007~Acetylation,KW-0488~Methylation,KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,REGION:Disordered,
Q0VCX2	heat shock protein family A (Hsp70) member 5(HSPA5)	Bos taurus			GO:0006983~ER overload response,GO:0021589~cerebellum structural organization,GO:0021680~cerebellar Purkinje cell layer development,GO:0030335~positive regulation of cell migration,GO:0030433~ubiquitin-dependent ERAD pathway,GO:0030512~negative regulation of transforming growth factor beta receptor signaling pathway,GO:0030968~endoplasmic reticulum unfolded protein response,GO:0031204~posttranslational protein targeting to membrane, translocation,GO:0031333~negative regulation of protein complex assembly,GO:0031398~positive regulation of protein ubiquitination,GO:0034620~cellular response to unfolded protein,GO:0035437~maintenance of protein localization in endoplasmic reticulum,GO:0042026~protein refolding,GO:0042149~cellular response to glucose starvation,GO:0043066~negative regulation of apoptotic process,GO:0051085~chaperone mediated protein folding requiring cofactor,GO:0071353~cellular response to interleukin-4,GO:1903895~negative regulation of IRE1-mediated unfolded protein response,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005788~endoplasmic reticulum lumen,GO:0005789~endoplasmic reticulum membrane,GO:0005793~endoplasmic reticulum-Golgi intermediate compartment,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0008180~COP9 signalosome,GO:0009986~cell surface,GO:0016020~membrane,GO:0030496~midbody,GO:0034663~endoplasmic reticulum chaperone complex,GO:0042470~melanosome,GO:0043231~intracellular membrane-bounded organelle,	GO:0005524~ATP binding,GO:0016887~ATPase activity,GO:0019904~protein domain specific binding,GO:0031072~heat shock protein binding,GO:0031625~ubiquitin protein ligase binding,GO:0043022~ribosome binding,GO:0044183~protein binding involved in protein folding,GO:0051082~unfolded protein binding,GO:0051787~misfolded protein binding,	IPR013126:Hsp_70_fam,IPR018181:Heat_shock_70_CS,IPR029047:HSP70_peptide-bd_sf,IPR029048:HSP70_C_sf,IPR042050:BIP_NBD,IPR043129:ATPase_NBD,	bta03060:Protein export,bta04141:Protein processing in endoplasmic reticulum,bta04612:Antigen processing and presentation,bta04918:Thyroid hormone synthesis,bta05012:Parkinson disease,bta05014:Amyotrophic lateral sclerosis,bta05020:Prion disease,bta05022:Pathways of neurodegeneration - multiple diseases,bta05417:Lipid and atherosclerosis,					KW-0256~Endoplasmic reticulum,KW-0963~Cytoplasm,			KW-0732~Signal,	KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0143~Chaperone,KW-0378~Hydrolase,	KW-0007~Acetylation,KW-0488~Methylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-0944~Nitration,KW-1017~Isopeptide bond,	CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),MOTIF:Prevents secretion from ER,REGION:Disordered,REGION:Interdomain linker,REGION:Nucleotide-binding (NBD),REGION:Required for interaction with KIAA1324,REGION:Substrate-binding (SBD),
Q5ZL72	heat shock protein family D (Hsp60) member 1(HSPD1)	Gallus gallus			GO:0002755~MyD88-dependent toll-like receptor signaling pathway,GO:0002842~positive regulation of T cell mediated immune response to tumor cell,GO:0006457~protein folding,GO:0008637~apoptotic mitochondrial changes,GO:0009409~response to cold,GO:0032727~positive regulation of interferon-alpha production,GO:0032729~positive regulation of interferon-gamma production,GO:0032733~positive regulation of interleukin-10 production,GO:0032735~positive regulation of interleukin-12 production,GO:0032755~positive regulation of interleukin-6 production,GO:0034514~mitochondrial unfolded protein response,GO:0042026~protein refolding,GO:0042100~B cell proliferation,GO:0042110~T cell activation,GO:0043032~positive regulation of macrophage activation,GO:0043065~positive regulation of apoptotic process,GO:0043066~negative regulation of apoptotic process,GO:0045041~protein import into mitochondrial intermembrane space,GO:0048291~isotype switching to IgG isotypes,GO:0050821~protein stabilization,GO:0050870~positive regulation of T cell activation,GO:0051702~interaction with symbiont,GO:0098761~cellular response to interleukin-7,	GO:0005737~cytoplasm,GO:0005743~mitochondrial inner membrane,GO:0005759~mitochondrial matrix,GO:0005769~early endosome,GO:0005829~cytosol,GO:0005905~clathrin-coated pit,GO:0009986~cell surface,GO:0030135~coated vesicle,GO:0030141~secretory granule,GO:0043025~neuronal cell body,GO:0046696~lipopolysaccharide receptor complex,GO:0070062~extracellular exosome,GO:0097225~sperm midpiece,GO:0097524~sperm plasma membrane,	GO:0001530~lipopolysaccharide binding,GO:0002039~p53 binding,GO:0003725~double-stranded RNA binding,GO:0005524~ATP binding,GO:0008035~high-density lipoprotein particle binding,GO:0016853~isomerase activity,GO:0031625~ubiquitin protein ligase binding,GO:0034186~apolipoprotein A-I binding,GO:0051087~chaperone binding,	IPR001844:Cpn60/GroEL,IPR002423:Cpn60/GroEL/TCP-1,IPR017998:Chaperone_TCP-1,IPR018370:Chaperonin_Cpn60_CS,IPR027409:GroEL-like_apical_dom_sf,IPR027410:TCP-1-like_intermed_sf,IPR027413:GROEL-like_equatorial_sf,	gga03018:RNA degradation,					KW-0496~Mitochondrion,			KW-0175~Coiled coil,KW-0809~Transit peptide,	KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0143~Chaperone,KW-0413~Isomerase,	KW-0597~Phosphoprotein,	TRANSIT:Mitochondrion,
Q96QV1	hedgehog interacting protein(HHIP)	Homo sapiens			GO:0007165~signal transduction,GO:0007405~neuroblast proliferation,GO:0009953~dorsal/ventral pattern formation,GO:0009968~negative regulation of signal transduction,GO:0040036~regulation of fibroblast growth factor receptor signaling pathway,GO:0043066~negative regulation of apoptotic process,GO:0045879~negative regulation of smoothened signaling pathway,GO:0048705~skeletal system morphogenesis,GO:0060441~epithelial tube branching involved in lung morphogenesis,	GO:0005576~extracellular region,GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0009986~cell surface,GO:0060170~ciliary membrane,	GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0097108~hedgehog family protein binding,	IPR000742:EGF-like_dom,IPR011041:Quinoprot_gluc/sorb_DH,IPR011042:6-blade_b-propeller_TolB-like,IPR012938:Glc/Sorbosone_DH,IPR013111:EGF_extracell,IPR018143:Folate_rcpt-like,	hsa04024:cAMP signaling pathway,hsa04340:Hedgehog signaling pathway,hsa05200:Pathways in cancer,hsa05217:Basal cell carcinoma,			SM00181:EGF,		KW-0472~Membrane,KW-0963~Cytoplasm,KW-0964~Secreted,KW-1003~Cell membrane,			KW-0245~EGF-like domain,KW-0677~Repeat,KW-0732~Signal,	KW-0479~Metal-binding,KW-0862~Zinc,		KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:EGF-like,DOMAIN:EGF-like 1,DOMAIN:EGF-like 2,MUTAGEN:D->A,R: Abolishes SHH binding.,MUTAGEN:D->A: Abolishes SHH binding.,MUTAGEN:E->A: Abolishes SHH binding.,MUTAGEN:M->A: Abolishes SHH binding.,REGION:Interaction with SHH zinc binding site,
P42694	helicase with zinc finger(HELZ)	Homo sapiens			GO:0035194~posttranscriptional gene silencing by RNA,	GO:0005634~nucleus,GO:0005829~cytosol,GO:0016020~membrane,GO:0043186~P granule,	GO:0003723~RNA binding,GO:0004386~helicase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016787~hydrolase activity,GO:0046872~metal ion binding,	IPR000571:Znf_CCCH,IPR006935:Helicase/UvrB_N,IPR011990:TPR-like_helical_dom_sf,IPR014016:UvrD-like_ATP-bd,IPR027417:P-loop_NTPase,IPR036855:Znf_CCCH_sf,IPR041677:DNA2/NAM7_AAA_11,IPR041679:DNA2/NAM7-like_C,IPR045055:DNA2/NAM7-like,IPR047187:SF1_C_Upf1,				SM00356:ZnF_C3H1,	KW-0945~Host-virus interaction,	KW-0472~Membrane,KW-0539~Nucleus,			KW-0812~Transmembrane,KW-0863~Zinc-finger,KW-1133~Transmembrane helix,	KW-0067~ATP-binding,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,KW-0862~Zinc,	KW-0347~Helicase,KW-0378~Hydrolase,	KW-0488~Methylation,KW-0597~Phosphoprotein,	COMPBIAS:Basic residues,COMPBIAS:Polar residues,DOMAIN:C3H1-type,MOTIF:DEAA box,REGION:Disordered,TRANSMEM:Helical,ZN_FING:C3H1-type,
P23711	heme oxygenase 2(Hmox2)	Rattus norvegicus			GO:0001666~response to hypoxia,GO:0006788~heme oxidation,GO:0006979~response to oxidative stress,GO:0042167~heme catabolic process,	GO:0005789~endoplasmic reticulum membrane,GO:0005886~plasma membrane,GO:0016020~membrane,	GO:0004392~heme oxygenase (decyclizing) activity,GO:0005515~protein binding,GO:0020037~heme binding,GO:0046872~metal ion binding,	IPR002051:Haem_Oase,IPR016053:Haem_Oase-like,IPR016084:Haem_Oase-like_multi-hlx,IPR018207:Haem_oxygenase_CS,	rno00860:Porphyrin metabolism,rno01100:Metabolic pathways,rno04978:Mineral absorption,					KW-0256~Endoplasmic reticulum,KW-0472~Membrane,KW-0492~Microsome,			KW-0677~Repeat,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0349~Heme,KW-0408~Iron,KW-0479~Metal-binding,	KW-0560~Oxidoreductase,	KW-0007~Acetylation,KW-0597~Phosphoprotein,	BINDING:axial binding residue,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,REGION:Disordered,REPEAT:HRM 1,REPEAT:HRM 2,SITE:Important for catalytic activity,TOPO_DOM:Cytoplasmic,TRANSMEM:Helical,TRANSMEM:Helical; Anchor for type IV membrane protein,
P08103	hemopoietic cell kinase(Hck)	Mus musculus		m_bArrestin-srcPathway:Roles of ï¿½-arrestin-dependent Recruitment of Src Kinases in GPCR Signaling,	GO:0002376~immune system process,GO:0006468~protein phosphorylation,GO:0006887~exocytosis,GO:0006909~phagocytosis,GO:0006954~inflammatory response,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0008284~positive regulation of cell proliferation,GO:0008360~regulation of cell shape,GO:0016310~phosphorylation,GO:0018108~peptidyl-tyrosine phosphorylation,GO:0030154~cell differentiation,GO:0032956~regulation of actin cytoskeleton organization,GO:0035556~intracellular signal transduction,GO:0043066~negative regulation of apoptotic process,GO:0045087~innate immune response,GO:0046777~protein autophosphorylation,GO:0050764~regulation of phagocytosis,GO:0050830~defense response to Gram-positive bacterium,GO:0051090~regulation of sequence-specific DNA binding transcription factor activity,GO:0051179~localization,GO:0071801~regulation of podosome assembly,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005764~lysosome,GO:0005794~Golgi apparatus,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005884~actin filament,GO:0005886~plasma membrane,GO:0005901~caveola,GO:0005925~focal adhesion,GO:0009898~cytoplasmic side of plasma membrane,GO:0016020~membrane,GO:0030133~transport vesicle,GO:0031234~extrinsic component of cytoplasmic side of plasma membrane,GO:0031410~cytoplasmic vesicle,GO:0042995~cell projection,GO:0043231~intracellular membrane-bounded organelle,GO:0070161~anchoring junction,	GO:0000166~nucleotide binding,GO:0001784~phosphotyrosine binding,GO:0004672~protein kinase activity,GO:0004713~protein tyrosine kinase activity,GO:0004715~non-membrane spanning protein tyrosine kinase activity,GO:0005102~receptor binding,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008289~lipid binding,GO:0016301~kinase activity,GO:0016740~transferase activity,	IPR000719:Prot_kinase_dom,IPR000980:SH2,IPR001245:Ser-Thr/Tyr_kinase_cat_dom,IPR001452:SH3_domain,IPR008266:Tyr_kinase_AS,IPR011009:Kinase-like_dom_sf,IPR017441:Protein_kinase_ATP_BS,IPR020635:Tyr_kinase_cat_dom,IPR035851:HCK_SH2,IPR036028:SH3-like_dom_sf,IPR036860:SH2_dom_sf,	mmu04062:Chemokine signaling pathway,mmu04666:Fc gamma R-mediated phagocytosis,mmu05167:Kaposi sarcoma-associated herpesvirus infection,			SM00219:TyrKc,SM00252:SH2,SM00326:SH3,	KW-0268~Exocytosis,KW-0391~Immunity,KW-0395~Inflammatory response,KW-0399~Innate immunity,KW-0581~Phagocytosis,	KW-0206~Cytoskeleton,KW-0333~Golgi apparatus,KW-0458~Lysosome,KW-0472~Membrane,KW-0539~Nucleus,KW-0963~Cytoplasm,KW-0965~Cell junction,KW-0966~Cell projection,KW-0968~Cytoplasmic vesicle,KW-1003~Cell membrane,		KW-0656~Proto-oncogene,	KW-0727~SH2 domain,KW-0728~SH3 domain,	KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0418~Kinase,KW-0808~Transferase,KW-0829~Tyrosine-protein kinase,	KW-0449~Lipoprotein,KW-0519~Myristate,KW-0564~Palmitate,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,	ACT_SITE:Proton acceptor,COMPBIAS:Polar residues,DOMAIN:Protein kinase,DOMAIN:SH2,DOMAIN:SH3,LIPID:N-myristoyl glycine,LIPID:S-palmitoyl cysteine,MUTAGEN:Y->F: Reduced autophosphorylation.,REGION:Disordered,
Q9ESG5	heparan sulfate-glucosamine 3-sulfotransferase 1(Hs3st1)	Rattus norvegicus			GO:0006024~glycosaminoglycan biosynthetic process,GO:0015012~heparan sulfate proteoglycan biosynthetic process,	GO:0005794~Golgi apparatus,GO:0005796~Golgi lumen,	GO:0008146~sulfotransferase activity,GO:0008467~[heparan sulfate]-glucosamine 3-sulfotransferase 1 activity,	IPR000863:Sulfotransferase_dom,IPR027417:P-loop_NTPase,IPR037359:NST/OST,	rno00534:Glycosaminoglycan biosynthesis - heparan sulfate / heparin,					KW-0333~Golgi apparatus,			KW-0732~Signal,		KW-0808~Transferase,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	ACT_SITE:For sulfotransferase activity,CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Sulfotransferase,
P51859	heparin binding growth factor(Hdgf)	Mus musculus			GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006338~chromatin remodeling,GO:0034504~protein localization to nucleus,GO:0043524~negative regulation of neuron apoptotic process,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0051781~positive regulation of cell division,GO:0098761~cellular response to interleukin-7,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0017053~transcriptional repressor complex,	GO:0000166~nucleotide binding,GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001222~transcription corepressor binding,GO:0001227~transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003677~DNA binding,GO:0003714~transcription corepressor activity,GO:0003779~actin binding,GO:0005515~protein binding,GO:0008083~growth factor activity,GO:0008201~heparin binding,GO:0015631~tubulin binding,	IPR000313:PWWP_dom,IPR047363:PWWP_HDGF,				SM00293:PWWP,	KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,KW-0963~Cytoplasm,KW-0964~Secreted,				KW-0547~Nucleotide-binding,	KW-0238~DNA-binding,KW-0339~Growth factor,KW-0358~Heparin-binding,KW-0678~Repressor,	KW-0007~Acetylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1015~Disulfide bond,KW-1017~Isopeptide bond,	COMPBIAS:Acidic residues,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate,DOMAIN:PWWP,MOTIF:Bipartite nuclear localization signal,MOTIF:Nuclear localization signal,MUTAGEN:C->A: Abolishes disulfide bond formation.,MUTAGEN:S->A: Abolishes secretion.,MUTAGEN:S->A: Does not affect secretion.,MUTAGEN:SS->AA: Does not affect secretion.,REGION:Disordered,
Q99020	heterogeneous nuclear ribonucleoprotein A/B(Hnrnpab)	Mus musculus			GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001837~epithelial to mesenchymal transition,GO:0010468~regulation of gene expression,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0016556~mRNA modification,GO:0045893~positive regulation of transcription, DNA-templated,GO:0060341~regulation of cellular localization,GO:1901537~positive regulation of DNA demethylation,GO:1904580~regulation of intracellular mRNA localization,GO:2000623~negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0030425~dendrite,GO:0045293~mRNA editing complex,GO:0071598~neuronal ribonucleoprotein granule,GO:0090575~RNA polymerase II transcription factor complex,GO:0099523~presynaptic cytosol,GO:1990124~messenger ribonucleoprotein complex,GO:1990904~ribonucleoprotein complex,	GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003723~RNA binding,GO:0005515~protein binding,GO:0044877~macromolecular complex binding,GO:1990837~sequence-specific double-stranded DNA binding,	IPR000504:RRM_dom,IPR012677:Nucleotide-bd_a/b_plait_sf,IPR012956:CARG-binding_factor_N,IPR034846:hnRNPAB_RRM1,IPR035979:RBD_domain_sf,				SM00360:RRM,	KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0677~Repeat,		KW-0238~DNA-binding,KW-0678~Repressor,KW-0694~RNA-binding,	KW-0007~Acetylation,KW-0488~Methylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Polar residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),DOMAIN:RRM,DOMAIN:RRM 1,DOMAIN:RRM 2,REGION:Disordered,
A5A6H4	heterogeneous nuclear ribonucleoprotein A1(HNRNPA1)	Pan troglodytes			GO:0000398~mRNA splicing, via spliceosome,GO:0006397~mRNA processing,GO:0008380~RNA splicing,GO:0051028~mRNA transport,GO:1903936~cellular response to sodium arsenite,	GO:0005634~nucleus,GO:0005681~spliceosomal complex,GO:0005737~cytoplasm,GO:0071013~catalytic step 2 spliceosome,GO:1990904~ribonucleoprotein complex,	GO:0003723~RNA binding,GO:0003730~mRNA 3'-UTR binding,	IPR000504:RRM_dom,IPR012677:Nucleotide-bd_a/b_plait_sf,IPR021662:HnRNPA1/A2_C,IPR034516:hnRNPA1/3_RRM2,IPR034845:hnRNPA1_RRM1,IPR035979:RBD_domain_sf,	ptr03040:Spliceosome,ptr05014:Amyotrophic lateral sclerosis,			SM00360:RRM,	KW-0507~mRNA processing,KW-0508~mRNA splicing,KW-0509~mRNA transport,KW-0813~Transport,	KW-0539~Nucleus,KW-0747~Spliceosome,KW-0963~Cytoplasm,			KW-0677~Repeat,		KW-0687~Ribonucleoprotein,KW-0694~RNA-binding,	KW-0007~Acetylation,KW-0488~Methylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Polar residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO),CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate,DOMAIN:RRM,DOMAIN:RRM 1,DOMAIN:RRM 2,REGION:Disordered,REGION:Globular A domain,REGION:Globular B domain,REGION:Nuclear targeting sequence,REGION:RNA-binding RGG-box,
A5A6H4	heterogeneous nuclear ribonucleoprotein A1-like 1(HNRPA1LK1)	Pan troglodytes			GO:0000398~mRNA splicing, via spliceosome,GO:0006397~mRNA processing,GO:0008380~RNA splicing,GO:0051028~mRNA transport,GO:1903936~cellular response to sodium arsenite,	GO:0005634~nucleus,GO:0005681~spliceosomal complex,GO:0005737~cytoplasm,GO:0071013~catalytic step 2 spliceosome,GO:1990904~ribonucleoprotein complex,	GO:0003723~RNA binding,GO:0003730~mRNA 3'-UTR binding,	IPR000504:RRM_dom,IPR012677:Nucleotide-bd_a/b_plait_sf,IPR021662:HnRNPA1/A2_C,IPR034516:hnRNPA1/3_RRM2,IPR034845:hnRNPA1_RRM1,IPR035979:RBD_domain_sf,	ptr03040:Spliceosome,ptr05014:Amyotrophic lateral sclerosis,			SM00360:RRM,	KW-0507~mRNA processing,KW-0508~mRNA splicing,KW-0509~mRNA transport,KW-0813~Transport,	KW-0539~Nucleus,KW-0747~Spliceosome,KW-0963~Cytoplasm,			KW-0677~Repeat,		KW-0687~Ribonucleoprotein,KW-0694~RNA-binding,	KW-0007~Acetylation,KW-0488~Methylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Polar residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO),CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate,DOMAIN:RRM,DOMAIN:RRM 1,DOMAIN:RRM 2,REGION:Disordered,REGION:Globular A domain,REGION:Globular B domain,REGION:Nuclear targeting sequence,REGION:RNA-binding RGG-box,
P14866	heterogeneous nuclear ribonucleoprotein L(HNRNPL)	Homo sapiens			GO:0000381~regulation of alternative mRNA splicing, via spliceosome,GO:0006396~RNA processing,GO:0006397~mRNA processing,GO:0043484~regulation of RNA splicing,GO:0045892~negative regulation of transcription, DNA-templated,	GO:0000785~chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0016020~membrane,GO:0035770~ribonucleoprotein granule,GO:0070062~extracellular exosome,GO:1990904~ribonucleoprotein complex,	GO:0000976~transcription regulatory region sequence-specific DNA binding,GO:0003723~RNA binding,GO:0003729~mRNA binding,GO:0005515~protein binding,GO:0097157~pre-mRNA intronic binding,	IPR000504:RRM_dom,IPR006536:HnRNP-L/PTB,IPR012677:Nucleotide-bd_a/b_plait_sf,IPR021790:PTBP1-like_RRM2,IPR034816:hnRNP-L_RRM3,IPR034817:hnRNPL_RRM4,IPR035005:hnRNPL_RRM1,IPR035008:hnRNPL_RRM2,IPR035979:RBD_domain_sf,				SM00360:RRM,		KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0677~Repeat,		KW-0687~Ribonucleoprotein,KW-0694~RNA-binding,	KW-0007~Acetylation,KW-0488~Methylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,COMPBIAS:Pro residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),DOMAIN:RRM,DOMAIN:RRM 1,DOMAIN:RRM 2,DOMAIN:RRM 3,DOMAIN:RRM 4,MUTAGEN:F->A: Significant decrease in RNA-binding affinity.,MUTAGEN:H->A: 6-fold decrease in RNA-binding affinity.,MUTAGEN:H->A: Significant decrease in RNA-binding affinity.,MUTAGEN:L->A: 15-fold decrease in RNA-binding affinity; when associated with A-174.,MUTAGEN:N->A: 1-fold increase in RNA-binding affinity.,MUTAGEN:S->A: 15-fold decrease in RNA-binding affinity; when associated with A-174.,MUTAGEN:V->A: 4-fold increase in RNA-binding affinity.,REGION:Disordered,
O95479	hexose-6-phosphate dehydrogenase/glucose 1-dehydrogenase(H6PD)	Homo sapiens			GO:0006006~glucose metabolic process,GO:0009051~pentose-phosphate shunt, oxidative branch,GO:0031667~response to nutrient levels,GO:0097305~response to alcohol,GO:2000064~regulation of cortisol biosynthetic process,	GO:0005783~endoplasmic reticulum,GO:0005788~endoplasmic reticulum lumen,	GO:0004345~glucose-6-phosphate dehydrogenase activity,GO:0017057~6-phosphogluconolactonase activity,GO:0030246~carbohydrate binding,GO:0047934~glucose 1-dehydrogenase (NAD+) activity,GO:0047935~glucose 1-dehydrogenase (NADP+) activity,GO:0047936~glucose 1-dehydrogenase [NAD(P)] activity,GO:0050661~NADP binding,	IPR001282:G6P_DH,IPR005900:6-phosphogluconolactonase_DevB,IPR006148:Glc/Gal-6P_isomerase,IPR019796:G6P_DH_AS,IPR022674:G6P_DH_NAD-bd,IPR022675:G6P_DH_C,IPR036291:NAD(P)-bd_dom_sf,IPR037171:NagB/RpiA_transferase-like,	hsa00030:Pentose phosphate pathway,hsa01100:Metabolic pathways,hsa01200:Carbon metabolism,	604931~Cortisone reductase deficiency 1,			KW-0119~Carbohydrate metabolism,KW-0313~Glucose metabolism,	KW-0256~Endoplasmic reticulum,		KW-0225~Disease variant,	KW-0732~Signal,	KW-0520~NAD,KW-0521~NADP,	KW-0378~Hydrolase,KW-0511~Multifunctional enzyme,KW-0560~Oxidoreductase,	KW-0325~Glycoprotein,KW-0873~Pyrrolidone carboxylic acid,	ACT_SITE:Proton acceptor,CARBOHYD:N-linked (GlcNAc...) asparagine,REGION:6-phosphogluconolactonase,REGION:Hexose-6-phosphate dehydrogenase,REGION:Linker,
P07746	high mobility group box 1a(hmgb1a)	Oncorhynchus mykiss			GO:0006357~regulation of transcription from RNA polymerase II promoter,	GO:0000785~chromatin,GO:0005634~nucleus,GO:0005694~chromosome,	GO:0003677~DNA binding,GO:0003690~double-stranded DNA binding,GO:0008301~DNA binding, bending,	IPR009057:Homeobox-like_sf,IPR009071:HMG_box_dom,IPR017967:HMG_boxA_CS,IPR036388:WH-like_DNA-bd_sf,IPR036910:HMG_box_dom_sf,				SM00398:HMG,		KW-0158~Chromosome,KW-0539~Nucleus,			KW-0677~Repeat,		KW-0238~DNA-binding,		COMPBIAS:Acidic residues,DNA_BIND:HMG box,DNA_BIND:HMG box 1,DNA_BIND:HMG box 2,DOMAIN:HMG box,REGION:Disordered,
P26584	high mobility group box 2(HMGB2)	Gallus gallus			GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001938~positive regulation of endothelial cell proliferation,GO:0002437~inflammatory response to antigenic stimulus,GO:0006310~DNA recombination,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0007289~spermatid nucleus differentiation,GO:0008584~male gonad development,GO:0008625~extrinsic apoptotic signaling pathway via death domain receptors,GO:0010628~positive regulation of gene expression,GO:0010629~negative regulation of gene expression,GO:0032392~DNA geometric change,GO:0032496~response to lipopolysaccharide,GO:0032728~positive regulation of interferon-beta production,GO:0045087~innate immune response,GO:0045089~positive regulation of innate immune response,GO:0045648~positive regulation of erythrocyte differentiation,GO:0045654~positive regulation of megakaryocyte differentiation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048545~response to steroid hormone,GO:0050767~regulation of neurogenesis,GO:0050829~defense response to Gram-negative bacterium,GO:0050830~defense response to Gram-positive bacterium,GO:0060326~cell chemotaxis,GO:0071222~cellular response to lipopolysaccharide,GO:0072091~regulation of stem cell proliferation,GO:1902042~negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,	GO:0000785~chromatin,GO:0000793~condensed chromosome,GO:0005615~extracellular space,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0048471~perinuclear region of cytoplasm,	GO:0000400~four-way junction DNA binding,GO:0000987~core promoter proximal region sequence-specific DNA binding,GO:0003684~damaged DNA binding,GO:0003713~transcription coactivator activity,GO:0008134~transcription factor binding,GO:0008301~DNA binding, bending,GO:0019904~protein domain specific binding,GO:0042056~chemoattractant activity,GO:0050786~RAGE receptor binding,	IPR009071:HMG_box_dom,IPR017967:HMG_boxA_CS,IPR036910:HMG_box_dom_sf,				SM00398:HMG,	KW-0233~DNA recombination,KW-0391~Immunity,KW-0395~Inflammatory response,KW-0399~Innate immunity,KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0158~Chromosome,KW-0539~Nucleus,KW-0963~Cytoplasm,KW-0964~Secreted,			KW-0677~Repeat,		KW-0238~DNA-binding,	KW-0558~Oxidation,KW-1015~Disulfide bond,	COMPBIAS:Acidic residues,COMPBIAS:Basic and acidic residues,DISULFID:In disulfide HMGB2,DNA_BIND:HMG box 1,DNA_BIND:HMG box 2,DOMAIN:HMG box,REGION:Disordered,
O54879	high mobility group box 3(Hmgb3)	Mus musculus			GO:0002376~immune system process,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0032392~DNA geometric change,GO:0045087~innate immune response,GO:0045578~negative regulation of B cell differentiation,GO:0045638~negative regulation of myeloid cell differentiation,	GO:0005634~nucleus,GO:0005694~chromosome,GO:0005737~cytoplasm,	GO:0000400~four-way junction DNA binding,GO:0003677~DNA binding,GO:0003723~RNA binding,GO:0008301~DNA binding, bending,	IPR009071:HMG_box_dom,IPR017967:HMG_boxA_CS,IPR036910:HMG_box_dom_sf,				SM00398:HMG,	KW-0391~Immunity,KW-0399~Innate immunity,KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0158~Chromosome,KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0677~Repeat,		KW-0238~DNA-binding,	KW-0007~Acetylation,KW-0558~Oxidation,KW-0597~Phosphoprotein,KW-1015~Disulfide bond,	COMPBIAS:Acidic residues,COMPBIAS:Basic and acidic residues,DISULFID:In disulfide HMGB3; alternate,DNA_BIND:HMG box,DNA_BIND:HMG box 1,DNA_BIND:HMG box 2,DOMAIN:HMG box,REGION:Disordered,
Q803H4	histone H3-like centromeric protein A(cenpa)	Danio rerio				GO:0000775~chromosome, centromeric region,GO:0000786~nucleosome,GO:0005634~nucleus,	GO:0003677~DNA binding,GO:0030527~structural constituent of chromatin,GO:0046982~protein heterodimerization activity,	IPR000164:Histone_H3/CENP-A,IPR007125:Histone_H2A/H2B/H3,IPR009072:Histone-fold,				SM00428:H3,		KW-0137~Centromere,KW-0158~Chromosome,KW-0539~Nucleus,KW-0544~Nucleosome core,					KW-0238~DNA-binding,	KW-0597~Phosphoprotein,	COMPBIAS:Basic residues,REGION:Disordered,REGION:H3-like,
Q1KKV1	homeobox protein Hox-C4a(LOC105419977)	Takifugu rubripes			GO:0006351~transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0009952~anterior/posterior pattern specification,GO:0048704~embryonic skeletal system morphogenesis,	GO:0005634~nucleus,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0003677~DNA binding,	IPR001356:Homeobox_dom,IPR001827:Homeobox_Antennapedia_CS,IPR006711:Hox9_activation_N,IPR009057:Homeobox-like_sf,IPR017112:HXA9/HXB9/HXC9,IPR017970:Homeobox_CS,IPR017995:Homeobox_antennapedia,IPR020479:Homeobox_metazoa,IPR022067:HoxA13_N,IPR046333:HXA10/ABDB-like,			PIRSF037109:Homeobox_Hox9,	SM00389:HOX,	KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,			KW-0371~Homeobox,		KW-0217~Developmental protein,KW-0238~DNA-binding,KW-9996~Developmental protein,		COMPBIAS:Acidic residues,COMPBIAS:Basic and acidic residues,COMPBIAS:Basic residues,COMPBIAS:Polar residues,DNA_BIND:Homeobox,DOMAIN:Homeobox,MOTIF:Antp-type hexapeptide,REGION:Disordered,
Q9D968	host cell factor C2(Hcfc2)	Mus musculus			GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006338~chromatin remodeling,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0034139~regulation of toll-like receptor 3 signaling pathway,GO:1902615~immune response involved in response to exogenous dsRNA,GO:1903025~regulation of RNA polymerase II regulatory region sequence-specific DNA binding,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0016604~nuclear body,GO:0035097~histone methyltransferase complex,GO:0044665~MLL1/2 complex,GO:0048188~Set1C/COMPASS complex,GO:0071339~MLL1 complex,	GO:0003712~transcription cofactor activity,GO:0003713~transcription coactivator activity,GO:0008134~transcription factor binding,	IPR003961:FN3_dom,IPR006652:Kelch_1,IPR013783:Ig-like_fold,IPR015915:Kelch-typ_b-propeller,IPR036116:FN3_sf,IPR043536:HCF1/2,	mmu03083:Polycomb repressive complex,mmu05168:Herpes simplex virus 1 infection,			SM00060:FN3,		KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0677~Repeat,KW-0880~Kelch repeat,				COMPBIAS:Polar residues,DOMAIN:Fibronectin type-III,DOMAIN:Fibronectin type-III 1,DOMAIN:Fibronectin type-III 2,DOMAIN:Fibronectin type-III 3,REGION:Disordered,REPEAT:Kelch 1,REPEAT:Kelch 2,REPEAT:Kelch 3,REPEAT:Kelch 4,
P97779	hyaluronan-mediated motility receptor(Hmmr)	Rattus norvegicus			GO:0006898~receptor-mediated endocytosis,GO:0007010~cytoskeleton organization,GO:0007267~cell-cell signaling,GO:0030214~hyaluronan catabolic process,	GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005819~spindle,GO:0005829~cytosol,GO:0009986~cell surface,GO:0015630~microtubule cytoskeleton,	GO:0005540~hyaluronic acid binding,GO:0038024~cargo receptor activity,	IPR026203:IHABP,IPR031794:HMMR_C,	rno04512:ECM-receptor interaction,					KW-0206~Cytoskeleton,KW-0963~Cytoplasm,			KW-0175~Coiled coil,KW-0677~Repeat,	KW-0373~Hyaluronic acid,	KW-0675~Receptor,	KW-0325~Glycoprotein,KW-0597~Phosphoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Polar residues,DOMAIN:Hyaluronan-mediated motility receptor C-terminal,REGION:Disordered,REGION:Hyaluronic acid-binding,REGION:Required for interaction with FAM83D,
Q6QA33	hydroxysteroid (17-beta) dehydrogenase 12b(hsd17b12b)	Danio rerio			GO:0006629~lipid metabolic process,GO:0006633~fatty acid biosynthetic process,GO:0006694~steroid biosynthetic process,GO:0006703~estrogen biosynthetic process,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0016020~membrane,	GO:0004303~estradiol 17-beta-dehydrogenase activity,GO:0016491~oxidoreductase activity,	IPR002347:SDR_fam,IPR036291:NAD(P)-bd_dom_sf,	dre00062:Fatty acid elongation,dre00140:Steroid hormone biosynthesis,dre01040:Biosynthesis of unsaturated fatty acids,dre01100:Metabolic pathways,dre01212:Fatty acid metabolism,		PIRSF000126:11-beta-HSD1,		KW-0443~Lipid metabolism,KW-0444~Lipid biosynthesis,KW-0752~Steroid biosynthesis,	KW-0256~Endoplasmic reticulum,KW-0472~Membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0521~NADP,	KW-0560~Oxidoreductase,		ACT_SITE:Proton acceptor,TRANSMEM:Helical,
Q62904	hydroxysteroid (17-beta) dehydrogenase 7(Hsd17b7)	Rattus norvegicus			GO:0006694~steroid biosynthetic process,GO:0006695~cholesterol biosynthetic process,GO:0006703~estrogen biosynthetic process,GO:0007399~nervous system development,GO:0007420~brain development,GO:0008209~androgen metabolic process,GO:0009410~response to xenobiotic stimulus,GO:0014070~response to organic cyclic compound,GO:0021766~hippocampus development,GO:0030154~cell differentiation,GO:0032355~response to estradiol,GO:0048568~embryonic organ development,GO:0048706~embryonic skeletal system development,GO:0060135~maternal process involved in female pregnancy,GO:1990637~response to prolactin,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,	GO:0000253~3-keto sterol reductase activity,GO:0004303~estradiol 17-beta-dehydrogenase activity,GO:0005148~prolactin receptor binding,GO:0047024~5alpha-androstane-3beta,17beta-diol dehydrogenase activity,	IPR002347:SDR_fam,IPR036291:NAD(P)-bd_dom_sf,IPR042829:HSD17B7/Erg27,	rno00100:Steroid biosynthesis,rno00140:Steroid hormone biosynthesis,rno01100:Metabolic pathways,rno04913:Ovarian steroidogenesis,				KW-0443~Lipid metabolism,KW-0444~Lipid biosynthesis,KW-0752~Steroid biosynthesis,	KW-0256~Endoplasmic reticulum,KW-0472~Membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0520~NAD,KW-0521~NADP,	KW-0560~Oxidoreductase,	KW-0325~Glycoprotein,	ACT_SITE:Proton acceptor,CARBOHYD:N-linked (GlcNAc...) asparagine,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q90W33	hypermethylated in cancer 2(hic2)	Danio rerio			GO:0006357~regulation of transcription from RNA polymerase II promoter,	GO:0005634~nucleus,	GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0003677~DNA binding,GO:0046872~metal ion binding,	IPR000210:BTB/POZ_dom,IPR011333:SKP1/BTB/POZ_sf,IPR013087:Znf_C2H2_type,IPR036236:Znf_C2H2_sf,				SM00225:BTB,SM00355:ZnF_C2H2,	KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,			KW-0677~Repeat,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0238~DNA-binding,KW-0678~Repressor,		COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:BTB,DOMAIN:C2H2-type,REGION:Disordered,ZN_FING:C2H2-type 1,ZN_FING:C2H2-type 2,ZN_FING:C2H2-type 3,ZN_FING:C2H2-type 4,ZN_FING:C2H2-type 5,
Q55EX9	hypothetical protein(DDB_G0268948)	Dictyostelium discoideum AX4			GO:0032259~methylation,	GO:0045335~phagocytic vesicle,	GO:0008168~methyltransferase activity,GO:0008757~S-adenosylmethionine-dependent methyltransferase activity,GO:0016740~transferase activity,	IPR013216:Methyltransf_11,IPR029063:SAM-dependent_MTases_sf,										KW-0949~S-adenosyl-L-methionine,	KW-0489~Methyltransferase,KW-0808~Transferase,
E9PZ19	immunoglobulin superfamily, member 9B(Igsf9b)	Mus musculus			GO:0007155~cell adhesion,GO:0007156~homophilic cell adhesion via plasma membrane adhesion molecules,GO:0007399~nervous system development,GO:0097151~positive regulation of inhibitory postsynaptic potential,GO:0099560~synaptic membrane adhesion,	GO:0005886~plasma membrane,GO:0014069~postsynaptic density,GO:0016020~membrane,GO:0030425~dendrite,GO:0043005~neuron projection,GO:0043025~neuronal cell body,GO:0045202~synapse,GO:0045211~postsynaptic membrane,GO:0060077~inhibitory synapse,GO:0098982~GABA-ergic synapse,GO:0099629~postsynaptic specialization of symmetric synapse,	GO:0019900~kinase binding,	IPR003598:Ig_sub2,IPR003599:Ig_sub,IPR003961:FN3_dom,IPR007110:Ig-like_dom,IPR013783:Ig-like_fold,IPR036116:FN3_sf,IPR036179:Ig-like_dom_sf,				SM00060:FN3,SM00408:IGc2,SM00409:IG,	KW-0130~Cell adhesion,KW-0524~Neurogenesis,	KW-0472~Membrane,KW-0628~Postsynaptic cell membrane,KW-0770~Synapse,KW-1003~Cell membrane,			KW-0393~Immunoglobulin domain,KW-0677~Repeat,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0325~Glycoprotein,KW-0488~Methylation,KW-0597~Phosphoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Polar residues,DOMAIN:Fibronectin type-III,DOMAIN:Fibronectin type-III 1,DOMAIN:Fibronectin type-III 2,DOMAIN:Ig-like,DOMAIN:Ig-like 1,DOMAIN:Ig-like 2,DOMAIN:Ig-like 3,DOMAIN:Ig-like 4,DOMAIN:Ig-like 5,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q91YE6	importin 9(Ipo9)	Mus musculus			GO:0006606~protein import into nucleus,GO:0006886~intracellular protein transport,GO:0006913~nucleocytoplasmic transport,GO:0015031~protein transport,GO:0031144~proteasome localization,GO:0042254~ribosome biogenesis,GO:0050821~protein stabilization,	GO:0005634~nucleus,GO:0005635~nuclear envelope,GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0031267~small GTPase binding,GO:0042393~histone binding,GO:0061608~nuclear import signal receptor activity,	IPR001494:Importin-beta_N,IPR011989:ARM-like,IPR016024:ARM-type_fold,	mmu03013:Nucleocytoplasmic transport,			SM00913:IBN_N,	KW-0653~Protein transport,KW-0813~Transport,	KW-0539~Nucleus,KW-0963~Cytoplasm,					KW-0143~Chaperone,	KW-0007~Acetylation,	COMPBIAS:Acidic residues,DOMAIN:Importin N-terminal,REGION:Disordered,
Q8R0V5	indoleamine 2,3-dioxygenase 2(Ido2)	Mus musculus			GO:0002376~immune system process,GO:0006569~tryptophan catabolic process,GO:0019441~tryptophan catabolic process to kynurenine,GO:0034354~'de novo' NAD biosynthetic process from tryptophan,	GO:0005737~cytoplasm,	GO:0004833~tryptophan 2,3-dioxygenase activity,GO:0016491~oxidoreductase activity,GO:0016702~oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen,GO:0020037~heme binding,GO:0033754~indoleamine 2,3-dioxygenase activity,GO:0046872~metal ion binding,GO:0051213~dioxygenase activity,	IPR000898:Indolamine_dOase,IPR037217:Trp/Indoleamine_2_3_dOase-like,	mmu00380:Tryptophan metabolism,mmu01100:Metabolic pathways,mmu01240:Biosynthesis of cofactors,mmu05143:African trypanosomiasis,				KW-0391~Immunity,KW-0823~Tryptophan catabolism,					KW-0349~Heme,KW-0408~Iron,KW-0479~Metal-binding,	KW-0223~Dioxygenase,KW-0560~Oxidoreductase,		BINDING:proximal binding residue,
Q5RG82	influenza virus NS1A binding protein a(ivns1abpa)	Danio rerio				GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005856~cytoskeleton,		IPR000210:BTB/POZ_dom,IPR006652:Kelch_1,IPR011333:SKP1/BTB/POZ_sf,IPR011705:BACK,IPR015915:Kelch-typ_b-propeller,IPR017096:BTB-kelch_protein,			PIRSF037037:Kelch-like_protein_gigaxonin,	SM00225:BTB,SM00612:Kelch,SM00875:BACK,		KW-0206~Cytoskeleton,KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0677~Repeat,KW-0880~Kelch repeat,				COMPBIAS:Polar residues,DOMAIN:BACK,DOMAIN:BTB,REGION:Disordered,REPEAT:Kelch 1,REPEAT:Kelch 2,REPEAT:Kelch 3,REPEAT:Kelch 4,REPEAT:Kelch 5,REPEAT:Kelch 6,
P27093	inhibin beta B subunit(INHBB)	Gallus gallus			GO:0009267~cellular response to starvation,GO:0009611~response to wounding,GO:0030509~BMP signaling pathway,GO:0032686~negative regulation of hepatocyte growth factor production,GO:0032869~cellular response to insulin stimulus,GO:0032924~activin receptor signaling pathway,GO:0044320~cellular response to leptin stimulus,GO:0045444~fat cell differentiation,GO:0046676~negative regulation of insulin secretion,GO:0046881~positive regulation of follicle-stimulating hormone secretion,GO:0046882~negative regulation of follicle-stimulating hormone secretion,GO:0048513~animal organ development,GO:0048599~oocyte development,GO:0060279~positive regulation of ovulation,GO:0060395~SMAD protein signal transduction,GO:0097190~apoptotic signaling pathway,GO:2001235~positive regulation of apoptotic signaling pathway,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0048471~perinuclear region of cytoplasm,GO:0071944~cell periphery,	GO:0005125~cytokine activity,GO:0005179~hormone activity,GO:0008083~growth factor activity,GO:0042803~protein homodimerization activity,	IPR000381:INHBB_C,IPR001111:TGF-b_propeptide,IPR001839:TGF-b_C,IPR006311:TAT_signal,IPR015615:TGF-beta-rel,IPR017948:TGFb_CS,IPR029034:Cystine-knot_cytokine,	gga04060:Cytokine-cytokine receptor interaction,gga04350:TGF-beta signaling pathway,			SM00204:TGFB,		KW-0964~Secreted,			KW-0732~Signal,		KW-0339~Growth factor,KW-0372~Hormone,	KW-0165~Cleavage on pair of basic residues,KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DISULFID:Interchain,DOMAIN:TGF-beta family profile,REGION:Disordered,
Q04998	inhibin beta-A(Inhba)	Mus musculus			GO:0001541~ovarian follicle development,GO:0001707~mesoderm formation,GO:0001934~positive regulation of protein phosphorylation,GO:0001942~hair follicle development,GO:0002244~hematopoietic progenitor cell differentiation,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0006914~autophagy,GO:0008285~negative regulation of cell proliferation,GO:0008584~male gonad development,GO:0010628~positive regulation of gene expression,GO:0019221~cytokine-mediated signaling pathway,GO:0021773~striatal medium spiny neuron differentiation,GO:0030308~negative regulation of cell growth,GO:0032924~activin receptor signaling pathway,GO:0032967~positive regulation of collagen biosynthetic process,GO:0035987~endodermal cell differentiation,GO:0042476~odontogenesis,GO:0042541~hemoglobin biosynthetic process,GO:0042701~progesterone secretion,GO:0045648~positive regulation of erythrocyte differentiation,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0045945~positive regulation of transcription from RNA polymerase III promoter,GO:0046880~regulation of follicle-stimulating hormone secretion,GO:0048333~mesodermal cell differentiation,GO:0051247~positive regulation of protein metabolic process,GO:0051799~negative regulation of hair follicle development,GO:0060021~palate development,GO:0060279~positive regulation of ovulation,GO:0060391~positive regulation of SMAD protein import into nucleus,GO:0060395~SMAD protein signal transduction,GO:0060936~cardiac fibroblast cell development,GO:0061029~eyelid development in camera-type eye,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0071372~cellular response to follicle-stimulating hormone stimulus,GO:0071397~cellular response to cholesterol,GO:0071456~cellular response to hypoxia,GO:0090650~cellular response to oxygen-glucose deprivation,GO:0097154~GABAergic neuron differentiation,GO:0097191~extrinsic apoptotic signaling pathway,GO:1904044~response to aldosterone,GO:1904385~cellular response to angiotensin,GO:2000134~negative regulation of G1/S transition of mitotic cell cycle,GO:2001241~positive regulation of extrinsic apoptotic signaling pathway in absence of ligand,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0043509~activin A complex,GO:0043512~inhibin A complex,GO:0048471~perinuclear region of cytoplasm,	GO:0005102~receptor binding,GO:0005125~cytokine activity,GO:0005179~hormone activity,GO:0008083~growth factor activity,GO:0017046~peptide hormone binding,GO:0042802~identical protein binding,GO:0044877~macromolecular complex binding,GO:0070699~type II activin receptor binding,	IPR000491:Inhibin_betaA,IPR001111:TGF-b_propeptide,IPR001839:TGF-b_C,IPR015615:TGF-beta-rel,IPR017948:TGFb_CS,IPR029034:Cystine-knot_cytokine,	mmu04060:Cytokine-cytokine receptor interaction,mmu04350:TGF-beta signaling pathway,mmu04550:Signaling pathways regulating pluripotency of stem cells,			SM00204:TGFB,		KW-0964~Secreted,			KW-0732~Signal,		KW-0339~Growth factor,KW-0372~Hormone,	KW-0165~Cleavage on pair of basic residues,KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Basic and acidic residues,DISULFID:Interchain,DOMAIN:TGF-beta family profile,REGION:Disordered,
P41134	inhibitor of DNA binding 1(ID1)	Homo sapiens	71.Id_proteins_G0-to-S_cell_cycle,		GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001525~angiogenesis,GO:0007179~transforming growth factor beta receptor signaling pathway,GO:0010621~negative regulation of transcription by transcription factor localization,GO:0030154~cell differentiation,GO:0032922~circadian regulation of gene expression,GO:0043433~negative regulation of sequence-specific DNA binding transcription factor activity,GO:0043534~blood vessel endothelial cell migration,GO:0045892~negative regulation of transcription, DNA-templated,GO:0048514~blood vessel morphogenesis,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,	GO:0005515~protein binding,GO:0046983~protein dimerization activity,	IPR011598:bHLH_dom,IPR026052:DNA-bd_prot-inh,IPR036638:HLH_DNA-bd_sf,	hsa04015:Rap1 signaling pathway,hsa04350:TGF-beta signaling pathway,hsa04390:Hippo signaling pathway,hsa04550:Signaling pathways regulating pluripotency of stem cells,			SM00353:HLH,	KW-0090~Biological rhythms,KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,KW-0963~Cytoplasm,					KW-0217~Developmental protein,KW-0678~Repressor,KW-9996~Developmental protein,		DOMAIN:bHLH,MOTIF:Nuclear export signal,
Q28I39	inner mitochondrial membrane peptidase subunit 1(immp1l)	Xenopus tropicalis			GO:0006465~signal peptide processing,GO:0006508~proteolysis,GO:0006627~protein processing involved in protein targeting to mitochondrion,GO:0030030~cell projection organization,	GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0016020~membrane,GO:0042720~mitochondrial inner membrane peptidase complex,	GO:0004252~serine-type endopeptidase activity,GO:0008233~peptidase activity,GO:0008236~serine-type peptidase activity,GO:0016787~hydrolase activity,	IPR000223:Pept_S26A_signal_pept_1,IPR011677:Tectonic_dom,IPR019533:Peptidase_S26,IPR036286:LexA/Signal_pep-like_sf,IPR040354:Tectonic,	xtr03060:Protein export,				KW-0970~Cilium biogenesis/degradation,	KW-0472~Membrane,KW-0496~Mitochondrion,KW-0999~Mitochondrion inner membrane,			KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0378~Hydrolase,KW-0645~Protease,	KW-0325~Glycoprotein,	DOMAIN:Peptidase S26,DOMAIN:Tectonic,TRANSMEM:Helical,
Q4R4D7	inositol polyphosphate-4-phosphatase type II B(INPP4B)	Macaca fascicularis				GO:0005737~cytoplasm,GO:0016020~membrane,	GO:0016316~phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity,GO:0017161~inositol-1,3,4-trisphosphate 4-phosphatase activity,GO:0052828~inositol-3,4-bisphosphate 4-phosphatase activity,	IPR000008:C2_dom,IPR035892:C2_domain_sf,IPR039034:INPP4,	mcf00562:Inositol phosphate metabolism,mcf01100:Metabolic pathways,mcf04070:Phosphatidylinositol signaling system,				KW-0443~Lipid metabolism,	KW-0472~Membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0378~Hydrolase,		COMPBIAS:Polar residues,DOMAIN:C2,REGION:Disordered,TRANSMEM:Helical,
Q8AV61	insulin induced gene 1(insig1)	Danio rerio			GO:0006629~lipid metabolic process,GO:0006695~cholesterol biosynthetic process,GO:0008202~steroid metabolic process,GO:0008203~cholesterol metabolic process,GO:0032869~cellular response to insulin stimulus,GO:0032933~SREBP signaling pathway,GO:0036316~SREBP-SCAP complex retention in endoplasmic reticulum,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0016020~membrane,GO:0032937~SREBP-SCAP-Insig complex,	GO:0008142~oxysterol binding,GO:0008289~lipid binding,	IPR025929:INSIG_fam,					KW-0153~Cholesterol metabolism,KW-0443~Lipid metabolism,KW-0753~Steroid metabolism,KW-1207~Sterol metabolism,	KW-0256~Endoplasmic reticulum,KW-0472~Membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0446~Lipid-binding,			MOTIF:KxHxx,SITE:Required for the recognition of 25-hydroxycholesterol,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,TRANSMEM:Helical; Name=1,TRANSMEM:Helical; Name=2,TRANSMEM:Helical; Name=3,TRANSMEM:Helical; Name=4,TRANSMEM:Helical; Name=5,TRANSMEM:Helical; Name=6,
P70389	insulin-like growth factor binding protein, acid labile subunit(Igfals)	Mus musculus			GO:0007155~cell adhesion,GO:0007411~axon guidance,GO:0050919~negative chemotaxis,	GO:0005576~extracellular region,GO:0042567~insulin-like growth factor ternary complex,	GO:0005515~protein binding,GO:0005520~insulin-like growth factor binding,GO:0008201~heparin binding,GO:0048495~Roundabout binding,	IPR000372:LRRNT,IPR000483:Cys-rich_flank_reg_C,IPR001611:Leu-rich_rpt,IPR003591:Leu-rich_rpt_typical-subtyp,IPR032675:LRR_dom_sf,	mmu04935:Growth hormone synthesis, secretion and action,			SM00013:LRRNT,SM00082:LRRCT,SM00365:LRR_SD22,SM00369:LRR_TYP,	KW-0130~Cell adhesion,	KW-0964~Secreted,			KW-0433~Leucine-rich repeat,KW-0677~Repeat,KW-0732~Signal,			KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:LRRCT,DOMAIN:LRRNT,REPEAT:LRR 1,REPEAT:LRR 10,REPEAT:LRR 11,REPEAT:LRR 12,REPEAT:LRR 13,REPEAT:LRR 14,REPEAT:LRR 15,REPEAT:LRR 16,REPEAT:LRR 17,REPEAT:LRR 18,REPEAT:LRR 19,REPEAT:LRR 2,REPEAT:LRR 3,REPEAT:LRR 4,REPEAT:LRR 5,REPEAT:LRR 6,REPEAT:LRR 7,REPEAT:LRR 8,REPEAT:LRR 9,
P05106	integrin subunit beta 3(ITGB3)	Homo sapiens		h_edg1Pathway:Phospholipids as signalling intermediaries,h_uCalpainPathway:uCalpain and friends in Cell spread,	GO:0001934~positive regulation of protein phosphorylation,GO:0001938~positive regulation of endothelial cell proliferation,GO:0001954~positive regulation of cell-matrix adhesion,GO:0007044~cell-substrate junction assembly,GO:0007155~cell adhesion,GO:0007160~cell-matrix adhesion,GO:0007229~integrin-mediated signaling pathway,GO:0007566~embryo implantation,GO:0007596~blood coagulation,GO:0010595~positive regulation of endothelial cell migration,GO:0010628~positive regulation of gene expression,GO:0010745~negative regulation of macrophage derived foam cell differentiation,GO:0010763~positive regulation of fibroblast migration,GO:0010888~negative regulation of lipid storage,GO:0014823~response to activity,GO:0014909~smooth muscle cell migration,GO:0014911~positive regulation of smooth muscle cell migration,GO:0016477~cell migration,GO:0030168~platelet activation,GO:0030949~positive regulation of vascular endothelial growth factor receptor signaling pathway,GO:0031589~cell-substrate adhesion,GO:0032147~activation of protein kinase activity,GO:0032369~negative regulation of lipid transport,GO:0032880~regulation of protein localization,GO:0032956~regulation of actin cytoskeleton organization,GO:0033627~cell adhesion mediated by integrin,GO:0033630~positive regulation of cell adhesion mediated by integrin,GO:0033690~positive regulation of osteoblast proliferation,GO:0034113~heterotypic cell-cell adhesion,GO:0034446~substrate adhesion-dependent cell spreading,GO:0035295~tube development,GO:0035313~wound healing, spreading of epidermal cells,GO:0036120~cellular response to platelet-derived growth factor stimulus,GO:0038027~apolipoprotein A-I-mediated signaling pathway,GO:0042060~wound healing,GO:0043277~apoptotic cell clearance,GO:0045124~regulation of bone resorption,GO:0045766~positive regulation of angiogenesis,GO:0045780~positive regulation of bone resorption,GO:0046718~viral entry into host cell,GO:0048008~platelet-derived growth factor receptor signaling pathway,GO:0048146~positive regulation of fibroblast proliferation,GO:0048333~mesodermal cell differentiation,GO:0048661~positive regulation of smooth muscle cell proliferation,GO:0050731~positive regulation of peptidyl-tyrosine phosphorylation,GO:0050748~negative regulation of lipoprotein metabolic process,GO:0050919~negative chemotaxis,GO:0051279~regulation of release of sequestered calcium ion into cytosol,GO:0051611~regulation of serotonin uptake,GO:0060055~angiogenesis involved in wound healing,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0070527~platelet aggregation,GO:0071260~cellular response to mechanical stimulus,GO:0071466~cellular response to xenobiotic stimulus,GO:0072126~positive regulation of glomerular mesangial cell proliferation,GO:0072378~blood coagulation, fibrin clot formation,GO:0098880~maintenance of postsynaptic specialization structure,GO:1900026~positive regulation of substrate adhesion-dependent cell spreading,GO:1900731~positive regulation of adenylate cyclase-inhibiting opioid receptor signaling pathway,GO:1901163~regulation of trophoblast cell migration,GO:1903053~regulation of extracellular matrix organization,GO:1905598~negative regulation of low-density lipoprotein receptor activity,GO:1990314~cellular response to insulin-like growth factor stimulus,GO:2000352~negative regulation of endothelial cell apoptotic process,GO:2000406~positive regulation of T cell migration,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005886~plasma membrane,GO:0005911~cell-cell junction,GO:0005925~focal adhesion,GO:0008305~integrin complex,GO:0009897~external side of plasma membrane,GO:0009986~cell surface,GO:0016324~apical plasma membrane,GO:0031092~platelet alpha granule membrane,GO:0031258~lamellipodium membrane,GO:0031527~filopodium membrane,GO:0031528~microvillus membrane,GO:0032587~ruffle membrane,GO:0032991~macromolecular complex,GO:0034683~integrin alphav-beta3 complex,GO:0035866~alphav-beta3 integrin-PKCalpha complex,GO:0035867~alphav-beta3 integrin-IGF-1-IGF1R complex,GO:0035868~alphav-beta3 integrin-HMGB1 complex,GO:0042470~melanosome,GO:0043235~receptor complex,GO:0045202~synapse,GO:0045211~postsynaptic membrane,GO:0070062~extracellular exosome,GO:0070161~anchoring junction,GO:0071062~alphav-beta3 integrin-vitronectin complex,GO:0071133~alpha9-beta1 integrin-ADAM8 complex,GO:0098978~glutamatergic synapse,	GO:0001618~virus receptor activity,GO:0001968~fibronectin binding,GO:0002020~protease binding,GO:0003756~protein disulfide isomerase activity,GO:0005080~protein kinase C binding,GO:0005161~platelet-derived growth factor receptor binding,GO:0005178~integrin binding,GO:0005515~protein binding,GO:0015026~coreceptor activity,GO:0017134~fibroblast growth factor binding,GO:0019899~enzyme binding,GO:0019960~C-X3-C chemokine binding,GO:0031994~insulin-like growth factor I binding,GO:0038132~neuregulin binding,GO:0042802~identical protein binding,GO:0043184~vascular endothelial growth factor receptor 2 binding,GO:0046872~metal ion binding,GO:0050839~cell adhesion molecule binding,GO:0050840~extracellular matrix binding,GO:0070051~fibrinogen binding,	IPR002369:Integrin_bsu_VWA,IPR012896:Integrin_bsu_tail,IPR013111:EGF_extracell,IPR014836:Integrin_bsu_cyt_dom,IPR015812:Integrin_bsu,IPR016201:PSI,IPR032695:Integrin_dom_sf,IPR033760:Integrin_beta_N,IPR036349:Integrin_bsu_tail_dom_sf,IPR036465:vWFA_dom_sf,IPR040622:I-EGF_1,	hsa03266:Virion - Herpesvirus,hsa04015:Rap1 signaling pathway,hsa04145:Phagosome,hsa04148:Efferocytosis,hsa04151:PI3K-Akt signaling pathway,hsa04380:Osteoclast differentiation,hsa04510:Focal adhesion,hsa04512:ECM-receptor interaction,hsa04611:Platelet activation,hsa04613:Neutrophil extracellular trap formation,hsa04640:Hematopoietic cell lineage,hsa04810:Regulation of actin cytoskeleton,hsa04919:Thyroid hormone signaling pathway,hsa05163:Human cytomegalovirus infection,hsa05165:Human papillomavirus infection,hsa05168:Herpes simplex virus 1 infection,hsa05205:Proteoglycans in cancer,hsa05206:MicroRNAs in cancer,hsa05410:Hypertrophic cardiomyopathy,hsa05412:Arrhythmogenic right ventricular cardiomyopathy,hsa05414:Dilated cardiomyopathy,hsa05418:Fluid shear stress and atherosclerosis,	608446~Myocardial infarction, susceptibility to,619267~Glanzmann thrombasthenia 2,619271~Bleeding disorder, platelet-type, 24, autosomal dominant,Purpura, posttransfusion~Purpura, posttransfusion,Thrombocytopenia, neonatal alloimmune~Thrombocytopenia, neonatal alloimmune,	PIRSF002512:Integrin_B,	SM00187:INB,SM00423:PSI,SM01241:Integrin_b_cyt,SM01242:Integrin_B_tail,	KW-0130~Cell adhesion,KW-0945~Host-virus interaction,	KW-0472~Membrane,KW-0628~Postsynaptic cell membrane,KW-0770~Synapse,KW-0965~Cell junction,KW-0966~Cell projection,KW-1003~Cell membrane,		KW-0225~Disease variant,	KW-0245~EGF-like domain,KW-0677~Repeat,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0106~Calcium,KW-0460~Magnesium,KW-0479~Metal-binding,	KW-0401~Integrin,KW-0675~Receptor,KW-1183~Host cell receptor for virus entry,	KW-0325~Glycoprotein,KW-0597~Phosphoprotein,KW-1015~Disulfide bond,	BINDING:in ADMIDAS binding site,BINDING:in ADMIDAS binding site and liganded-open conformation,BINDING:in ADMIDAS binding site and unliganded-closed conformation,BINDING:in LIMBS binding site,BINDING:in MIDAS binding site,CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Polar residues,DOMAIN:EGF-like,DOMAIN:EGF-like 1,DOMAIN:EGF-like 2,DOMAIN:EGF-like 3,DOMAIN:EGF-like 4,DOMAIN:Integrin beta epidermal growth factor-like,DOMAIN:Integrin beta subunit VWA,DOMAIN:Integrin beta subunit cytoplasmic,DOMAIN:Integrin beta subunit tail,DOMAIN:PSI,DOMAIN:VWFA,MOTIF:LIR,MUTAGEN:Missing: Increases ligand-binding activity.,MUTAGEN:Missing: Slight increase in ligand-binding activity; when associated with A-659.,MUTAGEN:R->A: Slight increase in ligand-binding activity; when associated with 698-D--K-702 del.,MUTAGEN:Y->A: No effect on cell surface location but impairs interaction with TNS3 and PEAK1.,REGION:CX3CL1-binding,REGION:Disordered,REGION:Involved in CX3CL1-, NRG1-, FGF1- and IGF1-binding,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q8TCB0	interferon induced protein 44(IFI44)	Homo sapiens			GO:0006955~immune response,GO:0009615~response to virus,GO:0009617~response to bacterium,	GO:0005737~cytoplasm,	GO:0005515~protein binding,	IPR006571:TLDc_dom,IPR027417:P-loop_NTPase,						KW-0963~Cytoplasm,							DOMAIN:TLDc,
P27473	interferon induced protein 44(IFI44)	Pan troglodytes			GO:0006955~immune response,GO:0009617~response to bacterium,	GO:0005737~cytoplasm,		IPR006571:TLDc_dom,IPR027417:P-loop_NTPase,						KW-0963~Cytoplasm,							DOMAIN:TLDc,
P70671	interferon regulatory factor 3(Irf3)	Mus musculus		m_pcafPathway:The information-processing pathway at the IFN-beta enhancer,	GO:0001819~positive regulation of cytokine production,GO:0002376~immune system process,GO:0002753~cytoplasmic pattern recognition receptor signaling pathway,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0009299~mRNA transcription,GO:0009617~response to bacterium,GO:0010468~regulation of gene expression,GO:0031663~lipopolysaccharide-mediated signaling pathway,GO:0032481~positive regulation of type I interferon production,GO:0032496~response to lipopolysaccharide,GO:0032606~type I interferon production,GO:0032727~positive regulation of interferon-alpha production,GO:0032728~positive regulation of interferon-beta production,GO:0034142~toll-like receptor 4 signaling pathway,GO:0035666~TRIF-dependent toll-like receptor signaling pathway,GO:0042981~regulation of apoptotic process,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling,GO:0043330~response to exogenous dsRNA,GO:0045087~innate immune response,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0050727~regulation of inflammatory response,GO:0051607~defense response to virus,GO:0060337~type I interferon signaling pathway,GO:0060340~positive regulation of type I interferon-mediated signaling pathway,GO:0071222~cellular response to lipopolysaccharide,GO:0097300~programmed necrotic cell death,GO:0098586~cellular response to virus,	GO:0000785~chromatin,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005829~cytosol,	GO:0000976~transcription regulatory region sequence-specific DNA binding,GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0001216~bacterial-type RNA polymerase transcriptional activator activity, sequence-specific DNA binding,GO:0001227~transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0019904~protein domain specific binding,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,GO:0043565~sequence-specific DNA binding,GO:1990837~sequence-specific double-stranded DNA binding,GO:1990841~promoter-specific chromatin binding,	IPR001346:Interferon_reg_fact_DNA-bd_dom,IPR008984:SMAD_FHA_dom_sf,IPR017855:SMAD-like_dom_sf,IPR019471:Interferon_reg_factor-3,IPR019817:Interferon_reg_fac_CS,IPR036388:WH-like_DNA-bd_sf,IPR036390:WH_DNA-bd_sf,	mmu04620:Toll-like receptor signaling pathway,mmu04621:NOD-like receptor signaling pathway,mmu04622:RIG-I-like receptor signaling pathway,mmu04623:Cytosolic DNA-sensing pathway,mmu04936:Alcoholic liver disease,mmu05133:Pertussis,mmu05135:Yersinia infection,mmu05160:Hepatitis C,mmu05161:Hepatitis B,mmu05162:Measles,mmu05163:Human cytomegalovirus infection,mmu05164:Influenza A,mmu05165:Human papillomavirus infection,mmu05167:Kaposi sarcoma-associated herpesvirus infection,mmu05168:Herpes simplex virus 1 infection,mmu05169:Epstein-Barr virus infection,mmu05170:Human immunodeficiency virus 1 infection,mmu05171:Coronavirus disease - COVID-19,mmu05203:Viral carcinogenesis,mmu05417:Lipid and atherosclerosis,			SM00348:IRF,SM01243:IRF-3,	KW-0051~Antiviral defense,KW-0391~Immunity,KW-0399~Innate immunity,KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0496~Mitochondrion,KW-0539~Nucleus,KW-0963~Cytoplasm,					KW-0010~Activator,KW-0238~DNA-binding,	KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ISG15),DNA_BIND:IRF tryptophan pentad repeat,DOMAIN:IRF tryptophan pentad repeat,DOMAIN:Interferon regulatory factor-3,REGION:Interaction with HERC5,REGION:Mediates interaction with ZDHHC11,SITE:Cleavage; by CASP3,
Q64287	interferon regulatory factor 4(Irf4)	Mus musculus			GO:0002376~immune system process,GO:0006338~chromatin remodeling,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0032733~positive regulation of interleukin-10 production,GO:0032736~positive regulation of interleukin-13 production,GO:0032743~positive regulation of interleukin-2 production,GO:0032753~positive regulation of interleukin-4 production,GO:0034122~negative regulation of toll-like receptor signaling pathway,GO:0042832~defense response to protozoan,GO:0043011~myeloid dendritic cell differentiation,GO:0043388~positive regulation of DNA binding,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0072540~T-helper 17 cell lineage commitment,	GO:0000786~nucleosome,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005829~cytosol,	GO:0000976~transcription regulatory region sequence-specific DNA binding,GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0000987~core promoter proximal region sequence-specific DNA binding,GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003713~transcription coactivator activity,GO:0005515~protein binding,GO:0043565~sequence-specific DNA binding,GO:1990837~sequence-specific double-stranded DNA binding,	IPR001346:Interferon_reg_fact_DNA-bd_dom,IPR008984:SMAD_FHA_dom_sf,IPR017855:SMAD-like_dom_sf,IPR019471:Interferon_reg_factor-3,IPR019817:Interferon_reg_fac_CS,IPR036388:WH-like_DNA-bd_sf,IPR036390:WH_DNA-bd_sf,	mmu04659:Th17 cell differentiation,			SM00348:IRF,SM01243:IRF-3,	KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,					KW-0010~Activator,KW-0238~DNA-binding,	KW-0597~Phosphoprotein,	DNA_BIND:IRF tryptophan pentad repeat,DOMAIN:IRF tryptophan pentad repeat,
P70434	interferon regulatory factor 7(Irf7)	Mus musculus			GO:0002376~immune system process,GO:0002753~cytoplasmic pattern recognition receptor signaling pathway,GO:0002819~regulation of adaptive immune response,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0010468~regulation of gene expression,GO:0016064~immunoglobulin mediated immune response,GO:0032481~positive regulation of type I interferon production,GO:0032606~type I interferon production,GO:0032727~positive regulation of interferon-alpha production,GO:0032728~positive regulation of interferon-beta production,GO:0034124~regulation of MyD88-dependent toll-like receptor signaling pathway,GO:0034127~regulation of MyD88-independent toll-like receptor signaling pathway,GO:0045087~innate immune response,GO:0045088~regulation of innate immune response,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0051607~defense response to virus,GO:0060337~type I interferon signaling pathway,GO:0060340~positive regulation of type I interferon-mediated signaling pathway,	GO:0000785~chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0000976~transcription regulatory region sequence-specific DNA binding,GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0000987~core promoter proximal region sequence-specific DNA binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:1990837~sequence-specific double-stranded DNA binding,	IPR001346:Interferon_reg_fact_DNA-bd_dom,IPR008984:SMAD_FHA_dom_sf,IPR017855:SMAD-like_dom_sf,IPR019471:Interferon_reg_factor-3,IPR019817:Interferon_reg_fac_CS,IPR036388:WH-like_DNA-bd_sf,IPR036390:WH_DNA-bd_sf,	mmu04620:Toll-like receptor signaling pathway,mmu04621:NOD-like receptor signaling pathway,mmu04622:RIG-I-like receptor signaling pathway,mmu04623:Cytosolic DNA-sensing pathway,mmu05160:Hepatitis C,mmu05161:Hepatitis B,mmu05162:Measles,mmu05164:Influenza A,mmu05167:Kaposi sarcoma-associated herpesvirus infection,mmu05168:Herpes simplex virus 1 infection,mmu05169:Epstein-Barr virus infection,mmu05203:Viral carcinogenesis,mmu05417:Lipid and atherosclerosis,			SM00348:IRF,SM01243:IRF-3,	KW-0391~Immunity,KW-0399~Innate immunity,KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,KW-0963~Cytoplasm,					KW-0010~Activator,KW-0238~DNA-binding,	KW-0007~Acetylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO),CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),DNA_BIND:IRF tryptophan pentad repeat,DOMAIN:IRF tryptophan pentad repeat,MUTAGEN:L->A: Strongly decreased transcriptional activation in response to viral infection.,MUTAGEN:L->D: No effect on transcriptional activation in response to viral infection.,MUTAGEN:S->A: Almost complete loss of transcriptional activation; when associated with A-437.,MUTAGEN:S->A: Almost complete loss of transcriptional activation; when associated with A-438.,MUTAGEN:S->A: Almost no effect on transcriptional activation in response to viral infection.,MUTAGEN:S->A: Strongly decreased transcriptional activation in response to viral infection; when associated with A-425.,MUTAGEN:S->A: Strongly decreased transcriptional activation in response to viral infection; when associated with A-426.,MUTAGEN:S->D: Increased transcriptional activation; when associated with D-437.,MUTAGEN:S->D: Increased transcriptional activation; when associated with D-438.,MUTAGEN:S->D: Strongly decreased transcriptional activation in response to viral infection; when associated with D-425.,MUTAGEN:S->D: Strongly decreased transcriptional activation in response to viral infection; when associated with D-426.,MUTAGEN:SSS->AAA: Almost no effect on transcriptional activation in response to viral infection.,MUTAGEN:SSS->DDD: Strongly increased transcriptional activation in response to viral infection.,REGION:Disordered,REGION:Necessary for the interaction with NMI,
Q08334	interleukin 10 receptor subunit beta(IL10RB)	Homo sapiens		h_il10Pathway:IL-10 Anti-inflammatory Signaling Pathway,	GO:0006954~inflammatory response,GO:0006955~immune response,GO:0007165~signal transduction,GO:0019221~cytokine-mediated signaling pathway,GO:0038196~type III interferon signaling pathway,GO:0046427~positive regulation of JAK-STAT cascade,GO:0051607~defense response to virus,GO:0098586~cellular response to virus,GO:1901857~positive regulation of cellular respiration,	GO:0005886~plasma membrane,GO:0016020~membrane,GO:0032002~interleukin-28 receptor complex,	GO:0004920~interleukin-10 receptor activity,GO:0005515~protein binding,GO:0038023~signaling receptor activity,	IPR003961:FN3_dom,IPR013783:Ig-like_fold,IPR015373:Interferon/interleukin_rcp_dom,IPR036116:FN3_sf,	hsa04060:Cytokine-cytokine receptor interaction,hsa04061:Viral protein interaction with cytokine and cytokine receptor,hsa04630:JAK-STAT signaling pathway,hsa05145:Toxoplasmosis,hsa05152:Tuberculosis,hsa05163:Human cytomegalovirus infection,	610424~Hepatitis B virus, susceptibility to,612567~Inflammatory bowel disease 25, early onset, autosomal recessive,			KW-0051~Antiviral defense,	KW-0472~Membrane,			KW-0677~Repeat,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0675~Receptor,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Polar residues,DOMAIN:Fibronectin type-III,DOMAIN:Fibronectin type-III 1,DOMAIN:Fibronectin type-III 2,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
P18520	intermediate filament protein ON3(LOC113092483)	Carassius auratus			GO:0007601~visual perception,GO:0031424~keratinization,GO:0045109~intermediate filament organization,GO:0050896~response to stimulus,	GO:0005615~extracellular space,GO:0045095~keratin filament,	GO:0030280~structural constituent of epidermis,	IPR003054:Keratin_II,IPR018039:IF_conserved,IPR032444:Keratin_2_head,IPR039008:IF_rod_dom,				SM01391:Filament,	KW-0716~Sensory transduction,KW-0844~Vision,	KW-0403~Intermediate filament,			KW-0175~Coiled coil,				DOMAIN:IF rod,REGION:Coil 1A,REGION:Coil 1B,REGION:Coil 2,REGION:Disordered,REGION:Head,REGION:Linker 1,REGION:Linker 12,REGION:Tail,
E7FCN8	inturned planar cell polarity protein(intu)	Danio rerio			GO:0001736~establishment of planar polarity,GO:0007399~nervous system development,GO:0008589~regulation of smoothened signaling pathway,GO:0016192~vesicle-mediated transport,GO:0030030~cell projection organization,GO:0060173~limb development,GO:0060271~cilium assembly,	GO:0005737~cytoplasm,GO:0005856~cytoskeleton,GO:0005929~cilium,GO:0009986~cell surface,GO:0042995~cell projection,		IPR001478:PDZ,IPR036034:PDZ_sf,IPR039151:INTU,IPR043987:CCZ1/INTU/HSP4_longin_1,IPR043988:CCZ1/INTU_longin_2,IPR043989:CCZ1/INTU/HSP4_longin_3,					KW-0970~Cilium biogenesis/degradation,	KW-0206~Cytoskeleton,KW-0963~Cytoplasm,KW-0966~Cell projection,					KW-0217~Developmental protein,KW-9996~Developmental protein,		COMPBIAS:Polar residues,DOMAIN:PDZ,REGION:Disordered,
Q0IHV1	inverted formin, FH2 and WH2 domain containing(inf2)	Xenopus tropicalis			GO:0016043~cellular component organization,GO:0030036~actin cytoskeleton organization,		GO:0003779~actin binding,GO:0031267~small GTPase binding,	IPR003124:WH2_dom,IPR010472:FH3_dom,IPR010473:GTPase-bd,IPR011989:ARM-like,IPR014768:GBD/FH3_dom,IPR015425:FH2_Formin,IPR016024:ARM-type_fold,IPR042201:FH2_Formin_sf,				SM00498:FH2,SM01139:Drf_FH3,SM01140:Drf_GBD,					KW-0175~Coiled coil,		KW-0009~Actin-binding,		COMPBIAS:Basic and acidic residues,COMPBIAS:Basic residues,COMPBIAS:Polar residues,COMPBIAS:Pro residues,DOMAIN:FH1,DOMAIN:FH2,DOMAIN:GBD/FH3,DOMAIN:WH2,REGION:Disordered,
P79747	iodothyronine deiodinase 2(dio2)	Fundulus heteroclitus			GO:0042403~thyroid hormone metabolic process,GO:0042446~hormone biosynthetic process,	GO:0016020~membrane,	GO:0004800~thyroxine 5'-deiodinase activity,	IPR000643:Iodothyronine_deiodinase,IPR008261:Iodothyronine_deiodinase_AS,IPR013766:Thioredoxin_domain,IPR036249:Thioredoxin-like_sf,			PIRSF001330:IOD,		KW-0893~Thyroid hormones biosynthesis,	KW-0472~Membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0560~Oxidoreductase,		DOMAIN:Thioredoxin,NON_STD:Selenocysteine,TRANSMEM:Helical,
Q9Y219	jagged canonical Notch ligand 2(JAG2)	Homo sapiens			GO:0001501~skeletal system development,GO:0001701~in utero embryonic development,GO:0003016~respiratory system process,GO:0007219~Notch signaling pathway,GO:0007283~spermatogenesis,GO:0009912~auditory receptor cell fate commitment,GO:0016331~morphogenesis of embryonic epithelium,GO:0030154~cell differentiation,GO:0030155~regulation of cell adhesion,GO:0030217~T cell differentiation,GO:0042127~regulation of cell proliferation,GO:0042475~odontogenesis of dentin-containing tooth,GO:0042492~gamma-delta T cell differentiation,GO:0045061~thymic T cell selection,GO:0045747~positive regulation of Notch signaling pathway,GO:1990134~epithelial cell apoptotic process involved in palatal shelf morphogenesis,	GO:0005886~plasma membrane,	GO:0005112~Notch binding,GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0008083~growth factor activity,	IPR000152:EGF-type_Asp/Asn_hydroxyl_site,IPR000742:EGF-like_dom,IPR001007:VWF_dom,IPR001774:DSL,IPR001881:EGF-like_Ca-bd_dom,IPR009030:Growth_fac_rcpt_cys_sf,IPR011651:Notch_ligand_N,IPR013032:EGF-like_CS,IPR018097:EGF_Ca-bd_CS,IPR026219:Jagged/Serrate,	hsa01522:Endocrine resistance,hsa04330:Notch signaling pathway,hsa04658:Th1 and Th2 cell differentiation,hsa05200:Pathways in cancer,hsa05224:Breast cancer,	619566~Muscular dystrophy, limb-girdle, autosomal recessive 27,		SM00051:DSL,SM00179:EGF_CA,SM00181:EGF,SM00214:VWC,SM00215:VWC_out,	KW-0914~Notch signaling pathway,	KW-0472~Membrane,		KW-0225~Disease variant,KW-0947~Limb-girdle muscular dystrophy,	KW-0245~EGF-like domain,KW-0677~Repeat,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0106~Calcium,	KW-0217~Developmental protein,KW-9996~Developmental protein,	KW-0325~Glycoprotein,KW-0597~Phosphoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Basic and acidic residues,DOMAIN:DSL,DOMAIN:EGF-like 1,DOMAIN:EGF-like 10; atypical,DOMAIN:EGF-like 11; calcium-binding,DOMAIN:EGF-like 12; calcium-binding,DOMAIN:EGF-like 13,DOMAIN:EGF-like 14,DOMAIN:EGF-like 15; calcium-binding,DOMAIN:EGF-like 16; calcium-binding,DOMAIN:EGF-like 2; atypical,DOMAIN:EGF-like 3,DOMAIN:EGF-like 4,DOMAIN:EGF-like 5; calcium-binding,DOMAIN:EGF-like 6; calcium-binding,DOMAIN:EGF-like 7; calcium-binding,DOMAIN:EGF-like 8,DOMAIN:EGF-like 9,DOMAIN:VWFC,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q9GKY7	junctophilin 2(JPH2)	Oryctolagus cuniculus				GO:0005634~nucleus,GO:0005789~endoplasmic reticulum membrane,GO:0005886~plasma membrane,GO:0016529~sarcoplasmic reticulum,GO:0030314~junctional membrane complex,GO:0033017~sarcoplasmic reticulum membrane,	GO:0001786~phosphatidylserine binding,GO:0003677~DNA binding,GO:0005546~phosphatidylinositol-4,5-bisphosphate binding,GO:0005547~phosphatidylinositol-3,4,5-trisphosphate binding,GO:0010314~phosphatidylinositol-5-phosphate binding,GO:0032266~phosphatidylinositol-3-phosphate binding,GO:0070273~phosphatidylinositol-4-phosphate binding,GO:0070300~phosphatidic acid binding,GO:0080025~phosphatidylinositol-3,5-bisphosphate binding,	IPR003409:MORN,IPR017191:Junctophilin,			PIRSF037387:Junctophilin,	SM00698:MORN,	KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0256~Endoplasmic reticulum,KW-0472~Membrane,KW-0539~Nucleus,KW-0703~Sarcoplasmic reticulum,KW-1003~Cell membrane,			KW-0677~Repeat,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0217~Developmental protein,KW-0238~DNA-binding,KW-0678~Repressor,KW-9996~Developmental protein,	KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,COMPBIAS:Pro residues,MOTIF:Bipartite nuclear localization signal,MOTIF:Nuclear localization signal,REGION:Disordered,REPEAT:MORN 1,REPEAT:MORN 2,REPEAT:MORN 3,REPEAT:MORN 4,REPEAT:MORN 5,REPEAT:MORN 6,REPEAT:MORN 7,REPEAT:MORN 8,SITE:Cleavage; by calpain,TOPO_DOM:Cytoplasmic,TRANSMEM:Helical; Anchor for type IV membrane protein,
P52293	karyopherin subunit alpha 2(Kpna2)	Mus musculus		m_ranMSPathway:Role of Ran in mitotic spindle regulation,	GO:0006606~protein import into nucleus,GO:0006607~NLS-bearing protein import into nucleus,GO:0075506~entry of viral genome into host nucleus through nuclear pore complex via importin,GO:0099527~postsynapse to nucleus signaling pathway,GO:1903902~positive regulation of viral life cycle,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0010494~cytoplasmic stress granule,GO:0014069~postsynaptic density,GO:0031965~nuclear membrane,GO:0042564~NLS-dependent protein nuclear import complex,GO:0043657~host cell,GO:0098978~glutamatergic synapse,	GO:0005515~protein binding,GO:0008139~nuclear localization sequence binding,GO:0042826~histone deacetylase binding,GO:0061608~nuclear import signal receptor activity,	IPR000225:Armadillo,IPR002652:Importin-a_IBB,IPR011989:ARM-like,IPR016024:ARM-type_fold,IPR024931:Importin_alpha,IPR032413:Arm_3,IPR036975:Importin-a_IBB_sf,	mmu03013:Nucleocytoplasmic transport,mmu05164:Influenza A,mmu05207:Chemical carcinogenesis - receptor activation,		PIRSF005673:Importin_alpha,	SM00185:ARM,	KW-0653~Protein transport,KW-0813~Transport,	KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0677~Repeat,			KW-0007~Acetylation,KW-0597~Phosphoprotein,	COMPBIAS:Polar residues,DOMAIN:IBB,MOTIF:Nuclear localization signal,REGION:Disordered,REGION:NLS binding site (major),REGION:NLS binding site (minor),REPEAT:ARM,REPEAT:ARM 10; atypical,REPEAT:ARM 1; truncated,REPEAT:ARM 2,REPEAT:ARM 3,REPEAT:ARM 4,REPEAT:ARM 5,REPEAT:ARM 6,REPEAT:ARM 7,REPEAT:ARM 8,REPEAT:ARM 9,
A6NCF5	kelch like family member 33(KLHL33)	Homo sapiens						IPR000210:BTB/POZ_dom,IPR006652:Kelch_1,IPR011333:SKP1/BTB/POZ_sf,IPR011705:BACK,IPR015915:Kelch-typ_b-propeller,IPR017096:BTB-kelch_protein,IPR030609:KLHL33_BACK,			PIRSF037037:Kelch-like_protein_gigaxonin,	SM00225:BTB,SM00612:Kelch,SM00875:BACK,					KW-0677~Repeat,KW-0880~Kelch repeat,				COMPBIAS:Acidic residues,DOMAIN:BACK,DOMAIN:BTB,REGION:Disordered,REPEAT:Kelch 1,REPEAT:Kelch 2,REPEAT:Kelch 3,REPEAT:Kelch 4,REPEAT:Kelch 5,REPEAT:Kelch 6,
Q8CE33	kelch-like 11(Klhl11)	Mus musculus						IPR000210:BTB/POZ_dom,IPR006652:Kelch_1,IPR011333:SKP1/BTB/POZ_sf,IPR011705:BACK,IPR015915:Kelch-typ_b-propeller,				SM00225:BTB,SM00612:Kelch,SM00875:BACK,	KW-0833~Ubl conjugation pathway,				KW-0677~Repeat,KW-0732~Signal,KW-0880~Kelch repeat,			KW-0597~Phosphoprotein,	DOMAIN:BACK,DOMAIN:BTB,REPEAT:Kelch 1,REPEAT:Kelch 2,REPEAT:Kelch 3,REPEAT:Kelch 4,REPEAT:Kelch 5,
Q56A24	kelch-like family member 24(Klhl24)	Rattus norvegicus			GO:0016567~protein ubiquitination,GO:0045109~intermediate filament organization,GO:0051865~protein autoubiquitination,	GO:0005737~cytoplasm,GO:0005912~adherens junction,GO:0030057~desmosome,GO:0030424~axon,GO:0031463~Cul3-RING ubiquitin ligase complex,GO:0043204~perikaryon,		IPR000210:BTB/POZ_dom,IPR006652:Kelch_1,IPR011333:SKP1/BTB/POZ_sf,IPR011705:BACK,IPR015915:Kelch-typ_b-propeller,IPR017096:BTB-kelch_protein,IPR030596:BTB_POZ_KLHL24,IPR047071:KLHL24_BACK,			PIRSF037037:Kelch-like_protein_gigaxonin,	SM00225:BTB,SM00612:Kelch,SM00875:BACK,	KW-0833~Ubl conjugation pathway,	KW-0963~Cytoplasm,KW-0965~Cell junction,KW-0966~Cell projection,			KW-0677~Repeat,KW-0880~Kelch repeat,			KW-0832~Ubl conjugation,	DOMAIN:BACK,DOMAIN:BTB,REPEAT:Kelch 1,REPEAT:Kelch 2,REPEAT:Kelch 3,REPEAT:Kelch 4,REPEAT:Kelch 5,REPEAT:Kelch 6,
Q02974	ketohexokinase(Khk)	Rattus norvegicus			GO:0006000~fructose metabolic process,GO:0006001~fructose catabolic process,GO:0009744~response to sucrose,GO:0009749~response to glucose,GO:0009750~response to fructose,GO:0010043~response to zinc ion,GO:0016052~carbohydrate catabolic process,GO:0032868~response to insulin,GO:0046835~carbohydrate phosphorylation,GO:0061624~fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate,GO:0070873~regulation of glycogen metabolic process,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0004454~ketohexokinase activity,GO:0005524~ATP binding,	IPR011611:PfkB_dom,IPR029056:Ribokinase-like,IPR034093:KHK,	rno00051:Fructose and mannose metabolism,rno01100:Metabolic pathways,				KW-0119~Carbohydrate metabolism,					KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0418~Kinase,KW-0808~Transferase,		DOMAIN:Carbohydrate kinase PfkB,
Q99PW8	kinesin family member 17(Kif17)	Mus musculus			GO:0007017~microtubule-based process,GO:0007018~microtubule-based movement,GO:0015031~protein transport,GO:0016192~vesicle-mediated transport,GO:0030030~cell projection organization,GO:0031503~protein complex localization,GO:0042073~intraciliary transport,GO:0098971~anterograde dendritic transport of neurotransmitter receptor complex,	GO:0001750~photoreceptor outer segment,GO:0001917~photoreceptor inner segment,GO:0005737~cytoplasm,GO:0005815~microtubule organizing center,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005871~kinesin complex,GO:0005874~microtubule,GO:0005929~cilium,GO:0005930~axoneme,GO:0015630~microtubule cytoskeleton,GO:0030425~dendrite,GO:0032391~photoreceptor connecting cilium,GO:0032839~dendrite cytoplasm,GO:0036064~ciliary basal body,GO:0042995~cell projection,GO:0043005~neuron projection,GO:1990075~periciliary membrane compartment,	GO:0000166~nucleotide binding,GO:0003777~microtubule motor activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008017~microtubule binding,GO:0008574~ATP-dependent microtubule motor activity, plus-end-directed,GO:0016887~ATPase activity,	IPR001752:Kinesin_motor_dom,IPR019821:Kinesin_motor_CS,IPR027417:P-loop_NTPase,IPR027640:Kinesin-like_fam,IPR036961:Kinesin_motor_dom_sf,	mmu04814:Motor proteins,			SM00129:KISc,	KW-0653~Protein transport,KW-0813~Transport,	KW-0206~Cytoskeleton,KW-0493~Microtubule,KW-0963~Cytoplasm,KW-0966~Cell projection,			KW-0175~Coiled coil,	KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0505~Motor protein,		COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:Kinesin motor,MUTAGEN:Missing: Abolishes interaction with APBA1. Abolishes transport of vesicles containing N-methyl-D-aspartate (NMDA) receptor subunit NR2B along microtubules.,REGION:Disordered,
O95235	kinesin family member 20A(KIF20A)	Homo sapiens			GO:0000281~mitotic cytokinesis,GO:0001578~microtubule bundle formation,GO:0007018~microtubule-based movement,GO:0015031~protein transport,GO:0032465~regulation of cytokinesis,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005794~Golgi apparatus,GO:0005819~spindle,GO:0005871~kinesin complex,GO:0005874~microtubule,GO:0030496~midbody,GO:0045171~intercellular bridge,	GO:0003777~microtubule motor activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008017~microtubule binding,GO:0016887~ATPase activity,GO:0019901~protein kinase binding,	IPR001752:Kinesin_motor_dom,IPR019821:Kinesin_motor_CS,IPR027417:P-loop_NTPase,IPR027640:Kinesin-like_fam,IPR036961:Kinesin_motor_dom_sf,IPR047149:KIF11-like,	hsa04814:Motor proteins,	619433~Cardiomyopathy, familial restrictive, 6,		SM00129:KISc,	KW-0653~Protein transport,KW-0813~Transport,	KW-0206~Cytoskeleton,KW-0333~Golgi apparatus,KW-0493~Microtubule,KW-0963~Cytoplasm,		KW-0122~Cardiomyopathy,KW-0225~Disease variant,	KW-0175~Coiled coil,	KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0505~Motor protein,	KW-0007~Acetylation,KW-0597~Phosphoprotein,	DOMAIN:Kinesin motor,MUTAGEN:S->A: Impairs phosphorylation by PLK1 and recruitment of PLK1 to the spindle.,REGION:Disordered,REGION:Globular,
Q5R9Y9	kinesin family member 2A(KIF2A)	Pongo abelii			GO:0007018~microtubule-based movement,GO:0007052~mitotic spindle organization,GO:0007399~nervous system development,GO:0030154~cell differentiation,GO:0030334~regulation of cell migration,GO:0051301~cell division,GO:0090307~mitotic spindle assembly,	GO:0000922~spindle pole,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005814~centriole,GO:0005874~microtubule,GO:0005876~spindle microtubule,GO:0016604~nuclear body,	GO:0003777~microtubule motor activity,GO:0005524~ATP binding,GO:0008017~microtubule binding,	IPR001752:Kinesin_motor_dom,IPR019821:Kinesin_motor_CS,IPR027417:P-loop_NTPase,IPR027640:Kinesin-like_fam,IPR036961:Kinesin_motor_dom_sf,	pon04814:Motor proteins,			SM00129:KISc,	KW-0131~Cell cycle,KW-0132~Cell division,KW-0221~Differentiation,KW-0498~Mitosis,KW-0524~Neurogenesis,	KW-0206~Cytoskeleton,KW-0493~Microtubule,KW-0963~Cytoplasm,			KW-0175~Coiled coil,	KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0217~Developmental protein,KW-0505~Motor protein,KW-9996~Developmental protein,	KW-0007~Acetylation,KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:Kinesin motor,REGION:Disordered,
P79955	kinesin family member C1 L homeolog(kifc1.L)	Xenopus laevis			GO:0007018~microtubule-based movement,	GO:0005737~cytoplasm,GO:0005856~cytoskeleton,GO:0005874~microtubule,	GO:0000166~nucleotide binding,GO:0003777~microtubule motor activity,GO:0005524~ATP binding,GO:0008017~microtubule binding,	IPR001752:Kinesin_motor_dom,IPR019821:Kinesin_motor_CS,IPR027417:P-loop_NTPase,IPR027640:Kinesin-like_fam,IPR036961:Kinesin_motor_dom_sf,	xla04814:Motor proteins,			SM00129:KISc,		KW-0206~Cytoskeleton,KW-0493~Microtubule,KW-0963~Cytoplasm,			KW-0175~Coiled coil,	KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0505~Motor protein,		COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:Kinesin motor,REGION:Disordered,REGION:Globular,
Q8IZU9	kirre like nephrin family adhesion molecule 3(KIRREL3)	Homo sapiens			GO:0001764~neuron migration,GO:0002121~inter-male aggressive behavior,GO:0007156~homophilic cell adhesion via plasma membrane adhesion molecules,GO:0007416~synapse assembly,GO:0021740~principal sensory nucleus of trigeminal nerve development,GO:0021766~hippocampus development,GO:0030097~hemopoiesis,GO:0048812~neuron projection morphogenesis,GO:0072102~glomerulus morphogenesis,GO:0098609~cell-cell adhesion,	GO:0005576~extracellular region,GO:0005886~plasma membrane,GO:0005911~cell-cell junction,GO:0008021~synaptic vesicle,GO:0016020~membrane,GO:0030424~axon,GO:0030425~dendrite,GO:0043198~dendritic shaft,	GO:0005515~protein binding,GO:0050839~cell adhesion molecule binding,	IPR003598:Ig_sub2,IPR003599:Ig_sub,IPR007110:Ig-like_dom,IPR013098:Ig_I-set,IPR013162:CD80_C2-set,IPR013783:Ig-like_fold,IPR036179:Ig-like_dom_sf,				SM00408:IGc2,SM00409:IG,		KW-0472~Membrane,KW-0964~Secreted,KW-1003~Cell membrane,		KW-0225~Disease variant,	KW-0393~Immunoglobulin domain,KW-0677~Repeat,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Ig-like,DOMAIN:Ig-like C2-type 1,DOMAIN:Ig-like C2-type 2,DOMAIN:Ig-like C2-type 3,DOMAIN:Ig-like C2-type 4,DOMAIN:Ig-like C2-type 5,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q3U9G9	lamin B receptor(Lbr)	Mus musculus			GO:0006629~lipid metabolic process,GO:0006694~steroid biosynthetic process,GO:0006695~cholesterol biosynthetic process,GO:0008202~steroid metabolic process,GO:0008203~cholesterol metabolic process,GO:0016126~sterol biosynthetic process,GO:0030223~neutrophil differentiation,	GO:0005634~nucleus,GO:0005635~nuclear envelope,GO:0005637~nuclear inner membrane,GO:0005643~nuclear pore,GO:0005652~nuclear lamina,GO:0005737~cytoplasm,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0016020~membrane,GO:0031965~nuclear membrane,	GO:0003677~DNA binding,GO:0005515~protein binding,GO:0008139~nuclear localization sequence binding,GO:0016491~oxidoreductase activity,GO:0016628~oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor,GO:0050613~delta14-sterol reductase activity,GO:0051087~chaperone binding,GO:0070087~chromo shadow domain binding,GO:0070402~NADPH binding,	IPR001171:ERG24_DHCR-like,IPR002999:Tudor,IPR018083:Sterol_reductase_CS,IPR019023:Lamin-B_rcpt_of_tudor,	mmu00100:Steroid biosynthesis,mmu01100:Metabolic pathways,			SM00333:TUDOR,	KW-0152~Cholesterol biosynthesis,KW-0153~Cholesterol metabolism,KW-0443~Lipid metabolism,KW-0444~Lipid biosynthesis,KW-0752~Steroid biosynthesis,KW-0753~Steroid metabolism,KW-0756~Sterol biosynthesis,KW-1207~Sterol metabolism,	KW-0256~Endoplasmic reticulum,KW-0472~Membrane,KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0238~DNA-binding,KW-0560~Oxidoreductase,KW-0675~Receptor,	KW-0007~Acetylation,KW-0325~Glycoprotein,KW-0597~Phosphoprotein,	CARBOHYD:O-linked (GlcNAc) serine,COMPBIAS:Basic and acidic residues,COMPBIAS:Basic residues,DOMAIN:Lamin-B receptor of TUDOR,DOMAIN:Tudor,REGION:Disordered,TOPO_DOM:Nuclear,TRANSMEM:Helical,
P07942	laminin subunit beta 1(LAMB1)	Homo sapiens		h_prionPathway:Prion Pathway,	GO:0007155~cell adhesion,GO:0021812~neuronal-glial interaction involved in cerebral cortex radial glia guided migration,GO:0030335~positive regulation of cell migration,GO:0031175~neuron projection development,GO:0034446~substrate adhesion-dependent cell spreading,GO:0035987~endodermal cell differentiation,GO:0042476~odontogenesis,GO:0045785~positive regulation of cell adhesion,GO:0050679~positive regulation of epithelial cell proliferation,GO:0051149~positive regulation of muscle cell differentiation,GO:2001046~positive regulation of integrin-mediated signaling pathway,	GO:0005576~extracellular region,GO:0005604~basement membrane,GO:0005606~laminin-1 complex,GO:0005607~laminin-2 complex,GO:0005615~extracellular space,GO:0005788~endoplasmic reticulum lumen,GO:0016020~membrane,GO:0043257~laminin-8 complex,GO:0043259~laminin-10 complex,GO:0048471~perinuclear region of cytoplasm,GO:0070062~extracellular exosome,GO:0098637~protein complex involved in cell-matrix adhesion,	GO:0005198~structural molecule activity,GO:0005201~extracellular matrix structural constituent,GO:0005515~protein binding,	IPR000742:EGF-like_dom,IPR002049:LE_dom,IPR008211:Laminin_N,IPR013015:Laminin_IV_B,	hsa04151:PI3K-Akt signaling pathway,hsa04510:Focal adhesion,hsa04512:ECM-receptor interaction,hsa05145:Toxoplasmosis,hsa05146:Amoebiasis,hsa05165:Human papillomavirus infection,hsa05200:Pathways in cancer,hsa05222:Small cell lung cancer,	615191~Lissencephaly 5,		SM00136:LamNT,SM00180:EGF_Lam,SM00181:EGF,	KW-0130~Cell adhesion,	KW-0084~Basement membrane,KW-0272~Extracellular matrix,KW-0964~Secreted,		KW-0451~Lissencephaly,	KW-0175~Coiled coil,KW-0424~Laminin EGF-like domain,KW-0677~Repeat,KW-0732~Signal,			KW-0325~Glycoprotein,KW-0597~Phosphoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Polar residues,DISULFID:Interchain,DOMAIN:Laminin EGF-like,DOMAIN:Laminin EGF-like 1,DOMAIN:Laminin EGF-like 10,DOMAIN:Laminin EGF-like 11,DOMAIN:Laminin EGF-like 12,DOMAIN:Laminin EGF-like 13,DOMAIN:Laminin EGF-like 2,DOMAIN:Laminin EGF-like 3,DOMAIN:Laminin EGF-like 4,DOMAIN:Laminin EGF-like 5; truncated,DOMAIN:Laminin EGF-like 6,DOMAIN:Laminin EGF-like 7,DOMAIN:Laminin EGF-like 8,DOMAIN:Laminin EGF-like 9,DOMAIN:Laminin IV type B,DOMAIN:Laminin N-terminal,REGION:Disordered,REGION:Domain I,REGION:Domain II,REGION:Domain alpha,
Q9Y6N6	laminin subunit gamma 3(LAMC3)	Homo sapiens			GO:0000902~cell morphogenesis,GO:0007155~cell adhesion,GO:0007601~visual perception,GO:0014002~astrocyte development,GO:0060041~retina development in camera-type eye,	GO:0005576~extracellular region,GO:0005604~basement membrane,GO:0016020~membrane,GO:0031012~extracellular matrix,	GO:0005198~structural molecule activity,	IPR000034:Laminin_IV,IPR000742:EGF-like_dom,IPR002049:LE_dom,IPR008211:Laminin_N,	hsa04151:PI3K-Akt signaling pathway,hsa04510:Focal adhesion,hsa04512:ECM-receptor interaction,hsa05145:Toxoplasmosis,hsa05146:Amoebiasis,hsa05165:Human papillomavirus infection,hsa05200:Pathways in cancer,hsa05222:Small cell lung cancer,	614115~Cortical malformations, occipital,		SM00136:LamNT,SM00180:EGF_Lam,SM00181:EGF,SM00281:LamB,	KW-0130~Cell adhesion,	KW-0084~Basement membrane,KW-0272~Extracellular matrix,KW-0964~Secreted,		KW-0225~Disease variant,	KW-0175~Coiled coil,KW-0424~Laminin EGF-like domain,KW-0677~Repeat,KW-0732~Signal,			KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Laminin EGF-like,DOMAIN:Laminin EGF-like 1,DOMAIN:Laminin EGF-like 10,DOMAIN:Laminin EGF-like 11,DOMAIN:Laminin EGF-like 2,DOMAIN:Laminin EGF-like 3,DOMAIN:Laminin EGF-like 4,DOMAIN:Laminin EGF-like 5; first part,DOMAIN:Laminin EGF-like 5; second part,DOMAIN:Laminin EGF-like 6,DOMAIN:Laminin EGF-like 7,DOMAIN:Laminin EGF-like 8,DOMAIN:Laminin EGF-like 9,DOMAIN:Laminin IV type A,DOMAIN:Laminin N-terminal,MOTIF:Cell attachment site,REGION:Disordered,REGION:Domain II and I,
Q28019	latent transforming growth factor beta binding protein 2(LTBP2)	Bos taurus			GO:0097435~supramolecular fiber organization,	GO:0001527~microfibril,GO:0005576~extracellular region,GO:0071953~elastic fiber,	GO:0005509~calcium ion binding,GO:0008201~heparin binding,GO:0019838~growth factor binding,GO:0050436~microfibril binding,	IPR000152:EGF-type_Asp/Asn_hydroxyl_site,IPR000742:EGF-like_dom,IPR001881:EGF-like_Ca-bd_dom,IPR009030:Growth_fac_rcpt_cys_sf,IPR013032:EGF-like_CS,IPR017878:TB_dom,IPR018097:EGF_Ca-bd_CS,IPR036773:TB_dom_sf,				SM00179:EGF_CA,SM00181:EGF,		KW-0272~Extracellular matrix,KW-0964~Secreted,			KW-0245~EGF-like domain,KW-0677~Repeat,KW-0732~Signal,		KW-0340~Growth factor binding,KW-0358~Heparin-binding,	KW-0325~Glycoprotein,KW-0379~Hydroxylation,KW-0597~Phosphoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:EGF-like,DOMAIN:EGF-like 1,DOMAIN:EGF-like 10; calcium-binding,DOMAIN:EGF-like 11; calcium-binding,DOMAIN:EGF-like 12; calcium-binding,DOMAIN:EGF-like 13; calcium-binding,DOMAIN:EGF-like 14; calcium-binding,DOMAIN:EGF-like 15; calcium-binding,DOMAIN:EGF-like 16; calcium-binding,DOMAIN:EGF-like 17; calcium-binding,DOMAIN:EGF-like 18; calcium-binding,DOMAIN:EGF-like 19; calcium-binding,DOMAIN:EGF-like 2,DOMAIN:EGF-like 20; calcium-binding,DOMAIN:EGF-like 3; calcium-binding,DOMAIN:EGF-like 4,DOMAIN:EGF-like 5; calcium-binding,DOMAIN:EGF-like 6; calcium-binding,DOMAIN:EGF-like 7; calcium-binding,DOMAIN:EGF-like 8; calcium-binding,DOMAIN:EGF-like 9; calcium-binding,DOMAIN:TB,DOMAIN:TB 1,DOMAIN:TB 2,DOMAIN:TB 3,DOMAIN:TB 4,MOTIF:Cell attachment site,REGION:C-terminal domain,REGION:Disordered,REGION:Heparin-binding,
Q9BGL2	lecithin retinol acyltransferase(LRAT)	Bos taurus			GO:0006776~vitamin A metabolic process,GO:0007601~visual perception,GO:0009617~response to bacterium,GO:0032370~positive regulation of lipid transport,GO:0042572~retinol metabolic process,GO:0050896~response to stimulus,GO:1990830~cellular response to leukemia inhibitory factor,	GO:0005771~multivesicular body,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005791~rough endoplasmic reticulum,GO:0016020~membrane,GO:0048471~perinuclear region of cytoplasm,	GO:0047173~phosphatidylcholine-retinol O-acyltransferase activity,GO:0102279~lecithin:11-cis retinol acyltransferase activity,	IPR007053:LRAT_dom,IPR042288:LRAT,	bta00830:Retinol metabolism,bta01100:Metabolic pathways,bta04977:Vitamin digestion and absorption,				KW-0443~Lipid metabolism,KW-0716~Sensory transduction,KW-0844~Vision,	KW-0256~Endoplasmic reticulum,KW-0472~Membrane,KW-0963~Cytoplasm,KW-0967~Endosome,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0012~Acyltransferase,KW-0808~Transferase,		ACT_SITE:Acyl-thioester intermediate,DOMAIN:LRAT,TOPO_DOM:Cytoplasmic,TOPO_DOM:Lumenal,TRANSMEM:Helical,
Q1EGL2	leucine rich glioma inactivated 1(LGI1)	Pan troglodytes			GO:0007411~axon guidance,GO:0030307~positive regulation of cell growth,GO:0050806~positive regulation of synaptic transmission,GO:0099645~neurotransmitter receptor localization to postsynaptic specialization membrane,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005737~cytoplasm,GO:0043083~synaptic cleft,GO:0098978~glutamatergic synapse,	GO:0005102~receptor binding,GO:0005515~protein binding,	IPR000483:Cys-rich_flank_reg_C,IPR001611:Leu-rich_rpt,IPR003591:Leu-rich_rpt_typical-subtyp,IPR005492:EPTP,IPR009039:EAR,IPR032675:LRR_dom_sf,				SM00082:LRRCT,SM00369:LRR_TYP,		KW-0770~Synapse,KW-0963~Cytoplasm,KW-0964~Secreted,			KW-0433~Leucine-rich repeat,KW-0677~Repeat,KW-0732~Signal,			KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:LRRCT,DOMAIN:LRRNT,REPEAT:EAR,REPEAT:EAR 1,REPEAT:EAR 2,REPEAT:EAR 3,REPEAT:EAR 4,REPEAT:EAR 5,REPEAT:EAR 6,REPEAT:EAR 7,REPEAT:LRR 1,REPEAT:LRR 2,REPEAT:LRR 3,
Q50LG9	leucine rich repeat containing 24(LRRC24)	Homo sapiens			GO:0051965~positive regulation of synapse assembly,	GO:0005615~extracellular space,GO:0009897~external side of plasma membrane,GO:0009986~cell surface,GO:0016020~membrane,GO:0031012~extracellular matrix,		IPR000372:LRRNT,IPR000483:Cys-rich_flank_reg_C,IPR001611:Leu-rich_rpt,IPR003591:Leu-rich_rpt_typical-subtyp,IPR003598:Ig_sub2,IPR003599:Ig_sub,IPR007110:Ig-like_dom,IPR013783:Ig-like_fold,IPR032675:LRR_dom_sf,IPR036179:Ig-like_dom_sf,				SM00013:LRRNT,SM00082:LRRCT,SM00369:LRR_TYP,SM00408:IGc2,SM00409:IG,		KW-0472~Membrane,			KW-0393~Immunoglobulin domain,KW-0433~Leucine-rich repeat,KW-0677~Repeat,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Pro residues,DOMAIN:Ig-like,DOMAIN:Ig-like C2-type,DOMAIN:LRRCT,DOMAIN:LRRNT,REGION:Disordered,REPEAT:LRR 1,REPEAT:LRR 2,REPEAT:LRR 3,REPEAT:LRR 4,REPEAT:LRR 5,REPEAT:LRR 6,TRANSMEM:Helical,
A2VDH3	leucine rich repeat containing 38(Lrrc38)	Mus musculus			GO:0006811~ion transport,GO:0034220~ion transmembrane transport,GO:0071805~potassium ion transmembrane transport,GO:1903818~positive regulation of voltage-gated potassium channel activity,	GO:0005886~plasma membrane,GO:0008076~voltage-gated potassium channel complex,GO:0016020~membrane,	GO:0005249~voltage-gated potassium channel activity,GO:0044325~ion channel binding,GO:0099104~potassium channel activator activity,	IPR000372:LRRNT,IPR000483:Cys-rich_flank_reg_C,IPR001611:Leu-rich_rpt,IPR003591:Leu-rich_rpt_typical-subtyp,IPR032675:LRR_dom_sf,				SM00013:LRRNT,SM00082:LRRCT,SM00369:LRR_TYP,	KW-0406~Ion transport,KW-0813~Transport,	KW-0472~Membrane,KW-1003~Cell membrane,			KW-0433~Leucine-rich repeat,KW-0677~Repeat,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0407~Ion channel,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:LRRCT,DOMAIN:LRRNT,REPEAT:LRR 1,REPEAT:LRR 2,REPEAT:LRR 3,REPEAT:LRR 4,REPEAT:LRR 5,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q6NWG1	leucine rich repeat containing 59(lrrc59)	Danio rerio			GO:0006470~protein dephosphorylation,GO:0007165~signal transduction,	GO:0005634~nucleus,GO:0005635~nuclear envelope,GO:0005737~cytoplasm,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0016020~membrane,GO:0043231~intracellular membrane-bounded organelle,	GO:0004722~protein serine/threonine phosphatase activity,	IPR001611:Leu-rich_rpt,IPR003591:Leu-rich_rpt_typical-subtyp,IPR032675:LRR_dom_sf,				SM00369:LRR_TYP,		KW-0256~Endoplasmic reticulum,KW-0472~Membrane,KW-0492~Microsome,KW-0539~Nucleus,			KW-0175~Coiled coil,KW-0433~Leucine-rich repeat,KW-0677~Repeat,KW-0735~Signal-anchor,KW-0812~Transmembrane,KW-1133~Transmembrane helix,				COMPBIAS:Basic and acidic residues,REGION:Disordered,REPEAT:LRR 1,REPEAT:LRR 2,REPEAT:LRR 3,REPEAT:LRR 4,REPEAT:LRR 5,TOPO_DOM:Cytoplasmic,TOPO_DOM:Lumenal,TRANSMEM:Helical,
A0JPI9	leucine rich repeat containing 74A(Lrrc74a)	Rattus norvegicus						IPR001611:Leu-rich_rpt,IPR032675:LRR_dom_sf,				SM00368:LRR_RI,					KW-0433~Leucine-rich repeat,KW-0677~Repeat,				REGION:Disordered,REPEAT:LRR 1,REPEAT:LRR 2,REPEAT:LRR 3,REPEAT:LRR 4,REPEAT:LRR 5,REPEAT:LRR 6,REPEAT:LRR 7,REPEAT:LRR 8,
Q6IP81	leukotriene A4 hydrolase L homeolog(lta4h.L)	Xenopus laevis			GO:0006508~proteolysis,GO:0019370~leukotriene biosynthetic process,	GO:0005737~cytoplasm,	GO:0004463~leukotriene-A4 hydrolase activity,GO:0008233~peptidase activity,GO:0008237~metallopeptidase activity,GO:0008270~zinc ion binding,GO:0016787~hydrolase activity,GO:0046872~metal ion binding,	IPR001930:Peptidase_M1,IPR012777:LTA4H,IPR014782:Peptidase_M1_dom,IPR015211:Peptidase_M1_C,IPR016024:ARM-type_fold,IPR027268:Peptidase_M4/M1_CTD_sf,IPR034015:M1_LTA4H,IPR038502:M1_LTA-4_hydro/amino_C_sf,IPR042097:Aminopeptidase_N-like_N_sf,IPR045357:Aminopeptidase_N-like_N,	xla00590:Arachidonic acid metabolism,xla01100:Metabolic pathways,			SM01263:Leuk-A4-hydro_C,	KW-0434~Leukotriene biosynthesis,	KW-0963~Cytoplasm,				KW-0479~Metal-binding,KW-0862~Zinc,	KW-0378~Hydrolase,KW-0482~Metalloprotease,KW-0645~Protease,		ACT_SITE:Proton acceptor,ACT_SITE:Proton donor,DOMAIN:Peptidase M1 leukotriene A4 hydrolase/aminopeptidase C-terminal,MUTAGEN:F->Y: Increased sensitivity to suicide inactivation. Epoxide hydrolase activity to produce LTB4 intact, but no production of delta6-trans-delta8-cis-LTB4.,SITE:Essential for epoxide hydrolase activity, but not for aminopeptidase activity,SITE:Pro-Gly-Pro binding,
P51892	ligase I, DNA, ATP-dependent L homeolog(lig1.L)	Xenopus laevis			GO:0006260~DNA replication,GO:0006281~DNA repair,GO:0006310~DNA recombination,GO:0006974~cellular response to DNA damage stimulus,GO:0007049~cell cycle,GO:0051301~cell division,GO:0071897~DNA biosynthetic process,	GO:0005634~nucleus,	GO:0000166~nucleotide binding,GO:0003677~DNA binding,GO:0003909~DNA ligase activity,GO:0003910~DNA ligase (ATP) activity,GO:0005524~ATP binding,GO:0016874~ligase activity,GO:0046872~metal ion binding,	IPR000977:DNA_ligase_ATP-dep,IPR012308:DNA_ligase_ATP-dep_N,IPR012309:DNA_ligase_ATP-dep_C,IPR012310:DNA_ligase_ATP-dep_cent,IPR012340:NA-bd_OB-fold,IPR016059:DNA_ligase_ATP-dep_CS,IPR036599:DNA_ligase_N_sf,	xla03030:DNA replication,xla03410:Base excision repair,xla03420:Nucleotide excision repair,xla03430:Mismatch repair,				KW-0131~Cell cycle,KW-0132~Cell division,KW-0227~DNA damage,KW-0233~DNA recombination,KW-0234~DNA repair,KW-0235~DNA replication,	KW-0539~Nucleus,				KW-0067~ATP-binding,KW-0460~Magnesium,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,	KW-0436~Ligase,		ACT_SITE:N6-AMP-lysine intermediate,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:ATP-dependent DNA ligase family profile,REGION:Disordered,REGION:Interaction with target DNA,SITE:Interaction with target DNA,
Q9R101	lipase E, hormone sensitive type(Lipe)	Ictidomys tridecemlineatus			GO:0006361~transcription initiation from RNA polymerase I promoter,GO:0006363~termination of RNA polymerase I transcription,GO:0008203~cholesterol metabolic process,GO:0016042~lipid catabolic process,GO:0019433~triglyceride catabolic process,GO:0046340~diacylglycerol catabolic process,GO:0046485~ether lipid metabolic process,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005811~lipid particle,GO:0005829~cytosol,GO:0005901~caveola,GO:0016020~membrane,	GO:0004771~sterol esterase activity,GO:0004806~triglyceride lipase activity,GO:0033878~hormone-sensitive lipase activity,GO:0042134~rRNA primary transcript binding,GO:0047372~acylglycerol lipase activity,GO:0047376~all-trans-retinyl-palmitate hydrolase, all-trans-retinol forming activity,GO:0050253~retinyl-palmitate esterase activity,	IPR002168:Lipase_GDXG_HIS_AS,IPR010468:HSL_N,IPR013094:AB_hydrolase_3,IPR029058:AB_hydrolase,IPR033140:Lipase_GDXG_put_SER_AS,					KW-0153~Cholesterol metabolism,KW-0442~Lipid degradation,KW-0443~Lipid metabolism,KW-0753~Steroid metabolism,KW-1207~Sterol metabolism,	KW-0472~Membrane,KW-0551~Lipid droplet,KW-0963~Cytoplasm,KW-1003~Cell membrane,					KW-0378~Hydrolase,	KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,DOMAIN:Alpha/beta hydrolase fold-3,DOMAIN:Hormone-sensitive lipase N-terminal,MOTIF:Involved in the stabilization of the negatively charged intermediate by the formation of the oxyanion hole,REGION:Disordered,
Q0P4Y8	lipase maturation factor 2(lmf2)	Xenopus tropicalis			GO:0051604~protein maturation,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0016020~membrane,		IPR009613:LMF,						KW-0256~Endoplasmic reticulum,KW-0472~Membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,REGION:Disordered,TRANSMEM:Helical,
Q14693	lipin 1(LPIN1)	Homo sapiens			GO:0006642~triglyceride mobilization,GO:0006654~phosphatidic acid biosynthetic process,GO:0007077~mitotic nuclear envelope disassembly,GO:0009062~fatty acid catabolic process,GO:0019432~triglyceride biosynthetic process,GO:0031100~animal organ regeneration,GO:0031642~negative regulation of myelination,GO:0032869~cellular response to insulin stimulus,GO:0045740~positive regulation of DNA replication,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046473~phosphatidic acid metabolic process,	GO:0005634~nucleus,GO:0005635~nuclear envelope,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005741~mitochondrial outer membrane,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005829~cytosol,GO:0031965~nuclear membrane,	GO:0003713~transcription coactivator activity,GO:0005515~protein binding,GO:0008195~phosphatidate phosphatase activity,	IPR007651:Lipin_N,IPR013209:LNS2,IPR026058:LIPIN,IPR031315:LNS2/PITP,IPR031703:Lipin_mid,IPR036412:HAD-like_sf,	hsa00561:Glycerolipid metabolism,hsa00564:Glycerophospholipid metabolism,hsa01100:Metabolic pathways,hsa04150:mTOR signaling pathway,hsa04936:Alcoholic liver disease,	268200~Myoglobinuria, acute recurrent, autosomal recessive,		SM00775:LNS2,	KW-0276~Fatty acid metabolism,KW-0443~Lipid metabolism,KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0256~Endoplasmic reticulum,KW-0472~Membrane,KW-0539~Nucleus,KW-0963~Cytoplasm,					KW-0378~Hydrolase,	KW-0007~Acetylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Polar residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO),DOMAIN:Lipin N-terminal,DOMAIN:Lipin middle,DOMAIN:Lipin/Ned1/Smp2 (LNS2),MOTIF:DXDXT motif,MOTIF:LXXIL motif,MOTIF:Nuclear localization signal,MUTAGEN:K->R: Decreased acetylation by KAT5.,REGION:C-LIP,REGION:Disordered,REGION:N-LIP,
Q924S5	lon peptidase 1, mitochondrial(Lonp1)	Rattus norvegicus			GO:0001666~response to hypoxia,GO:0006508~proteolysis,GO:0006515~misfolded or incompletely synthesized protein catabolic process,GO:0007005~mitochondrion organization,GO:0009725~response to hormone,GO:0010044~response to aluminum ion,GO:0030163~protein catabolic process,GO:0034599~cellular response to oxidative stress,GO:0046627~negative regulation of insulin receptor signaling pathway,GO:0050730~regulation of peptidyl-tyrosine phosphorylation,GO:0051131~chaperone-mediated protein complex assembly,GO:0051603~proteolysis involved in cellular protein catabolic process,GO:0065003~macromolecular complex assembly,GO:0070407~oxidation-dependent protein catabolic process,	GO:0005654~nucleoplasm,GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,GO:0005829~cytosol,GO:0042645~mitochondrial nucleoid,	GO:0001018~mitochondrial RNA polymerase regulatory region DNA binding,GO:0003697~single-stranded DNA binding,GO:0003727~single-stranded RNA binding,GO:0004176~ATP-dependent peptidase activity,GO:0004252~serine-type endopeptidase activity,GO:0005524~ATP binding,GO:0016887~ATPase activity,GO:0042731~PH domain binding,GO:0042802~identical protein binding,GO:0043531~ADP binding,GO:0043560~insulin receptor substrate binding,GO:0043565~sequence-specific DNA binding,GO:0051880~G-quadruplex DNA binding,GO:0070182~DNA polymerase binding,	IPR003111:Lon_prtase_N,IPR003593:AAA+_ATPase,IPR003959:ATPase_AAA_core,IPR004815:Lon_bac/euk-typ,IPR008268:Peptidase_S16_AS,IPR008269:Lon_proteolytic,IPR014721:Ribsml_uS5_D2-typ_fold_subgr,IPR015947:PUA-like_sf,IPR020568:Ribosomal_Su5_D2-typ_SF,IPR027065:Lon_Prtase,IPR027417:P-loop_NTPase,IPR027503:Lonm_euk,IPR046336:Lon_prtase_N_sf,			PIRSF001174:Lon_proteas,	SM00382:AAA,SM00464:LON,		KW-0496~Mitochondrion,			KW-0809~Transit peptide,	KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0238~DNA-binding,KW-0378~Hydrolase,KW-0645~Protease,KW-0720~Serine protease,		DOMAIN:Lon N-terminal,DOMAIN:Lon proteolytic,REGION:Disordered,TRANSIT:Mitochondrion,
Q5SZI1	low density lipoprotein receptor class A domain containing 2(LDLRAD2)	Homo sapiens				GO:0016020~membrane,		IPR002172:LDrepeatLR_classA_rpt,IPR035914:Sperma_CUB_dom_sf,IPR036055:LDL_receptor-like_sf,				SM00192:LDLa,		KW-0472~Membrane,			KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0675~Receptor,	KW-0325~Glycoprotein,KW-0449~Lipoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Polar residues,DOMAIN:LDL-receptor class A,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
O15550	lysine demethylase 6A(KDM6A)	Homo sapiens			GO:0001701~in utero embryonic development,GO:0001843~neural tube closure,GO:0003007~heart morphogenesis,GO:0003016~respiratory system process,GO:0006338~chromatin remodeling,GO:0007507~heart development,GO:0010468~regulation of gene expression,GO:0010628~positive regulation of gene expression,GO:0032525~somite rostral/caudal axis specification,GO:0035264~multicellular organism growth,GO:0036211~protein modification process,GO:0045793~positive regulation of cell size,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048333~mesodermal cell differentiation,GO:0048570~notochord morphogenesis,GO:0071305~cellular response to vitamin D,GO:0071456~cellular response to hypoxia,GO:0071560~cellular response to transforming growth factor beta stimulus,GO:1903298~negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway,GO:1904385~cellular response to angiotensin,GO:1990859~cellular response to endothelin,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0035097~histone methyltransferase complex,GO:0044666~MLL3/4 complex,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0005515~protein binding,GO:0016491~oxidoreductase activity,GO:0031490~chromatin DNA binding,GO:0032452~histone demethylase activity,GO:0042802~identical protein binding,GO:0046872~metal ion binding,GO:0071558~histone demethylase activity (H3-K27 specific),	IPR001440:TPR_1,IPR003347:JmjC_dom,IPR011990:TPR-like_helical_dom_sf,IPR019734:TPR_repeat,IPR046941:KDM6_GATAL_sf,IPR048560:KDM6A_B-like_GATAL,IPR048562:KDM6A_B-like_C-hel,	hsa05202:Transcriptional misregulation in cancer,	300867~Kabuki syndrome 2,		SM00028:TPR,SM00558:JmjC,		KW-0539~Nucleus,		KW-0991~Intellectual disability,	KW-0677~Repeat,KW-0802~TPR repeat,	KW-0408~Iron,KW-0479~Metal-binding,KW-0862~Zinc,	KW-0156~Chromatin regulator,KW-0223~Dioxygenase,KW-0560~Oxidoreductase,	KW-0488~Methylation,KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,COMPBIAS:Pro residues,DOMAIN:JmjC,DOMAIN:Lysine-specific demethylase 6A/B-like GATA-like,MUTAGEN:H->A: Abolishes histone demethylase activity.,REGION:Disordered,REGION:Interaction with SUPT6H,REPEAT:TPR,REPEAT:TPR 1,REPEAT:TPR 2,REPEAT:TPR 3,REPEAT:TPR 4,REPEAT:TPR 5,REPEAT:TPR 6,REPEAT:TPR 7,REPEAT:TPR 8,
Q2YDJ8	lysine methyltransferase 5A(KMT5A)	Bos taurus			GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0007049~cell cycle,GO:0018026~peptidyl-lysine monomethylation,GO:0043516~regulation of DNA damage response, signal transduction by p53 class mediator,GO:0051301~cell division,	GO:0005634~nucleus,GO:0005694~chromosome,GO:0005700~polytene chromosome,	GO:0005515~protein binding,GO:0016279~protein-lysine N-methyltransferase activity,GO:0042054~histone methyltransferase activity,GO:0042799~histone methyltransferase activity (H4-K20 specific),	IPR001214:SET_dom,IPR016858:KMT5A-like,IPR046341:SET_dom_sf,IPR047266:KMT5A-like_SET,	bta00310:Lysine degradation,bta01100:Metabolic pathways,		PIRSF027717:Histone_H4-K20_mtfrase,	SM00317:SET,	KW-0131~Cell cycle,KW-0132~Cell division,KW-0498~Mitosis,KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0158~Chromosome,KW-0539~Nucleus,				KW-0949~S-adenosyl-L-methionine,	KW-0156~Chromatin regulator,KW-0489~Methyltransferase,KW-0678~Repressor,KW-0808~Transferase,	KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,	COMPBIAS:Basic and acidic residues,COMPBIAS:Basic residues,COMPBIAS:Polar residues,DOMAIN:SET,REGION:Disordered,
Q5U3H2	lysine methyltransferase 5B(kmt5b)	Danio rerio			GO:0006281~DNA repair,GO:0006325~chromatin organization,GO:0007517~muscle organ development,GO:0032259~methylation,GO:0040014~regulation of multicellular organism growth,GO:0045830~positive regulation of isotype switching,GO:2001034~positive regulation of double-strand break repair via nonhomologous end joining,	GO:0005634~nucleus,GO:0005694~chromosome,	GO:0003682~chromatin binding,GO:0008168~methyltransferase activity,GO:0016740~transferase activity,GO:0042799~histone methyltransferase activity (H4-K20 specific),GO:0046872~metal ion binding,GO:1904047~S-adenosyl-L-methionine binding,	IPR001214:SET_dom,IPR025790:Suv4-20_animal,IPR039977:Suv4-20/Set9,IPR041938:Hist-Lys_N-MTase_N,IPR044424:KMT5B_SET,IPR046341:SET_dom_sf,	dre00310:Lysine degradation,dre01100:Metabolic pathways,			SM00317:SET,	KW-0517~Myogenesis,KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0158~Chromosome,KW-0539~Nucleus,				KW-0479~Metal-binding,KW-0862~Zinc,KW-0949~S-adenosyl-L-methionine,	KW-0156~Chromatin regulator,KW-0489~Methyltransferase,KW-0678~Repressor,KW-0808~Transferase,		COMPBIAS:Basic and acidic residues,COMPBIAS:Basic residues,COMPBIAS:Polar residues,DOMAIN:SET,REGION:Disordered,
Q5ZKJ5	major facilitator superfamily domain containing 13A(MFSD13A)	Gallus gallus				GO:0016020~membrane,		IPR036259:MFS_trans_sf,IPR040035:TMEM180,						KW-0472~Membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,				TRANSMEM:Helical,
P21145	mal, T cell differentiation protein(MAL)	Homo sapiens		h_malPathway:Role of MAL in Rho-Mediated Activation of SRF,	GO:0001766~membrane raft polarization,GO:0002175~protein localization to paranode region of axon,GO:0006915~apoptotic process,GO:0007417~central nervous system development,GO:0022010~central nervous system myelination,GO:0030154~cell differentiation,GO:0042552~myelination,GO:0045176~apical protein localization,GO:0098737~protein insertion into plasma membrane,GO:1902043~positive regulation of extrinsic apoptotic signaling pathway via death domain receptors,	GO:0005783~endoplasmic reticulum,GO:0016324~apical plasma membrane,GO:0043220~Schmidt-Lanterman incisure,GO:0044853~plasma membrane raft,GO:0045121~membrane raft,GO:0120003~hinge region between urothelial plaques of apical plasma membrane,	GO:0005515~protein binding,GO:0008289~lipid binding,GO:0016505~peptidase activator activity involved in apoptotic process,GO:0019911~structural constituent of myelin sheath,	IPR008253:Marvel,IPR013295:MAL,						KW-0472~Membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0449~Lipoprotein,	DOMAIN:MARVEL,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
P46013	marker of proliferation Ki-67(MKI67)	Homo sapiens			GO:0007049~cell cycle,GO:0007088~regulation of mitotic nuclear division,GO:0008283~cell proliferation,GO:0051983~regulation of chromosome segregation,GO:1902275~regulation of chromatin organization,	GO:0000793~condensed chromosome,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0005730~nucleolus,GO:0016020~membrane,GO:0016604~nuclear body,	GO:0003677~DNA binding,GO:0003723~RNA binding,GO:0005515~protein binding,GO:0005524~ATP binding,	IPR000253:FHA_dom,IPR008984:SMAD_FHA_dom_sf,IPR012568:KI67R,IPR029334:PP1-bd,				SM00240:FHA,SM01295:K167R,	KW-0131~Cell cycle,	KW-0158~Chromosome,KW-0539~Nucleus,			KW-0677~Repeat,	KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0238~DNA-binding,	KW-0007~Acetylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1),CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate,DOMAIN:FHA,DOMAIN:PP1-binding,REGION:16 X 122 AA approximate repeats,REGION:Disordered,REPEAT:K167R 1,REPEAT:K167R 10,REPEAT:K167R 11,REPEAT:K167R 12,REPEAT:K167R 13,REPEAT:K167R 14,REPEAT:K167R 15,REPEAT:K167R 16,REPEAT:K167R 2,REPEAT:K167R 3,REPEAT:K167R 4,REPEAT:K167R 5,REPEAT:K167R 6,REPEAT:K167R 7,REPEAT:K167R 8,REPEAT:K167R 9,
F1QGZ6	maternal embryonic leucine zipper kinase(melk)	Danio rerio			GO:0006468~protein phosphorylation,GO:0006915~apoptotic process,GO:0007049~cell cycle,GO:0008016~regulation of heart contraction,GO:0008283~cell proliferation,GO:0016310~phosphorylation,GO:0030097~hemopoiesis,GO:0035556~intracellular signal transduction,GO:0043065~positive regulation of apoptotic process,GO:0046777~protein autophosphorylation,GO:0048821~erythrocyte development,GO:0061351~neural precursor cell proliferation,	GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0005938~cell cortex,GO:0016020~membrane,	GO:0000166~nucleotide binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0004715~non-membrane spanning protein tyrosine kinase activity,GO:0005509~calcium ion binding,GO:0005524~ATP binding,GO:0008289~lipid binding,GO:0016301~kinase activity,GO:0016740~transferase activity,	IPR000719:Prot_kinase_dom,IPR001772:KA1_dom,IPR008271:Ser/Thr_kinase_AS,IPR011009:Kinase-like_dom_sf,IPR017441:Protein_kinase_ATP_BS,IPR028375:KA1/Ssp2_C,IPR034673:MELK,IPR048637:MELK_UBA,				SM00220:S_TKc,	KW-0053~Apoptosis,KW-0131~Cell cycle,	KW-0472~Membrane,KW-1003~Cell membrane,				KW-0067~ATP-binding,KW-0446~Lipid-binding,KW-0547~Nucleotide-binding,	KW-0418~Kinase,KW-0723~Serine/threonine-protein kinase,KW-0808~Transferase,	KW-0597~Phosphoprotein,	ACT_SITE:Proton acceptor,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:KA1,DOMAIN:Protein kinase,REGION:Autoinhibitory region,REGION:Disordered,REGION:UBA-like,
Q10835	matrix metallopeptidase 13 (collagenase 3) like L homeolog(mmp13l.L)	Xenopus laevis			GO:0006508~proteolysis,GO:0022617~extracellular matrix disassembly,GO:0030574~collagen catabolic process,GO:0060349~bone morphogenesis,	GO:0005576~extracellular region,GO:0031012~extracellular matrix,	GO:0004222~metalloendopeptidase activity,GO:0005509~calcium ion binding,GO:0005518~collagen binding,GO:0008233~peptidase activity,GO:0008237~metallopeptidase activity,GO:0008270~zinc ion binding,GO:0016787~hydrolase activity,GO:0046872~metal ion binding,	IPR000585:Hemopexin-like_dom,IPR001818:Pept_M10_metallopeptidase,IPR002477:Peptidoglycan-bd-like,IPR006026:Peptidase_Metallo,IPR018486:Hemopexin_CS,IPR018487:Hemopexin-like_repeat,IPR021158:Pept_M10A_Zn_BS,IPR021190:Pept_M10A,IPR024079:MetalloPept_cat_dom_sf,IPR033739:M10A_MMP,IPR036365:PGBD-like_sf,IPR036375:Hemopexin-like_dom_sf,			PIRSF001191:Peptidase_M10A_matrix,	SM00120:HX,SM00235:ZnMc,	KW-0177~Collagen degradation,	KW-0272~Extracellular matrix,KW-0964~Secreted,			KW-0677~Repeat,KW-0732~Signal,	KW-0106~Calcium,KW-0479~Metal-binding,KW-0862~Zinc,	KW-0378~Hydrolase,KW-0482~Metalloprotease,KW-0645~Protease,	KW-0325~Glycoprotein,KW-0865~Zymogen,KW-1015~Disulfide bond,	BINDING:in inhibited form,CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Peptidase metallopeptidase,MOTIF:Cysteine switch,PROPEP:Activation peptide,REGION:Interaction with collagen,REPEAT:Hemopexin,REPEAT:Hemopexin 1,REPEAT:Hemopexin 2,REPEAT:Hemopexin 3,REPEAT:Hemopexin 4,
Q10739	matrix metallopeptidase 14(Mmp14)	Rattus norvegicus			GO:0001501~skeletal system development,GO:0001503~ossification,GO:0001525~angiogenesis,GO:0001541~ovarian follicle development,GO:0001666~response to hypoxia,GO:0001935~endothelial cell proliferation,GO:0001958~endochondral ossification,GO:0006508~proteolysis,GO:0006979~response to oxidative stress,GO:0008584~male gonad development,GO:0009612~response to mechanical stimulus,GO:0009725~response to hormone,GO:0010831~positive regulation of myotube differentiation,GO:0010954~positive regulation of protein processing,GO:0014070~response to organic cyclic compound,GO:0016477~cell migration,GO:0030198~extracellular matrix organization,GO:0030307~positive regulation of cell growth,GO:0030324~lung development,GO:0030335~positive regulation of cell migration,GO:0030574~collagen catabolic process,GO:0031638~zymogen activation,GO:0035987~endodermal cell differentiation,GO:0035988~chondrocyte proliferation,GO:0043615~astrocyte cell migration,GO:0043627~response to estrogen,GO:0045579~positive regulation of B cell differentiation,GO:0045746~negative regulation of Notch signaling pathway,GO:0048701~embryonic cranial skeleton morphogenesis,GO:0048754~branching morphogenesis of an epithelial tube,GO:0048771~tissue remodeling,GO:0051895~negative regulation of focal adhesion assembly,GO:0060322~head development,GO:0060348~bone development,GO:0097094~craniofacial suture morphogenesis,GO:1903076~regulation of protein localization to plasma membrane,GO:1905523~positive regulation of macrophage migration,GO:1990834~response to odorant,	GO:0005615~extracellular space,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0031012~extracellular matrix,GO:0031410~cytoplasmic vesicle,GO:0042470~melanosome,GO:0044354~macropinosome,GO:0045111~intermediate filament cytoskeleton,	GO:0004175~endopeptidase activity,GO:0004222~metalloendopeptidase activity,GO:0005178~integrin binding,GO:0008270~zinc ion binding,GO:0070006~metalloaminopeptidase activity,	IPR000585:Hemopexin-like_dom,IPR001818:Pept_M10_metallopeptidase,IPR002477:Peptidoglycan-bd-like,IPR006026:Peptidase_Metallo,IPR018486:Hemopexin_CS,IPR018487:Hemopexin-like_repeat,IPR021158:Pept_M10A_Zn_BS,IPR021190:Pept_M10A,IPR021805:Pept_M10A_metallopeptidase_C,IPR024079:MetalloPept_cat_dom_sf,IPR033739:M10A_MMP,IPR036365:PGBD-like_sf,IPR036366:PGBDSf,IPR036375:Hemopexin-like_dom_sf,	rno04668:TNF signaling pathway,rno04912:GnRH signaling pathway,rno04928:Parathyroid hormone synthesis, secretion and action,		PIRSF001191:Peptidase_M10A_matrix,	SM00120:HX,SM00235:ZnMc,		KW-0472~Membrane,KW-0963~Cytoplasm,			KW-0677~Repeat,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0106~Calcium,KW-0479~Metal-binding,KW-0862~Zinc,	KW-0378~Hydrolase,KW-0482~Metalloprotease,KW-0645~Protease,	KW-0165~Cleavage on pair of basic residues,KW-0597~Phosphoprotein,KW-0865~Zymogen,KW-1015~Disulfide bond,	BINDING:in inhibited form,DOMAIN:Peptidase metallopeptidase,MOTIF:Cysteine switch,PROPEP:Activation peptide,REGION:Disordered,REPEAT:Hemopexin,REPEAT:Hemopexin 1,REPEAT:Hemopexin 2,REPEAT:Hemopexin 3,REPEAT:Hemopexin 4,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
P13388	melanoma receptor tyrosine-protein kinase(LOC102228937)	Xiphophorus maculatus			GO:0006468~protein phosphorylation,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0007275~multicellular organism development,GO:0016310~phosphorylation,GO:0030154~cell differentiation,GO:0033674~positive regulation of kinase activity,GO:0038127~ERBB signaling pathway,GO:0042127~regulation of cell proliferation,GO:0043066~negative regulation of apoptotic process,GO:0050679~positive regulation of epithelial cell proliferation,	GO:0009925~basal plasma membrane,GO:0043235~receptor complex,GO:0098590~plasma membrane region,	GO:0004714~transmembrane receptor protein tyrosine kinase activity,GO:0005006~epidermal growth factor-activated receptor activity,GO:0005524~ATP binding,GO:0048408~epidermal growth factor binding,	IPR000494:Rcpt_L-dom,IPR000719:Prot_kinase_dom,IPR001245:Ser-Thr/Tyr_kinase_cat_dom,IPR006211:Furin-like_Cys-rich_dom,IPR006212:Furin_repeat,IPR008266:Tyr_kinase_AS,IPR009030:Growth_fac_rcpt_cys_sf,IPR011009:Kinase-like_dom_sf,IPR016245:Tyr_kinase_EGF/ERB/XmrK_rcpt,IPR017441:Protein_kinase_ATP_BS,IPR020635:Tyr_kinase_cat_dom,IPR032778:GF_recep_IV,IPR036941:Rcpt_L-dom_sf,IPR044912:Egfr_JX_dom,IPR049328:TM_ErbB1,	xma04010:MAPK signaling pathway,xma04012:ErbB signaling pathway,xma04020:Calcium signaling pathway,xma04068:FoxO signaling pathway,xma04144:Endocytosis,xma04510:Focal adhesion,xma04520:Adherens junction,xma04540:Gap junction,xma04810:Regulation of actin cytoskeleton,xma04912:GnRH signaling pathway,		PIRSF000619:TyrPK_EGF-R,	SM00219:TyrKc,SM00261:FU,		KW-0472~Membrane,		KW-0656~Proto-oncogene,	KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0418~Kinase,KW-0675~Receptor,KW-0808~Transferase,KW-0829~Tyrosine-protein kinase,	KW-0325~Glycoprotein,KW-0597~Phosphoprotein,KW-1015~Disulfide bond,	ACT_SITE:Proton acceptor,CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Protein kinase,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
P13388	melanoma receptor tyrosine-protein kinase-like(LOC111606142)	Xiphophorus maculatus			GO:0006468~protein phosphorylation,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0007275~multicellular organism development,GO:0016310~phosphorylation,GO:0030154~cell differentiation,GO:0033674~positive regulation of kinase activity,GO:0038127~ERBB signaling pathway,GO:0042127~regulation of cell proliferation,GO:0043066~negative regulation of apoptotic process,GO:0050679~positive regulation of epithelial cell proliferation,	GO:0009925~basal plasma membrane,GO:0043235~receptor complex,GO:0098590~plasma membrane region,	GO:0004714~transmembrane receptor protein tyrosine kinase activity,GO:0005006~epidermal growth factor-activated receptor activity,GO:0005524~ATP binding,GO:0048408~epidermal growth factor binding,	IPR000494:Rcpt_L-dom,IPR000719:Prot_kinase_dom,IPR001245:Ser-Thr/Tyr_kinase_cat_dom,IPR006211:Furin-like_Cys-rich_dom,IPR006212:Furin_repeat,IPR008266:Tyr_kinase_AS,IPR009030:Growth_fac_rcpt_cys_sf,IPR011009:Kinase-like_dom_sf,IPR016245:Tyr_kinase_EGF/ERB/XmrK_rcpt,IPR017441:Protein_kinase_ATP_BS,IPR020635:Tyr_kinase_cat_dom,IPR032778:GF_recep_IV,IPR036941:Rcpt_L-dom_sf,IPR044912:Egfr_JX_dom,IPR049328:TM_ErbB1,	xma04010:MAPK signaling pathway,xma04012:ErbB signaling pathway,xma04020:Calcium signaling pathway,xma04068:FoxO signaling pathway,xma04144:Endocytosis,xma04510:Focal adhesion,xma04520:Adherens junction,xma04540:Gap junction,xma04810:Regulation of actin cytoskeleton,xma04912:GnRH signaling pathway,		PIRSF000619:TyrPK_EGF-R,	SM00219:TyrKc,SM00261:FU,		KW-0472~Membrane,		KW-0656~Proto-oncogene,	KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0418~Kinase,KW-0675~Receptor,KW-0808~Transferase,KW-0829~Tyrosine-protein kinase,	KW-0325~Glycoprotein,KW-0597~Phosphoprotein,KW-1015~Disulfide bond,	ACT_SITE:Proton acceptor,CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Protein kinase,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q6NW52	methionine sulfoxide reductase B2(msrb2)	Danio rerio			GO:0006979~response to oxidative stress,GO:0030041~actin filament polymerization,GO:0030091~protein repair,	GO:0005737~cytoplasm,GO:0005739~mitochondrion,	GO:0003779~actin binding,GO:0016491~oxidoreductase activity,GO:0016671~oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor,GO:0033743~peptide-methionine (R)-S-oxide reductase activity,GO:0033745~L-methionine-(R)-S-oxide reductase activity,GO:0046872~metal ion binding,	IPR002579:Met_Sox_Rdtase_MsrB_dom,IPR011057:Mss4-like_sf,IPR028427:Met_Sox_Rdtase_MsrB,						KW-0496~Mitochondrion,			KW-0809~Transit peptide,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0560~Oxidoreductase,		ACT_SITE:Nucleophile,DOMAIN:MsrB,TRANSIT:Mitochondrion,
Q922D8	methylenetetrahydrofolate dehydrogenase (NADP+ dependent), methenyltetrahydrofolate cyclohydrolase, formyltetrahydrofolate synthase(Mthfd1)	Mus musculus			GO:0000105~histidine biosynthetic process,GO:0001780~neutrophil homeostasis,GO:0001843~neural tube closure,GO:0006164~purine nucleotide biosynthetic process,GO:0006555~methionine metabolic process,GO:0006730~one-carbon metabolic process,GO:0007507~heart development,GO:0008152~metabolic process,GO:0008652~cellular amino acid biosynthetic process,GO:0009069~serine family amino acid metabolic process,GO:0009070~serine family amino acid biosynthetic process,GO:0009086~methionine biosynthetic process,GO:0009152~purine ribonucleotide biosynthetic process,GO:0009257~10-formyltetrahydrofolate biosynthetic process,GO:0019346~transsulfuration,GO:0035999~tetrahydrofolate interconversion,GO:0061053~somite development,	GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005829~cytosol,	GO:0000166~nucleotide binding,GO:0003824~catalytic activity,GO:0004329~formate-tetrahydrofolate ligase activity,GO:0004477~methenyltetrahydrofolate cyclohydrolase activity,GO:0004486~methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity,GO:0004487~methylenetetrahydrofolate dehydrogenase (NAD+) activity,GO:0004488~methylenetetrahydrofolate dehydrogenase (NADP+) activity,GO:0005524~ATP binding,GO:0016491~oxidoreductase activity,GO:0016787~hydrolase activity,GO:0016874~ligase activity,	IPR000559:Formate_THF_ligase,IPR000672:THF_DH/CycHdrlase,IPR020628:Formate_THF_ligase_CS,IPR020630:THF_DH/CycHdrlase_cat_dom,IPR020631:THF_DH/CycHdrlase_NAD-bd_dom,IPR020867:THF_DH/CycHdrlase_CS,IPR027417:P-loop_NTPase,IPR036291:NAD(P)-bd_dom_sf,IPR046346:Aminoacid_DH-like_N_sf,	mmu00670:One carbon pool by folate,mmu01100:Metabolic pathways,mmu01240:Biosynthesis of cofactors,				KW-0028~Amino-acid biosynthesis,KW-0368~Histidine biosynthesis,KW-0486~Methionine biosynthesis,KW-0554~One-carbon metabolism,KW-0658~Purine biosynthesis,	KW-0963~Cytoplasm,				KW-0067~ATP-binding,KW-0521~NADP,KW-0547~Nucleotide-binding,	KW-0378~Hydrolase,KW-0436~Ligase,KW-0511~Multifunctional enzyme,KW-0560~Oxidoreductase,	KW-0007~Acetylation,KW-0597~Phosphoprotein,	DOMAIN:Tetrahydrofolate dehydrogenase/cyclohydrolase NAD(P)-binding,DOMAIN:Tetrahydrofolate dehydrogenase/cyclohydrolase catalytic,REGION:Formyltetrahydrofolate synthetase domain,REGION:Methylenetetrahydrofolate dehydrogenase and methenyltetrahydrofolate cyclohydrolase (D/C) domain,
A8KBL7	methyltransferase 2A, methylcytidine(mettl2a)	Danio rerio			GO:0008033~tRNA processing,GO:0030488~tRNA methylation,GO:0032259~methylation,	GO:0005737~cytoplasm,	GO:0008168~methyltransferase activity,GO:0008169~C-methyltransferase activity,GO:0008170~N-methyltransferase activity,GO:0008171~O-methyltransferase activity,GO:0008172~S-methyltransferase activity,GO:0008425~2-polyprenyl-6-methoxy-1,4-benzoquinone methyltransferase activity,GO:0016427~tRNA (cytosine) methyltransferase activity,GO:0016740~transferase activity,GO:0030792~methylarsonite methyltransferase activity,GO:0051994~P-methyltransferase activity,GO:0052735~tRNA (cytosine-3-)-methyltransferase activity,	IPR013217:Methyltransf_12,IPR026113:METTL2/6/8-like,IPR029063:SAM-dependent_MTases_sf,			PIRSF037755:Mettl2_prd,		KW-0819~tRNA processing,	KW-0963~Cytoplasm,				KW-0949~S-adenosyl-L-methionine,	KW-0489~Methyltransferase,KW-0808~Transferase,		REGION:Disordered,
P55002	microfibrillar-associated protein 2(Mfap2)	Mus musculus			GO:0030220~platelet formation,GO:0048048~embryonic eye morphogenesis,GO:0048050~post-embryonic eye morphogenesis,	GO:0001527~microfibril,GO:0005576~extracellular region,	GO:0001968~fibronectin binding,GO:0005201~extracellular matrix structural constituent,GO:0005515~protein binding,GO:0070051~fibrinogen binding,	IPR003582:ShKT_dom,IPR008673:MAGP,						KW-0272~Extracellular matrix,KW-0964~Secreted,			KW-0732~Signal,			KW-0325~Glycoprotein,KW-0765~Sulfation,KW-0873~Pyrrolidone carboxylic acid,KW-1015~Disulfide bond,	COMPBIAS:Polar residues,DOMAIN:ShKT,REGION:Disordered,SIGNAL:Or 18,
P27448	microtubule affinity regulating kinase 3(MARK3)	Homo sapiens			GO:0006468~protein phosphorylation,GO:0016310~phosphorylation,GO:0018105~peptidyl-serine phosphorylation,GO:0032092~positive regulation of protein binding,GO:0035331~negative regulation of hippo signaling,GO:0035556~intracellular signal transduction,GO:0036289~peptidyl-serine autophosphorylation,GO:1900181~negative regulation of protein localization to nucleus,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0030425~dendrite,GO:0070062~extracellular exosome,	GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0048156~tau protein binding,GO:0050321~tau-protein kinase activity,	IPR000719:Prot_kinase_dom,IPR001772:KA1_dom,IPR008271:Ser/Thr_kinase_AS,IPR011009:Kinase-like_dom_sf,IPR015940:UBA,IPR017441:Protein_kinase_ATP_BS,IPR028375:KA1/Ssp2_C,		618283~Visual impairment and progressive phthisis bulbi,		SM00165:UBA,SM00220:S_TKc,		KW-0472~Membrane,KW-0963~Cytoplasm,KW-0966~Cell projection,KW-1003~Cell membrane,		KW-0225~Disease variant,	KW-0732~Signal,	KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0418~Kinase,KW-0723~Serine/threonine-protein kinase,KW-0808~Transferase,	KW-0597~Phosphoprotein,	ACT_SITE:Proton acceptor,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:KA1,DOMAIN:Protein kinase,DOMAIN:UBA,MUTAGEN:T->A: Prevents phosphorylation and activation by STK11/LKB1 complex.,REGION:Disordered,
Q9CQ86	migration and invasion enhancer 1(Mien1)	Mus musculus			GO:0006915~apoptotic process,GO:0030335~positive regulation of cell migration,GO:0043066~negative regulation of apoptotic process,GO:0051491~positive regulation of filopodium assembly,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0009898~cytoplasmic side of plasma membrane,GO:0016020~membrane,	GO:0005515~protein binding,	IPR011893:Selenoprotein_Rdx-typ,IPR036249:Thioredoxin-like_sf,					KW-0053~Apoptosis,	KW-0472~Membrane,KW-0963~Cytoplasm,KW-1003~Cell membrane,			KW-0676~Redox-active center,			KW-0007~Acetylation,KW-0449~Lipoprotein,KW-0636~Prenylation,KW-1015~Disulfide bond,	DISULFID:Redox-active,LIPID:S-geranylgeranyl cysteine,MUTAGEN:C->S: No effect on interaction with GPX1.,PROPEP:Removed in mature form,
Q561P5	minichromosome maintenance complex component 5(mcm5)	Xenopus tropicalis			GO:0000727~double-strand break repair via break-induced replication,GO:0006260~DNA replication,GO:0006268~DNA unwinding involved in DNA replication,GO:0006270~DNA replication initiation,GO:0007049~cell cycle,GO:0030174~regulation of DNA-dependent DNA replication initiation,GO:0032508~DNA duplex unwinding,	GO:0000785~chromatin,GO:0005634~nucleus,GO:0005694~chromosome,GO:0042555~MCM complex,GO:0071162~CMG complex,	GO:0000166~nucleotide binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003688~DNA replication origin binding,GO:0003697~single-stranded DNA binding,GO:0004386~helicase activity,GO:0005524~ATP binding,GO:0016787~hydrolase activity,GO:0016887~ATPase activity,GO:0017116~single-stranded DNA-dependent ATP-dependent DNA helicase activity,GO:0043138~3'-5' DNA helicase activity,	IPR001208:MCM_dom,IPR008048:MCM5,IPR012340:NA-bd_OB-fold,IPR018525:MCM_CS,IPR027417:P-loop_NTPase,IPR027925:MCM_N,IPR031327:MCM,IPR033762:MCM_OB,IPR041562:MCM_lid,	xtr03030:DNA replication,xtr04110:Cell cycle,			SM00350:MCM,	KW-0131~Cell cycle,KW-0235~DNA replication,	KW-0158~Chromosome,KW-0539~Nucleus,				KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0238~DNA-binding,KW-0347~Helicase,KW-0378~Hydrolase,		DOMAIN:MCM,MOTIF:Arginine finger,
Q14566	minichromosome maintenance complex component 6(MCM6)	Homo sapiens		h_mcmPathway:CDK Regulation of DNA Replication,	GO:0000727~double-strand break repair via break-induced replication,GO:0006260~DNA replication,GO:0006268~DNA unwinding involved in DNA replication,GO:0006270~DNA replication initiation,GO:0007049~cell cycle,GO:0030174~regulation of DNA-dependent DNA replication initiation,GO:1902969~mitotic DNA replication,	GO:0000781~chromosome, telomeric region,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0042555~MCM complex,GO:0071162~CMG complex,	GO:0003677~DNA binding,GO:0003678~DNA helicase activity,GO:0003697~single-stranded DNA binding,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016887~ATPase activity,GO:0042802~identical protein binding,GO:1990518~single-stranded DNA-dependent ATP-dependent 3'-5' DNA helicase activity,	IPR001208:MCM_dom,IPR008049:MCM6,IPR012340:NA-bd_OB-fold,IPR018525:MCM_CS,IPR027417:P-loop_NTPase,IPR027925:MCM_N,IPR031327:MCM,IPR033762:MCM_OB,IPR041024:Mcm6_C,IPR041562:MCM_lid,	hsa03030:DNA replication,hsa04110:Cell cycle,	223100~Lactase persistence/nonpersistence,		SM00350:MCM,	KW-0131~Cell cycle,KW-0235~DNA replication,	KW-0158~Chromosome,KW-0539~Nucleus,		KW-0225~Disease variant,		KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0238~DNA-binding,KW-0347~Helicase,KW-0378~Hydrolase,	KW-0007~Acetylation,KW-0325~Glycoprotein,KW-0597~Phosphoprotein,	DOMAIN:MCM,MOTIF:Arginine finger,MUTAGEN:E->A,D: Impairs interaction with CTD1.,MUTAGEN:L->A: Impairs interaction with CTD1.,
Q99797	mitochondrial intermediate peptidase(MIPEP)	Homo sapiens			GO:0006518~peptide metabolic process,GO:0006627~protein processing involved in protein targeting to mitochondrion,	GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,	GO:0004222~metalloendopeptidase activity,GO:0046872~metal ion binding,	IPR001567:Pept_M3A_M3B_dom,IPR024077:Neurolysin/TOP_dom2,IPR024079:MetalloPept_cat_dom_sf,IPR033851:M3A_MIP,IPR045090:Pept_M3A_M3B,		617228~Combined oxidative phosphorylation deficiency 31,				KW-0496~Mitochondrion,		KW-0225~Disease variant,KW-1274~Primary mitochondrial disease,	KW-0809~Transit peptide,	KW-0106~Calcium,KW-0170~Cobalt,KW-0408~Iron,KW-0460~Magnesium,KW-0464~Manganese,KW-0479~Metal-binding,KW-0862~Zinc,	KW-0378~Hydrolase,KW-0482~Metalloprotease,KW-0645~Protease,	KW-0007~Acetylation,	TRANSIT:Mitochondrion,
Q6PBK1	mitochondrial matrix import factor 23(mix23)	Danio rerio				GO:0005739~mitochondrion,GO:0005758~mitochondrial intermembrane space,		IPR019171:MIX23,									KW-0175~Coiled coil,
Q503X2	mitochondrial ribosomal protein L4(mrpl4)	Danio rerio			GO:0006412~translation,	GO:0005739~mitochondrion,GO:0005762~mitochondrial large ribosomal subunit,GO:0005840~ribosome,GO:1990904~ribonucleoprotein complex,	GO:0003735~structural constituent of ribosome,	IPR002136:Ribosomal_uL4,IPR013005:Ribosomal_uL4-like,IPR023574:Ribosomal_uL4_dom_sf,	dre03010:Ribosome,					KW-0496~Mitochondrion,					KW-0687~Ribonucleoprotein,KW-0689~Ribosomal protein,
Q9NVS2	mitochondrial ribosomal protein S18A(MRPS18A)	Homo sapiens			GO:0006412~translation,GO:0032543~mitochondrial translation,	GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0005762~mitochondrial large ribosomal subunit,GO:0005763~mitochondrial small ribosomal subunit,GO:0005840~ribosome,GO:1990904~ribonucleoprotein complex,	GO:0003735~structural constituent of ribosome,GO:0070181~small ribosomal subunit rRNA binding,	IPR001648:Ribosomal_bS18,IPR036870:Ribosomal_bS18_sf,	hsa03010:Ribosome,					KW-0496~Mitochondrion,			KW-0809~Transit peptide,		KW-0687~Ribonucleoprotein,KW-0689~Ribosomal protein,		REGION:Disordered,TRANSIT:Mitochondrion,
Q7Z6M4	mitochondrial transcription termination factor 4(MTERF4)	Homo sapiens			GO:0006355~regulation of transcription, DNA-templated,GO:0006364~rRNA processing,GO:0006390~transcription from mitochondrial promoter,GO:0006626~protein targeting to mitochondrion,GO:0007507~heart development,GO:0043010~camera-type eye development,GO:0061668~mitochondrial ribosome assembly,	GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,GO:0005762~mitochondrial large ribosomal subunit,GO:0005829~cytosol,	GO:0003690~double-stranded DNA binding,GO:0005515~protein binding,GO:0019843~rRNA binding,	IPR003690:MTERF,IPR016024:ARM-type_fold,IPR038538:MTERF_sf,				SM00733:Mterf,	KW-0698~rRNA processing,	KW-0496~Mitochondrion,			KW-0677~Repeat,KW-0809~Transit peptide,		KW-0694~RNA-binding,		COMPBIAS:Acidic residues,COMPBIAS:Basic and acidic residues,REGION:Dimerization with NSUN4,REGION:Disordered,REPEAT:MTERF 1,REPEAT:MTERF 2,REPEAT:MTERF 3,REPEAT:MTERF 4,REPEAT:MTERF 5,TRANSIT:Mitochondrion,
Q13257	mitotic arrest deficient 2 like 1(MAD2L1)	Homo sapiens			GO:0000070~mitotic sister chromatid segregation,GO:0000132~establishment of mitotic spindle orientation,GO:0007094~mitotic spindle assembly checkpoint,GO:0042177~negative regulation of protein catabolic process,GO:0043066~negative regulation of apoptotic process,GO:0045930~negative regulation of mitotic cell cycle,GO:0051301~cell division,GO:0051660~establishment of centrosome localization,GO:0090267~positive regulation of mitotic cell cycle spindle assembly checkpoint,GO:1904667~negative regulation of ubiquitin protein ligase activity,	GO:0000776~kinetochore,GO:0000922~spindle pole,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0033597~mitotic checkpoint complex,GO:0044615~nuclear pore nuclear basket,GO:0048471~perinuclear region of cytoplasm,GO:0072686~mitotic spindle,GO:1990728~mitotic spindle assembly checkpoint MAD1-MAD2 complex,	GO:0005515~protein binding,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,	IPR003511:HORMA_dom,IPR036570:HORMA_dom_sf,IPR045091:Mad2-like,	hsa04110:Cell cycle,hsa04114:Oocyte meiosis,hsa04914:Progesterone-mediated oocyte maturation,hsa05166:Human T-cell leukemia virus 1 infection,				KW-0131~Cell cycle,KW-0132~Cell division,KW-0498~Mitosis,	KW-0137~Centromere,KW-0158~Chromosome,KW-0206~Cytoskeleton,KW-0539~Nucleus,KW-0963~Cytoplasm,KW-0995~Kinetochore,						KW-0007~Acetylation,KW-0597~Phosphoprotein,	DOMAIN:HORMA,MUTAGEN:F->A: Prevents formation of the closed conformation and interaction with CDC20; when associated with A-133.,MUTAGEN:H->A: Prevents formation of the closed conformation and interaction with CDC20; when associated with A-133.,MUTAGEN:L->A: Leads to formation of the closed conformation; when associated with A-133.,MUTAGEN:L->A: Leads to formation the closed conformation and homodimerization. Reduces binding to MAD1L1.,MUTAGEN:R->A: Prevents aggregation and promotes formation of monomeric protein that slowly interconverts between the open and closed conformation.,MUTAGEN:S->A: Abolishes phosphorylation on serine residues; when associated with A-170 and A-178.,MUTAGEN:S->A: Reduces phosphorylation on serine residues; when associated with A-170. Abolishes phosphorylation on serine residues; when associated with A-170 and A-195.,MUTAGEN:S->A: Reduces phosphorylation on serine residues; when associated with A-178. Abolishes phosphorylation on serine residues; when associated with A-178 and A-195.,MUTAGEN:S->D: Abolishes interaction with MAD1L1 and reduces interaction with CDC20; when associated with D-170 and D-195.,MUTAGEN:S->D: Abolishes interaction with MAD1L1 and reduces interaction with CDC20; when associated with D-178 and D-195.,MUTAGEN:S->D: Binds to the N and C-terminus of MAD1L1. Abolishes interaction with MAD1L1 and reduces interaction with CDC20; when associated with D-170 and D-178.,MUTAGEN:T->A: Prevents formation of the closed conformation and interaction with CDC20; when associated with A-133.,MUTAGEN:V->A: Prevents formation of the closed conformation and interaction with CDC20; when associated with A-133.,MUTAGEN:W->A: Prevents interaction with CDC20 and leads to formation of the closed conformation; when associated with A-133.,MUTAGEN:Y->A: Leads to formation of the closed conformation; when associated with A-133.,MUTAGEN:Y->A: Prevents formation of the closed conformation and interaction with CDC20; when associated with A-133.,REGION:Required for assuming the closed conformation and for interaction with CDC20,
Q96DH6	musashi RNA binding protein 2(MSI2)	Homo sapiens			GO:0006417~regulation of translation,GO:0007417~central nervous system development,GO:0048864~stem cell development,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005844~polysome,GO:0043231~intracellular membrane-bounded organelle,	GO:0003723~RNA binding,GO:0003729~mRNA binding,GO:0005515~protein binding,GO:0008266~poly(U) RNA binding,GO:0042802~identical protein binding,	IPR000504:RRM_dom,IPR012677:Nucleotide-bd_a/b_plait_sf,IPR034126:MSI_RRM2,IPR035979:RBD_domain_sf,	hsa03015:mRNA surveillance pathway,			SM00360:RRM,		KW-0963~Cytoplasm,			KW-0677~Repeat,		KW-0694~RNA-binding,	KW-0007~Acetylation,KW-0488~Methylation,KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:RRM,DOMAIN:RRM 1,DOMAIN:RRM 2,REGION:Disordered,SITE:Breakpoint for translocation to form MSI2/HOXA9 fusion protein,
P43247	mutS homolog 2(Msh2)	Mus musculus			GO:0001701~in utero embryonic development,GO:0002204~somatic recombination of immunoglobulin genes involved in immune response,GO:0006119~oxidative phosphorylation,GO:0006281~DNA repair,GO:0006298~mismatch repair,GO:0006301~postreplication repair,GO:0006302~double-strand break repair,GO:0006312~mitotic recombination,GO:0006974~cellular response to DNA damage stimulus,GO:0007049~cell cycle,GO:0007281~germ cell development,GO:0008340~determination of adult lifespan,GO:0008584~male gonad development,GO:0008630~intrinsic apoptotic signaling pathway in response to DNA damage,GO:0010165~response to X-ray,GO:0010224~response to UV-B,GO:0016446~somatic hypermutation of immunoglobulin genes,GO:0016447~somatic recombination of immunoglobulin gene segments,GO:0019724~B cell mediated immunity,GO:0030183~B cell differentiation,GO:0031573~intra-S DNA damage checkpoint,GO:0042771~intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,GO:0043524~negative regulation of neuron apoptotic process,GO:0043570~maintenance of DNA repeat elements,GO:0045190~isotype switching,GO:0045910~negative regulation of DNA recombination,GO:0048298~positive regulation of isotype switching to IgA isotypes,GO:0048304~positive regulation of isotype switching to IgG isotypes,GO:0051096~positive regulation of helicase activity,GO:0051726~regulation of cell cycle,GO:0071168~protein localization to chromatin,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0032301~MutSalpha complex,GO:0032302~MutSbeta complex,	GO:0000166~nucleotide binding,GO:0000287~magnesium ion binding,GO:0000400~four-way junction DNA binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003684~damaged DNA binding,GO:0003690~double-stranded DNA binding,GO:0003697~single-stranded DNA binding,GO:0005524~ATP binding,GO:0008094~DNA-dependent ATPase activity,GO:0016887~ATPase activity,GO:0019237~centromeric DNA binding,GO:0030983~mismatched DNA binding,GO:0032137~guanine/thymine mispair binding,GO:0032139~dinucleotide insertion or deletion binding,GO:0032142~single guanine insertion binding,GO:0032143~single thymine insertion binding,GO:0032181~dinucleotide repeat insertion binding,GO:0032357~oxidized purine DNA binding,GO:0032405~MutLalpha complex binding,GO:0042803~protein homodimerization activity,GO:0043531~ADP binding,	IPR000432:DNA_mismatch_repair_MutS_C,IPR007695:DNA_mismatch_repair_MutS-lik_N,IPR007696:DNA_mismatch_repair_MutS_core,IPR007860:DNA_mmatch_repair_MutS_con_dom,IPR007861:DNA_mismatch_repair_MutS_clamp,IPR011184:DNA_mismatch_repair_Msh2,IPR016151:DNA_mismatch_repair_MutS_N,IPR027417:P-loop_NTPase,IPR032642:Msh2_ATP-bd,IPR036187:DNA_mismatch_repair_MutS_sf,IPR036678:MutS_con_dom_sf,IPR045076:MutS_family,	mmu01524:Platinum drug resistance,mmu03430:Mismatch repair,mmu05200:Pathways in cancer,mmu05210:Colorectal cancer,		PIRSF005813:MSH2,	SM00533:MUTSd,SM00534:MUTSac,	KW-0131~Cell cycle,KW-0227~DNA damage,KW-0234~DNA repair,	KW-0158~Chromosome,KW-0539~Nucleus,				KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0238~DNA-binding,	KW-0007~Acetylation,KW-0597~Phosphoprotein,	DOMAIN:DNA mismatch repair protein MutS connector,DOMAIN:DNA mismatch repair protein MutS-like N-terminal,DOMAIN:DNA mismatch repair proteins mutS family,REGION:Interaction with EXO1,
E1BYJ2	mutS homolog 6(MSH6)	Gallus gallus			GO:0006298~mismatch repair,GO:0007095~mitotic G2 DNA damage checkpoint,GO:0030890~positive regulation of B cell proliferation,GO:0032876~negative regulation of DNA endoreduplication,	GO:0005634~nucleus,GO:0032301~MutSalpha complex,	GO:0005524~ATP binding,GO:0030983~mismatched DNA binding,	IPR000313:PWWP_dom,IPR000432:DNA_mismatch_repair_MutS_C,IPR007695:DNA_mismatch_repair_MutS-lik_N,IPR007696:DNA_mismatch_repair_MutS_core,IPR007860:DNA_mmatch_repair_MutS_con_dom,IPR007861:DNA_mismatch_repair_MutS_clamp,IPR016151:DNA_mismatch_repair_MutS_N,IPR017261:DNA_mismatch_repair_MutS/MSH,IPR027417:P-loop_NTPase,IPR036187:DNA_mismatch_repair_MutS_sf,IPR036678:MutS_con_dom_sf,IPR045076:MutS_family,	gga03430:Mismatch repair,		PIRSF037677:DNA_mis_repair_Msh6,	SM00293:PWWP,SM00533:MUTSd,SM00534:MUTSac,	KW-0227~DNA damage,KW-0234~DNA repair,	KW-0539~Nucleus,			KW-0175~Coiled coil,	KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0238~DNA-binding,		COMPBIAS:Acidic residues,COMPBIAS:Basic and acidic residues,DOMAIN:DNA mismatch repair proteins mutS family,DOMAIN:PWWP,REGION:Disordered,
P17920	myogenin(MYOG)	Gallus gallus			GO:0006355~regulation of transcription, DNA-templated,GO:0007517~muscle organ development,GO:0008285~negative regulation of cell proliferation,GO:0009408~response to heat,GO:0010831~positive regulation of myotube differentiation,GO:0014737~positive regulation of muscle atrophy,GO:0014842~regulation of skeletal muscle satellite cell proliferation,GO:0014873~response to muscle activity involved in regulation of muscle adaptation,GO:0014878~response to electrical stimulus involved in regulation of muscle adaptation,GO:0014891~striated muscle atrophy,GO:0014894~response to denervation involved in regulation of muscle adaptation,GO:0030154~cell differentiation,GO:0035914~skeletal muscle cell differentiation,GO:0042693~muscle cell fate commitment,GO:0045445~myoblast differentiation,GO:0045663~positive regulation of myoblast differentiation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048743~positive regulation of skeletal muscle fiber development,GO:0051726~regulation of cell cycle,GO:0060290~transdifferentiation,GO:0071392~cellular response to estradiol stimulus,GO:1901739~regulation of myoblast fusion,	GO:0005634~nucleus,GO:0005667~transcription factor complex,GO:0032993~protein-DNA complex,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0001216~bacterial-type RNA polymerase transcriptional activator activity, sequence-specific DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0042802~identical protein binding,GO:0043425~bHLH transcription factor binding,GO:0046983~protein dimerization activity,GO:0070888~E-box binding,	IPR002546:MyoD_N,IPR011598:bHLH_dom,IPR036638:HLH_DNA-bd_sf,IPR039704:Myogenic_factor,				SM00353:HLH,SM00520:BASIC,	KW-0221~Differentiation,KW-0517~Myogenesis,KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,					KW-0010~Activator,KW-0217~Developmental protein,KW-0238~DNA-binding,KW-9996~Developmental protein,		COMPBIAS:Polar residues,DOMAIN:BHLH,DOMAIN:bHLH,REGION:Disordered,
Q5RBA4	myosin light chain 9(MYL9)	Pongo abelii			GO:0030239~myofibril assembly,GO:0070527~platelet aggregation,	GO:0001725~stress fiber,GO:0005737~cytoplasm,GO:0005938~cell cortex,GO:0016459~myosin complex,GO:0016460~myosin II complex,GO:0030016~myofibril,GO:0030018~Z disc,	GO:0005509~calcium ion binding,GO:0032036~myosin heavy chain binding,	IPR002048:EF_hand_dom,IPR011992:EF-hand-dom_pair,IPR018247:EF_Hand_1_Ca_BS,	pon04022:cGMP-PKG signaling pathway,pon04024:cAMP signaling pathway,pon04270:Vascular smooth muscle contraction,pon04360:Axon guidance,pon04510:Focal adhesion,pon04520:Adherens junction,pon04530:Tight junction,pon04670:Leukocyte transendothelial migration,pon04810:Regulation of actin cytoskeleton,pon04814:Motor proteins,pon04921:Oxytocin signaling pathway,pon05132:Salmonella infection,			SM00054:EFh,		KW-0206~Cytoskeleton,KW-0963~Cytoplasm,			KW-0677~Repeat,	KW-0106~Calcium,KW-0479~Metal-binding,	KW-0505~Motor protein,KW-0514~Muscle protein,KW-0518~Myosin,	KW-0007~Acetylation,KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,DOMAIN:EF-hand,DOMAIN:EF-hand 1,DOMAIN:EF-hand 2,DOMAIN:EF-hand 3,REGION:Disordered,
Q6AXL3	negative regulator of reactive oxygen species(nrros)	Danio rerio			GO:0006954~inflammatory response,GO:0006955~immune response,GO:0007179~transforming growth factor beta receptor signaling pathway,GO:0014005~microglia development,GO:0035583~sequestering of TGFbeta in extracellular matrix,GO:0036364~transforming growth factor beta1 activation,	GO:0005615~extracellular space,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005886~plasma membrane,GO:0009986~cell surface,GO:0016020~membrane,GO:0031012~extracellular matrix,	GO:0019838~growth factor binding,	IPR001611:Leu-rich_rpt,IPR003591:Leu-rich_rpt_typical-subtyp,IPR026906:LRR_5,IPR032675:LRR_dom_sf,	dre04350:TGF-beta signaling pathway,			SM00364:LRR_BAC,SM00369:LRR_TYP,		KW-0256~Endoplasmic reticulum,KW-0472~Membrane,KW-1003~Cell membrane,			KW-0433~Leucine-rich repeat,KW-0677~Repeat,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0340~Growth factor binding,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DISULFID:Interchain (with C-? in TGFB1); in linked form,DOMAIN:LRRCT,DOMAIN:LRRNT,REPEAT:LRR 1,REPEAT:LRR 10,REPEAT:LRR 11,REPEAT:LRR 12,REPEAT:LRR 13,REPEAT:LRR 14,REPEAT:LRR 15,REPEAT:LRR 16,REPEAT:LRR 17,REPEAT:LRR 18,REPEAT:LRR 19,REPEAT:LRR 2,REPEAT:LRR 20,REPEAT:LRR 3,REPEAT:LRR 4,REPEAT:LRR 5,REPEAT:LRR 6,REPEAT:LRR 7,REPEAT:LRR 8,REPEAT:LRR 9,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q8K4Q6	nei endonuclease VIII-like 1 (E. coli)(Neil1)	Mus musculus			GO:0006281~DNA repair,GO:0006284~base-excision repair,GO:0006974~cellular response to DNA damage stimulus,GO:0006979~response to oxidative stress,GO:0008152~metabolic process,GO:0032074~negative regulation of nuclease activity,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005856~cytoskeleton,	GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003684~damaged DNA binding,GO:0003824~catalytic activity,GO:0003906~DNA-(apurinic or apyrimidinic site) lyase activity,GO:0008270~zinc ion binding,GO:0016787~hydrolase activity,GO:0016798~hydrolase activity, acting on glycosyl bonds,GO:0016799~hydrolase activity, hydrolyzing N-glycosyl compounds,GO:0016829~lyase activity,GO:0019104~DNA N-glycosylase activity,	IPR010979:Ribosomal_uS13-like_H2TH,IPR012319:FPG_cat,IPR015371:Endonuclease-VIII_DNA-bd,IPR015886:DNA_glyclase/AP_lyase_DNA-bd,IPR035937:MutM-like_N-ter,	mmu03410:Base excision repair,			SM00898:Fapy_DNA_glyco,SM01232:H2TH,	KW-0227~DNA damage,KW-0234~DNA repair,	KW-0158~Chromosome,KW-0206~Cytoskeleton,KW-0539~Nucleus,KW-0963~Cytoplasm,					KW-0238~DNA-binding,KW-0326~Glycosidase,KW-0378~Hydrolase,KW-0456~Lyase,KW-0511~Multifunctional enzyme,		ACT_SITE:Proton donor,ACT_SITE:Proton donor; for beta-elimination activity,ACT_SITE:Schiff-base intermediate with DNA,COMPBIAS:Basic and acidic residues,DOMAIN:DNA glycosylase/AP lyase H2TH DNA-binding,REGION:Disordered,
Q14511	neural precursor cell expressed, developmentally down-regulated 9(NEDD9)	Homo sapiens			GO:0007010~cytoskeleton organization,GO:0007049~cell cycle,GO:0007155~cell adhesion,GO:0007165~signal transduction,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0007229~integrin-mediated signaling pathway,GO:0007611~learning or memory,GO:0016477~cell migration,GO:0030335~positive regulation of cell migration,GO:0030336~negative regulation of cell migration,GO:0032956~regulation of actin cytoskeleton organization,GO:0045672~positive regulation of osteoclast differentiation,GO:0051017~actin filament bundle assembly,GO:0051301~cell division,GO:0061098~positive regulation of protein tyrosine kinase activity,GO:0061523~cilium disassembly,GO:0097021~lymphocyte migration into lymphoid organs,GO:1900026~positive regulation of substrate adhesion-dependent cell spreading,GO:1902952~positive regulation of dendritic spine maintenance,GO:1903829~positive regulation of cellular protein localization,GO:2000522~positive regulation of immunological synapse formation,	GO:0000922~spindle pole,GO:0001772~immunological synapse,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0005819~spindle,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005925~focal adhesion,GO:0005938~cell cortex,GO:0016323~basolateral plasma membrane,GO:0030027~lamellipodium,GO:0036064~ciliary basal body,GO:0072686~mitotic spindle,	GO:0005515~protein binding,GO:1990782~protein tyrosine kinase binding,	IPR001452:SH3_domain,IPR014928:Serine_rich_dom,IPR021901:CAS_C,IPR035746:NEDD9_SH3,IPR036028:SH3-like_dom_sf,IPR037362:CAS_fam,IPR038319:Serine_rich_sf,				SM00326:SH3,	KW-0130~Cell adhesion,KW-0131~Cell cycle,KW-0132~Cell division,KW-0341~Growth regulation,KW-0498~Mitosis,	KW-0206~Cytoskeleton,KW-0333~Golgi apparatus,KW-0472~Membrane,KW-0539~Nucleus,KW-0963~Cytoplasm,KW-0965~Cell junction,KW-0966~Cell projection,KW-1003~Cell membrane,			KW-0728~SH3 domain,			KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,	COMPBIAS:Polar residues,DOMAIN:CAS family C-terminal,DOMAIN:SH3,DOMAIN:Serine rich protein interaction,MOTIF:Caspase cleavage related site,MUTAGEN:C->A: Abolishes the oxidation-mediated reduction in interaction with SMAD3.,MUTAGEN:F->D: No effect on interaction with BCAR3.,MUTAGEN:H->D: No effect on interaction with BCAR3.,MUTAGEN:L->D: Abolishes interaction with BCAR3.,MUTAGEN:M->D: No effect on interaction with BCAR3.,MUTAGEN:S->A: No effect on interaction with PLK1.,MUTAGEN:S->A: Reduces interaction with PLK1. Reduces protein phosphorylation by CSNK1D; when associated with A-804.,MUTAGEN:S->D: Reduces interaction with PLK1. Abolishes interaction with PLK1; when associated with D-804.,MUTAGEN:S->E: Abolishes interaction with PLK1.,MUTAGEN:T->A: Reduces interaction with PLK1. Reduces protein phosphorylation by CSNK1D; when associated with A-780.,MUTAGEN:T->D: Reduces interaction with PLK1. Abolishes interaction with PLK1; when associated with D-780.,MUTAGEN:T->E: No effect on interaction with PLK1.,REGION:Disordered,REGION:Divergent helix-loop-helix motif,REGION:Interacts strongly with spindle-regulatory protein D1M1,REGION:Interacts with CTTN,REGION:Required for interaction with ITCH,REGION:Required for interaction with PLK1,
A1XQX0	neurexin 1a(nrxn1a)	Danio rerio			GO:0002040~sprouting angiogenesis,GO:0007155~cell adhesion,GO:0048856~anatomical structure development,	GO:0016020~membrane,	GO:0046872~metal ion binding,	IPR000742:EGF-like_dom,IPR001791:Laminin_G,IPR003585:Neurexin-like,IPR013320:ConA-like_dom_sf,IPR027789:Syndecan/Neurexin_dom,	dre04514:Cell adhesion molecules,			SM00181:EGF,SM00282:LamG,SM00294:4.1m,	KW-0130~Cell adhesion,	KW-0472~Membrane,			KW-0245~EGF-like domain,KW-0677~Repeat,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0106~Calcium,KW-0479~Metal-binding,		KW-1015~Disulfide bond,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:EGF-like,DOMAIN:EGF-like 1,DOMAIN:EGF-like 2,DOMAIN:EGF-like 3,DOMAIN:Laminin G,DOMAIN:Laminin G-like,DOMAIN:Laminin G-like 1,DOMAIN:Laminin G-like 2,DOMAIN:Laminin G-like 3,DOMAIN:Laminin G-like 4,DOMAIN:Laminin G-like 5,DOMAIN:Laminin G-like 6,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
P62168	neuronal calcium sensor 1(Ncs1)	Rattus norvegicus			GO:0010975~regulation of neuron projection development,GO:0045921~positive regulation of exocytosis,GO:0050850~positive regulation of calcium-mediated signaling,GO:0070588~calcium ion transmembrane transport,GO:0099509~regulation of presynaptic cytosolic calcium ion concentration,GO:2000300~regulation of synaptic vesicle exocytosis,	GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0014069~postsynaptic density,GO:0030424~axon,GO:0030425~dendrite,GO:0031045~dense core granule,GO:0043231~intracellular membrane-bounded organelle,GO:0044305~calyx of Held,GO:0048471~perinuclear region of cytoplasm,GO:0098794~postsynapse,GO:0098978~glutamatergic synapse,GO:0099523~presynaptic cytosol,GO:0099524~postsynaptic cytosol,	GO:0000287~magnesium ion binding,GO:0005245~voltage-gated calcium channel activity,GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0008048~calcium sensitive guanylate cyclase activator activity,GO:0008427~calcium-dependent protein kinase inhibitor activity,GO:0019901~protein kinase binding,	IPR002048:EF_hand_dom,IPR011992:EF-hand-dom_pair,IPR018247:EF_Hand_1_Ca_BS,IPR028846:Recoverin,				SM00054:EFh,		KW-0333~Golgi apparatus,KW-0472~Membrane,KW-0770~Synapse,KW-0963~Cytoplasm,KW-1003~Cell membrane,			KW-0677~Repeat,	KW-0106~Calcium,KW-0479~Metal-binding,		KW-0449~Lipoprotein,KW-0519~Myristate,	DOMAIN:EF-hand,DOMAIN:EF-hand 1,DOMAIN:EF-hand 2,DOMAIN:EF-hand 3,DOMAIN:EF-hand 4,LIPID:N-myristoyl glycine,MUTAGEN:D->A: Loss of magnesium-binding; when associated with A-73, Q-84 and Q-120.,MUTAGEN:D->A: Loss of magnesium-binding; when associated with Q-84, A-109 and Q-120.,MUTAGEN:E->Q: Loss of magnesium-binding; when associated with A-73, A-109 and Q-120.,MUTAGEN:E->Q: Loss of magnesium-binding; when associated with A-73, Q-84 and A-109.,REGION:Ancestral calcium site 1,REGION:Interaction with IL1RAPL1,
Q6NZ07	nicalin(ncln)	Danio rerio			GO:0003140~determination of left/right asymmetry in lateral mesoderm,GO:0009966~regulation of signal transduction,GO:0048484~enteric nervous system development,GO:1900108~negative regulation of nodal signaling pathway,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0016020~membrane,	GO:0043022~ribosome binding,	IPR007484:Peptidase_M28,IPR016574:Nicalin,			PIRSF011018:Nicalin,			KW-0256~Endoplasmic reticulum,KW-0472~Membrane,			KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0217~Developmental protein,KW-9996~Developmental protein,	KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Peptidase M28,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q6P3H4	nicotinate phosphoribosyltransferase(naprt)	Danio rerio			GO:0006979~response to oxidative stress,GO:0009435~NAD biosynthetic process,GO:0019363~pyridine nucleotide biosynthetic process,GO:0034355~NAD salvage,	GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0004516~nicotinate phosphoribosyltransferase activity,GO:0016740~transferase activity,GO:0016757~transferase activity, transferring glycosyl groups,GO:0016874~ligase activity,GO:0046872~metal ion binding,	IPR006405:Nic_PRibTrfase_pncB,IPR007229:Nic_PRibTrfase-Fam,IPR013785:Aldolase_TIM,IPR036068:Nicotinate_pribotase-like_C,IPR040727:NAPRTase_N,IPR041619:NAPRTase_C,	dre00760:Nicotinate and nicotinamide metabolism,dre01100:Metabolic pathways,dre01240:Biosynthesis of cofactors,		PIRSF000484:NAPRT,		KW-0662~Pyridine nucleotide biosynthesis,	KW-0963~Cytoplasm,				KW-0460~Magnesium,KW-0464~Manganese,KW-0479~Metal-binding,	KW-0328~Glycosyltransferase,KW-0436~Ligase,KW-0808~Transferase,	KW-0597~Phosphoprotein,	DOMAIN:Nicotinate phosphoribosyltransferase C-terminal,DOMAIN:Nicotinate phosphoribosyltransferase N-terminal,
O75052	nitric oxide synthase 1 adaptor protein(NOS1AP)	Homo sapiens			GO:0003062~regulation of heart rate by chemical signal,GO:0010628~positive regulation of gene expression,GO:0010750~positive regulation of nitric oxide mediated signal transduction,GO:0045428~regulation of nitric oxide biosynthetic process,GO:0045429~positive regulation of nitric oxide biosynthetic process,GO:0050999~regulation of nitric-oxide synthase activity,GO:0051000~positive regulation of nitric-oxide synthase activity,GO:0060307~regulation of ventricular cardiac muscle cell membrane repolarization,GO:0098901~regulation of cardiac muscle cell action potential,GO:0098974~postsynaptic actin cytoskeleton organization,GO:1901381~positive regulation of potassium ion transmembrane transport,GO:1901841~regulation of high voltage-gated calcium channel activity,GO:1902261~positive regulation of delayed rectifier potassium channel activity,GO:1902514~regulation of calcium ion transmembrane transport via high voltage-gated calcium channel,GO:1903762~positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization,GO:2000170~positive regulation of peptidyl-cysteine S-nitrosylation,	GO:0002102~podosome,GO:0005634~nucleus,GO:0005739~mitochondrion,GO:0005829~cytosol,GO:0005901~caveola,GO:0030018~Z disc,GO:0030175~filopodium,GO:0030315~T-tubule,GO:0031965~nuclear membrane,GO:0033017~sarcoplasmic reticulum membrane,GO:0042383~sarcolemma,GO:0048471~perinuclear region of cytoplasm,GO:0070161~anchoring junction,GO:0098978~glutamatergic synapse,	GO:0005515~protein binding,GO:0035591~signaling adaptor activity,GO:0050998~nitric-oxide synthase binding,	IPR006020:PTB/PI_dom,IPR011993:PH-like_dom_sf,	hsa04713:Circadian entrainment,	619155~Nephrotic syndrome, type 22,		SM00462:PTB,		KW-0965~Cell junction,KW-0966~Cell projection,		KW-0225~Disease variant,	KW-0175~Coiled coil,			KW-0597~Phosphoprotein,	COMPBIAS:Polar residues,DOMAIN:PID,MOTIF:PDZ-binding,REGION:Disordered,REGION:Interaction with NOS1,
Q6GN08	non-SMC condensin II complex subunit D3 L homeolog(ncapd3.L)	Xenopus laevis			GO:0007049~cell cycle,GO:0007076~mitotic chromosome condensation,GO:0010032~meiotic chromosome condensation,GO:0030261~chromosome condensation,GO:0051301~cell division,	GO:0000779~condensed chromosome, centromeric region,GO:0000796~condensin complex,GO:0005634~nucleus,	GO:0005515~protein binding,	IPR011989:ARM-like,IPR012371:NCAPD3,IPR016024:ARM-type_fold,IPR026971:CND1/NCAPD3,IPR032682:Cnd1_C,			PIRSF036508:Condns_HCP-6,		KW-0131~Cell cycle,KW-0132~Cell division,KW-0226~DNA condensation,KW-0498~Mitosis,	KW-0539~Nucleus,			KW-0677~Repeat,				COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:Condensin complex subunit 1 C-terminal,REGION:Disordered,REPEAT:HEAT 1,REPEAT:HEAT 2,REPEAT:HEAT 3,
Q2TAW0	non-SMC condensin II complex subunit G2 L homeolog(ncapg2.L)	Xenopus laevis			GO:0007049~cell cycle,GO:0030261~chromosome condensation,GO:0051301~cell division,	GO:0005634~nucleus,		IPR011989:ARM-like,IPR016024:ARM-type_fold,IPR024741:Condensin2_G2,					KW-0131~Cell cycle,KW-0132~Cell division,KW-0226~DNA condensation,KW-0498~Mitosis,	KW-0539~Nucleus,							COMPBIAS:Acidic residues,REGION:Disordered,REPEAT:HEAT,
Q5RH01	non-SMC condensin II complex, subunit H2(ncaph2)	Danio rerio			GO:0010032~meiotic chromosome condensation,GO:0030261~chromosome condensation,GO:0051306~mitotic sister chromatid separation,	GO:0000796~condensin complex,GO:0005634~nucleus,	GO:0003682~chromatin binding,	IPR009378:H2_N,IPR031737:CNDH2_C,IPR031739:Ncaph2,					KW-0226~DNA condensation,	KW-0539~Nucleus,							REGION:Disordered,
Q04721	notch 2 N-terminal like B(NOTCH2NLB)	Homo sapiens			GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001701~in utero embryonic development,GO:0001709~cell fate determination,GO:0001947~heart looping,GO:0002011~morphogenesis of an epithelial sheet,GO:0002315~marginal zone B cell differentiation,GO:0002437~inflammatory response to antigenic stimulus,GO:0003162~atrioventricular node development,GO:0003184~pulmonary valve morphogenesis,GO:0006915~apoptotic process,GO:0006959~humoral immune response,GO:0007219~Notch signaling pathway,GO:0007399~nervous system development,GO:0007411~axon guidance,GO:0009887~animal organ morphogenesis,GO:0010629~negative regulation of gene expression,GO:0010838~positive regulation of keratinocyte proliferation,GO:0021987~cerebral cortex development,GO:0030097~hemopoiesis,GO:0030326~embryonic limb morphogenesis,GO:0030509~BMP signaling pathway,GO:0030513~positive regulation of BMP signaling pathway,GO:0035264~multicellular organism growth,GO:0035556~intracellular signal transduction,GO:0035622~intrahepatic bile duct development,GO:0042060~wound healing,GO:0042742~defense response to bacterium,GO:0043011~myeloid dendritic cell differentiation,GO:0043065~positive regulation of apoptotic process,GO:0043066~negative regulation of apoptotic process,GO:0045672~positive regulation of osteoclast differentiation,GO:0045747~positive regulation of Notch signaling pathway,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046579~positive regulation of Ras protein signal transduction,GO:0046849~bone remodeling,GO:0051152~positive regulation of smooth muscle cell differentiation,GO:0060413~atrial septum morphogenesis,GO:0060674~placenta blood vessel development,GO:0061073~ciliary body morphogenesis,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0070986~left/right axis specification,GO:0071228~cellular response to tumor cell,GO:0072014~proximal tubule development,GO:0072015~glomerular visceral epithelial cell development,GO:0072104~glomerular capillary formation,GO:0072574~hepatocyte proliferation,GO:1902895~positive regulation of pri-miRNA transcription from RNA polymerase II promoter,GO:1990705~cholangiocyte proliferation,GO:2001204~regulation of osteoclast development,	GO:0000139~Golgi membrane,GO:0005576~extracellular region,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005789~endoplasmic reticulum membrane,GO:0005886~plasma membrane,GO:0005929~cilium,GO:0009986~cell surface,GO:0016020~membrane,GO:0043235~receptor complex,	GO:0000987~core promoter proximal region sequence-specific DNA binding,GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0005112~Notch binding,GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0019899~enzyme binding,GO:0038023~signaling receptor activity,GO:0051059~NF-kappaB binding,	IPR000152:EGF-type_Asp/Asn_hydroxyl_site,IPR000742:EGF-like_dom,IPR000800:Notch_dom,IPR001881:EGF-like_Ca-bd_dom,IPR002110:Ankyrin_rpt,IPR008297:Notch,IPR009030:Growth_fac_rcpt_cys_sf,IPR010660:Notch_NOD_dom,IPR011656:Notch_NODP_dom,IPR013032:EGF-like_CS,IPR018097:EGF_Ca-bd_CS,IPR022336:Notch_2,IPR024600:Notch_C,IPR035993:Notch-like_dom_sf,IPR036770:Ankyrin_rpt-contain_sf,			PIRSF002279:Notch,	SM00004:NL,SM00179:EGF_CA,SM00181:EGF,SM00248:ANK,SM01334:DUF3454,SM01338:NOD,SM01339:NODP,	KW-0221~Differentiation,KW-0804~Transcription,KW-0805~Transcription regulation,KW-0914~Notch signaling pathway,	KW-0472~Membrane,KW-0539~Nucleus,KW-0963~Cytoplasm,KW-0964~Secreted,KW-1003~Cell membrane,		KW-0225~Disease variant,	KW-0040~ANK repeat,KW-0245~EGF-like domain,KW-0677~Repeat,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0106~Calcium,	KW-0010~Activator,KW-0217~Developmental protein,KW-0675~Receptor,KW-9996~Developmental protein,	KW-0325~Glycoprotein,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,CARBOHYD:O-linked (Glc...) serine; alternate,CARBOHYD:O-linked (Xyl...) serine; alternate,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:EGF-like,DOMAIN:EGF-like 1,DOMAIN:EGF-like 10,DOMAIN:EGF-like 11; calcium-binding,DOMAIN:EGF-like 12; calcium-binding,DOMAIN:EGF-like 13; calcium-binding,DOMAIN:EGF-like 14; calcium-binding,DOMAIN:EGF-like 15; calcium-binding,DOMAIN:EGF-like 16; calcium-binding,DOMAIN:EGF-like 17; calcium-binding,DOMAIN:EGF-like 18; calcium-binding,DOMAIN:EGF-like 19,DOMAIN:EGF-like 2,DOMAIN:EGF-like 20; calcium-binding,DOMAIN:EGF-like 21; calcium-binding,DOMAIN:EGF-like 22,DOMAIN:EGF-like 23; calcium-binding,DOMAIN:EGF-like 24; calcium-binding,DOMAIN:EGF-like 25; calcium-binding,DOMAIN:EGF-like 26; calcium-binding,DOMAIN:EGF-like 27; calcium-binding,DOMAIN:EGF-like 28,DOMAIN:EGF-like 29,DOMAIN:EGF-like 3,DOMAIN:EGF-like 30; calcium-binding,DOMAIN:EGF-like 31; calcium-binding,DOMAIN:EGF-like 32; calcium-binding,DOMAIN:EGF-like 33,DOMAIN:EGF-like 34,DOMAIN:EGF-like 35,DOMAIN:EGF-like 4,DOMAIN:EGF-like 5; calcium-binding,DOMAIN:EGF-like 6,DOMAIN:EGF-like 7; calcium-binding,DOMAIN:EGF-like 8; calcium-binding,DOMAIN:EGF-like 9; calcium-binding,MUTAGEN:T->A: Loss of interaction with FBW7. Results in decreased ubiquitination and degradation.,REGION:Disordered,REGION:Negative regulatory region (NRR),REPEAT:ANK 1,REPEAT:ANK 2,REPEAT:ANK 3,REPEAT:ANK 4,REPEAT:ANK 5,REPEAT:ANK 6,REPEAT:LNR 1,REPEAT:LNR 2,REPEAT:LNR 3,SITE:Essential for O-xylosylation,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q04721	notch 2 N-terminal like C(NOTCH2NLC)	Homo sapiens			GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001701~in utero embryonic development,GO:0001709~cell fate determination,GO:0001947~heart looping,GO:0002011~morphogenesis of an epithelial sheet,GO:0002315~marginal zone B cell differentiation,GO:0002437~inflammatory response to antigenic stimulus,GO:0003162~atrioventricular node development,GO:0003184~pulmonary valve morphogenesis,GO:0006915~apoptotic process,GO:0006959~humoral immune response,GO:0007219~Notch signaling pathway,GO:0007399~nervous system development,GO:0007411~axon guidance,GO:0009887~animal organ morphogenesis,GO:0010629~negative regulation of gene expression,GO:0010838~positive regulation of keratinocyte proliferation,GO:0021987~cerebral cortex development,GO:0030097~hemopoiesis,GO:0030326~embryonic limb morphogenesis,GO:0030509~BMP signaling pathway,GO:0030513~positive regulation of BMP signaling pathway,GO:0035264~multicellular organism growth,GO:0035556~intracellular signal transduction,GO:0035622~intrahepatic bile duct development,GO:0042060~wound healing,GO:0042742~defense response to bacterium,GO:0043011~myeloid dendritic cell differentiation,GO:0043065~positive regulation of apoptotic process,GO:0043066~negative regulation of apoptotic process,GO:0045672~positive regulation of osteoclast differentiation,GO:0045747~positive regulation of Notch signaling pathway,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046579~positive regulation of Ras protein signal transduction,GO:0046849~bone remodeling,GO:0051152~positive regulation of smooth muscle cell differentiation,GO:0060413~atrial septum morphogenesis,GO:0060674~placenta blood vessel development,GO:0061073~ciliary body morphogenesis,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0070986~left/right axis specification,GO:0071228~cellular response to tumor cell,GO:0072014~proximal tubule development,GO:0072015~glomerular visceral epithelial cell development,GO:0072104~glomerular capillary formation,GO:0072574~hepatocyte proliferation,GO:1902895~positive regulation of pri-miRNA transcription from RNA polymerase II promoter,GO:1990705~cholangiocyte proliferation,GO:2001204~regulation of osteoclast development,	GO:0000139~Golgi membrane,GO:0005576~extracellular region,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005789~endoplasmic reticulum membrane,GO:0005886~plasma membrane,GO:0005929~cilium,GO:0009986~cell surface,GO:0016020~membrane,GO:0043235~receptor complex,	GO:0000987~core promoter proximal region sequence-specific DNA binding,GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0019899~enzyme binding,GO:0038023~signaling receptor activity,GO:0051059~NF-kappaB binding,	IPR000152:EGF-type_Asp/Asn_hydroxyl_site,IPR000742:EGF-like_dom,IPR000800:Notch_dom,IPR001881:EGF-like_Ca-bd_dom,IPR002110:Ankyrin_rpt,IPR008297:Notch,IPR009030:Growth_fac_rcpt_cys_sf,IPR010660:Notch_NOD_dom,IPR011656:Notch_NODP_dom,IPR013032:EGF-like_CS,IPR018097:EGF_Ca-bd_CS,IPR022336:Notch_2,IPR024600:Notch_C,IPR035993:Notch-like_dom_sf,IPR036770:Ankyrin_rpt-contain_sf,		603472~Neuronal intranuclear inclusion disease,618866~Tremor, hereditary essential, 6,619473~Oculopharyngodistal myopathy 3,	PIRSF002279:Notch,	SM00004:NL,SM00179:EGF_CA,SM00181:EGF,SM00248:ANK,SM01334:DUF3454,SM01338:NOD,SM01339:NODP,	KW-0221~Differentiation,KW-0804~Transcription,KW-0805~Transcription regulation,KW-0914~Notch signaling pathway,	KW-0472~Membrane,KW-0539~Nucleus,KW-0963~Cytoplasm,KW-0964~Secreted,KW-1003~Cell membrane,		KW-0225~Disease variant,KW-0523~Neurodegeneration,	KW-0040~ANK repeat,KW-0245~EGF-like domain,KW-0677~Repeat,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0106~Calcium,	KW-0010~Activator,KW-0217~Developmental protein,KW-0675~Receptor,KW-9996~Developmental protein,	KW-0325~Glycoprotein,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,CARBOHYD:O-linked (Glc...) serine; alternate,CARBOHYD:O-linked (Xyl...) serine; alternate,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:EGF-like,DOMAIN:EGF-like 1,DOMAIN:EGF-like 10,DOMAIN:EGF-like 11; calcium-binding,DOMAIN:EGF-like 12; calcium-binding,DOMAIN:EGF-like 13; calcium-binding,DOMAIN:EGF-like 14; calcium-binding,DOMAIN:EGF-like 15; calcium-binding,DOMAIN:EGF-like 16; calcium-binding,DOMAIN:EGF-like 17; calcium-binding,DOMAIN:EGF-like 18; calcium-binding,DOMAIN:EGF-like 19,DOMAIN:EGF-like 2,DOMAIN:EGF-like 20; calcium-binding,DOMAIN:EGF-like 21; calcium-binding,DOMAIN:EGF-like 22,DOMAIN:EGF-like 23; calcium-binding,DOMAIN:EGF-like 24; calcium-binding,DOMAIN:EGF-like 25; calcium-binding,DOMAIN:EGF-like 26; calcium-binding,DOMAIN:EGF-like 27; calcium-binding,DOMAIN:EGF-like 28,DOMAIN:EGF-like 29,DOMAIN:EGF-like 3,DOMAIN:EGF-like 30; calcium-binding,DOMAIN:EGF-like 31; calcium-binding,DOMAIN:EGF-like 32; calcium-binding,DOMAIN:EGF-like 33,DOMAIN:EGF-like 34,DOMAIN:EGF-like 35,DOMAIN:EGF-like 4,DOMAIN:EGF-like 5; calcium-binding,DOMAIN:EGF-like 6,DOMAIN:EGF-like 7; calcium-binding,DOMAIN:EGF-like 8; calcium-binding,DOMAIN:EGF-like 9; calcium-binding,MUTAGEN:T->A: Loss of interaction with FBW7. Results in decreased ubiquitination and degradation.,REGION:Disordered,REGION:Negative regulatory region (NRR),REPEAT:ANK 1,REPEAT:ANK 2,REPEAT:ANK 3,REPEAT:ANK 4,REPEAT:ANK 5,REPEAT:ANK 6,REPEAT:LNR 1,REPEAT:LNR 2,REPEAT:LNR 3,SITE:Essential for O-xylosylation,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q04721	notch 2 N-terminal like R(NOTCH2NLR)	Homo sapiens			GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001701~in utero embryonic development,GO:0001709~cell fate determination,GO:0001947~heart looping,GO:0002011~morphogenesis of an epithelial sheet,GO:0002315~marginal zone B cell differentiation,GO:0002437~inflammatory response to antigenic stimulus,GO:0003162~atrioventricular node development,GO:0003184~pulmonary valve morphogenesis,GO:0006915~apoptotic process,GO:0006959~humoral immune response,GO:0007219~Notch signaling pathway,GO:0007399~nervous system development,GO:0007411~axon guidance,GO:0009887~animal organ morphogenesis,GO:0010629~negative regulation of gene expression,GO:0010838~positive regulation of keratinocyte proliferation,GO:0030097~hemopoiesis,GO:0030326~embryonic limb morphogenesis,GO:0030509~BMP signaling pathway,GO:0030513~positive regulation of BMP signaling pathway,GO:0035264~multicellular organism growth,GO:0035556~intracellular signal transduction,GO:0035622~intrahepatic bile duct development,GO:0042060~wound healing,GO:0042742~defense response to bacterium,GO:0043011~myeloid dendritic cell differentiation,GO:0043065~positive regulation of apoptotic process,GO:0043066~negative regulation of apoptotic process,GO:0045672~positive regulation of osteoclast differentiation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046579~positive regulation of Ras protein signal transduction,GO:0046849~bone remodeling,GO:0051152~positive regulation of smooth muscle cell differentiation,GO:0060413~atrial septum morphogenesis,GO:0060674~placenta blood vessel development,GO:0061073~ciliary body morphogenesis,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0070986~left/right axis specification,GO:0071228~cellular response to tumor cell,GO:0072014~proximal tubule development,GO:0072015~glomerular visceral epithelial cell development,GO:0072104~glomerular capillary formation,GO:0072574~hepatocyte proliferation,GO:1902895~positive regulation of pri-miRNA transcription from RNA polymerase II promoter,GO:1990705~cholangiocyte proliferation,GO:2001204~regulation of osteoclast development,	GO:0000139~Golgi membrane,GO:0005576~extracellular region,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005789~endoplasmic reticulum membrane,GO:0005886~plasma membrane,GO:0005929~cilium,GO:0009986~cell surface,GO:0016020~membrane,GO:0043235~receptor complex,	GO:0000987~core promoter proximal region sequence-specific DNA binding,GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0005509~calcium ion binding,GO:0019899~enzyme binding,GO:0038023~signaling receptor activity,GO:0051059~NF-kappaB binding,	IPR000152:EGF-type_Asp/Asn_hydroxyl_site,IPR000742:EGF-like_dom,IPR000800:Notch_dom,IPR001881:EGF-like_Ca-bd_dom,IPR002110:Ankyrin_rpt,IPR008297:Notch,IPR009030:Growth_fac_rcpt_cys_sf,IPR010660:Notch_NOD_dom,IPR011656:Notch_NODP_dom,IPR013032:EGF-like_CS,IPR018097:EGF_Ca-bd_CS,IPR022336:Notch_2,IPR024600:Notch_C,IPR035993:Notch-like_dom_sf,IPR036770:Ankyrin_rpt-contain_sf,			PIRSF002279:Notch,	SM00004:NL,SM00179:EGF_CA,SM00181:EGF,SM00248:ANK,SM01334:DUF3454,SM01338:NOD,SM01339:NODP,	KW-0221~Differentiation,KW-0804~Transcription,KW-0805~Transcription regulation,KW-0914~Notch signaling pathway,	KW-0472~Membrane,KW-0539~Nucleus,KW-0963~Cytoplasm,KW-1003~Cell membrane,		KW-0225~Disease variant,	KW-0040~ANK repeat,KW-0245~EGF-like domain,KW-0677~Repeat,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0010~Activator,KW-0217~Developmental protein,KW-0675~Receptor,KW-9996~Developmental protein,	KW-0325~Glycoprotein,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,CARBOHYD:O-linked (Glc...) serine; alternate,CARBOHYD:O-linked (Xyl...) serine; alternate,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:EGF-like,DOMAIN:EGF-like 1,DOMAIN:EGF-like 10,DOMAIN:EGF-like 11; calcium-binding,DOMAIN:EGF-like 12; calcium-binding,DOMAIN:EGF-like 13; calcium-binding,DOMAIN:EGF-like 14; calcium-binding,DOMAIN:EGF-like 15; calcium-binding,DOMAIN:EGF-like 16; calcium-binding,DOMAIN:EGF-like 17; calcium-binding,DOMAIN:EGF-like 18; calcium-binding,DOMAIN:EGF-like 19,DOMAIN:EGF-like 2,DOMAIN:EGF-like 20; calcium-binding,DOMAIN:EGF-like 21; calcium-binding,DOMAIN:EGF-like 22,DOMAIN:EGF-like 23; calcium-binding,DOMAIN:EGF-like 24; calcium-binding,DOMAIN:EGF-like 25; calcium-binding,DOMAIN:EGF-like 26; calcium-binding,DOMAIN:EGF-like 27; calcium-binding,DOMAIN:EGF-like 28,DOMAIN:EGF-like 29,DOMAIN:EGF-like 3,DOMAIN:EGF-like 30; calcium-binding,DOMAIN:EGF-like 31; calcium-binding,DOMAIN:EGF-like 32; calcium-binding,DOMAIN:EGF-like 33,DOMAIN:EGF-like 34,DOMAIN:EGF-like 35,DOMAIN:EGF-like 4,DOMAIN:EGF-like 5; calcium-binding,DOMAIN:EGF-like 6,DOMAIN:EGF-like 7; calcium-binding,DOMAIN:EGF-like 8; calcium-binding,DOMAIN:EGF-like 9; calcium-binding,MUTAGEN:T->A: Loss of interaction with FBW7. Results in decreased ubiquitination and degradation.,REGION:Disordered,REGION:Negative regulatory region (NRR),REPEAT:ANK 1,REPEAT:ANK 2,REPEAT:ANK 3,REPEAT:ANK 4,REPEAT:ANK 5,REPEAT:ANK 6,REPEAT:LNR 1,REPEAT:LNR 2,REPEAT:LNR 3,SITE:Essential for O-xylosylation,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q04721	notch receptor 2(NOTCH2)	Homo sapiens		h_hesPathway:Segmentation Clock,	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001701~in utero embryonic development,GO:0001709~cell fate determination,GO:0001947~heart looping,GO:0002011~morphogenesis of an epithelial sheet,GO:0002315~marginal zone B cell differentiation,GO:0002437~inflammatory response to antigenic stimulus,GO:0003162~atrioventricular node development,GO:0003184~pulmonary valve morphogenesis,GO:0006355~regulation of transcription, DNA-templated,GO:0006915~apoptotic process,GO:0006959~humoral immune response,GO:0007219~Notch signaling pathway,GO:0007399~nervous system development,GO:0007411~axon guidance,GO:0009887~animal organ morphogenesis,GO:0010629~negative regulation of gene expression,GO:0010838~positive regulation of keratinocyte proliferation,GO:0030097~hemopoiesis,GO:0030326~embryonic limb morphogenesis,GO:0030509~BMP signaling pathway,GO:0030513~positive regulation of BMP signaling pathway,GO:0035264~multicellular organism growth,GO:0035556~intracellular signal transduction,GO:0035622~intrahepatic bile duct development,GO:0042060~wound healing,GO:0042742~defense response to bacterium,GO:0043011~myeloid dendritic cell differentiation,GO:0043065~positive regulation of apoptotic process,GO:0043066~negative regulation of apoptotic process,GO:0045672~positive regulation of osteoclast differentiation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046579~positive regulation of Ras protein signal transduction,GO:0046849~bone remodeling,GO:0051152~positive regulation of smooth muscle cell differentiation,GO:0060413~atrial septum morphogenesis,GO:0060674~placenta blood vessel development,GO:0061073~ciliary body morphogenesis,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0070986~left/right axis specification,GO:0071228~cellular response to tumor cell,GO:0072014~proximal tubule development,GO:0072015~glomerular visceral epithelial cell development,GO:0072104~glomerular capillary formation,GO:0072574~hepatocyte proliferation,GO:1902895~positive regulation of pri-miRNA transcription from RNA polymerase II promoter,GO:1990705~cholangiocyte proliferation,GO:2001204~regulation of osteoclast development,	GO:0000139~Golgi membrane,GO:0005576~extracellular region,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005789~endoplasmic reticulum membrane,GO:0005886~plasma membrane,GO:0005929~cilium,GO:0009986~cell surface,GO:0016020~membrane,GO:0043235~receptor complex,	GO:0000987~core promoter proximal region sequence-specific DNA binding,GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0019899~enzyme binding,GO:0038023~signaling receptor activity,GO:0051059~NF-kappaB binding,	IPR000152:EGF-type_Asp/Asn_hydroxyl_site,IPR000742:EGF-like_dom,IPR000800:Notch_dom,IPR001881:EGF-like_Ca-bd_dom,IPR002110:Ankyrin_rpt,IPR008297:Notch,IPR009030:Growth_fac_rcpt_cys_sf,IPR010660:Notch_NOD_dom,IPR011656:Notch_NODP_dom,IPR013032:EGF-like_CS,IPR018097:EGF_Ca-bd_CS,IPR022336:Notch_2,IPR024600:Notch_C,IPR035993:Notch-like_dom_sf,IPR036770:Ankyrin_rpt-contain_sf,	hsa01522:Endocrine resistance,hsa04330:Notch signaling pathway,hsa04658:Th1 and Th2 cell differentiation,hsa04919:Thyroid hormone signaling pathway,hsa05165:Human papillomavirus infection,hsa05200:Pathways in cancer,hsa05206:MicroRNAs in cancer,hsa05207:Chemical carcinogenesis - receptor activation,hsa05224:Breast cancer,	102500~Hajdu-Cheney syndrome,610205~Alagille syndrome 2,	PIRSF002279:Notch,	SM00004:NL,SM00179:EGF_CA,SM00181:EGF,SM00248:ANK,SM01334:DUF3454,SM01338:NOD,SM01339:NODP,	KW-0221~Differentiation,KW-0804~Transcription,KW-0805~Transcription regulation,KW-0914~Notch signaling pathway,	KW-0472~Membrane,KW-0539~Nucleus,KW-0963~Cytoplasm,KW-1003~Cell membrane,		KW-0225~Disease variant,	KW-0040~ANK repeat,KW-0245~EGF-like domain,KW-0677~Repeat,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0010~Activator,KW-0217~Developmental protein,KW-0675~Receptor,KW-9996~Developmental protein,	KW-0325~Glycoprotein,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,CARBOHYD:O-linked (Glc...) serine; alternate,CARBOHYD:O-linked (Xyl...) serine; alternate,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:EGF-like,DOMAIN:EGF-like 1,DOMAIN:EGF-like 10,DOMAIN:EGF-like 11; calcium-binding,DOMAIN:EGF-like 12; calcium-binding,DOMAIN:EGF-like 13; calcium-binding,DOMAIN:EGF-like 14; calcium-binding,DOMAIN:EGF-like 15; calcium-binding,DOMAIN:EGF-like 16; calcium-binding,DOMAIN:EGF-like 17; calcium-binding,DOMAIN:EGF-like 18; calcium-binding,DOMAIN:EGF-like 19,DOMAIN:EGF-like 2,DOMAIN:EGF-like 20; calcium-binding,DOMAIN:EGF-like 21; calcium-binding,DOMAIN:EGF-like 22,DOMAIN:EGF-like 23; calcium-binding,DOMAIN:EGF-like 24; calcium-binding,DOMAIN:EGF-like 25; calcium-binding,DOMAIN:EGF-like 26; calcium-binding,DOMAIN:EGF-like 27; calcium-binding,DOMAIN:EGF-like 28,DOMAIN:EGF-like 29,DOMAIN:EGF-like 3,DOMAIN:EGF-like 30; calcium-binding,DOMAIN:EGF-like 31; calcium-binding,DOMAIN:EGF-like 32; calcium-binding,DOMAIN:EGF-like 33,DOMAIN:EGF-like 34,DOMAIN:EGF-like 35,DOMAIN:EGF-like 4,DOMAIN:EGF-like 5; calcium-binding,DOMAIN:EGF-like 6,DOMAIN:EGF-like 7; calcium-binding,DOMAIN:EGF-like 8; calcium-binding,DOMAIN:EGF-like 9; calcium-binding,DOMAIN:Notch C-terminal,MUTAGEN:T->A: Loss of interaction with FBW7. Results in decreased ubiquitination and degradation.,REGION:Disordered,REGION:Negative regulatory region (NRR),REPEAT:ANK,REPEAT:ANK 1,REPEAT:ANK 2,REPEAT:ANK 3,REPEAT:ANK 4,REPEAT:ANK 5,REPEAT:ANK 6,REPEAT:LNR 1,REPEAT:LNR 2,REPEAT:LNR 3,SITE:Essential for O-xylosylation,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q8BMA5	nuclear protein in the AT region(Npat)	Mus musculus			GO:0000083~regulation of transcription involved in G1/S transition of mitotic cell cycle,GO:0001701~in utero embryonic development,GO:0007049~cell cycle,GO:0010468~regulation of gene expression,GO:0044843~cell cycle G1/S phase transition,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0015030~Cajal body,GO:0097504~Gemini of coiled bodies,	GO:0003712~transcription cofactor activity,GO:0003713~transcription coactivator activity,GO:0003714~transcription corepressor activity,	IPR006594:LisH,IPR031442:NPAT_C,				SM00667:LisH,	KW-0131~Cell cycle,KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,					KW-0010~Activator,	KW-0007~Acetylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),DOMAIN:LisH,REGION:Disordered,REGION:Interaction with MIZF,REGION:Mediates transcriptional activation,REGION:Required for acceleration of G1 phase,REGION:Required for activation of histone gene transcription and interaction with MIZF,
Q08E02	nuclear receptor subfamily 1 group D member 1(NR1D1)	Bos taurus			GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001678~cellular glucose homeostasis,GO:0005978~glycogen biosynthetic process,GO:0009755~hormone-mediated signaling pathway,GO:0010498~proteasomal protein catabolic process,GO:0019216~regulation of lipid metabolic process,GO:0030154~cell differentiation,GO:0031648~protein destabilization,GO:0032922~circadian regulation of gene expression,GO:0042632~cholesterol homeostasis,GO:0042749~regulation of circadian sleep/wake cycle,GO:0042752~regulation of circadian rhythm,GO:0043124~negative regulation of I-kappaB kinase/NF-kappaB signaling,GO:0044321~response to leptin,GO:0045598~regulation of fat cell differentiation,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0050728~negative regulation of inflammatory response,GO:0060086~circadian temperature homeostasis,GO:0061178~regulation of insulin secretion involved in cellular response to glucose stimulus,GO:0061469~regulation of type B pancreatic cell proliferation,GO:0070859~positive regulation of bile acid biosynthetic process,GO:0071347~cellular response to interleukin-1,GO:0071356~cellular response to tumor necrosis factor,GO:1903979~negative regulation of microglial cell activation,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0030425~dendrite,GO:0043197~dendritic spine,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001222~transcription corepressor binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0004879~RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding,GO:0008270~zinc ion binding,GO:0043565~sequence-specific DNA binding,GO:0070888~E-box binding,	IPR000536:Nucl_hrmn_rcpt_lig-bd,IPR001628:Znf_hrmn_rcpt,IPR001723:Nuclear_hrmn_rcpt,IPR013088:Znf_NHR/GATA,IPR035500:NHR-like_dom_sf,	bta04710:Circadian rhythm,			SM00399:ZnF_C4,SM00430:HOLI,	KW-0090~Biological rhythms,KW-0221~Differentiation,KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,KW-0770~Synapse,KW-0963~Cytoplasm,KW-0966~Cell projection,			KW-0863~Zinc-finger,	KW-0349~Heme,KW-0408~Iron,KW-0479~Metal-binding,KW-0862~Zinc,	KW-0010~Activator,KW-0238~DNA-binding,KW-0675~Receptor,KW-0678~Repressor,	KW-0007~Acetylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,	COMPBIAS:Polar residues,COMPBIAS:Pro residues,DNA_BIND:Nuclear receptor,DOMAIN:NR LBD,DOMAIN:Nuclear receptor,REGION:Crucial for activation of GJA1,REGION:Disordered,REGION:Modulating,REGION:Required for phosphorylation by CSNK1E and cytoplasmic localization,ZN_FING:NR C4-type,
O42101	nuclear receptor subfamily 5 group A member 2(NR5A2)	Gallus gallus			GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0008206~bile acid metabolic process,GO:0009755~hormone-mediated signaling pathway,GO:0009888~tissue development,GO:0042127~regulation of cell proliferation,GO:0042632~cholesterol homeostasis,GO:0045070~positive regulation of viral genome replication,GO:0045893~positive regulation of transcription, DNA-templated,GO:0061113~pancreas morphogenesis,GO:0090425~acinar cell differentiation,GO:1990830~cellular response to leukemia inhibitory factor,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0090575~RNA polymerase II transcription factor complex,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001221~transcription cofactor binding,GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003682~chromatin binding,GO:0004879~RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding,GO:0005543~phospholipid binding,GO:0008270~zinc ion binding,GO:0043565~sequence-specific DNA binding,	IPR000536:Nucl_hrmn_rcpt_lig-bd,IPR001628:Znf_hrmn_rcpt,IPR001723:Nuclear_hrmn_rcpt,IPR013088:Znf_NHR/GATA,IPR016355:NR5_fam,IPR035500:NHR-like_dom_sf,			PIRSF002530:Nuc_orph_FTZ-F1,	SM00399:ZnF_C4,SM00430:HOLI,	KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,			KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0010~Activator,KW-0238~DNA-binding,KW-0675~Receptor,		DNA_BIND:Nuclear receptor,DOMAIN:NR LBD,DOMAIN:Nuclear receptor,MOTIF:FTZ-F1 box,REGION:Disordered,ZN_FING:NR C4-type,
A1L2F3	nucleolar and spindle associated protein 1(nusap1)	Danio rerio			GO:0000226~microtubule cytoskeleton organization,GO:0000281~mitotic cytokinesis,GO:0001755~neural crest cell migration,GO:0007049~cell cycle,GO:0007076~mitotic chromosome condensation,GO:0040001~establishment of mitotic spindle localization,GO:0051301~cell division,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005819~spindle,GO:0005856~cytoskeleton,GO:0005874~microtubule,GO:0005876~spindle microtubule,GO:0072686~mitotic spindle,	GO:0003677~DNA binding,GO:0008017~microtubule binding,	IPR026756:NuSAP,					KW-0131~Cell cycle,KW-0132~Cell division,KW-0498~Mitosis,	KW-0206~Cytoskeleton,KW-0493~Microtubule,KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0175~Coiled coil,		KW-0238~DNA-binding,		COMPBIAS:Basic and acidic residues,COMPBIAS:Basic residues,REGION:Disordered,
Q8JIY8	nucleolar protein interacting with the FHA domain of MKI67(nifk)	Danio rerio			GO:0000463~maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),	GO:0005634~nucleus,GO:0005730~nucleolus,	GO:0003676~nucleic acid binding,GO:0003723~RNA binding,	IPR000504:RRM_dom,IPR012677:Nucleotide-bd_a/b_plait_sf,IPR021043:NIFK_FHA_Ki67-binding,IPR035979:RBD_domain_sf,				SM00360:RRM,		KW-0539~Nucleus,					KW-0217~Developmental protein,KW-0694~RNA-binding,KW-9996~Developmental protein,		COMPBIAS:Acidic residues,DOMAIN:RRM,REGION:Disordered,
P20397	nucleolin L homeolog(ncl.L)	Xenopus laevis				GO:0005634~nucleus,GO:0005730~nucleolus,	GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003723~RNA binding,	IPR000504:RRM_dom,IPR012677:Nucleotide-bd_a/b_plait_sf,IPR034230:Nucleolin_RRM1,IPR034233:Nucleolin_RRM2,IPR034234:Nucleolin_RRM3,IPR034235:Nucleolin_RRM4,IPR035979:RBD_domain_sf,				SM00360:RRM,		KW-0539~Nucleus,			KW-0677~Repeat,		KW-0238~DNA-binding,KW-0694~RNA-binding,	KW-0488~Methylation,KW-0597~Phosphoprotein,	COMPBIAS:Acidic residues,COMPBIAS:Basic and acidic residues,DOMAIN:RRM,DOMAIN:RRM 1,DOMAIN:RRM 2,DOMAIN:RRM 3,DOMAIN:RRM 4,REGION:Disordered,
Q8NFH4	nucleoporin 37(NUP37)	Homo sapiens			GO:0006913~nucleocytoplasmic transport,GO:0007059~chromosome segregation,GO:0015031~protein transport,GO:0051028~mRNA transport,GO:0051301~cell division,	GO:0000776~kinetochore,GO:0005634~nucleus,GO:0005635~nuclear envelope,GO:0005643~nuclear pore,GO:0005654~nucleoplasm,GO:0005829~cytosol,GO:0031080~nuclear pore outer ring,	GO:0005515~protein binding,	IPR001680:WD40_rpt,IPR015943:WD40/YVTN_repeat-like_dom_sf,IPR019775:WD40_repeat_CS,IPR036322:WD40_repeat_dom_sf,IPR037626:NUP37,	hsa03013:Nucleocytoplasmic transport,hsa05014:Amyotrophic lateral sclerosis,	618179~Microcephaly 24, primary, autosomal recessive,		SM00320:WD40,	KW-0131~Cell cycle,KW-0132~Cell division,KW-0159~Chromosome partition,KW-0498~Mitosis,KW-0509~mRNA transport,KW-0653~Protein transport,KW-0811~Translocation,KW-0813~Transport,	KW-0137~Centromere,KW-0158~Chromosome,KW-0539~Nucleus,KW-0906~Nuclear pore complex,KW-0995~Kinetochore,		KW-0225~Disease variant,KW-0905~Primary microcephaly,	KW-0677~Repeat,KW-0853~WD repeat,				REPEAT:WD,REPEAT:WD 1,REPEAT:WD 2,REPEAT:WD 3,REPEAT:WD 4,REPEAT:WD 5,REPEAT:WD 6,REPEAT:WD 7,
Q78ZA7	nucleosome assembly protein 1-like 4(Nap1l4)	Mus musculus			GO:0006334~nucleosome assembly,	GO:0000785~chromatin,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0030425~dendrite,GO:0043025~neuronal cell body,	GO:0003682~chromatin binding,GO:0031491~nucleosome binding,GO:0042393~histone binding,	IPR002164:NAP_family,IPR037231:NAP-like_sf,						KW-0539~Nucleus,KW-0963~Cytoplasm,					KW-0143~Chaperone,	KW-0007~Acetylation,KW-0597~Phosphoprotein,	COMPBIAS:Acidic residues,COMPBIAS:Polar residues,MOTIF:Nuclear localization signal,REGION:Disordered,
O35685	nudC nuclear distribution protein(Nudc)	Mus musculus			GO:0006457~protein folding,GO:0007049~cell cycle,GO:0007052~mitotic spindle organization,GO:0007080~mitotic metaphase plate congression,GO:0007097~nuclear migration,GO:0043434~response to peptide hormone,GO:0051301~cell division,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005874~microtubule,GO:0030496~midbody,GO:0072686~mitotic spindle,	GO:0005515~protein binding,GO:0051082~unfolded protein binding,	IPR007052:CS_dom,IPR008978:HSP20-like_chaperone,IPR025934:NudC_N_dom,IPR032572:NuDC,IPR037898:NudC_fam,					KW-0131~Cell cycle,KW-0132~Cell division,KW-0498~Mitosis,	KW-0206~Cytoskeleton,KW-0493~Microtubule,KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0175~Coiled coil,			KW-0007~Acetylation,KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,DOMAIN:CS,MOTIF:Nuclear localization signal,REGION:Disordered,REGION:Interaction with EML4,
Q9UKK9	nudix hydrolase 5(NUDT5)	Homo sapiens			GO:0006338~chromatin remodeling,GO:0006753~nucleoside phosphate metabolic process,GO:0009117~nucleotide metabolic process,GO:0009191~ribonucleoside diphosphate catabolic process,GO:0019303~D-ribose catabolic process,GO:0019693~ribose phosphate metabolic process,GO:0055086~nucleobase-containing small molecule metabolic process,GO:1990966~ATP generation from poly-ADP-D-ribose,	GO:0005634~nucleus,GO:0005829~cytosol,GO:0070062~extracellular exosome,	GO:0000287~magnesium ion binding,GO:0005515~protein binding,GO:0016779~nucleotidyltransferase activity,GO:0016787~hydrolase activity,GO:0019144~ADP-sugar diphosphatase activity,GO:0030515~snoRNA binding,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,GO:0044715~8-oxo-dGDP phosphatase activity,GO:0044716~8-oxo-GDP phosphatase activity,GO:0047631~ADP-ribose diphosphatase activity,	IPR000086:NUDIX_hydrolase_dom,IPR015797:NUDIX_hydrolase-like_dom_sf,IPR020084:NUDIX_hydrolase_CS,IPR020476:Nudix_hydrolase,	hsa00230:Purine metabolism,hsa01100:Metabolic pathways,					KW-0539~Nucleus,				KW-0460~Magnesium,KW-0479~Metal-binding,	KW-0378~Hydrolase,KW-0694~RNA-binding,KW-0808~Transferase,	KW-0007~Acetylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	BINDING:in other chain,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),DOMAIN:Nudix hydrolase,MOTIF:Nudix box,MUTAGEN:E->Q: Catalytic inactive mutant for both ADP-sugar pyrophosphatase and nuclear ATP-synthesis activities. Reduces catalytic rate 6300-fold.,MUTAGEN:E->Q: Reduces catalytic rate 120-fold.,MUTAGEN:E->Q: Reduces catalytic rate 2000-fold.,MUTAGEN:L->A: Reduces affinity for substrate about 6-fold.,MUTAGEN:R->Q: Reduces affinity for substrate about 15-fold and reduces catalytic rate about 17-fold.,MUTAGEN:R->Q: Reduces affinity for substrate about 5-fold and reduces catalytic rate 67-fold.,MUTAGEN:T->A: Impaired phosphorylation; generates ATP in the presence of diphosphate.,MUTAGEN:T->D: Phosphomimetic mutant; unable to generate ATP in the presence of diphosphate.,MUTAGEN:W->A: Reduces affinity for substrate about 6-fold. Strongly reduced catalytic activity and strongly reduced affinity for substrate; when associated with A-28.,MUTAGEN:W->A: Reduces affinity for substrate about 8-fold. Strongly reduced catalytic activity and strongly reduced affinity for substrate; when associated with A-46.,
Q5R6Z7	origin recognition complex subunit 4(ORC4)	Pongo abelii			GO:0006260~DNA replication,GO:0006270~DNA replication initiation,GO:0040038~polar body extrusion after meiotic divisions,GO:0051258~protein polymerization,	GO:0000781~chromosome, telomeric region,GO:0000808~origin recognition complex,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005664~nuclear origin of replication recognition complex,GO:0005730~nucleolus,GO:0005829~cytosol,	GO:0000166~nucleotide binding,GO:0003677~DNA binding,GO:0003688~DNA replication origin binding,GO:0005524~ATP binding,GO:0016887~ATPase activity,	IPR003593:AAA+_ATPase,IPR003959:ATPase_AAA_core,IPR016527:ORC4,IPR027417:P-loop_NTPase,IPR032705:ORC4_C,IPR041664:AAA_16,	pon04110:Cell cycle,		PIRSF007858:ORC4,	SM00382:AAA,	KW-0235~DNA replication,	KW-0539~Nucleus,				KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0238~DNA-binding,	KW-0488~Methylation,	DOMAIN:AAA+ ATPase,DOMAIN:ATPase AAA-type core,DOMAIN:Origin recognition complex subunit 4 C-terminal,
Q5SPC5	otoferlin a(otofa)	Danio rerio			GO:0001964~startle response,GO:0007009~plasma membrane organization,GO:0007605~sensory perception of sound,GO:0010996~response to auditory stimulus,GO:0016079~synaptic vesicle exocytosis,GO:0016082~synaptic vesicle priming,GO:0036465~synaptic vesicle recycling,GO:0050885~neuromuscular process controlling balance,	GO:0000139~Golgi membrane,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0016323~basolateral plasma membrane,GO:0030672~synaptic vesicle membrane,GO:0031410~cytoplasmic vesicle,GO:0042995~cell projection,GO:0045202~synapse,GO:0048787~presynaptic active zone membrane,	GO:0005509~calcium ion binding,GO:0035612~AP-2 adaptor complex binding,GO:0046872~metal ion binding,	IPR000008:C2_dom,IPR012561:Ferlin_B-domain,IPR012968:FerIin_dom,IPR032362:Ferlin_C,IPR035892:C2_domain_sf,IPR037720:C2B_Ferlin,IPR037721:Ferlin,IPR037722:C2C_Ferlin,IPR037723:C2D_Ferlin,IPR037724:C2E_Ferlin,IPR037725:C2F_Ferlin,IPR037726:C2A_Ferlin,				SM00239:C2,SM01201:FerB,SM01202:FerI,		KW-0256~Endoplasmic reticulum,KW-0333~Golgi apparatus,KW-0472~Membrane,KW-0770~Synapse,KW-0966~Cell projection,KW-0968~Cytoplasmic vesicle,KW-1003~Cell membrane,			KW-0175~Coiled coil,KW-0677~Repeat,KW-0735~Signal-anchor,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0106~Calcium,KW-0479~Metal-binding,			COMPBIAS:Acidic residues,COMPBIAS:Basic and acidic residues,DOMAIN:C2,DOMAIN:C2 1,DOMAIN:C2 2,DOMAIN:C2 3,DOMAIN:C2 4,DOMAIN:C2 5,DOMAIN:C2 6,DOMAIN:C2 7,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q9UJX0	oxidative stress induced growth inhibitor 1(OSGIN1)	Homo sapiens			GO:0007165~signal transduction,GO:0030154~cell differentiation,GO:0030308~negative regulation of cell growth,GO:0030334~regulation of cell migration,GO:0042127~regulation of cell proliferation,GO:0042981~regulation of apoptotic process,		GO:0005515~protein binding,GO:0008083~growth factor activity,	IPR029731:OKL38_fam,IPR036188:FAD/NAD-bd_sf,					KW-0221~Differentiation,KW-0341~Growth regulation,						KW-0217~Developmental protein,KW-9996~Developmental protein,	KW-0597~Phosphoprotein,
A2T756	pancreatic and duodenal homeobox 1(PDX1)	Pan troglodytes			GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001889~liver development,GO:0003309~type B pancreatic cell differentiation,GO:0006006~glucose metabolic process,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0007263~nitric oxide mediated signal transduction,GO:0016331~morphogenesis of embryonic epithelium,GO:0030073~insulin secretion,GO:0031017~exocrine pancreas development,GO:0032024~positive regulation of insulin secretion,GO:0035774~positive regulation of insulin secretion involved in cellular response to glucose stimulus,GO:0042593~glucose homeostasis,GO:0044342~type B pancreatic cell proliferation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048565~digestive tract development,GO:0050680~negative regulation of epithelial cell proliferation,GO:0070059~intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,GO:0097050~type B pancreatic cell apoptotic process,GO:1902236~negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,GO:1904692~positive regulation of type B pancreatic cell proliferation,GO:2000675~negative regulation of type B pancreatic cell apoptotic process,	GO:0005634~nucleus,GO:0005829~cytosol,GO:0016607~nuclear speck,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0003682~chromatin binding,	IPR001356:Homeobox_dom,IPR009057:Homeobox-like_sf,IPR017970:Homeobox_CS,IPR017995:Homeobox_antennapedia,IPR020479:Homeobox_metazoa,	ptr04911:Insulin secretion,ptr04930:Type II diabetes mellitus,ptr04950:Maturity onset diabetes of the young,			SM00389:HOX,	KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0371~Homeobox,		KW-0010~Activator,KW-0238~DNA-binding,	KW-0597~Phosphoprotein,	COMPBIAS:Pro residues,DNA_BIND:Homeobox,DOMAIN:Homeobox,MOTIF:Antp-type hexapeptide,MOTIF:Nuclear localization signal,REGION:Disordered,REGION:Transactivation domain,
P0C548	patatin-like phospholipase domain containing 2(Pnpla2)	Rattus norvegicus			GO:0006651~diacylglycerol biosynthetic process,GO:0010891~negative regulation of sequestering of triglyceride,GO:0010898~positive regulation of triglyceride catabolic process,GO:0016042~lipid catabolic process,GO:0019433~triglyceride catabolic process,GO:0019915~lipid storage,GO:0034389~lipid particle organization,GO:0042572~retinol metabolic process,GO:0044242~cellular lipid catabolic process,GO:0055088~lipid homeostasis,GO:1905691~lipid particle disassembly,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005811~lipid particle,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0016020~membrane,	GO:0004623~phospholipase A2 activity,GO:0004806~triglyceride lipase activity,GO:0005515~protein binding,GO:0016411~acylglycerol O-acyltransferase activity,GO:0050253~retinyl-palmitate esterase activity,GO:0051264~mono-olein transacylation activity,GO:0051265~diolein transacylation activity,	IPR002641:PNPLA_dom,IPR016035:Acyl_Trfase/lysoPLipase,IPR033562:PLPL,IPR033903:PNPLA2,	rno00561:Glycerolipid metabolism,rno01100:Metabolic pathways,rno04714:Thermogenesis,rno04923:Regulation of lipolysis in adipocytes,				KW-0442~Lipid degradation,KW-0443~Lipid metabolism,	KW-0472~Membrane,KW-0551~Lipid droplet,KW-0963~Cytoplasm,KW-1003~Cell membrane,			KW-0735~Signal-anchor,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0378~Hydrolase,	KW-0325~Glycoprotein,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	ACT_SITE:Nucleophile,ACT_SITE:Proton acceptor,CARBOHYD:N-linked (GlcNAc...) asparagine,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),DOMAIN:PNPLA,MOTIF:DGA/G,MOTIF:GXGXXG,MOTIF:GXSXG,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q08E11	peptidylprolyl isomerase C(PPIC)	Bos taurus			GO:0000413~protein peptidyl-prolyl isomerization,GO:0006457~protein folding,	GO:0005737~cytoplasm,GO:0043231~intracellular membrane-bounded organelle,	GO:0003755~peptidyl-prolyl cis-trans isomerase activity,GO:0016018~cyclosporin A binding,	IPR002130:Cyclophilin-type_PPIase_dom,IPR020892:Cyclophilin-type_PPIase_CS,IPR029000:Cyclophilin-like_dom_sf,						KW-0963~Cytoplasm,					KW-0413~Isomerase,KW-0697~Rotamase,		DOMAIN:PPIase cyclophilin-type,
Q4PLW0	perilipin 2(PLIN2)	Sus scrofa			GO:0010890~positive regulation of sequestering of triglyceride,GO:0015909~long-chain fatty acid transport,GO:0019915~lipid storage,GO:0042149~cellular response to glucose starvation,GO:1905691~lipid particle disassembly,	GO:0005622~intracellular,GO:0005634~nucleus,GO:0005811~lipid particle,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0016020~membrane,		IPR004279:Perilipin,	ssc03320:PPAR signaling pathway,		PIRSF036881:PAT,			KW-0472~Membrane,KW-0551~Lipid droplet,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0007~Acetylation,KW-0597~Phosphoprotein,	REGION:Disordered,TRANSMEM:Helical,
Q9Y6I8	peroxisomal membrane protein 4(PXMP4)	Homo sapiens			GO:0046485~ether lipid metabolic process,	GO:0005777~peroxisome,GO:0005778~peroxisomal membrane,GO:0005829~cytosol,	GO:0005515~protein binding,	IPR019531:Pmp4,	hsa04146:Peroxisome,		PIRSF013674:PXMP4,			KW-0472~Membrane,KW-0576~Peroxisome,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,TRANSMEM:Helical,
Q99MZ7	peroxisomal trans-2-enoyl-CoA reductase(Pecr)	Mus musculus			GO:0006629~lipid metabolic process,GO:0006631~fatty acid metabolic process,GO:0006633~fatty acid biosynthetic process,GO:0030497~fatty acid elongation,GO:0033306~phytol metabolic process,	GO:0005739~mitochondrion,GO:0005777~peroxisome,GO:0005778~peroxisomal membrane,GO:0043231~intracellular membrane-bounded organelle,	GO:0005102~receptor binding,GO:0016491~oxidoreductase activity,GO:0019166~trans-2-enoyl-CoA reductase (NADPH) activity,	IPR002347:SDR_fam,IPR036291:NAD(P)-bd_dom_sf,	mmu04146:Peroxisome,				KW-0275~Fatty acid biosynthesis,KW-0276~Fatty acid metabolism,KW-0443~Lipid metabolism,KW-0444~Lipid biosynthesis,	KW-0576~Peroxisome,				KW-0521~NADP,	KW-0560~Oxidoreductase,	KW-0007~Acetylation,KW-0597~Phosphoprotein,	ACT_SITE:Proton acceptor,MOTIF:Microbody targeting signal,
Q07869	peroxisome proliferator activated receptor alpha(PPARA)	Homo sapiens		h_bArrestinPathway:ï¿½-arrestins in GPCR Desensitization,h_nuclearRsPathway:Nuclear Receptors in Lipid Metabolism and Toxicity,h_pgc1aPathway:Regulation of PGC-1a,h_PparaPathway:Mechanism of Gene Regulation by Peroxisome Proliferators via PPARa(alpha),h_pparPathway:Basic mechanism of action of PPARa, PPARb(d) and PPARg and effects on gene expression,h_tollPathway:Toll-Like Receptor Pathway,	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001666~response to hypoxia,GO:0006094~gluconeogenesis,GO:0006631~fatty acid metabolic process,GO:0007507~heart development,GO:0007584~response to nutrient,GO:0008544~epidermis development,GO:0009267~cellular response to starvation,GO:0009755~hormone-mediated signaling pathway,GO:0010565~regulation of cellular ketone metabolic process,GO:0010745~negative regulation of macrophage derived foam cell differentiation,GO:0010883~regulation of lipid storage,GO:0010887~negative regulation of cholesterol storage,GO:0010891~negative regulation of sequestering of triglyceride,GO:0014070~response to organic cyclic compound,GO:0019217~regulation of fatty acid metabolic process,GO:0030154~cell differentiation,GO:0030512~negative regulation of transforming growth factor beta receptor signaling pathway,GO:0030522~intracellular receptor signaling pathway,GO:0032000~positive regulation of fatty acid beta-oxidation,GO:0032099~negative regulation of appetite,GO:0032868~response to insulin,GO:0032922~circadian regulation of gene expression,GO:0035095~behavioral response to nicotine,GO:0042060~wound healing,GO:0042157~lipoprotein metabolic process,GO:0042752~regulation of circadian rhythm,GO:0043401~steroid hormone mediated signaling pathway,GO:0045471~response to ethanol,GO:0045722~positive regulation of gluconeogenesis,GO:0045776~negative regulation of blood pressure,GO:0045820~negative regulation of glycolytic process,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045923~positive regulation of fatty acid metabolic process,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046209~nitric oxide metabolic process,GO:0046321~positive regulation of fatty acid oxidation,GO:0046889~positive regulation of lipid biosynthetic process,GO:0050728~negative regulation of inflammatory response,GO:0051898~negative regulation of protein kinase B signaling,GO:0061052~negative regulation of cell growth involved in cardiac muscle cell development,GO:0070166~enamel mineralization,GO:0071332~cellular response to fructose stimulus,GO:1900016~negative regulation of cytokine production involved in inflammatory response,GO:1902894~negative regulation of pri-miRNA transcription from RNA polymerase II promoter,GO:1903038~negative regulation of leukocyte cell-cell adhesion,GO:1903427~negative regulation of reactive oxygen species biosynthetic process,GO:1903944~negative regulation of hepatocyte apoptotic process,GO:1904189~positive regulation of transformation of host cell by virus,GO:2000191~regulation of fatty acid transport,GO:2000272~negative regulation of receptor activity,GO:2001171~positive regulation of ATP biosynthetic process,	GO:0000785~chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0001216~bacterial-type RNA polymerase transcriptional activator activity, sequence-specific DNA binding,GO:0001223~transcription coactivator binding,GO:0001227~transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003707~steroid hormone receptor activity,GO:0004879~RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0008289~lipid binding,GO:0019902~phosphatase binding,GO:0019904~protein domain specific binding,GO:0031435~mitogen-activated protein kinase kinase kinase binding,GO:0031624~ubiquitin conjugating enzyme binding,GO:0043565~sequence-specific DNA binding,GO:0044877~macromolecular complex binding,GO:0051525~NFAT protein binding,GO:0061629~RNA polymerase II sequence-specific DNA binding transcription factor binding,GO:0097371~MDM2/MDM4 family protein binding,	IPR000536:Nucl_hrmn_rcpt_lig-bd,IPR001628:Znf_hrmn_rcpt,IPR001723:Nuclear_hrmn_rcpt,IPR003074:1Cnucl_rcpt,IPR003076:PPAR-alpha,IPR013088:Znf_NHR/GATA,IPR035500:NHR-like_dom_sf,	hsa03320:PPAR signaling pathway,hsa04024:cAMP signaling pathway,hsa04920:Adipocytokine signaling pathway,hsa04922:Glucagon signaling pathway,hsa04931:Insulin resistance,hsa04932:Non-alcoholic fatty liver disease,hsa04936:Alcoholic liver disease,hsa05160:Hepatitis C,hsa05207:Chemical carcinogenesis - receptor activation,hsa05415:Diabetic cardiomyopathy,			SM00399:ZnF_C4,SM00430:HOLI,	KW-0090~Biological rhythms,KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,			KW-0863~Zinc-finger,	KW-0446~Lipid-binding,KW-0479~Metal-binding,KW-0862~Zinc,	KW-0010~Activator,KW-0238~DNA-binding,KW-0675~Receptor,		DNA_BIND:Nuclear receptor,DOMAIN:NR LBD,DOMAIN:Nuclear receptor,MUTAGEN:A->T: No effect on heterodimerization with RXRA nor on DNA binding.,MUTAGEN:C->G: Prevents DNA binding but no effect on heterodimerization with RXRA.,MUTAGEN:D->A: Reduced heterodimerization with RXRA. Reduced DNA binding.,MUTAGEN:L->R: Abolishes heterodimerization with RXRA, DNA binding and transactivation activity.,MUTAGEN:L->R: Abolishes heterodimerization with RXRA. No DNA binding.,MUTAGEN:L->R: No effect on heterodimerization with RXRA nor on DNA binding and transactivation activity.,REGION:Required for heterodimerization with RXRA,SITE:Essential for heterodimerization with RXRA,ZN_FING:NR C4-type,
Q8TBF5	phosphatidylinositol glycan anchor biosynthesis class X(PIGX)	Homo sapiens			GO:0006506~GPI anchor biosynthetic process,	GO:0005789~endoplasmic reticulum membrane,		IPR013233:PIG-X/PBN1,IPR040039:PIGX,	hsa00563:Glycosylphosphatidylinositol (GPI)-anchor biosynthesis,hsa01100:Metabolic pathways,			SM00780:PIG-X,	KW-0337~GPI-anchor biosynthesis,	KW-0256~Endoplasmic reticulum,KW-0472~Membrane,			KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,TOPO_DOM:Cytoplasmic,TOPO_DOM:Lumenal,TRANSMEM:Helical,
Q70Z35	phosphatidylinositol-3,4,5-trisphosphate dependent Rac exchange factor 2(PREX2)	Homo sapiens			GO:0007186~G-protein coupled receptor signaling pathway,GO:0008344~adult locomotory behavior,GO:0023051~regulation of signaling,GO:0035556~intracellular signal transduction,GO:0043491~protein kinase B signaling,GO:0043547~positive regulation of GTPase activity,GO:0048813~dendrite morphogenesis,GO:0051056~regulation of small GTPase mediated signal transduction,	GO:0005829~cytosol,GO:0005886~plasma membrane,	GO:0005085~guanyl-nucleotide exchange factor activity,GO:0005096~GTPase activator activity,	IPR000219:DH-domain,IPR000591:DEP_dom,IPR001331:GDS_CDC24_CS,IPR001478:PDZ,IPR001849:PH_domain,IPR011993:PH-like_dom_sf,IPR035899:DBL_dom_sf,IPR036034:PDZ_sf,IPR036388:WH-like_DNA-bd_sf,IPR036390:WH_DNA-bd_sf,IPR037367:Rex2_DEP_1,				SM00049:DEP,SM00228:PDZ,SM00233:PH,SM00325:RhoGEF,					KW-0677~Repeat,		KW-0344~Guanine-nucleotide releasing factor,		DOMAIN:DEP,DOMAIN:DEP 1,DOMAIN:DEP 2,DOMAIN:DH,DOMAIN:PDZ,DOMAIN:PDZ 1,DOMAIN:PDZ 2,DOMAIN:PH,REGION:Disordered,
Q9QYJ6	phosphodiesterase 10A(Pde10a)	Rattus norvegicus			GO:0006198~cAMP catabolic process,GO:0007165~signal transduction,GO:0010738~regulation of protein kinase A signaling,GO:0010754~negative regulation of cGMP-mediated signaling,GO:0019933~cAMP-mediated signaling,GO:0043951~negative regulation of cAMP-mediated signaling,GO:0046069~cGMP catabolic process,	GO:0005829~cytosol,GO:0043025~neuronal cell body,GO:0043204~perikaryon,	GO:0004112~cyclic-nucleotide phosphodiesterase activity,GO:0004114~3',5'-cyclic-nucleotide phosphodiesterase activity,GO:0004115~3',5'-cyclic-AMP phosphodiesterase activity,GO:0004118~cGMP-stimulated cyclic-nucleotide phosphodiesterase activity,GO:0030552~cAMP binding,GO:0030553~cGMP binding,GO:0046872~metal ion binding,GO:0047555~3',5'-cyclic-GMP phosphodiesterase activity,	IPR002073:PDEase_catalytic_dom,IPR003018:GAF,IPR003607:HD/PDEase_dom,IPR023088:PDEase,IPR023174:PDEase_CS,IPR029016:GAF-like_dom_sf,IPR036971:PDEase_catalytic_dom_sf,	rno00230:Purine metabolism,rno01100:Metabolic pathways,rno04024:cAMP signaling pathway,rno05032:Morphine addiction,			SM00065:GAF,SM00471:HDc,		KW-0963~Cytoplasm,			KW-0677~Repeat,	KW-0114~cAMP,KW-0116~cAMP-binding,KW-0140~cGMP,KW-0142~cGMP-binding,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,	KW-0021~Allosteric enzyme,KW-0378~Hydrolase,		ACT_SITE:Proton donor,DOMAIN:PDEase,REGION:Disordered,
O95263	phosphodiesterase 8B(PDE8B)	Homo sapiens			GO:0001662~behavioral fear response,GO:0006198~cAMP catabolic process,GO:0007165~signal transduction,GO:0008542~visual learning,GO:0019933~cAMP-mediated signaling,GO:0035106~operant conditioning,GO:0050885~neuromuscular process controlling balance,GO:0061179~negative regulation of insulin secretion involved in cellular response to glucose stimulus,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0090032~negative regulation of steroid hormone biosynthetic process,	GO:0005634~nucleus,GO:0005829~cytosol,GO:0048471~perinuclear region of cytoplasm,	GO:0004114~3',5'-cyclic-nucleotide phosphodiesterase activity,GO:0004115~3',5'-cyclic-AMP phosphodiesterase activity,GO:0046872~metal ion binding,GO:0047555~3',5'-cyclic-GMP phosphodiesterase activity,	IPR000014:PAS,IPR002073:PDEase_catalytic_dom,IPR003607:HD/PDEase_dom,IPR011006:CheY-like_superfamily,IPR013938:PDEase_PDE8,IPR023088:PDEase,IPR023174:PDEase_CS,IPR035965:PAS-like_dom_sf,IPR036971:PDEase_catalytic_dom_sf,	hsa00230:Purine metabolism,hsa01100:Metabolic pathways,hsa04927:Cortisol synthesis and secretion,hsa04934:Cushing syndrome,hsa05032:Morphine addiction,	609161~Striatal degeneration, autosomal dominant,614190~Pigmented nodular adrenocortical disease, primary, 3,		SM00091:PAS,SM00471:HDc,				KW-0225~Disease variant,KW-1062~Cushing syndrome,		KW-0114~cAMP,KW-0479~Metal-binding,	KW-0378~Hydrolase,	KW-0597~Phosphoprotein,	ACT_SITE:Proton donor,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:PAS,DOMAIN:PDEase,REGION:Disordered,
Q8CHP8	phosphoglycolate phosphatase(Pgp)	Mus musculus			GO:0005975~carbohydrate metabolic process,GO:0006114~glycerol biosynthetic process,GO:0006650~glycerophospholipid metabolic process,GO:0045721~negative regulation of gluconeogenesis,	GO:0005737~cytoplasm,	GO:0000121~glycerol-1-phosphatase activity,GO:0000287~magnesium ion binding,GO:0004721~phosphoprotein phosphatase activity,GO:0004725~protein tyrosine phosphatase activity,GO:0008967~phosphoglycolate phosphatase activity,GO:0016787~hydrolase activity,GO:0016791~phosphatase activity,GO:0043136~glycerol-3-phosphatase activity,GO:0043262~adenosine-diphosphatase activity,GO:0046872~metal ion binding,	IPR006349:PGP_euk,IPR006357:HAD-SF_hydro_IIA,IPR023214:HAD_sf,IPR036412:HAD-like_sf,	mmu00630:Glyoxylate and dicarboxylate metabolism,mmu01100:Metabolic pathways,mmu01200:Carbon metabolism,		PIRSF000915:PGP-type_phosphatase,		KW-0119~Carbohydrate metabolism,					KW-0460~Magnesium,KW-0479~Metal-binding,	KW-0378~Hydrolase,KW-0904~Protein phosphatase,		ACT_SITE:Nucleophile,ACT_SITE:Proton donor,MUTAGEN:A->I: Slightly increases phosphatase activity with p-nitrophenylphosphate; when associated with N-41 and R-44.,MUTAGEN:D->N: Abolishes phosphatase activity.,MUTAGEN:K->R: Mildly reduces phosphatase activity; when associated with R-71 and A-73. Strongly reduces phosphatase activity; when associated with S-67; R-71 and A-73. Abolishes phosphatase activity; when associated with S-67 and A-73.,MUTAGEN:L->H: Strongly increases activity with pyridoxal phosphate.,MUTAGEN:R->N: Slightly increases phosphatase activity with p-nitrophenylphosphate; when associated with R-44 and I-45.,MUTAGEN:S->R: Mildly reduces phosphatase activity; when associated with R-72 and A-73. Strongly reduces phosphatase activity; when associated with S-67; R-72 and A-73.,MUTAGEN:T->A: Abolishes phosphatase activity. Abolishes phosphatase activity; when associated with S-67 and R-72. Strongly reduces phosphatase activity; when associated with S-67; R-71 and R-72. Mildly reduces phosphatase activity; when associated with R-71 and R-72.,MUTAGEN:T->R: Slightly increases phosphatase activity with p-nitrophenylphosphate; when associated with N-41 and I-45.,MUTAGEN:T->S: Strongly reduces phosphatase activity; when associated with R-71; R-72 and A-73. Abolishes phosphatase activity; when associated with R-72 and A-73.,SITE:Important for substrate specificity,
Q7SXB3	phosphoinositide-3-kinase interacting protein 1(pik3ip1)	Danio rerio			GO:0051898~negative regulation of protein kinase B signaling,	GO:0005615~extracellular space,GO:0005886~plasma membrane,GO:0016020~membrane,	GO:0004175~endopeptidase activity,GO:0005102~receptor binding,GO:0036313~phosphatidylinositol 3-kinase catalytic subunit binding,	IPR000001:Kringle,IPR013806:Kringle-like,IPR018056:Kringle_CS,IPR038178:Kringle_sf,				SM00130:KR,		KW-0472~Membrane,KW-1003~Cell membrane,			KW-0420~Kringle,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Kringle,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q5R685	phosphoinositide-3-kinase regulatory subunit 1(PIK3R1)	Pongo abelii			GO:0001678~cellular glucose homeostasis,GO:0001953~negative regulation of cell-matrix adhesion,GO:0002687~positive regulation of leukocyte migration,GO:0006366~transcription from RNA polymerase II promoter,GO:0006606~protein import into nucleus,GO:0007165~signal transduction,GO:0008286~insulin receptor signaling pathway,GO:0008625~extrinsic apoptotic signaling pathway via death domain receptors,GO:0008630~intrinsic apoptotic signaling pathway in response to DNA damage,GO:0010592~positive regulation of lamellipodium assembly,GO:0015031~protein transport,GO:0030183~B cell differentiation,GO:0030316~osteoclast differentiation,GO:0032760~positive regulation of tumor necrosis factor production,GO:0032869~cellular response to insulin stimulus,GO:0033120~positive regulation of RNA splicing,GO:0034143~regulation of toll-like receptor 4 signaling pathway,GO:0034644~cellular response to UV,GO:0034976~response to endoplasmic reticulum stress,GO:0035655~interleukin-18-mediated signaling pathway,GO:0042307~positive regulation of protein import into nucleus,GO:0043066~negative regulation of apoptotic process,GO:0043491~protein kinase B signaling,GO:0045671~negative regulation of osteoclast differentiation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046854~phosphatidylinositol phosphorylation,GO:0048009~insulin-like growth factor receptor signaling pathway,GO:0048661~positive regulation of smooth muscle cell proliferation,GO:0050821~protein stabilization,GO:0051491~positive regulation of filopodium assembly,GO:0051497~negative regulation of stress fiber assembly,GO:0060396~growth hormone receptor signaling pathway,GO:0097529~myeloid leukocyte migration,GO:1900103~positive regulation of endoplasmic reticulum unfolded protein response,GO:1903076~regulation of protein localization to plasma membrane,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005801~cis-Golgi network,GO:0005829~cytosol,GO:0005911~cell-cell junction,GO:0005942~phosphatidylinositol 3-kinase complex,GO:0005943~phosphatidylinositol 3-kinase complex, class IA,GO:1990578~perinuclear endoplasmic reticulum membrane,	GO:0001784~phosphotyrosine binding,GO:0005158~insulin receptor binding,GO:0005159~insulin-like growth factor receptor binding,GO:0005168~neurotrophin TRKA receptor binding,GO:0005515~protein binding,GO:0019209~kinase activator activity,GO:0019903~protein phosphatase binding,GO:0036312~phosphatidylinositol 3-kinase regulatory subunit binding,GO:0043125~ErbB-3 class receptor binding,GO:0043559~insulin binding,GO:0043560~insulin receptor substrate binding,GO:0046935~1-phosphatidylinositol-3-kinase regulator activity,GO:0046982~protein heterodimerization activity,	IPR000198:RhoGAP_dom,IPR000980:SH2,IPR001452:SH3_domain,IPR008936:Rho_GTPase_activation_prot,IPR032498:PI3K_P85_iSH2,IPR035020:PI3kinase_P85_cSH2,IPR035022:PI3kinase_P85_nSH2,IPR035591:PI3K_p85alpha_SH3,IPR036028:SH3-like_dom_sf,IPR036860:SH2_dom_sf,IPR044124:ISH2_PIK3R1,	pon01521:EGFR tyrosine kinase inhibitor resistance,pon01522:Endocrine resistance,pon01524:Platinum drug resistance,pon04012:ErbB signaling pathway,pon04014:Ras signaling pathway,pon04015:Rap1 signaling pathway,pon04024:cAMP signaling pathway,pon04062:Chemokine signaling pathway,pon04066:HIF-1 signaling pathway,pon04068:FoxO signaling pathway,pon04070:Phosphatidylinositol signaling system,pon04071:Sphingolipid signaling pathway,pon04072:Phospholipase D signaling pathway,pon04140:Autophagy - animal,pon04150:mTOR signaling pathway,pon04151:PI3K-Akt signaling pathway,pon04152:AMPK signaling pathway,pon04210:Apoptosis,pon04211:Longevity regulating pathway,pon04213:Longevity regulating pathway - multiple species,pon04218:Cellular senescence,pon04360:Axon guidance,pon04370:VEGF signaling pathway,pon04380:Osteoclast differentiation,pon04510:Focal adhesion,pon04550:Signaling pathways regulating pluripotency of stem cells,pon04611:Platelet activation,pon04613:Neutrophil extracellular trap formation,pon04620:Toll-like receptor signaling pathway,pon04625:C-type lectin receptor signaling pathway,pon04630:JAK-STAT signaling pathway,pon04650:Natural killer cell mediated cytotoxicity,pon04660:T cell receptor signaling pathway,pon04662:B cell receptor signaling pathway,pon04664:Fc epsilon RI signaling pathway,pon04666:Fc gamma R-mediated phagocytosis,pon04668:TNF signaling pathway,pon04670:Leukocyte transendothelial migration,pon04722:Neurotrophin signaling pathway,pon04725:Cholinergic synapse,pon04750:Inflammatory mediator regulation of TRP channels,pon04810:Regulation of actin cytoskeleton,pon04910:Insulin signaling pathway,pon04914:Progesterone-mediated oocyte maturation,pon04915:Estrogen signaling pathway,pon04917:Prolactin signaling pathway,pon04919:Thyroid hormone signaling pathway,pon04923:Regulation of lipolysis in adipocytes,pon04926:Relaxin signaling pathway,pon04929:GnRH secretion,pon04930:Type II diabetes mellitus,pon04931:Insulin resistance,pon04932:Non-alcoholic fatty liver disease,pon04933:AGE-RAGE signaling pathway in diabetic complications,pon04935:Growth hormone synthesis, secretion and action,pon04960:Aldosterone-regulated sodium reabsorption,pon04973:Carbohydrate digestion and absorption,pon05010:Alzheimer disease,pon05017:Spinocerebellar ataxia,pon05020:Prion disease,pon05100:Bacterial invasion of epithelial cells,pon05135:Yersinia infection,pon05142:Chagas disease,pon05146:Amoebiasis,pon05160:Hepatitis C,pon05161:Hepatitis B,pon05162:Measles,pon05163:Human cytomegalovirus infection,pon05164:Influenza A,pon05165:Human papillomavirus infection,pon05166:Human T-cell leukemia virus 1 infection,pon05167:Kaposi sarcoma-associated herpesvirus infection,pon05168:Herpes simplex virus 1 infection,pon05169:Epstein-Barr virus infection,pon05170:Human immunodeficiency virus 1 infection,pon05171:Coronavirus disease - COVID-19,pon05200:Pathways in cancer,pon05203:Viral carcinogenesis,pon05205:Proteoglycans in cancer,pon05206:MicroRNAs in cancer,pon05207:Chemical carcinogenesis - receptor activation,pon05208:Chemical carcinogenesis - reactive oxygen species,pon05210:Colorectal cancer,pon05211:Renal cell carcinoma,pon05212:Pancreatic cancer,pon05213:Endometrial cancer,pon05214:Glioma,pon05215:Prostate cancer,pon05218:Melanoma,pon05220:Chronic myeloid leukemia,pon05221:Acute myeloid leukemia,pon05222:Small cell lung cancer,pon05223:Non-small cell lung cancer,pon05224:Breast cancer,pon05225:Hepatocellular carcinoma,pon05226:Gastric cancer,pon05230:Central carbon metabolism in cancer,pon05231:Choline metabolism in cancer,pon05235:PD-L1 expression and PD-1 checkpoint pathway in cancer,pon05415:Diabetic cardiomyopathy,pon05417:Lipid and atherosclerosis,pon05418:Fluid shear stress and atherosclerosis,			SM00252:SH2,SM00324:RhoGAP,SM00326:SH3,	KW-0346~Stress response,KW-0653~Protein transport,KW-0813~Transport,				KW-0175~Coiled coil,KW-0677~Repeat,KW-0727~SH2 domain,KW-0728~SH3 domain,			KW-0007~Acetylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,	COMPBIAS:Pro residues,DOMAIN:Rho-GAP,DOMAIN:SH2,DOMAIN:SH2 1,DOMAIN:SH2 2,DOMAIN:SH3,REGION:Disordered,
P27986	phosphoinositide-3-kinase regulatory subunit 1(PIK3R1)	Homo sapiens	104.Insulin_signaling,105.Signaling_glucose_uptake,106.Glycogen_synthase-synthesis,107.mRNA_translation-protein_synthesis,2.Cytokine_Receptors,37.Akt-PKB_Effector_of_P13K_in_Vivo,63.LAT_couples_T-cell_receptor,	h_achPathway:Role of nicotinic acetylcholine receptors in the regulation of apoptosis,h_aktPathway:AKT Signaling Pathway,h_arfPathway:Tumor Suppressor Arf Inhibits Ribosomal Biogenesis,h_badPathway:Regulation of BAD phosphorylation,h_bcellsurvivalPathway:B Cell Survival Pathway,h_cdc42racPathway:Role of PI3K subunit p85 in regulation of Actin Organization and Cell Migration,h_crebPathway:Transcription factor CREB and its extracellular signals,h_ctcfPathway:CTCF: First Multivalent Nuclear Factor,h_ctla4Pathway:The Co-Stimulatory Signal During T-cell Activation,h_cxcr4Pathway:CXCR4 Signaling Pathway,h_ecmPathway:Erk and PI-3 Kinase Are Necessary for Collagen Binding in Corneal Epithelia,h_edg1Pathway:Phospholipids as signalling intermediaries,h_egfPathway:EGF Signaling Pathway,h_eif4Pathway:Regulation of eIF4e and p70 S6 Kinase,h_erk5Pathway:Role of Erk5 in Neuronal Survival,h_fcer1Pathway:Fc Epsilon Receptor I Signaling in Mast Cells,h_gcrpathway:Corticosteroids and cardioprotection,h_ghPathway:Growth Hormone Signaling Pathway,h_gleevecPathway:Inhibition of Cellular Proliferation by Gleevec,H_gsk3Pathway:Inactivation of Gsk3 by AKT causes accumulation of b-catenin in Alveolar Macrophages,h_hcmvPathway:Human Cytomegalovirus and Map Kinase Pathways,h_hdacPathway:Control of skeletal myogenesis by HDAC & calcium/calmodulin-dependent kinase (CaMK),h_her2Pathway:Role of ERBB2 in Signal Transduction and Oncology,h_igf1mtorPathway:Skeletal muscle hypertrophy is regulated via AKT/mTOR pathway,h_igf1Pathway:IGF-1 Signaling Pathway,h_igf1rPathway:Multiple antiapoptotic pathways from IGF-1R signaling lead to BAD phosphorylation,h_il2rbPathway:IL-2 Receptor Beta Chain in T cell Activation,h_il7Pathway:IL-7 Signal Transduction,h_insulinPathway:Insulin Signaling Pathway,h_longevityPathway:The IGF-1 Receptor and Longevity,h_metPathway:Signaling of Hepatocyte Growth Factor Receptor,h_mtorPathway:mTOR Signaling Pathway,h_nfatPathway:NFAT and Hypertrophy of the heart (Transcription in the broken heart),h_ngfPathway:Nerve growth factor pathway (NGF),h_nkcellsPathway:Ras-Independent pathway in NK cell-mediated cytotoxicity,h_par1pathway:Thrombin signaling and protease-activated receptors,h_pdgfPathway:PDGF Signaling Pathway,h_plcPathway:Phospholipase C Signaling Pathway,h_PparaPathway:Mechanism of Gene Regulation by Peroxisome Proliferators via PPARa(alpha),h_ptenPathway:PTEN dependent cell cycle arrest and apoptosis,h_rac1Pathway:Rac 1 cell motility signaling pathway,h_raccycdPathway:Influence of Ras and Rho proteins on G1 to S Transition,h_rasPathway:Ras Signaling Pathway,h_tcrPathway:T Cell Receptor Signaling Pathway,h_tffPathway:Trefoil Factors Initiate  Mucosal Healing,h_tpoPathway:TPO Signaling Pathway,h_trkaPathway:Trka Receptor Signaling Pathway,h_vegfPathway:VEGF, Hypoxia, and Angiogenesis,	GO:0001678~cellular glucose homeostasis,GO:0001953~negative regulation of cell-matrix adhesion,GO:0002687~positive regulation of leukocyte migration,GO:0006366~transcription from RNA polymerase II promoter,GO:0006606~protein import into nucleus,GO:0006955~immune response,GO:0007165~signal transduction,GO:0008286~insulin receptor signaling pathway,GO:0008625~extrinsic apoptotic signaling pathway via death domain receptors,GO:0008630~intrinsic apoptotic signaling pathway in response to DNA damage,GO:0010592~positive regulation of lamellipodium assembly,GO:0015031~protein transport,GO:0016310~phosphorylation,GO:0019221~cytokine-mediated signaling pathway,GO:0030183~B cell differentiation,GO:0030217~T cell differentiation,GO:0030316~osteoclast differentiation,GO:0032760~positive regulation of tumor necrosis factor production,GO:0032869~cellular response to insulin stimulus,GO:0033120~positive regulation of RNA splicing,GO:0034143~regulation of toll-like receptor 4 signaling pathway,GO:0034446~substrate adhesion-dependent cell spreading,GO:0034644~cellular response to UV,GO:0034976~response to endoplasmic reticulum stress,GO:0035655~interleukin-18-mediated signaling pathway,GO:0042307~positive regulation of protein import into nucleus,GO:0043066~negative regulation of apoptotic process,GO:0043491~protein kinase B signaling,GO:0045671~negative regulation of osteoclast differentiation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046326~positive regulation of glucose import,GO:0046854~phosphatidylinositol phosphorylation,GO:0048009~insulin-like growth factor receptor signaling pathway,GO:0048661~positive regulation of smooth muscle cell proliferation,GO:0050821~protein stabilization,GO:0051491~positive regulation of filopodium assembly,GO:0051497~negative regulation of stress fiber assembly,GO:0060396~growth hormone receptor signaling pathway,GO:0097529~myeloid leukocyte migration,GO:1900103~positive regulation of endoplasmic reticulum unfolded protein response,GO:1903076~regulation of protein localization to plasma membrane,GO:1903078~positive regulation of protein localization to plasma membrane,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005801~cis-Golgi network,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005911~cell-cell junction,GO:0005942~phosphatidylinositol 3-kinase complex,GO:0005943~phosphatidylinositol 3-kinase complex, class IA,GO:0016020~membrane,GO:0048471~perinuclear region of cytoplasm,GO:1990578~perinuclear endoplasmic reticulum membrane,	GO:0001784~phosphotyrosine binding,GO:0003677~DNA binding,GO:0004879~RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding,GO:0005068~transmembrane receptor protein tyrosine kinase adaptor activity,GO:0005158~insulin receptor binding,GO:0005159~insulin-like growth factor receptor binding,GO:0005168~neurotrophin TRKA receptor binding,GO:0005515~protein binding,GO:0016301~kinase activity,GO:0019209~kinase activator activity,GO:0019903~protein phosphatase binding,GO:0035014~phosphatidylinositol 3-kinase regulator activity,GO:0036312~phosphatidylinositol 3-kinase regulatory subunit binding,GO:0043125~ErbB-3 class receptor binding,GO:0043548~phosphatidylinositol 3-kinase binding,GO:0043559~insulin binding,GO:0043560~insulin receptor substrate binding,GO:0046935~1-phosphatidylinositol-3-kinase regulator activity,GO:0046982~protein heterodimerization activity,GO:0052742~phosphatidylinositol kinase activity,	IPR000198:RhoGAP_dom,IPR000980:SH2,IPR001452:SH3_domain,IPR003070:NR4A1-3,IPR008936:Rho_GTPase_activation_prot,IPR032498:PI3K_P85_iSH2,IPR035020:PI3kinase_P85_cSH2,IPR035022:PI3kinase_P85_nSH2,IPR035591:PI3K_p85alpha_SH3,IPR036028:SH3-like_dom_sf,IPR036860:SH2_dom_sf,IPR044124:ISH2_PIK3R1,	hsa01521:EGFR tyrosine kinase inhibitor resistance,hsa01522:Endocrine resistance,hsa01524:Platinum drug resistance,hsa04012:ErbB signaling pathway,hsa04014:Ras signaling pathway,hsa04015:Rap1 signaling pathway,hsa04024:cAMP signaling pathway,hsa04062:Chemokine signaling pathway,hsa04066:HIF-1 signaling pathway,hsa04068:FoxO signaling pathway,hsa04070:Phosphatidylinositol signaling system,hsa04071:Sphingolipid signaling pathway,hsa04072:Phospholipase D signaling pathway,hsa04140:Autophagy - animal,hsa04150:mTOR signaling pathway,hsa04151:PI3K-Akt signaling pathway,hsa04152:AMPK signaling pathway,hsa04210:Apoptosis,hsa04211:Longevity regulating pathway,hsa04213:Longevity regulating pathway - multiple species,hsa04218:Cellular senescence,hsa04360:Axon guidance,hsa04370:VEGF signaling pathway,hsa04380:Osteoclast differentiation,hsa04510:Focal adhesion,hsa04550:Signaling pathways regulating pluripotency of stem cells,hsa04611:Platelet activation,hsa04613:Neutrophil extracellular trap formation,hsa04620:Toll-like receptor signaling pathway,hsa04625:C-type lectin receptor signaling pathway,hsa04630:JAK-STAT signaling pathway,hsa04650:Natural killer cell mediated cytotoxicity,hsa04660:T cell receptor signaling pathway,hsa04662:B cell receptor signaling pathway,hsa04664:Fc epsilon RI signaling pathway,hsa04666:Fc gamma R-mediated phagocytosis,hsa04668:TNF signaling pathway,hsa04670:Leukocyte transendothelial migration,hsa04722:Neurotrophin signaling pathway,hsa04725:Cholinergic synapse,hsa04750:Inflammatory mediator regulation of TRP channels,hsa04810:Regulation of actin cytoskeleton,hsa04910:Insulin signaling pathway,hsa04914:Progesterone-mediated oocyte maturation,hsa04915:Estrogen signaling pathway,hsa04917:Prolactin signaling pathway,hsa04919:Thyroid hormone signaling pathway,hsa04923:Regulation of lipolysis in adipocytes,hsa04926:Relaxin signaling pathway,hsa04929:GnRH secretion,hsa04930:Type II diabetes mellitus,hsa04931:Insulin resistance,hsa04932:Non-alcoholic fatty liver disease,hsa04933:AGE-RAGE signaling pathway in diabetic complications,hsa04935:Growth hormone synthesis, secretion and action,hsa04960:Aldosterone-regulated sodium reabsorption,hsa04973:Carbohydrate digestion and absorption,hsa05010:Alzheimer disease,hsa05017:Spinocerebellar ataxia,hsa05020:Prion disease,hsa05100:Bacterial invasion of epithelial cells,hsa05131:Shigellosis,hsa05135:Yersinia infection,hsa05142:Chagas disease,hsa05146:Amoebiasis,hsa05160:Hepatitis C,hsa05161:Hepatitis B,hsa05162:Measles,hsa05163:Human cytomegalovirus infection,hsa05164:Influenza A,hsa05165:Human papillomavirus infection,hsa05166:Human T-cell leukemia virus 1 infection,hsa05167:Kaposi sarcoma-associated herpesvirus infection,hsa05168:Herpes simplex virus 1 infection,hsa05169:Epstein-Barr virus infection,hsa05170:Human immunodeficiency virus 1 infection,hsa05171:Coronavirus disease - COVID-19,hsa05200:Pathways in cancer,hsa05203:Viral carcinogenesis,hsa05205:Proteoglycans in cancer,hsa05206:MicroRNAs in cancer,hsa05207:Chemical carcinogenesis - receptor activation,hsa05208:Chemical carcinogenesis - reactive oxygen species,hsa05210:Colorectal cancer,hsa05211:Renal cell carcinoma,hsa05212:Pancreatic cancer,hsa05213:Endometrial cancer,hsa05214:Glioma,hsa05215:Prostate cancer,hsa05218:Melanoma,hsa05220:Chronic myeloid leukemia,hsa05221:Acute myeloid leukemia,hsa05222:Small cell lung cancer,hsa05223:Non-small cell lung cancer,hsa05224:Breast cancer,hsa05225:Hepatocellular carcinoma,hsa05226:Gastric cancer,hsa05230:Central carbon metabolism in cancer,hsa05231:Choline metabolism in cancer,hsa05235:PD-L1 expression and PD-1 checkpoint pathway in cancer,hsa05415:Diabetic cardiomyopathy,hsa05417:Lipid and atherosclerosis,hsa05418:Fluid shear stress and atherosclerosis,	269880~SHORT syndrome,615214~Agammaglobulinemia 7, autosomal recessive,616005~Immunodeficiency 36,		SM00252:SH2,SM00324:RhoGAP,SM00326:SH3,	KW-0346~Stress response,KW-0653~Protein transport,KW-0813~Transport,KW-0945~Host-virus interaction,			KW-0225~Disease variant,KW-0242~Dwarfism,	KW-0175~Coiled coil,KW-0677~Repeat,KW-0727~SH2 domain,KW-0728~SH3 domain,		KW-0418~Kinase,KW-0808~Transferase,	KW-0007~Acetylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,	COMPBIAS:Pro residues,DOMAIN:Rho-GAP,DOMAIN:SH2,DOMAIN:SH2 1,DOMAIN:SH2 2,DOMAIN:SH3,REGION:Disordered,
Q9UL19	phospholipase A and acyltransferase 4(PLAAT4)	Homo sapiens			GO:0006644~phospholipid metabolic process,GO:0008285~negative regulation of cell proliferation,GO:0016042~lipid catabolic process,GO:0036152~phosphatidylethanolamine acyl-chain remodeling,GO:0045618~positive regulation of keratinocyte differentiation,GO:0070292~N-acylphosphatidylethanolamine metabolic process,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0016020~membrane,	GO:0004623~phospholipase A2 activity,GO:0005515~protein binding,GO:0008970~phosphatidylcholine 1-acylhydrolase activity,GO:0016410~N-acyltransferase activity,GO:0016746~transferase activity, transferring acyl groups,GO:0052739~phosphatidylserine 1-acylhydrolase activity,GO:0052740~1-acyl-2-lysophosphatidylserine acylhydrolase activity,	IPR007053:LRAT_dom,					KW-0442~Lipid degradation,KW-0443~Lipid metabolism,	KW-0472~Membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0378~Hydrolase,KW-0808~Transferase,		ACT_SITE:Acyl-thioester intermediate,DOMAIN:LRAT,REGION:Essential for its ability regulate keratinocyte differentiation,REGION:Interaction with TGM1,TOPO_DOM:Cytoplasmic,TOPO_DOM:Lumenal,TRANSMEM:Helical,
Q9BX93	phospholipase A2 group XIIB(PLA2G12B)	Homo sapiens			GO:0006644~phospholipid metabolic process,GO:0016042~lipid catabolic process,GO:0042632~cholesterol homeostasis,GO:0050482~arachidonic acid secretion,GO:0070328~triglyceride homeostasis,	GO:0005576~extracellular region,	GO:0004623~phospholipase A2 activity,GO:0005509~calcium ion binding,	IPR010711:PLA2G12,IPR036444:PLipase_A2_dom_sf,	hsa00564:Glycerophospholipid metabolism,hsa00565:Ether lipid metabolism,hsa00590:Arachidonic acid metabolism,hsa00591:Linoleic acid metabolism,hsa00592:alpha-Linolenic acid metabolism,hsa01100:Metabolic pathways,hsa04014:Ras signaling pathway,hsa04270:Vascular smooth muscle contraction,hsa04972:Pancreatic secretion,hsa04975:Fat digestion and absorption,					KW-0964~Secreted,			KW-0732~Signal,	KW-0106~Calcium,KW-0479~Metal-binding,
Q64GA5	phospholipase A2, group IVC (cytosolic, calcium-independent)(Pla2g4c)	Mus musculus			GO:0006629~lipid metabolic process,GO:0006663~platelet activating factor biosynthetic process,GO:0009395~phospholipid catabolic process,GO:0036151~phosphatidylcholine acyl-chain remodeling,GO:0036152~phosphatidylethanolamine acyl-chain remodeling,GO:0046475~glycerophospholipid catabolic process,	GO:0005634~nucleus,GO:0005635~nuclear envelope,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005789~endoplasmic reticulum membrane,GO:0005811~lipid particle,GO:0005819~spindle,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005938~cell cortex,GO:0031966~mitochondrial membrane,	GO:0004620~phospholipase activity,GO:0004622~lysophospholipase activity,GO:0004623~phospholipase A2 activity,GO:0005509~calcium ion binding,GO:0005544~calcium-dependent phospholipid binding,GO:0008374~O-acyltransferase activity,GO:0016740~transferase activity,GO:0016787~hydrolase activity,GO:0047498~calcium-dependent phospholipase A2 activity,GO:0047499~calcium-independent phospholipase A2 activity,	IPR002642:LysoPLipase_cat_dom,IPR016035:Acyl_Trfase/lysoPLipase,	mmu00564:Glycerophospholipid metabolism,mmu00565:Ether lipid metabolism,mmu00590:Arachidonic acid metabolism,mmu00591:Linoleic acid metabolism,mmu00592:alpha-Linolenic acid metabolism,mmu01100:Metabolic pathways,mmu04010:MAPK signaling pathway,mmu04014:Ras signaling pathway,mmu04072:Phospholipase D signaling pathway,mmu04217:Necroptosis,mmu04270:Vascular smooth muscle contraction,mmu04370:VEGF signaling pathway,mmu04611:Platelet activation,mmu04664:Fc epsilon RI signaling pathway,mmu04666:Fc gamma R-mediated phagocytosis,mmu04724:Glutamatergic synapse,mmu04726:Serotonergic synapse,mmu04730:Long-term depression,mmu04750:Inflammatory mediator regulation of TRP channels,mmu04912:GnRH signaling pathway,mmu04913:Ovarian steroidogenesis,mmu04921:Oxytocin signaling pathway,mmu05231:Choline metabolism in cancer,			SM00022:PLAc,	KW-0443~Lipid metabolism,KW-1208~Phospholipid metabolism,	KW-0206~Cytoskeleton,KW-0539~Nucleus,KW-0963~Cytoplasm,					KW-0378~Hydrolase,KW-0808~Transferase,		ACT_SITE:Nucleophile,ACT_SITE:Proton acceptor,DOMAIN:PLA2c,REGION:Disordered,
Q06HQ7	phospholipase B1(PLB1)	Monodelphis domestica			GO:0006644~phospholipid metabolic process,GO:2000344~positive regulation of acrosome reaction,	GO:0016324~apical plasma membrane,GO:0031526~brush border membrane,	GO:0004622~lysophospholipase activity,GO:0004623~phospholipase A2 activity,GO:0004806~triglyceride lipase activity,GO:0050253~retinyl-palmitate esterase activity,	IPR001087:GDSL,IPR008265:Lipase_GDSL_AS,IPR035547:Phospholipase_B,IPR036514:SGNH_hydro_sf,IPR038885:PLB1,	mdo00564:Glycerophospholipid metabolism,mdo00565:Ether lipid metabolism,mdo00590:Arachidonic acid metabolism,mdo00591:Linoleic acid metabolism,mdo00592:alpha-Linolenic acid metabolism,mdo01100:Metabolic pathways,mdo04977:Vitamin digestion and absorption,				KW-0443~Lipid metabolism,KW-1208~Phospholipid metabolism,	KW-0472~Membrane,KW-1003~Cell membrane,			KW-0677~Repeat,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0378~Hydrolase,	KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,REGION:4 X 308-326 AA approximate repeats,REGION:Necessary for membrane localization,REPEAT:1,REPEAT:2,REPEAT:3,REPEAT:4,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q32NH8	phospholipase C delta 4 L homeolog(plcd4.L)	Xenopus laevis			GO:0006629~lipid metabolic process,GO:0007165~signal transduction,GO:0016042~lipid catabolic process,GO:0035556~intracellular signal transduction,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005783~endoplasmic reticulum,GO:0016020~membrane,	GO:0004435~phosphatidylinositol phospholipase C activity,GO:0005509~calcium ion binding,GO:0008081~phosphoric diester hydrolase activity,GO:0016787~hydrolase activity,GO:0046872~metal ion binding,	IPR000008:C2_dom,IPR000909:PLipase_C_PInositol-sp_X_dom,IPR001192:PI-PLC_fam,IPR001711:PLipase_C_Pinositol-sp_Y,IPR001849:PH_domain,IPR002048:EF_hand_dom,IPR011992:EF-hand-dom_pair,IPR011993:PH-like_dom_sf,IPR015359:PLC_EF-hand-like,IPR017946:PLC-like_Pdiesterase_TIM-brl,IPR018247:EF_Hand_1_Ca_BS,IPR035892:C2_domain_sf,	xla00562:Inositol phosphate metabolism,xla01100:Metabolic pathways,xla04020:Calcium signaling pathway,xla04070:Phosphatidylinositol signaling system,			SM00054:EFh,SM00148:PLCXc,SM00149:PLCYc,SM00233:PH,SM00239:C2,	KW-0442~Lipid degradation,KW-0443~Lipid metabolism,	KW-0256~Endoplasmic reticulum,KW-0472~Membrane,KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0677~Repeat,	KW-0106~Calcium,KW-0479~Metal-binding,	KW-0378~Hydrolase,KW-0807~Transducer,		COMPBIAS:Acidic residues,DOMAIN:C2,DOMAIN:EF-hand,DOMAIN:EF-hand 1,DOMAIN:EF-hand 2,DOMAIN:EF-hand 3,DOMAIN:PH,DOMAIN:PI-PLC X-box,DOMAIN:PI-PLC Y-box,MOTIF:GBA,MOTIF:PDZ-binding,REGION:Disordered,REGION:Substrate binding,
Q9UPR0	phospholipase C like 2(PLCL2)	Homo sapiens			GO:0002322~B cell proliferation involved in immune response,GO:0002337~B-1a B cell differentiation,GO:0006629~lipid metabolic process,GO:0007214~gamma-aminobutyric acid signaling pathway,GO:0016042~lipid catabolic process,GO:0032228~regulation of synaptic transmission, GABAergic,GO:0035556~intracellular signal transduction,GO:0050859~negative regulation of B cell receptor signaling pathway,	GO:0005737~cytoplasm,	GO:0004435~phosphatidylinositol phospholipase C activity,GO:0005515~protein binding,GO:0050811~GABA receptor binding,GO:0070679~inositol 1,4,5 trisphosphate binding,	IPR000008:C2_dom,IPR000909:PLipase_C_PInositol-sp_X_dom,IPR001192:PI-PLC_fam,IPR001711:PLipase_C_Pinositol-sp_Y,IPR001849:PH_domain,IPR011992:EF-hand-dom_pair,IPR011993:PH-like_dom_sf,IPR015359:PLC_EF-hand-like,IPR017946:PLC-like_Pdiesterase_TIM-brl,IPR028382:PLCL2_EFh,IPR035892:C2_domain_sf,				SM00148:PLCXc,SM00149:PLCYc,SM00233:PH,SM00239:C2,	KW-0442~Lipid degradation,KW-0443~Lipid metabolism,	KW-0963~Cytoplasm,					KW-0378~Hydrolase,KW-0807~Transducer,	KW-0007~Acetylation,KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,DOMAIN:C2,DOMAIN:PH,DOMAIN:PI-PLC X-box,DOMAIN:PI-PLC Y-box,REGION:Disordered,
A5D6R3	phospholipase C, delta 3a(plcd3a)	Danio rerio			GO:0006629~lipid metabolic process,GO:0007165~signal transduction,GO:0016042~lipid catabolic process,GO:0035556~intracellular signal transduction,	GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0032154~cleavage furrow,	GO:0004435~phosphatidylinositol phospholipase C activity,GO:0005509~calcium ion binding,GO:0008081~phosphoric diester hydrolase activity,GO:0016787~hydrolase activity,GO:0046872~metal ion binding,	IPR000008:C2_dom,IPR000909:PLipase_C_PInositol-sp_X_dom,IPR001192:PI-PLC_fam,IPR001711:PLipase_C_Pinositol-sp_Y,IPR001849:PH_domain,IPR002048:EF_hand_dom,IPR011992:EF-hand-dom_pair,IPR011993:PH-like_dom_sf,IPR017946:PLC-like_Pdiesterase_TIM-brl,IPR018247:EF_Hand_1_Ca_BS,IPR035892:C2_domain_sf,IPR039504:PLC-delta3_EF-hand,	dre00562:Inositol phosphate metabolism,dre01100:Metabolic pathways,dre04020:Calcium signaling pathway,dre04070:Phosphatidylinositol signaling system,			SM00148:PLCXc,SM00149:PLCYc,SM00233:PH,SM00239:C2,	KW-0442~Lipid degradation,KW-0443~Lipid metabolism,	KW-0472~Membrane,KW-0963~Cytoplasm,			KW-0677~Repeat,	KW-0106~Calcium,KW-0479~Metal-binding,	KW-0378~Hydrolase,KW-0807~Transducer,	KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,DOMAIN:C2,DOMAIN:EF-hand 1,DOMAIN:EF-hand 2,DOMAIN:EF-hand 3,DOMAIN:PH,DOMAIN:PI-PLC X-box,DOMAIN:PI-PLC Y-box,REGION:Disordered,REGION:Substrate binding,
O14494	phospholipid phosphatase 1(PLPP1)	Homo sapiens			GO:0006644~phospholipid metabolic process,GO:0006665~sphingolipid metabolic process,GO:0006670~sphingosine metabolic process,GO:0006672~ceramide metabolic process,GO:0007165~signal transduction,GO:0007205~protein kinase C-activating G-protein coupled receptor signaling pathway,GO:0008285~negative regulation of cell proliferation,GO:0019216~regulation of lipid metabolic process,GO:0030148~sphingolipid biosynthetic process,GO:0030518~intracellular steroid hormone receptor signaling pathway,GO:0030521~androgen receptor signaling pathway,GO:0046839~phospholipid dephosphorylation,	GO:0005886~plasma membrane,GO:0005901~caveola,GO:0016020~membrane,GO:0016324~apical plasma membrane,GO:0045121~membrane raft,GO:0070062~extracellular exosome,	GO:0000810~diacylglycerol diphosphate phosphatase activity,GO:0005515~protein binding,GO:0008195~phosphatidate phosphatase activity,GO:0042392~sphingosine-1-phosphate phosphatase activity,GO:0042577~lipid phosphatase activity,	IPR000326:P_Acid_Pase_2/haloperoxidase,IPR036938:P_Acid_Pase_2/haloperoxi_sf,IPR043216:PA_PP_rel,	hsa00561:Glycerolipid metabolism,hsa00564:Glycerophospholipid metabolism,hsa00565:Ether lipid metabolism,hsa00600:Sphingolipid metabolism,hsa01100:Metabolic pathways,hsa04072:Phospholipase D signaling pathway,hsa04666:Fc gamma R-mediated phagocytosis,hsa04975:Fat digestion and absorption,hsa05231:Choline metabolism in cancer,			SM00014:acidPPc,	KW-0443~Lipid metabolism,	KW-0472~Membrane,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0378~Hydrolase,	KW-0325~Glycoprotein,	ACT_SITE:Nucleophile,ACT_SITE:Proton donors,CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Polar residues,MOTIF:PDZ-binding; involved in localization to the apical cell membrane,MUTAGEN:R->K: Decreased lipid phosphatase activity.,REGION:Disordered,REGION:Phosphatase sequence motif I,REGION:Phosphatase sequence motif II,REGION:Phosphatase sequence motif III,SITE:Stabilizes the active site histidine for nucleophilic attack,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q5U3U0	phytanoyl-CoA dioxygenase domain containing 1(phyhd1)	Danio rerio					GO:0016491~oxidoreductase activity,GO:0016706~oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors,GO:0046872~metal ion binding,GO:0051213~dioxygenase activity,	IPR008775:Phytyl_CoA_dOase-like,										KW-0408~Iron,KW-0479~Metal-binding,	KW-0223~Dioxygenase,KW-0560~Oxidoreductase,
Q9PU36	piccolo presynaptic cytomatrix protein(PCLO)	Gallus gallus			GO:0007010~cytoskeleton organization,GO:0035418~protein localization to synapse,GO:1904071~presynaptic active zone assembly,	GO:0016020~membrane,GO:0030424~axon,GO:0042995~cell projection,GO:0043226~organelle,GO:0045202~synapse,GO:0048786~presynaptic active zone,GO:0048788~cytoskeleton of presynaptic active zone,GO:0098978~glutamatergic synapse,GO:0098982~GABA-ergic synapse,	GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0005522~profilin binding,GO:0005544~calcium-dependent phospholipid binding,GO:0046872~metal ion binding,GO:0098882~structural constituent of presynaptic active zone,	IPR000008:C2_dom,IPR001478:PDZ,IPR001565:Synaptotagmin,IPR008899:Znf_piccolo,IPR011011:Znf_FYVE_PHD,IPR013083:Znf_RING/FYVE/PHD,IPR035892:C2_domain_sf,IPR036034:PDZ_sf,IPR042720:PCLO_FYVE1,				SM00228:PDZ,SM00239:C2,		KW-0770~Synapse,KW-0966~Cell projection,			KW-0175~Coiled coil,KW-0677~Repeat,KW-0863~Zinc-finger,	KW-0106~Calcium,KW-0111~Calcium/phospholipid-binding,KW-0479~Metal-binding,KW-0862~Zinc,			COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,COMPBIAS:Pro residues,DOMAIN:C2,DOMAIN:C2 1,DOMAIN:C2 2,DOMAIN:PDZ,REGION:10 X 10 AA tandem approximate repeats of P-A-K-P-Q-P-Q-Q-P-X,REGION:Disordered,ZN_FING:C4-type,
P79749	platelet-derived growth factor receptor, beta polypeptide(pdgfrb)	Takifugu rubripes			GO:0001525~angiogenesis,GO:0006468~protein phosphorylation,GO:0006935~chemotaxis,GO:0007275~multicellular organism development,GO:0014911~positive regulation of smooth muscle cell migration,GO:0016310~phosphorylation,GO:0033674~positive regulation of kinase activity,GO:0048008~platelet-derived growth factor receptor signaling pathway,GO:0060326~cell chemotaxis,	GO:0005886~plasma membrane,GO:0031410~cytoplasmic vesicle,GO:0043202~lysosomal lumen,GO:0043235~receptor complex,	GO:0004714~transmembrane receptor protein tyrosine kinase activity,GO:0005019~platelet-derived growth factor beta-receptor activity,GO:0005524~ATP binding,GO:0048407~platelet-derived growth factor binding,	IPR000719:Prot_kinase_dom,IPR001245:Ser-Thr/Tyr_kinase_cat_dom,IPR003598:Ig_sub2,IPR003599:Ig_sub,IPR007110:Ig-like_dom,IPR008266:Tyr_kinase_AS,IPR011009:Kinase-like_dom_sf,IPR013098:Ig_I-set,IPR013783:Ig-like_fold,IPR017441:Protein_kinase_ATP_BS,IPR020635:Tyr_kinase_cat_dom,IPR027288:PGFRB,IPR036179:Ig-like_dom_sf,	tru04010:MAPK signaling pathway,tru04020:Calcium signaling pathway,tru04510:Focal adhesion,tru04540:Gap junction,tru04810:Regulation of actin cytoskeleton,		PIRSF000615:TyrPK_CSF1-R,PIRSF500948:Beta-PDGF_receptor,	SM00219:TyrKc,SM00408:IGc2,SM00409:IG,	KW-0145~Chemotaxis,	KW-0458~Lysosome,KW-0472~Membrane,KW-0968~Cytoplasmic vesicle,KW-1003~Cell membrane,			KW-0393~Immunoglobulin domain,KW-0677~Repeat,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0067~ATP-binding,KW-0460~Magnesium,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,	KW-0217~Developmental protein,KW-0418~Kinase,KW-0675~Receptor,KW-0808~Transferase,KW-0829~Tyrosine-protein kinase,KW-9996~Developmental protein,	KW-0325~Glycoprotein,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1015~Disulfide bond,	ACT_SITE:Proton acceptor,CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Basic and acidic residues,DOMAIN:Ig-like,DOMAIN:Ig-like C2-type 1,DOMAIN:Ig-like C2-type 2,DOMAIN:Ig-like C2-type 3,DOMAIN:Protein kinase,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q96PX9	pleckstrin homology and RhoGEF domain containing G4B(PLEKHG4B)	Homo sapiens			GO:0007411~axon guidance,GO:0051056~regulation of small GTPase mediated signal transduction,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0019898~extrinsic component of membrane,	GO:0005085~guanyl-nucleotide exchange factor activity,GO:0005515~protein binding,	IPR000219:DH-domain,IPR001849:PH_domain,IPR011993:PH-like_dom_sf,IPR035899:DBL_dom_sf,IPR036865:CRAL-TRIO_dom_sf,				SM00233:PH,SM00325:RhoGEF,									COMPBIAS:Polar residues,DOMAIN:DH,DOMAIN:PH,REGION:Disordered,
P70206	plexin A1(Plxna1)	Mus musculus			GO:0007162~negative regulation of cell adhesion,GO:0008360~regulation of cell shape,GO:0014910~regulation of smooth muscle cell migration,GO:0021628~olfactory nerve formation,GO:0021828~gonadotrophin-releasing hormone neuronal migration to the hypothalamus,GO:0030334~regulation of cell migration,GO:0043087~regulation of GTPase activity,GO:0050772~positive regulation of axonogenesis,GO:0060666~dichotomous subdivision of terminal units involved in salivary gland branching,GO:0071526~semaphorin-plexin signaling pathway,GO:0097485~neuron projection guidance,GO:1902287~semaphorin-plexin signaling pathway involved in axon guidance,GO:1990138~neuron projection extension,	GO:0002116~semaphorin receptor complex,GO:0005654~nucleoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0016020~membrane,	GO:0005515~protein binding,GO:0017154~semaphorin receptor activity,	IPR001627:Semap_dom,IPR002165:Plexin_repeat,IPR002909:IPT_dom,IPR008936:Rho_GTPase_activation_prot,IPR013548:Plexin_cytoplasmic_RasGAP_dom,IPR013783:Ig-like_fold,IPR014756:Ig_E-set,IPR015943:WD40/YVTN_repeat-like_dom_sf,IPR016201:PSI,IPR031148:Plexin,IPR036352:Semap_dom_sf,IPR041019:TIG1_plexin,IPR041362:TIG2_plexin,IPR042744:Plexin-A1_Sema,IPR046800:Plexin_RBD,	mmu04360:Axon guidance,			SM00423:PSI,SM00429:IPT,SM00630:Sema,		KW-0472~Membrane,KW-1003~Cell membrane,			KW-0175~Coiled coil,KW-0677~Repeat,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:IPT/TIG,DOMAIN:IPT/TIG 1,DOMAIN:IPT/TIG 2,DOMAIN:IPT/TIG 3,DOMAIN:IPT/TIG 4,DOMAIN:Sema,MUTAGEN:KRK->AAA: Loss of interaction with FARP2.,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q6BEA0	plexin A4(plxna4)	Danio rerio			GO:0001763~morphogenesis of a branching structure,GO:0007162~negative regulation of cell adhesion,GO:0007411~axon guidance,GO:0007414~axonal defasciculation,GO:0008360~regulation of cell shape,GO:0030334~regulation of cell migration,GO:0043087~regulation of GTPase activity,GO:0050772~positive regulation of axonogenesis,GO:0071526~semaphorin-plexin signaling pathway,GO:1902287~semaphorin-plexin signaling pathway involved in axon guidance,	GO:0002116~semaphorin receptor complex,GO:0005886~plasma membrane,GO:0016020~membrane,	GO:0017154~semaphorin receptor activity,	IPR001627:Semap_dom,IPR002165:Plexin_repeat,IPR002909:IPT_dom,IPR008936:Rho_GTPase_activation_prot,IPR013548:Plexin_cytoplasmic_RasGAP_dom,IPR013783:Ig-like_fold,IPR014756:Ig_E-set,IPR015943:WD40/YVTN_repeat-like_dom_sf,IPR016201:PSI,IPR031148:Plexin,IPR036352:Semap_dom_sf,IPR041019:TIG1_plexin,IPR041362:TIG2_plexin,IPR046800:Plexin_RBD,				SM00423:PSI,SM00429:IPT,SM00630:Sema,		KW-0472~Membrane,KW-1003~Cell membrane,			KW-0175~Coiled coil,KW-0677~Repeat,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0217~Developmental protein,KW-0675~Receptor,KW-9996~Developmental protein,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:IPT/TIG 1,DOMAIN:IPT/TIG 2,DOMAIN:IPT/TIG 3,DOMAIN:IPT/TIG 4,DOMAIN:PSI 1,DOMAIN:PSI 2,DOMAIN:PSI 3,DOMAIN:Sema,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
P62205	polo like kinase 1(plk1)	Xenopus tropicalis			GO:0000278~mitotic cell cycle,GO:0006099~tricarboxylic acid cycle,GO:0006468~protein phosphorylation,GO:0007049~cell cycle,GO:0007052~mitotic spindle organization,GO:0007095~mitotic G2 DNA damage checkpoint,GO:0016310~phosphorylation,GO:0051301~cell division,GO:0071168~protein localization to chromatin,	GO:0000776~kinetochore,GO:0000922~spindle pole,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005819~spindle,GO:0005856~cytoskeleton,GO:0030496~midbody,	GO:0000166~nucleotide binding,GO:0004591~oxoglutarate dehydrogenase (succinyl-transferring) activity,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005524~ATP binding,GO:0016301~kinase activity,GO:0016740~transferase activity,GO:0030976~thiamine pyrophosphate binding,	IPR000719:Prot_kinase_dom,IPR000959:POLO_box_dom,IPR008271:Ser/Thr_kinase_AS,IPR011009:Kinase-like_dom_sf,IPR011603:2oxoglutarate_DH_E1,IPR017441:Protein_kinase_ATP_BS,IPR031717:KGD_C,IPR032106:2-oxogl_dehyd_N,IPR033695:POLO_box_2,IPR033701:POLO_box_1,IPR033702:PLK1_cat,IPR036947:POLO_box_dom_sf,IPR042179:KGD_C_sf,	xtr04068:FoxO signaling pathway,xtr04110:Cell cycle,xtr04114:Oocyte meiosis,xtr04914:Progesterone-mediated oocyte maturation,			SM00220:S_TKc,	KW-0131~Cell cycle,KW-0132~Cell division,KW-0498~Mitosis,	KW-0206~Cytoskeleton,KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0677~Repeat,	KW-0067~ATP-binding,KW-0547~Nucleotide-binding,KW-0786~Thiamine pyrophosphate,	KW-0418~Kinase,KW-0560~Oxidoreductase,KW-0723~Serine/threonine-protein kinase,KW-0808~Transferase,	KW-0597~Phosphoprotein,	ACT_SITE:Proton acceptor,DOMAIN:2-oxoglutarate dehydrogenase E1 component N-terminal,DOMAIN:Multifunctional 2-oxoglutarate metabolism enzyme C-terminal,DOMAIN:POLO box 1,DOMAIN:POLO box 2,DOMAIN:Protein kinase,MOTIF:D-box that targets the protein for proteasomal degradation in anaphase,REGION:Activation loop,REGION:Disordered,REGION:Important for interaction with phosphorylated proteins,REGION:Linker,
Q13310	poly(A) binding protein cytoplasmic 4(PABPC4)	Homo sapiens			GO:0006396~RNA processing,GO:0006401~RNA catabolic process,GO:0006412~translation,GO:0007596~blood coagulation,GO:0043488~regulation of mRNA stability,GO:0061515~myeloid cell development,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0010494~cytoplasmic stress granule,GO:1990904~ribonucleoprotein complex,	GO:0003723~RNA binding,GO:0003730~mRNA 3'-UTR binding,GO:0005515~protein binding,GO:0008143~poly(A) binding,GO:0008266~poly(U) RNA binding,	IPR000504:RRM_dom,IPR002004:PABP_HYD,IPR003954:RRM_dom_euk,IPR006515:PABP_1234,IPR012677:Nucleotide-bd_a/b_plait_sf,IPR034364:PABP_RRM1,IPR035979:RBD_domain_sf,IPR036053:PABP-dom,IPR045305:RRM2_I_PABPs,	hsa03015:mRNA surveillance pathway,hsa03018:RNA degradation,			SM00360:RRM,SM00361:RRM_1,SM00517:PolyA,		KW-0963~Cytoplasm,			KW-0677~Repeat,		KW-0694~RNA-binding,	KW-0488~Methylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Polar residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate,DOMAIN:PABC,DOMAIN:RRM,DOMAIN:RRM 1,DOMAIN:RRM 2,DOMAIN:RRM 3,DOMAIN:RRM 4,REGION:Disordered,
F1QB54	poly(A) binding protein, cytoplasmic 1a(pabpc1a)	Danio rerio			GO:0006397~mRNA processing,GO:0006412~translation,GO:0006417~regulation of translation,GO:0007507~heart development,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0010494~cytoplasmic stress granule,GO:1990904~ribonucleoprotein complex,	GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0003730~mRNA 3'-UTR binding,GO:0005515~protein binding,GO:0008143~poly(A) binding,GO:0008266~poly(U) RNA binding,	IPR000504:RRM_dom,IPR002004:PABP_HYD,IPR003954:RRM_dom_euk,IPR006515:PABP_1234,IPR012677:Nucleotide-bd_a/b_plait_sf,IPR034364:PABP_RRM1,IPR035979:RBD_domain_sf,IPR036053:PABP-dom,IPR045305:RRM2_I_PABPs,	dre03015:mRNA surveillance pathway,dre03018:RNA degradation,			SM00360:RRM,SM00361:RRM_1,SM00517:PolyA,	KW-0507~mRNA processing,KW-0648~Protein biosynthesis,KW-0810~Translation regulation,	KW-0963~Cytoplasm,			KW-0677~Repeat,		KW-0694~RNA-binding,		DOMAIN:PABC,DOMAIN:RRM 1,DOMAIN:RRM 2,DOMAIN:RRM 3,DOMAIN:RRM 4,
Q9H0J9	poly(ADP-ribose) polymerase family member 12(PARP12)	Homo sapiens			GO:0070213~protein auto-ADP-ribosylation,	GO:0005634~nucleus,	GO:0003723~RNA binding,GO:0003950~NAD+ ADP-ribosyltransferase activity,GO:0016779~nucleotidyltransferase activity,GO:0046872~metal ion binding,GO:1990404~protein ADP-ribosylase activity,	IPR000571:Znf_CCCH,IPR004170:WWE-dom,IPR012317:Poly(ADP-ribose)pol_cat_dom,IPR036388:WH-like_DNA-bd_sf,IPR037197:WWE_dom_sf,				SM00356:ZnF_C3H1,		KW-0539~Nucleus,			KW-0677~Repeat,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0520~NAD,KW-0862~Zinc,	KW-0328~Glycosyltransferase,KW-0548~Nucleotidyltransferase,KW-0808~Transferase,	KW-0013~ADP-ribosylation,KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:C3H1-type,DOMAIN:PARP catalytic,DOMAIN:WWE,DOMAIN:WWE 1,DOMAIN:WWE 2,REGION:Disordered,ZN_FING:C3H1-type,ZN_FING:C3H1-type 1,ZN_FING:C3H1-type 2,ZN_FING:C3H1-type 3,ZN_FING:C3H1-type 4,
Q2HJG2	poly(U) binding splicing factor 60(PUF60)	Bos taurus			GO:0000380~alternative mRNA splicing, via spliceosome,GO:0000381~regulation of alternative mRNA splicing, via spliceosome,GO:0006376~mRNA splice site selection,GO:0006397~mRNA processing,GO:0006915~apoptotic process,GO:0008380~RNA splicing,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0030054~cell junction,GO:0071011~precatalytic spliceosome,GO:0071013~catalytic step 2 spliceosome,GO:1990904~ribonucleoprotein complex,	GO:0003677~DNA binding,GO:0003723~RNA binding,GO:0042802~identical protein binding,	IPR000504:RRM_dom,IPR003954:RRM_dom_euk,IPR006532:PUF60-like,IPR012677:Nucleotide-bd_a/b_plait_sf,IPR034209:PUF60_RRM1,IPR034211:PUF60_RRM2,IPR034212:PUF60_RRM3,IPR035979:RBD_domain_sf,	bta03040:Spliceosome,			SM00360:RRM,SM00361:RRM_1,	KW-0053~Apoptosis,KW-0507~mRNA processing,KW-0508~mRNA splicing,KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,			KW-0677~Repeat,		KW-0238~DNA-binding,KW-0678~Repressor,KW-0687~Ribonucleoprotein,KW-0694~RNA-binding,	KW-0007~Acetylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Basic and acidic residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),DOMAIN:RRM,DOMAIN:RRM 1,DOMAIN:RRM 2,DOMAIN:RRM 3; atypical,REGION:Disordered,REGION:Inhibits homodimerization,REGION:Inhibits transcriptional repression, interaction with ERCC3 and apoptosis induction,
Q9WVF7	polymerase (DNA directed), epsilon(Pole)	Mus musculus			GO:0000082~G1/S transition of mitotic cell cycle,GO:0000278~mitotic cell cycle,GO:0000731~DNA synthesis involved in DNA repair,GO:0006260~DNA replication,GO:0006261~DNA-dependent DNA replication,GO:0006272~leading strand elongation,GO:0006281~DNA repair,GO:0006287~base-excision repair, gap-filling,GO:0006297~nucleotide-excision repair, DNA gap filling,GO:0006974~cellular response to DNA damage stimulus,GO:0045004~DNA replication proofreading,GO:0048568~embryonic organ development,GO:0071897~DNA biosynthetic process,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005886~plasma membrane,GO:0008622~epsilon DNA polymerase complex,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003887~DNA-directed DNA polymerase activity,GO:0008270~zinc ion binding,GO:0008310~single-stranded DNA 3'-5' exodeoxyribonuclease activity,GO:0016740~transferase activity,GO:0016779~nucleotidyltransferase activity,GO:0016787~hydrolase activity,GO:0046872~metal ion binding,GO:0051536~iron-sulfur cluster binding,GO:0051539~4 iron, 4 sulfur cluster binding,	IPR006133:DNA-dir_DNA_pol_B_exonuc,IPR006134:DNA-dir_DNA_pol_B_multi_dom,IPR006172:DNA-dir_DNA_pol_B,IPR012337:RNaseH-like_sf,IPR013697:DNA_pol_e_suA_C,IPR023211:DNA_pol_palm_dom_sf,IPR029703:POL2,IPR036397:RNaseH_sf,IPR042087:DNA_pol_B_thumb,IPR043502:DNA/RNA_pol_sf,	mmu03030:DNA replication,mmu03410:Base excision repair,mmu03420:Nucleotide excision repair,			SM00486:POLBc,SM01159:DUF1744,	KW-0227~DNA damage,KW-0234~DNA repair,KW-0235~DNA replication,	KW-0539~Nucleus,			KW-0863~Zinc-finger,	KW-0004~4Fe-4S,KW-0408~Iron,KW-0411~Iron-sulfur,KW-0479~Metal-binding,KW-0862~Zinc,	KW-0238~DNA-binding,KW-0239~DNA-directed DNA polymerase,KW-0378~Hydrolase,KW-0548~Nucleotidyltransferase,KW-0808~Transferase,	KW-0597~Phosphoprotein,	COMPBIAS:Acidic residues,COMPBIAS:Polar residues,DOMAIN:DNA polymerase epsilon catalytic subunit A C-terminal,DOMAIN:DNA-directed DNA polymerase family B exonuclease,DOMAIN:DNA-directed DNA polymerase family B multifunctional,MOTIF:CysB motif,REGION:Disordered,ZN_FING:CysA-type,
P58392	potassium calcium-activated channel subfamily N member 3(KCNN3)	Sus scrofa			GO:0071805~potassium ion transmembrane transport,	GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0043005~neuron projection,GO:0043025~neuronal cell body,	GO:0005242~inward rectifier potassium channel activity,GO:0005516~calmodulin binding,GO:0016286~small conductance calcium-activated potassium channel activity,	IPR004178:CaM-bd_dom,IPR013099:K_chnl_dom,IPR015449:K_chnl_Ca-activ_SK,IPR036122:CaM-bd_dom_sf,	ssc04911:Insulin secretion,ssc04929:GnRH secretion,			SM01053:CaMBD,	KW-0406~Ion transport,KW-0813~Transport,	KW-0472~Membrane,			KW-0175~Coiled coil,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0112~Calmodulin-binding,KW-0407~Ion channel,	KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,COMPBIAS:Pro residues,DOMAIN:Calmodulin-binding,INTRAMEM:Pore-forming; Name=Segment H5,REGION:Calmodulin-binding,REGION:Disordered,TRANSMEM:Helical,TRANSMEM:Helical; Name=Segment S1,TRANSMEM:Helical; Name=Segment S2,TRANSMEM:Helical; Name=Segment S3,TRANSMEM:Helical; Name=Segment S4,TRANSMEM:Helical; Name=Segment S5,TRANSMEM:Helical; Name=Segment S6,
Q8R4G8	potassium channel tetramerization domain containing 1(Kctd1)	Rattus norvegicus			GO:0034220~ion transmembrane transport,GO:0045892~negative regulation of transcription, DNA-templated,GO:0051260~protein homooligomerization,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005829~cytosol,GO:0034451~centriolar satellite,GO:0045171~intercellular bridge,	GO:0003714~transcription corepressor activity,GO:0008134~transcription factor binding,GO:0042802~identical protein binding,	IPR000210:BTB/POZ_dom,IPR003131:T1-type_BTB,IPR011333:SKP1/BTB/POZ_sf,IPR021893:DUF3504,IPR048595:KCTD1-15-like_C,IPR048599:BTB_POZ_KCTD1,				SM00225:BTB,	KW-0406~Ion transport,KW-0804~Transcription,KW-0805~Transcription regulation,KW-0813~Transport,	KW-0539~Nucleus,					KW-0407~Ion channel,KW-0678~Repressor,	KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,	COMPBIAS:Acidic residues,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:BTB,DOMAIN:BTB/POZ,REGION:Disordered,
Q9JL58	potassium two pore domain channel subfamily K member 9(Kcnk9)	Cavia porcellus			GO:0030322~stabilization of membrane potential,GO:0071805~potassium ion transmembrane transport,GO:1990573~potassium ion import across plasma membrane,	GO:0005886~plasma membrane,GO:0016020~membrane,	GO:0005249~voltage-gated potassium channel activity,GO:0005267~potassium channel activity,GO:0015271~outward rectifier potassium channel activity,GO:0022841~potassium ion leak channel activity,	IPR003092:2pore_dom_K_chnl_TASK,IPR003280:2pore_dom_K_chnl,IPR005407:KCNK9,IPR013099:K_chnl_dom,	cpoc04925:Aldosterone synthesis and secretion,		PIRSF038061:K_channel_subfamily_K_type,		KW-0406~Ion transport,KW-0633~Potassium transport,KW-0813~Transport,	KW-0472~Membrane,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0630~Potassium,	KW-0407~Ion channel,KW-0631~Potassium channel,	KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Potassium channel,INTRAMEM:Pore-forming; Name=Pore-forming 1,INTRAMEM:Pore-forming; Name=Pore-forming 2,MUTAGEN:H->N,Y: Reduces sensitivity to alterations in external pH.,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q05037	potassium voltage-gated channel subfamily A member 4(KCNA4)	Bos taurus			GO:0051260~protein homooligomerization,GO:0071805~potassium ion transmembrane transport,	GO:0005886~plasma membrane,GO:0008076~voltage-gated potassium channel complex,GO:0016020~membrane,GO:0030424~axon,GO:0043194~axon initial segment,GO:0043197~dendritic spine,	GO:0005249~voltage-gated potassium channel activity,GO:0005251~delayed rectifier potassium channel activity,GO:0005515~protein binding,GO:0030955~potassium ion binding,GO:0099508~voltage-gated ion channel activity involved in regulation of presynaptic membrane potential,	IPR000210:BTB/POZ_dom,IPR003131:T1-type_BTB,IPR003968:K_chnl_volt-dep_Kv,IPR003972:K_chnl_volt-dep_Kv1,IPR005821:Ion_trans_dom,IPR011333:SKP1/BTB/POZ_sf,IPR012897:K_chnl_volt-dep_Kv1.4_TID,IPR020467:K_chnl_volt-dep_Kv1.4,IPR027359:Volt_channel_dom_sf,IPR037065:K_chnl_volt-dep_Kv1.4_TID_sf,	bta04927:Cortisol synthesis and secretion,bta04934:Cushing syndrome,			SM00225:BTB,	KW-0406~Ion transport,KW-0633~Potassium transport,KW-0813~Transport,	KW-0472~Membrane,KW-0966~Cell projection,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0630~Potassium,	KW-0407~Ion channel,KW-0631~Potassium channel,KW-0851~Voltage-gated channel,	KW-0325~Glycoprotein,KW-0597~Phosphoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Acidic residues,COMPBIAS:Basic residues,DOMAIN:BTB,INTRAMEM:Helical; Name=Pore helix,MOTIF:PDZ-binding,MOTIF:Selectivity filter,REGION:Disordered,REGION:S4-S5 linker,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,TRANSMEM:Helical; Name=Segment S1,TRANSMEM:Helical; Name=Segment S2,TRANSMEM:Helical; Name=Segment S3,TRANSMEM:Helical; Name=Segment S5,TRANSMEM:Helical; Name=Segment S6,TRANSMEM:Helical; Voltage-sensor; Name=Segment S4,
Q9PT84	potassium voltage-gated channel subfamily H member 6(KCNH6)	Gallus gallus			GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0060307~regulation of ventricular cardiac muscle cell membrane repolarization,GO:0071805~potassium ion transmembrane transport,GO:0086011~membrane repolarization during action potential,GO:0086091~regulation of heart rate by cardiac conduction,	GO:0005634~nucleus,GO:0016020~membrane,GO:0034702~ion channel complex,	GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005242~inward rectifier potassium channel activity,GO:0005249~voltage-gated potassium channel activity,GO:0043565~sequence-specific DNA binding,	IPR000014:PAS,IPR000418:Ets_dom,IPR000595:cNMP-bd_dom,IPR001660:SAM,IPR003118:Pointed_dom,IPR003938:K_chnl_volt-dep_EAG/ELK/ERG,IPR003967:K_chnl_volt-dep_ERG,IPR005821:Ion_trans_dom,IPR013761:SAM/pointed_sf,IPR014710:RmlC-like_jellyroll,IPR018490:cNMP-bd_dom_sf,IPR035965:PAS-like_dom_sf,IPR036388:WH-like_DNA-bd_sf,IPR036390:WH_DNA-bd_sf,IPR046328:ETS_fam,				SM00100:cNMP,SM00251:SAM_PNT,SM00413:ETS,	KW-0406~Ion transport,KW-0633~Potassium transport,KW-0804~Transcription,KW-0805~Transcription regulation,KW-0813~Transport,	KW-0472~Membrane,KW-0539~Nucleus,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0630~Potassium,	KW-0010~Activator,KW-0238~DNA-binding,KW-0407~Ion channel,KW-0631~Potassium channel,KW-0851~Voltage-gated channel,	KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DNA_BIND:ETS,DOMAIN:Cyclic nucleotide-binding,DOMAIN:ETS,DOMAIN:PAC,DOMAIN:PAS,DOMAIN:PNT,DOMAIN:SAM,INTRAMEM:Pore-forming; Name=Segment H5,MOTIF:Selectivity filter,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,TRANSMEM:Helical; Name=Segment S1,TRANSMEM:Helical; Name=Segment S2,TRANSMEM:Helical; Name=Segment S3,TRANSMEM:Helical; Name=Segment S5,TRANSMEM:Helical; Name=Segment S6,TRANSMEM:Helical; Voltage-sensor; Name=Segment S4,
Q9NS40	potassium voltage-gated channel subfamily H member 7(KCNH7)	Homo sapiens			GO:0007623~circadian rhythm,GO:0042391~regulation of membrane potential,GO:0071805~potassium ion transmembrane transport,GO:0086011~membrane repolarization during action potential,	GO:0005886~plasma membrane,GO:0034702~ion channel complex,	GO:0005242~inward rectifier potassium channel activity,GO:0044877~macromolecular complex binding,	IPR000014:PAS,IPR000595:cNMP-bd_dom,IPR003938:K_chnl_volt-dep_EAG/ELK/ERG,IPR003967:K_chnl_volt-dep_ERG,IPR005821:Ion_trans_dom,IPR014710:RmlC-like_jellyroll,IPR018490:cNMP-bd_dom_sf,IPR035965:PAS-like_dom_sf,				SM00100:cNMP,	KW-0406~Ion transport,KW-0633~Potassium transport,KW-0813~Transport,	KW-0472~Membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0630~Potassium,	KW-0407~Ion channel,KW-0631~Potassium channel,KW-0851~Voltage-gated channel,	KW-0325~Glycoprotein,KW-0597~Phosphoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Basic and acidic residues,DOMAIN:PAC,DOMAIN:PAS,INTRAMEM:Pore-forming; Name=Segment H5,MOTIF:Selectivity filter,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical; Name=Segment S1,TRANSMEM:Helical; Name=Segment S2,TRANSMEM:Helical; Name=Segment S3,TRANSMEM:Helical; Name=Segment S5,TRANSMEM:Helical; Name=Segment S6,TRANSMEM:Helical; Voltage-sensor; Name=Segment S4,
B4F6V6	pre-B-cell leukemia homeobox 1(pbx1)	Xenopus tropicalis			GO:0001654~eye development,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0007399~nervous system development,GO:0007420~brain development,GO:0009887~animal organ morphogenesis,GO:0014036~neural crest cell fate specification,GO:0030154~cell differentiation,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048513~animal organ development,GO:0048568~embryonic organ development,GO:0048666~neuron development,	GO:0005634~nucleus,GO:0005667~transcription factor complex,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0043565~sequence-specific DNA binding,	IPR001356:Homeobox_dom,IPR005542:PBX_PBC_dom,IPR008422:Homeobox_KN_domain,IPR009057:Homeobox-like_sf,IPR017970:Homeobox_CS,	xtr04148:Efferocytosis,			SM00389:HOX,	KW-0221~Differentiation,KW-0524~Neurogenesis,KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,			KW-0371~Homeobox,		KW-0010~Activator,KW-0217~Developmental protein,KW-0238~DNA-binding,KW-9996~Developmental protein,		COMPBIAS:Polar residues,DNA_BIND:Homeobox,DNA_BIND:Homeobox; TALE-type,DOMAIN:Homeobox,DOMAIN:PBC,REGION:Disordered,REGION:PBC-A,REGION:PBC-B,
Q9UMS4	pre-mRNA processing factor 19(PRPF19)	Homo sapiens			GO:0000077~DNA damage checkpoint,GO:0000209~protein polyubiquitination,GO:0000244~spliceosomal tri-snRNP complex assembly,GO:0000245~spliceosomal complex assembly,GO:0000398~mRNA splicing, via spliceosome,GO:0006281~DNA repair,GO:0006303~double-strand break repair via nonhomologous end joining,GO:0008104~protein localization,GO:0008610~lipid biosynthetic process,GO:0010498~proteasomal protein catabolic process,GO:0048026~positive regulation of mRNA splicing, via spliceosome,GO:0070534~protein K63-linked ubiquitination,	GO:0000974~Prp19 complex,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005662~DNA replication factor A complex,GO:0005681~spliceosomal complex,GO:0005737~cytoplasm,GO:0005811~lipid particle,GO:0005819~spindle,GO:0016020~membrane,GO:0016607~nuclear speck,GO:0035861~site of double-strand break,GO:0071006~U2-type catalytic step 1 spliceosome,GO:0071007~U2-type catalytic step 2 spliceosome,GO:0071013~catalytic step 2 spliceosome,	GO:0004842~ubiquitin-protein transferase activity,GO:0005515~protein binding,GO:0034450~ubiquitin-ubiquitin ligase activity,GO:0042802~identical protein binding,GO:0061630~ubiquitin protein ligase activity,	IPR001680:WD40_rpt,IPR003613:Ubox_domain,IPR013083:Znf_RING/FYVE/PHD,IPR013915:Pre-mRNA_splic_Prp19,IPR015943:WD40/YVTN_repeat-like_dom_sf,IPR019775:WD40_repeat_CS,IPR020472:G-protein_beta_WD-40_rep,IPR036322:WD40_repeat_dom_sf,IPR038959:Prp19,	hsa03040:Spliceosome,hsa04120:Ubiquitin mediated proteolysis,			SM00320:WD40,SM00504:Ubox,	KW-0227~DNA damage,KW-0234~DNA repair,KW-0507~mRNA processing,KW-0508~mRNA splicing,KW-0833~Ubl conjugation pathway,	KW-0206~Cytoskeleton,KW-0539~Nucleus,KW-0551~Lipid droplet,KW-0747~Spliceosome,KW-0963~Cytoplasm,			KW-0677~Repeat,KW-0853~WD repeat,		KW-0808~Transferase,	KW-0007~Acetylation,	DOMAIN:Pre-mRNA-splicing factor 19,DOMAIN:U-box,MUTAGEN:Y->A: Loss of interaction with the RPA complex and loss of recruitment to sites of DNA damage.,REGION:May mediate interaction with PSMC5,REPEAT:WD,REPEAT:WD 1,REPEAT:WD 2,REPEAT:WD 3,REPEAT:WD 4,REPEAT:WD 5,REPEAT:WD 6,REPEAT:WD 7,
Q4KL13	predicted gene 527(Gm527)	Mus musculus						IPR040029:C14orf28-like,
Q9UHG3	prenylcysteine oxidase 1(PCYOX1)	Homo sapiens			GO:0030327~prenylated protein catabolic process,GO:0030328~prenylcysteine catabolic process,	GO:0005764~lysosome,GO:0034361~very-low-density lipoprotein particle,GO:0070062~extracellular exosome,	GO:0001735~prenylcysteine oxidase activity,GO:0005515~protein binding,GO:0071949~FAD binding,	IPR010795:Prenylcys_lyase,IPR017046:Prenylcysteine_Oxase,IPR036188:FAD/NAD-bd_sf,	hsa00900:Terpenoid backbone biosynthesis,		PIRSF036292:Prenylcysteine_oxidase,			KW-0458~Lysosome,			KW-0732~Signal,	KW-0274~FAD,KW-0285~Flavoprotein,	KW-0560~Oxidoreductase,	KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Prenylcysteine lyase,
Q32PL8	primase and polymerase (DNA-directed)(primpol)	Danio rerio			GO:0006264~mitochondrial DNA replication,GO:0006281~DNA repair,GO:0006974~cellular response to DNA damage stimulus,GO:0009411~response to UV,GO:0019985~translesion synthesis,GO:0031297~replication fork processing,GO:0042276~error-prone translesion synthesis,GO:0043504~mitochondrial DNA repair,	GO:0000428~DNA-directed RNA polymerase complex,GO:0005634~nucleus,GO:0005657~replication fork,GO:0005694~chromosome,GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,	GO:0003682~chromatin binding,GO:0003887~DNA-directed DNA polymerase activity,GO:0003896~DNA primase activity,GO:0008270~zinc ion binding,GO:0016740~transferase activity,GO:0016779~nucleotidyltransferase activity,GO:0030145~manganese ion binding,GO:0046872~metal ion binding,	IPR044917:PRIMPOL,					KW-0227~DNA damage,KW-0234~DNA repair,KW-0804~Transcription,	KW-0158~Chromosome,KW-0240~DNA-directed RNA polymerase,KW-0496~Mitochondrion,KW-0539~Nucleus,KW-9994~DNA-directed RNA polymerase,				KW-0464~Manganese,KW-0479~Metal-binding,KW-0862~Zinc,	KW-0239~DNA-directed DNA polymerase,KW-0548~Nucleotidyltransferase,KW-0808~Transferase,		COMPBIAS:Acidic residues,COMPBIAS:Basic and acidic residues,MOTIF:Zinc knuckle motif,REGION:Disordered,
P24802	procollagen-lysine, 2-oxoglutarate 5-dioxygenase 1(PLOD1)	Gallus gallus			GO:0017185~peptidyl-lysine hydroxylation,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0030867~rough endoplasmic reticulum membrane,	GO:0005506~iron ion binding,GO:0008475~procollagen-lysine 5-dioxygenase activity,GO:0031418~L-ascorbic acid binding,	IPR001006:Procol_lys_dOase,IPR005123:Oxoglu/Fe-dep_dioxygenase,IPR006620:Pro_4_hyd_alph,IPR029044:Nucleotide-diphossugar_trans,IPR044861:IPNS-like_FE2OG_OXY,	gga00310:Lysine degradation,gga01100:Metabolic pathways,			SM00702:P4Hc,		KW-0256~Endoplasmic reticulum,KW-0472~Membrane,			KW-0732~Signal,	KW-0408~Iron,KW-0479~Metal-binding,KW-0847~Vitamin C,	KW-0223~Dioxygenase,KW-0560~Oxidoreductase,	KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Fe2OG dioxygenase,
Q9GKN8	proline and arginine rich end leucine rich repeat protein(PRELP)	Bos taurus			GO:0090398~cellular senescence,	GO:0005615~extracellular space,GO:0070062~extracellular exosome,	GO:0005515~protein binding,GO:0008201~heparin binding,	IPR000372:LRRNT,IPR001611:Leu-rich_rpt,IPR003591:Leu-rich_rpt_typical-subtyp,IPR025875:Leu-rich_rpt_4,IPR032675:LRR_dom_sf,				SM00013:LRRNT,SM00364:LRR_BAC,SM00369:LRR_TYP,		KW-0272~Extracellular matrix,KW-0964~Secreted,			KW-0433~Leucine-rich repeat,KW-0677~Repeat,KW-0732~Signal,		KW-0358~Heparin-binding,	KW-0325~Glycoprotein,KW-0357~Heparan sulfate,KW-0654~Proteoglycan,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Pro residues,DOMAIN:LRRNT,REGION:Disordered,REPEAT:LRR 1,REPEAT:LRR 10,REPEAT:LRR 11,REPEAT:LRR 12,REPEAT:LRR 2,REPEAT:LRR 3,REPEAT:LRR 4,REPEAT:LRR 5,REPEAT:LRR 6,REPEAT:LRR 7,REPEAT:LRR 8,REPEAT:LRR 9,
D4A9R4	proline-rich transmembrane protein 4(Prrt4)	Rattus norvegicus				GO:0016020~membrane,								KW-0472~Membrane,			KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0597~Phosphoprotein,	COMPBIAS:Polar residues,REGION:Disordered,TRANSMEM:Helical,
Q9NXG6	prolyl 4-hydroxylase, transmembrane(P4HTM)	Homo sapiens			GO:0018401~peptidyl-proline hydroxylation to 4-hydroxy-L-proline,GO:0045646~regulation of erythrocyte differentiation,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0016020~membrane,	GO:0004656~procollagen-proline 4-dioxygenase activity,GO:0005506~iron ion binding,GO:0005509~calcium ion binding,GO:0016706~oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors,GO:0031418~L-ascorbic acid binding,GO:0046872~metal ion binding,	IPR002048:EF_hand_dom,IPR005123:Oxoglu/Fe-dep_dioxygenase,IPR006620:Pro_4_hyd_alph,IPR011992:EF-hand-dom_pair,IPR018247:EF_Hand_1_Ca_BS,IPR044862:Pro_4_hyd_alph_FE2OG_OXY,IPR045054:P4HA-like,		618493~Hypotonia, hypoventilation, impaired intellectual development, dysautonomia, epilepsy, and eye abnormalities,		SM00702:P4Hc,		KW-0256~Endoplasmic reticulum,KW-0472~Membrane,		KW-0225~Disease variant,KW-0887~Epilepsy,KW-0991~Intellectual disability,	KW-0677~Repeat,KW-0735~Signal-anchor,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0106~Calcium,KW-0408~Iron,KW-0479~Metal-binding,KW-0847~Vitamin C,	KW-0223~Dioxygenase,KW-0560~Oxidoreductase,	KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:EF-hand 1,DOMAIN:EF-hand 2,DOMAIN:Fe2OG dioxygenase,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Lumenal,TRANSMEM:Helical,TRANSMEM:Helical; Signal-anchor for type II membrane protein,
Q5ZKL5	prolyl endopeptidase-like(PREPL)	Gallus gallus			GO:0006508~proteolysis,	GO:0005794~Golgi apparatus,GO:0005829~cytosol,GO:0005856~cytoskeleton,	GO:0004252~serine-type endopeptidase activity,	IPR001375:Peptidase_S9,IPR002470:Peptidase_S9A,IPR023302:Pept_S9A_N,IPR029058:AB_hydrolase,						KW-0963~Cytoplasm,					KW-0378~Hydrolase,KW-0645~Protease,KW-0720~Serine protease,		ACT_SITE:Charge relay system,DOMAIN:Peptidase S9 prolyl oligopeptidase catalytic,DOMAIN:Peptidase S9A N-terminal,REGION:Disordered,
G1TGF1	prostaglandin E synthase 3(LOC100351480)	Oryctolagus cuniculus			GO:0001516~prostaglandin biosynthetic process,GO:0006457~protein folding,GO:0007004~telomere maintenance via telomerase,GO:0051131~chaperone-mediated protein complex assembly,GO:0051973~positive regulation of telomerase activity,GO:1905323~telomerase holoenzyme complex assembly,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0050220~prostaglandin-E synthase activity,GO:0051087~chaperone binding,GO:0051879~Hsp90 protein binding,GO:0070182~DNA polymerase binding,	IPR007052:CS_dom,IPR008978:HSP20-like_chaperone,IPR045250:p23-like,	ocu00590:Arachidonic acid metabolism,ocu01100:Metabolic pathways,ocu05207:Chemical carcinogenesis - receptor activation,				KW-0275~Fatty acid biosynthesis,KW-0276~Fatty acid metabolism,KW-0443~Lipid metabolism,KW-0444~Lipid biosynthesis,KW-0643~Prostaglandin biosynthesis,KW-0644~Prostaglandin metabolism,	KW-0963~Cytoplasm,					KW-0143~Chaperone,KW-0413~Isomerase,	KW-0007~Acetylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Acidic residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),DOMAIN:CS,MOTIF:PXLE motif,REGION:Disordered,SITE:Cleavage; by caspase-7,
G1TGF1	prostaglandin E synthase 3(LOC100355572)	Oryctolagus cuniculus			GO:0001516~prostaglandin biosynthetic process,GO:0006457~protein folding,GO:0007004~telomere maintenance via telomerase,GO:0051131~chaperone-mediated protein complex assembly,GO:0051973~positive regulation of telomerase activity,GO:1905323~telomerase holoenzyme complex assembly,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0050220~prostaglandin-E synthase activity,GO:0051087~chaperone binding,GO:0051879~Hsp90 protein binding,GO:0070182~DNA polymerase binding,	IPR007052:CS_dom,IPR008978:HSP20-like_chaperone,IPR045250:p23-like,	ocu00590:Arachidonic acid metabolism,ocu01100:Metabolic pathways,ocu05207:Chemical carcinogenesis - receptor activation,				KW-0275~Fatty acid biosynthesis,KW-0276~Fatty acid metabolism,KW-0443~Lipid metabolism,KW-0444~Lipid biosynthesis,KW-0643~Prostaglandin biosynthesis,KW-0644~Prostaglandin metabolism,	KW-0963~Cytoplasm,					KW-0143~Chaperone,KW-0413~Isomerase,	KW-0007~Acetylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Acidic residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),DOMAIN:CS,MOTIF:PXLE motif,REGION:Disordered,SITE:Cleavage; by caspase-7,
Q3SZJ4	prostaglandin reductase 1(PTGR1)	Bos taurus			GO:0006693~prostaglandin metabolic process,GO:0036102~leukotriene B4 metabolic process,GO:2001302~lipoxin A4 metabolic process,	GO:0005737~cytoplasm,	GO:0032440~2-alkenal reductase [NAD(P)] activity,GO:0035798~2-alkenal reductase (NADP+) activity,GO:0036132~13-prostaglandin reductase activity,GO:0036185~13-lipoxin reductase activity,GO:0047522~15-oxoprostaglandin 13-oxidase activity,GO:0097257~leukotriene B4 12-hydroxy dehydrogenase activity,	IPR011032:GroES-like_sf,IPR013149:ADH-like_C,IPR014190:PTGR1,IPR020843:PKS_ER,IPR036291:NAD(P)-bd_dom_sf,IPR041694:ADH_N_2,IPR045010:MDR_fam,	bta00590:Arachidonic acid metabolism,			SM00829:PKS_ER,	KW-0276~Fatty acid metabolism,KW-0443~Lipid metabolism,KW-0644~Prostaglandin metabolism,	KW-0963~Cytoplasm,				KW-0521~NADP,	KW-0560~Oxidoreductase,	KW-0007~Acetylation,KW-0379~Hydroxylation,KW-0597~Phosphoprotein,	DOMAIN:Enoyl reductase (ER),
Q9D9N8	protease-associated domain containing 1(Pradc1)	Mus musculus				GO:0005576~extracellular region,		IPR003137:PA_domain,IPR037323:PRADC1-like_PA,IPR046450:PA_dom_sf,						KW-0964~Secreted,			KW-0732~Signal,			KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:PA,
Q5F3J5	proteasome activator subunit 3(PSME3)	Gallus gallus			GO:0010950~positive regulation of endopeptidase activity,GO:0061136~regulation of proteasomal protein catabolic process,GO:2000045~regulation of G1/S transition of mitotic cell cycle,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0008537~proteasome activator complex,	GO:0061133~endopeptidase activator activity,	IPR003185:Proteasome_activ_PA28_N,IPR003186:PA28_C,IPR009077:Proteasome_activ_PA28,IPR036252:Proteasome_activ_sf,IPR036996:PA28_N_sf,IPR036997:PA28_C_sf,	gga03050:Proteasome,					KW-0647~Proteasome,						KW-0007~Acetylation,	COMPBIAS:Pro residues,DOMAIN:Proteasome activator PA28 C-terminal,DOMAIN:Proteasome activator PA28 N-terminal,REGION:Disordered,
Q3SZV5	proteasome maturation protein(POMP)	Bos taurus			GO:0043248~proteasome assembly,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005783~endoplasmic reticulum,GO:0005829~cytosol,GO:0016020~membrane,GO:0016607~nuclear speck,		IPR008012:Ump1,	bta03050:Proteasome,					KW-0256~Endoplasmic reticulum,KW-0472~Membrane,KW-0492~Microsome,KW-0539~Nucleus,KW-0963~Cytoplasm,					KW-0143~Chaperone,	KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),
Q7ZVE6	protein O-glucosyltransferase 2(poglut2)	Danio rerio			GO:0018242~protein O-linked glycosylation via serine,	GO:0005783~endoplasmic reticulum,GO:0005788~endoplasmic reticulum lumen,GO:0012505~endomembrane system,	GO:0016740~transferase activity,GO:0016757~transferase activity, transferring glycosyl groups,GO:0016763~transferase activity, transferring pentosyl groups,GO:0035251~UDP-glucosyltransferase activity,GO:0035252~UDP-xylosyltransferase activity,GO:0046527~glucosyltransferase activity,	IPR001298:Filamin/ABP280_rpt,IPR006598:CAP10,IPR013783:Ig-like_fold,IPR014756:Ig_E-set,IPR017868:Filamin/ABP280_repeat-like,				SM00557:IG_FLMN,SM00672:CAP10,		KW-0256~Endoplasmic reticulum,			KW-0732~Signal,		KW-0328~Glycosyltransferase,KW-0808~Transferase,	KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,MOTIF:Prevents secretion from ER,REPEAT:Filamin,
Q28F07	protein arginine methyltransferase 1(prmt1)	Xenopus tropicalis			GO:0006479~protein methylation,GO:0006807~nitrogen compound metabolic process,GO:0007399~nervous system development,GO:0007552~metamorphosis,GO:0008284~positive regulation of cell proliferation,GO:0008380~RNA splicing,GO:0018216~peptidyl-arginine methylation,GO:0022008~neurogenesis,GO:0030154~cell differentiation,GO:0032259~methylation,GO:0043170~macromolecule metabolic process,GO:0044238~primary metabolic process,GO:0045652~regulation of megakaryocyte differentiation,GO:0045653~negative regulation of megakaryocyte differentiation,GO:0045893~positive regulation of transcription, DNA-templated,GO:0048738~cardiac muscle tissue development,GO:0051260~protein homooligomerization,GO:0061431~cellular response to methionine,GO:1904263~positive regulation of TORC1 signaling,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0003713~transcription coactivator activity,GO:0008168~methyltransferase activity,GO:0008170~N-methyltransferase activity,GO:0008276~protein methyltransferase activity,GO:0016274~protein-arginine N-methyltransferase activity,GO:0016740~transferase activity,GO:0035241~protein-arginine omega-N monomethyltransferase activity,GO:0035242~protein-arginine omega-N asymmetric methyltransferase activity,GO:0042054~histone methyltransferase activity,GO:0042802~identical protein binding,GO:0044020~histone methyltransferase activity (H4-R3 specific),GO:1904047~S-adenosyl-L-methionine binding,	IPR025799:Arg_MeTrfase,IPR029063:SAM-dependent_MTases_sf,IPR041698:Methyltransf_25,	xtr04068:FoxO signaling pathway,				KW-0221~Differentiation,KW-0524~Neurogenesis,KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,KW-0963~Cytoplasm,				KW-0949~S-adenosyl-L-methionine,	KW-0010~Activator,KW-0217~Developmental protein,KW-0489~Methyltransferase,KW-0808~Transferase,KW-9996~Developmental protein,		DOMAIN:Methyltransferase,DOMAIN:SAM-dependent MTase PRMT-type,
Q5R698	protein arginine methyltransferase 5(PRMT5)	Pongo abelii			GO:0000387~spliceosomal snRNP assembly,GO:0006353~DNA-templated transcription, termination,GO:0006355~regulation of transcription, DNA-templated,GO:0018216~peptidyl-arginine methylation,GO:0032259~methylation,GO:0032922~circadian regulation of gene expression,GO:0035246~peptidyl-arginine N-methylation,GO:0042118~endothelial cell activation,GO:0090161~Golgi ribbon formation,GO:1904992~positive regulation of adenylate cyclase-inhibiting dopamine receptor signaling pathway,	GO:0000785~chromatin,GO:0005634~nucleus,GO:0005794~Golgi apparatus,GO:0005829~cytosol,GO:0034709~methylosome,GO:0035097~histone methyltransferase complex,	GO:0002039~p53 binding,GO:0003714~transcription corepressor activity,GO:0008327~methyl-CpG binding,GO:0008469~histone-arginine N-methyltransferase activity,GO:0016274~protein-arginine N-methyltransferase activity,GO:0035243~protein-arginine omega-N symmetric methyltransferase activity,GO:0042802~identical protein binding,GO:0043021~ribonucleoprotein complex binding,GO:0044020~histone methyltransferase activity (H4-R3 specific),GO:0046982~protein heterodimerization activity,GO:0070888~E-box binding,	IPR007857:Arg_MeTrfase_PRMT5,IPR025799:Arg_MeTrfase,IPR029063:SAM-dependent_MTases_sf,IPR035075:PRMT5,IPR035247:PRMT5_TIM,IPR035248:PRMT5_C,			PIRSF015894:Skb1_MeTrfase,		KW-0090~Biological rhythms,KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0333~Golgi apparatus,KW-0539~Nucleus,KW-0963~Cytoplasm,				KW-0949~S-adenosyl-L-methionine,	KW-0156~Chromatin regulator,KW-0489~Methyltransferase,KW-0678~Repressor,KW-0808~Transferase,	KW-0007~Acetylation,	ACT_SITE:Proton donor/acceptor,DOMAIN:PRMT5 TIM barrel,DOMAIN:PRMT5 arginine-N-methyltransferase,DOMAIN:PRMT5 oligomerisation,DOMAIN:SAM-dependent MTase PRMT-type,REGION:Beta barrel,REGION:Dimerization,REGION:Disordered,REGION:TIM barrel,SITE:Critical for specifying symmetric addition of methyl groups,
Q5RGQ2	protein arginine methyltransferase 8b(prmt8b)	Danio rerio			GO:0006479~protein methylation,GO:0018216~peptidyl-arginine methylation,GO:0030917~midbrain-hindbrain boundary development,GO:0032259~methylation,GO:0043009~chordate embryonic development,GO:0048666~neuron development,GO:0048813~dendrite morphogenesis,GO:0051260~protein homooligomerization,	GO:0005886~plasma membrane,GO:0009898~cytoplasmic side of plasma membrane,GO:0016020~membrane,	GO:0008168~methyltransferase activity,GO:0008757~S-adenosylmethionine-dependent methyltransferase activity,GO:0016273~arginine N-methyltransferase activity,GO:0016274~protein-arginine N-methyltransferase activity,GO:0016740~transferase activity,GO:0035241~protein-arginine omega-N monomethyltransferase activity,GO:0035242~protein-arginine omega-N asymmetric methyltransferase activity,GO:0042802~identical protein binding,GO:1904047~S-adenosyl-L-methionine binding,	IPR025799:Arg_MeTrfase,IPR029063:SAM-dependent_MTases_sf,IPR041698:Methyltransf_25,						KW-0472~Membrane,KW-1003~Cell membrane,			KW-0677~Repeat,	KW-0949~S-adenosyl-L-methionine,	KW-0489~Methyltransferase,KW-0808~Transferase,	KW-0449~Lipoprotein,KW-0488~Methylation,KW-0519~Myristate,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,COMPBIAS:Pro residues,DOMAIN:Methyltransferase,DOMAIN:SAM-dependent MTase PRMT-type,LIPID:N-myristoyl glycine,REGION:Disordered,
Q922R8	protein disulfide isomerase associated 6(Pdia6)	Mus musculus			GO:0030168~platelet activation,GO:0034976~response to endoplasmic reticulum stress,GO:0070527~platelet aggregation,GO:1903895~negative regulation of IRE1-mediated unfolded protein response,	GO:0005615~extracellular space,GO:0005783~endoplasmic reticulum,GO:0005788~endoplasmic reticulum lumen,GO:0005790~smooth endoplasmic reticulum,GO:0005793~endoplasmic reticulum-Golgi intermediate compartment,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0034663~endoplasmic reticulum chaperone complex,GO:0042470~melanosome,	GO:0003756~protein disulfide isomerase activity,GO:0015035~protein disulfide oxidoreductase activity,GO:0016853~isomerase activity,	IPR005788:PDI_thioredoxin-like_dom,IPR013766:Thioredoxin_domain,IPR017937:Thioredoxin_CS,IPR036249:Thioredoxin-like_sf,IPR044569:PDIA6-like,	mmu04141:Protein processing in endoplasmic reticulum,					KW-0256~Endoplasmic reticulum,KW-0472~Membrane,KW-1003~Cell membrane,			KW-0676~Redox-active center,KW-0677~Repeat,KW-0732~Signal,		KW-0143~Chaperone,KW-0413~Isomerase,	KW-0597~Phosphoprotein,KW-1015~Disulfide bond,	COMPBIAS:Acidic residues,DISULFID:Redox-active,DOMAIN:Thioredoxin,DOMAIN:Thioredoxin 1,DOMAIN:Thioredoxin 2,MOTIF:Prevents secretion from ER,REGION:Disordered,
P13667	protein disulfide isomerase family A member 4(PDIA4)	Homo sapiens			GO:0006457~protein folding,GO:0009306~protein secretion,GO:0034976~response to endoplasmic reticulum stress,GO:0061077~chaperone-mediated protein folding,	GO:0005615~extracellular space,GO:0005783~endoplasmic reticulum,GO:0005788~endoplasmic reticulum lumen,GO:0009986~cell surface,GO:0042470~melanosome,	GO:0003723~RNA binding,GO:0003756~protein disulfide isomerase activity,GO:0005515~protein binding,GO:0015035~protein disulfide oxidoreductase activity,	IPR005788:PDI_thioredoxin-like_dom,IPR005792:Prot_disulphide_isomerase,IPR013766:Thioredoxin_domain,IPR017068:Protein_diS-isomerase_A4,IPR017937:Thioredoxin_CS,IPR036249:Thioredoxin-like_sf,IPR041866:PDIA4_PDI_b,	hsa04141:Protein processing in endoplasmic reticulum,hsa04918:Thyroid hormone synthesis,hsa05110:Vibrio cholerae infection,		PIRSF036862:Disulphide_isom_A4,			KW-0256~Endoplasmic reticulum,			KW-0676~Redox-active center,KW-0677~Repeat,KW-0732~Signal,		KW-0413~Isomerase,	KW-0007~Acetylation,KW-1015~Disulfide bond,	COMPBIAS:Acidic residues,COMPBIAS:Basic and acidic residues,DISULFID:Redox-active,DOMAIN:Thioredoxin,DOMAIN:Thioredoxin 1,DOMAIN:Thioredoxin 2,DOMAIN:Thioredoxin 3,MOTIF:CXXC,MOTIF:Prevents secretion from ER,REGION:Disordered,
Q9UGJ0	protein kinase AMP-activated non-catalytic subunit gamma 2(PRKAG2)	Homo sapiens		h_chrebpPathway:ChREBP regulation by carbohydrates and cAMP,h_leptinPathway:Reversal of Insulin Resistance by Leptin,	GO:0005977~glycogen metabolic process,GO:0006110~regulation of glycolytic process,GO:0006468~protein phosphorylation,GO:0006469~negative regulation of protein kinase activity,GO:0006633~fatty acid biosynthetic process,GO:0006754~ATP biosynthetic process,GO:0010800~positive regulation of peptidyl-threonine phosphorylation,GO:0016126~sterol biosynthetic process,GO:0016310~phosphorylation,GO:0019217~regulation of fatty acid metabolic process,GO:0031669~cellular response to nutrient levels,GO:0035556~intracellular signal transduction,GO:0045860~positive regulation of protein kinase activity,GO:0046320~regulation of fatty acid oxidation,GO:0046324~regulation of glucose import,GO:0050790~regulation of catalytic activity,	GO:0005615~extracellular space,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0016020~membrane,GO:0031588~nucleotide-activated protein kinase complex,	GO:0004679~AMP-activated protein kinase activity,GO:0004862~cAMP-dependent protein kinase inhibitor activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008603~cAMP-dependent protein kinase regulator activity,GO:0008607~phosphorylase kinase regulator activity,GO:0016208~AMP binding,GO:0016301~kinase activity,GO:0019887~protein kinase regulator activity,GO:0019901~protein kinase binding,GO:0030295~protein kinase activator activity,GO:0043531~ADP binding,	IPR000644:CBS_dom,IPR046342:CBS_dom_sf,	hsa04068:FoxO signaling pathway,hsa04152:AMPK signaling pathway,hsa04211:Longevity regulating pathway,hsa04213:Longevity regulating pathway - multiple species,hsa04371:Apelin signaling pathway,hsa04530:Tight junction,hsa04710:Circadian rhythm,hsa04714:Thermogenesis,hsa04910:Insulin signaling pathway,hsa04920:Adipocytokine signaling pathway,hsa04921:Oxytocin signaling pathway,hsa04922:Glucagon signaling pathway,hsa04931:Insulin resistance,hsa04932:Non-alcoholic fatty liver disease,hsa04936:Alcoholic liver disease,hsa05410:Hypertrophic cardiomyopathy,	194200~Wolff-Parkinson-White syndrome,261740~Glycogen storage disease of heart, lethal congenital,600858~Cardiomyopathy, hypertrophic 6,		SM00116:CBS,	KW-0275~Fatty acid biosynthesis,KW-0276~Fatty acid metabolism,KW-0443~Lipid metabolism,KW-0444~Lipid biosynthesis,	KW-0472~Membrane,		KW-0122~Cardiomyopathy,KW-0225~Disease variant,KW-0322~Glycogen storage disease,	KW-0129~CBS domain,KW-0677~Repeat,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0418~Kinase,KW-0808~Transferase,	KW-0325~Glycoprotein,KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:CBS,DOMAIN:CBS 1,DOMAIN:CBS 2,DOMAIN:CBS 3,DOMAIN:CBS 4,MOTIF:AMPK pseudosubstrate,MUTAGEN:V->S: Induces phosphorylation by AMPK.,REGION:Disordered,TRANSMEM:Helical,
P00516	protein kinase cGMP-dependent 1(PRKG1)	Bos taurus			GO:0001764~neuron migration,GO:0006468~protein phosphorylation,GO:0016310~phosphorylation,GO:0016358~dendrite development,GO:0019934~cGMP-mediated signaling,GO:0030900~forebrain development,GO:0043087~regulation of GTPase activity,GO:0048668~collateral sprouting,GO:0060087~relaxation of vascular smooth muscle,GO:0090331~negative regulation of platelet aggregation,GO:1904706~negative regulation of vascular smooth muscle cell proliferation,GO:1904753~negative regulation of vascular associated smooth muscle cell migration,	GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0005829~cytosol,GO:0005886~plasma membrane,	GO:0004692~cGMP-dependent protein kinase activity,GO:0005246~calcium channel regulator activity,GO:0005524~ATP binding,GO:0030553~cGMP binding,GO:0042802~identical protein binding,	IPR000595:cNMP-bd_dom,IPR000719:Prot_kinase_dom,IPR000961:AGC-kinase_C,IPR002374:cGMP_dep_kinase,IPR008271:Ser/Thr_kinase_AS,IPR011009:Kinase-like_dom_sf,IPR014710:RmlC-like_jellyroll,IPR017441:Protein_kinase_ATP_BS,IPR018488:cNMP-bd_CS,IPR018490:cNMP-bd_dom_sf,IPR031831:PKcGMP_CC,IPR035014:STKc_cGK,	bta04022:cGMP-PKG signaling pathway,bta04270:Vascular smooth muscle contraction,bta04540:Gap junction,bta04611:Platelet activation,bta04713:Circadian entrainment,bta04714:Thermogenesis,bta04730:Long-term depression,bta04740:Olfactory transduction,bta04923:Regulation of lipolysis in adipocytes,bta04970:Salivary secretion,		PIRSF000559:cGMP-dep_kinase,	SM00100:cNMP,SM00133:S_TK_X,SM00220:S_TKc,		KW-0963~Cytoplasm,			KW-0175~Coiled coil,	KW-0067~ATP-binding,KW-0114~cAMP,KW-0116~cAMP-binding,KW-0140~cGMP,KW-0142~cGMP-binding,KW-0547~Nucleotide-binding,	KW-0021~Allosteric enzyme,KW-0418~Kinase,KW-0723~Serine/threonine-protein kinase,KW-0808~Transferase,	KW-0007~Acetylation,KW-0597~Phosphoprotein,KW-1015~Disulfide bond,	ACT_SITE:Proton acceptor,COMPBIAS:Acidic residues,COMPBIAS:Polar residues,DISULFID:Interchain,DOMAIN:AGC-kinase C-terminal,DOMAIN:Cyclic nucleotide-binding,DOMAIN:Protein kinase,REGION:Autoinhibitory domain,REGION:Disordered,REGION:Leucine-zipper,REGION:Required for dimerization,REGION:cGMP-binding, high affinity,REGION:cGMP-binding, low affinity,SITE:Cleavage,
Q13237	protein kinase cGMP-dependent 2(PRKG2)	Homo sapiens		h_no1Pathway:Actions of Nitric Oxide in the Heart,h_raccPathway:Ion Channels and Their Functional Role in Vascular Endothelium,	GO:0006468~protein phosphorylation,GO:0007165~signal transduction,GO:0016310~phosphorylation,GO:0032332~positive regulation of chondrocyte differentiation,GO:0046146~tetrahydrobiopterin metabolic process,GO:0072659~protein localization to plasma membrane,GO:1903829~positive regulation of cellular protein localization,GO:2001226~negative regulation of chloride transport,	GO:0005829~cytosol,GO:0016324~apical plasma membrane,GO:0031965~nuclear membrane,	GO:0004672~protein kinase activity,GO:0004692~cGMP-dependent protein kinase activity,GO:0005524~ATP binding,GO:0030553~cGMP binding,GO:0042802~identical protein binding,GO:0051019~mitogen-activated protein kinase binding,	IPR000595:cNMP-bd_dom,IPR000719:Prot_kinase_dom,IPR000961:AGC-kinase_C,IPR002374:cGMP_dep_kinase,IPR008271:Ser/Thr_kinase_AS,IPR011009:Kinase-like_dom_sf,IPR014710:RmlC-like_jellyroll,IPR017441:Protein_kinase_ATP_BS,IPR018488:cNMP-bd_CS,IPR018490:cNMP-bd_dom_sf,IPR035014:STKc_cGK,	hsa04022:cGMP-PKG signaling pathway,hsa04540:Gap junction,hsa04611:Platelet activation,hsa04713:Circadian entrainment,hsa04714:Thermogenesis,hsa04730:Long-term depression,hsa04740:Olfactory transduction,hsa04923:Regulation of lipolysis in adipocytes,hsa04924:Renin secretion,hsa04970:Salivary secretion,	619636~Acromesomelic dysplasia 4,619638~Spondylometaphyseal dysplasia, Pagnamenta type,	PIRSF000559:cGMP-dep_kinase,	SM00100:cNMP,SM00133:S_TK_X,SM00220:S_TKc,		KW-0472~Membrane,KW-1003~Cell membrane,		KW-0225~Disease variant,KW-0242~Dwarfism,	KW-0175~Coiled coil,	KW-0067~ATP-binding,KW-0140~cGMP,KW-0142~cGMP-binding,KW-0547~Nucleotide-binding,	KW-0418~Kinase,KW-0723~Serine/threonine-protein kinase,KW-0808~Transferase,	KW-0449~Lipoprotein,KW-0519~Myristate,KW-0597~Phosphoprotein,	ACT_SITE:Proton acceptor,DOMAIN:AGC-kinase C-terminal,DOMAIN:Cyclic nucleotide-binding,DOMAIN:Protein kinase,LIPID:N-myristoyl glycine,MUTAGEN:D->A: Reduces cGMP binding affinity; when associated with A-415.,MUTAGEN:R->A: Reduces cGMP binding affinity; when associated with A-412.,REGION:Disordered,REGION:cGMP-binding, high affinity; cAMP-binding, low affinity,REGION:cGMP-binding, high affinity; cAMP-binding, moderate affinity,
P0C605	protein kinase, cGMP-dependent, type I(Prkg1)	Mus musculus			GO:0001764~neuron migration,GO:0006468~protein phosphorylation,GO:0007165~signal transduction,GO:0007204~positive regulation of cytosolic calcium ion concentration,GO:0007286~spermatid development,GO:0008152~metabolic process,GO:0010920~negative regulation of inositol phosphate biosynthetic process,GO:0014050~negative regulation of glutamate secretion,GO:0016310~phosphorylation,GO:0016358~dendrite development,GO:0019934~cGMP-mediated signaling,GO:0021549~cerebellum development,GO:0030900~forebrain development,GO:0042753~positive regulation of circadian rhythm,GO:0043087~regulation of GTPase activity,GO:0045986~negative regulation of smooth muscle contraction,GO:0048668~collateral sprouting,GO:0060087~relaxation of vascular smooth muscle,GO:0061049~cell growth involved in cardiac muscle cell development,GO:0090331~negative regulation of platelet aggregation,GO:1904706~negative regulation of vascular smooth muscle cell proliferation,GO:1904753~negative regulation of vascular associated smooth muscle cell migration,GO:2000224~regulation of testosterone biosynthetic process,	GO:0001669~acrosomal vesicle,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0042383~sarcolemma,	GO:0000166~nucleotide binding,GO:0003824~catalytic activity,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0004692~cGMP-dependent protein kinase activity,GO:0005246~calcium channel regulator activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016301~kinase activity,GO:0016740~transferase activity,GO:0030553~cGMP binding,GO:0042802~identical protein binding,GO:0048273~mitogen-activated protein kinase p38 binding,	IPR000595:cNMP-bd_dom,IPR000719:Prot_kinase_dom,IPR000961:AGC-kinase_C,IPR002374:cGMP_dep_kinase,IPR008271:Ser/Thr_kinase_AS,IPR011009:Kinase-like_dom_sf,IPR014710:RmlC-like_jellyroll,IPR017441:Protein_kinase_ATP_BS,IPR017892:Pkinase_C,IPR018488:cNMP-bd_CS,IPR018490:cNMP-bd_dom_sf,IPR031831:PKcGMP_CC,IPR035014:STKc_cGK,	mmu04022:cGMP-PKG signaling pathway,mmu04270:Vascular smooth muscle contraction,mmu04540:Gap junction,mmu04611:Platelet activation,mmu04713:Circadian entrainment,mmu04714:Thermogenesis,mmu04730:Long-term depression,mmu04740:Olfactory transduction,mmu04923:Regulation of lipolysis in adipocytes,mmu04970:Salivary secretion,		PIRSF000559:cGMP-dep_kinase,	SM00100:cNMP,SM00133:S_TK_X,SM00220:S_TKc,		KW-0963~Cytoplasm,			KW-0175~Coiled coil,	KW-0067~ATP-binding,KW-0140~cGMP,KW-0142~cGMP-binding,KW-0547~Nucleotide-binding,	KW-0021~Allosteric enzyme,KW-0418~Kinase,KW-0723~Serine/threonine-protein kinase,KW-0808~Transferase,	KW-0007~Acetylation,KW-0597~Phosphoprotein,KW-1015~Disulfide bond,	ACT_SITE:Proton acceptor,COMPBIAS:Acidic residues,DISULFID:Interchain,DOMAIN:AGC-kinase C-terminal,DOMAIN:Cyclic nucleotide-binding,DOMAIN:Protein kinase,REGION:Autoinhibitory domain,REGION:Disordered,REGION:Leucine-zipper,REGION:Required for dimerization,REGION:cGMP-binding, high affinity,REGION:cGMP-binding, low affinity,
Q9ESG9	protein kinase, membrane associated tyrosine/threonine 1(Pkmyt1)	Mus musculus			GO:0006468~protein phosphorylation,GO:0007049~cell cycle,GO:0010972~negative regulation of G2/M transition of mitotic cell cycle,GO:0016310~phosphorylation,GO:0051321~meiotic cell cycle,	GO:0000139~Golgi membrane,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005794~Golgi apparatus,GO:0016020~membrane,	GO:0000166~nucleotide binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005524~ATP binding,GO:0016301~kinase activity,GO:0016740~transferase activity,GO:0046872~metal ion binding,	IPR000719:Prot_kinase_dom,IPR008271:Ser/Thr_kinase_AS,IPR011009:Kinase-like_dom_sf,IPR016235:Tyr/Thr_kinase_Cdc2_inhib,IPR017441:Protein_kinase_ATP_BS,	mmu04110:Cell cycle,mmu04114:Oocyte meiosis,mmu04914:Progesterone-mediated oocyte maturation,		PIRSF000567:TYPK_Myt1,	SM00220:S_TKc,	KW-0131~Cell cycle,	KW-0256~Endoplasmic reticulum,KW-0333~Golgi apparatus,KW-0472~Membrane,				KW-0067~ATP-binding,KW-0460~Magnesium,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,	KW-0418~Kinase,KW-0723~Serine/threonine-protein kinase,KW-0808~Transferase,	KW-0597~Phosphoprotein,	ACT_SITE:Proton acceptor,DOMAIN:Protein kinase,MOTIF:Membrane-association motif,REGION:Disordered,REGION:Interaction with CDC2-CCNB1,REGION:Interaction with PIN1,
Q9Y2T4	protein phosphatase 2 regulatory subunit Bgamma(PPP2R2C)	Homo sapiens				GO:0000159~protein phosphatase type 2A complex,GO:0005829~cytosol,	GO:0005515~protein binding,GO:0019888~protein phosphatase regulator activity,	IPR000009:PP2A_PR55,IPR001680:WD40_rpt,IPR015943:WD40/YVTN_repeat-like_dom_sf,IPR018067:PP2A_PR55_CS,IPR036322:WD40_repeat_dom_sf,	hsa03015:mRNA surveillance pathway,hsa04071:Sphingolipid signaling pathway,hsa04151:PI3K-Akt signaling pathway,hsa04152:AMPK signaling pathway,hsa04261:Adrenergic signaling in cardiomyocytes,hsa04390:Hippo signaling pathway,hsa04530:Tight junction,hsa04660:T cell receptor signaling pathway,hsa04728:Dopaminergic synapse,hsa05142:Chagas disease,hsa05160:Hepatitis C,hsa05165:Human papillomavirus infection,		PIRSF037309:PP2A_PR55,	SM00320:WD40,					KW-0677~Repeat,KW-0853~WD repeat,				REGION:Disordered,REPEAT:WD 1,REPEAT:WD 2,REPEAT:WD 3,REPEAT:WD 4,REPEAT:WD 5,REPEAT:WD 6,REPEAT:WD 7,
Q8BSS9	protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 2(Ppfia2)	Mus musculus			GO:0050808~synapse organization,GO:0060998~regulation of dendritic spine development,GO:0061001~regulation of dendritic spine morphogenesis,GO:0099519~dense core granule cytoskeletal transport,GO:2000300~regulation of synaptic vesicle exocytosis,	GO:0005737~cytoplasm,GO:0008021~synaptic vesicle,GO:0009986~cell surface,GO:0030424~axon,GO:0042734~presynaptic membrane,GO:0042995~cell projection,GO:0043197~dendritic spine,GO:0045202~synapse,GO:0048786~presynaptic active zone,GO:0098978~glutamatergic synapse,GO:0099523~presynaptic cytosol,GO:0099572~postsynaptic specialization,	GO:0005515~protein binding,GO:0044877~macromolecular complex binding,	IPR001660:SAM,IPR013761:SAM/pointed_sf,IPR029515:Liprin,IPR037620:Liprin-alpha_SAM_rpt_1,IPR037621:Liprin-alpha_SAM_rpt_2,IPR037622:Liprin-alpha_SAM_rpt_3,				SM00454:SAM,		KW-0770~Synapse,KW-0963~Cytoplasm,KW-0966~Cell projection,			KW-0175~Coiled coil,KW-0677~Repeat,			KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:SAM,DOMAIN:SAM 1,DOMAIN:SAM 2,DOMAIN:SAM 3,REGION:Disordered,
O46560	pyridoxal kinase(PDXK)	Sus scrofa			GO:0009443~pyridoxal 5'-phosphate salvage,GO:0016310~phosphorylation,	GO:0005654~nucleoplasm,GO:0005829~cytosol,	GO:0000287~magnesium ion binding,GO:0005524~ATP binding,GO:0008270~zinc ion binding,GO:0008478~pyridoxal kinase activity,GO:0030170~pyridoxal phosphate binding,GO:0030955~potassium ion binding,GO:0031402~sodium ion binding,GO:0031403~lithium ion binding,GO:0042803~protein homodimerization activity,GO:0046872~metal ion binding,	IPR004625:PyrdxlKinase,IPR013749:PM/HMP-P_kinase-1,IPR029056:Ribokinase-like,	ssc00750:Vitamin B6 metabolism,ssc01100:Metabolic pathways,ssc01240:Biosynthesis of cofactors,					KW-0963~Cytoplasm,				KW-0067~ATP-binding,KW-0460~Magnesium,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,KW-0862~Zinc,KW-0915~Sodium,	KW-0418~Kinase,KW-0808~Transferase,	KW-0007~Acetylation,KW-0597~Phosphoprotein,	ACT_SITE:Proton acceptor,DOMAIN:Pyridoxamine kinase/Phosphomethylpyrimidine kinase,REGION:Disordered,
Q91XF0	pyridoxine 5'-phosphate oxidase(Pnpo)	Mus musculus			GO:0008615~pyridoxine biosynthetic process,GO:0042818~pyridoxamine metabolic process,GO:0042822~pyridoxal phosphate metabolic process,GO:0042823~pyridoxal phosphate biosynthetic process,	GO:0005829~cytosol,	GO:0004733~pyridoxamine-phosphate oxidase activity,GO:0010181~FMN binding,GO:0016491~oxidoreductase activity,GO:0016638~oxidoreductase activity, acting on the CH-NH2 group of donors,GO:0030170~pyridoxal phosphate binding,GO:0042803~protein homodimerization activity,	IPR000659:Pyridox_Oxase,IPR011576:Pyridox_Oxase_put,IPR012349:Split_barrel_FMN-bd,IPR019576:Pyridoxamine_oxidase_dimer_C,IPR019740:Pyridox_Oxase_CS,	mmu00750:Vitamin B6 metabolism,mmu01100:Metabolic pathways,mmu01240:Biosynthesis of cofactors,		PIRSF000190:Pyd_amn-ph_oxd,		KW-0664~Pyridoxine biosynthesis,					KW-0285~Flavoprotein,KW-0288~FMN,KW-0663~Pyridoxal phosphate,	KW-0560~Oxidoreductase,	KW-0597~Phosphoprotein,
Q5R9X6	pyrroline-5-carboxylate reductase 1(PYCR1)	Pongo abelii			GO:0006561~proline biosynthetic process,GO:0034599~cellular response to oxidative stress,GO:0051881~regulation of mitochondrial membrane potential,GO:0055129~L-proline biosynthetic process,GO:1903377~negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,	GO:0005739~mitochondrion,	GO:0004735~pyrroline-5-carboxylate reductase activity,GO:0016491~oxidoreductase activity,GO:0042802~identical protein binding,	IPR000304:Pyrroline-COOH_reductase,IPR008927:6-PGluconate_DH-like_C_sf,IPR028939:P5C_Rdtase_cat_N,IPR029036:P5CR_dimer,IPR036291:NAD(P)-bd_dom_sf,	pon00330:Arginine and proline metabolism,pon01100:Metabolic pathways,pon01230:Biosynthesis of amino acids,		PIRSF000193:Pyrrol-5-carb_rd,		KW-0028~Amino-acid biosynthesis,KW-0346~Stress response,KW-0641~Proline biosynthesis,	KW-0496~Mitochondrion,			KW-0732~Signal,	KW-0521~NADP,	KW-0560~Oxidoreductase,	KW-0007~Acetylation,KW-0597~Phosphoprotein,	DOMAIN:Pyrroline-5-carboxylate reductase catalytic N-terminal,DOMAIN:Pyrroline-5-carboxylate reductase dimerisation,REGION:Disordered,
Q922W5	pyrroline-5-carboxylate reductase 1(Pycr1)	Mus musculus			GO:0006561~proline biosynthetic process,GO:0008652~cellular amino acid biosynthetic process,GO:0034599~cellular response to oxidative stress,GO:0051881~regulation of mitochondrial membrane potential,GO:0055129~L-proline biosynthetic process,GO:1903377~negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,	GO:0005739~mitochondrion,	GO:0004735~pyrroline-5-carboxylate reductase activity,GO:0016491~oxidoreductase activity,GO:0042802~identical protein binding,	IPR000304:Pyrroline-COOH_reductase,IPR008927:6-PGluconate_DH-like_C_sf,IPR028939:P5C_Rdtase_cat_N,IPR029036:P5CR_dimer,IPR036291:NAD(P)-bd_dom_sf,	mmu00330:Arginine and proline metabolism,mmu01100:Metabolic pathways,mmu01230:Biosynthesis of amino acids,		PIRSF000193:Pyrrol-5-carb_rd,		KW-0028~Amino-acid biosynthesis,KW-0346~Stress response,KW-0641~Proline biosynthesis,	KW-0496~Mitochondrion,				KW-0521~NADP,	KW-0560~Oxidoreductase,	KW-0007~Acetylation,KW-0597~Phosphoprotein,	DOMAIN:Pyrroline-5-carboxylate reductase catalytic N-terminal,DOMAIN:Pyrroline-5-carboxylate reductase dimerisation,
P11966	pyruvate dehydrogenase E1 subunit beta(PDHB)	Bos taurus			GO:0006006~glucose metabolic process,GO:0006086~acetyl-CoA biosynthetic process from pyruvate,GO:0006099~tricarboxylic acid cycle,	GO:0005654~nucleoplasm,GO:0005967~mitochondrial pyruvate dehydrogenase complex,GO:0045254~pyruvate dehydrogenase complex,	GO:0004739~pyruvate dehydrogenase (acetyl-transferring) activity,GO:0034604~pyruvate dehydrogenase (NAD+) activity,	IPR005475:Transketolase-like_Pyr-bd,IPR009014:Transketo_C/PFOR_II,IPR027110:PDHB,IPR029061:THDP-binding,IPR033248:Transketolase_C,	bta00010:Glycolysis / Gluconeogenesis,bta00020:Citrate cycle (TCA cycle),bta00620:Pyruvate metabolism,bta00785:Lipoic acid metabolism,bta01100:Metabolic pathways,bta01200:Carbon metabolism,bta01210:2-Oxocarboxylic acid metabolism,bta04066:HIF-1 signaling pathway,bta04922:Glucagon signaling pathway,bta05230:Central carbon metabolism in cancer,bta05415:Diabetic cardiomyopathy,			SM00861:Transket_pyr,	KW-0119~Carbohydrate metabolism,KW-0313~Glucose metabolism,KW-0816~Tricarboxylic acid cycle,	KW-0496~Mitochondrion,			KW-0809~Transit peptide,	KW-0670~Pyruvate,KW-0786~Thiamine pyrophosphate,	KW-0560~Oxidoreductase,	KW-0007~Acetylation,KW-0597~Phosphoprotein,	DOMAIN:Transketolase-like pyrimidine-binding,SITE:Important for interaction with DLAT,TRANSIT:Mitochondrion,
O88484	pyruvate dehydrogenase phosphatase catalytic subunit 2(Pdp2)	Rattus norvegicus			GO:0006470~protein dephosphorylation,GO:0035970~peptidyl-threonine dephosphorylation,GO:0042093~T-helper cell differentiation,GO:0042594~response to starvation,	GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,	GO:0004722~protein serine/threonine phosphatase activity,GO:0004741~[pyruvate dehydrogenase (lipoamide)] phosphatase activity,GO:0019909~[pyruvate dehydrogenase (lipoamide)] phosphatase regulator activity,GO:0046872~metal ion binding,	IPR000222:PP2C_BS,IPR001932:PPM-type_phosphatase-like_dom,IPR015655:PP2C,IPR036457:PPM-type-like_dom_sf,				SM00332:PP2Cc,		KW-0496~Mitochondrion,			KW-0809~Transit peptide,	KW-0460~Magnesium,KW-0464~Manganese,KW-0479~Metal-binding,	KW-0378~Hydrolase,KW-0904~Protein phosphatase,		DOMAIN:PPM-type phosphatase,TRANSIT:Mitochondrion,
Q92122	pyruvate kinase M1/2 S homeolog(pkm.S)	Xenopus laevis			GO:0006096~glycolytic process,GO:0016310~phosphorylation,		GO:0000166~nucleotide binding,GO:0000287~magnesium ion binding,GO:0003824~catalytic activity,GO:0004743~pyruvate kinase activity,GO:0005524~ATP binding,GO:0016301~kinase activity,GO:0016740~transferase activity,GO:0030955~potassium ion binding,GO:0046872~metal ion binding,	IPR001697:Pyr_Knase,IPR011037:Pyrv_Knase-like_insert_dom_sf,IPR015793:Pyrv_Knase_brl,IPR015795:Pyrv_Knase_C,IPR015806:Pyrv_Knase_insert_dom_sf,IPR015813:Pyrv/PenolPyrv_Kinase-like_dom,IPR018209:Pyrv_Knase_AS,IPR036918:Pyrv_Knase_C_sf,IPR040442:Pyrv_Kinase-like_dom_sf,	xla00010:Glycolysis / Gluconeogenesis,xla00620:Pyruvate metabolism,xla01100:Metabolic pathways,xla01200:Carbon metabolism,xla01230:Biosynthesis of amino acids,				KW-0324~Glycolysis,					KW-0067~ATP-binding,KW-0460~Magnesium,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,KW-0630~Potassium,KW-0670~Pyruvate,	KW-0418~Kinase,KW-0808~Transferase,		DOMAIN:Pyruvate kinase C-terminal,DOMAIN:Pyruvate kinase barrel,SITE:Transition state stabilizer,
Q6EE23	radical S-adenosyl methionine domain containing 2(rsad2)	Siniperca chuatsi			GO:0045087~innate immune response,GO:0050778~positive regulation of immune response,GO:0051607~defense response to virus,	GO:0005739~mitochondrion,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005811~lipid particle,	GO:0003824~catalytic activity,GO:0046872~metal ion binding,GO:0051539~4 iron, 4 sulfur cluster binding,	IPR006638:Elp3/MiaA/NifB-like_rSAM,IPR007197:rSAM,IPR013785:Aldolase_TIM,IPR026372:RSAD2,				SM00729:Elp3,	KW-0051~Antiviral defense,KW-0391~Immunity,KW-0399~Innate immunity,	KW-0256~Endoplasmic reticulum,KW-0472~Membrane,				KW-0004~4Fe-4S,KW-0408~Iron,KW-0411~Iron-sulfur,KW-0479~Metal-binding,KW-0949~S-adenosyl-L-methionine,			DOMAIN:Radical SAM core,
Q9NZL6	ral guanine nucleotide dissociation stimulator like 1(RGL1)	Homo sapiens			GO:0007264~small GTPase mediated signal transduction,GO:0007265~Ras protein signal transduction,GO:0043547~positive regulation of GTPase activity,	GO:0005829~cytosol,GO:0005886~plasma membrane,	GO:0005085~guanyl-nucleotide exchange factor activity,GO:0005515~protein binding,	IPR000159:RA_dom,IPR000651:Ras-like_Gua-exchang_fac_N,IPR001895:RASGEF_cat_dom,IPR008937:Ras-like_GEF,IPR019804:Ras_G-nucl-exch_fac_CS,IPR023578:Ras_GEF_dom_sf,IPR029071:Ubiquitin-like_domsf,IPR030748:RGL1_RA,IPR036964:RASGEF_cat_dom_sf,	hsa04014:Ras signaling pathway,			SM00147:RasGEF,SM00229:RasGEFN,SM00314:RA,							KW-0344~Guanine-nucleotide releasing factor,	KW-0597~Phosphoprotein,	COMPBIAS:Polar residues,DOMAIN:N-terminal Ras-GEF,DOMAIN:Ras-GEF,DOMAIN:Ras-associating,REGION:Disordered,
Q9UBG7	recombination signal binding protein for immunoglobulin kappa J region like(RBPJL)	Homo sapiens			GO:0007165~signal transduction,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,	GO:0000785~chromatin,GO:0005634~nucleus,GO:0005667~transcription factor complex,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003682~chromatin binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,	IPR008967:p53-like_TF_DNA-bd_sf,IPR013783:Ig-like_fold,IPR014756:Ig_E-set,IPR015350:Beta-trefoil_DNA-bd_dom,IPR015351:RBP-J/Cbf11/Cbf12_DNA-bd,IPR036358:BTD_sf,IPR037095:RBP-J/Cbf11_DNA-bd_sf,IPR038007:RBP-Jkappa_IPT,IPR040159:CLS_fam,	hsa04330:Notch signaling pathway,hsa04658:Th1 and Th2 cell differentiation,hsa05017:Spinocerebellar ataxia,hsa05165:Human papillomavirus infection,hsa05169:Epstein-Barr virus infection,hsa05203:Viral carcinogenesis,			SM01267:LAG1_DNAbind,SM01268:BTD,	KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,					KW-0238~DNA-binding,		DOMAIN:Beta-trefoil DNA-binding,DOMAIN:IPT/TIG,DOMAIN:RBP-J/Cbf11/Cbf12 DNA binding,REGION:DNA-binding,REGION:Disordered,
Q9JIR4	regulating synaptic membrane exocytosis 1(Rims1)	Rattus norvegicus			GO:0006836~neurotransmitter transport,GO:0006886~intracellular protein transport,GO:0006887~exocytosis,GO:0007269~neurotransmitter secretion,GO:0010628~positive regulation of gene expression,GO:0010808~positive regulation of synaptic vesicle priming,GO:0016081~synaptic vesicle docking,GO:0016082~synaptic vesicle priming,GO:0030154~cell differentiation,GO:0031632~positive regulation of synaptic vesicle fusion to presynaptic membrane,GO:0042391~regulation of membrane potential,GO:0048167~regulation of synaptic plasticity,GO:0048169~regulation of long-term neuronal synaptic plasticity,GO:0048790~maintenance of presynaptic active zone structure,GO:0048791~calcium ion-regulated exocytosis of neurotransmitter,GO:0050806~positive regulation of synaptic transmission,GO:0060291~long-term synaptic potentiation,GO:0060478~acrosomal vesicle exocytosis,GO:0061669~spontaneous neurotransmitter secretion,GO:0065003~macromolecular complex assembly,GO:0097151~positive regulation of inhibitory postsynaptic potential,GO:0099525~presynaptic dense core vesicle exocytosis,GO:1903861~positive regulation of dendrite extension,GO:2000300~regulation of synaptic vesicle exocytosis,GO:2000463~positive regulation of excitatory postsynaptic potential,	GO:0005886~plasma membrane,GO:0014069~postsynaptic density,GO:0016020~membrane,GO:0031982~vesicle,GO:0042734~presynaptic membrane,GO:0042995~cell projection,GO:0045202~synapse,GO:0048788~cytoskeleton of presynaptic active zone,GO:0060077~inhibitory synapse,GO:0098831~presynaptic active zone cytoplasmic component,GO:0098891~extrinsic component of presynaptic active zone membrane,GO:0098978~glutamatergic synapse,GO:0098982~GABA-ergic synapse,	GO:0005515~protein binding,GO:0017124~SH3 domain binding,GO:0019901~protein kinase binding,GO:0031267~small GTPase binding,GO:0044325~ion channel binding,GO:0046872~metal ion binding,GO:0098882~structural constituent of presynaptic active zone,	IPR000008:C2_dom,IPR001478:PDZ,IPR010911:Rab_BD,IPR011011:Znf_FYVE_PHD,IPR013083:Znf_RING/FYVE/PHD,IPR017455:Znf_FYVE-rel,IPR035892:C2_domain_sf,IPR036034:PDZ_sf,IPR039032:Rim-like,IPR041282:FYVE_2,	rno04721:Synaptic vesicle cycle,rno04723:Retrograde endocannabinoid signaling,			SM00228:PDZ,SM00239:C2,	KW-0221~Differentiation,KW-0268~Exocytosis,KW-0532~Neurotransmitter transport,KW-0813~Transport,	KW-0472~Membrane,KW-0770~Synapse,KW-0966~Cell projection,KW-1003~Cell membrane,			KW-0175~Coiled coil,KW-0677~Repeat,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,		KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,COMPBIAS:Pro residues,DOMAIN:C2,DOMAIN:C2 1,DOMAIN:C2 2,DOMAIN:FYVE-type,DOMAIN:PDZ,DOMAIN:RabBD,REGION:Disordered,ZN_FING:FYVE-type,
A2BGA0	regulatory factor X, 4(rfx4)	Danio rerio			GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0007418~ventral midline development,GO:0021914~negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning,	GO:0005634~nucleus,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,	IPR003150:DNA-bd_RFX,IPR036388:WH-like_DNA-bd_sf,IPR036390:WH_DNA-bd_sf,IPR039779:RFX-like,					KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,					KW-0010~Activator,KW-0238~DNA-binding,		DNA_BIND:RFX-type winged-helix,REGION:Disordered,REGION:Necessary for dimerization,
Q9D0F6	replication factor C (activator 1) 5(Rfc5)	Mus musculus			GO:0006260~DNA replication,GO:0006261~DNA-dependent DNA replication,GO:0006281~DNA repair,GO:1900264~positive regulation of DNA-directed DNA polymerase activity,	GO:0005634~nucleus,GO:0005663~DNA replication factor C complex,GO:0031390~Ctf18 RFC-like complex,	GO:0000166~nucleotide binding,GO:0003677~DNA binding,GO:0003689~DNA clamp loader activity,GO:0005524~ATP binding,GO:0016887~ATPase activity,GO:0017116~single-stranded DNA-dependent ATP-dependent DNA helicase activity,GO:0019899~enzyme binding,	IPR003593:AAA+_ATPase,IPR003959:ATPase_AAA_core,IPR008921:DNA_pol3_clamp-load_cplx_C,IPR013748:Rep_factorC_C,IPR027417:P-loop_NTPase,IPR047854:RFC_lid,	mmu03030:DNA replication,mmu03410:Base excision repair,mmu03420:Nucleotide excision repair,mmu03430:Mismatch repair,			SM00382:AAA,	KW-0235~DNA replication,	KW-0539~Nucleus,				KW-0067~ATP-binding,KW-0547~Nucleotide-binding,			DOMAIN:AAA+ ATPase,
Q05B83	replication factor C subunit 2(RFC2)	Bos taurus			GO:0006260~DNA replication,GO:0006261~DNA-dependent DNA replication,GO:0006281~DNA repair,GO:0032508~DNA duplex unwinding,GO:1900264~positive regulation of DNA-directed DNA polymerase activity,	GO:0005634~nucleus,GO:0005663~DNA replication factor C complex,GO:0031390~Ctf18 RFC-like complex,	GO:0003677~DNA binding,GO:0003689~DNA clamp loader activity,GO:0005524~ATP binding,GO:0016887~ATPase activity,	IPR003593:AAA+_ATPase,IPR003959:ATPase_AAA_core,IPR008921:DNA_pol3_clamp-load_cplx_C,IPR013748:Rep_factorC_C,IPR027417:P-loop_NTPase,IPR047854:RFC_lid,	bta03030:DNA replication,bta03410:Base excision repair,bta03420:Nucleotide excision repair,bta03430:Mismatch repair,			SM00382:AAA,	KW-0235~DNA replication,	KW-0539~Nucleus,				KW-0067~ATP-binding,KW-0547~Nucleotide-binding,		KW-0007~Acetylation,KW-0597~Phosphoprotein,	DOMAIN:AAA+ ATPase,REGION:Disordered,
Q6IP18	replication protein A2 L homeolog(rpa2.L)	Xenopus laevis			GO:0000076~DNA replication checkpoint,GO:0000723~telomere maintenance,GO:0000724~double-strand break repair via homologous recombination,GO:0006260~DNA replication,GO:0006281~DNA repair,GO:0006284~base-excision repair,GO:0006289~nucleotide-excision repair,GO:0006298~mismatch repair,GO:0006310~DNA recombination,GO:0006974~cellular response to DNA damage stimulus,GO:0034502~protein localization to chromosome,	GO:0000785~chromatin,GO:0005634~nucleus,GO:0005662~DNA replication factor A complex,GO:0016605~PML body,	GO:0003677~DNA binding,GO:0003684~damaged DNA binding,GO:0003697~single-stranded DNA binding,	IPR012340:NA-bd_OB-fold,IPR014646:Rfa2/RPA32,IPR014892:RPA_C,IPR036388:WH-like_DNA-bd_sf,IPR036390:WH_DNA-bd_sf,IPR040260:RFA2-like,	xla03030:DNA replication,xla03420:Nucleotide excision repair,xla03430:Mismatch repair,xla03440:Homologous recombination,xla03460:Fanconi anemia pathway,		PIRSF036949:RPA32,		KW-0227~DNA damage,KW-0233~DNA recombination,KW-0234~DNA repair,KW-0235~DNA replication,	KW-0539~Nucleus,					KW-0238~DNA-binding,	KW-0597~Phosphoprotein,	DNA_BIND:OB,DOMAIN:Replication protein A C-terminal,MUTAGEN:S->A: Not phosphorylated but normally recruited to chromatin and able to stimulate replication checkpoint signaling upon replication fork stalling; when associated with A-26 and A-36.,MUTAGEN:S->A: Not phosphorylated but normally recruited to chromatin and able to stimulate replication checkpoint signaling upon replication fork stalling; when associated with A-32 and A-36.,MUTAGEN:T->A: Not phosphorylated but normally recruited to chromatin and able to stimulate replication checkpoint signaling upon replication fork stalling; when associated with A-26 and A-32.,REGION:Disordered,
Q9CQ71	replication protein A3(Rpa3)	Mus musculus			GO:0000724~double-strand break repair via homologous recombination,GO:0006260~DNA replication,GO:0006281~DNA repair,GO:0006284~base-excision repair,GO:0006289~nucleotide-excision repair,GO:0006298~mismatch repair,GO:0006310~DNA recombination,GO:0006974~cellular response to DNA damage stimulus,GO:0007346~regulation of mitotic cell cycle,GO:0042127~regulation of cell proliferation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005662~DNA replication factor A complex,GO:0035861~site of double-strand break,	GO:0003677~DNA binding,GO:0003684~damaged DNA binding,GO:0003697~single-stranded DNA binding,	IPR012340:NA-bd_OB-fold,IPR013970:Rfa2,	mmu03030:DNA replication,mmu03420:Nucleotide excision repair,mmu03430:Mismatch repair,mmu03440:Homologous recombination,mmu03460:Fanconi anemia pathway,				KW-0227~DNA damage,KW-0233~DNA recombination,KW-0234~DNA repair,KW-0235~DNA replication,	KW-0539~Nucleus,						KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),
E1C1U1	retinaldehyde binding protein 1(RLBP1)	Gallus gallus			GO:0007601~visual perception,GO:0050896~response to stimulus,	GO:0005654~nucleoplasm,GO:0005813~centrosome,GO:0005829~cytosol,GO:0016020~membrane,	GO:0005502~11-cis retinal binding,GO:0019841~retinol binding,GO:1902936~phosphatidylinositol bisphosphate binding,	IPR001251:CRAL-TRIO_dom,IPR011074:CRAL/TRIO_N_dom,IPR036273:CRAL/TRIO_N_dom_sf,IPR036865:CRAL-TRIO_dom_sf,				SM00516:SEC14,SM01100:CRAL_TRIO_N,	KW-0716~Sensory transduction,KW-0813~Transport,KW-0844~Vision,	KW-0963~Cytoplasm,			KW-0175~Coiled coil,	KW-0683~Retinol-binding,		KW-0007~Acetylation,	DOMAIN:CRAL-TRIO,
Q96NR8	retinol dehydrogenase 12(RDH12)	Homo sapiens			GO:0001523~retinoid metabolic process,GO:0007601~visual perception,GO:0042572~retinol metabolic process,GO:0045494~photoreceptor cell maintenance,	GO:0001917~photoreceptor inner segment,GO:0005789~endoplasmic reticulum membrane,GO:0060342~photoreceptor inner segment membrane,	GO:0004745~retinol dehydrogenase activity,GO:0005515~protein binding,GO:0052650~NADP-retinol dehydrogenase activity,	IPR002347:SDR_fam,IPR036291:NAD(P)-bd_dom_sf,	hsa00830:Retinol metabolism,hsa01100:Metabolic pathways,hsa01240:Biosynthesis of cofactors,	612712~Leber congenital amaurosis 13,			KW-0443~Lipid metabolism,KW-0716~Sensory transduction,KW-0844~Vision,	KW-0256~Endoplasmic reticulum,KW-0472~Membrane,		KW-0225~Disease variant,KW-0682~Retinitis pigmentosa,KW-0901~Leber congenital amaurosis,	KW-0732~Signal,	KW-0521~NADP,	KW-0560~Oxidoreductase,		ACT_SITE:Proton acceptor,
Q9ERI6	retinol dehydrogenase 14 (all-trans and 9-cis)(Rdh14)	Mus musculus			GO:0006629~lipid metabolic process,GO:0042572~retinol metabolic process,	GO:0005654~nucleoplasm,GO:0005739~mitochondrion,GO:0005783~endoplasmic reticulum,GO:0005829~cytosol,	GO:0008106~alcohol dehydrogenase (NADP+) activity,GO:0016491~oxidoreductase activity,GO:0052650~NADP-retinol dehydrogenase activity,	IPR002347:SDR_fam,IPR036291:NAD(P)-bd_dom_sf,					KW-0443~Lipid metabolism,					KW-0521~NADP,	KW-0560~Oxidoreductase,		ACT_SITE:Proton acceptor,
Q9HCJ3	ribonucleoprotein, PTB binding 2(RAVER2)	Homo sapiens				GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0003676~nucleic acid binding,GO:0003723~RNA binding,	IPR000504:RRM_dom,IPR012677:Nucleotide-bd_a/b_plait_sf,IPR034636:RAVER2_RRM2,IPR035979:RBD_domain_sf,IPR047942:RAVER2_RRM3,IPR047943:RAVER2_RRM1,				SM00360:RRM,		KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0677~Repeat,		KW-0694~RNA-binding,	KW-0007~Acetylation,	COMPBIAS:Polar residues,DOMAIN:RRM 1,DOMAIN:RRM 2,DOMAIN:RRM 3,REGION:Disordered,
A4FV97	ribosomal L1 domain containing 1(RSL1D1)	Bos taurus			GO:0000470~maturation of LSU-rRNA,GO:0032880~regulation of protein localization,GO:0042981~regulation of apoptotic process,GO:2000772~regulation of cellular senescence,	GO:0005694~chromosome,GO:0005730~nucleolus,GO:0022625~cytosolic large ribosomal subunit,GO:0030686~90S preribosome,	GO:0003723~RNA binding,GO:0003730~mRNA 3'-UTR binding,GO:0048027~mRNA 5'-UTR binding,	IPR016095:Ribosomal_uL1_3-a/b-sand,IPR023674:Ribosomal_uL1-like,IPR028364:Ribosomal_uL1/biogenesis,						KW-0539~Nucleus,			KW-0175~Coiled coil,			KW-0007~Acetylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),REGION:Disordered,
P51410	ribosomal protein L9(Rpl9)	Mus musculus			GO:0002181~cytoplasmic translation,GO:0006412~translation,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005840~ribosome,GO:0022625~cytosolic large ribosomal subunit,GO:0022626~cytosolic ribosome,GO:0045202~synapse,GO:0098793~presynapse,GO:0098794~postsynapse,GO:1990904~ribonucleoprotein complex,	GO:0003735~structural constituent of ribosome,GO:0019843~rRNA binding,	IPR000702:Ribosomal_uL6-like,IPR002359:Ribosomal_uL6_CS2,IPR020040:Ribosomal_uL6_a/b-dom,IPR036789:Ribosomal_uL6-like_a/b-dom_sf,	mmu03010:Ribosome,mmu05171:Coronavirus disease - COVID-19,		PIRSF002162:Ribosomal_L6,			KW-0963~Cytoplasm,					KW-0687~Ribonucleoprotein,KW-0689~Ribosomal protein,KW-0825~Tumor antigen,	KW-0007~Acetylation,	DOMAIN:Large ribosomal subunit protein uL6 alpha-beta,
O42387	ribosomal protein S24(rps24)	Takifugu rubripes			GO:0006412~translation,	GO:0005737~cytoplasm,GO:0005840~ribosome,GO:0044391~ribosomal subunit,	GO:0003735~structural constituent of ribosome,	IPR001976:Ribosomal_eS24,IPR012678:Ribosomal_uL23/eL15/eS24_sf,IPR018098:Ribosomal_eS24_CS,	tru03010:Ribosome,					KW-0963~Cytoplasm,					KW-0687~Ribonucleoprotein,KW-0689~Ribosomal protein,		COMPBIAS:Basic residues,REGION:Disordered,
Q3T0B7	ribosomal protein S27 like(RPS27L)	Bos taurus			GO:0000028~ribosomal small subunit assembly,GO:0006412~translation,	GO:0005840~ribosome,GO:0022627~cytosolic small ribosomal subunit,	GO:0003723~RNA binding,GO:0003735~structural constituent of ribosome,GO:0046872~metal ion binding,	IPR000592:Ribosomal_eS27,IPR011332:Ribosomal_zn-bd,IPR023407:Ribosomal_eS27_Zn-bd_dom_sf,	bta03010:Ribosome,bta05171:Coronavirus disease - COVID-19,								KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0687~Ribonucleoprotein,KW-0689~Ribosomal protein,		REGION:Disordered,ZN_FING:C4-type,
Q9P2E9	ribosome binding protein 1(RRBP1)	Homo sapiens			GO:0001649~osteoblast differentiation,GO:0006412~translation,GO:0015031~protein transport,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005840~ribosome,GO:0016020~membrane,	GO:0003723~RNA binding,GO:0038023~signaling receptor activity,	IPR007794:Rib_rcpt_KP,IPR040248:RRBP1,	hsa04141:Protein processing in endoplasmic reticulum,				KW-0653~Protein transport,KW-0811~Translocation,KW-0813~Transport,	KW-0256~Endoplasmic reticulum,KW-0472~Membrane,			KW-0175~Coiled coil,KW-0677~Repeat,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0675~Receptor,	KW-0007~Acetylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1),CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),DOMAIN:Ribosome receptor lysine/proline rich,REGION:41 X 10 AA approximate tandem repeats of [TN]-Q-[GSA]-[KRQT]-K-[ATGSV]-[ED]-[GTAS]-[ATIS]-[PQTAS],REGION:Disordered,REPEAT:1,REPEAT:10,REPEAT:11,REPEAT:12,REPEAT:13,REPEAT:14,REPEAT:15,REPEAT:16,REPEAT:17,REPEAT:18,REPEAT:19,REPEAT:2,REPEAT:20,REPEAT:21,REPEAT:22,REPEAT:23,REPEAT:24,REPEAT:25,REPEAT:26,REPEAT:27,REPEAT:28,REPEAT:29,REPEAT:3,REPEAT:30,REPEAT:31,REPEAT:32,REPEAT:33,REPEAT:34; approximate,REPEAT:35,REPEAT:36; approximate,REPEAT:37,REPEAT:38,REPEAT:39; approximate,REPEAT:4,REPEAT:40,REPEAT:41,REPEAT:5,REPEAT:6,REPEAT:7,REPEAT:8,REPEAT:9,TOPO_DOM:Cytoplasmic,TOPO_DOM:Lumenal,TRANSMEM:Helical,
Q4U5R4	ring finger protein 114(RNF114)	Bos taurus			GO:0000209~protein polyubiquitination,GO:0006511~ubiquitin-dependent protein catabolic process,GO:0007283~spermatogenesis,GO:0030154~cell differentiation,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0046872~metal ion binding,GO:0061630~ubiquitin protein ligase activity,	IPR001841:Znf_RING,IPR008598:Di19_Zn-bd,IPR013083:Znf_RING/FYVE/PHD,IPR017907:Znf_RING_CS,IPR027370:Znf-RING_euk,IPR034734:ZF_C2HC_RNF,IPR042716:RNF114_RING-HC,				SM00184:RING,	KW-0221~Differentiation,KW-0744~Spermatogenesis,KW-0833~Ubl conjugation pathway,	KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0217~Developmental protein,KW-0808~Transferase,KW-9996~Developmental protein,	KW-0007~Acetylation,KW-0832~Ubl conjugation,	ZN_FING:C2HC RNF-type,ZN_FING:RING-type,
A0A0R4I9Y1	ring finger protein 213b(rnf213b)	Danio rerio			GO:0002040~sprouting angiogenesis,GO:0002376~immune system process,GO:0006511~ubiquitin-dependent protein catabolic process,GO:0019216~regulation of lipid metabolic process,GO:0042742~defense response to bacterium,GO:0070534~protein K63-linked ubiquitination,GO:0098792~xenophagy,GO:2000051~negative regulation of non-canonical Wnt signaling pathway,	GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005811~lipid particle,GO:0005829~cytosol,	GO:0004842~ubiquitin-protein transferase activity,GO:0005524~ATP binding,GO:0016887~ATPase activity,GO:0046872~metal ion binding,GO:0061630~ubiquitin protein ligase activity,	IPR001841:Znf_RING,IPR003593:AAA+_ATPase,IPR013083:Znf_RING/FYVE/PHD,IPR017907:Znf_RING_CS,IPR027417:P-loop_NTPase,IPR031248:RNF213,IPR046439:ZF_RZ_dom,				SM00184:RING,SM00382:AAA,	KW-0037~Angiogenesis,KW-0391~Immunity,KW-0443~Lipid metabolism,KW-0833~Ubl conjugation pathway,	KW-0551~Lipid droplet,KW-0963~Cytoplasm,			KW-0863~Zinc-finger,	KW-0067~ATP-binding,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,KW-0862~Zinc,	KW-0378~Hydrolase,KW-0511~Multifunctional enzyme,KW-0808~Transferase,		ACT_SITE:Nucleophile; for E3 ubiquitin-lipopolysaccharide ligase activity,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:RING-type,DOMAIN:RZ-type,REGION:Disordered,ZN_FING:RING-type,ZN_FING:RZ-type,
Q924T7	ring finger protein 31(Rnf31)	Mus musculus			GO:0000209~protein polyubiquitination,GO:0016567~protein ubiquitination,GO:0019538~protein metabolic process,GO:0023035~CD40 signaling pathway,GO:0033209~tumor necrosis factor-mediated signaling pathway,GO:0042742~defense response to bacterium,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling,GO:0050852~T cell receptor signaling pathway,GO:0051092~positive regulation of NF-kappaB transcription factor activity,GO:0060546~negative regulation of necroptotic process,GO:0097039~protein linear polyubiquitination,GO:1904417~positive regulation of xenophagy,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0009898~cytoplasmic side of plasma membrane,GO:0035631~CD40 receptor complex,GO:0071797~LUBAC complex,	GO:0004842~ubiquitin-protein transferase activity,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0016740~transferase activity,GO:0016874~ligase activity,GO:0031625~ubiquitin protein ligase binding,GO:0036435~K48-linked polyubiquitin binding,GO:0042802~identical protein binding,GO:0043130~ubiquitin binding,GO:0046872~metal ion binding,GO:0061630~ubiquitin protein ligase activity,GO:0070530~K63-linked polyubiquitin binding,GO:1990450~linear polyubiquitin binding,	IPR001876:Znf_RanBP2,IPR002867:IBR_dom,IPR013083:Znf_RING/FYVE/PHD,IPR015940:UBA,IPR017907:Znf_RING_CS,IPR018997:PUB_domain,IPR026254:RNF31-like,IPR032065:RNF31-UBA,IPR036339:PUB-like_dom_sf,IPR036443:Znf_RanBP2_sf,IPR040641:RNF31_PUB,IPR041031:RNF31_C,IPR044066:TRIAD_supradom,IPR047539:UBA_RNF31,IPR047540:BRcat_RBR_RNF31-like,IPR047541:RNF31_RBR_mRING-HC-like,IPR047542:Rcat_RBR_RNF31-like,IPR047543:Bbox1_RNF31-like,	mmu04217:Necroptosis,mmu04621:NOD-like receptor signaling pathway,			SM00547:ZnF_RBZ,SM00647:IBR,	KW-0833~Ubl conjugation pathway,	KW-0963~Cytoplasm,			KW-0677~Repeat,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0436~Ligase,KW-0808~Transferase,	KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,	COMPBIAS:Polar residues,DOMAIN:PUB,DOMAIN:RING-type,DOMAIN:RNF31 C-terminal,DOMAIN:RanBP2-type,DOMAIN:UBA,REGION:Disordered,REGION:Interaction with RBCK1,REGION:LDD domain,REGION:Polyubiquitin-binding,REGION:TRIAD supradomain,SITE:Cleavage; by caspase,ZN_FING:IBR-type,ZN_FING:RING-type 1,ZN_FING:RING-type 2; atypical,ZN_FING:RanBP2-type 1,ZN_FING:RanBP2-type 2,ZN_FING:RanBP2-type 3,
Q9Y252	ring finger protein 6(RNF6)	Homo sapiens			GO:0006355~regulation of transcription, DNA-templated,GO:0006511~ubiquitin-dependent protein catabolic process,GO:0016567~protein ubiquitination,GO:0030517~negative regulation of axon extension,GO:0044314~protein K27-linked ubiquitination,GO:0045893~positive regulation of transcription, DNA-templated,GO:0048675~axon extension,GO:0060765~regulation of androgen receptor signaling pathway,GO:0070936~protein K48-linked ubiquitination,GO:0085020~protein K6-linked ubiquitination,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0016605~PML body,GO:0030424~axon,GO:0031965~nuclear membrane,GO:0043231~intracellular membrane-bounded organelle,	GO:0003677~DNA binding,GO:0004842~ubiquitin-protein transferase activity,GO:0005515~protein binding,GO:0046872~metal ion binding,GO:0050681~androgen receptor binding,GO:0061630~ubiquitin protein ligase activity,	IPR001841:Znf_RING,IPR013083:Znf_RING/FYVE/PHD,		133239~Esophageal carcinoma, somatic,		SM00184:RING,	KW-0833~Ubl conjugation pathway,	KW-0539~Nucleus,KW-0963~Cytoplasm,KW-0966~Cell projection,			KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0808~Transferase,		COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:RING-type,REGION:Disordered,ZN_FING:RING-type,
Q2WG80	ripply transcriptional repressor 1(ripply1)	Danio rerio			GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001756~somitogenesis,GO:0001757~somite specification,GO:0009880~embryonic pattern specification,GO:0032525~somite rostral/caudal axis specification,GO:0045892~negative regulation of transcription, DNA-templated,GO:0048641~regulation of skeletal muscle tissue development,GO:0061053~somite development,	GO:0005634~nucleus,	GO:0005515~protein binding,	IPR028127:Ripply_fam,					KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,					KW-0217~Developmental protein,KW-0678~Repressor,KW-9996~Developmental protein,		MOTIF:WRPW motif; required for gro2-binding,MUTAGEN:Missing: Disrupts gro2-binding.,REGION:Disordered,REGION:Ripply homology domain,
Q8NBX0	saccharopine dehydrogenase (putative)(SCCPDH)	Homo sapiens			GO:0009247~glycolipid biosynthetic process,	GO:0005576~extracellular region,GO:0005634~nucleus,GO:0005739~mitochondrion,GO:0005811~lipid particle,GO:0016020~membrane,GO:0030496~midbody,GO:0031093~platelet alpha granule lumen,	GO:0016491~oxidoreductase activity,	IPR005097:Sacchrp_dh_NADP,IPR036291:NAD(P)-bd_dom_sf,						KW-0472~Membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0560~Oxidoreductase,	KW-0007~Acetylation,KW-0597~Phosphoprotein,	DOMAIN:Saccharopine dehydrogenase NADP binding,TRANSMEM:Helical,
Q9NZJ4	sacsin molecular chaperone(SACS)	Homo sapiens			GO:0006457~protein folding,GO:0090084~negative regulation of inclusion body assembly,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0030424~axon,GO:0030425~dendrite,GO:0070852~cell body fiber,	GO:0030544~Hsp70 protein binding,GO:0042802~identical protein binding,GO:0051087~chaperone binding,GO:0070628~proteasome binding,	IPR000626:Ubiquitin-like_dom,IPR001623:DnaJ_domain,IPR007842:HEPN_dom,IPR029071:Ubiquitin-like_domsf,IPR036869:J_dom_sf,IPR036890:HATPase_C_sf,		270550~Spastic ataxia, Charlevoix-Saguenay type,		SM00748:HEPN,		KW-0963~Cytoplasm,		KW-0225~Disease variant,KW-0523~Neurodegeneration,			KW-0143~Chaperone,	KW-0007~Acetylation,KW-0597~Phosphoprotein,	COMPBIAS:Polar residues,DOMAIN:HEPN,DOMAIN:J,DOMAIN:Ubiquitin-like,REGION:Disordered,
Q14151	scaffold attachment factor B2(SAFB2)	Homo sapiens			GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0050684~regulation of mRNA processing,GO:0060008~Sertoli cell differentiation,GO:0060765~regulation of androgen receptor signaling pathway,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0016604~nuclear body,GO:0043231~intracellular membrane-bounded organelle,GO:0070062~extracellular exosome,	GO:0003723~RNA binding,GO:0005515~protein binding,GO:0042802~identical protein binding,GO:0043565~sequence-specific DNA binding,	IPR000504:RRM_dom,IPR003034:SAP_dom,IPR012677:Nucleotide-bd_a/b_plait_sf,IPR034781:SAFB1_2_RBD,IPR035979:RBD_domain_sf,IPR036361:SAP_dom_sf,				SM00360:RRM,SM00513:SAP,	KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,KW-0963~Cytoplasm,					KW-0238~DNA-binding,KW-0678~Repressor,KW-0694~RNA-binding,	KW-0007~Acetylation,KW-0488~Methylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Acidic residues,COMPBIAS:Basic and acidic residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO),CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate,DOMAIN:RRM,DOMAIN:SAP,MOTIF:Nuclear localization signal,REGION:Disordered,REGION:Interaction with SAFB1,
P27615	scavenger receptor class B, member 2(Scarb2)	Rattus norvegicus			GO:0006622~protein targeting to lysosome,GO:0006897~endocytosis,GO:0006898~receptor-mediated endocytosis,GO:0007605~sensory perception of sound,GO:0010467~gene expression,GO:0010976~positive regulation of neuron projection development,GO:0015917~aminophospholipid transport,GO:0043470~regulation of carbohydrate catabolic process,GO:0099638~endosome to plasma membrane protein transport,GO:1905123~regulation of glucosylceramidase activity,	GO:0005737~cytoplasm,GO:0005764~lysosome,GO:0005765~lysosomal membrane,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0030666~endocytic vesicle membrane,GO:0043202~lysosomal lumen,	GO:0001786~phosphatidylserine binding,GO:0005044~scavenger receptor activity,GO:0015485~cholesterol binding,GO:0019899~enzyme binding,GO:0031210~phosphatidylcholine binding,GO:0038024~cargo receptor activity,GO:0042803~protein homodimerization activity,GO:0051087~chaperone binding,	IPR002159:CD36_fam,IPR005429:LimpII,	rno04142:Lysosome,					KW-0458~Lysosome,KW-0472~Membrane,			KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0675~Receptor,	KW-0325~Glycoprotein,KW-0449~Lipoprotein,KW-0564~Palmitate,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,REGION:Important for interaction with GBA1,TOPO_DOM:Cytoplasmic,TOPO_DOM:Lumenal,TRANSMEM:Helical,
Q70I47	secreted phosphoprotein 2(spp2)	Oncorhynchus mykiss			GO:0046849~bone remodeling,	GO:0005576~extracellular region,		IPR010892:Spp-24,IPR046350:Cystatin_sf,						KW-0964~Secreted,			KW-0732~Signal,			KW-0597~Phosphoprotein,KW-1015~Disulfide bond,	COMPBIAS:Polar residues,REGION:Disordered,
P47872	secretin receptor(SCTR)	Homo sapiens			GO:0002024~diet induced thermogenesis,GO:0007166~cell surface receptor signaling pathway,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007188~adenylate cyclase-modulating G-protein coupled receptor signaling pathway,GO:0009992~cellular water homeostasis,GO:0031667~response to nutrient levels,GO:0032098~regulation of appetite,GO:0043950~positive regulation of cAMP-mediated signaling,GO:0048167~regulation of synaptic plasticity,	GO:0005881~cytoplasmic microtubule,GO:0005886~plasma membrane,GO:0016020~membrane,	GO:0004930~G-protein coupled receptor activity,GO:0008528~G-protein coupled peptide receptor activity,GO:0015055~secretin receptor activity,GO:0017046~peptide hormone binding,	IPR000832:GPCR_2_secretin-like,IPR001879:GPCR_2_extracellular_dom,IPR002144:GPCR_2_secretin_rcpt,IPR017981:GPCR_2-like_7TM,IPR017983:GPCR_2_secretin-like_CS,IPR036445:GPCR_2_extracell_dom_sf,IPR047037:Secretin_7TM,	hsa04080:Neuroactive ligand-receptor interaction,hsa04972:Pancreatic secretion,hsa04976:Bile secretion,			SM00008:HormR,		KW-0472~Membrane,KW-1003~Cell membrane,			KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0297~G-protein coupled receptor,KW-0675~Receptor,KW-0807~Transducer,	KW-0325~Glycoprotein,KW-0597~Phosphoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:G-protein coupled receptors family 2 profile 1,DOMAIN:G-protein coupled receptors family 2 profile 2,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,TRANSMEM:Helical; Name=1,TRANSMEM:Helical; Name=2,TRANSMEM:Helical; Name=3,TRANSMEM:Helical; Name=4,TRANSMEM:Helical; Name=5,TRANSMEM:Helical; Name=6,TRANSMEM:Helical; Name=7,
Q80YD6	secretion regulating guanine nucleotide exchange factor(Sergef)	Mus musculus			GO:0050709~negative regulation of protein secretion,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0005085~guanyl-nucleotide exchange factor activity,	IPR000408:Reg_chr_condens,IPR009091:RCC1/BLIP-II,						KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0677~Repeat,		KW-0344~Guanine-nucleotide releasing factor,	KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,REGION:Disordered,REPEAT:RCC1,REPEAT:RCC1 1,REPEAT:RCC1 2,REPEAT:RCC1 3,REPEAT:RCC1 4,REPEAT:RCC1 5,REPEAT:RCC1 6,REPEAT:RCC1 7,
Q9W7J1	sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3Aa(sema3aa)	Danio rerio			GO:0001570~vasculogenesis,GO:0001755~neural crest cell migration,GO:0007399~nervous system development,GO:0008045~motor neuron axon guidance,GO:0016477~cell migration,GO:0030154~cell differentiation,GO:0035441~cell migration involved in vasculogenesis,GO:0048755~branching morphogenesis of a nerve,GO:0048843~negative regulation of axon extension involved in axon guidance,GO:0048844~artery morphogenesis,GO:0050919~negative chemotaxis,GO:0071526~semaphorin-plexin signaling pathway,GO:2001224~positive regulation of neuron migration,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005886~plasma membrane,GO:0030424~axon,GO:0098978~glutamatergic synapse,	GO:0030215~semaphorin receptor binding,GO:0038191~neuropilin binding,GO:0045499~chemorepellent activity,	IPR001627:Semap_dom,IPR003599:Ig_sub,IPR007110:Ig-like_dom,IPR013151:Immunoglobulin,IPR013783:Ig-like_fold,IPR015943:WD40/YVTN_repeat-like_dom_sf,IPR016201:PSI,IPR027231:Semaphorin,IPR036179:Ig-like_dom_sf,IPR036352:Semap_dom_sf,				SM00409:IG,SM00423:PSI,SM00630:Sema,	KW-0221~Differentiation,KW-0524~Neurogenesis,	KW-0964~Secreted,			KW-0393~Immunoglobulin domain,KW-0732~Signal,		KW-0217~Developmental protein,KW-9996~Developmental protein,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:Ig-like C2-type,DOMAIN:Sema,REGION:Disordered,
Q64151	sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4C(Sema4c)	Mus musculus			GO:0001755~neural crest cell migration,GO:0001843~neural tube closure,GO:0007275~multicellular organism development,GO:0007399~nervous system development,GO:0007411~axon guidance,GO:0009653~anatomical structure morphogenesis,GO:0021535~cell migration in hindbrain,GO:0021549~cerebellum development,GO:0030154~cell differentiation,GO:0030335~positive regulation of cell migration,GO:0032874~positive regulation of stress-activated MAPK cascade,GO:0042692~muscle cell differentiation,GO:0048843~negative regulation of axon extension involved in axon guidance,GO:0050919~negative chemotaxis,GO:0071526~semaphorin-plexin signaling pathway,	GO:0005886~plasma membrane,GO:0014069~postsynaptic density,GO:0016020~membrane,GO:0030672~synaptic vesicle membrane,GO:0031410~cytoplasmic vesicle,GO:0045202~synapse,GO:0045211~postsynaptic membrane,GO:0098839~postsynaptic density membrane,	GO:0005515~protein binding,GO:0030215~semaphorin receptor binding,GO:0045499~chemorepellent activity,	IPR001627:Semap_dom,IPR002165:Plexin_repeat,IPR003599:Ig_sub,IPR007110:Ig-like_dom,IPR013783:Ig-like_fold,IPR015943:WD40/YVTN_repeat-like_dom_sf,IPR016201:PSI,IPR027231:Semaphorin,IPR036179:Ig-like_dom_sf,IPR036352:Semap_dom_sf,	mmu04360:Axon guidance,			SM00409:IG,SM00423:PSI,SM00630:Sema,	KW-0221~Differentiation,KW-0524~Neurogenesis,	KW-0472~Membrane,KW-0628~Postsynaptic cell membrane,KW-0770~Synapse,KW-0968~Cytoplasmic vesicle,KW-1003~Cell membrane,			KW-0393~Immunoglobulin domain,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0217~Developmental protein,KW-9996~Developmental protein,	KW-0325~Glycoprotein,KW-0597~Phosphoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Basic and acidic residues,COMPBIAS:Pro residues,DOMAIN:Ig-like,DOMAIN:Ig-like C2-type,DOMAIN:PSI,DOMAIN:Sema,MOTIF:PDZ-binding,MUTAGEN:S->A: Loss of interaction with DLG4; when associated with A-832 and A-834.,MUTAGEN:S->A: Loss of the effect on myogenic differentiation; when associated with A-834. Loss of interaction with DLG4; when associated with A-833 and A-834.,MUTAGEN:V->A: Loss of the effect on myogenic differentiation; when associated with A-832. Loss of interaction with DLG4; when associated with A-832 and A-833.,REGION:Disordered,REGION:Dominant negative effect on myogenic differentiation,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q5R1W5	serine and arginine rich splicing factor 2(SRSF2)	Pan troglodytes			GO:0000381~regulation of alternative mRNA splicing, via spliceosome,GO:0000398~mRNA splicing, via spliceosome,GO:0006397~mRNA processing,GO:0008380~RNA splicing,	GO:0005681~spliceosomal complex,GO:0005829~cytosol,GO:0016607~nuclear speck,	GO:0003723~RNA binding,GO:0036002~pre-mRNA binding,	IPR000504:RRM_dom,IPR003954:RRM_dom_euk,IPR012677:Nucleotide-bd_a/b_plait_sf,IPR035979:RBD_domain_sf,	ptr03040:Spliceosome,ptr05168:Herpes simplex virus 1 infection,			SM00360:RRM,SM00361:RRM_1,	KW-0507~mRNA processing,KW-0508~mRNA splicing,	KW-0539~Nucleus,					KW-0694~RNA-binding,	KW-0007~Acetylation,KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Basic residues,DOMAIN:RRM,REGION:Disordered,
Q9R0U0	serine and arginine-rich splicing factor 10(Srsf10)	Mus musculus			GO:0000375~RNA splicing, via transesterification reactions,GO:0000398~mRNA splicing, via spliceosome,GO:0006355~regulation of transcription, DNA-templated,GO:0006376~mRNA splice site selection,GO:0006397~mRNA processing,GO:0008380~RNA splicing,GO:0016482~cytosolic transport,GO:0048024~regulation of mRNA splicing, via spliceosome,GO:0048025~negative regulation of mRNA splicing, via spliceosome,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005829~cytosol,GO:0016607~nuclear speck,GO:0030425~dendrite,GO:0043025~neuronal cell body,GO:0043679~axon terminus,	GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0051082~unfolded protein binding,	IPR000504:RRM_dom,IPR012677:Nucleotide-bd_a/b_plait_sf,IPR035979:RBD_domain_sf,	mmu03040:Spliceosome,			SM00360:RRM,	KW-0507~mRNA processing,KW-0508~mRNA splicing,	KW-0539~Nucleus,					KW-0694~RNA-binding,	KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:RRM,REGION:Disordered,
Q9Z1W9	serine/threonine kinase 39(Stk39)	Mus musculus			GO:0002021~response to dietary excess,GO:0006468~protein phosphorylation,GO:0006884~cell volume homeostasis,GO:0006954~inflammatory response,GO:0007165~signal transduction,GO:0008217~regulation of blood pressure,GO:0010820~positive regulation of T cell chemotaxis,GO:0016310~phosphorylation,GO:0018105~peptidyl-serine phosphorylation,GO:0018107~peptidyl-threonine phosphorylation,GO:0030644~cellular chloride ion homeostasis,GO:0035556~intracellular signal transduction,GO:0035725~sodium ion transmembrane transport,GO:0035865~cellular response to potassium ion,GO:0036438~maintenance of lens transparency,GO:0038146~chemokine (C-X-C motif) ligand 12 signaling pathway,GO:0042116~macrophage activation,GO:0043268~positive regulation of potassium ion transport,GO:0046777~protein autophosphorylation,GO:0050727~regulation of inflammatory response,GO:0050801~ion homeostasis,GO:0070294~renal sodium ion absorption,GO:0071474~cellular hyperosmotic response,GO:0071476~cellular hypotonic response,GO:0090188~negative regulation of pancreatic juice secretion,GO:1900745~positive regulation of p38MAPK cascade,GO:1901017~negative regulation of potassium ion transmembrane transporter activity,GO:1901380~negative regulation of potassium ion transmembrane transport,GO:1904044~response to aldosterone,GO:1905408~negative regulation of creatine transmembrane transporter activity,GO:1990869~cellular response to chemokine,GO:2000650~negative regulation of sodium ion transmembrane transporter activity,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005938~cell cortex,GO:0016020~membrane,GO:0016323~basolateral plasma membrane,GO:0016324~apical plasma membrane,GO:0043231~intracellular membrane-bounded organelle,GO:0044297~cell body,	GO:0000166~nucleotide binding,GO:0004674~protein serine/threonine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016301~kinase activity,GO:0016740~transferase activity,GO:0019901~protein kinase binding,GO:0043539~protein serine/threonine kinase activator activity,	IPR000719:Prot_kinase_dom,IPR011009:Kinase-like_dom_sf,IPR017441:Protein_kinase_ATP_BS,IPR024678:Kinase_OSR1/WNK_CCT,IPR047173:STRAD_A/B-like,				SM00220:S_TKc,		KW-0539~Nucleus,KW-0963~Cytoplasm,				KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0418~Kinase,KW-0723~Serine/threonine-protein kinase,KW-0808~Transferase,	KW-0007~Acetylation,KW-0597~Phosphoprotein,	ACT_SITE:Proton acceptor,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,COMPBIAS:Pro residues,DOMAIN:Protein kinase,DOMAIN:Serine/threonine-protein kinase OSR1/WNK CCT,MOTIF:Caspase cleavage related site,MOTIF:Nuclear localization signal,MUTAGEN:K->E: Loss of kinase activity but no loss of interaction with RELT.,MUTAGEN:T->A: Abolished ability to activate SLC12A2/NKCC1.,MUTAGEN:T->A: Impaired phosphorylation by WNK4 and activation. Abolished ability to activate SLC12A2/NKCC1. Knockin mice are unable to activate SLC12A3/NCC.,MUTAGEN:T->Q: Increased kinase activity and autophosphorylation.,REGION:Disordered,REGION:Interaction with RELT,
Q6J9G0	serine/threonine/tyrosine kinase 1(STYK1)	Homo sapiens			GO:0006468~protein phosphorylation,GO:0016310~phosphorylation,GO:0042981~regulation of apoptotic process,	GO:0005886~plasma membrane,GO:0016020~membrane,	GO:0004672~protein kinase activity,GO:0004713~protein tyrosine kinase activity,GO:0004715~non-membrane spanning protein tyrosine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,	IPR000719:Prot_kinase_dom,IPR001245:Ser-Thr/Tyr_kinase_cat_dom,IPR008266:Tyr_kinase_AS,IPR011009:Kinase-like_dom_sf,						KW-0472~Membrane,		KW-0656~Proto-oncogene,	KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0418~Kinase,KW-0808~Transferase,KW-0829~Tyrosine-protein kinase,		ACT_SITE:Proton acceptor,DOMAIN:Protein kinase,REGION:Disordered,TRANSMEM:Helical,
Q5R536	serpin family A member 3(SERPINA3)	Pongo abelii			GO:0006953~acute-phase response,GO:0010951~negative regulation of endopeptidase activity,	GO:0005615~extracellular space,	GO:0004867~serine-type endopeptidase inhibitor activity,	IPR000215:Serpin_fam,IPR023795:Serpin_CS,IPR023796:Serpin_dom,IPR036186:Serpin_sf,IPR042178:Serpin_sf_1,IPR042185:Serpin_sf_2,				SM00093:SERPIN,	KW-0011~Acute phase,	KW-0964~Secreted,			KW-0732~Signal,		KW-0646~Protease inhibitor,KW-0722~Serine protease inhibitor,	KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Serpin,REGION:RCL,SITE:Reactive bond,
P13731	serpin family H member 1(SERPINH1)	Gallus gallus			GO:0010951~negative regulation of endopeptidase activity,GO:0030199~collagen fibril organization,	GO:0005615~extracellular space,GO:0005783~endoplasmic reticulum,GO:0005788~endoplasmic reticulum lumen,	GO:0004867~serine-type endopeptidase inhibitor activity,GO:0005518~collagen binding,	IPR000215:Serpin_fam,IPR023795:Serpin_CS,IPR023796:Serpin_dom,IPR033830:Serpin_H1_serpin_dom,IPR036186:Serpin_sf,IPR042178:Serpin_sf_1,IPR042185:Serpin_sf_2,				SM00093:SERPIN,	KW-0346~Stress response,	KW-0256~Endoplasmic reticulum,			KW-0732~Signal,		KW-0143~Chaperone,	KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Serpin,MOTIF:Prevents secretion from ER,SITE:Reactive bond homolog,
Q9CY58	serpine1 mRNA binding protein 1(Serbp1)	Mus musculus			GO:0006417~regulation of translation,GO:0017148~negative regulation of translation,GO:0030578~PML body organization,GO:0042981~regulation of apoptotic process,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0048471~perinuclear region of cytoplasm,	GO:0003723~RNA binding,GO:0003730~mRNA 3'-UTR binding,GO:0030371~translation repressor activity,GO:0032183~SUMO binding,GO:0043022~ribosome binding,GO:0061770~translation elongation factor binding,	IPR006861:HABP4_PAIRBP1-bd,IPR032381:IHABP4_N,IPR039764:HABP4/SERBP1-like,				SM01233:HABP4_PAI-RBP1,	KW-0810~Translation regulation,	KW-0539~Nucleus,KW-0963~Cytoplasm,					KW-0694~RNA-binding,	KW-0007~Acetylation,KW-0488~Methylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate,DOMAIN:Hyaluronan/mRNA-binding protein,DOMAIN:Intracellular hyaluronan-binding protein 4 N-terminal,REGION:Disordered,
Q9HBY8	serum/glucocorticoid regulated kinase 2(SGK2)	Homo sapiens			GO:0001558~regulation of cell growth,GO:0006468~protein phosphorylation,GO:0006979~response to oxidative stress,GO:0016310~phosphorylation,GO:0018105~peptidyl-serine phosphorylation,GO:0032411~positive regulation of transporter activity,GO:0035556~intracellular signal transduction,GO:0042127~regulation of cell proliferation,	GO:0005654~nucleoplasm,GO:0005829~cytosol,	GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0015459~potassium channel regulator activity,GO:0017080~sodium channel regulator activity,	IPR000719:Prot_kinase_dom,IPR000961:AGC-kinase_C,IPR008271:Ser/Thr_kinase_AS,IPR011009:Kinase-like_dom_sf,IPR017441:Protein_kinase_ATP_BS,IPR017892:Pkinase_C,	hsa04068:FoxO signaling pathway,hsa04151:PI3K-Akt signaling pathway,			SM00133:S_TK_X,SM00220:S_TKc,		KW-0539~Nucleus,KW-0963~Cytoplasm,				KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0418~Kinase,KW-0723~Serine/threonine-protein kinase,KW-0808~Transferase,	KW-0597~Phosphoprotein,	ACT_SITE:Proton acceptor,DOMAIN:AGC-kinase C-terminal,DOMAIN:Protein kinase,MOTIF:Nuclear localization signal,MUTAGEN:S->D: Increased activation.,REGION:Disordered,
Q7ZVG6	siah E3 ubiquitin protein ligase 1(siah1)	Danio rerio			GO:0006511~ubiquitin-dependent protein catabolic process,GO:0016567~protein ubiquitination,GO:0043161~proteasome-mediated ubiquitin-dependent protein catabolic process,GO:0051402~neuron apoptotic process,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0004842~ubiquitin-protein transferase activity,GO:0008270~zinc ion binding,GO:0016740~transferase activity,GO:0031624~ubiquitin conjugating enzyme binding,GO:0046872~metal ion binding,GO:0061630~ubiquitin protein ligase activity,	IPR001841:Znf_RING,IPR004162:SINA-like_animal,IPR008974:TRAF-like,IPR013010:Znf_SIAH,IPR013083:Znf_RING/FYVE/PHD,IPR018121:7-in-absentia-prot_TRAF-dom,	dre04115:p53 signaling pathway,dre04120:Ubiquitin mediated proteolysis,dre04137:Mitophagy - animal,dre04310:Wnt signaling pathway,				KW-0833~Ubl conjugation pathway,				KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0808~Transferase,		COMPBIAS:Polar residues,DOMAIN:RING-type,DOMAIN:SIAH-type,REGION:Disordered,REGION:SBD,ZN_FING:RING-type,ZN_FING:SIAH-type,
Q9CUS9	signal peptide peptidase 3(Sppl3)	Mus musculus			GO:0006465~signal peptide processing,GO:0006508~proteolysis,GO:0007204~positive regulation of cytosolic calcium ion concentration,GO:0032092~positive regulation of protein binding,GO:0033619~membrane protein proteolysis,GO:0035307~positive regulation of protein dephosphorylation,GO:0050852~T cell receptor signaling pathway,GO:0070886~positive regulation of calcineurin-NFAT signaling cascade,	GO:0005783~endoplasmic reticulum,GO:0005791~rough endoplasmic reticulum,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0030660~Golgi-associated vesicle membrane,GO:0031090~organelle membrane,GO:0033116~endoplasmic reticulum-Golgi intermediate compartment membrane,GO:0043229~intracellular organelle,GO:0043231~intracellular membrane-bounded organelle,GO:0098553~lumenal side of endoplasmic reticulum membrane,GO:0098554~cytoplasmic side of endoplasmic reticulum membrane,	GO:0005515~protein binding,GO:0008233~peptidase activity,GO:0016787~hydrolase activity,GO:0042500~aspartic endopeptidase activity, intramembrane cleaving,GO:0042803~protein homodimerization activity,	IPR006639:Preselin/SPP,IPR007369:Peptidase_A22B_SPP,				SM00730:PSN,		KW-0256~Endoplasmic reticulum,KW-0333~Golgi apparatus,KW-0472~Membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0378~Hydrolase,KW-0645~Protease,		MOTIF:PAL,MUTAGEN:D->A: Does not inhibit NFAT-induced transcription activation.,TOPO_DOM:Cytoplasmic,TOPO_DOM:Lumenal,TRANSMEM:Helical,
O76094	signal recognition particle 72(SRP72)	Homo sapiens			GO:0006614~SRP-dependent cotranslational protein targeting to membrane,	GO:0005783~endoplasmic reticulum,GO:0005786~signal recognition particle, endoplasmic reticulum targeting,GO:0005829~cytosol,GO:0048500~signal recognition particle,GO:1990904~ribonucleoprotein complex,	GO:0003723~RNA binding,GO:0005047~signal recognition particle binding,GO:0005515~protein binding,GO:0008312~7S RNA binding,GO:0030911~TPR domain binding,GO:0043022~ribosome binding,	IPR011990:TPR-like_helical_dom_sf,IPR013699:Signal_recog_part_SRP72_RNA-bd,IPR019734:TPR_repeat,IPR026270:SRP72,IPR031545:SRP72_TPR-like,	hsa03060:Protein export,	614675~Bone marrow failure syndrome 1,	PIRSF038922:SRP72,	SM00028:TPR,		KW-0256~Endoplasmic reticulum,KW-0733~Signal recognition particle,KW-0963~Cytoplasm,		KW-0225~Disease variant,	KW-0677~Repeat,KW-0802~TPR repeat,		KW-0687~Ribonucleoprotein,	KW-0007~Acetylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Basic and acidic residues,COMPBIAS:Basic residues,COMPBIAS:Polar residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate,DOMAIN:Signal recognition particle SRP72 subunit RNA-binding,MUTAGEN:D->E: Reduced interaction with SRP68.,MUTAGEN:I->A: Loss of interaction with SRP72; when associated with A-598 in SRP68.,MUTAGEN:KK->AA: Diminished RNA binding.,MUTAGEN:KKKKKK->AAAAAA: Loss of RNA binding.,MUTAGEN:M->A: Does not affect RNA binding.,MUTAGEN:Missing: Loss of interaction with SRP68.,MUTAGEN:P->A: Strongly reduced RNA binding.,MUTAGEN:PM->AA: Diminished RNA binding.,MUTAGEN:RE->AA: Diminished RNA binding.,MUTAGEN:RG->AA: No impact on RNA binding.,MUTAGEN:RK->AA: No impact on RNA binding.,MUTAGEN:RS->AA: Loss of RNA binding.,MUTAGEN:V->I: Reduced interaction with SRP68.,MUTAGEN:V->I: Reduced interaction with SRP68. Diminished localization to endoplasmic reticulum.,MUTAGEN:VR->AA: Stronger interaction with SRP68.,MUTAGEN:WL->AA: Loss of RNA binding.,MUTAGEN:Y->C: Loss of interaction with SRP68. Diminished localization to endoplasmic reticulum.,MUTAGEN:YY->AA: Diminished RNA binding.,REGION:Disordered,REGION:RNA-binding,REGION:Required for interaction with SRP68,REGION:Required for the interaction with the SRP68/7SL RNA complex,REPEAT:TPR,REPEAT:TPR 1,REPEAT:TPR 2,REPEAT:TPR 3,REPEAT:TPR 4,REPEAT:TPR 5,
P45433	signal sequence receptor, alpha(LOC100136780)	Oncorhynchus mykiss				GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,		IPR005595:TRAP_alpha,	omy04141:Protein processing in endoplasmic reticulum,					KW-0256~Endoplasmic reticulum,KW-0472~Membrane,			KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0106~Calcium,		KW-0325~Glycoprotein,KW-0597~Phosphoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Acidic residues,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Lumenal,TRANSMEM:Helical,
Q764M5	signal transducer and activator of transcription 1(STAT1)	Sus scrofa			GO:0001937~negative regulation of endothelial cell proliferation,GO:0002230~positive regulation of defense response to virus by host,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006919~activation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0006952~defense response,GO:0007165~signal transduction,GO:0007259~JAK-STAT cascade,GO:0007584~response to nutrient,GO:0008015~blood circulation,GO:0008284~positive regulation of cell proliferation,GO:0010033~response to organic substance,GO:0010742~macrophage derived foam cell differentiation,GO:0016525~negative regulation of angiogenesis,GO:0032727~positive regulation of interferon-alpha production,GO:0032869~cellular response to insulin stimulus,GO:0033209~tumor necrosis factor-mediated signaling pathway,GO:0034097~response to cytokine,GO:0034341~response to interferon-gamma,GO:0035458~cellular response to interferon-beta,GO:0038113~interleukin-9-mediated signaling pathway,GO:0042127~regulation of cell proliferation,GO:0043124~negative regulation of I-kappaB kinase/NF-kappaB signaling,GO:0043434~response to peptide hormone,GO:0045648~positive regulation of erythrocyte differentiation,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046725~negative regulation by virus of viral protein levels in host cell,GO:0048661~positive regulation of smooth muscle cell proliferation,GO:0051591~response to cAMP,GO:0051607~defense response to virus,GO:0060333~interferon-gamma-mediated signaling pathway,GO:0060337~type I interferon signaling pathway,GO:0061326~renal tubule development,GO:0070106~interleukin-27-mediated signaling pathway,GO:0072136~metanephric mesenchymal cell proliferation involved in metanephros development,GO:0072162~metanephric mesenchymal cell differentiation,GO:0072308~negative regulation of metanephric nephron tubule epithelial cell differentiation,	GO:0000785~chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0048471~perinuclear region of cytoplasm,GO:0070721~ISGF3 complex,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000979~RNA polymerase II core promoter sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0001222~transcription corepressor binding,GO:0001223~transcription coactivator binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005164~tumor necrosis factor receptor binding,GO:0016922~ligand-dependent nuclear receptor binding,GO:0035035~histone acetyltransferase binding,GO:0042393~histone binding,GO:0042803~protein homodimerization activity,GO:0044389~ubiquitin-like protein ligase binding,GO:1990841~promoter-specific chromatin binding,	IPR000980:SH2,IPR001217:STAT,IPR008967:p53-like_TF_DNA-bd_sf,IPR012345:STAT_TF_DNA-bd_N,IPR013799:STAT_TF_prot_interaction,IPR013800:STAT_TF_alpha,IPR013801:STAT_TF_DNA-bd,IPR015988:STAT_TF_coiled-coil,IPR022752:STAT1_TAZ2-bd_C,IPR035859:STAT1_SH2,IPR036535:STAT_N_sf,IPR036860:SH2_dom_sf,IPR038295:STAT1_C_sf,IPR048988:STAT_linker,	ssc04062:Chemokine signaling pathway,ssc04217:Necroptosis,ssc04380:Osteoclast differentiation,ssc04620:Toll-like receptor signaling pathway,ssc04621:NOD-like receptor signaling pathway,ssc04625:C-type lectin receptor signaling pathway,ssc04630:JAK-STAT signaling pathway,ssc04658:Th1 and Th2 cell differentiation,ssc04659:Th17 cell differentiation,ssc04917:Prolactin signaling pathway,ssc04919:Thyroid hormone signaling pathway,ssc04933:AGE-RAGE signaling pathway in diabetic complications,ssc04935:Growth hormone synthesis, secretion and action,ssc05140:Leishmaniasis,ssc05145:Toxoplasmosis,ssc05152:Tuberculosis,ssc05160:Hepatitis C,ssc05161:Hepatitis B,ssc05162:Measles,ssc05164:Influenza A,ssc05165:Human papillomavirus infection,ssc05167:Kaposi sarcoma-associated herpesvirus infection,ssc05168:Herpes simplex virus 1 infection,ssc05169:Epstein-Barr virus infection,ssc05171:Coronavirus disease - COVID-19,ssc05200:Pathways in cancer,ssc05212:Pancreatic cancer,ssc05235:PD-L1 expression and PD-1 checkpoint pathway in cancer,ssc05321:Inflammatory bowel disease,			SM00964:STAT_int,	KW-0804~Transcription,KW-0805~Transcription regulation,KW-0945~Host-virus interaction,	KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0175~Coiled coil,KW-0727~SH2 domain,		KW-0010~Activator,KW-0238~DNA-binding,	KW-0007~Acetylation,KW-0013~ADP-ribosylation,KW-0488~Methylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate,DOMAIN:SH2,SITE:Required for recruitment of EP300/p300,
P40763	signal transducer and activator of transcription 3(STAT3)	Homo sapiens	11.IL-6_gp130-Jak-STAT,12.IL-6_type_cytok-signal-transduct,48.mice_minus_JAKs_and_STATs,	h_biopeptidesPathway:Bioactive Peptide Induced Signaling Pathway,h_egfPathway:EGF Signaling Pathway,h_erkPathway:Erk1/Erk2 Mapk Signaling pathway,h_her2Pathway:Role of ERBB2 in Signal Transduction and Oncology,h_il10Pathway:IL-10 Anti-inflammatory Signaling Pathway,h_il22bpPathway:IL22 Soluble Receptor Signaling Pathway ,h_il6Pathway:IL 6 signaling pathway,h_metPathway:Signaling of Hepatocyte Growth Factor Receptor,h_pdgfPathway:PDGF Signaling Pathway,h_stat3Pathway:Stat3 Signaling Pathway,h_tpoPathway:TPO Signaling Pathway,	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001659~temperature homeostasis,GO:0001754~eye photoreceptor cell differentiation,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006606~protein import into nucleus,GO:0006952~defense response,GO:0006954~inflammatory response,GO:0007165~signal transduction,GO:0007166~cell surface receptor signaling pathway,GO:0007179~transforming growth factor beta receptor signaling pathway,GO:0007259~JAK-STAT cascade,GO:0007399~nervous system development,GO:0008283~cell proliferation,GO:0008285~negative regulation of cell proliferation,GO:0010507~negative regulation of autophagy,GO:0010575~positive regulation of vascular endothelial growth factor production,GO:0010628~positive regulation of gene expression,GO:0010629~negative regulation of gene expression,GO:0016310~phosphorylation,GO:0019221~cytokine-mediated signaling pathway,GO:0019953~sexual reproduction,GO:0030154~cell differentiation,GO:0030335~positive regulation of cell migration,GO:0030522~intracellular receptor signaling pathway,GO:0032355~response to estradiol,GO:0032731~positive regulation of interleukin-1 beta production,GO:0032733~positive regulation of interleukin-10 production,GO:0032755~positive regulation of interleukin-6 production,GO:0032757~positive regulation of interleukin-8 production,GO:0032760~positive regulation of tumor necrosis factor production,GO:0032870~cellular response to hormone stimulus,GO:0033210~leptin-mediated signaling pathway,GO:0035019~somatic stem cell population maintenance,GO:0035723~interleukin-15-mediated signaling pathway,GO:0038110~interleukin-2-mediated signaling pathway,GO:0038113~interleukin-9-mediated signaling pathway,GO:0038154~interleukin-11-mediated signaling pathway,GO:0040014~regulation of multicellular organism growth,GO:0042127~regulation of cell proliferation,GO:0042593~glucose homeostasis,GO:0042755~eating behavior,GO:0042789~mRNA transcription from RNA polymerase II promoter,GO:0043434~response to peptide hormone,GO:0043491~protein kinase B signaling,GO:0044320~cellular response to leptin stimulus,GO:0044321~response to leptin,GO:0045648~positive regulation of erythrocyte differentiation,GO:0045747~positive regulation of Notch signaling pathway,GO:0045766~positive regulation of angiogenesis,GO:0045820~negative regulation of glycolytic process,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048708~astrocyte differentiation,GO:0050728~negative regulation of inflammatory response,GO:0051092~positive regulation of NF-kappaB transcription factor activity,GO:0051726~regulation of cell cycle,GO:0060019~radial glial cell differentiation,GO:0060221~retinal rod cell differentiation,GO:0060259~regulation of feeding behavior,GO:0060396~growth hormone receptor signaling pathway,GO:0060397~JAK-STAT cascade involved in growth hormone signaling pathway,GO:0070102~interleukin-6-mediated signaling pathway,GO:0071310~cellular response to organic substance,GO:0072538~T-helper 17 type immune response,GO:0072540~T-helper 17 cell lineage commitment,GO:0097009~energy homeostasis,GO:0097398~cellular response to interleukin-17,GO:0097696~STAT cascade,GO:1900017~positive regulation of cytokine production involved in inflammatory response,GO:1902895~positive regulation of pri-miRNA transcription from RNA polymerase II promoter,GO:1904685~positive regulation of metalloendopeptidase activity,GO:1905564~positive regulation of vascular endothelial cell proliferation,GO:2000635~negative regulation of primary miRNA processing,GO:2000737~negative regulation of stem cell differentiation,GO:2001223~negative regulation of neuron migration,	GO:0000785~chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0090575~RNA polymerase II transcription factor complex,	GO:0000976~transcription regulatory region sequence-specific DNA binding,GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0004879~RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding,GO:0005102~receptor binding,GO:0005515~protein binding,GO:0019901~protein kinase binding,GO:0019903~protein phosphatase binding,GO:0031490~chromatin DNA binding,GO:0035591~signaling adaptor activity,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,GO:0046983~protein dimerization activity,GO:0061629~RNA polymerase II sequence-specific DNA binding transcription factor binding,GO:0070878~primary miRNA binding,	IPR000980:SH2,IPR001217:STAT,IPR008967:p53-like_TF_DNA-bd_sf,IPR012345:STAT_TF_DNA-bd_N,IPR013799:STAT_TF_prot_interaction,IPR013800:STAT_TF_alpha,IPR013801:STAT_TF_DNA-bd,IPR015988:STAT_TF_coiled-coil,IPR035855:STAT3_SH2,IPR036535:STAT_N_sf,IPR036860:SH2_dom_sf,IPR048988:STAT_linker,	hsa01521:EGFR tyrosine kinase inhibitor resistance,hsa04062:Chemokine signaling pathway,hsa04066:HIF-1 signaling pathway,hsa04068:FoxO signaling pathway,hsa04217:Necroptosis,hsa04550:Signaling pathways regulating pluripotency of stem cells,hsa04630:JAK-STAT signaling pathway,hsa04659:Th17 cell differentiation,hsa04917:Prolactin signaling pathway,hsa04920:Adipocytokine signaling pathway,hsa04931:Insulin resistance,hsa04933:AGE-RAGE signaling pathway in diabetic complications,hsa04935:Growth hormone synthesis, secretion and action,hsa05145:Toxoplasmosis,hsa05160:Hepatitis C,hsa05161:Hepatitis B,hsa05162:Measles,hsa05163:Human cytomegalovirus infection,hsa05167:Kaposi sarcoma-associated herpesvirus infection,hsa05169:Epstein-Barr virus infection,hsa05171:Coronavirus disease - COVID-19,hsa05200:Pathways in cancer,hsa05203:Viral carcinogenesis,hsa05205:Proteoglycans in cancer,hsa05206:MicroRNAs in cancer,hsa05207:Chemical carcinogenesis - receptor activation,hsa05212:Pancreatic cancer,hsa05221:Acute myeloid leukemia,hsa05223:Non-small cell lung cancer,hsa05235:PD-L1 expression and PD-1 checkpoint pathway in cancer,hsa05321:Inflammatory bowel disease,hsa05417:Lipid and atherosclerosis,	147060~Hyper-IgE syndrome 1, autosomal dominant, with recurrent infections,615952~Autoimmune disease, multisystem, infantile-onset, 1,		SM00964:STAT_int,	KW-0804~Transcription,KW-0805~Transcription regulation,KW-0945~Host-virus interaction,	KW-0539~Nucleus,KW-0963~Cytoplasm,		KW-0219~Diabetes mellitus,KW-0225~Disease variant,KW-0242~Dwarfism,	KW-0175~Coiled coil,KW-0727~SH2 domain,KW-0732~Signal,		KW-0010~Activator,KW-0238~DNA-binding,	KW-0007~Acetylation,KW-0597~Phosphoprotein,	DOMAIN:SH2,DOMAIN:STAT transcription factor protein interaction,MOTIF:Essential for nuclear import,MUTAGEN:EE->AA: Inhibits leptin-mediated transactivation of CCND1 promoter. No effect on interaction with INPP5F.,MUTAGEN:Y->F: Inhibits leptin-mediated transactivation of CCND1 promoter. Abolished phosphorylation by isoform M2 of PKM (PKM2).,REGION:Disordered,
P08579	small nuclear ribonucleoprotein polypeptide B2(SNRPB2)	Homo sapiens		h_smPathway:Spliceosomal Assembly,	GO:0000398~mRNA splicing, via spliceosome,GO:1903241~U2-type prespliceosome assembly,	GO:0001650~fibrillar center,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005681~spliceosomal complex,GO:0005684~U2-type spliceosomal complex,GO:0005685~U1 snRNP,GO:0005686~U2 snRNP,GO:0016607~nuclear speck,GO:0036464~cytoplasmic ribonucleoprotein granule,GO:0071005~U2-type precatalytic spliceosome,GO:0071007~U2-type catalytic step 2 spliceosome,GO:0071013~catalytic step 2 spliceosome,GO:1990904~ribonucleoprotein complex,	GO:0003723~RNA binding,GO:0005515~protein binding,GO:0030619~U1 snRNA binding,GO:0070990~snRNP binding,	IPR000504:RRM_dom,IPR012677:Nucleotide-bd_a/b_plait_sf,IPR034562:U2B''_RRM2,IPR034564:U2B''_RRM1,IPR035979:RBD_domain_sf,	hsa03040:Spliceosome,			SM00360:RRM,	KW-0507~mRNA processing,KW-0508~mRNA splicing,	KW-0539~Nucleus,KW-0747~Spliceosome,			KW-0677~Repeat,		KW-0687~Ribonucleoprotein,KW-0694~RNA-binding,	KW-0007~Acetylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate,DOMAIN:RRM,DOMAIN:RRM 1,DOMAIN:RRM 2,REGION:Disordered,
Q7ZUG0	small nuclear ribonucleoprotein polypeptide E(snrpe)	Danio rerio			GO:0000387~spliceosomal snRNP assembly,GO:0000398~mRNA splicing, via spliceosome,GO:0006397~mRNA processing,GO:0008380~RNA splicing,	GO:0005634~nucleus,GO:0005681~spliceosomal complex,GO:0005682~U5 snRNP,GO:0005684~U2-type spliceosomal complex,GO:0005685~U1 snRNP,GO:0005686~U2 snRNP,GO:0005687~U4 snRNP,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0034709~methylosome,GO:0034715~pICln-Sm protein complex,GO:0034719~SMN-Sm protein complex,GO:0046540~U4/U6 x U5 tri-snRNP complex,GO:0071005~U2-type precatalytic spliceosome,GO:0071007~U2-type catalytic step 2 spliceosome,GO:0071011~precatalytic spliceosome,GO:1990904~ribonucleoprotein complex,	GO:0003723~RNA binding,	IPR001163:Sm_dom_euk/arc,IPR010920:LSM_dom_sf,IPR027078:snRNP-E,IPR047575:Sm,	dre03040:Spliceosome,			SM00651:Sm,	KW-0507~mRNA processing,KW-0508~mRNA splicing,	KW-0539~Nucleus,KW-0747~Spliceosome,KW-0963~Cytoplasm,					KW-0687~Ribonucleoprotein,KW-0694~RNA-binding,		DOMAIN:Sm,
P62321	small nuclear ribonucleoprotein polypeptide F S homeolog(snrpf.S)	Xenopus laevis			GO:0000387~spliceosomal snRNP assembly,GO:0000398~mRNA splicing, via spliceosome,GO:0006397~mRNA processing,GO:0008380~RNA splicing,	GO:0005634~nucleus,GO:0005681~spliceosomal complex,GO:0005684~U2-type spliceosomal complex,GO:0005685~U1 snRNP,GO:0005687~U4 snRNP,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0034709~methylosome,GO:0034715~pICln-Sm protein complex,GO:0034719~SMN-Sm protein complex,GO:0043229~intracellular organelle,GO:0046540~U4/U6 x U5 tri-snRNP complex,GO:0071005~U2-type precatalytic spliceosome,GO:0071007~U2-type catalytic step 2 spliceosome,GO:1990904~ribonucleoprotein complex,	GO:0003723~RNA binding,	IPR001163:Sm_dom_euk/arc,IPR010920:LSM_dom_sf,IPR016487:Lsm6/sSmF,IPR034100:Sm_F,IPR047575:Sm,	xla03040:Spliceosome,		PIRSF006609:snRNP_SmF,	SM00651:Sm,	KW-0507~mRNA processing,KW-0508~mRNA splicing,	KW-0539~Nucleus,KW-0747~Spliceosome,KW-0963~Cytoplasm,					KW-0687~Ribonucleoprotein,KW-0694~RNA-binding,		DOMAIN:Sm,
Q9PV94	small nuclear ribonucleoprotein polypeptide N(SNRPN)	Gallus gallus			GO:0000387~spliceosomal snRNP assembly,GO:0000398~mRNA splicing, via spliceosome,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005682~U5 snRNP,GO:0005683~U7 snRNP,GO:0005684~U2-type spliceosomal complex,GO:0005685~U1 snRNP,GO:0005686~U2 snRNP,GO:0005687~U4 snRNP,GO:0005689~U12-type spliceosomal complex,GO:0005697~telomerase holoenzyme complex,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0034709~methylosome,GO:0034719~SMN-Sm protein complex,GO:0046540~U4/U6 x U5 tri-snRNP complex,GO:0071004~U2-type prespliceosome,GO:0071005~U2-type precatalytic spliceosome,GO:0071007~U2-type catalytic step 2 spliceosome,GO:0071013~catalytic step 2 spliceosome,GO:1990904~ribonucleoprotein complex,	GO:0003723~RNA binding,GO:0070034~telomerase RNA binding,	IPR001163:Sm_dom_euk/arc,IPR010920:LSM_dom_sf,IPR017131:snRNP-assoc_SmB/SmN,IPR047575:Sm,	gga03040:Spliceosome,		PIRSF037187:snRNP_SmB/SmN,	SM00651:Sm,	KW-0507~mRNA processing,KW-0508~mRNA splicing,	KW-0539~Nucleus,KW-0747~Spliceosome,KW-0963~Cytoplasm,			KW-0677~Repeat,		KW-0687~Ribonucleoprotein,KW-0694~RNA-binding,		COMPBIAS:Pro residues,DOMAIN:Sm,REGION:Disordered,REGION:Repeat-rich region,
Q9WTU3	sodium channel, voltage-gated, type VIII, alpha(Scn8a)	Mus musculus			GO:0006811~ion transport,GO:0006814~sodium ion transport,GO:0007422~peripheral nervous system development,GO:0007517~muscle organ development,GO:0007605~sensory perception of sound,GO:0007626~locomotory behavior,GO:0007628~adult walking behavior,GO:0009636~response to toxic substance,GO:0019228~neuronal action potential,GO:0021554~optic nerve development,GO:0021675~nerve development,GO:0034220~ion transmembrane transport,GO:0035725~sodium ion transmembrane transport,GO:0042552~myelination,GO:0050877~neurological system process,GO:0055085~transmembrane transport,GO:0086010~membrane depolarization during action potential,	GO:0001518~voltage-gated sodium channel complex,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0030018~Z disc,GO:0030054~cell junction,GO:0030424~axon,GO:0030425~dendrite,GO:0033268~node of Ranvier,GO:0034702~ion channel complex,GO:0034706~sodium channel complex,GO:0042995~cell projection,GO:0043025~neuronal cell body,GO:0043194~axon initial segment,GO:0048787~presynaptic active zone membrane,GO:0098688~parallel fiber to Purkinje cell synapse,GO:0098839~postsynaptic density membrane,GO:0098978~glutamatergic synapse,	GO:0000166~nucleotide binding,GO:0005216~ion channel activity,GO:0005248~voltage-gated sodium channel activity,GO:0005261~cation channel activity,GO:0005272~sodium channel activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0031402~sodium ion binding,GO:0046872~metal ion binding,	IPR000048:IQ_motif_EF-hand-BS,IPR001696:Na_channel_asu,IPR005821:Ion_trans_dom,IPR008054:Na_channel_a8su,IPR010526:Na_trans_assoc_dom,IPR024583:Na_trans_cytopl,IPR027359:Volt_channel_dom_sf,IPR043203:VGCC_Ca_Na,IPR044564:Na_chnl_inactivation_gate,				SM00015:IQ,	KW-0406~Ion transport,KW-0739~Sodium transport,KW-0813~Transport,	KW-0472~Membrane,KW-0966~Cell projection,KW-1003~Cell membrane,		KW-0225~Disease variant,	KW-0677~Repeat,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0067~ATP-binding,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,KW-0915~Sodium,	KW-0407~Ion channel,KW-0851~Voltage-gated channel,KW-0894~Sodium channel,	KW-0325~Glycoprotein,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Basic and acidic residues,DISULFID:Interchain; with SCN2B or SCN4B,DISULFID:Interchain; with the conotoxin GVIIJ (when the channel is not linked to SCN2B or SCN4B; the bond to SCN2B or SCN4B protects the channel from the inhibition by toxin),DOMAIN:IQ,DOMAIN:Ion transport,DOMAIN:Sodium ion transport-associated,DOMAIN:Voltage-gated Na+ ion channel cytoplasmic,INTRAMEM:Pore-forming,MUTAGEN:D->E: Decrease in sensitivity to the scorpion toxin BMK M1.,MUTAGEN:Q->A: Decreases interaction with CALM1 in the absence of calcium.,MUTAGEN:R->A: Decreases interaction with CALM1 in the absence of calcium.,MUTAGEN:R->A: Decreases interaction with CALM1 in the presence and absence of calcium and reduces rate of channel inactivation.,MUTAGEN:Y->A: Decreases interaction with CALM1 in the presence and absence of calcium and reduces rate of channel inactivation.,REGION:Disordered,REPEAT:I,REPEAT:II,REPEAT:III,REPEAT:IV,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,TRANSMEM:Helical; Name=S1 of repeat I,TRANSMEM:Helical; Name=S1 of repeat II,TRANSMEM:Helical; Name=S1 of repeat III,TRANSMEM:Helical; Name=S1 of repeat IV,TRANSMEM:Helical; Name=S2 of repeat I,TRANSMEM:Helical; Name=S2 of repeat II,TRANSMEM:Helical; Name=S2 of repeat III,TRANSMEM:Helical; Name=S2 of repeat IV,TRANSMEM:Helical; Name=S3 of repeat I,TRANSMEM:Helical; Name=S3 of repeat II,TRANSMEM:Helical; Name=S3 of repeat III,TRANSMEM:Helical; Name=S3 of repeat IV,TRANSMEM:Helical; Name=S4 of repeat I,TRANSMEM:Helical; Name=S4 of repeat II,TRANSMEM:Helical; Name=S4 of repeat III,TRANSMEM:Helical; Name=S4 of repeat IV,TRANSMEM:Helical; Name=S5 of repeat I,TRANSMEM:Helical; Name=S5 of repeat II,TRANSMEM:Helical; Name=S5 of repeat III,TRANSMEM:Helical; Name=S5 of repeat IV,TRANSMEM:Helical; Name=S6 of repeat I,TRANSMEM:Helical; Name=S6 of repeat II,TRANSMEM:Helical; Name=S6 of repeat III,TRANSMEM:Helical; Name=S6 of repeat IV,
Q9JIS8	solute carrier family 12, member 4(Slc12a4)	Mus musculus			GO:0006811~ion transport,GO:0006813~potassium ion transport,GO:0006884~cell volume homeostasis,GO:0007268~chemical synaptic transmission,GO:0055064~chloride ion homeostasis,GO:0055075~potassium ion homeostasis,GO:0055085~transmembrane transport,GO:0071805~potassium ion transmembrane transport,GO:1902476~chloride transmembrane transport,GO:1990573~potassium ion import across plasma membrane,	GO:0005886~plasma membrane,GO:0016020~membrane,GO:0045202~synapse,	GO:0000166~nucleotide binding,GO:0005524~ATP binding,GO:0015293~symporter activity,GO:0015377~cation:chloride symporter activity,GO:0015379~potassium:chloride symporter activity,GO:0019901~protein kinase binding,GO:0022857~transmembrane transporter activity,GO:0046872~metal ion binding,	IPR000076:KCL_cotranspt,IPR000622:KCC1,IPR004841:AA-permease/SLC12A_dom,IPR004842:SLC12A_fam,IPR018491:SLC12_C,					KW-0406~Ion transport,KW-0633~Potassium transport,KW-0769~Symport,KW-0813~Transport,	KW-0472~Membrane,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0067~ATP-binding,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,KW-0630~Potassium,KW-0868~Chloride,		KW-0325~Glycoprotein,KW-0597~Phosphoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Basic and acidic residues,DOMAIN:Amino acid permease/ SLC12A,DOMAIN:SLC12A transporter C-terminal,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Discontinuously helical,TRANSMEM:Helical,
Q86YT5	solute carrier family 13 member 5(SLC13A5)	Homo sapiens			GO:0015729~oxaloacetate transport,GO:0015741~fumarate transport,GO:0015742~alpha-ketoglutarate transport,GO:0015744~succinate transport,GO:0015746~citrate transport,GO:0035674~tricarboxylic acid transmembrane transport,GO:0035725~sodium ion transmembrane transport,GO:0055085~transmembrane transport,GO:0071285~cellular response to lithium ion,GO:0071422~succinate transmembrane transport,	GO:0005654~nucleoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0016020~membrane,	GO:0005343~organic acid:sodium symporter activity,GO:0005515~protein binding,GO:0015137~citrate transmembrane transporter activity,GO:0015141~succinate transmembrane transporter activity,GO:0015370~solute:sodium symporter activity,GO:0017153~sodium:dicarboxylate symporter activity,GO:0042802~identical protein binding,	IPR001898:SLC13A/DASS,IPR031312:Na/sul_symport_CS,		615905~Developmental and epileptic encephalopathy 25, with amelogenesis imperfecta,			KW-0406~Ion transport,KW-0739~Sodium transport,KW-0769~Symport,KW-0813~Transport,	KW-0472~Membrane,KW-1003~Cell membrane,		KW-0225~Disease variant,KW-0887~Epilepsy,KW-0986~Amelogenesis imperfecta,	KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0915~Sodium,		KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,MUTAGEN:G->Q: No effect on its function in citrate transport.,MUTAGEN:I->A,F: Significant loss of function in citrate transport.,MUTAGEN:I->V: No effect on its function in citrate transport.,TRANSMEM:Helical,
Q9HC58	solute carrier family 24 member 3(SLC24A3)	Homo sapiens			GO:0006811~ion transport,GO:0006874~cellular calcium ion homeostasis,GO:0010628~positive regulation of gene expression,GO:0010629~negative regulation of gene expression,GO:0030282~bone mineralization,GO:0035725~sodium ion transmembrane transport,GO:0070588~calcium ion transmembrane transport,GO:0071805~potassium ion transmembrane transport,	GO:0005886~plasma membrane,GO:0071944~cell periphery,	GO:0005262~calcium channel activity,GO:0008273~calcium, potassium:sodium antiporter activity,GO:0015293~symporter activity,	IPR004481:K/Na/Ca-exchanger,IPR004837:NaCa_Exmemb,IPR044880:NCX_ion-bd_dom_sf,					KW-0050~Antiport,KW-0109~Calcium transport,KW-0406~Ion transport,KW-0633~Potassium transport,KW-0739~Sodium transport,KW-0769~Symport,KW-0813~Transport,	KW-0472~Membrane,KW-1003~Cell membrane,			KW-0677~Repeat,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0106~Calcium,KW-0630~Potassium,KW-0915~Sodium,		KW-0325~Glycoprotein,KW-0597~Phosphoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Acidic residues,REGION:Disordered,REPEAT:Alpha-1,REPEAT:Alpha-2,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q6GQS1	solute carrier family 25 (mitochondrial carrier; phosphate carrier), member 23(Slc25a23)	Mus musculus			GO:0002082~regulation of oxidative phosphorylation,GO:0003014~renal system process,GO:0006851~mitochondrial calcium ion transport,GO:0015866~ADP transport,GO:0015867~ATP transport,GO:0036444~mitochondrial calcium uptake,GO:0043457~regulation of cellular respiration,GO:0051282~regulation of sequestering of calcium ion,GO:0051503~adenine nucleotide transport,GO:0051561~positive regulation of mitochondrial calcium ion concentration,GO:0055085~transmembrane transport,GO:0071277~cellular response to calcium ion,GO:1900069~regulation of cellular hyperosmotic salinity response,GO:1990544~mitochondrial ATP transmembrane transport,	GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0016020~membrane,	GO:0000295~adenine nucleotide transmembrane transporter activity,GO:0005347~ATP transmembrane transporter activity,GO:0005509~calcium ion binding,GO:0015297~antiporter activity,GO:0046872~metal ion binding,	IPR002048:EF_hand_dom,IPR002067:Mit_carrier,IPR011992:EF-hand-dom_pair,IPR018108:Mitochondrial_sb/sol_carrier,IPR018247:EF_Hand_1_Ca_BS,IPR023395:Mt_carrier_dom_sf,				SM00054:EFh,	KW-0050~Antiport,KW-0813~Transport,	KW-0472~Membrane,KW-0496~Mitochondrion,KW-0999~Mitochondrion inner membrane,			KW-0677~Repeat,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0106~Calcium,KW-0479~Metal-binding,			COMPBIAS:Polar residues,DOMAIN:EF-hand,DOMAIN:EF-hand 1,DOMAIN:EF-hand 2,DOMAIN:EF-hand 3,REGION:C-terminal transmembrane transporter domain,REGION:Disordered,REGION:Linker region,REGION:Regulatory N-terminal domain,REPEAT:Solcar,REPEAT:Solcar 1,REPEAT:Solcar 2,REPEAT:Solcar 3,TOPO_DOM:Mitochondrial intermembrane,TOPO_DOM:Mitochondrial matrix,TRANSMEM:Helical,TRANSMEM:Helical; Name=1,TRANSMEM:Helical; Name=2,TRANSMEM:Helical; Name=3,TRANSMEM:Helical; Name=4,TRANSMEM:Helical; Name=5,TRANSMEM:Helical; Name=6,
O35488	solute carrier family 27 (fatty acid transporter), member 2(Slc27a2)	Mus musculus			GO:0000038~very long-chain fatty acid metabolic process,GO:0001561~fatty acid alpha-oxidation,GO:0001676~long-chain fatty acid metabolic process,GO:0006629~lipid metabolic process,GO:0006631~fatty acid metabolic process,GO:0006635~fatty acid beta-oxidation,GO:0006699~bile acid biosynthetic process,GO:0006869~lipid transport,GO:0008206~bile acid metabolic process,GO:0015908~fatty acid transport,GO:0042760~very long-chain fatty acid catabolic process,GO:0044281~small molecule metabolic process,GO:0044539~long-chain fatty acid import,GO:0097089~methyl-branched fatty acid metabolic process,GO:1905039~carboxylic acid transmembrane transport,	GO:0005739~mitochondrion,GO:0005777~peroxisome,GO:0005778~peroxisomal membrane,GO:0005783~endoplasmic reticulum,GO:0005788~endoplasmic reticulum lumen,GO:0005789~endoplasmic reticulum membrane,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0043231~intracellular membrane-bounded organelle,	GO:0000166~nucleotide binding,GO:0003824~catalytic activity,GO:0004467~long-chain fatty acid-CoA ligase activity,GO:0005324~long-chain fatty acid transporter activity,GO:0005524~ATP binding,GO:0015245~fatty acid transporter activity,GO:0016874~ligase activity,GO:0019899~enzyme binding,GO:0031957~very long-chain fatty acid-CoA ligase activity,GO:0047676~arachidonate-CoA ligase activity,GO:0047747~cholate-CoA ligase activity,GO:0050197~phytanate-CoA ligase activity,GO:0070251~pristanate-CoA ligase activity,GO:1901480~oleate transporter activity,	IPR000873:AMP-dep_Synth/Lig_com,IPR020845:AMP-binding_CS,IPR025110:AMP-bd_C,IPR042099:ANL_N_sf,IPR045851:AMP-bd_C_sf,	mmu03320:PPAR signaling pathway,mmu04146:Peroxisome,mmu04931:Insulin resistance,				KW-0276~Fatty acid metabolism,KW-0443~Lipid metabolism,KW-0445~Lipid transport,KW-0813~Transport,	KW-0256~Endoplasmic reticulum,KW-0472~Membrane,KW-0492~Microsome,KW-0576~Peroxisome,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0436~Ligase,	KW-0007~Acetylation,KW-0597~Phosphoprotein,	DOMAIN:AMP-binding enzyme C-terminal,DOMAIN:AMP-dependent synthetase/ligase,TOPO_DOM:Cytoplasmic,TOPO_DOM:Lumenal,TRANSMEM:Helical,
Q9Y6M5	solute carrier family 30 member 1(SLC30A1)	Homo sapiens			GO:0001701~in utero embryonic development,GO:0006829~zinc II ion transport,GO:0006874~cellular calcium ion homeostasis,GO:0006882~cellular zinc ion homeostasis,GO:0010312~detoxification of zinc ion,GO:0042742~defense response to bacterium,GO:0046929~negative regulation of neurotransmitter secretion,GO:0070509~calcium ion import,GO:0070574~cadmium ion transmembrane transport,GO:0071577~zinc II ion transmembrane transport,GO:0071584~negative regulation of zinc ion transmembrane import,GO:0071585~detoxification of cadmium ion,GO:0090281~negative regulation of calcium ion import,	GO:0005737~cytoplasm,GO:0005783~endoplasmic reticulum,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0016323~basolateral plasma membrane,GO:0030315~T-tubule,GO:0030659~cytoplasmic vesicle membrane,GO:0031965~nuclear membrane,GO:0098685~Schaffer collateral - CA1 synapse,GO:0098839~postsynaptic density membrane,	GO:0005385~zinc ion transmembrane transporter activity,GO:0005515~protein binding,GO:0008324~cation transmembrane transporter activity,GO:0019855~calcium channel inhibitor activity,GO:0046872~metal ion binding,	IPR002524:Cation_efflux,IPR027469:Cation_efflux_TMD_sf,IPR036837:Cation_efflux_CTD_sf,	hsa04978:Mineral absorption,				KW-0050~Antiport,KW-0406~Ion transport,KW-0813~Transport,KW-0864~Zinc transport,	KW-0472~Membrane,KW-0968~Cytoplasmic vesicle,KW-1003~Cell membrane,			KW-0677~Repeat,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0479~Metal-binding,KW-0862~Zinc,		KW-0325~Glycoprotein,KW-0597~Phosphoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Polar residues,MUTAGEN:N->A: Loss of N-glycosylation. No effect on localization to the plasma membrane. Increased stability at the plasma membrane. No effect on resistance to zinc-induced cytotoxicity.,REGION:6 X 2 AA approximate repeats of H-G,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q7Z2H8	solute carrier family 36 member 1(SLC36A1)	Homo sapiens			GO:0006811~ion transport,GO:0006865~amino acid transport,GO:0015734~taurine transport,GO:0015808~L-alanine transport,GO:0015816~glycine transport,GO:0015824~proline transport,GO:0032328~alanine transport,GO:0035524~proline transmembrane transport,GO:0089718~amino acid import across plasma membrane,GO:1902600~hydrogen ion transmembrane transport,	GO:0005765~lysosomal membrane,GO:0005774~vacuolar membrane,GO:0005783~endoplasmic reticulum,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0016324~apical plasma membrane,	GO:0005280~hydrogen:amino acid symporter activity,GO:0005297~hydrogen:proline symporter activity,GO:0005368~taurine transmembrane transporter activity,GO:0005515~protein binding,GO:0015171~amino acid transmembrane transporter activity,GO:0015180~L-alanine transmembrane transporter activity,GO:0015187~glycine transmembrane transporter activity,GO:0015193~L-proline transmembrane transporter activity,GO:0022858~alanine transmembrane transporter activity,	IPR013057:AA_transpt_TM,	hsa04974:Protein digestion and absorption,				KW-0029~Amino-acid transport,KW-0769~Symport,KW-0813~Transport,	KW-0458~Lysosome,KW-0472~Membrane,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:Amino acid transporter transmembrane,MUTAGEN:C->A,S: Loss amino acid:proton symporter activity. No effect on localization to the plasma membrane.,MUTAGEN:C->A,S: No effect on amino acid:proton symporter activity. No effect on localization to the plasma membrane.,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,TRANSMEM:Helical; Name=1,TRANSMEM:Helical; Name=10,TRANSMEM:Helical; Name=11,TRANSMEM:Helical; Name=2,TRANSMEM:Helical; Name=3,TRANSMEM:Helical; Name=4,TRANSMEM:Helical; Name=5,TRANSMEM:Helical; Name=6,TRANSMEM:Helical; Name=7,TRANSMEM:Helical; Name=8,TRANSMEM:Helical; Name=9,
Q6QQT1	solute carrier family 39 member 1(slc39a1)	Takifugu rubripes			GO:0006829~zinc II ion transport,GO:0071577~zinc II ion transmembrane transport,	GO:0005789~endoplasmic reticulum membrane,GO:0005886~plasma membrane,GO:0016020~membrane,	GO:0005385~zinc ion transmembrane transporter activity,GO:0008270~zinc ion binding,GO:0046873~metal ion transmembrane transporter activity,	IPR003689:ZIP,					KW-0406~Ion transport,KW-0813~Transport,KW-0864~Zinc transport,	KW-0256~Endoplasmic reticulum,KW-0472~Membrane,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0862~Zinc,			REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q9WVR6	solute carrier family 7 member 8(Slc7a8)	Rattus norvegicus			GO:0003333~amino acid transmembrane transport,GO:0006865~amino acid transport,GO:0015695~organic cation transport,GO:0015804~neutral amino acid transport,GO:0015807~L-amino acid transport,GO:0015816~glycine transport,GO:0015820~leucine transport,GO:0015827~tryptophan transport,GO:0015829~valine transport,GO:0035524~proline transmembrane transport,GO:0070327~thyroid hormone transport,GO:0089718~amino acid import across plasma membrane,GO:0098713~leucine import across plasma membrane,GO:1901998~toxin transport,GO:1903801~L-leucine import into cell,GO:1904273~L-alanine import across plasma membrane,	GO:0005886~plasma membrane,GO:0009925~basal plasma membrane,GO:0016020~membrane,GO:0016323~basolateral plasma membrane,GO:0016324~apical plasma membrane,GO:0031528~microvillus membrane,	GO:0015101~organic cation transmembrane transporter activity,GO:0015171~amino acid transmembrane transporter activity,GO:0015175~neutral amino acid transmembrane transporter activity,GO:0015179~L-amino acid transmembrane transporter activity,GO:0015180~L-alanine transmembrane transporter activity,GO:0015187~glycine transmembrane transporter activity,GO:0015190~L-leucine transmembrane transporter activity,GO:0015297~antiporter activity,GO:0015349~thyroid hormone transmembrane transporter activity,GO:0019534~toxin transporter activity,GO:0022857~transmembrane transporter activity,GO:0042605~peptide antigen binding,GO:0046982~protein heterodimerization activity,	IPR002293:AA/rel_permease1,IPR004760:L_AA_transporter,	rno04974:Protein digestion and absorption,		PIRSF006060:AA_transporter,		KW-0029~Amino-acid transport,KW-0050~Antiport,KW-0813~Transport,	KW-0472~Membrane,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0597~Phosphoprotein,KW-1015~Disulfide bond,	COMPBIAS:Basic and acidic residues,DISULFID:Interchain (with C-103 in SLC3A2),REGION:Disordered,SITE:Important for substrate specificity,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,TRANSMEM:Helical; Name=1,TRANSMEM:Helical; Name=10,TRANSMEM:Helical; Name=11,TRANSMEM:Helical; Name=12,TRANSMEM:Helical; Name=2,TRANSMEM:Helical; Name=3,TRANSMEM:Helical; Name=4,TRANSMEM:Helical; Name=5,TRANSMEM:Helical; Name=6,TRANSMEM:Helical; Name=7,TRANSMEM:Helical; Name=8,TRANSMEM:Helical; Name=9,
Q8BLV3	solute carrier family 9 (sodium/hydrogen exchanger), member 7(Slc9a7)	Mus musculus			GO:0006811~ion transport,GO:0006812~cation transport,GO:0006813~potassium ion transport,GO:0006814~sodium ion transport,GO:0006885~regulation of pH,GO:0051453~regulation of intracellular pH,GO:0055085~transmembrane transport,GO:0071805~potassium ion transmembrane transport,GO:0098719~sodium ion import across plasma membrane,GO:1902600~hydrogen ion transmembrane transport,GO:1905526~regulation of Golgi lumen acidification,	GO:0005768~endosome,GO:0005794~Golgi apparatus,GO:0005802~trans-Golgi network,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0043231~intracellular membrane-bounded organelle,GO:0055037~recycling endosome,GO:0055038~recycling endosome membrane,	GO:0015297~antiporter activity,GO:0015385~sodium:proton antiporter activity,GO:0015386~potassium:proton antiporter activity,	IPR002090:NHE-6/7/9,IPR004709:NaH_exchanger,IPR006153:Cation/H_exchanger,IPR018422:Cation/H_exchanger_CPA1,	mmu04260:Cardiac muscle contraction,				KW-0050~Antiport,KW-0406~Ion transport,KW-0633~Potassium transport,KW-0739~Sodium transport,KW-0813~Transport,	KW-0333~Golgi apparatus,KW-0472~Membrane,KW-0967~Endosome,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0630~Potassium,KW-0915~Sodium,		KW-0325~Glycoprotein,KW-0597~Phosphoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:Cation/H+ exchanger,REGION:Disordered,REGION:Required for trans-Golgi network localization,TOPO_DOM:Cytoplasmic,TOPO_DOM:Lumenal,TRANSMEM:Helical,
F1MV99	somatostatin receptor 5(SSTR5)	Bos taurus			GO:0007218~neuropeptide signaling pathway,GO:0032467~positive regulation of cytokinesis,GO:0050796~regulation of insulin secretion,GO:0071385~cellular response to glucocorticoid stimulus,	GO:0005886~plasma membrane,GO:0016020~membrane,GO:0043005~neuron projection,	GO:0004994~somatostatin receptor activity,GO:0042923~neuropeptide binding,	IPR000276:GPCR_Rhodpsn,IPR000586:Somatstn_rcpt,IPR001184:Somatstn_rcpt_5,IPR017452:GPCR_Rhodpsn_7TM,	bta04024:cAMP signaling pathway,bta04080:Neuroactive ligand-receptor interaction,bta04935:Growth hormone synthesis, secretion and action,			SM01381:7TM_GPCR_Srsx,		KW-0472~Membrane,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0297~G-protein coupled receptor,KW-0675~Receptor,KW-0807~Transducer,	KW-0325~Glycoprotein,KW-0449~Lipoprotein,KW-0564~Palmitate,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:G-protein coupled receptors family 1 profile,LIPID:S-palmitoyl cysteine; by ZDHHC5,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q9ER58	sparc/osteonectin, cwcv and kazal-like domains proteoglycan 2(Spock2)	Mus musculus			GO:0010811~positive regulation of cell-substrate adhesion,GO:0030198~extracellular matrix organization,GO:1990830~cellular response to leukemia inhibitory factor,	GO:0005576~extracellular region,	GO:0005509~calcium ion binding,GO:0005539~glycosaminoglycan binding,GO:0030021~extracellular matrix structural constituent conferring compression resistance,GO:0050840~extracellular matrix binding,	IPR000716:Thyroglobulin_1,IPR002350:Kazal_dom,IPR011992:EF-hand-dom_pair,IPR019577:SPARC/Testican_Ca-bd-dom,IPR036058:Kazal_dom_sf,IPR036857:Thyroglobulin_1_sf,				SM00211:TY,SM00280:KAZAL,		KW-0272~Extracellular matrix,KW-0964~Secreted,			KW-0732~Signal,	KW-0106~Calcium,		KW-0325~Glycoprotein,KW-0357~Heparan sulfate,KW-0597~Phosphoprotein,KW-0654~Proteoglycan,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,CARBOHYD:O-linked (Xyl...) (glycosaminoglycan) serine,COMPBIAS:Acidic residues,DOMAIN:Kazal-like,DOMAIN:Thyroglobulin type-1,REGION:Disordered,
Q9NWM0	spermine oxidase(SMOX)	Homo sapiens			GO:0006596~polyamine biosynthetic process,GO:0006598~polyamine catabolic process,GO:0006805~xenobiotic metabolic process,GO:0046208~spermine catabolic process,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0031965~nuclear membrane,GO:0043231~intracellular membrane-bounded organelle,	GO:0016491~oxidoreductase activity,GO:0046592~polyamine oxidase activity,GO:0052894~norspermine:oxygen oxidoreductase activity,GO:0052895~N1-acetylspermine:oxygen oxidoreductase (N1-acetylspermidine-forming) activity,GO:0052901~spermine:oxygen oxidoreductase (spermidine-forming) activity,	IPR002937:Amino_oxidase,IPR036188:FAD/NAD-bd_sf,	hsa00330:Arginine and proline metabolism,hsa00410:beta-Alanine metabolism,hsa01100:Metabolic pathways,					KW-0539~Nucleus,KW-0963~Cytoplasm,				KW-0274~FAD,KW-0285~Flavoprotein,	KW-0560~Oxidoreductase,		COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:Amine oxidase,MUTAGEN:C->R: No change in enzymatic activity.,REGION:Disordered,
Q58EL7	spindle and kinetochore associated complex subunit 3(ska3)	Danio rerio			GO:0000278~mitotic cell cycle,GO:0007049~cell cycle,GO:0007059~chromosome segregation,GO:0031110~regulation of microtubule polymerization or depolymerization,GO:0051301~cell division,GO:0051315~attachment of mitotic spindle microtubules to kinetochore,	GO:0000775~chromosome, centromeric region,GO:0000776~kinetochore,GO:0000940~condensed chromosome outer kinetochore,GO:0005694~chromosome,GO:0005737~cytoplasm,GO:0005819~spindle,GO:0005856~cytoskeleton,GO:0005874~microtubule,GO:0005876~spindle microtubule,	GO:0008017~microtubule binding,	IPR033341:SKA3,					KW-0131~Cell cycle,KW-0132~Cell division,KW-0498~Mitosis,	KW-0137~Centromere,KW-0158~Chromosome,KW-0206~Cytoskeleton,KW-0493~Microtubule,KW-0963~Cytoplasm,KW-0995~Kinetochore,						KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,REGION:Disordered,
Q7Z698	sprouty related EVH1 domain containing 2(SPRED2)	Homo sapiens			GO:0009966~regulation of signal transduction,GO:0010719~negative regulation of epithelial to mesenchymal transition,GO:0010801~negative regulation of peptidyl-threonine phosphorylation,GO:0030512~negative regulation of transforming growth factor beta receptor signaling pathway,GO:0043409~negative regulation of MAPK cascade,GO:0043517~positive regulation of DNA damage response, signal transduction by p53 class mediator,GO:0070373~negative regulation of ERK1 and ERK2 cascade,GO:0090311~regulation of protein deacetylation,GO:1902747~negative regulation of lens fiber cell differentiation,	GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0030658~transport vesicle membrane,	GO:0005173~stem cell factor receptor binding,GO:0005515~protein binding,GO:0019901~protein kinase binding,GO:0030291~protein serine/threonine kinase inhibitor activity,	IPR000697:WH1/EVH1_dom,IPR007875:Sprouty,IPR011993:PH-like_dom_sf,IPR023337:KBD,IPR041937:SPRE_EVH1,		619745~Noonan syndrome 14,		SM00461:WH1,		KW-0472~Membrane,KW-0963~Cytoplasm,KW-0968~Cytoplasmic vesicle,KW-1003~Cell membrane,		KW-0225~Disease variant,				KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,	COMPBIAS:Polar residues,DOMAIN:KBD,DOMAIN:SPR,DOMAIN:WH1,MUTAGEN:Y->F: No effect on phosphorylation or ubiquitination.,MUTAGEN:Y->F: No effect on phosphorylation or ubiquitination; when associated with F-264.,MUTAGEN:Y->F: No effect on phosphorylation or ubiquitination; when associated with F-266.,MUTAGEN:Y->F: Reduces ubiquitination and CBL-induced phosphorylation; when associated with F-228.,MUTAGEN:Y->F: Reduces ubiquitination and CBL-induced phosphorylation; when associated with F-231.,REGION:Disordered,
Q5VXD3	sterile alpha motif domain containing 13(SAMD13)	Homo sapiens						IPR001660:SAM,IPR013761:SAM/pointed_sf,IPR039971:CWC24-like,													COMPBIAS:Basic and acidic residues,DOMAIN:SAM,REGION:Disordered,
O18765	steroid 5 alpha-reductase 2(SRD5A2)	Sus scrofa			GO:0006629~lipid metabolic process,GO:0006694~steroid biosynthetic process,GO:0006702~androgen biosynthetic process,GO:0008584~male gonad development,GO:0030154~cell differentiation,GO:0030539~male genitalia development,GO:0061370~testosterone biosynthetic process,	GO:0005789~endoplasmic reticulum membrane,GO:0016020~membrane,	GO:0003865~3-oxo-5-alpha-steroid 4-dehydrogenase activity,GO:0009917~sterol 5-alpha reductase activity,GO:0016627~oxidoreductase activity, acting on the CH-CH group of donors,GO:0030283~testosterone dehydrogenase [NAD(P)] activity,GO:0047751~cholestenone 5-alpha-reductase activity,	IPR001104:3-oxo-5_a-steroid_4-DH_C,IPR016636:3-oxo-5-alpha-steroid_4-DH,IPR039357:SRD5A/TECR,	ssc00140:Steroid hormone biosynthesis,ssc01100:Metabolic pathways,ssc05215:Prostate cancer,		PIRSF015596:5_alpha-SR2,		KW-0221~Differentiation,KW-0443~Lipid metabolism,KW-0726~Sexual differentiation,	KW-0256~Endoplasmic reticulum,KW-0472~Membrane,KW-0492~Microsome,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0521~NADP,	KW-0560~Oxidoreductase,		DOMAIN:Steroid 5-alpha reductase C-terminal,TRANSMEM:Helical,
P35610	sterol O-acyltransferase 1(SOAT1)	Homo sapiens			GO:0008203~cholesterol metabolic process,GO:0010742~macrophage derived foam cell differentiation,GO:0010878~cholesterol storage,GO:0033344~cholesterol efflux,GO:0034379~very-low-density lipoprotein particle assembly,GO:0034383~low-density lipoprotein particle clearance,GO:0042632~cholesterol homeostasis,GO:0042986~positive regulation of amyloid precursor protein biosynthetic process,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0016020~membrane,	GO:0000062~fatty-acyl-CoA binding,GO:0004772~sterol O-acyltransferase activity,GO:0005515~protein binding,GO:0008374~O-acyltransferase activity,GO:0015485~cholesterol binding,GO:0034736~cholesterol O-acyltransferase activity,GO:0042802~identical protein binding,	IPR004299:MBOAT_fam,IPR014371:Oat_ACAT_DAG_ARE,IPR030687:Sterol_acyltranf_meta,	hsa00100:Steroid biosynthesis,hsa04979:Cholesterol metabolism,		PIRSF000439:Oat_ACAT_DAG_ARE,PIRSF500230:Sterol_acyltranf_ACAT,		KW-0153~Cholesterol metabolism,KW-0443~Lipid metabolism,KW-0753~Steroid metabolism,KW-1207~Sterol metabolism,	KW-0256~Endoplasmic reticulum,KW-0472~Membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0012~Acyltransferase,KW-0808~Transferase,	KW-0007~Acetylation,KW-0597~Phosphoprotein,KW-1015~Disulfide bond,	COMPBIAS:Basic and acidic residues,MOTIF:FYXDWWN motif,MUTAGEN:D->N: Low expression, loss of enzymatic activity.,MUTAGEN:F->A: Abolished homodimerization; when associated with 504-A--A-508.,MUTAGEN:F->A: Strongly reduced cholesterol O-acyltransferase activity.,MUTAGEN:H->A,C,N: Abolished cholesterol O-acyltransferase activity.,MUTAGEN:H->A: Abolished cholesterol O-acyltransferase activity.,MUTAGEN:H->A: Strongly reduced cholesterol O-acyltransferase activity.,MUTAGEN:K->A: Reduced cholesterol O-acyltransferase activity.,MUTAGEN:L->A: Strongly reduced cholesterol O-acyltransferase activity.,MUTAGEN:L->N: Strongly reduced cholesterol O-acyltransferase activity.,MUTAGEN:L->Q: Almost abolished cholesterol O-acyltransferase activity.,MUTAGEN:N->A: Almost abolished cholesterol O-acyltransferase activity.,MUTAGEN:N->G: Reduced cholesterol O-acyltransferase activity.,MUTAGEN:R->A: Reduced cholesterol O-acyltransferase activity.,MUTAGEN:R->A: Strongly reduced cholesterol O-acyltransferase activity.,MUTAGEN:S->A,T: Nearly normal expression and enzyme activity.,MUTAGEN:S->A: Abolished cholesterol O-acyltransferase activity.,MUTAGEN:S->L: No expression nor activity.,MUTAGEN:VF->AA: Almost abolished cholesterol O-acyltransferase activity.,MUTAGEN:VFAVS->QFAVQ: In QQ mutant; almost abolished cholesterol O-acyltransferase activity.,MUTAGEN:W->A: Almost abolished cholesterol O-acyltransferase activity.,MUTAGEN:WTSLF->ATSLA: Abolished homodimerization; when associated with A-367.,MUTAGEN:Y->A: Strongly reduced cholesterol O-acyltransferase activity.,MUTAGEN:Y->F: Loss of enzymatic activity.,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Lumenal,TRANSMEM:Helical,TRANSMEM:Helical; Name=1,TRANSMEM:Helical; Name=2,TRANSMEM:Helical; Name=3,TRANSMEM:Helical; Name=4,TRANSMEM:Helical; Name=5,TRANSMEM:Helical; Name=6,TRANSMEM:Helical; Name=7,TRANSMEM:Helical; Name=8,TRANSMEM:Helical; Name=9,
P54116	stomatin(Stom)	Mus musculus			GO:0034765~regulation of ion transmembrane transport,GO:0044829~positive regulation by host of viral genome replication,GO:0048524~positive regulation of viral process,GO:0090314~positive regulation of protein targeting to membrane,GO:1901585~regulation of acid-sensing ion channel activity,	GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005783~endoplasmic reticulum,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0031410~cytoplasmic vesicle,GO:0042470~melanosome,GO:0045121~membrane raft,GO:0048471~perinuclear region of cytoplasm,	GO:0005515~protein binding,GO:0008200~ion channel inhibitor activity,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,GO:0070063~RNA polymerase binding,	IPR001107:Band_7,IPR001972:Stomatin_HflK_fam,IPR018080:Band_7/stomatin-like_CS,IPR036013:Band_7/SPFH_dom_sf,IPR043202:Band-7_stomatin-like,				SM00244:PHB,		KW-0206~Cytoskeleton,KW-0472~Membrane,KW-0963~Cytoplasm,KW-0968~Cytoplasmic vesicle,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0449~Lipoprotein,KW-0564~Palmitate,KW-0597~Phosphoprotein,	DOMAIN:Band 7,LIPID:S-palmitoyl cysteine,MUTAGEN:L->D: Does not abolish interaction with ASIC3, but abolishes regulation of ASIC3 channel activity; when associated with D-97 and D-109.,MUTAGEN:L->D: Does not abolish interaction with ASIC3, but abolishes regulation of ASIC3 channel activity; when associated with D-97 and D-145.,MUTAGEN:R->D: Does not abolish interaction with ASIC3, but abolishes regulation of ASIC3 channel activity; when associated with D-109 and D-145.,MUTAGEN:T->W: Does not abolish interaction with ASIC3, but abolishes regulation of ASIC2 and ASIC3 channel activity.,MUTAGEN:V->P: Abolishes homodimerization and oligomerization. Abolishes regulation of ASIC2 and ASIC3 channel activity.,REGION:Interaction with LANCL1,REGION:Required for homooligomerization,REGION:Required for lipid raft association,TOPO_DOM:Cytoplasmic,TRANSMEM:Helical,
Q499E5	storkhead box 2(Stox2)	Mus musculus			GO:0001893~maternal placenta development,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0009617~response to bacterium,GO:0009792~embryo development ending in birth or egg hatching,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,	IPR019391:Storkhead-box_winged-helix,IPR040126:STOX1/2,													COMPBIAS:Basic and acidic residues,COMPBIAS:Basic residues,COMPBIAS:Polar residues,DOMAIN:Winged helix Storkhead-box1,REGION:Disordered,
P50533	structural maintenance of chromosomes 2 L homeolog(smc2.L)	Xenopus laevis			GO:0007049~cell cycle,GO:0030261~chromosome condensation,GO:0051276~chromosome organization,GO:0051301~cell division,	GO:0005634~nucleus,GO:0005694~chromosome,GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0000166~nucleotide binding,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016887~ATPase activity,	IPR003395:RecF/RecN/SMC_N,IPR010935:SMC_hinge,IPR024704:SMC,IPR027120:Smc2_ABC,IPR027417:P-loop_NTPase,IPR036277:SMC_hinge_sf,			PIRSF005719:SMC,	SM00968:SMC_hinge,	KW-0131~Cell cycle,KW-0132~Cell division,KW-0226~DNA condensation,KW-0498~Mitosis,	KW-0158~Chromosome,KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0175~Coiled coil,	KW-0067~ATP-binding,KW-0547~Nucleotide-binding,			COMPBIAS:Basic and acidic residues,DOMAIN:SMC hinge,REGION:Disordered,
P51687	sulfite oxidase(SUOX)	Homo sapiens			GO:0006790~sulfur compound metabolic process,	GO:0005739~mitochondrion,GO:0005758~mitochondrial intermembrane space,GO:0005759~mitochondrial matrix,	GO:0005515~protein binding,GO:0008482~sulfite oxidase activity,GO:0020037~heme binding,GO:0030151~molybdenum ion binding,GO:0043546~molybdopterin cofactor binding,GO:0046872~metal ion binding,	IPR000572:OxRdtase_Mopterin-bd_dom,IPR001199:Cyt_B5-like_heme/steroid-bd,IPR005066:MoCF_OxRdtse_dimer,IPR008335:Mopterin_OxRdtase_euk,IPR014756:Ig_E-set,IPR018506:Cyt_B5_heme-BS,IPR022407:OxRdtase_Mopterin_BS,IPR036374:OxRdtase_Mopterin-bd_sf,IPR036400:Cyt_B5-like_heme/steroid_sf,	hsa00920:Sulfur metabolism,hsa01100:Metabolic pathways,	272300~Sulfite oxidase deficiency,		SM01117:Cyt-b5,	KW-0813~Transport,	KW-0496~Mitochondrion,		KW-0225~Disease variant,KW-0887~Epilepsy,KW-0991~Intellectual disability,	KW-0809~Transit peptide,	KW-0349~Heme,KW-0408~Iron,KW-0479~Metal-binding,KW-0500~Molybdenum,	KW-0560~Oxidoreductase,	KW-0597~Phosphoprotein,	BINDING:axial binding residue,DOMAIN:Cytochrome b5 heme-binding,REGION:Disordered,REGION:Hinge,REGION:Homodimerization,REGION:Moco domain,TRANSIT:Mitochondrion,
O35716	suppressor of cytokine signaling 1(Socs1)	Mus musculus		m_ghPathway:Growth Hormone Signaling Pathway,m_il2rbPathway:IL-2 Receptor Beta Chain in T cell Activation,	GO:0001817~regulation of cytokine production,GO:0001932~regulation of protein phosphorylation,GO:0007259~JAK-STAT cascade,GO:0009968~negative regulation of signal transduction,GO:0010533~regulation of activation of Janus kinase activity,GO:0016567~protein ubiquitination,GO:0019221~cytokine-mediated signaling pathway,GO:0030225~macrophage differentiation,GO:0035556~intracellular signal transduction,GO:0042509~regulation of tyrosine phosphorylation of STAT protein,GO:0042532~negative regulation of tyrosine phosphorylation of STAT protein,GO:0043372~positive regulation of CD4-positive, alpha-beta T cell differentiation,GO:0043377~negative regulation of CD8-positive, alpha-beta T cell differentiation,GO:0045444~fat cell differentiation,GO:0045591~positive regulation of regulatory T cell differentiation,GO:0046425~regulation of JAK-STAT cascade,GO:0046426~negative regulation of JAK-STAT cascade,GO:0046627~negative regulation of insulin receptor signaling pathway,GO:0046854~phosphatidylinositol phosphorylation,GO:0071230~cellular response to amino acid stimulus,GO:0071345~cellular response to cytokine stimulus,GO:0071407~cellular response to organic cyclic compound,GO:1904898~negative regulation of hepatic stellate cell proliferation,GO:2000271~positive regulation of fibroblast apoptotic process,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005829~cytosol,GO:0005942~phosphatidylinositol 3-kinase complex,GO:0031410~cytoplasmic vesicle,GO:0036464~cytoplasmic ribonucleoprotein granule,	GO:0005159~insulin-like growth factor receptor binding,GO:0005515~protein binding,GO:0019210~kinase inhibitor activity,GO:0019901~protein kinase binding,GO:0046935~1-phosphatidylinositol-3-kinase regulator activity,	IPR000980:SH2,IPR001496:SOCS_box,IPR035861:SOCS1_SH2,IPR036036:SOCS_box-like_dom_sf,IPR036860:SH2_dom_sf,	mmu04120:Ubiquitin mediated proteolysis,mmu04380:Osteoclast differentiation,mmu04630:JAK-STAT signaling pathway,mmu04910:Insulin signaling pathway,mmu04917:Prolactin signaling pathway,mmu04930:Type II diabetes mellitus,mmu04935:Growth hormone synthesis, secretion and action,mmu05145:Toxoplasmosis,mmu05206:MicroRNAs in cancer,			SM00252:SH2,SM00253:SOCS,SM00969:SOCS_box,	KW-0341~Growth regulation,KW-0833~Ubl conjugation pathway,	KW-0539~Nucleus,KW-0968~Cytoplasmic vesicle,			KW-0727~SH2 domain,		KW-0734~Signal transduction inhibitor,		COMPBIAS:Polar residues,DOMAIN:SH2,DOMAIN:SOCS box,MUTAGEN:C->F: Abolishes interaction with elongin BC complex; when associated with P-175.,MUTAGEN:D->A,R: No effect on LIF signal transduction suppression.,MUTAGEN:D->R: Loss of JAK signal transduction suppression. Reduced binding to JH1.,MUTAGEN:F->A,E: Loss of JAK signal transduction suppression. Reduced binding to JH1.,MUTAGEN:F->A,S,D: Loss of JAK signal transduction suppression.,MUTAGEN:F->D: Loss of JAK signal transduction suppression. Destabilization of SOCS1.,MUTAGEN:F->E,S: Reduced binding to JH1.,MUTAGEN:F->L: No effect on JAK signal transduction inhibition nor on binding to JH1.,MUTAGEN:F->L: No effect on JAK signal transduction suppression nor on binding to JH1.,MUTAGEN:G->A: No effect on LIF signal transduction suppression.,MUTAGEN:H->A,D: No effect on JAK signal transduction suppression.,MUTAGEN:H->E: No effect on JAK signal transduction suppression.,MUTAGEN:I->E: Loss of binding to JH1/Y-1007 of JAK2 and loss of signal transduction suppression.,MUTAGEN:L->E: Loss of binding to JH1/Y-1007 of JAK2 and loss of signal transduction suppression.,MUTAGEN:L->P: Abolishes interaction with elongin BC complex; when associated with F-179.,MUTAGEN:P->A: No effect on LIF signal transduction suppression.,MUTAGEN:R->A,E: No effect on JAK signal transduction suppression.,MUTAGEN:R->A: No effect on LIF signal transduction suppression.,MUTAGEN:R->E: No effect on LIF signal transduction suppression.,MUTAGEN:R->K: Loss of LIF signal transduction suppression. Loss of binding to KIT. No effect on binding to VAV.,MUTAGEN:R->Q: Loss of IL-6 signal transduction suppression. No effect on binding to TYK2.,MUTAGEN:S->E: No effect on JAK signal transduction suppression.,MUTAGEN:T->A: No effect on JAK signal transduction suppression.,MUTAGEN:T->A: No effect on LIF signal transduction suppression.,MUTAGEN:Y->A: Some loss of JAK signal transduction signaling. Reduced binding to JH1.,REGION:Disordered,REGION:Extended SH2 subdomain (ESS),REGION:Interaction with Elongin BC complex,REGION:Kinase inhibitory region (KIR),
Q9DBX3	sushi domain containing 2(Susd2)	Mus musculus			GO:0051782~negative regulation of cell division,GO:1902807~negative regulation of cell cycle G1/S phase transition,	GO:0005615~extracellular space,GO:0005886~plasma membrane,GO:0016020~membrane,		IPR000436:Sushi_SCR_CCP_dom,IPR001212:Somatomedin_B_dom,IPR001846:VWF_type-D,IPR005533:AMOP_dom,IPR035976:Sushi/SCR/CCP_sf,IPR036024:Somatomedin_B-like_dom_sf,				SM00032:CCP,SM00216:VWD,SM00723:AMOP,		KW-0472~Membrane,KW-1003~Cell membrane,		KW-0043~Tumor suppressor,	KW-0732~Signal,KW-0768~Sushi,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0675~Receptor,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DISULFID:Alternate,DOMAIN:AMOP,DOMAIN:SMB,DOMAIN:Sushi,DOMAIN:VWFD,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q9BX26	synaptonemal complex protein 2(SYCP2)	Homo sapiens			GO:0000080~mitotic G1 phase,GO:0006915~apoptotic process,GO:0007130~synaptonemal complex assembly,GO:0007140~male meiosis,GO:0007143~female meiotic division,GO:0009566~fertilization,GO:0035234~ectopic germ cell programmed cell death,GO:0043066~negative regulation of apoptotic process,GO:0048808~male genitalia morphogenesis,GO:0051093~negative regulation of developmental process,GO:0051301~cell division,GO:2000242~negative regulation of reproductive process,	GO:0000795~synaptonemal complex,GO:0000800~lateral element,GO:0005634~nucleus,GO:0005694~chromosome,	GO:0003677~DNA binding,	IPR024835:SYCP2-like,IPR040560:SYCP2_SLD,IPR041322:SYCP2_ARLD,		258150~Spermatogenic failure 1,			KW-0131~Cell cycle,KW-0132~Cell division,KW-0469~Meiosis,	KW-0158~Chromosome,KW-0539~Nucleus,					KW-0238~DNA-binding,	KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:Synaptonemal complex protein 2 Spt16M-like,DOMAIN:Synaptonemal complex protein 2 armadillo-repeat-like,REGION:Disordered,
Q9H2B2	synaptotagmin 4(SYT4)	Homo sapiens			GO:0006906~vesicle fusion,GO:0007613~memory,GO:0014049~positive regulation of glutamate secretion,GO:0014059~regulation of dopamine secretion,GO:0017158~regulation of calcium ion-dependent exocytosis,GO:0030100~regulation of endocytosis,GO:0030154~cell differentiation,GO:0031338~regulation of vesicle fusion,GO:0033604~negative regulation of catecholamine secretion,GO:0045955~negative regulation of calcium ion-dependent exocytosis,GO:0045956~positive regulation of calcium ion-dependent exocytosis,GO:0048174~negative regulation of short-term neuronal synaptic plasticity,GO:0048791~calcium ion-regulated exocytosis of neurotransmitter,GO:0050709~negative regulation of protein secretion,GO:0071277~cellular response to calcium ion,GO:0099519~dense core granule cytoskeletal transport,GO:1903861~positive regulation of dendrite extension,GO:1905415~positive regulation of dense core granule exocytosis,GO:1905433~negative regulation of retrograde trans-synaptic signaling by neuropeptide,GO:2000301~negative regulation of synaptic vesicle exocytosis,	GO:0000139~Golgi membrane,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0030424~axon,GO:0030425~dendrite,GO:0030672~synaptic vesicle membrane,GO:0032127~dense core granule membrane,GO:0043025~neuronal cell body,GO:0045202~synapse,GO:0048471~perinuclear region of cytoplasm,GO:0070382~exocytic vesicle,GO:0097449~astrocyte projection,GO:0098978~glutamatergic synapse,GO:0098992~neuronal dense core vesicle,GO:0099012~neuronal dense core vesicle membrane,GO:1990742~microvesicle,	GO:0000149~SNARE binding,GO:0001786~phosphatidylserine binding,GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0005544~calcium-dependent phospholipid binding,GO:0030276~clathrin binding,	IPR000008:C2_dom,IPR001565:Synaptotagmin,IPR035892:C2_domain_sf,				SM00239:C2,	KW-0221~Differentiation,	KW-0472~Membrane,KW-0968~Cytoplasmic vesicle,			KW-0677~Repeat,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0106~Calcium,KW-0479~Metal-binding,		KW-0597~Phosphoprotein,	DOMAIN:C2,DOMAIN:C2 1,DOMAIN:C2 2,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Vesicular,TRANSMEM:Helical,
Q16623	syntaxin 1A(STX1A)	Homo sapiens		h_botulinPathway:Blockade of Neurotransmitter Relase by Botulinum Toxin,	GO:0001956~positive regulation of neurotransmitter secretion,GO:0006886~intracellular protein transport,GO:0006887~exocytosis,GO:0010701~positive regulation of norepinephrine secretion,GO:0010807~regulation of synaptic vesicle priming,GO:0016079~synaptic vesicle exocytosis,GO:0016192~vesicle-mediated transport,GO:0016925~protein sumoylation,GO:0017156~calcium ion regulated exocytosis,GO:0030073~insulin secretion,GO:0031629~synaptic vesicle fusion to presynaptic active zone membrane,GO:0032940~secretion by cell,GO:0033605~positive regulation of catecholamine secretion,GO:0045956~positive regulation of calcium ion-dependent exocytosis,GO:0048278~vesicle docking,GO:0048488~synaptic vesicle endocytosis,GO:0050796~regulation of insulin secretion,GO:2000463~positive regulation of excitatory postsynaptic potential,	GO:0005576~extracellular region,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0008021~synaptic vesicle,GO:0008076~voltage-gated potassium channel complex,GO:0012505~endomembrane system,GO:0016020~membrane,GO:0030424~axon,GO:0030672~synaptic vesicle membrane,GO:0031201~SNARE complex,GO:0031965~nuclear membrane,GO:0043005~neuron projection,GO:0048787~presynaptic active zone membrane,GO:0070044~synaptobrevin 2-SNAP-25-syntaxin-1a complex,	GO:0000149~SNARE binding,GO:0005484~SNAP receptor activity,GO:0005515~protein binding,GO:0019855~calcium channel inhibitor activity,GO:0019869~chloride channel inhibitor activity,GO:0019900~kinase binding,GO:0042802~identical protein binding,	IPR000727:T_SNARE_dom,IPR006011:Syntaxin_N,IPR006012:Syntaxin/epimorphin_CS,IPR010989:SNARE,IPR045242:Syntaxin,	hsa04130:SNARE interactions in vesicular transport,hsa04721:Synaptic vesicle cycle,hsa04911:Insulin secretion,hsa05016:Huntington disease,hsa05022:Pathways of neurodegeneration - multiple diseases,hsa05031:Amphetamine addiction,			SM00397:t_SNARE,SM00503:SynN,	KW-0268~Exocytosis,KW-0532~Neurotransmitter transport,KW-0813~Transport,	KW-0472~Membrane,KW-0770~Synapse,KW-0771~Synaptosome,KW-0964~Secreted,KW-0968~Cytoplasmic vesicle,KW-1003~Cell membrane,		KW-0856~Williams-Beuren syndrome,	KW-0175~Coiled coil,KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO),DOMAIN:T-SNARE coiled-coil homology,DOMAIN:t-SNARE coiled-coil homology,MUTAGEN:K->R: Complete loss of sumoylation; when associated with R-252 and R-253.,MUTAGEN:K->R: Complete loss of sumoylation; when associated with R-252 and R-256.,MUTAGEN:K->R: Complete loss of sumoylation; when associated with R-253 and R-256.,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,TRANSMEM:Helical; Anchor for type IV membrane protein,
Q3ZBT5	syntaxin 7(STX7)	Bos taurus			GO:0001916~positive regulation of T cell mediated cytotoxicity,GO:0006886~intracellular protein transport,GO:0006906~vesicle fusion,GO:0016192~vesicle-mediated transport,GO:0048278~vesicle docking,GO:0070925~organelle assembly,GO:1902685~positive regulation of receptor localization to synapse,GO:1903076~regulation of protein localization to plasma membrane,	GO:0001772~immunological synapse,GO:0005770~late endosome,GO:0008021~synaptic vesicle,GO:0012505~endomembrane system,GO:0016020~membrane,GO:0030139~endocytic vesicle,GO:0031201~SNARE complex,GO:0031901~early endosome membrane,GO:0042582~azurophil granule,GO:0048471~perinuclear region of cytoplasm,GO:0055037~recycling endosome,GO:0070820~tertiary granule,	GO:0000149~SNARE binding,GO:0005484~SNAP receptor activity,GO:0019869~chloride channel inhibitor activity,GO:0019905~syntaxin binding,	IPR000727:T_SNARE_dom,IPR006011:Syntaxin_N,IPR006012:Syntaxin/epimorphin_CS,IPR010989:SNARE,IPR045242:Syntaxin,	bta04130:SNARE interactions in vesicular transport,bta04140:Autophagy - animal,bta04145:Phagosome,			SM00397:t_SNARE,SM00503:SynN,		KW-0472~Membrane,KW-0967~Endosome,			KW-0175~Coiled coil,KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0007~Acetylation,KW-0597~Phosphoprotein,	DOMAIN:T-SNARE coiled-coil homology,DOMAIN:t-SNARE coiled-coil homology,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Vesicular,TRANSMEM:Helical,TRANSMEM:Helical; Anchor for type IV membrane protein,
Q99L88	syntrophin, basic 1(Sntb1)	Mus musculus				GO:0005622~intracellular,GO:0005737~cytoplasm,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0016010~dystrophin-associated glycoprotein complex,GO:0016020~membrane,GO:0032991~macromolecular complex,GO:0042383~sarcolemma,GO:0045202~synapse,GO:0070161~anchoring junction,	GO:0003779~actin binding,GO:0005198~structural molecule activity,GO:0005515~protein binding,GO:0005516~calmodulin binding,GO:0030165~PDZ domain binding,	IPR001478:PDZ,IPR001849:PH_domain,IPR011993:PH-like_dom_sf,IPR015482:Syntrophin,IPR036034:PDZ_sf,IPR041428:PHsplit_syntrophin,	mmu05410:Hypertrophic cardiomyopathy,mmu05412:Arrhythmogenic right ventricular cardiomyopathy,mmu05414:Dilated cardiomyopathy,mmu05416:Viral myocarditis,			SM00228:PDZ,SM00233:PH,		KW-0206~Cytoskeleton,KW-0472~Membrane,KW-0963~Cytoplasm,KW-0965~Cell junction,KW-1003~Cell membrane,			KW-0677~Repeat,	KW-0106~Calcium,	KW-0009~Actin-binding,KW-0112~Calmodulin-binding,	KW-0007~Acetylation,KW-0597~Phosphoprotein,	DOMAIN:PDZ,DOMAIN:PH 1,DOMAIN:PH 2,DOMAIN:SU,REGION:Calmodulin-binding,REGION:Disordered,
Q5ZIN2	tRNA splicing endonuclease subunit 2(TSEN2)	Gallus gallus			GO:0000379~tRNA-type intron splice site recognition and cleavage,GO:0006388~tRNA splicing, via endonucleolytic cleavage and ligation,GO:0006397~mRNA processing,	GO:0000214~tRNA-intron endonuclease complex,	GO:0000213~tRNA-intron endonuclease activity,GO:0003676~nucleic acid binding,GO:0016829~lyase activity,	IPR006676:tRNA_splic,IPR006677:tRNA_intron_Endonuc_cat-like,IPR006678:tRNA_intron_Endonuc_N,IPR011856:tRNA_endonuc-like_dom_sf,IPR016589:tRNA_splic_SEN2,IPR036167:tRNA_intron_Endo_cat-like_sf,			PIRSF011789:tRNA_splic_SEN2,		KW-0507~mRNA processing,KW-0819~tRNA processing,	KW-0539~Nucleus,					KW-0456~Lyase,		COMPBIAS:Polar residues,DOMAIN:tRNA intron endonuclease N-terminal,DOMAIN:tRNA intron endonuclease catalytic,REGION:Disordered,
D3Z5S8	terminal nucleotidyltransferase 5A(Tent5a)	Mus musculus			GO:0009617~response to bacterium,GO:0030278~regulation of ossification,GO:0030501~positive regulation of bone mineralization,GO:0045669~positive regulation of osteoblast differentiation,GO:0048255~mRNA stabilization,	GO:0005737~cytoplasm,	GO:0016740~transferase activity,GO:1990817~RNA adenylyltransferase activity,	IPR012937:TET5,				SM01153:DUF1693,		KW-0963~Cytoplasm,			KW-0732~Signal,		KW-0808~Transferase,		MUTAGEN:Missing: Homozygous mice show severe morphological and skeletal abnormalities including short stature along with limb, rib, pelvis, and skull deformities with minimal trabecular bone and reduced cortical bone thickness in long bones.,
Q96SJ8	tetraspanin 18(TSPAN18)	Homo sapiens			GO:0006954~inflammatory response,GO:0007599~hemostasis,GO:0017156~calcium ion regulated exocytosis,GO:0051649~establishment of localization in cell,GO:1903670~regulation of sprouting angiogenesis,	GO:0016020~membrane,	GO:0005515~protein binding,	IPR000301:Tetraspanin_animals,IPR008952:Tetraspanin_EC2_sf,IPR018499:Tetraspanin/Peripherin,IPR018503:Tetraspanin_CS,			PIRSF002419:Tetraspanin,			KW-0472~Membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q86UF1	tetraspanin 33(TSPAN33)	Homo sapiens			GO:0046931~pore complex assembly,GO:0051604~protein maturation,GO:0072659~protein localization to plasma membrane,	GO:0005788~endoplasmic reticulum lumen,GO:0005886~plasma membrane,GO:0005912~adherens junction,GO:0009986~cell surface,GO:0046930~pore complex,GO:0097197~tetraspanin-enriched microdomain,	GO:0005515~protein binding,GO:0019899~enzyme binding,	IPR000301:Tetraspanin_animals,IPR008952:Tetraspanin_EC2_sf,IPR018499:Tetraspanin/Peripherin,			PIRSF002419:Tetraspanin,			KW-0472~Membrane,KW-0963~Cytoplasm,KW-0965~Cell junction,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q5TAA0	tetratricopeptide repeat domain 22(TTC22)	Homo sapiens						IPR011990:TPR-like_helical_dom_sf,IPR019734:TPR_repeat,IPR042342:TTC22,				SM00028:TPR,					KW-0677~Repeat,KW-0802~TPR repeat,				REPEAT:TPR 1,REPEAT:TPR 2,REPEAT:TPR 3,REPEAT:TPR 4,REPEAT:TPR 5,REPEAT:TPR 6,REPEAT:TPR 7,
Q49AM3	tetratricopeptide repeat domain 31(TTC31)	Homo sapiens						IPR011990:TPR-like_helical_dom_sf,IPR019734:TPR_repeat,				SM00028:TPR,					KW-0175~Coiled coil,KW-0677~Repeat,KW-0802~TPR repeat,			KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,REGION:Disordered,REPEAT:TPR,REPEAT:TPR 1,REPEAT:TPR 2,REPEAT:TPR 3,
Q0IHI1	thioredoxin domain containing 15 L homeolog(txndc15.L)	Xenopus laevis			GO:0030030~cell projection organization,GO:0045880~positive regulation of smoothened signaling pathway,GO:0060271~cilium assembly,	GO:0005886~plasma membrane,GO:0005929~cilium,GO:0016020~membrane,GO:0042995~cell projection,GO:0060170~ciliary membrane,		IPR013766:Thioredoxin_domain,IPR036249:Thioredoxin-like_sf,IPR042418:TXNDC15,					KW-0970~Cilium biogenesis/degradation,	KW-0472~Membrane,KW-0966~Cell projection,KW-1003~Cell membrane,			KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Basic and acidic residues,DOMAIN:Thioredoxin,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
P04818	thymidylate synthetase(TYMS)	Homo sapiens	1.RBphosphoE2F,		GO:0006231~dTMP biosynthetic process,GO:0006235~dTTP biosynthetic process,GO:0006417~regulation of translation,GO:0007623~circadian rhythm,GO:0009410~response to xenobiotic stimulus,GO:0009636~response to toxic substance,GO:0017148~negative regulation of translation,GO:0019860~uracil metabolic process,GO:0032259~methylation,GO:0032570~response to progesterone,GO:0033189~response to vitamin A,GO:0034097~response to cytokine,GO:0035999~tetrahydrofolate interconversion,GO:0045471~response to ethanol,GO:0046683~response to organophosphorus,GO:0048589~developmental growth,GO:0051216~cartilage development,GO:0051384~response to glucocorticoid,GO:0051593~response to folic acid,GO:0060574~intestinal epithelial cell maturation,GO:0071897~DNA biosynthetic process,GO:0097421~liver regeneration,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0005759~mitochondrial matrix,GO:0005829~cytosol,	GO:0000900~translation repressor activity, nucleic acid binding,GO:0003729~mRNA binding,GO:0004799~thymidylate synthase activity,GO:0005542~folic acid binding,GO:0042803~protein homodimerization activity,GO:1990825~sequence-specific mRNA binding,	IPR000398:Thymidylate_synthase,IPR020940:Thymidylate_synthase_AS,IPR023451:Thymidate_synth/dCMP_Mease_dom,IPR036926:Thymidate_synth/dCMP_Mease_sf,IPR045097:Thymidate_synth/dCMP_Mease,	hsa00240:Pyrimidine metabolism,hsa00670:One carbon pool by folate,hsa01100:Metabolic pathways,hsa01232:Nucleotide metabolism,hsa01523:Antifolate resistance,	620040~Dyskeratosis congenita, digenic,			KW-0545~Nucleotide biosynthesis,	KW-0472~Membrane,KW-0496~Mitochondrion,KW-0539~Nucleus,KW-0963~Cytoplasm,KW-0999~Mitochondrion inner membrane,		KW-0225~Disease variant,KW-1011~Dyskeratosis congenita,			KW-0489~Methyltransferase,KW-0808~Transferase,	KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	ACT_SITE:Nucleophile,BINDING:in other chain,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),DOMAIN:Thymidylate synthase/dCMP hydroxymethylase,REGION:Disordered,
Q6PFL8	thymocyte nuclear protein 1(thyn1)	Danio rerio				GO:0005634~nucleus,		IPR002740:EVE_domain,IPR015947:PUA-like_sf,IPR047197:THYN1-like_EVE,						KW-0539~Nucleus,						KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,DOMAIN:EVE,MOTIF:Nuclear localization signal,REGION:Disordered,
P14650	thyroid peroxidase(Tpo)	Rattus norvegicus			GO:0006590~thyroid hormone generation,GO:0006979~response to oxidative stress,GO:0033993~response to lipid,GO:0035162~embryonic hemopoiesis,GO:0042446~hormone biosynthetic process,GO:0042744~hydrogen peroxide catabolic process,GO:0071732~cellular response to nitric oxide,GO:0098869~cellular oxidant detoxification,	GO:0005615~extracellular space,GO:0009986~cell surface,GO:0016020~membrane,	GO:0004447~iodide peroxidase activity,GO:0004601~peroxidase activity,GO:0005509~calcium ion binding,GO:0020037~heme binding,	IPR000152:EGF-type_Asp/Asn_hydroxyl_site,IPR000436:Sushi_SCR_CCP_dom,IPR000742:EGF-like_dom,IPR001881:EGF-like_Ca-bd_dom,IPR010255:Haem_peroxidase_sf,IPR018097:EGF_Ca-bd_CS,IPR019791:Haem_peroxidase_animal,IPR029589:TPO,IPR035976:Sushi/SCR/CCP_sf,IPR037120:Haem_peroxidase_sf_animal,	rno00350:Tyrosine metabolism,rno01100:Metabolic pathways,rno04918:Thyroid hormone synthesis,rno05320:Autoimmune thyroid disease,			SM00032:CCP,SM00179:EGF_CA,SM00181:EGF,	KW-0376~Hydrogen peroxide,KW-0893~Thyroid hormones biosynthesis,	KW-0472~Membrane,			KW-0245~EGF-like domain,KW-0732~Signal,KW-0768~Sushi,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0106~Calcium,KW-0349~Heme,KW-0408~Iron,KW-0479~Metal-binding,	KW-0560~Oxidoreductase,KW-0575~Peroxidase,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	ACT_SITE:Proton acceptor,BINDING:axial binding residue,BINDING:covalent,CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:EGF-like,DOMAIN:EGF-like; calcium-binding,DOMAIN:Sushi,REGION:Disordered,SITE:Transition state stabilizer,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
A7YD35	thyroxine 5-deiodinase-like(LOC115573513)	Sparus aurata			GO:0042446~hormone biosynthetic process,	GO:0005886~plasma membrane,GO:0010008~endosome membrane,	GO:0004800~thyroxine 5'-deiodinase activity,GO:0033798~thyroxine 5-deiodinase activity,	IPR000643:Iodothyronine_deiodinase,IPR008261:Iodothyronine_deiodinase_AS,IPR027252:Iodothyronine_deiodinase_I/III,			PIRSF001330:IOD,PIRSF500144:IODI_III,		KW-0893~Thyroid hormones biosynthesis,	KW-0472~Membrane,KW-0967~Endosome,KW-1003~Cell membrane,			KW-0735~Signal-anchor,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0560~Oxidoreductase,		NON_STD:Selenocysteine,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical; Signal-anchor for type II membrane protein,
O97758	tight junction protein 1(TJP1)	Canis lupus familiaris			GO:0001825~blastocyst formation,GO:0007605~sensory perception of sound,GO:0042981~regulation of apoptotic process,GO:0045216~cell-cell junction organization,GO:0051497~negative regulation of stress fiber assembly,GO:0070830~bicellular tight junction assembly,GO:0071277~cellular response to calcium ion,GO:0090557~establishment of endothelial intestinal barrier,GO:0098609~cell-cell adhesion,GO:1903672~positive regulation of sprouting angiogenesis,GO:1905605~positive regulation of maintenance of permeability of blood-brain barrier,	GO:0005634~nucleus,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005911~cell-cell junction,GO:0005912~adherens junction,GO:0005921~gap junction,GO:0005923~bicellular tight junction,GO:0009986~cell surface,GO:0014704~intercalated disc,GO:0016324~apical plasma membrane,GO:0016327~apicolateral plasma membrane,GO:0031410~cytoplasmic vesicle,GO:0032991~macromolecular complex,GO:0046581~intercellular canaliculus,GO:0070160~occluding junction,	GO:0005516~calmodulin binding,GO:0019904~protein domain specific binding,GO:0050839~cell adhesion molecule binding,GO:0071253~connexin binding,	IPR000906:ZU5_dom,IPR001315:CARD,IPR001452:SH3_domain,IPR001478:PDZ,IPR005417:ZO,IPR005418:ZO-1,IPR008144:Guanylate_kin-like_dom,IPR008145:GK/Ca_channel_bsu,IPR011029:DEATH-like_dom_sf,IPR027417:P-loop_NTPase,IPR035597:ZO-1_SH3,IPR036028:SH3-like_dom_sf,IPR036034:PDZ_sf,	cfa04520:Adherens junction,cfa04530:Tight junction,cfa04540:Gap junction,			SM00072:GuKc,SM00218:ZU5,SM00228:PDZ,		KW-0303~Gap junction,KW-0472~Membrane,KW-0796~Tight junction,KW-0965~Cell junction,KW-1003~Cell membrane,			KW-0677~Repeat,KW-0728~SH3 domain,		KW-0112~Calmodulin-binding,	KW-0597~Phosphoprotein,	COMPBIAS:Acidic residues,COMPBIAS:Basic and acidic residues,COMPBIAS:Basic residues,COMPBIAS:Polar residues,COMPBIAS:Pro residues,DOMAIN:CARD,DOMAIN:Guanylate kinase-like,DOMAIN:PDZ,DOMAIN:PDZ 1,DOMAIN:PDZ 2,DOMAIN:PDZ 3,DOMAIN:SH3,DOMAIN:ZU5,REGION:Actin-binding region (ABR),REGION:Disordered,REGION:Occludin (OCLN)-binding region,
Q9UNS1	timeless circadian regulator(TIMELESS)	Homo sapiens			GO:0000076~DNA replication checkpoint,GO:0002009~morphogenesis of an epithelium,GO:0006281~DNA repair,GO:0006974~cellular response to DNA damage stimulus,GO:0007623~circadian rhythm,GO:0009582~detection of abiotic stimulus,GO:0030324~lung development,GO:0042752~regulation of circadian rhythm,GO:0043111~replication fork arrest,GO:0044770~cell cycle phase transition,GO:0045892~negative regulation of transcription, DNA-templated,GO:0048754~branching morphogenesis of an epithelial tube,GO:0051301~cell division,GO:0072711~cellular response to hydroxyurea,GO:0072719~cellular response to cisplatin,GO:1904976~cellular response to bleomycin,GO:1905168~positive regulation of double-strand break repair via homologous recombination,GO:2000781~positive regulation of double-strand break repair,	GO:0000785~chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0031298~replication fork protection complex,GO:0035861~site of double-strand break,	GO:0003677~DNA binding,GO:0005515~protein binding,GO:0042802~identical protein binding,	IPR006906:Timeless_N,IPR007725:TIMELESS_C,IPR044998:Timeless,		620015~Advance sleep phase syndrome, familial, 4,			KW-0090~Biological rhythms,KW-0131~Cell cycle,KW-0132~Cell division,KW-0227~DNA damage,KW-0234~DNA repair,KW-0498~Mitosis,KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0158~Chromosome,KW-0539~Nucleus,		KW-0225~Disease variant,			KW-0217~Developmental protein,KW-9996~Developmental protein,	KW-0597~Phosphoprotein,	COMPBIAS:Acidic residues,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,MUTAGEN:R->G: Abolishes interaction with PARP1.,REGION:DNA-binding domain,REGION:Disordered,REGION:Interaction with PARP1,REGION:Required for homodimerization and for interaction with CRY1 and CHEK1,REGION:Required for nuclear localization,
Q9DD78	toll like receptor 2A(TLR2A)	Gallus gallus			GO:0002224~toll-like receptor signaling pathway,GO:0006954~inflammatory response,GO:0006955~immune response,GO:0045087~innate immune response,	GO:0005886~plasma membrane,GO:0016020~membrane,	GO:0004888~transmembrane signaling receptor activity,GO:0005515~protein binding,GO:0038023~signaling receptor activity,GO:0042497~triacyl lipopeptide binding,GO:0050135~NAD(P)+ nucleosidase activity,GO:0061809~NAD+ nucleotidase, cyclic ADP-ribose generating,	IPR000157:TIR_dom,IPR000483:Cys-rich_flank_reg_C,IPR001611:Leu-rich_rpt,IPR003591:Leu-rich_rpt_typical-subtyp,IPR017241:Toll-like_receptor,IPR018247:EF_Hand_1_Ca_BS,IPR032675:LRR_dom_sf,IPR035897:Toll_tir_struct_dom_sf,	gga04145:Phagosome,gga04620:Toll-like receptor signaling pathway,gga05132:Salmonella infection,gga05168:Herpes simplex virus 1 infection,		PIRSF037595:Toll-like_receptor,	SM00082:LRRCT,SM00255:TIR,SM00364:LRR_BAC,SM00369:LRR_TYP,	KW-0391~Immunity,KW-0395~Inflammatory response,KW-0399~Innate immunity,	KW-0472~Membrane,			KW-0433~Leucine-rich repeat,KW-0677~Repeat,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0520~NAD,	KW-0675~Receptor,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:LRRCT,DOMAIN:TIR,REPEAT:LRR 1,REPEAT:LRR 10,REPEAT:LRR 11,REPEAT:LRR 12,REPEAT:LRR 13,REPEAT:LRR 2,REPEAT:LRR 3,REPEAT:LRR 4,REPEAT:LRR 5,REPEAT:LRR 6,REPEAT:LRR 7,REPEAT:LRR 8,REPEAT:LRR 9,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
A9JR78	tonsoku-like, DNA repair protein(tonsl)	Danio rerio			GO:0000724~double-strand break repair via homologous recombination,GO:0006281~DNA repair,GO:0006325~chromatin organization,GO:0006974~cellular response to DNA damage stimulus,GO:0031297~replication fork processing,	GO:0005634~nucleus,GO:0005662~DNA replication factor A complex,GO:0005694~chromosome,GO:0005737~cytoplasm,GO:0035101~FACT complex,GO:0035861~site of double-strand break,GO:0042555~MCM complex,GO:0043596~nuclear replication fork,	GO:0042393~histone binding,	IPR001611:Leu-rich_rpt,IPR002110:Ankyrin_rpt,IPR006553:Leu-rich_rpt_Cys-con_subtyp,IPR011990:TPR-like_helical_dom_sf,IPR019734:TPR_repeat,IPR032675:LRR_dom_sf,IPR036770:Ankyrin_rpt-contain_sf,				SM00028:TPR,SM00248:ANK,SM00367:LRR_CC,SM00368:LRR_RI,	KW-0227~DNA damage,KW-0234~DNA repair,	KW-0158~Chromosome,KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0040~ANK repeat,KW-0433~Leucine-rich repeat,KW-0677~Repeat,KW-0802~TPR repeat,		KW-0156~Chromatin regulator,		COMPBIAS:Acidic residues,COMPBIAS:Polar residues,REGION:Disordered,REPEAT:ANK 1,REPEAT:ANK 2,REPEAT:ANK 3,REPEAT:LRR 1,REPEAT:LRR 2,REPEAT:LRR 3,REPEAT:LRR 4,REPEAT:LRR 5,REPEAT:LRR 6,REPEAT:LRR 7,REPEAT:TPR 1,REPEAT:TPR 2,REPEAT:TPR 3,REPEAT:TPR 4,REPEAT:TPR 5,REPEAT:TPR 6,REPEAT:TPR 7,REPEAT:TPR 8,
O42131	topoisomerase (DNA) II beta(TOP2B)	Gallus gallus			GO:0000712~resolution of meiotic recombination intermediates,GO:0000819~sister chromatid segregation,GO:0006265~DNA topological change,GO:0030183~B cell differentiation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:1990904~ribonucleoprotein complex,	GO:0003677~DNA binding,GO:0003916~DNA topoisomerase activity,GO:0003918~DNA topoisomerase type II (ATP-hydrolyzing) activity,GO:0005524~ATP binding,GO:0046872~metal ion binding,	IPR001154:TopoII_euk,IPR001241:Topo_IIA,IPR002205:Topo_IIA_dom_A,IPR003594:HATPase_C,IPR006171:TOPRIM_domain,IPR012542:DTHCT,IPR013506:Topo_IIA_bsu_dom2,IPR013757:Topo_IIA_A_a_sf,IPR013758:Topo_IIA_A/C_ab,IPR013759:Topo_IIA_B_C,IPR013760:Topo_IIA-like_dom_sf,IPR014721:Ribsml_uS5_D2-typ_fold_subgr,IPR018522:TopoIIA_CS,IPR020568:Ribosomal_Su5_D2-typ_SF,IPR031660:TOPRIM_C,IPR034157:TOPRIM_TopoII,IPR036890:HATPase_C_sf,				SM00433:TOP2c,SM00434:TOP4c,		KW-0539~Nucleus,			KW-0175~Coiled coil,	KW-0067~ATP-binding,KW-0460~Magnesium,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,	KW-0238~DNA-binding,KW-0413~Isomerase,KW-0799~Topoisomerase,		ACT_SITE:O-(5'-phospho-DNA)-tyrosine intermediate,COMPBIAS:Acidic residues,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:Histidine kinase/HSP90-like ATPase,DOMAIN:Topo IIA-type catalytic,DOMAIN:Toprim,REGION:Disordered,REGION:Interaction with DNA,SITE:Important for DNA bending; intercalates between base pairs of target DNA,SITE:Interaction with DNA,SITE:Transition state stabilizer,
O70157	topoisomerase (DNA) III alpha(Top3a)	Mus musculus			GO:0000724~double-strand break repair via homologous recombination,GO:0006265~DNA topological change,GO:0006281~DNA repair,GO:0006310~DNA recombination,GO:0032042~mitochondrial DNA metabolic process,GO:0051304~chromosome separation,GO:0071139~resolution of recombination intermediates,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,GO:0016605~PML body,GO:0031422~RecQ helicase-Topo III complex,	GO:0003677~DNA binding,GO:0003697~single-stranded DNA binding,GO:0003916~DNA topoisomerase activity,GO:0003917~DNA topoisomerase type I activity,GO:0008270~zinc ion binding,GO:0016853~isomerase activity,GO:0046872~metal ion binding,	IPR000380:Topo_IA,IPR003601:Topo_IA_2,IPR003602:Topo_IA_DNA-bd_dom,IPR006171:TOPRIM_domain,IPR010666:Znf_GRF,IPR013497:Topo_IA_cen,IPR013498:Topo_IA_Znf,IPR013824:Topo_IA_cen_sub1,IPR013825:Topo_IA_cen_sub2,IPR013826:Topo_IA_cen_sub3,IPR023405:Topo_IA_core_domain,IPR023406:Topo_IA_AS,IPR034144:TOPRIM_TopoIII,	mmu03440:Homologous recombination,mmu03460:Fanconi anemia pathway,			SM00436:TOP1Bc,SM00437:TOP1Ac,SM00493:TOPRIM,		KW-0496~Mitochondrion,			KW-0677~Repeat,KW-0863~Zinc-finger,	KW-0460~Magnesium,KW-0479~Metal-binding,KW-0862~Zinc,	KW-0238~DNA-binding,KW-0413~Isomerase,KW-0799~Topoisomerase,		ACT_SITE:O-(5'-phospho-DNA)-tyrosine intermediate,COMPBIAS:Polar residues,DOMAIN:GRF-type,DOMAIN:Topo IA-type catalytic,DOMAIN:Toprim,REGION:Disordered,ZN_FING:C4-type,ZN_FING:GRF-type 1,ZN_FING:GRF-type 2,
Q9R099	transducin (beta)-like 2(Tbl2)	Mus musculus			GO:0030968~endoplasmic reticulum unfolded protein response,GO:0042149~cellular response to glucose starvation,GO:0071456~cellular response to hypoxia,	GO:0005783~endoplasmic reticulum,	GO:0019901~protein kinase binding,GO:0031369~translation initiation factor binding,GO:0051219~phosphoprotein binding,	IPR001680:WD40_rpt,IPR015943:WD40/YVTN_repeat-like_dom_sf,IPR019775:WD40_repeat_CS,IPR020472:G-protein_beta_WD-40_rep,IPR036322:WD40_repeat_dom_sf,IPR042410:WBSCR13,				SM00320:WD40,					KW-0175~Coiled coil,KW-0677~Repeat,KW-0732~Signal,KW-0853~WD repeat,			KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Basic and acidic residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),REGION:Disordered,REPEAT:WD,REPEAT:WD 1,REPEAT:WD 2,REPEAT:WD 3,REPEAT:WD 4,REPEAT:WD 5,REPEAT:WD 6,REPEAT:WD 7,
Q99376	transferrin receptor(Tfrc)	Rattus norvegicus			GO:0001666~response to hypoxia,GO:0001934~positive regulation of protein phosphorylation,GO:0006826~iron ion transport,GO:0006879~cellular iron ion homeostasis,GO:0006953~acute-phase response,GO:0007584~response to nutrient,GO:0010033~response to organic substance,GO:0010035~response to inorganic substance,GO:0010039~response to iron ion,GO:0010042~response to manganese ion,GO:0010628~positive regulation of gene expression,GO:0010637~negative regulation of mitochondrial fusion,GO:0030316~osteoclast differentiation,GO:0030890~positive regulation of B cell proliferation,GO:0031334~positive regulation of protein complex assembly,GO:0031623~receptor internalization,GO:0032526~response to retinoic acid,GO:0033138~positive regulation of peptidyl-serine phosphorylation,GO:0033572~transferrin transport,GO:0035556~intracellular signal transduction,GO:0042102~positive regulation of T cell proliferation,GO:0043066~negative regulation of apoptotic process,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling,GO:0045780~positive regulation of bone resorption,GO:0045830~positive regulation of isotype switching,GO:0046688~response to copper ion,GO:0071466~cellular response to xenobiotic stimulus,GO:1900182~positive regulation of protein localization to nucleus,GO:1990830~cellular response to leukemia inhibitory factor,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005768~endosome,GO:0005769~early endosome,GO:0005886~plasma membrane,GO:0005905~clathrin-coated pit,GO:0009897~external side of plasma membrane,GO:0009986~cell surface,GO:0010008~endosome membrane,GO:0016020~membrane,GO:0016323~basolateral plasma membrane,GO:0031410~cytoplasmic vesicle,GO:0042470~melanosome,GO:0043231~intracellular membrane-bounded organelle,GO:0048471~perinuclear region of cytoplasm,GO:0055037~recycling endosome,GO:0055038~recycling endosome membrane,GO:0070062~extracellular exosome,GO:1990712~HFE-transferrin receptor complex,	GO:0003725~double-stranded RNA binding,GO:0004998~transferrin receptor activity,GO:0005515~protein binding,GO:0019901~protein kinase binding,GO:0030544~Hsp70 protein binding,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,GO:0044877~macromolecular complex binding,GO:0051087~chaperone binding,	IPR003137:PA_domain,IPR007365:TFR-like_dimer_dom,IPR007484:Peptidase_M28,IPR036757:TFR-like_dimer_dom_sf,IPR037324:TfR1/2_PA,IPR039373:Peptidase_M28B,IPR046450:PA_dom_sf,	rno04066:HIF-1 signaling pathway,rno04144:Endocytosis,rno04145:Phagosome,rno04216:Ferroptosis,rno04350:TGF-beta signaling pathway,rno04640:Hematopoietic cell lineage,				KW-0254~Endocytosis,	KW-0472~Membrane,KW-1003~Cell membrane,			KW-0735~Signal-anchor,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0675~Receptor,	KW-0325~Glycoprotein,KW-0449~Lipoprotein,KW-0564~Palmitate,KW-0597~Phosphoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DISULFID:Interchain,DOMAIN:PA,DOMAIN:Peptidase M28,DOMAIN:Transferrin receptor-like dimerisation,LIPID:S-palmitoyl cysteine,MOTIF:Cell attachment site; required for binding to transferrin,MOTIF:Endocytosis signal,MOTIF:Stop-transfer sequence,REGION:Ligand-binding,REGION:Mediates interaction with SH3BP4,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,TRANSMEM:Helical; Signal-anchor for type II membrane protein,
Q9PTG8	transforming acidic coiled-coil containing protein 3 S homeolog(tacc3.S)	Xenopus laevis			GO:0006417~regulation of translation,GO:0007049~cell cycle,GO:0007052~mitotic spindle organization,GO:0017148~negative regulation of translation,GO:0051301~cell division,	GO:0000922~spindle pole,GO:0005737~cytoplasm,GO:0005819~spindle,GO:0005856~cytoskeleton,GO:0032991~macromolecular complex,	GO:0005515~protein binding,GO:0031369~translation initiation factor binding,	IPR007707:TACC_C,IPR039915:TACC,					KW-0131~Cell cycle,KW-0132~Cell division,KW-0498~Mitosis,KW-0810~Translation regulation,	KW-0206~Cytoskeleton,KW-0963~Cytoplasm,			KW-0175~Coiled coil,		KW-0652~Protein synthesis inhibitor,KW-0678~Repressor,	KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:Transforming acidic coiled-coil-containing protein C-terminal,MUTAGEN:D->K: Disrupts interactions with ckap5-a.,MUTAGEN:DD->AA: Disrupts interactions with ckap5-a.,MUTAGEN:FLL->AAA: Fails to bind eif4e; when associated with A-577.,MUTAGEN:T->A: Fails to bind eif4e; when associated with 581-AAA-583.,REGION:Disordered,
Q568N3	translocase of inner mitochondrial membrane domain containing 1(timmdc1)	Danio rerio				GO:0005739~mitochondrion,GO:0016020~membrane,GO:0031966~mitochondrial membrane,								KW-0472~Membrane,KW-0496~Mitochondrion,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0143~Chaperone,		TRANSMEM:Helical,
O94826	translocase of outer mitochondrial membrane 70(TOMM70)	Homo sapiens			GO:0002218~activation of innate immune response,GO:0002230~positive regulation of defense response to virus by host,GO:0006626~protein targeting to mitochondrion,GO:0030150~protein import into mitochondrial matrix,GO:0032728~positive regulation of interferon-beta production,GO:0042981~regulation of apoptotic process,GO:0045039~protein import into mitochondrial inner membrane,GO:0045040~protein import into mitochondrial outer membrane,GO:0061052~negative regulation of cell growth involved in cardiac muscle cell development,GO:0097068~response to thyroxine,GO:0098586~cellular response to virus,GO:1903955~positive regulation of protein targeting to mitochondrion,	GO:0005739~mitochondrion,GO:0005741~mitochondrial outer membrane,GO:0005742~mitochondrial outer membrane translocase complex,GO:0016020~membrane,GO:0031966~mitochondrial membrane,GO:0070062~extracellular exosome,	GO:0005515~protein binding,GO:0008320~protein transmembrane transporter activity,GO:0030943~mitochondrion targeting sequence binding,GO:0060090~binding, bridging,	IPR001440:TPR_1,IPR011990:TPR-like_helical_dom_sf,IPR019734:TPR_repeat,	hsa04137:Mitophagy - animal,			SM00028:TPR,	KW-0945~Host-virus interaction,	KW-0472~Membrane,KW-0496~Mitochondrion,KW-1000~Mitochondrion outer membrane,			KW-0677~Repeat,KW-0802~TPR repeat,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0675~Receptor,	KW-0007~Acetylation,KW-0488~Methylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Basic and acidic residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),MUTAGEN:K->A: No effect on interaction with HSP90AA1.,MUTAGEN:R->A: Unable to induce IRF3 activation upon Sendai virus infection. Loss of interaction with HSPA8 and HSP90AA1. No effect on mitochondrial location.,REGION:Disordered,REPEAT:TPR,REPEAT:TPR 1,REPEAT:TPR 10,REPEAT:TPR 2,REPEAT:TPR 3,REPEAT:TPR 4,REPEAT:TPR 5,REPEAT:TPR 6,REPEAT:TPR 7,REPEAT:TPR 8,REPEAT:TPR 9,TOPO_DOM:Cytoplasmic,TOPO_DOM:Mitochondrial intermembrane,TRANSMEM:Helical,
Q28BQ6	transmembrane p24 trafficking protein 1(tmed1)	Xenopus tropicalis			GO:0006094~gluconeogenesis,GO:0006096~glycolytic process,GO:0006886~intracellular protein transport,GO:0006888~ER to Golgi vesicle-mediated transport,GO:0007030~Golgi organization,GO:0015031~protein transport,GO:1901135~carbohydrate derivative metabolic process,	GO:0005615~extracellular space,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005793~endoplasmic reticulum-Golgi intermediate compartment,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0030134~ER to Golgi transport vesicle,GO:0033116~endoplasmic reticulum-Golgi intermediate compartment membrane,GO:0043231~intracellular membrane-bounded organelle,	GO:0004347~glucose-6-phosphate isomerase activity,GO:0005125~cytokine activity,GO:0038024~cargo receptor activity,GO:0097367~carbohydrate derivative binding,	IPR001672:G6P_Isomerase,IPR009038:GOLD_dom,IPR015720:Emp24-like,IPR018189:Phosphoglucose_isomerase_CS,IPR035476:SIS_PGI_1,IPR035482:SIS_PGI_2,IPR036598:GOLD_dom_sf,IPR046348:SIS_dom_sf,				SM01190:EMP24_GP25L,	KW-0324~Glycolysis,KW-0653~Protein transport,KW-0813~Transport,	KW-0256~Endoplasmic reticulum,KW-0333~Golgi apparatus,KW-0472~Membrane,KW-1003~Cell membrane,			KW-0175~Coiled coil,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0202~Cytokine,KW-0413~Isomerase,		DOMAIN:GOLD,MOTIF:COPI vesicle coat-binding,MOTIF:COPII vesicle coat-binding,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q6AY25	transmembrane p24 trafficking protein 3(Tmed3)	Rattus norvegicus			GO:0006886~intracellular protein transport,GO:0006888~ER to Golgi vesicle-mediated transport,GO:0007030~Golgi organization,GO:0015031~protein transport,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005793~endoplasmic reticulum-Golgi intermediate compartment,GO:0005794~Golgi apparatus,GO:0030126~COPI vesicle coat,GO:0030134~ER to Golgi transport vesicle,GO:0032580~Golgi cisterna membrane,GO:0033116~endoplasmic reticulum-Golgi intermediate compartment membrane,	GO:0038024~cargo receptor activity,	IPR009038:GOLD_dom,IPR015720:Emp24-like,IPR036598:GOLD_dom_sf,				SM01190:EMP24_GP25L,	KW-0653~Protein transport,KW-0813~Transport,	KW-0256~Endoplasmic reticulum,KW-0333~Golgi apparatus,KW-0472~Membrane,KW-0968~Cytoplasmic vesicle,			KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0488~Methylation,	DOMAIN:GOLD,MOTIF:COPI vesicle coat-binding,MOTIF:COPII vesicle coat-binding,TOPO_DOM:Cytoplasmic,TOPO_DOM:Lumenal,TRANSMEM:Helical,
Q5R9S0	transmembrane p24 trafficking protein family member 8(TMED8)	Pongo abelii						IPR009038:GOLD_dom,IPR036598:GOLD_dom_sf,												KW-0007~Acetylation,	COMPBIAS:Acidic residues,DOMAIN:GOLD,REGION:Disordered,
Q6DGL7	transmembrane protein 147(tmem147)	Danio rerio			GO:0036228~protein targeting to nuclear inner membrane,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0031965~nuclear membrane,	GO:0005515~protein binding,GO:0043022~ribosome binding,	IPR019164:TMEM147,						KW-0256~Endoplasmic reticulum,KW-0472~Membrane,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,				TOPO_DOM:Cytoplasmic,TOPO_DOM:Lumenal,TRANSMEM:Helical,
Q6GPL4	transmembrane protein 150A L homeolog(tmem150a.L)	Xenopus laevis			GO:0046854~phosphatidylinositol phosphorylation,GO:0072659~protein localization to plasma membrane,	GO:0005886~plasma membrane,GO:0016020~membrane,		IPR019402:Frag1/DRAM/Sfk1,						KW-0472~Membrane,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q6AZD1	transmembrane protein 179(tmem179)	Danio rerio				GO:0016020~membrane,		IPR029673:TMEM179,						KW-0472~Membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,TRANSMEM:Helical,
Q6AZD1	transmembrane protein 179a, genome duplicate A(tmem179aa)	Danio rerio				GO:0016020~membrane,		IPR029673:TMEM179,						KW-0472~Membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,TRANSMEM:Helical,
Q498W5	transmembrane protein 198b(tmem198b)	Danio rerio			GO:0090263~positive regulation of canonical Wnt signaling pathway,	GO:0005886~plasma membrane,GO:0016020~membrane,GO:0031410~cytoplasmic vesicle,		IPR025256:DUF4203,IPR040236:TMEM198,						KW-0472~Membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,				DOMAIN:DUF4203,REGION:Disordered,TRANSMEM:Helical,
B9EJI9	transmembrane protein 229A(Tmem229a)	Mus musculus				GO:0016020~membrane,								KW-0472~Membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,				REGION:Disordered,TRANSMEM:Helical,
Q8TBM7	transmembrane protein 254(TMEM254)	Homo sapiens				GO:0016020~membrane,	GO:0005515~protein binding,	IPR028110:TMEM254,						KW-0472~Membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0007~Acetylation,	COMPBIAS:Basic and acidic residues,REGION:Disordered,TRANSMEM:Helical,
Q9D4Y8	transmembrane protein 269(Tmem269)	Mus musculus				GO:0016020~membrane,								KW-0472~Membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,				TRANSMEM:Helical,
Q7ZVP8	transmembrane protein 38B(tmem38b)	Danio rerio			GO:0006811~ion transport,GO:0006813~potassium ion transport,GO:0071805~potassium ion transmembrane transport,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0016020~membrane,	GO:0005267~potassium channel activity,GO:0042802~identical protein binding,	IPR007866:TRIC_channel,					KW-0406~Ion transport,KW-0633~Potassium transport,KW-0813~Transport,	KW-0256~Endoplasmic reticulum,KW-0472~Membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0630~Potassium,	KW-0407~Ion channel,KW-0631~Potassium channel,		REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Lumenal,TRANSMEM:Helical;Name=1,TRANSMEM:Helical;Name=2,TRANSMEM:Helical;Name=3,TRANSMEM:Helical;Name=4,TRANSMEM:Helical;Name=5,TRANSMEM:Helical;Name=6,TRANSMEM:Helical;Name=7,
P98074	transmembrane serine protease 15(TMPRSS15)	Sus scrofa			GO:0006508~proteolysis,	GO:0016020~membrane,	GO:0004252~serine-type endopeptidase activity,GO:0005044~scavenger receptor activity,GO:0005515~protein binding,GO:0008236~serine-type peptidase activity,	IPR000082:SEA_dom,IPR000859:CUB_dom,IPR000998:MAM_dom,IPR001190:SRCR,IPR001254:Trypsin_dom,IPR001314:Peptidase_S1A,IPR002172:LDrepeatLR_classA_rpt,IPR009003:Peptidase_S1_PA,IPR011163:Pept_S1A_enterop,IPR013320:ConA-like_dom_sf,IPR017448:SRCR-like_dom,IPR018114:TRYPSIN_HIS,IPR023415:LDLR_class-A_CS,IPR033116:TRYPSIN_SER,IPR035914:Sperma_CUB_dom_sf,IPR036055:LDL_receptor-like_sf,IPR036364:SEA_dom_sf,IPR036772:SRCR-like_dom_sf,IPR043504:Peptidase_S1_PA_chymotrypsin,			PIRSF001138:Enteropeptidase,	SM00020:Tryp_SPc,SM00042:CUB,SM00137:MAM,SM00192:LDLa,SM00200:SEA,SM00202:SR,		KW-0472~Membrane,			KW-0677~Repeat,KW-0735~Signal-anchor,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0378~Hydrolase,KW-0645~Protease,KW-0720~Serine protease,	KW-0325~Glycoprotein,KW-0865~Zymogen,KW-1015~Disulfide bond,	ACT_SITE:Charge relay system,CARBOHYD:N-linked (GlcNAc...) asparagine,DISULFID:Interchain (between heavy and light chains),DOMAIN:CUB,DOMAIN:CUB 1,DOMAIN:CUB 2,DOMAIN:LDL-receptor class A 1,DOMAIN:LDL-receptor class A 2,DOMAIN:MAM,DOMAIN:Peptidase S1,DOMAIN:SEA,DOMAIN:SRCR,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,TRANSMEM:Helical; Signal-anchor for type II membrane protein,
P14373	tripartite motif containing 27(TRIM27)	Homo sapiens			GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0002820~negative regulation of adaptive immune response,GO:0006469~negative regulation of protein kinase activity,GO:0007283~spermatogenesis,GO:0010507~negative regulation of autophagy,GO:0016925~protein sumoylation,GO:0032480~negative regulation of type I interferon production,GO:0032703~negative regulation of interleukin-2 production,GO:0032720~negative regulation of tumor necrosis factor production,GO:0032729~positive regulation of interferon-gamma production,GO:0032897~negative regulation of viral transcription,GO:0034314~Arp2/3 complex-mediated actin nucleation,GO:0042147~retrograde transport, endosome to Golgi,GO:0044790~negative regulation by host of viral release from host cell,GO:0045087~innate immune response,GO:0045814~negative regulation of gene expression, epigenetic,GO:0045893~positive regulation of transcription, DNA-templated,GO:0051091~positive regulation of sequence-specific DNA binding transcription factor activity,GO:0051127~positive regulation of actin nucleation,GO:0070534~protein K63-linked ubiquitination,GO:0090281~negative regulation of calcium ion import,	GO:0001650~fibrillar center,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005768~endosome,GO:0005769~early endosome,GO:0005829~cytosol,GO:0016605~PML body,GO:0030904~retromer complex,GO:0031965~nuclear membrane,	GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003713~transcription coactivator activity,GO:0004842~ubiquitin-protein transferase activity,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0019789~SUMO transferase activity,GO:0042802~identical protein binding,GO:0046872~metal ion binding,GO:0061630~ubiquitin protein ligase activity,	IPR000315:Znf_B-box,IPR001841:Znf_RING,IPR001870:B30.2/SPRY,IPR003877:SPRY_dom,IPR003879:Butyrophylin_SPRY,IPR006574:PRY,IPR013083:Znf_RING/FYVE/PHD,IPR013320:ConA-like_dom_sf,IPR017907:Znf_RING_CS,IPR020457:Znf_B-box_chordata,IPR035791:SPRY/PRY_TRIM27,IPR043136:B30.2/SPRY_sf,				SM00184:RING,SM00336:BBOX,SM00449:SPRY,SM00589:PRY,	KW-0804~Transcription,KW-0805~Transcription regulation,KW-0813~Transport,KW-0833~Ubl conjugation pathway,	KW-0496~Mitochondrion,KW-0539~Nucleus,KW-0963~Cytoplasm,KW-0967~Endosome,		KW-0656~Proto-oncogene,	KW-0175~Coiled coil,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0238~DNA-binding,KW-0678~Repressor,KW-0808~Transferase,		DOMAIN:B box-type,DOMAIN:B30.2/SPRY,DOMAIN:RING-type,DOMAIN:SPRY-associated,MUTAGEN:C->A: Abolished E3 ubiquitin-protein ligase activity; when associated with A-16.,MUTAGEN:C->A: Abolished E3 ubiquitin-protein ligase activity; when associated with A-31.,SITE:Breakpoint for translocation to form the TRIM27/RET oncogene,ZN_FING:B box-type,ZN_FING:RING-type,
Q9HCM9	tripartite motif containing 39(TRIM39)	Homo sapiens			GO:0006915~apoptotic process,GO:0007095~mitotic G2 DNA damage checkpoint,GO:0016567~protein ubiquitination,GO:0032435~negative regulation of proteasomal ubiquitin-dependent protein catabolic process,GO:0043124~negative regulation of I-kappaB kinase/NF-kappaB signaling,GO:0050821~protein stabilization,GO:1902806~regulation of cell cycle G1/S phase transition,GO:2000059~negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process,GO:2001235~positive regulation of apoptotic signaling pathway,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005829~cytosol,	GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0042802~identical protein binding,GO:0046872~metal ion binding,GO:0061630~ubiquitin protein ligase activity,	IPR000315:Znf_B-box,IPR001841:Znf_RING,IPR001870:B30.2/SPRY,IPR003877:SPRY_dom,IPR003879:Butyrophylin_SPRY,IPR006574:PRY,IPR013083:Znf_RING/FYVE/PHD,IPR013320:ConA-like_dom_sf,IPR017907:Znf_RING_CS,IPR035033:PRY/SPRY_TRIM39,IPR043136:B30.2/SPRY_sf,				SM00184:RING,SM00336:BBOX,SM00449:SPRY,SM00589:PRY,	KW-0053~Apoptosis,KW-0131~Cell cycle,KW-0833~Ubl conjugation pathway,	KW-0496~Mitochondrion,KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0175~Coiled coil,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0808~Transferase,	KW-0832~Ubl conjugation,	DOMAIN:B box-type,DOMAIN:B30.2/SPRY,DOMAIN:RING-type,REGION:Interaction with CDKN1A,ZN_FING:B box-type,ZN_FING:RING-type,
Q1XHU0	tripartite motif containing 39(TRIM39)	Pan troglodytes			GO:0006915~apoptotic process,GO:0007095~mitotic G2 DNA damage checkpoint,GO:0016567~protein ubiquitination,GO:0032435~negative regulation of proteasomal ubiquitin-dependent protein catabolic process,GO:0034470~ncRNA processing,GO:0043124~negative regulation of I-kappaB kinase/NF-kappaB signaling,GO:0050821~protein stabilization,GO:1902806~regulation of cell cycle G1/S phase transition,GO:2001235~positive regulation of apoptotic signaling pathway,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005829~cytosol,GO:1902555~endoribonuclease complex,GO:1990904~ribonucleoprotein complex,	GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0042802~identical protein binding,GO:0061630~ubiquitin protein ligase activity,	IPR000315:Znf_B-box,IPR001841:Znf_RING,IPR001870:B30.2/SPRY,IPR003877:SPRY_dom,IPR003879:Butyrophylin_SPRY,IPR006574:PRY,IPR007175:Rpr2/Snm1/Rpp21,IPR013083:Znf_RING/FYVE/PHD,IPR013320:ConA-like_dom_sf,IPR017907:Znf_RING_CS,IPR035033:PRY/SPRY_TRIM39,IPR043136:B30.2/SPRY_sf,				SM00184:RING,SM00336:BBOX,SM00449:SPRY,SM00589:PRY,	KW-0053~Apoptosis,KW-0819~tRNA processing,KW-0833~Ubl conjugation pathway,	KW-0496~Mitochondrion,KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0175~Coiled coil,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0808~Transferase,	KW-0832~Ubl conjugation,	COMPBIAS:Polar residues,DOMAIN:B box-type,DOMAIN:B30.2/SPRY,DOMAIN:RING-type,REGION:Disordered,REGION:Interaction with CDKN1A,ZN_FING:B box-type,ZN_FING:RING-type,
Q99PP9	tripartite motif-containing 16(Trim16)	Mus musculus			GO:0032526~response to retinoic acid,GO:0032731~positive regulation of interleukin-1 beta production,GO:0045618~positive regulation of keratinocyte differentiation,GO:0045893~positive regulation of transcription, DNA-templated,GO:0046683~response to organophosphorus,GO:0048386~positive regulation of retinoic acid receptor signaling pathway,GO:0060416~response to growth hormone,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0016605~PML body,	GO:0003677~DNA binding,GO:0008270~zinc ion binding,GO:0016740~transferase activity,GO:0019966~interleukin-1 binding,GO:0032089~NACHT domain binding,GO:0046872~metal ion binding,	IPR000315:Znf_B-box,IPR001870:B30.2/SPRY,IPR003877:SPRY_dom,IPR003879:Butyrophylin_SPRY,IPR006574:PRY,IPR013320:ConA-like_dom_sf,IPR043136:B30.2/SPRY_sf,				SM00336:BBOX,SM00449:SPRY,SM00589:PRY,	KW-0833~Ubl conjugation pathway,	KW-0963~Cytoplasm,			KW-0175~Coiled coil,KW-0677~Repeat,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0808~Transferase,	KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,	COMPBIAS:Basic and acidic residues,DOMAIN:B30.2/SPRY,REGION:Disordered,ZN_FING:B box-type 1,ZN_FING:B box-type 2,
Q9ESN2	tripartite motif-containing 39(Trim39)	Mus musculus			GO:0006915~apoptotic process,GO:0007095~mitotic G2 DNA damage checkpoint,GO:0016567~protein ubiquitination,GO:0032435~negative regulation of proteasomal ubiquitin-dependent protein catabolic process,GO:0043124~negative regulation of I-kappaB kinase/NF-kappaB signaling,GO:0050821~protein stabilization,GO:1902806~regulation of cell cycle G1/S phase transition,GO:2000059~negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process,GO:2001235~positive regulation of apoptotic signaling pathway,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005829~cytosol,	GO:0008270~zinc ion binding,GO:0016740~transferase activity,GO:0042802~identical protein binding,GO:0046872~metal ion binding,GO:0061630~ubiquitin protein ligase activity,	IPR000315:Znf_B-box,IPR001841:Znf_RING,IPR001870:B30.2/SPRY,IPR003877:SPRY_dom,IPR003879:Butyrophylin_SPRY,IPR006574:PRY,IPR013083:Znf_RING/FYVE/PHD,IPR013320:ConA-like_dom_sf,IPR017907:Znf_RING_CS,IPR035033:PRY/SPRY_TRIM39,IPR043136:B30.2/SPRY_sf,				SM00184:RING,SM00336:BBOX,SM00449:SPRY,SM00589:PRY,	KW-0053~Apoptosis,KW-0833~Ubl conjugation pathway,	KW-0496~Mitochondrion,KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0175~Coiled coil,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0808~Transferase,	KW-0832~Ubl conjugation,	COMPBIAS:Polar residues,DOMAIN:B box-type,DOMAIN:B30.2/SPRY,DOMAIN:RING-type,REGION:Disordered,REGION:Interaction with CDKN1A,ZN_FING:B box-type,ZN_FING:RING-type,
Q5R4J1	tryptophanyl-tRNA synthetase 1(WARS1)	Pongo abelii			GO:0001525~angiogenesis,GO:0006418~tRNA aminoacylation for protein translation,GO:0006436~tryptophanyl-tRNA aminoacylation,GO:0010628~positive regulation of gene expression,GO:0031334~positive regulation of protein complex assembly,GO:0045765~regulation of angiogenesis,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0032991~macromolecular complex,	GO:0004812~aminoacyl-tRNA ligase activity,GO:0004830~tryptophan-tRNA ligase activity,GO:0005524~ATP binding,GO:0019210~kinase inhibitor activity,GO:0019901~protein kinase binding,GO:0019904~protein domain specific binding,GO:0042803~protein homodimerization activity,	IPR000738:WHEP-TRS_dom,IPR001412:aa-tRNA-synth_I_CS,IPR002305:aa-tRNA-synth_Ic,IPR002306:Trp-tRNA-ligase,IPR009068:uS15_NS1_RNA-bd_sf,IPR014729:Rossmann-like_a/b/a_fold,	pon00970:Aminoacyl-tRNA biosynthesis,			SM00991:WHEP-TRS,	KW-0037~Angiogenesis,KW-0648~Protein biosynthesis,	KW-0963~Cytoplasm,				KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0030~Aminoacyl-tRNA synthetase,KW-0436~Ligase,	KW-0597~Phosphoprotein,	DOMAIN:WHEP-TRS,MOTIF:'HIGH' region,MOTIF:'KMSKS' region,REGION:Disordered,
P09653	tubulin beta 6 class V(TUBB6)	Gallus gallus			GO:0000226~microtubule cytoskeleton organization,GO:0000278~mitotic cell cycle,GO:0007017~microtubule-based process,	GO:0005737~cytoplasm,GO:0005874~microtubule,	GO:0003924~GTPase activity,GO:0005200~structural constituent of cytoskeleton,GO:0005525~GTP binding,GO:0046872~metal ion binding,	IPR000217:Tubulin,IPR002453:Beta_tubulin,IPR003008:Tubulin_FtsZ_GTPase,IPR008280:Tub_FtsZ_C,IPR013838:Beta-tubulin_BS,IPR017975:Tubulin_CS,IPR018316:Tubulin/FtsZ_2-layer-sand-dom,IPR023123:Tubulin_C,IPR036525:Tubulin/FtsZ_GTPase_sf,IPR037103:Tubulin/FtsZ-like_C,	gga04145:Phagosome,gga04540:Gap junction,gga04814:Motor proteins,gga05132:Salmonella infection,			SM00864:Tubulin,SM00865:Tubulin_C,		KW-0206~Cytoskeleton,KW-0493~Microtubule,KW-0963~Cytoplasm,				KW-0342~GTP-binding,KW-0460~Magnesium,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,		KW-1017~Isopeptide bond,	COMPBIAS:Acidic residues,DOMAIN:Tubulin/FtsZ 2-layer sandwich,DOMAIN:Tubulin/FtsZ GTPase,MOTIF:MREI motif,REGION:Disordered,
P09244	tubulin beta class I(TUBB)	Gallus gallus			GO:0000226~microtubule cytoskeleton organization,GO:0000278~mitotic cell cycle,	GO:0005737~cytoplasm,GO:0005874~microtubule,	GO:0003924~GTPase activity,GO:0005200~structural constituent of cytoskeleton,GO:0005525~GTP binding,GO:0046872~metal ion binding,	IPR000217:Tubulin,IPR002453:Beta_tubulin,IPR003008:Tubulin_FtsZ_GTPase,IPR008280:Tub_FtsZ_C,IPR013838:Beta-tubulin_BS,IPR017975:Tubulin_CS,IPR018316:Tubulin/FtsZ_2-layer-sand-dom,IPR023123:Tubulin_C,IPR036525:Tubulin/FtsZ_GTPase_sf,IPR037103:Tubulin/FtsZ-like_C,	gga04145:Phagosome,gga04540:Gap junction,gga04814:Motor proteins,gga05132:Salmonella infection,			SM00864:Tubulin,SM00865:Tubulin_C,		KW-0206~Cytoskeleton,KW-0493~Microtubule,KW-0963~Cytoplasm,				KW-0342~GTP-binding,KW-0460~Magnesium,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,		KW-1017~Isopeptide bond,	COMPBIAS:Acidic residues,MOTIF:MREI motif,REGION:Disordered,
Q8NG68	tubulin tyrosine ligase(TTL)	Homo sapiens			GO:0000226~microtubule cytoskeleton organization,GO:0030516~regulation of axon extension,GO:0043687~post-translational protein modification,GO:0045931~positive regulation of mitotic cell cycle,GO:0090235~regulation of metaphase plate congression,	GO:0005876~spindle microtubule,	GO:0004835~tubulin-tyrosine ligase activity,GO:0005524~ATP binding,	IPR004344:TTL/TTLL_fam,										KW-0067~ATP-binding,KW-0460~Magnesium,KW-0547~Nucleotide-binding,KW-0630~Potassium,	KW-0436~Ligase,		DOMAIN:TTL,
A8CVX7	tubulin tyrosine ligase-like family, member 6(ttll6)	Danio rerio			GO:0000226~microtubule cytoskeleton organization,GO:0003341~cilium movement,GO:0018095~protein polyglutamylation,GO:0030030~cell projection organization,GO:0035082~axoneme assembly,GO:0036211~protein modification process,GO:0060296~regulation of cilium beat frequency involved in ciliary motility,	GO:0005737~cytoplasm,GO:0005856~cytoskeleton,GO:0005874~microtubule,GO:0005929~cilium,GO:0036064~ciliary basal body,GO:0042995~cell projection,	GO:0000166~nucleotide binding,GO:0005524~ATP binding,GO:0015631~tubulin binding,GO:0016874~ligase activity,GO:0016881~acid-amino acid ligase activity,GO:0046872~metal ion binding,GO:0070739~protein-glutamic acid ligase activity,GO:0070740~tubulin-glutamic acid ligase activity,	IPR004344:TTL/TTLL_fam,					KW-0970~Cilium biogenesis/degradation,	KW-0206~Cytoskeleton,KW-0493~Microtubule,KW-0963~Cytoplasm,KW-0966~Cell projection,KW-0969~Cilium,				KW-0067~ATP-binding,KW-0460~Magnesium,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,	KW-0436~Ligase,		COMPBIAS:Basic and acidic residues,DOMAIN:TTL,REGION:Disordered,REGION:c-MTBD region,SITE:Essential for specifying alpha-elongation versus initiation step of the polyglutamylase activity,SITE:Important for specifying alpha-elongation versus initiation step of the polyglutamylase activity,
P85108	tubulin, beta 2A class IIa(Tubb2a)	Rattus norvegicus			GO:0000226~microtubule cytoskeleton organization,GO:0000278~mitotic cell cycle,GO:0001764~neuron migration,GO:0007010~cytoskeleton organization,GO:0007017~microtubule-based process,GO:0021987~cerebral cortex development,GO:0050804~modulation of synaptic transmission,GO:1902669~positive regulation of axon guidance,GO:1990403~embryonic brain development,	GO:0005737~cytoplasm,GO:0005874~microtubule,GO:0015630~microtubule cytoskeleton,GO:0045171~intercellular bridge,GO:0072686~mitotic spindle,GO:0098685~Schaffer collateral - CA1 synapse,	GO:0003924~GTPase activity,GO:0005200~structural constituent of cytoskeleton,GO:0005525~GTP binding,GO:0046872~metal ion binding,GO:0046982~protein heterodimerization activity,	IPR000217:Tubulin,IPR002453:Beta_tubulin,IPR003008:Tubulin_FtsZ_GTPase,IPR008280:Tub_FtsZ_C,IPR013838:Beta-tubulin_BS,IPR017975:Tubulin_CS,IPR018316:Tubulin/FtsZ_2-layer-sand-dom,IPR023123:Tubulin_C,IPR036525:Tubulin/FtsZ_GTPase_sf,IPR037103:Tubulin/FtsZ-like_C,	rno04145:Phagosome,rno04540:Gap junction,rno04814:Motor proteins,rno05010:Alzheimer disease,rno05012:Parkinson disease,rno05014:Amyotrophic lateral sclerosis,rno05016:Huntington disease,rno05020:Prion disease,rno05022:Pathways of neurodegeneration - multiple diseases,rno05132:Salmonella infection,			SM00864:Tubulin,SM00865:Tubulin_C,	KW-0524~Neurogenesis,	KW-0206~Cytoskeleton,KW-0493~Microtubule,KW-0963~Cytoplasm,			KW-0732~Signal,	KW-0342~GTP-binding,KW-0460~Magnesium,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,		KW-0007~Acetylation,KW-0488~Methylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Acidic residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate,DOMAIN:Tubulin/FtsZ 2-layer sandwich,DOMAIN:Tubulin/FtsZ GTPase,MOTIF:MREI motif,REGION:Disordered,
P85108	tubulin, beta 2B class IIb(Tubb2b)	Rattus norvegicus			GO:0000226~microtubule cytoskeleton organization,GO:0000278~mitotic cell cycle,GO:0001764~neuron migration,GO:0007010~cytoskeleton organization,GO:0007017~microtubule-based process,GO:0021987~cerebral cortex development,GO:0050804~modulation of synaptic transmission,GO:1902669~positive regulation of axon guidance,GO:1990403~embryonic brain development,	GO:0005737~cytoplasm,GO:0005874~microtubule,GO:0015630~microtubule cytoskeleton,GO:0045171~intercellular bridge,GO:0072686~mitotic spindle,GO:0098685~Schaffer collateral - CA1 synapse,	GO:0003924~GTPase activity,GO:0005200~structural constituent of cytoskeleton,GO:0005525~GTP binding,GO:0046872~metal ion binding,GO:0046982~protein heterodimerization activity,	IPR000217:Tubulin,IPR002453:Beta_tubulin,IPR003008:Tubulin_FtsZ_GTPase,IPR008280:Tub_FtsZ_C,IPR013838:Beta-tubulin_BS,IPR017975:Tubulin_CS,IPR018316:Tubulin/FtsZ_2-layer-sand-dom,IPR023123:Tubulin_C,IPR036525:Tubulin/FtsZ_GTPase_sf,IPR037103:Tubulin/FtsZ-like_C,	rno04145:Phagosome,rno04540:Gap junction,rno04814:Motor proteins,rno05010:Alzheimer disease,rno05012:Parkinson disease,rno05014:Amyotrophic lateral sclerosis,rno05016:Huntington disease,rno05020:Prion disease,rno05022:Pathways of neurodegeneration - multiple diseases,rno05132:Salmonella infection,			SM00864:Tubulin,SM00865:Tubulin_C,	KW-0524~Neurogenesis,	KW-0206~Cytoskeleton,KW-0493~Microtubule,KW-0963~Cytoplasm,			KW-0732~Signal,	KW-0342~GTP-binding,KW-0460~Magnesium,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,		KW-0007~Acetylation,KW-0488~Methylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Acidic residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate,DOMAIN:Tubulin/FtsZ 2-layer sandwich,DOMAIN:Tubulin/FtsZ GTPase,MOTIF:MREI motif,REGION:Disordered,
Q5T0D9	tumor protein p63 regulated 1 like(TPRG1L)	Homo sapiens			GO:0016081~synaptic vesicle docking,GO:0050805~negative regulation of synaptic transmission,GO:0051966~regulation of synaptic transmission, glutamatergic,GO:0099004~calmodulin dependent kinase signaling pathway,	GO:0005737~cytoplasm,GO:0008021~synaptic vesicle,GO:0030672~synaptic vesicle membrane,GO:0044305~calyx of Held,GO:0048786~presynaptic active zone,GO:0070062~extracellular exosome,	GO:0005516~calmodulin binding,GO:0042802~identical protein binding,	IPR022158:Inositol_phosphatase,IPR034753:hSac2,IPR040242:TPRG1-like,						KW-0472~Membrane,KW-0770~Synapse,KW-0966~Cell projection,KW-0968~Cytoplasmic vesicle,						KW-0597~Phosphoprotein,	DOMAIN:HSac2,DOMAIN:hSac2,REGION:Disordered,REGION:Important for homomultimer formation,REGION:Important for homomultimer formation and localization to presynaptic regions,
Q0V9V9	tweety family member 1(ttyh1)	Xenopus tropicalis			GO:0006811~ion transport,GO:0006821~chloride transport,GO:0034220~ion transmembrane transport,	GO:0005886~plasma membrane,GO:0016020~membrane,GO:0030868~smooth endoplasmic reticulum membrane,GO:0034707~chloride channel complex,	GO:0005229~intracellular calcium activated chloride channel activity,GO:0005254~chloride channel activity,GO:0072320~volume-sensitive chloride channel activity,	IPR006990:Tweety,					KW-0406~Ion transport,KW-0813~Transport,	KW-0472~Membrane,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0868~Chloride,	KW-0407~Ion channel,KW-0869~Chloride channel,	KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,TRANSMEM:Helical; Name=1,TRANSMEM:Helical; Name=2,TRANSMEM:Helical; Name=3,TRANSMEM:Helical; Name=4,TRANSMEM:Helical; Name=5,
Q6GMH3	twinfilin actin binding protein 2(twf2)	Danio rerio			GO:0010591~regulation of lamellipodium assembly,GO:0010976~positive regulation of neuron projection development,GO:0030042~actin filament depolymerization,GO:0030837~negative regulation of actin filament polymerization,GO:0042989~sequestering of actin monomers,GO:0051016~barbed-end actin filament capping,	GO:0005737~cytoplasm,GO:0005856~cytoskeleton,GO:0005884~actin filament,GO:0030016~myofibril,GO:0048471~perinuclear region of cytoplasm,	GO:0003779~actin binding,GO:0003785~actin monomer binding,GO:0051015~actin filament binding,	IPR002108:ADF-H,IPR028458:Twinfilin,IPR029006:ADF-H/Gelsolin-like_dom_sf,				SM00102:ADF,		KW-0206~Cytoskeleton,KW-0963~Cytoplasm,			KW-0677~Repeat,		KW-0009~Actin-binding,		DOMAIN:ADF-H,DOMAIN:ADF-H 1,DOMAIN:ADF-H 2,REGION:Disordered,
Q5R651	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta(YWHAZ)	Pongo abelii			GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006468~protein phosphorylation,GO:0007165~signal transduction,GO:0008104~protein localization,GO:0042149~cellular response to glucose starvation,GO:0045824~negative regulation of innate immune response,GO:0051683~establishment of Golgi localization,GO:0070372~regulation of ERK1 and ERK2 cascade,GO:0090128~regulation of synapse maturation,GO:0090168~Golgi reassembly,GO:1900181~negative regulation of protein localization to nucleus,GO:1904262~negative regulation of TORC1 signaling,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0042470~melanosome,GO:0098978~glutamatergic synapse,	GO:0019901~protein kinase binding,GO:0031625~ubiquitin protein ligase binding,GO:0042802~identical protein binding,GO:0044325~ion channel binding,GO:0050815~phosphoserine binding,	IPR000308:14-3-3,IPR023409:14-3-3_CS,IPR023410:14-3-3_domain,IPR036815:14-3-3_dom_sf,	pon04110:Cell cycle,pon04114:Oocyte meiosis,pon04151:PI3K-Akt signaling pathway,pon04390:Hippo signaling pathway,pon05160:Hepatitis C,pon05161:Hepatitis B,pon05203:Viral carcinogenesis,		PIRSF000868:14-3-3,	SM00101:14_3_3,		KW-0963~Cytoplasm,			KW-0175~Coiled coil,			KW-0007~Acetylation,KW-0597~Phosphoprotein,	DOMAIN:14-3-3,SITE:Interaction with phosphoserine on interacting protein,
Q6UFZ9	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta polypeptide a(ywhaba)	Oncorhynchus mykiss			GO:0007165~signal transduction,	GO:0005737~cytoplasm,		IPR000308:14-3-3,IPR023409:14-3-3_CS,IPR023410:14-3-3_domain,IPR036815:14-3-3_dom_sf,	omy04110:Cell cycle,omy04114:Oocyte meiosis,		PIRSF000868:14-3-3,	SM00101:14_3_3,		KW-0963~Cytoplasm,			KW-0175~Coiled coil,			KW-0007~Acetylation,	DOMAIN:14-3-3,SITE:Interaction with phosphoserine on interacting protein,
P24529	tyrosine hydroxylase(Th)	Mus musculus			GO:0001666~response to hypoxia,GO:0001963~synaptic transmission, dopaminergic,GO:0001975~response to amphetamine,GO:0006585~dopamine biosynthetic process from tyrosine,GO:0006631~fatty acid metabolic process,GO:0006665~sphingolipid metabolic process,GO:0007507~heart development,GO:0007601~visual perception,GO:0007612~learning,GO:0007613~memory,GO:0007617~mating behavior,GO:0007626~locomotory behavior,GO:0008016~regulation of heart contraction,GO:0009072~aromatic amino acid family metabolic process,GO:0009416~response to light stimulus,GO:0009635~response to herbicide,GO:0009651~response to salt stress,GO:0009887~animal organ morphogenesis,GO:0010043~response to zinc ion,GO:0014823~response to activity,GO:0015842~aminergic neurotransmitter loading into synaptic vesicle,GO:0016137~glycoside metabolic process,GO:0018963~phthalate metabolic process,GO:0021987~cerebral cortex development,GO:0031667~response to nutrient levels,GO:0032355~response to estradiol,GO:0032496~response to lipopolysaccharide,GO:0033076~isoquinoline alkaloid metabolic process,GO:0035176~social behavior,GO:0035900~response to isolation stress,GO:0035902~response to immobilization stress,GO:0042214~terpene metabolic process,GO:0042416~dopamine biosynthetic process,GO:0042418~epinephrine biosynthetic process,GO:0042421~norepinephrine biosynthetic process,GO:0042423~catecholamine biosynthetic process,GO:0042462~eye photoreceptor cell development,GO:0042745~circadian sleep/wake cycle,GO:0042755~eating behavior,GO:0043434~response to peptide hormone,GO:0045471~response to ethanol,GO:0045472~response to ether,GO:0046684~response to pyrethroid,GO:0048596~embryonic camera-type eye morphogenesis,GO:0051412~response to corticosterone,GO:0051602~response to electrical stimulus,GO:0052314~phytoalexin metabolic process,GO:0071287~cellular response to manganese ion,GO:0071312~cellular response to alkaloid,GO:0071316~cellular response to nicotine,GO:0071333~cellular response to glucose stimulus,GO:0071363~cellular response to growth factor stimulus,GO:0071466~cellular response to xenobiotic stimulus,GO:1990384~hyaloid vascular plexus regression,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005790~smooth endoplasmic reticulum,GO:0008021~synaptic vesicle,GO:0009898~cytoplasmic side of plasma membrane,GO:0030424~axon,GO:0030425~dendrite,GO:0030659~cytoplasmic vesicle membrane,GO:0031410~cytoplasmic vesicle,GO:0033162~melanosome membrane,GO:0042995~cell projection,GO:0043005~neuron projection,GO:0043025~neuronal cell body,GO:0043195~terminal bouton,GO:0043204~perikaryon,GO:0045202~synapse,GO:0048471~perinuclear region of cytoplasm,	GO:0004497~monooxygenase activity,GO:0004511~tyrosine 3-monooxygenase activity,GO:0005506~iron ion binding,GO:0008198~ferrous iron binding,GO:0008199~ferric iron binding,GO:0016491~oxidoreductase activity,GO:0016597~amino acid binding,GO:0016714~oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen,GO:0019825~oxygen binding,GO:0019899~enzyme binding,GO:0019904~protein domain specific binding,GO:0034617~tetrahydrobiopterin binding,GO:0035240~dopamine binding,GO:0036094~small molecule binding,GO:0042802~identical protein binding,GO:0046872~metal ion binding,	IPR001273:ArAA_hydroxylase,IPR005962:Tyr_3_mOase,IPR018301:ArAA_hydroxylase_Fe/CU_BS,IPR019773:Tyrosine_3-monooxygenase-like,IPR019774:Aromatic-AA_hydroxylase_C,IPR021164:Tyrosine_hydroxylase_CS,IPR036329:Aro-AA_hydroxylase_C_sf,IPR036951:ArAA_hydroxylase_sf,IPR041903:Eu_TyrOH_cat,IPR045865:ACT-like_dom_sf,IPR049321:TH_ACT,	mmu00350:Tyrosine metabolism,mmu00790:Folate biosynthesis,mmu01100:Metabolic pathways,mmu04728:Dopaminergic synapse,mmu04917:Prolactin signaling pathway,mmu05012:Parkinson disease,mmu05030:Cocaine addiction,mmu05031:Amphetamine addiction,mmu05034:Alcoholism,		PIRSF000336:TH,		KW-0127~Catecholamine biosynthesis,KW-0530~Neurotransmitter biosynthesis,	KW-0539~Nucleus,KW-0770~Synapse,KW-0963~Cytoplasm,KW-0966~Cell projection,KW-0968~Cytoplasmic vesicle,				KW-0408~Iron,KW-0479~Metal-binding,	KW-0503~Monooxygenase,KW-0560~Oxidoreductase,	KW-0597~Phosphoprotein,	DOMAIN:Biopterin-dependent aromatic amino acid hydroxylase family profile,REGION:Disordered,SITE:Important for substrate specificity,
E7EXZ6	ubiquinol-cytochrome c reductase complex assembly factor 6(uqcc6)	Danio rerio			GO:0033617~mitochondrial respiratory chain complex IV assembly,GO:0034551~mitochondrial respiratory chain complex III assembly,	GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0016020~membrane,		IPR027858:BRAWNIN,						KW-0472~Membrane,KW-0496~Mitochondrion,KW-0999~Mitochondrion inner membrane,			KW-0735~Signal-anchor,KW-0812~Transmembrane,KW-1133~Transmembrane helix,				TOPO_DOM:Mitochondrial intermembrane,TOPO_DOM:Mitochondrial matrix,TRANSMEM:Helical; Signal-anchor for type II membrane protein,
P56616	ubiquitin conjugating enzyme E2 C L homeolog(ube2c.L)	Xenopus laevis			GO:0006511~ubiquitin-dependent protein catabolic process,GO:0007049~cell cycle,GO:0010458~exit from mitosis,GO:0010994~free ubiquitin chain polymerization,GO:0016567~protein ubiquitination,GO:0019538~protein metabolic process,GO:0031145~anaphase-promoting complex-dependent catabolic process,GO:0051301~cell division,GO:0070979~protein K11-linked ubiquitination,	GO:0005680~anaphase-promoting complex,	GO:0000166~nucleotide binding,GO:0004842~ubiquitin-protein transferase activity,GO:0005524~ATP binding,GO:0016740~transferase activity,GO:0061631~ubiquitin conjugating enzyme activity,	IPR000608:UBQ-conjugat_E2,IPR016135:UBQ-conjugating_enzyme/RWD,IPR023313:UBQ-conjugating_AS,	xla04120:Ubiquitin mediated proteolysis,			SM00212:UBCc,	KW-0131~Cell cycle,KW-0132~Cell division,KW-0498~Mitosis,KW-0833~Ubl conjugation pathway,					KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0808~Transferase,	KW-0832~Ubl conjugation,	ACT_SITE:Glycyl thioester intermediate,DOMAIN:UBC core,REGION:Disordered,
A3KMV5	ubiquitin like modifier activating enzyme 1(UBA1)	Bos taurus			GO:0006511~ubiquitin-dependent protein catabolic process,GO:0006974~cellular response to DNA damage stimulus,GO:0016567~protein ubiquitination,GO:0016925~protein sumoylation,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0031510~SUMO activating enzyme complex,	GO:0004839~ubiquitin activating enzyme activity,GO:0005524~ATP binding,GO:0019948~SUMO activating enzyme activity,	IPR000011:UBQ/SUMO-activ_enz_E1-like,IPR000594:ThiF_NAD_FAD-bd,IPR018074:UBQ-activ_enz_E1_CS,IPR018075:UBQ-activ_enz_E1,IPR018965:Ub-activating_enz_E1_C,IPR019572:UBA_E1_SCCH,IPR032418:E1_FCCH,IPR032420:E1_4HB,IPR033127:UBQ-activ_enz_E1_Cys_AS,IPR035985:Ubiquitin-activating_enz,IPR038252:UBA_E1_C_sf,IPR042063:Ubi_acti_E1_SCCH,IPR042302:E1_FCCH_sf,IPR042449:Ub-E1_IAD_1,IPR045886:ThiF/MoeB/HesA,	bta04120:Ubiquitin mediated proteolysis,bta05012:Parkinson disease,bta05022:Pathways of neurodegeneration - multiple diseases,			SM00985:UBA_e1_C,	KW-0833~Ubl conjugation pathway,	KW-0496~Mitochondrion,KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0677~Repeat,	KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0436~Ligase,	KW-0007~Acetylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,	ACT_SITE:Glycyl thioester intermediate,DOMAIN:Ubiquitin-activating enzyme E1 C-terminal,REGION:2 approximate repeats,REGION:Disordered,REPEAT:1-1,REPEAT:1-2,
P57080	ubiquitin specific peptidase 25(Usp25)	Mus musculus			GO:0001816~cytokine production,GO:0006508~proteolysis,GO:0006511~ubiquitin-dependent protein catabolic process,GO:0006955~immune response,GO:0006979~response to oxidative stress,GO:0007252~I-kappaB phosphorylation,GO:0016071~mRNA metabolic process,GO:0016579~protein deubiquitination,GO:0031098~stress-activated protein kinase signaling cascade,GO:0031647~regulation of protein stability,GO:0032602~chemokine production,GO:0070536~protein K63-linked deubiquitination,GO:0071108~protein K48-linked deubiquitination,GO:0097400~interleukin-17-mediated signaling pathway,GO:1904293~negative regulation of ERAD pathway,	GO:0000502~proteasome complex,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005783~endoplasmic reticulum,GO:0005829~cytosol,	GO:0004843~thiol-dependent ubiquitin-specific protease activity,GO:0008233~peptidase activity,GO:0008234~cysteine-type peptidase activity,GO:0016787~hydrolase activity,GO:0031625~ubiquitin protein ligase binding,GO:0032183~SUMO binding,GO:0051117~ATPase binding,	IPR001394:Peptidase_C19_UCH,IPR003903:UIM_dom,IPR009060:UBA-like_sf,IPR018200:USP_CS,IPR028889:USP_dom,IPR038765:Papain-like_cys_pep_sf,	mmu04657:IL-17 signaling pathway,			SM00726:UIM,	KW-0833~Ubl conjugation pathway,	KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0175~Coiled coil,KW-0677~Repeat,		KW-0378~Hydrolase,KW-0645~Protease,KW-0788~Thiol protease,	KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	ACT_SITE:Nucleophile,ACT_SITE:Proton acceptor,COMPBIAS:Polar residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate,DOMAIN:UBA-like,DOMAIN:UIM 1,DOMAIN:UIM 2,DOMAIN:USP,MOTIF:Required for SUMO paralog-specific binding,REGION:Disordered,REGION:SUMO interaction domain (SIM),
Q70EL4	ubiquitin specific peptidase 43(USP43)	Homo sapiens			GO:0006508~proteolysis,GO:0019985~translesion synthesis,	GO:0005654~nucleoplasm,	GO:0004843~thiol-dependent ubiquitin-specific protease activity,GO:0019785~ISG15-specific protease activity,	IPR001394:Peptidase_C19_UCH,IPR018200:USP_CS,IPR028889:USP_dom,IPR038765:Papain-like_cys_pep_sf,					KW-0833~Ubl conjugation pathway,						KW-0378~Hydrolase,KW-0645~Protease,KW-0788~Thiol protease,	KW-0488~Methylation,KW-0597~Phosphoprotein,	ACT_SITE:Nucleophile,ACT_SITE:Proton acceptor,COMPBIAS:Polar residues,COMPBIAS:Pro residues,DOMAIN:USP,REGION:Disordered,
Q08BH7	ubiquitin-conjugating enzyme E2T (putative)(ube2t)	Danio rerio			GO:0000209~protein polyubiquitination,GO:0006281~DNA repair,GO:0006513~protein monoubiquitination,GO:0006974~cellular response to DNA damage stimulus,GO:0051865~protein autoubiquitination,	GO:0005634~nucleus,	GO:0000166~nucleotide binding,GO:0003682~chromatin binding,GO:0004842~ubiquitin-protein transferase activity,GO:0005524~ATP binding,GO:0016740~transferase activity,GO:0061631~ubiquitin conjugating enzyme activity,	IPR000608:UBQ-conjugat_E2,IPR016135:UBQ-conjugating_enzyme/RWD,IPR023313:UBQ-conjugating_AS,	dre03460:Fanconi anemia pathway,			SM00212:UBCc,	KW-0227~DNA damage,KW-0234~DNA repair,KW-0833~Ubl conjugation pathway,	KW-0539~Nucleus,				KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0808~Transferase,		ACT_SITE:Glycyl thioester intermediate,DOMAIN:UBC core,REGION:Disordered,
B9ENM6	ubiquitin-fold modifier 1(ufm1)	Salmo salar			GO:0034976~response to endoplasmic reticulum stress,GO:0061709~reticulophagy,GO:0071569~protein ufmylation,GO:1990592~protein K69-linked ufmylation,	GO:0005634~nucleus,GO:0005737~cytoplasm,		IPR005375:UFM1,IPR029071:Ubiquitin-like_domsf,			PIRSF038027:Ubiquitin-like_Ufm1,		KW-0833~Ubl conjugation pathway,	KW-0539~Nucleus,KW-0963~Cytoplasm,						KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	CROSSLNK:Glycyl lysine isopeptide (Gly-Lys) (interchain with K-? in acceptor proteins),CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in UFM1),PROPEP:Removed in mature form,REGION:Disordered,
Q9Z1N9	unc-13 homolog B(Unc13b)	Mus musculus			GO:0006887~exocytosis,GO:0007268~chemical synaptic transmission,GO:0007528~neuromuscular junction development,GO:0010808~positive regulation of synaptic vesicle priming,GO:0016079~synaptic vesicle exocytosis,GO:0016081~synaptic vesicle docking,GO:0016082~synaptic vesicle priming,GO:0016188~synaptic vesicle maturation,GO:0031914~negative regulation of synaptic plasticity,GO:0035249~synaptic transmission, glutamatergic,GO:0043065~positive regulation of apoptotic process,GO:0045921~positive regulation of exocytosis,GO:0048172~regulation of short-term neuronal synaptic plasticity,GO:0050714~positive regulation of protein secretion,GO:0050804~modulation of synaptic transmission,GO:0060384~innervation,GO:0060478~acrosomal vesicle exocytosis,GO:0061669~spontaneous neurotransmitter secretion,GO:0061789~dense core granule priming,GO:0071333~cellular response to glucose stimulus,GO:0090382~phagosome maturation,GO:0097151~positive regulation of inhibitory postsynaptic potential,GO:0099011~neuronal dense core vesicle exocytosis,GO:0099525~presynaptic dense core vesicle exocytosis,GO:1900426~positive regulation of defense response to bacterium,	GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0030672~synaptic vesicle membrane,GO:0031594~neuromuscular junction,GO:0032009~early phagosome,GO:0042734~presynaptic membrane,GO:0043195~terminal bouton,GO:0044305~calyx of Held,GO:0045202~synapse,GO:0048786~presynaptic active zone,GO:0097060~synaptic membrane,GO:0097470~ribbon synapse,GO:0098686~hippocampal mossy fiber to CA3 synapse,GO:0098793~presynapse,GO:0098831~presynaptic active zone cytoplasmic component,GO:0098978~glutamatergic synapse,	GO:0001566~non-kinase phorbol ester receptor activity,GO:0005509~calcium ion binding,GO:0005516~calmodulin binding,GO:0005543~phospholipid binding,GO:0017075~syntaxin-1 binding,GO:0019905~syntaxin binding,GO:0019992~diacylglycerol binding,GO:0030742~GTP-dependent protein binding,GO:0046872~metal ion binding,	IPR000008:C2_dom,IPR002219:PE/DAG-bd,IPR010439:MUN_dom,IPR014770:Munc13_1,IPR014772:Munc13_dom-2,IPR020454:DAG/PE-bd,IPR027080:Unc-13,IPR035892:C2_domain_sf,IPR037302:Unc-13_C2B,IPR046349:C1-like_sf,	mmu04721:Synaptic vesicle cycle,			SM00109:C1,SM00239:C2,SM01145:DUF1041,	KW-0268~Exocytosis,	KW-0333~Golgi apparatus,KW-0472~Membrane,KW-0770~Synapse,KW-0963~Cytoplasm,			KW-0175~Coiled coil,KW-0677~Repeat,KW-0863~Zinc-finger,	KW-0106~Calcium,KW-0479~Metal-binding,KW-0862~Zinc,		KW-0597~Phosphoprotein,	COMPBIAS:Acidic residues,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:C2,DOMAIN:C2 1,DOMAIN:C2 2,DOMAIN:C2 3,DOMAIN:MHD1,DOMAIN:MHD2,DOMAIN:Phorbol-ester/DAG-type,REGION:Disordered,ZN_FING:Phorbol-ester/DAG-type,
Q9P2D8	unc-79 homolog, NALCN channel complex subunit(UNC79)	Homo sapiens				GO:0005886~plasma membrane,		IPR016024:ARM-type_fold,IPR024855:UNC79,						KW-0472~Membrane,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,REGION:Disordered,TRANSMEM:Helical,
Q68DE3	upstream transcription factor family member 3(USF3)	Homo sapiens			GO:0010719~negative regulation of epithelial to mesenchymal transition,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,	GO:0005634~nucleus,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0046983~protein dimerization activity,	IPR011598:bHLH_dom,IPR036638:HLH_DNA-bd_sf,IPR048064:USF3_bHLH,				SM00353:HLH,		KW-0539~Nucleus,			KW-0175~Coiled coil,		KW-0238~DNA-binding,		COMPBIAS:Basic and acidic residues,COMPBIAS:Basic residues,COMPBIAS:Polar residues,DOMAIN:BHLH,DOMAIN:bHLH,REGION:Disordered,
P18756	v-ets avian erythroblastosis virus E26 oncogene homolog 1 L homeolog(ets1.L)	Xenopus laevis			GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0010595~positive regulation of endothelial cell migration,GO:0045765~regulation of angiogenesis,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0043565~sequence-specific DNA binding,	IPR000418:Ets_dom,IPR003118:Pointed_dom,IPR013761:SAM/pointed_sf,IPR016311:Transform_prot_C-ets,IPR036388:WH-like_DNA-bd_sf,IPR036390:WH_DNA-bd_sf,IPR041886:SAM_PNT-ETS-1,IPR045688:Ets1_N_flank,IPR046328:ETS_fam,	xla04218:Cellular senescence,		PIRSF001698:Transforming_factor_C-ets,	SM00251:SAM_PNT,SM00413:ETS,	KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,KW-0963~Cytoplasm,					KW-0238~DNA-binding,	KW-0597~Phosphoprotein,	DNA_BIND:ETS,DOMAIN:ETS,DOMAIN:PNT,REGION:Helix H4,REGION:Helix H5,REGION:Helix HI-1,REGION:Helix HI-2,
P53450	v-fos FBJ murine osteosarcoma viral oncogene homolog Ab(fosab)	Takifugu rubripes			GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0033555~multicellular organismal response to stress,GO:0061026~cardiac muscle tissue regeneration,	GO:0005634~nucleus,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0003677~DNA binding,GO:0003690~double-stranded DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,	IPR000837:AP-1,IPR004827:bZIP,IPR046347:bZIP_sf,	tru04010:MAPK signaling pathway,tru04210:Apoptosis,tru04620:Toll-like receptor signaling pathway,tru05132:Salmonella infection,			SM00338:BRLZ,		KW-0539~Nucleus,		KW-0656~Proto-oncogene,			KW-0238~DNA-binding,	KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:BZIP,DOMAIN:bZIP,REGION:Basic motif,REGION:Disordered,REGION:Leucine-zipper,
O54790	v-maf musculoaponeurotic fibrosarcoma oncogene family, protein G (avian)(Mafg)	Mus musculus		m_arenrf2Pathway:Oxidative Stress Induced Gene Expression Via Nrf2,	GO:0001701~in utero embryonic development,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0010628~positive regulation of gene expression,GO:0030534~adult behavior,GO:0030641~regulation of cellular pH,GO:0042127~regulation of cell proliferation,GO:0045604~regulation of epidermal cell differentiation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,	GO:0005634~nucleus,GO:0005667~transcription factor complex,GO:0016020~membrane,GO:0090575~RNA polymerase II transcription factor complex,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0042802~identical protein binding,GO:1990837~sequence-specific double-stranded DNA binding,	IPR004826:bZIP_Maf,IPR004827:bZIP,IPR008917:TF_DNA-bd_sf,IPR024874:Transcription_factor_Maf_fam,IPR046347:bZIP_sf,				SM00338:BRLZ,	KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0472~Membrane,KW-0539~Nucleus,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0238~DNA-binding,KW-0678~Repressor,	KW-0007~Acetylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate,DOMAIN:bZIP,REGION:Basic motif,REGION:Disordered,REGION:Leucine-zipper,TRANSMEM:Helical,
P49696	valyl-tRNA synthetase 1(vars1)	Takifugu rubripes			GO:0006438~valyl-tRNA aminoacylation,	GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0002161~aminoacyl-tRNA editing activity,GO:0004832~valine-tRNA ligase activity,GO:0005524~ATP binding,	IPR001412:aa-tRNA-synth_I_CS,IPR002300:aa-tRNA-synth_Ia,IPR002303:Valyl-tRNA_ligase,IPR004046:GST_C,IPR009008:Val/Leu/Ile-tRNA-synth_edit,IPR009080:tRNAsynth_Ia_anticodon-bd,IPR010978:tRNA-bd_arm,IPR010987:Glutathione-S-Trfase_C-like,IPR013155:M/V/L/I-tRNA-synth_anticd-bd,IPR014729:Rossmann-like_a/b/a_fold,IPR019499:Val-tRNA_synth_tRNA-bd,IPR033705:Anticodon_Ia_Val,IPR036282:Glutathione-S-Trfase_C_sf,IPR037118:Val-tRNA_synth_C_sf,	tru00970:Aminoacyl-tRNA biosynthesis,				KW-0648~Protein biosynthesis,				KW-0175~Coiled coil,	KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0030~Aminoacyl-tRNA synthetase,KW-0436~Ligase,		DOMAIN:Aminoacyl-tRNA synthetase class Ia,DOMAIN:GST C-terminal,DOMAIN:Methionyl/Valyl/Leucyl/Isoleucyl-tRNA synthetase anticodon-binding,MOTIF:'HIGH' region,MOTIF:'KMSKS' region,REGION:Disordered,
P49767	vascular endothelial growth factor C(VEGFC)	Homo sapiens			GO:0001666~response to hypoxia,GO:0001934~positive regulation of protein phosphorylation,GO:0001938~positive regulation of endothelial cell proliferation,GO:0002040~sprouting angiogenesis,GO:0002052~positive regulation of neuroblast proliferation,GO:0006929~substrate-dependent cell migration,GO:0007165~signal transduction,GO:0008284~positive regulation of cell proliferation,GO:0009410~response to xenobiotic stimulus,GO:0009887~animal organ morphogenesis,GO:0014009~glial cell proliferation,GO:0016331~morphogenesis of embryonic epithelium,GO:0030947~regulation of vascular endothelial growth factor receptor signaling pathway,GO:0031954~positive regulation of protein autophosphorylation,GO:0038084~vascular endothelial growth factor signaling pathway,GO:0043536~positive regulation of blood vessel endothelial cell migration,GO:0045668~negative regulation of osteoblast differentiation,GO:0045766~positive regulation of angiogenesis,GO:0045776~negative regulation of blood pressure,GO:0048010~vascular endothelial growth factor receptor signaling pathway,GO:0050714~positive regulation of protein secretion,GO:0050918~positive chemotaxis,GO:0050930~induction of positive chemotaxis,GO:0051781~positive regulation of cell division,GO:0060252~positive regulation of glial cell proliferation,GO:0060754~positive regulation of mast cell chemotaxis,GO:1901492~positive regulation of lymphangiogenesis,GO:1902462~positive regulation of mesenchymal stem cell proliferation,GO:1990830~cellular response to leukemia inhibitory factor,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0016020~membrane,GO:0031093~platelet alpha granule lumen,	GO:0005172~vascular endothelial growth factor receptor binding,GO:0005515~protein binding,GO:0008083~growth factor activity,GO:0042056~chemoattractant activity,GO:0043185~vascular endothelial growth factor receptor 3 binding,	IPR000072:PDGF/VEGF_dom,IPR004153:CXCXC_repeat,IPR023581:PD_growth_factor_CS,IPR029034:Cystine-knot_cytokine,	hsa04010:MAPK signaling pathway,hsa04014:Ras signaling pathway,hsa04015:Rap1 signaling pathway,hsa04020:Calcium signaling pathway,hsa04151:PI3K-Akt signaling pathway,hsa04510:Focal adhesion,hsa04668:TNF signaling pathway,hsa04926:Relaxin signaling pathway,hsa04933:AGE-RAGE signaling pathway in diabetic complications,hsa05200:Pathways in cancer,	615907~Lymphatic malformation 4,		SM00141:PDGF,	KW-0037~Angiogenesis,KW-0221~Differentiation,	KW-0964~Secreted,			KW-0677~Repeat,KW-0732~Signal,		KW-0217~Developmental protein,KW-0339~Growth factor,KW-0497~Mitogen,KW-9996~Developmental protein,	KW-0165~Cleavage on pair of basic residues,KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DISULFID:Interchain,DOMAIN:Platelet-derived growth factor (PDGF) family profile,MUTAGEN:R->S: No proteolytic processing and lower effect on VEGFR-2 and VEGFR-3.,PROPEP:Or 102,REGION:4 X 16 AA repeats of C-X(10)-C-X-C-X(1,3)-C,REPEAT:1,REPEAT:2,REPEAT:3,REPEAT:4,
P81004	voltage-dependent anion channel 2 S homeolog(vdac2.S)	Xenopus laevis			GO:0055085~transmembrane transport,GO:0098656~anion transmembrane transport,	GO:0005741~mitochondrial outer membrane,GO:0016020~membrane,GO:0043227~membrane-bounded organelle,GO:0046930~pore complex,	GO:0000166~nucleotide binding,GO:0008308~voltage-gated anion channel activity,GO:0015288~porin activity,	IPR001925:Porin_Euk,IPR023614:Porin_dom_sf,IPR027246:Porin_Euk/Tom40,	xla04020:Calcium signaling pathway,xla04216:Ferroptosis,xla04217:Necroptosis,xla04218:Cellular senescence,xla04621:NOD-like receptor signaling pathway,				KW-0406~Ion transport,KW-0813~Transport,	KW-0472~Membrane,KW-0496~Mitochondrion,KW-1000~Mitochondrion outer membrane,			KW-0812~Transmembrane,KW-1134~Transmembrane beta strand,	KW-0520~NAD,KW-0547~Nucleotide-binding,	KW-0626~Porin,	KW-0007~Acetylation,	SITE:Involved in hexokinase binding,TRANSMEM:Beta stranded,
E7FF10	von Willebrand factor A domain containing 1(vwa1)	Danio rerio			GO:0007409~axonogenesis,GO:0014032~neural crest cell development,GO:0051124~synaptic growth at neuromuscular junction,GO:0061035~regulation of cartilage development,	GO:0005576~extracellular region,GO:0005604~basement membrane,		IPR002035:VWF_A,IPR003961:FN3_dom,IPR013783:Ig-like_fold,IPR036116:FN3_sf,IPR036465:vWFA_dom_sf,				SM00060:FN3,SM00327:VWA,		KW-0084~Basement membrane,KW-0272~Extracellular matrix,KW-0964~Secreted,			KW-0677~Repeat,KW-0732~Signal,			KW-0597~Phosphoprotein,KW-1015~Disulfide bond,	DOMAIN:Fibronectin type-III 1,DOMAIN:Fibronectin type-III 2,DOMAIN:VWFA,
Q9Y334	von Willebrand factor A domain containing 7(VWA7)	Homo sapiens				GO:0005576~extracellular region,		IPR036465:vWFA_dom_sf,						KW-0964~Secreted,			KW-0732~Signal,			KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Polar residues,DOMAIN:VWFA,REGION:Disordered,
A4QNZ7	zgc:123105(zgc:123105)	Danio rerio				GO:0005737~cytoplasm,	GO:0016491~oxidoreductase activity,	IPR026759:P33MONOX,						KW-0963~Cytoplasm,				KW-0521~NADP,	KW-0560~Oxidoreductase,	KW-0597~Phosphoprotein,	COMPBIAS:Polar residues,REGION:Disordered,
A8WG43	zgc:172182(zgc:172182)	Danio rerio				GO:0005634~nucleus,GO:0005737~cytoplasm,		IPR043450:CCDC89-like,						KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0175~Coiled coil,
O96006	zinc finger BED-type containing 1(ZBED1)	Homo sapiens			GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0016925~protein sumoylation,GO:0044828~negative regulation by host of viral genome replication,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:1990466~protein autosumoylation,	GO:0000785~chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005813~centrosome,GO:0016605~PML body,GO:0031965~nuclear membrane,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003677~DNA binding,GO:0003712~transcription cofactor activity,GO:0003713~transcription coactivator activity,GO:0005515~protein binding,GO:0019789~SUMO transferase activity,GO:0042802~identical protein binding,GO:0043565~sequence-specific DNA binding,GO:0046872~metal ion binding,GO:0046983~protein dimerization activity,GO:0061665~SUMO ligase activity,GO:1990837~sequence-specific double-stranded DNA binding,	IPR003656:Znf_BED,IPR008906:HATC_C_dom,IPR012337:RNaseH-like_sf,IPR036236:Znf_C2H2_sf,				SM00614:ZnF_BED,	KW-0804~Transcription,KW-0805~Transcription regulation,KW-0833~Ubl conjugation pathway,KW-0945~Host-virus interaction,	KW-0539~Nucleus,			KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0238~DNA-binding,KW-0808~Transferase,	KW-0832~Ubl conjugation,	DOMAIN:BED-type,MOTIF:Nuclear localization signal,MUTAGEN:C->A: Abolishes autosumoylation.,MUTAGEN:ER->AA: No effect on homodimerization or nuclear localization.,MUTAGEN:F->A: No effect on homodimerization or nuclear localization.,MUTAGEN:H->A: Abolishes autosumoylation.,MUTAGEN:KK->AA: Abolishes nuclear localization, however has no effect on homodimerization; when associated with A-534.,MUTAGEN:LL->AA: Abolishes homodimerization and nuclear localization. Abolishes homodimerization, multimerization, nuclear localization, and DNA binding activity; when associated with A-604-A-A-605. Abolishes interaction with SUMO1 and reduces sumoylation of CHD3/Mi2-alpha; when associated with 604-A-A-605.,MUTAGEN:Missing: Abolishes interaction with SUMO1.,MUTAGEN:P->A: No effect on homodimerization or nuclear localization.,MUTAGEN:R->A: Abolishes nuclear localization, however has no effect on homodimerization; when associated with A-530-A-A-531.,MUTAGEN:R->A: No effect on homodimerization or nuclear localization.,MUTAGEN:VL->AA: Reduces homodimerization and nuclear localization. Abolishes homodimerization, multimerization, nuclear localization, and DNA binding activity; when associated with A-600-A-A-601. Abolishes interaction with SUMO1 and reduces sumoylation of CHD3/Mi2-alpha; when associated with A-600-A-A-601.,MUTAGEN:WW->AA: Abolishes homodimerization, multimerization, interaction with KPNB1, nuclear localization and DNA binding activity. Abolishes interaction with SUMO1 and reduces SUMOylation of CHD3/Mi2-alpha.,REGION:Required for DNA binding,REGION:Required for interaction with human adenovirus early E1A protein,REGION:Required for nuclear localization and homodimerization,REGION:Required for the formation of higher order complexes of ZBED1 with consensus DNA binding sequences,ZN_FING:BED-type,
Q9C0D7	zinc finger CCCH-type containing 12C(ZC3H12C)	Homo sapiens				GO:0005634~nucleus,GO:0036464~cytoplasmic ribonucleoprotein granule,	GO:0003729~mRNA binding,GO:0004519~endonuclease activity,GO:0004521~endoribonuclease activity,GO:0005515~protein binding,GO:0046872~metal ion binding,	IPR000571:Znf_CCCH,IPR021869:RNase_Zc3h12_NYN,IPR040546:Rege-1_UBA-like,IPR040757:Regnase_1/ZC3H12_C,									KW-0863~Zinc-finger,	KW-0460~Magnesium,KW-0479~Metal-binding,KW-0862~Zinc,	KW-0255~Endonuclease,KW-0378~Hydrolase,KW-0540~Nuclease,	KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:C3H1-type,DOMAIN:RNase NYN,REGION:Disordered,ZN_FING:C3H1-type,
Q9UGR2	zinc finger CCCH-type containing 7B(ZC3H7B)	Homo sapiens			GO:0010608~posttranscriptional regulation of gene expression,GO:0035196~production of miRNAs involved in gene silencing by miRNA,	GO:0005634~nucleus,	GO:0003723~RNA binding,GO:0005515~protein binding,GO:0035198~miRNA binding,GO:0046872~metal ion binding,	IPR000571:Znf_CCCH,IPR011990:TPR-like_helical_dom_sf,IPR019734:TPR_repeat,IPR036236:Znf_C2H2_sf,IPR036855:Znf_CCCH_sf,IPR039691:ZC3H7A/B,				SM00028:TPR,SM00356:ZnF_C3H1,	KW-0945~Host-virus interaction,	KW-0539~Nucleus,			KW-0677~Repeat,KW-0802~TPR repeat,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,		KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,MOTIF:LD motif; interaction with NSP3,MUTAGEN:DSS->AAA: Almost no effect on NSP3 binding.,MUTAGEN:LDD->AAA: Complete loss of NSP3 binding.,REGION:Disordered,REPEAT:TPR 1,REPEAT:TPR 2,REPEAT:TPR 3,ZN_FING:C2H2-type,ZN_FING:C3H1-type 1,ZN_FING:C3H1-type 2,ZN_FING:C3H1-type 3,ZN_FING:C3H1-type 4,
Q66IH9	zinc finger CCHC-type containing 4(zcchc4)	Xenopus tropicalis			GO:0031167~rRNA methylation,GO:0032259~methylation,GO:0045727~positive regulation of translation,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005737~cytoplasm,	GO:0003676~nucleic acid binding,GO:0008168~methyltransferase activity,GO:0008270~zinc ion binding,GO:0008988~rRNA (adenine-N6-)-methyltransferase activity,GO:0016740~transferase activity,GO:0046872~metal ion binding,GO:1904047~S-adenosyl-L-methionine binding,	IPR002052:DNA_methylase_N6_adenine_CS,IPR010666:Znf_GRF,IPR039846:ZCCHC4,IPR041370:Mlase_EEF1AKMT1/ZCCHC4,						KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,KW-0949~S-adenosyl-L-methionine,	KW-0489~Methyltransferase,KW-0808~Transferase,		DOMAIN:DHHC,DOMAIN:GRF-type,REGION:Disordered,REGION:Regulatory loop,ZN_FING:CCHC-type,ZN_FING:GRF-type,
Q5RFL4	zinc finger FYVE-type containing 1(ZFYVE1)	Pongo abelii			GO:0009267~cellular response to starvation,GO:0016236~macroautophagy,GO:0044829~positive regulation by host of viral genome replication,	GO:0000407~pre-autophagosomal structure,GO:0005739~mitochondrion,GO:0005776~autophagosome,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005794~Golgi apparatus,GO:0005795~Golgi stack,GO:0005811~lipid particle,GO:0044233~ER-mitochondrion membrane contact site,GO:0048471~perinuclear region of cytoplasm,GO:0097629~extrinsic component of omegasome membrane,GO:1990462~omegasome,	GO:0005545~1-phosphatidylinositol binding,GO:0005547~phosphatidylinositol-3,4,5-trisphosphate binding,GO:0032266~phosphatidylinositol-3-phosphate binding,GO:0043325~phosphatidylinositol-3,4-bisphosphate binding,GO:0046872~metal ion binding,	IPR000306:Znf_FYVE,IPR009030:Growth_fac_rcpt_cys_sf,IPR011011:Znf_FYVE_PHD,IPR013083:Znf_RING/FYVE/PHD,IPR017455:Znf_FYVE-rel,IPR027417:P-loop_NTPase,IPR042427:ZFYV1,IPR047855:ZFYVE1_second_BBox1,IPR047856:ZFYVE1_first_BBox1,	pon04140:Autophagy - animal,pon05022:Pathways of neurodegeneration - multiple diseases,			SM00064:FYVE,		KW-0256~Endoplasmic reticulum,KW-0333~Golgi apparatus,KW-0496~Mitochondrion,KW-0551~Lipid droplet,			KW-0677~Repeat,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,			DOMAIN:FYVE-type,REGION:Required for localization in the lipid droplets,ZN_FING:FYVE-type 1,ZN_FING:FYVE-type 2,
Q8TBF5	zinc finger protein 177(ZNF177)	Homo sapiens			GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,	GO:0005634~nucleus,GO:0005789~endoplasmic reticulum membrane,GO:0072562~blood microparticle,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0001227~transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0005515~protein binding,GO:0046872~metal ion binding,GO:1990837~sequence-specific double-stranded DNA binding,	IPR001909:KRAB,IPR013087:Znf_C2H2_type,IPR013233:PIG-X/PBN1,IPR036051:KRAB_dom_sf,IPR036236:Znf_C2H2_sf,IPR040039:PIGX,	hsa05168:Herpes simplex virus 1 infection,			SM00349:KRAB,SM00355:ZnF_C2H2,SM00780:PIG-X,	KW-0337~GPI-anchor biosynthesis,KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0256~Endoplasmic reticulum,KW-0472~Membrane,KW-0539~Nucleus,			KW-0677~Repeat,KW-0732~Signal,KW-0812~Transmembrane,KW-0863~Zinc-finger,KW-1133~Transmembrane helix,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0238~DNA-binding,	KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Polar residues,DOMAIN:KRAB,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Lumenal,TRANSMEM:Helical,ZN_FING:C2H2-type 10,ZN_FING:C2H2-type 1; degenerate,ZN_FING:C2H2-type 2; degenerate,ZN_FING:C2H2-type 3; atypical,ZN_FING:C2H2-type 4,ZN_FING:C2H2-type 5,ZN_FING:C2H2-type 6,ZN_FING:C2H2-type 7,ZN_FING:C2H2-type 8,ZN_FING:C2H2-type 9,
O43345	zinc finger protein 208(ZNF208)	Homo sapiens			GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,	GO:0005634~nucleus,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0008270~zinc ion binding,	IPR001909:KRAB,IPR013087:Znf_C2H2_type,IPR036051:KRAB_dom_sf,IPR036236:Znf_C2H2_sf,	hsa05168:Herpes simplex virus 1 infection,			SM00349:KRAB,SM00355:ZnF_C2H2,	KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,			KW-0677~Repeat,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0238~DNA-binding,		DOMAIN:KRAB,ZN_FING:C2H2-type 10,ZN_FING:C2H2-type 11,ZN_FING:C2H2-type 12,ZN_FING:C2H2-type 13,ZN_FING:C2H2-type 14,ZN_FING:C2H2-type 15,ZN_FING:C2H2-type 16,ZN_FING:C2H2-type 17,ZN_FING:C2H2-type 18,ZN_FING:C2H2-type 19,ZN_FING:C2H2-type 1; degenerate,ZN_FING:C2H2-type 20,ZN_FING:C2H2-type 21,ZN_FING:C2H2-type 22,ZN_FING:C2H2-type 23,ZN_FING:C2H2-type 24,ZN_FING:C2H2-type 25,ZN_FING:C2H2-type 26,ZN_FING:C2H2-type 27,ZN_FING:C2H2-type 28,ZN_FING:C2H2-type 29; degenerate,ZN_FING:C2H2-type 2; degenerate,ZN_FING:C2H2-type 3,ZN_FING:C2H2-type 30,ZN_FING:C2H2-type 31,ZN_FING:C2H2-type 32,ZN_FING:C2H2-type 33,ZN_FING:C2H2-type 34,ZN_FING:C2H2-type 35,ZN_FING:C2H2-type 36,ZN_FING:C2H2-type 37,ZN_FING:C2H2-type 38,ZN_FING:C2H2-type 39,ZN_FING:C2H2-type 4,ZN_FING:C2H2-type 5,ZN_FING:C2H2-type 6,ZN_FING:C2H2-type 7,ZN_FING:C2H2-type 8,ZN_FING:C2H2-type 9,
Q9H6B1	zinc finger protein 385D(ZNF385D)	Homo sapiens				GO:0005634~nucleus,	GO:0003676~nucleic acid binding,GO:0008270~zinc ion binding,GO:1990837~sequence-specific double-stranded DNA binding,	IPR003604:Matrin/U1-like-C_Znf_C2H2,IPR013087:Znf_C2H2_type,IPR036236:Znf_C2H2_sf,				SM00355:ZnF_C2H2,SM00451:ZnF_U1,		KW-0539~Nucleus,			KW-0677~Repeat,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,			COMPBIAS:Polar residues,DOMAIN:C2H2-type,DOMAIN:U1-type,REGION:Disordered,ZN_FING:Matrin-type 1,ZN_FING:Matrin-type 2,ZN_FING:Matrin-type 3,
Q5ZMM5	zinc finger protein 706(ZNF706)	Gallus gallus			GO:0006417~regulation of translation,GO:0045892~negative regulation of transcription, DNA-templated,GO:1902455~negative regulation of stem cell population maintenance,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0046872~metal ion binding,	IPR007513:SERF-like_N,IPR013087:Znf_C2H2_type,IPR026939:ZNF706/At2g23090_sf,IPR045230:MBS1/2-like,					KW-0810~Translation regulation,	KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0678~Repressor,		COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,REGION:Disordered,ZN_FING:C2H2-type,
O43345	zinc finger protein 728(ZNF728)	Homo sapiens			GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,	GO:0005634~nucleus,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003677~DNA binding,GO:0008270~zinc ion binding,GO:0046872~metal ion binding,	IPR001909:KRAB,IPR013087:Znf_C2H2_type,IPR036051:KRAB_dom_sf,IPR036236:Znf_C2H2_sf,IPR039938:Sp4-like,	hsa05168:Herpes simplex virus 1 infection,			SM00349:KRAB,SM00355:ZnF_C2H2,	KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,			KW-0677~Repeat,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0238~DNA-binding,		DOMAIN:KRAB,ZN_FING:C2H2-type 1,ZN_FING:C2H2-type 10,ZN_FING:C2H2-type 11,ZN_FING:C2H2-type 12,ZN_FING:C2H2-type 13,ZN_FING:C2H2-type 14,ZN_FING:C2H2-type 15,ZN_FING:C2H2-type 16,ZN_FING:C2H2-type 17,ZN_FING:C2H2-type 18,ZN_FING:C2H2-type 19,ZN_FING:C2H2-type 1; degenerate,ZN_FING:C2H2-type 2,ZN_FING:C2H2-type 20,ZN_FING:C2H2-type 21,ZN_FING:C2H2-type 22,ZN_FING:C2H2-type 23,ZN_FING:C2H2-type 24,ZN_FING:C2H2-type 25,ZN_FING:C2H2-type 26,ZN_FING:C2H2-type 27,ZN_FING:C2H2-type 28,ZN_FING:C2H2-type 29; degenerate,ZN_FING:C2H2-type 2; degenerate,ZN_FING:C2H2-type 3,ZN_FING:C2H2-type 30,ZN_FING:C2H2-type 31,ZN_FING:C2H2-type 32,ZN_FING:C2H2-type 33,ZN_FING:C2H2-type 34,ZN_FING:C2H2-type 35,ZN_FING:C2H2-type 36,ZN_FING:C2H2-type 37,ZN_FING:C2H2-type 38,ZN_FING:C2H2-type 39,ZN_FING:C2H2-type 4,ZN_FING:C2H2-type 5,ZN_FING:C2H2-type 6,ZN_FING:C2H2-type 7,ZN_FING:C2H2-type 8,ZN_FING:C2H2-type 9,
Q6ZMW2	zinc finger protein 782(ZNF782)	Homo sapiens			GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,	GO:0005634~nucleus,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0046872~metal ion binding,	IPR001909:KRAB,IPR013087:Znf_C2H2_type,IPR036051:KRAB_dom_sf,IPR036236:Znf_C2H2_sf,	hsa05168:Herpes simplex virus 1 infection,			SM00349:KRAB,SM00355:ZnF_C2H2,	KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,			KW-0677~Repeat,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0238~DNA-binding,		DOMAIN:KRAB,REGION:Disordered,ZN_FING:C2H2-type 10,ZN_FING:C2H2-type 11,ZN_FING:C2H2-type 12,ZN_FING:C2H2-type 13,ZN_FING:C2H2-type 14,ZN_FING:C2H2-type 15,ZN_FING:C2H2-type 1; degenerate,ZN_FING:C2H2-type 2; degenerate,ZN_FING:C2H2-type 3; degenerate,ZN_FING:C2H2-type 4; degenerate,ZN_FING:C2H2-type 5,ZN_FING:C2H2-type 6,ZN_FING:C2H2-type 7,ZN_FING:C2H2-type 8,ZN_FING:C2H2-type 9,
E9QAG8	zinc finger protein 932(Zfp932)	Mus musculus			GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0030154~cell differentiation,GO:0043433~negative regulation of sequence-specific DNA binding transcription factor activity,GO:0045668~negative regulation of osteoblast differentiation,	GO:0005634~nucleus,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0003682~chromatin binding,GO:0005515~protein binding,GO:0042826~histone deacetylase binding,GO:0046872~metal ion binding,	IPR001909:KRAB,IPR013087:Znf_C2H2_type,IPR036051:KRAB_dom_sf,IPR036236:Znf_C2H2_sf,				SM00349:KRAB,SM00355:ZnF_C2H2,	KW-0221~Differentiation,KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,			KW-0677~Repeat,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0238~DNA-binding,KW-0678~Repressor,		DOMAIN:C2H2-type,DOMAIN:KRAB,ZN_FING:C2H2-type 1,ZN_FING:C2H2-type 10,ZN_FING:C2H2-type 11,ZN_FING:C2H2-type 12,ZN_FING:C2H2-type 13,ZN_FING:C2H2-type 14,ZN_FING:C2H2-type 15,ZN_FING:C2H2-type 2,ZN_FING:C2H2-type 3,ZN_FING:C2H2-type 4,ZN_FING:C2H2-type 5,ZN_FING:C2H2-type 6,ZN_FING:C2H2-type 7,ZN_FING:C2H2-type 8,ZN_FING:C2H2-type 9,
Q8WW38	zinc finger protein, FOG family member 2(ZFPM2)	Homo sapiens			GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001570~vasculogenesis,GO:0001701~in utero embryonic development,GO:0003148~outflow tract septum morphogenesis,GO:0003221~right ventricular cardiac muscle tissue morphogenesis,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0007506~gonadal mesoderm development,GO:0007507~heart development,GO:0009653~anatomical structure morphogenesis,GO:0030154~cell differentiation,GO:0030324~lung development,GO:0045444~fat cell differentiation,GO:0045599~negative regulation of fat cell differentiation,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048568~embryonic organ development,GO:0060045~positive regulation of cardiac muscle cell proliferation,GO:0060412~ventricular septum morphogenesis,GO:2000020~positive regulation of male gonad development,GO:2000195~negative regulation of female gonad development,	GO:0000785~chromatin,GO:0001673~male germ cell nucleus,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,	GO:0003677~DNA binding,GO:0003713~transcription coactivator activity,GO:0003714~transcription corepressor activity,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0046872~metal ion binding,GO:0061629~RNA polymerase II sequence-specific DNA binding transcription factor binding,	IPR013087:Znf_C2H2_type,IPR034731:ZF_CCHC_FOG,IPR036236:Znf_C2H2_sf,IPR039746:FOG,IPR049361:ZFPM1/2_PR,	hsa05206:MicroRNAs in cancer,	187500~Tetralogy of Fallot,610187~Diaphragmatic hernia 3,616067~46XY sex reversal 9,		SM00355:ZnF_C2H2,	KW-0221~Differentiation,KW-0334~Gonadal differentiation,KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,		KW-0122~Cardiomyopathy,KW-0225~Disease variant,	KW-0677~Repeat,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0010~Activator,KW-0238~DNA-binding,KW-0678~Repressor,	KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1),CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),DOMAIN:C2H2-type,DOMAIN:CCHC FOG-type,MOTIF:Nuclear localization signal,REGION:Disordered,REGION:Interaction with CTBP2,ZN_FING:C2H2-type 1,ZN_FING:C2H2-type 2,ZN_FING:C2H2-type 3,ZN_FING:CCHC FOG-type 1,ZN_FING:CCHC FOG-type 2,ZN_FING:CCHC FOG-type 3,ZN_FING:CCHC FOG-type 4,ZN_FING:CCHC FOG-type 5,
Q8R151	zinc finger, NFX1-type containing 1(Znfx1)	Mus musculus			GO:0002218~activation of innate immune response,GO:0002376~immune system process,GO:0031048~chromatin silencing by small RNA,GO:0042742~defense response to bacterium,GO:0045071~negative regulation of viral genome replication,GO:0045087~innate immune response,GO:0051607~defense response to virus,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005741~mitochondrial outer membrane,GO:0010494~cytoplasmic stress granule,GO:0016020~membrane,GO:0031380~nuclear RNA-directed RNA polymerase complex,	GO:0003723~RNA binding,GO:0004386~helicase activity,GO:0008270~zinc ion binding,GO:0046872~metal ion binding,	IPR000967:Znf_NFX1,IPR027417:P-loop_NTPase,IPR041677:DNA2/NAM7_AAA_11,IPR041679:DNA2/NAM7-like_C,IPR045055:DNA2/NAM7-like,IPR046439:ZF_RZ_dom,IPR047187:SF1_C_Upf1,				SM00438:ZnF_NFX,	KW-0051~Antiviral defense,KW-0391~Immunity,KW-0399~Innate immunity,	KW-0472~Membrane,KW-0496~Mitochondrion,KW-0963~Cytoplasm,KW-1000~Mitochondrion outer membrane,			KW-0175~Coiled coil,KW-0677~Repeat,KW-0732~Signal,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0694~RNA-binding,		COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:DNA2/NAM7 helicase helicase,DOMAIN:RZ-type,REGION:Disordered,ZN_FING:NF-X1-type 1,ZN_FING:NF-X1-type 2,ZN_FING:NF-X1-type 3,ZN_FING:NF-X1-type 4,ZN_FING:RZ-type,
Q6QQT1	zinc transporter ZIP1-like(LOC115251996)	Takifugu rubripes			GO:0006829~zinc II ion transport,GO:0071577~zinc II ion transmembrane transport,	GO:0005789~endoplasmic reticulum membrane,GO:0005886~plasma membrane,GO:0016020~membrane,	GO:0005385~zinc ion transmembrane transporter activity,GO:0008270~zinc ion binding,GO:0046873~metal ion transmembrane transporter activity,	IPR003689:ZIP,					KW-0406~Ion transport,KW-0813~Transport,KW-0864~Zinc transport,	KW-0256~Endoplasmic reticulum,KW-0472~Membrane,KW-1003~Cell membrane,			KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0862~Zinc,			REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
I6M4H4	zona pellucida glycoprotein 1(ZP1)	Oryctolagus cuniculus			GO:0007338~single fertilization,GO:0007339~binding of sperm to zona pellucida,GO:0060468~prevention of polyspermy,	GO:0005576~extracellular region,GO:0005886~plasma membrane,GO:0035805~egg coat,	GO:0032190~acrosin binding,GO:0035804~structural constituent of egg coat,	IPR000519:P_trefoil_dom,IPR001507:ZP_dom,IPR017957:P_trefoil_CS,IPR042235:ZP-C,IPR044913:P_trefoil_dom_sf,IPR048290:ZP_chr,				SM00018:PD,SM00241:ZP,	KW-0278~Fertilization,	KW-0272~Extracellular matrix,KW-0472~Membrane,KW-0964~Secreted,KW-1003~Cell membrane,			KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0165~Cleavage on pair of basic residues,KW-0325~Glycoprotein,KW-0873~Pyrrolidone carboxylic acid,KW-1015~Disulfide bond,	DOMAIN:P-type,DOMAIN:ZP,PROPEP:Removed in mature form,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
P79762	zona pellucida sperm-binding protein 3(ZP3)	Gallus gallus			GO:0007339~binding of sperm to zona pellucida,GO:0032570~response to progesterone,GO:0033574~response to testosterone,GO:0035803~egg coat formation,GO:2000344~positive regulation of acrosome reaction,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005886~plasma membrane,GO:0031012~extracellular matrix,GO:0035805~egg coat,GO:0045177~apical part of cell,	GO:0032190~acrosin binding,GO:0035804~structural constituent of egg coat,GO:0042802~identical protein binding,	IPR001507:ZP_dom,IPR017977:ZP_dom_CS,IPR042235:ZP-C,IPR048290:ZP_chr,				SM00241:ZP,	KW-0278~Fertilization,	KW-0272~Extracellular matrix,KW-0472~Membrane,KW-0964~Secreted,KW-1003~Cell membrane,			KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0165~Cleavage on pair of basic residues,KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,CARBOHYD:O-linked (GalNAc...) threonine,COMPBIAS:Polar residues,DOMAIN:ZP,MUTAGEN:C->A: Abolishes secretion of processed zona pellucida sperm-binding protein 3; when associated with A-111.,MUTAGEN:C->A: Abolishes secretion of processed zona pellucida sperm-binding protein 3; when associated with A-152.,MUTAGEN:C->A: Abolishes secretion of processed zona pellucida sperm-binding protein 3; when associated with A-251.,MUTAGEN:C->A: Abolishes secretion of processed zona pellucida sperm-binding protein 3; when associated with A-313.,MUTAGEN:C->A: Abolishes secretion of processed zona pellucida sperm-binding protein 3; when associated with A-332.,MUTAGEN:C->A: Abolishes secretion of processed zona pellucida sperm-binding protein 3; when associated with A-334.,MUTAGEN:C->A: Abolishes secretion of processed zona pellucida sperm-binding protein 3; when associated with A-335.,MUTAGEN:C->A: Abolishes secretion of processed zona pellucida sperm-binding protein 3; when associated with A-340.,MUTAGEN:C->A: Abolishes secretion of processed zona pellucida sperm-binding protein 3; when associated with A-58.,MUTAGEN:C->A: Abolishes secretion of processed zona pellucida sperm-binding protein 3; when associated with A-90.,MUTAGEN:C->A: Impaired secretion of processed zona pellucida sperm-binding protein 3; when associated with A-229.,MUTAGEN:C->A: Impaired secretion of processed zona pellucida sperm-binding protein 3; when associated with A-295.,MUTAGEN:E->A: No effect on secretion.,MUTAGEN:N->Q: Loss of N-glycosylation.,MUTAGEN:P->A: No effect on dimerization or secretion.,MUTAGEN:P->D: Abolishes secretion of processed zona pellucida sperm-binding protein 3.,MUTAGEN:R->A: Impaired homodimerization and abolished secretion of processed zona pellucida sperm-binding protein 3.,MUTAGEN:RFRR->AFAA: Abolishes cleavage of C-terminal propeptide.,MUTAGEN:T->A: Loss of O-glycosylation. No effect on secretion. Reduces binding to the sperm head by about 80%.,MUTAGEN:Y->A: Abolishes secretion of processed zona pellucida sperm-binding protein 3.,PROPEP:Removed in mature form,REGION:Disordered,REGION:Extracellular hydrophobic patch,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
A5WWB6	zwilch kinetochore protein(zwilch)	Danio rerio			GO:0007049~cell cycle,GO:0007094~mitotic spindle assembly checkpoint,GO:0034501~protein localization to kinetochore,GO:0051301~cell division,	GO:0000775~chromosome, centromeric region,GO:0000776~kinetochore,GO:0005694~chromosome,GO:1990423~RZZ complex,		IPR018630:Zwilch,					KW-0131~Cell cycle,KW-0132~Cell division,KW-0498~Mitosis,	KW-0137~Centromere,KW-0158~Chromosome,KW-0995~Kinetochore,
